{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "_cell_guid": "b1076dfc-b9ad-4769-8c92-a6c4dae69d19",
    "_uuid": "8f2839f25d086af736a60e9eeb907d3b93b6e0e5"
   },
   "outputs": [],
   "source": [
    "import numpy as np \n",
    "import pandas as pd \n",
    "import os"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "# COVID-19 knowledge graph"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "Relations between chemicals, genes and disease offer insights into the mechanisms behind higher order biochemical phenomena, such as drug-drug interactions, drug response and gene-disease associations. This work focused on extracting relations between chemicals, genes and disease from research articles to build a biomedical knowledge graph related to COVID-19. We used entities collected by BioSNAP to identify instances of chemical, gene and disease names in abstracts.\n",
    "\n",
    "To understand what relationship types are possible and map unstructured natural language descriptions onto these structured classes, we used labeled sentences in Percha B 2018 to classify relations bewteen entities."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "_cell_guid": "79c7e3d0-c299-4dcb-8224-4455121ee9b0",
    "_uuid": "d629ff2d2480ee46fbb7e2d37f6b5fab8052498a"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting pyecharts\r\n",
      "  Downloading pyecharts-1.7.1-py3-none-any.whl (128 kB)\r\n",
      "\u001b[K     |████████████████████████████████| 128 kB 4.9 MB/s \r\n",
      "\u001b[?25hRequirement already satisfied: prettytable in /opt/conda/lib/python3.7/site-packages (from pyecharts) (0.7.2)\r\n",
      "Requirement already satisfied: jinja2 in /opt/conda/lib/python3.7/site-packages (from pyecharts) (2.11.2)\r\n",
      "Requirement already satisfied: simplejson in /opt/conda/lib/python3.7/site-packages (from pyecharts) (3.17.0)\r\n",
      "Requirement already satisfied: MarkupSafe>=0.23 in /opt/conda/lib/python3.7/site-packages (from jinja2->pyecharts) (1.1.1)\r\n",
      "Installing collected packages: pyecharts\r\n",
      "Successfully installed pyecharts-1.7.1\r\n",
      "\u001b[33mWARNING: You are using pip version 20.1; however, version 20.1.1 is available.\r\n",
      "You should consider upgrading via the '/opt/conda/bin/python3.7 -m pip install --upgrade pip' command.\u001b[0m\r\n"
     ]
    }
   ],
   "source": [
    "!pip install pyecharts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Using TensorFlow backend.\n"
     ]
    }
   ],
   "source": [
    "import numpy as np \n",
    "import pandas as pd\n",
    "from tqdm import tqdm_notebook as tqdm\n",
    "from pyecharts import options as opts\n",
    "from pyecharts.charts import Graph\n",
    "import torch\n",
    "import torch.nn.functional as F\n",
    "from torch.utils.data import Dataset,TensorDataset,DataLoader\n",
    "from keras.preprocessing import sequence\n",
    "from transformers import BertTokenizer, BertForSequenceClassification\n",
    "\n",
    "import os\n",
    "import warnings\n",
    "warnings.simplefilter(action='ignore', category=FutureWarning)\n",
    "warnings.filterwarnings('ignore')"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "**Load marked sentences**\n",
    "These sentences containing more than two biomedical entities were extracted from abstracts and stored in a csv file. We combined the pairwise entities in each sentence to build relations."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start_entity</th>\n",
       "      <th>end_entity</th>\n",
       "      <th>start_entity_type</th>\n",
       "      <th>end_entity_type</th>\n",
       "      <th>marked_sentence</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6660</th>\n",
       "      <td>Diabetes Mellitus</td>\n",
       "      <td>cough</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>start_entity correlated with an increased risk...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>751</th>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Paraneoplastic Syndromes, Ocular</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>As far as the retina is concerned end_entity a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16684</th>\n",
       "      <td>Bleomycin</td>\n",
       "      <td>Fibrosis</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Lemessurier, Josepha Moore, Jeoung-Eun Park, A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29058</th>\n",
       "      <td>GCNT2</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Disease</td>\n",
       "      <td>The type start_entity transmembrane serine pro...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16065</th>\n",
       "      <td>CYP2R1</td>\n",
       "      <td>Dermatitis, Contact</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Pieters A245 How to Define Chronic Cough: Base...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            start_entity                        end_entity start_entity_type  \\\n",
       "6660   Diabetes Mellitus                             cough           Disease   \n",
       "751             Melanoma  Paraneoplastic Syndromes, Ocular           Disease   \n",
       "16684          Bleomycin                          Fibrosis          Chemical   \n",
       "29058              GCNT2                          COVID-19              Gene   \n",
       "16065             CYP2R1               Dermatitis, Contact              Gene   \n",
       "\n",
       "      end_entity_type                                    marked_sentence  \n",
       "6660          Disease  start_entity correlated with an increased risk...  \n",
       "751           Disease  As far as the retina is concerned end_entity a...  \n",
       "16684         Disease  Lemessurier, Josepha Moore, Jeoung-Eun Park, A...  \n",
       "29058         Disease  The type start_entity transmembrane serine pro...  \n",
       "16065         Disease  Pieters A245 How to Define Chronic Cough: Base...  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "marked_sentence_df = pd.read_csv('/kaggle/input/covid19-knowledge-graphs-relation-files/marked_sentence/marked_sentence.csv')\n",
    "marked_sentence_df.sample(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "def Build_graph(df,relation=False,repulsion=40,title='COVID-19 knowledge graph',labelShow=False):\n",
    "    entity_type_dic = dict(df.drop_duplicates(['start_entity']).set_index(['start_entity'])['start_entity_type'])\n",
    "    entity_type_dic.update(dict(df.drop_duplicates(['end_entity']).set_index(['end_entity'])['end_entity_type']))\n",
    "    color = {'Disease':'#FF7F50','Gene':'#48D1CC','Chemical':'#B3EE3A'}\n",
    "    cate =  {'Disease':0,'Gene':1,'Chemical':2}\n",
    "    categories = [{'name':'Disease','itemStyle': {'normal': {'color': color['Disease']}}},{'name':'Gene','itemStyle': {'normal': {'color': color['Gene']}}},{'name':'Chemical','itemStyle': {'normal': {'color': color['Chemical']}}}]\n",
    "    nodes = []\n",
    "    for entity in list(set(df['start_entity'])|set(df['end_entity'])):\n",
    "        nodes.append({'name': entity, 'symbolSize': max(10,np.log1p(df.loc[(df['start_entity']==entity)|(df['end_entity']==entity)].shape[0])*10//1),\n",
    "                     'category':cate[entity_type_dic[entity]]})\n",
    "    links = []\n",
    "    for i in df.index:\n",
    "        if not relation:\n",
    "            links.append({'source': df.loc[i,'start_entity'], 'target': df.loc[i,'end_entity'],'value':df.loc[i,'marked_sentence']})\n",
    "        else:\n",
    "            links.append({'source': df.loc[i,'start_entity'], 'target': df.loc[i,'end_entity'], 'value':df.loc[i,'theme']})\n",
    "    g = (\n",
    "        Graph()\n",
    "        .add('', nodes, links,categories, repulsion=repulsion,label_opts=opts.LabelOpts(is_show=labelShow))\n",
    "        .set_global_opts(title_opts=opts.TitleOpts(title=title),legend_opts=opts.LegendOpts(orient='vertical', pos_left='2%', pos_top='40%',legend_icon='circle'))\n",
    "        .render_notebook()\n",
    "        )\n",
    "    g1 = (\n",
    "        Graph()\n",
    "        .add('', nodes, links,categories, repulsion=repulsion,label_opts=opts.LabelOpts(is_show=labelShow))\n",
    "        .set_global_opts(title_opts=opts.TitleOpts(title=title),legend_opts=opts.LegendOpts(orient='vertical', pos_left='2%', pos_top='40%',legend_icon='circle'))\n",
    "        .render(path=title+'.html')\n",
    "        )\n",
    "    return g\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<script>\n",
       "    require.config({\n",
       "        paths: {\n",
       "            'echarts':'https://assets.pyecharts.org/assets/echarts.min'\n",
       "        }\n",
       "    });\n",
       "</script>\n",
       "\n",
       "        <div id=\"ec2bfce2d9d946878a3ecea4dac819ce\" style=\"width:900px; height:500px;\"></div>\n",
       "\n",
       "<script>\n",
       "        require(['echarts'], function(echarts) {\n",
       "                var chart_ec2bfce2d9d946878a3ecea4dac819ce = echarts.init(\n",
       "                    document.getElementById('ec2bfce2d9d946878a3ecea4dac819ce'), 'white', {renderer: 'canvas'});\n",
       "                var option_ec2bfce2d9d946878a3ecea4dac819ce = {\n",
       "    \"animation\": true,\n",
       "    \"animationThreshold\": 2000,\n",
       "    \"animationDuration\": 1000,\n",
       "    \"animationEasing\": \"cubicOut\",\n",
       "    \"animationDelay\": 0,\n",
       "    \"animationDurationUpdate\": 300,\n",
       "    \"animationEasingUpdate\": \"cubicOut\",\n",
       "    \"animationDelayUpdate\": 0,\n",
       "    \"color\": [\n",
       "        \"#c23531\",\n",
       "        \"#2f4554\",\n",
       "        \"#61a0a8\",\n",
       "        \"#d48265\",\n",
       "        \"#749f83\",\n",
       "        \"#ca8622\",\n",
       "        \"#bda29a\",\n",
       "        \"#6e7074\",\n",
       "        \"#546570\",\n",
       "        \"#c4ccd3\",\n",
       "        \"#f05b72\",\n",
       "        \"#ef5b9c\",\n",
       "        \"#f47920\",\n",
       "        \"#905a3d\",\n",
       "        \"#fab27b\",\n",
       "        \"#2a5caa\",\n",
       "        \"#444693\",\n",
       "        \"#726930\",\n",
       "        \"#b2d235\",\n",
       "        \"#6d8346\",\n",
       "        \"#ac6767\",\n",
       "        \"#1d953f\",\n",
       "        \"#6950a1\",\n",
       "        \"#918597\"\n",
       "    ],\n",
       "    \"series\": [\n",
       "        {\n",
       "            \"type\": \"graph\",\n",
       "            \"layout\": \"force\",\n",
       "            \"symbolSize\": 10,\n",
       "            \"circular\": {\n",
       "                \"rotateLabel\": false\n",
       "            },\n",
       "            \"force\": {\n",
       "                \"repulsion\": 40,\n",
       "                \"edgeLength\": 50,\n",
       "                \"gravity\": 0.2\n",
       "            },\n",
       "            \"label\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"lineStyle\": {\n",
       "                \"show\": true,\n",
       "                \"width\": 1,\n",
       "                \"opacity\": 1,\n",
       "                \"curveness\": 0,\n",
       "                \"type\": \"solid\"\n",
       "            },\n",
       "            \"roam\": true,\n",
       "            \"draggable\": false,\n",
       "            \"focusNodeAdjacency\": true,\n",
       "            \"data\": [\n",
       "                {\n",
       "                    \"name\": \"GLS2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MBL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TTN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TFRC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACE2\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"diarrhea\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PORCN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TSPAN7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Newcastle Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DUSP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pranlukast\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypersensitivity, Immediate\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UXT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bronchiolitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD80\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CHM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL20\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FCGR3B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Wounds and Injuries\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ectromelia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"USP33\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MYOZ3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSF3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Familial paroxysmal dystonia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis, Contact\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL17A\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CADM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LIF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Wheat Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNL1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MERTK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CIA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PGF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Eosinophilia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSME3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SERPINC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Multiple Sclerosis\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV1D-37\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C7orf49\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IER3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Urticaria\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLPI\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL-21\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dysequilibrium syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPL35\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IDO1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis, Allergic\",\n",
       "                    \"symbolSize\": 26.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GYPC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ataxia Telangiectasia\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PHB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RCVRN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL1RA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Salmonella Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CX3CR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PCNA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL-27\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SETD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"alanine aminotransferase\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p44\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AHSG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CBARP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPLP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NPIPB3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LYZ\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Eczema\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NSP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Asthma\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLAMF7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"vomiting\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ORF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CASP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ITPKC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NDUFB6\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MIF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Niemann-Pick Disease, Type C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Equine Infectious Anemia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MCT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFRSF1B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SRPK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis E\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD83\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OCLN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFSF10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PTX3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SOD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PEA15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPR50\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLRG1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF2AK3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEBPA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRKAA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HLA-B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC2A5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP2K2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LRRC23\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD209\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NOS2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCND1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL-22\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GCNT2\",\n",
       "                    \"symbolSize\": 30.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSPA8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNMD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD58\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Retinitis Pigmentosa\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Terazosin\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cyclosporine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PICK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Herpes Simplex\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL9\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Distal Myopathies\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARP9\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Obesity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TGFB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gastroenteritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Spherocytosis, Type 1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mucolipidoses\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NLRP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FARP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cholera\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SCAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Erythematosus, Systemic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD163\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Yellow Fever\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FGF4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Coronavirus Infections\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Communicable Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Central Nervous System Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"URI1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TAX1BP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HIV Seropositivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL18\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"P1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Exanthema\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Sounds\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRIM3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p40\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDKN2B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carney Complex\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MUC5B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pigmentary Disorder, Reticulate, with Systemic Manifestations\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B3GNT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"3CLpro\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDIA6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NFKBIZ\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL5\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FKBP4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"USP25\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COVID-19\",\n",
       "                    \"symbolSize\": 44.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Overdose\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GCG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PNOC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC4A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNF\",\n",
       "                    \"symbolSize\": 28.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC5A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"African Swine Fever\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK8\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CRP\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD40LG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRIM25\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NLRP3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NEAT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ITGAM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCR5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MOG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAVS\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Toluene\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MERS\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MEF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SIRPA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OAS1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD32\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SBS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NAC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSF2\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV1-17\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDI\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MUC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DNAJB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BMP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BCR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DOK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEACAM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNS1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"cough\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sialic Acid Storage Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MITF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK14\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP1LC3A\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR4\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Giardiasis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RHOA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Metabolic Syndrome X\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HPGDS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRAF2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MYO10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SPARC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AGTR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MPO\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD81\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL13\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p38\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RTCB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TJP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ABCC4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAPDH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p115\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GLI3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADI1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC25A5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AKT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSPA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL5\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ENPP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"USP14\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV6-21\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BRAF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM3\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"WDR11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FGF2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GATA3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CBP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MRLN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"POU5F1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SRF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"viral RNA transcription\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neuraminidase 1 deficiency\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C4A\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MYD88\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Infection\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diclofenac\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UPP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD14\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Inflammation\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSPA5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KRT8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Emergencies\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLpro\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NR3C2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL13\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Purpura, Thrombocytopenic, Idiopathic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diabetic Retinopathy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VDR\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KCNK5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Eosinophilic Esophagitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACE\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NAGPA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SCPEP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Alzheimer Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NAA50\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPARA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARK2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MCL1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AQP4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ginseng\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TPCN2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCR7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Necrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p24\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV5-2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Androgen-Insensitivity Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EGF\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BAG6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GTF2IRD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RNF130\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL18R1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RBP4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ALK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PFDN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pneumonia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TP53\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STT3A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p62\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RSAD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MBP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis, Infectious Canine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADM2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SOCS1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CLSTN2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRCP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HMBS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Encephalitis, Japanese\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypotrichosis simplex\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFRSF1A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neutropenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CASP3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RELN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SAA1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATF6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV1-16\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Recurrence\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLAUR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ANPEP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Spasm\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP2K1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Attention Deficit Disorder with Hyperactivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Guillain-Barre Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S100A9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF2AK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNL3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cone-Rod Dystrophy 1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"sputum\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Porphyria, Erythropoietic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Non-alcoholic Fatty Liver Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dengue\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bronchitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nephritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neutrophil Chemotactic Response, Abnormal\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Doxycycline\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan syndrome 3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KPNA3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP6AP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PCBD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pirfenidone\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AHR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF2AK2\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL26\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SACM1L\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AGTR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p50\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Burkitt Lymphoma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OST\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Arthritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NCR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"THBD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MME\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Virus Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CR2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL10\",\n",
       "                    \"symbolSize\": 29.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX60\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VHLL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD274\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SAMHD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C4B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ESR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OTOF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VTRNA1-1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD8A\",\n",
       "                    \"symbolSize\": 28.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDKN2A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Tissue Adhesions\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ventilation\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carcinoma, Non-Small-Cell Lung\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DUSP4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPIP5K1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSL\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EHF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGHD2-15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GMIP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LEP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EREG\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neopterin\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Intraabdominal Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KCNE1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZBTB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Autism Spectrum Disorder\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"symbolSize\": 37.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LCP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC6A3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Vulgaris\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSD17B6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Halofuginone\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polyps\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neoplasms\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VWF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBK1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BDNF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OAS3\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FCER1G\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AKT1S1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"JAK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Shock\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MSN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dehydrated Hereditary Stomatocytosis, Pseudohyperkalemia, and Perinatal Edema\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PROCR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSB\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bietti Crystalline Dystrophy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DCX\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nephritis, Interstitial\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCND3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MTB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UBR5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Glatiramer Acetate\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MPZL2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HLA-DRB1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSG1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AGT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CFD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"membrane oxygenation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL6\",\n",
       "                    \"symbolSize\": 31.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sarcoma, Ewing\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STK26\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTNNB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CALR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pruritus\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cyclophosphamide\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NCL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug Toxicity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIT5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"G10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Anaphylaxis\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Shock, Septic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PBRM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NEK9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYTIP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"T1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSTA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SAT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis, Atopic\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SOAT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SDF4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Melanoma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Milk Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFRSF11B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAGT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Allopurinol\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL10\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Epilepsy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Harlequin type ichthyosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Adenomatous Polyposis Coli\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MUC5AC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TF\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MB21D1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NEDD4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypohidrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZBTB17\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PIK3CA\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AKAP7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR3\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CFH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Esophagitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E2\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KPNA4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Coinfection\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Marburg Virus Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYP4F3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VEGFA\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"YARS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RBMS3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BAAT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypersensitivity\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD25\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sveinsson Chorioretinal Atrophy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"lung transplantation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RHOJ\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E1\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL8\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD40\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"alanine \",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ESD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diarrhea 5, With Tufting Enteropathy, Congenital\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNLR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF3\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lymphopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lung Diseases, Interstitial\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mumps\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LMOD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Influenza, Human\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDCD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PTH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hereditary pancreatitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD16\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSP90B1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OARD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RELA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TCF7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HACE1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cataract congenital Volkmann type\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MSR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSF2RA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNA1\",\n",
       "                    \"symbolSize\": 28.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BAMBI\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Arthritis, Rheumatoid\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Feline Infectious Peritonitis\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ichthyosis Bullosa of Siemens\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Imiquimod\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LGALS3BP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ARIH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SPR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"oseltamivir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ISG15\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DPP4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD19\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPP1R15A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SNCG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemorrhagic Fever with Renal Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFI16\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRTN3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL2\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Fever\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"autoimmunity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTTN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Connective Tissue Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nasal Polyps\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemorrhage\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BSG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL4\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIH1\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD86\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Psoriasis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLK5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERVW-1\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C6orf47\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CHAF1A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AP-1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLRC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPS6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GHITM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chlorhexidine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mucocutaneous Lymph Node Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD44\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"L9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD69\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRPV1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nail-Patella Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SERPINA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC5A5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ALB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Helicase\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RGN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cystic Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p19\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug Eruptions\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MRAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Demyelinating Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FKBP11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"JUN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PML\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Airway Obstruction\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cough\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FXR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"G2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLRF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"USP5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDH23\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S2\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLOD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Norrie disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DOCK11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AURKB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPRE2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Molluscum Contagiosum\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC10A3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Short Stature, Idiopathic, X-Linked\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PES1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPA33\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ASAH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERK\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDK4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADAM17\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX58\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PA\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GFAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TWF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCR4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SQSTM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DHX58\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFAIP3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL1A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Stickler syndrome, type 1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HMOX1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD68\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carcinoma, Hepatocellular\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCDC88A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sarcoma, Kaposi\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Behcet Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPIA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP3K7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Tract Infections\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lung Injury\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPTOR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSMD1\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COX2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Syndrome\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemochromatosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD4\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZBTB16\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPS15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDE4B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neurotoxicity Syndromes\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRIM27\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"creatine kinase\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL2\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MEFV\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"thrombocytopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OASL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EDN2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Angelman Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IQGAP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AXIN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CASP8AP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KCNQ1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SOCS3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPLP0\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAX\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CNTF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNL2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EDEM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Viremia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bjornstad syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC17A5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPL32\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD28\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ARG1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRAT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VEGFC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Food Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TSLP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBATA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL17\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Huntington Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMIE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"\\u00a0C-reactive protein\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCR3\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Montelukast\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Acute Lung Injury\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FASLG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MALAT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bluetongue\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SEL1L\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"XBP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"INS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polycythemia Vera\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPS9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPS20\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chanarin-Dorfman Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Van der Woude syndrome\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NR4A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Atherosclerosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CHAC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLOD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLRK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"USP18\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADAM10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HAVCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP1A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COX8A\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SPON1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GSR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GBF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neural Tube Defects\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ABCB11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RNASE3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL16\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD244\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MCOLN3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPNMB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Leukoencephalopathy, Progressive Multifocal\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SFTPB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                }\n",
       "            ],\n",
       "            \"categories\": [\n",
       "                {\n",
       "                    \"name\": \"Disease\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#FF7F50\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gene\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#48D1CC\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chemical\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#B3EE3A\"\n",
       "                        }\n",
       "                    }\n",
       "                }\n",
       "            ],\n",
       "            \"edgeLabel\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"edgeSymbol\": [\n",
       "                null,\n",
       "                null\n",
       "            ],\n",
       "            \"edgeSymbolSize\": 10,\n",
       "            \"links\": [\n",
       "                {\n",
       "                    \"source\": \"B1\",\n",
       "                    \"target\": \"PCNA\",\n",
       "                    \"value\": \"TGEV infection promoted p21 accumulation, down-regulated cell cycle-regulatory proteins cyclins start_entity, cdc2, cdk2 and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSME3\",\n",
       "                    \"target\": \"Eczema\",\n",
       "                    \"value\": \"Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Akira Akasawa, Michihiro Hide, Hiroko Shizukawa A442 Evaluation of the Adherence Starts with Knowledge-20 ASK-20 to Inhaled Drug in Patients with Asthma Naoto Watanabe A443 The Epidemiology and Clinical Manifestation of Hmpv Infection in Children during Recent 4 Years: 2011-2014 Meeyong Shin, Myeong Sun Jang A444 Neutropenia Induced By Intravenous_Immunoglobulin Young-Hee Nam, Yeo Myeong Noh, Dong Sub Jeon, Hee-Joo Nam, NAA50g Hee start_entitym start_entitym, Ye Suel Park, Soo-Keol Lee A445 A First Case of Lymphocytic Lung_Diseases,_Interstitial in Healthy Child Ji-in Jung, Ha-Su start_entitym, Hyun-a start_entitym, Jin-a Jung A446 Cytokine Production upon House Dust Mite Stimulation of Cord Blood Mononuclear Cells from Caesarean Section-Delivered Singaporean Infants Anne Goh, Rajeshwar Rao, Bindu Nandanan, Ruurd Van Elburg, Chua Mei Chien, Juandy Jo, Johan Garssen, Johan Garssen, Leon Knippels, Elena NAA50dalova, Wen Chin Chiang A447 Dress Syndrome with Acute Nephritis,_Interstitial Caused By Quinolone and Nonsteroidal Anti-Inflammatory Drugs Young-Hee Nam, Ji Young Juong, Soo Jin start_entitym, Eun Young start_entitym, Su Mi Lee, Young start_entity Son, Hee-Joo Nam, start_entity-Ho start_entitym, Soo-Keol Lee A448 IL23A Roles in the Development of House Dust Mite Allergic Sensitization and Asthma Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Hyun Seung Lee, Yoon-Seok Chang, Jung-Won Park, NAA50g-Heon Cho, Kyung-up Min, Woo-Jung Song A449 Exposure Profile of Indoor Risk Factors in Dwellings of Children with Dermatitis,_Atopic Hyunwook Lim, Sungchul Seo, Ji Tae Choung, Young Yoo, Jun-Sik Park, Byung Kwan start_entitym A450 Epidemiological Characterization of Blood Eosinophils in the Elderly Population Ha Kyeong Won, Hye-Ryun Kang, Byung-Keun start_entitym, Sung Do Moon, Ju-Young start_entitym, So-Hee Lee, Woo-Jung Song, Heung Woo Park, Min-Koo Kang, Sun-Sin start_entitym, NAA50g-Heon Cho, Kyung-up Min, Yoon-Seok Chang, Kyoung Hee Sohn, Kyung-Mook start_entitym, start_entity-Woong start_entitym, Hak Chul Jang A451 Stevens-Johnson_Syndrome Caused By Methotrexate in the Treatment of Psoriasis Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee start_entitym start_entitym, Ye Suel Park, Soo-Keol Lee A452 Genetic Determinants for Lung Function Growth in Asthma Children Ting Fan Leung, Man Fung Tang, Hing Yee Sy, Wa Cheong Chan, Wilson Wai NAA50 Tam A453 The Power of Allergen Specific Ig E in the Classification of Rhinitis, Korean National Hanes 2010 Seung Kyu Chung, Sujin start_entitym, NAA50g Duk Hong, Hyo Yeol start_entitym Hyo Yeol start_entitym, Hun-Jong Dhong, Jong in Jeong A454 Analysis of Allergen Immunotherapy Practice and Patients Knowledge and Attitude about Allergen Immunotherapy in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A455 Roles of Staphylococcal Enterotoxin B in House Dust Mite-Induced Acute Asthma Models Ji Won Lee, Mingyu Kang, Soon-Hee start_entitym A456 A Clinical Comparison of Drug_Hypersensitivity_Syndrome in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee start_entitym start_entitym, Ye Suel Park, Soo-Keol Lee A457 The Beneficial Effect of Lactobacillus Gasseri PM-A0005 and Its Immunoregulatory Protein PMA5P40 on Milk-Induced Allergic Enteritis Yung-I Hou, Jiu-Yao Wang A458 Relationship Between Serum Folate Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong start_entitym, Seol Jae Hee, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho start_entitym, Namsoo Chang A459 Effects of Vitamin D in Patients with Chronic Rhinosinusitis Yuta Soma, So Watanabe, Ruby Pawankar, Ruby Pawankar, Harumi Suzaki, Harumi Suzaki, Hitome Kobayashi A460 Clinical Features of Systemic Dermatitis,_Contact from Ingestion of Rhus Young-Hee Nam, Chansun Park, Soo-Keol Lee A461 Sublingual Immunotherapy Efficacy in Patients with Dermatitis,_Atopic in Korea Jongrok Lee, Jooyoung Roh, Haryeong Ryu A462 Characteristics of Serious Drug-Related_Side_Effects_and_Adverse_Reactions in a Tertiary University Hospital Cheol-Woo start_entitym, Jae Hwa Cho, Mi Ra Eom, Ji Young Kang, Hye Gyeung Lee A463 Eyelid Dermatitis: Patch Test Results during a 15-Year Period in Korea and Evaluation of Metal Contents in Eye Shadows Hae Young Choi, Hye Jin Lee, Ju Yun Woo, Ji Yeon Byun, You Won Choi A464 Relationship Between Lipid Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong start_entitym, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho start_entitym, Namsoo Chang A465 IL-32 in the Induced Sputum of Patients with Asthma Jae-Woo Kwon, Hun Soo Chang, Jeong-Seok Heo, Jong-Uk Lee, Jong-Sook Park, Eusom start_entitym, Soo Hyun start_entitym, Choon-Sik Park A466 Clinical Characteristics of Patients with Chromium Hypersensitivity in a Single University Hospital in Korea Hae Young Choi, Ji Yeon Byun, Ju Yun Woo, You Won Choi A467 Efficacy and Safety of Oral Acitretin in Chronic Hand end_entity Hyun-Ju Jin, Jin-Hwa Son, Jeong-Min start_entitym, Gun-Wook start_entitym, Je-Ho Mun, Margaret Song, Hyun-Chang Ko, Moon-Bum start_entitym, Hoon-Soo start_entitym, Byung Soo start_entitym A468 Atypical Antipsychotics and Anticholinergic Agents Mimicking Anaphylaxis Sheryl Van Nunen, Dinh Van Nguyen, Anthony Elias, Susannah Olivia Lauer A469 Introducing Reach Reliable Estimation of Dermatitis,_Atopic in ChildHood: Novel, Questionnaire-Based Diagnostic Criteria for Childhood Dermatitis,_Atopic Seung-Chul Lee, Ho-June Lee, Jung Min Bae A470 Comprehensive Assessment to Identify the Causative Factors in Oral Hypersensitivity Syndrome Emi Ono A471 Comparison of Interpretation Methods in Allergic Skin Test Sung-Hwa Dong, Tae Kyung Koh, Young Seok Byun, Sung Wan start_entitym, Joong-Saeng Jo, Chul Kwon, Kun Hee Lee A472 Refraining Aminophylline Use Increases Hospitalization Among Children with Acute Asthma: A 10-Years Retrospective Cohort Study Li-Fan Liu A473 The Prevalence and Risk Factors of Dermatitis,_Atopic from Nationwide Study for Korean School Students Sunghee Lee A474 Probiotic Recombination Protein Effect on Dermatitis,_Atopic Wei-Leng Chen, Jiu-Yao Wang A475 Allergic Sensitization Status in Various Inflammatory Skin_Diseases Youin Bae, Gyeong-Hun Park A476 Two Cases of Good's Syndrome: A Rare Acquired Immunologic_Deficiency_Syndromes Associated with Thymoma Suk Yeon start_entitym A477 IL23A Has a Role to Play in the Development of Asthma in Short-Term Cigarette Smoke Exposure-Induced House-Dust Mite Allergic Model Hyun Seung Lee, Woo-Jung Song, Mingyu Kang, Han-start_entity Park, Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Hye-Young start_entitym, Kyung-up Min, NAA50g-Heon Cho, Ji-Won Lee, Boram Bae, Jung-Won Park A478 The Relationship Between the Relevance of Allergic Disease and the Value of Non-Specific IgE Yasuhiro Suzuki A479 Two Caces of Prawn Hypersensitivity in Adult Patients Ismet Bulut, Zeynep Ferhan Ozseker A480 Early Gut Bifidobacterium Breve and B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPS20\",\n",
       "                    \"target\": \"S10\",\n",
       "                    \"value\": \"Each recombinant baculovirus expressed both glycosylated S, 170K; PSMD1, 95K; S2, 80K and unglycosylated S0, 140K; end_entity, 75K; and start_entity, 65K forms of BCV spike polypeptides in Sf9 cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RNASE3\",\n",
       "                    \"target\": \"TSLP\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum start_entity Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and Urticaria Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, end_entity, Periostin, IL13 and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous Urticaria Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression KLRK1 and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute Urticaria at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The recent outbreak of Middle East respiratory syndrome end_entity start_entity end_entity-CoV infection has led to more than 800 laboratory-confirmed end_entity cases with a high case fatality rate 35, posing a serious threat to global public health and calling for the development of effective and safe therapeutic and prophylactic strategies to treat and prevent end_entity-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CNTF\",\n",
       "                    \"target\": \"Neurotoxicity Syndromes\",\n",
       "                    \"value\": \"One was start_entity receptor alpha CNTFR-, which appeared to modulate eSNCA-mediated end_entity via mechanisms related to JAK1STAT3 signaling but independent of eSNCA endocytosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Markers of the rough start_entity signal sequence receptor, Golgi complex mannosidase end_entity, and the trans Golgi network TGOLN2 were essentially restricted to the cell body and the initial segment of one of the cell's dendrites\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD58\",\n",
       "                    \"target\": \"CD86\",\n",
       "                    \"value\": \"HLA-DR, CD80, end_entity, ICOSLG, ICAM1, start_entity surface expression were studied in resting conditions as well as after IFN-TNF- treatment, two inflammatory cytokines, known to modulate some of these markers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PGF\",\n",
       "                    \"target\": \"VEGFC\",\n",
       "                    \"value\": \"We did not observe induction of end_entity or start_entity by PSG1 in any of the cells tested\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSB\",\n",
       "                    \"target\": \"Hypotrichosis simplex\",\n",
       "                    \"value\": \"Recently, a group of small molecules were identified to have inhibitory activity against start_entity through high throughput screening end_entity tests\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PES1\",\n",
       "                    \"target\": \"Dysequilibrium syndrome\",\n",
       "                    \"value\": \"Drug-eluting stenting end_entity, including paclitaxel-eluting stenting start_entity and sirolimus-eluting stenting SES, has been proven to have a lower restenotic rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL17\",\n",
       "                    \"target\": \"MCT\",\n",
       "                    \"value\": \"Kowalski A507 The Role of EIF2AK2 Pathway in Acute Exacerbation of Severe Asthma So Ri Kim, Yong Chul Lee, Dong Im Kim, Yang Keun Rhee, Heung Bum Lee, Seoung Ju Park, Yeong Hun Choe Choe, Seung Yong Park A508 Diversity of Clinical Manifestations and Treatment Responses for Hypereosinophilic_Syndrome Joo-Hee Kim, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A509 Effect of Dexamethasone in Th17 Cell Mediating Neutrophilic Asthma Nong Guang-Min, Jiang Min A510 Allergen Profile for AsthmaRhinitis and Eczema Among Patients in North India: An Immunocap Allergen Specific IgE Antibodies Assay Based Study Nalin Nag A511 Clinical Profile of Rhinitis,_Allergic in Children in Jakarta Wahyuni Indawati A512 Preclinical Study on the Use of Micro Crystalline Tyrosine end_entity Adjuvants in Hypersensitivity Immunotherapy Alan David Bullimore, Matthew Heath, Murray Skinner A513 Genetic Diversity of Filaggrin Mutation and Its Clinical Implication in East Asian Dermatitis,_Atopic Patients Seong Jun Seo, Won Jong Oh A514 Protein and MPL Adsorption Capacities for end_entity in Candidate Therapeutic Formulations for Use in Immunotherapy, Compared Against Existing Adjuvants Alan David Bullimore, Murray Skinner, Matthew Heath, Andrew Bell A515 Interleukin-22 Gene Variation in Inflammatory_Bowel_Diseases Alireza Zarebidoki, Hournaz Hasanzadeh, Salman Sadeghzade, Nima Rezaei A516 Immunomodulatory Effects of Adipose-Derived Stem Cell Secretome in a Mouse Model of Asthma Kyu-Sup Cho A517 Diffuse Alveolar Hemorrhage with Positive Anti-Neutrophil Cytoplasmic Antibody in a Child : A Case Report Sung-Woo Kim, Moo-Young Oh A518 Clinical Analys the Serum start_entity Levels As the Condition Index of Dermatitis,_Atopic in the Early Infancy Munemitsu Koizumi, Kazuyo Kuzume A519 An Analysis of the Filaggrin Gene Polymorphism in Korean Dermatitis,_Atopic Patients Kui Young Park, Won Jong Oh A520 A New Protocol for Wheat Oral Immunotherapy in Patients with Anaphylaxis Delara Babaie, Mohammad Nabavi, Fariborz Zandieh, Mehrdad Amir Moini, Zahra Chavoshzadeh, Hamideh Seifi, Mitra Sahragard, Mehrnaz Mesdaghi, Mohammad Hassan Bemanian A521 Clinical Characteristics of Filaggrin-Related Dermatitis,_Atopic Patients in Korea Sun Young Choi, Yeon a No A522 Early Hypersensitivity Diagnosis in Children - Self- Administered Questionnaire Vs Medical Verification Andrzej M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Fever\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"start_entity, rhinorrhea, end_entity, retractions, tachypnea and wheezing are common findings\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Pend_entityK and IRE1XBP1 in the unfolded protein response differentially regulate the expression of start_entity and CCL2 likely through modulation of end_entity stress-induced NF-B RelA and STAT3 activation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MEF\",\n",
       "                    \"target\": \"PNOC\",\n",
       "                    \"value\": \"RESULTS: Gene expression in start_entity among children who were sOP was significantly different in upregulation of CXCL8, SLPI, and CCL3, and in downregulation of IRF7 and its related signaling molecules interferon alpha, Toll-like receptor adaptor molecule 2, CCL5, and MAPK8 compared with children who were end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PPIP5K1\",\n",
       "                    \"target\": \"TBK1\",\n",
       "                    \"value\": \"Additionally, ZC3H12A interacts with important modulators of IFNA1 expression pathway including start_entity, TRAF3, end_entity and IKK\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR4\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced end_entity, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic end_entity Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with start_entity Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD32\",\n",
       "                    \"target\": \"SIRPA\",\n",
       "                    \"value\": \"Phenotypic analysis identified these cells as bovine pDCs CD3 CD14 CR2 ITGAX NK TCR CD4 MHC GCNT2 CD45RB end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HR\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"In bivariate Cox regression analysis, risk factors associated with the development of end_entity and progression from end_entity to death included older age hazard ratio start_entity, 3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"ORF1\",\n",
       "                    \"value\": \"Overall, this study provides evidence that the predicted MetYPCP domain of HEV end_entity antagonises STAT1 activation to modulate the start_entity response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Diseases, Interstitial\",\n",
       "                    \"target\": \"Nephritis, Interstitial\",\n",
       "                    \"value\": \"Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Akira Akasawa, Michihiro Hide, Hiroko Shizukawa A442 Evaluation of the Adherence Starts with Knowledge-20 ASK-20 to Inhaled Drug in Patients with Asthma Naoto Watanabe A443 The Epidemiology and Clinical Manifestation of Hmpv Infection in Children during Recent 4 Years: 2011-2014 Meeyong Shin, Myeong Sun Jang A444 Neutropenia Induced By Intravenous_Immunoglobulin Young-Hee Nam, Yeo Myeong Noh, Dong Sub Jeon, Hee-Joo Nam, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A445 A First Case of Lymphocytic start_entity in Healthy Child Ji-in Jung, Ha-Su PSME3m, Hyun-a PSME3m, Jin-a Jung A446 Cytokine Production upon House Dust Mite Stimulation of Cord Blood Mononuclear Cells from Caesarean Section-Delivered Singaporean Infants Anne Goh, Rajeshwar Rao, Bindu Nandanan, Ruurd Van Elburg, Chua Mei Chien, Juandy Jo, Johan Garssen, Johan Garssen, Leon Knippels, Elena NAA50dalova, Wen Chin Chiang A447 Dress Syndrome with Acute end_entity Caused By Quinolone and Nonsteroidal Anti-Inflammatory Drugs Young-Hee Nam, Ji Young Juong, Soo Jin PSME3m, Eun Young PSME3m, Su Mi Lee, Young PSME3 Son, Hee-Joo Nam, PSME3-Ho PSME3m, Soo-Keol Lee A448 IL23A Roles in the Development of House Dust Mite Allergic Sensitization and Asthma Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Hyun Seung Lee, Yoon-Seok Chang, Jung-Won Park, NAA50g-Heon Cho, Kyung-up Min, Woo-Jung Song A449 Exposure Profile of Indoor Risk Factors in Dwellings of Children with Dermatitis,_Atopic Hyunwook Lim, Sungchul Seo, Ji Tae Choung, Young Yoo, Jun-Sik Park, Byung Kwan PSME3m A450 Epidemiological Characterization of Blood Eosinophils in the Elderly Population Ha Kyeong Won, Hye-Ryun Kang, Byung-Keun PSME3m, Sung Do Moon, Ju-Young PSME3m, So-Hee Lee, Woo-Jung Song, Heung Woo Park, Min-Koo Kang, Sun-Sin PSME3m, NAA50g-Heon Cho, Kyung-up Min, Yoon-Seok Chang, Kyoung Hee Sohn, Kyung-Mook PSME3m, PSME3-Woong PSME3m, Hak Chul Jang A451 Stevens-Johnson_Syndrome Caused By Methotrexate in the Treatment of Psoriasis Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A452 Genetic Determinants for Lung Function Growth in Asthma Children Ting Fan Leung, Man Fung Tang, Hing Yee Sy, Wa Cheong Chan, Wilson Wai NAA50 Tam A453 The Power of Allergen Specific Ig E in the Classification of Rhinitis, Korean National Hanes 2010 Seung Kyu Chung, Sujin PSME3m, NAA50g Duk Hong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Hun-Jong Dhong, Jong in Jeong A454 Analysis of Allergen Immunotherapy Practice and Patients Knowledge and Attitude about Allergen Immunotherapy in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A455 Roles of Staphylococcal Enterotoxin B in House Dust Mite-Induced Acute Asthma Models Ji Won Lee, Mingyu Kang, Soon-Hee PSME3m A456 A Clinical Comparison of Drug_Hypersensitivity_Syndrome in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A457 The Beneficial Effect of Lactobacillus Gasseri PM-A0005 and Its Immunoregulatory Protein PMA5P40 on Milk-Induced Allergic Enteritis Yung-I Hou, Jiu-Yao Wang A458 Relationship Between Serum Folate Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Seol Jae Hee, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A459 Effects of Vitamin D in Patients with Chronic Rhinosinusitis Yuta Soma, So Watanabe, Ruby Pawankar, Ruby Pawankar, Harumi Suzaki, Harumi Suzaki, Hitome Kobayashi A460 Clinical Features of Systemic Dermatitis,_Contact from Ingestion of Rhus Young-Hee Nam, Chansun Park, Soo-Keol Lee A461 Sublingual Immunotherapy Efficacy in Patients with Dermatitis,_Atopic in Korea Jongrok Lee, Jooyoung Roh, Haryeong Ryu A462 Characteristics of Serious Drug-Related_Side_Effects_and_Adverse_Reactions in a Tertiary University Hospital Cheol-Woo PSME3m, Jae Hwa Cho, Mi Ra Eom, Ji Young Kang, Hye Gyeung Lee A463 Eyelid Dermatitis: Patch Test Results during a 15-Year Period in Korea and Evaluation of Metal Contents in Eye Shadows Hae Young Choi, Hye Jin Lee, Ju Yun Woo, Ji Yeon Byun, You Won Choi A464 Relationship Between Lipid Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A465 IL-32 in the Induced Sputum of Patients with Asthma Jae-Woo Kwon, Hun Soo Chang, Jeong-Seok Heo, Jong-Uk Lee, Jong-Sook Park, Eusom PSME3m, Soo Hyun PSME3m, Choon-Sik Park A466 Clinical Characteristics of Patients with Chromium Hypersensitivity in a Single University Hospital in Korea Hae Young Choi, Ji Yeon Byun, Ju Yun Woo, You Won Choi A467 Efficacy and Safety of Oral Acitretin in Chronic Hand Eczema Hyun-Ju Jin, Jin-Hwa Son, Jeong-Min PSME3m, Gun-Wook PSME3m, Je-Ho Mun, Margaret Song, Hyun-Chang Ko, Moon-Bum PSME3m, Hoon-Soo PSME3m, Byung Soo PSME3m A468 Atypical Antipsychotics and Anticholinergic Agents Mimicking Anaphylaxis Sheryl Van Nunen, Dinh Van Nguyen, Anthony Elias, Susannah Olivia Lauer A469 Introducing Reach Reliable Estimation of Dermatitis,_Atopic in ChildHood: Novel, Questionnaire-Based Diagnostic Criteria for Childhood Dermatitis,_Atopic Seung-Chul Lee, Ho-June Lee, Jung Min Bae A470 Comprehensive Assessment to Identify the Causative Factors in Oral Hypersensitivity Syndrome Emi Ono A471 Comparison of Interpretation Methods in Allergic Skin Test Sung-Hwa Dong, Tae Kyung Koh, Young Seok Byun, Sung Wan PSME3m, Joong-Saeng Jo, Chul Kwon, Kun Hee Lee A472 Refraining Aminophylline Use Increases Hospitalization Among Children with Acute Asthma: A 10-Years Retrospective Cohort Study Li-Fan Liu A473 The Prevalence and Risk Factors of Dermatitis,_Atopic from Nationwide Study for Korean School Students Sunghee Lee A474 Probiotic Recombination Protein Effect on Dermatitis,_Atopic Wei-Leng Chen, Jiu-Yao Wang A475 Allergic Sensitization Status in Various Inflammatory Skin_Diseases Youin Bae, Gyeong-Hun Park A476 Two Cases of Good's Syndrome: A Rare Acquired Immunologic_Deficiency_Syndromes Associated with Thymoma Suk Yeon PSME3m A477 IL23A Has a Role to Play in the Development of Asthma in Short-Term Cigarette Smoke Exposure-Induced House-Dust Mite Allergic Model Hyun Seung Lee, Woo-Jung Song, Mingyu Kang, Han-PSME3 Park, Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Hye-Young PSME3m, Kyung-up Min, NAA50g-Heon Cho, Ji-Won Lee, Boram Bae, Jung-Won Park A478 The Relationship Between the Relevance of Allergic Disease and the Value of Non-Specific IgE Yasuhiro Suzuki A479 Two Caces of Prawn Hypersensitivity in Adult Patients Ismet Bulut, Zeynep Ferhan Ozseker A480 Early Gut Bifidobacterium Breve and B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like protease start_entity of severe acute respiratory syndrome-associated COVID-19 end_entity-CoV is one of the most promising targets for discovery of drugs against end_entity, because of its critical role in the viral life cycle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AHR\",\n",
       "                    \"target\": \"GLI3\",\n",
       "                    \"value\": \"The toxic manifestations of 2,3,7,8-tetrachlorodibenzo-p-dioxin TCDD, an environmental contaminant, primarily depend on its ability to activate start_entity AhR, which is a ligand-dependent transcription factor belonging to the superfamily of basic-helix-loop-helix end_entitys\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and Allopurinol Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to Glatiramer_Acetate: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 start_entity Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent end_entity Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic start_entity Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic start_entity Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with end_entity Chellaa R A615 Study of Incidence of Severe Persistent end_entity in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent end_entity in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent end_entity in Central India Subir Jain A617 Dermatitis,_Atopic: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe Dermatitis,_Atopic Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of end_entity Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao Pigmentary_Disorder,_Reticulate,_with_Systemic_Manifestations Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, end_entity, Dermatitis,_Atopic, and Acute Upper Respiratory_Tract_Infections and Levels of Severity of start_entity in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in Eosinophilic_Esophagitis Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent Dermatitis,_Atopic Associated with Parasitic Infection Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and start_entity Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in start_entity, end_entity, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via ERK and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of start_entity Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of Anaphylaxis and start_entity Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe Dermatitis,_Atopic Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IDO1\",\n",
       "                    \"target\": \"SAT1\",\n",
       "                    \"value\": \"This review reflects on our current understanding of the complex networking that occurs between the virus and host at the interface of cellular metabolism, with a focus on the ISGs in particular, cholesterol-25-hydroxylase CH25H, spermidinespermine acetyltransferase 1 end_entity, indoleamine-2,3-dioxygenase start_entity and sterile alpha motif and histidineaspartic acid domain-containing protein 1 SAMHD1, which were recently discovered to modulate specific metabolic events and consequently deter viral infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL-27\",\n",
       "                    \"target\": \"IL2\",\n",
       "                    \"value\": \"Additionally, we showed that treatment with a second cytokine, start_entity, decreased end_entity expression without augmenting Tconv and CD8A T cell proliferation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In order to enhance the sensitivity of conventional immunoassay technology for the detection of end_entity start_entity end_entity-CoV nucleocapsid protein N protein, we developed a localized surface plasmon coupled fluorescence LSPCF fiber-optic biosensor that combines sandwich immunoassay with the LSP technique\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": \"Meanwhile, according to correspondence analysis CoA based on RSCU and phylogenetic analysis, the Flaviviridae viruses mainly are made up of two groups, Group I Yellow fever virus, Apoi virus, Tembusu virus, Dengue virus 1, and others and Group start_entity West Nile virus lineage 2, end_entity virus, Usutu virus, Kedougou virus, and others\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have shown previously that an Abl kinase inhibitor, imatinib, significantly reduces end_entity-CoV and start_entity-CoV viral titers and prevents endosomal entry by HIV end_entity S and start_entity S pseudotyped virions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food end_entity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of end_entity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk end_entity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus start_entity Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam end_entity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral end_entity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal end_entity Is Associated with Acute start_entity Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLOD1\",\n",
       "                    \"target\": \"PLOD2\",\n",
       "                    \"value\": \"Similar to Duck adenovirus A, the novel adenovirus lacks start_entity, end_entity and PLOD3, which distinguishes it from other viruses in the Atadenovirus genus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Compared with continuous invasive start_entity, noninvasive start_entity used at PIC window significantly reduced mortality, ventilator-associated end_entity, weaning failures, reintubations, duration of invasive start_entity, total duration of mechanical start_entity, length of stay LOS in intensive care unit, and LOS in hospital as well as hospital costs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FCGR3B\",\n",
       "                    \"target\": \"ITPKC\",\n",
       "                    \"value\": \"Genetic studies have identified several susceptibility genes for KD and its sequelae in different ethnic populations, including FCGR2A, CD40, end_entity, FAM167A-BLK and CASP3, as well as genes influencing response to intravenous immunoglobulin IVIG and aneurysm formation such as start_entity, and transforming growth factor TGF pathway genes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Arthritis, Rheumatoid\",\n",
       "                    \"target\": \"Lupus Erythematosus, Systemic\",\n",
       "                    \"value\": \"For a long time, viruses have been shown to modify the clinical picture of several autoimmune diseases, including type 1 diabetes T1D, systemic lupus erythematosus end_entity, rheumatoid arthritis start_entity, Sjogren's_Syndrome SS, herpetic stromal keratitis HSK, celiac disease Hamartoma_Syndrome,_Multiple, and multiple sclerosis Multiple_Sclerosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These data imply that a mouse transgenically expressing human start_entity may be a useful animal model of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dengue\",\n",
       "                    \"target\": \"Yellow Fever\",\n",
       "                    \"value\": \"DCVMN members presented their progress in developing novel Hexavalent, Meningitis,_Pneumococcal Conjugate Vaccine, Shigella, Mumps, Rotavirus, end_entity, Poliomyelitis, Hepatitis_E and start_entity vaccines, and a novel monoclonal antibody cocktail for post-bite prophylaxis against rabies infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The complete genome of the end_entity start_entity end_entity-CoV has since been sequenced\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD58\",\n",
       "                    \"target\": \"LRRC23\",\n",
       "                    \"value\": \"However ICAM1 ICAM-1 and start_entity LFA-3 adhesion molecules, known to be implicated in end_entity independent co-stimulatory signals, were well expressed on the two cell types\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNLR1\",\n",
       "                    \"target\": \"SOAT1\",\n",
       "                    \"value\": \"Arg99His in the gene encoding start_entity start_entity a protein that functions in the Jak end_entity pathway are associated with ADNSHL\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL5\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"The role of cytokines in clearance was investigated by using an RNase protection assay for interleukin-1 alpha IL-1 alpha, IL-1 beta, IL2, IL3, IL4, start_entity, IL6, end_entity alpha end_entity, TNF-beta, and gamma interferon IFN-gamma\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"NDUFB6\",\n",
       "                    \"value\": \"41; NNTB 311 95 end_entity 244 to 1086, but not start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A4\",\n",
       "                    \"target\": \"CD19\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher start_entity Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, IL5, IL17A, and end_entity,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn start_entity0 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang start_entity1 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li start_entity2 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi start_entity3 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu start_entity4 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim start_entity5 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won start_entity6 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Nephritis\",\n",
       "                    \"value\": \"Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Akira Akasawa, Michihiro Hide, Hiroko Shizukawa A442 Evaluation of the Adherence Starts with Knowledge-20 ASK-20 to Inhaled Drug in Patients with start_entity Naoto Watanabe A443 The Epidemiology and Clinical Manifestation of Hmpv Infection in Children during Recent 4 Years: 2011-2014 Meeyong Shin, Myeong Sun Jang A444 Neutropenia Induced By Intravenous_Immunoglobulin Young-Hee Nam, Yeo Myeong Noh, Dong Sub Jeon, Hee-Joo Nam, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A445 A First Case of Lymphocytic Lung_Diseases,_Interstitial in Healthy Child Ji-in Jung, Ha-Su PSME3m, Hyun-a PSME3m, Jin-a Jung A446 Cytokine Production upon House Dust Mite Stimulation of Cord Blood Mononuclear Cells from Caesarean Section-Delivered Singaporean Infants Anne Goh, Rajeshwar Rao, Bindu Nandanan, Ruurd Van Elburg, Chua Mei Chien, Juandy Jo, Johan Garssen, Johan Garssen, Leon Knippels, Elena NAA50dalova, Wen Chin Chiang A447 Dress Syndrome with Acute Interstitial end_entity Caused By Quinolone and Nonsteroidal Anti-Inflammatory Drugs Young-Hee Nam, Ji Young Juong, Soo Jin PSME3m, Eun Young PSME3m, Su Mi Lee, Young PSME3 Son, Hee-Joo Nam, PSME3-Ho PSME3m, Soo-Keol Lee A448 IL23A Roles in the Development of House Dust Mite Allergic Sensitization and start_entity Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Hyun Seung Lee, Yoon-Seok Chang, Jung-Won Park, NAA50g-Heon Cho, Kyung-up Min, Woo-Jung Song A449 Exposure Profile of Indoor Risk Factors in Dwellings of Children with Dermatitis,_Atopic Hyunwook Lim, Sungchul Seo, Ji Tae Choung, Young Yoo, Jun-Sik Park, Byung Kwan PSME3m A450 Epidemiological Characterization of Blood Eosinophils in the Elderly Population Ha Kyeong Won, Hye-Ryun Kang, Byung-Keun PSME3m, Sung Do Moon, Ju-Young PSME3m, So-Hee Lee, Woo-Jung Song, Heung Woo Park, Min-Koo Kang, Sun-Sin PSME3m, NAA50g-Heon Cho, Kyung-up Min, Yoon-Seok Chang, Kyoung Hee Sohn, Kyung-Mook PSME3m, PSME3-Woong PSME3m, Hak Chul Jang A451 Stevens-Johnson_Syndrome Caused By Methotrexate in the Treatment of Psoriasis Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A452 Genetic Determinants for Lung Function Growth in start_entity Children Ting Fan Leung, Man Fung Tang, Hing Yee Sy, Wa Cheong Chan, Wilson Wai NAA50 Tam A453 The Power of Allergen Specific Ig E in the Classification of Rhinitis, Korean National Hanes 2010 Seung Kyu Chung, Sujin PSME3m, NAA50g Duk Hong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Hun-Jong Dhong, Jong in Jeong A454 Analysis of Allergen Immunotherapy Practice and Patients Knowledge and Attitude about Allergen Immunotherapy in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A455 Roles of Staphylococcal Enterotoxin B in House Dust Mite-Induced Acute start_entity Models Ji Won Lee, Mingyu Kang, Soon-Hee PSME3m A456 A Clinical Comparison of Drug_Hypersensitivity_Syndrome in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A457 The Beneficial Effect of Lactobacillus Gasseri PM-A0005 and Its Immunoregulatory Protein PMA5P40 on Milk-Induced Allergic Enteritis Yung-I Hou, Jiu-Yao Wang A458 Relationship Between Serum Folate Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Seol Jae Hee, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A459 Effects of Vitamin D in Patients with Chronic Rhinosinusitis Yuta Soma, So Watanabe, Ruby Pawankar, Ruby Pawankar, Harumi Suzaki, Harumi Suzaki, Hitome Kobayashi A460 Clinical Features of Systemic Dermatitis,_Contact from Ingestion of Rhus Young-Hee Nam, Chansun Park, Soo-Keol Lee A461 Sublingual Immunotherapy Efficacy in Patients with Dermatitis,_Atopic in Korea Jongrok Lee, Jooyoung Roh, Haryeong Ryu A462 Characteristics of Serious Drug-Related_Side_Effects_and_Adverse_Reactions in a Tertiary University Hospital Cheol-Woo PSME3m, Jae Hwa Cho, Mi Ra Eom, Ji Young Kang, Hye Gyeung Lee A463 Eyelid Dermatitis: Patch Test Results during a 15-Year Period in Korea and Evaluation of Metal Contents in Eye Shadows Hae Young Choi, Hye Jin Lee, Ju Yun Woo, Ji Yeon Byun, You Won Choi A464 Relationship Between Lipid Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A465 IL-32 in the Induced Sputum of Patients with start_entity Jae-Woo Kwon, Hun Soo Chang, Jeong-Seok Heo, Jong-Uk Lee, Jong-Sook Park, Eusom PSME3m, Soo Hyun PSME3m, Choon-Sik Park A466 Clinical Characteristics of Patients with Chromium Hypersensitivity in a Single University Hospital in Korea Hae Young Choi, Ji Yeon Byun, Ju Yun Woo, You Won Choi A467 Efficacy and Safety of Oral Acitretin in Chronic Hand Eczema Hyun-Ju Jin, Jin-Hwa Son, Jeong-Min PSME3m, Gun-Wook PSME3m, Je-Ho Mun, Margaret Song, Hyun-Chang Ko, Moon-Bum PSME3m, Hoon-Soo PSME3m, Byung Soo PSME3m A468 Atypical Antipsychotics and Anticholinergic Agents Mimicking Anaphylaxis Sheryl Van Nunen, Dinh Van Nguyen, Anthony Elias, Susannah Olivia Lauer A469 Introducing Reach Reliable Estimation of Dermatitis,_Atopic in ChildHood: Novel, Questionnaire-Based Diagnostic Criteria for Childhood Dermatitis,_Atopic Seung-Chul Lee, Ho-June Lee, Jung Min Bae A470 Comprehensive Assessment to Identify the Causative Factors in Oral Hypersensitivity Syndrome Emi Ono A471 Comparison of Interpretation Methods in Allergic Skin Test Sung-Hwa Dong, Tae Kyung Koh, Young Seok Byun, Sung Wan PSME3m, Joong-Saeng Jo, Chul Kwon, Kun Hee Lee A472 Refraining Aminophylline Use Increases Hospitalization Among Children with Acute start_entity: A 10-Years Retrospective Cohort Study Li-Fan Liu A473 The Prevalence and Risk Factors of Dermatitis,_Atopic from Nationwide Study for Korean School Students Sunghee Lee A474 Probiotic Recombination Protein Effect on Dermatitis,_Atopic Wei-Leng Chen, Jiu-Yao Wang A475 Allergic Sensitization Status in Various Inflammatory Skin_Diseases Youin Bae, Gyeong-Hun Park A476 Two Cases of Good's Syndrome: A Rare Acquired Immunologic_Deficiency_Syndromes Associated with Thymoma Suk Yeon PSME3m A477 IL23A Has a Role to Play in the Development of start_entity in Short-Term Cigarette Smoke Exposure-Induced House-Dust Mite Allergic Model Hyun Seung Lee, Woo-Jung Song, Mingyu Kang, Han-PSME3 Park, Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Hye-Young PSME3m, Kyung-up Min, NAA50g-Heon Cho, Ji-Won Lee, Boram Bae, Jung-Won Park A478 The Relationship Between the Relevance of Allergic Disease and the Value of Non-Specific IgE Yasuhiro Suzuki A479 Two Caces of Prawn Hypersensitivity in Adult Patients Ismet Bulut, Zeynep Ferhan Ozseker A480 Early Gut Bifidobacterium Breve and B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"ADAM17\",\n",
       "                    \"value\": \"The aim of the study was to investigate whether exercise training andor metformin improve glucose homeostasis, albuminuria and downregulate renal end_entity and start_entity shedding in dbdb mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Recurrence\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food start_entity with end_entity Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG start_entity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Immediate start_entity Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with start_entity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal start_entity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for start_entity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSION: start_entity -28 G allele plays a role in the pathogenesis of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPS15\",\n",
       "                    \"target\": \"UXT\",\n",
       "                    \"value\": \"In this study, an effort was made to evaluate a panel of 10 candidate reference genes glyceraldehyde 3-phosphate dehydrogenase GAPDH, beta- actin ACTB, ubiquitously expressed transcript end_entity, start_entity start_entity, ribosomal protein L-4 RPL4, RPS9 RPS9, RPRPS23 RPRPS23, HMBS HMBS, 2 Microglobulin 2M and EEF1A1 EEF1A1 across 12 tissues mammary gland, kidney, spleen, liver, heart, intestine, ovary, lung, muscle, brain, subcutaneous fat and testis of riverine buffaloes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CBP\",\n",
       "                    \"target\": \"IRF3\",\n",
       "                    \"value\": \"While end_entity was stable, start_entity was degraded, and start_entity degradation was proteasome-dependent, suggesting that start_entity degradation is not due to the protease activity of Nsp1 but an intermediary is involved\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CASP1\",\n",
       "                    \"target\": \"NLRP1\",\n",
       "                    \"value\": \"IFI16 and start_entity are coded by p53-regulated genes which led us to investigate regulation of end_entity, NLRX1, STING, IFIT1 and IFIT3 in p53-dependent mode\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL18\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"In spleen samples of IBV-infected animals reduced expression of IL-1, end_entity, CXCL8, IL10, start_entity and IFN- mRNA was found 1dpi\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KD\",\n",
       "                    \"target\": \"Mucocutaneous Lymph Node Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity is an acute self-limiting inflammatory disorder, associated with vasculitis, affecting predominantly medium-sized arteries, particularly the coronary arteries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AHSG\",\n",
       "                    \"target\": \"Ichthyosis Bullosa of Siemens\",\n",
       "                    \"value\": \"METHODS: start_entity serum levels were determined in treatment-nave newly-diagnosed patients, 96 with ulcerative colitis UC, 84 with Crohn's disease Hamartoma_Syndrome,_Multiple, 62 with diarrhea-predominant or mixed irritable bowel syndrome end_entity, D- and M- types and 180 healthy controls HC, by an enzyme linked immunosorbent assay ELISA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": \"CONCLUSION: These results suggest that positive viral end_entity and low start_entity results are infrequently associated with discontinuation of antibiotic therapy in proven or possible respiratory infections at our institution\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ectromelia\",\n",
       "                    \"target\": \"Epilepsy\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation start_entity Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, end_entity Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired COVID-19 demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSL\",\n",
       "                    \"target\": \"LE\",\n",
       "                    \"value\": \"Since the only endosomal requirement for Severe_Acute_Respiratory_Syndrome entry is start_entity activity, we tested and provide evidence that Niemann-Pick_Disease,_Type_C end_entityLys have higher start_entity activity than end_entity, with no detectable activity in earlier endosomes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KLRC1\",\n",
       "                    \"target\": \"KLRG1\",\n",
       "                    \"value\": \"Results: In the present study, based on gene expression microarray analysis, we showed four inhibitory receptors KLRB1, KLRD1, KLRF1, end_entity and four activating receptors start_entity, KLRC3, KLRK1 and NCR1 on NK cells were remarkably down-regulated and the cytological experiment demonstrated the proportion of CD16CD56 NK cells among PBMCs decreased in the PE group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD25\",\n",
       "                    \"target\": \"CD69\",\n",
       "                    \"value\": \"FLT3-L also increased serum levels of IL-12, at least transiently, and elicited higher surface expression of HLA-DR and the activation markers start_entity and end_entity on NK and T cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity, Immediate\",\n",
       "                    \"target\": \"Shock, Septic\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to end_entity Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing start_entity Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"African Swine Fever\",\n",
       "                    \"value\": \"Taken together the results provide evidence for the binding of end_entity virus structural proteins to a specific membrane compartment and implicate a role for the start_entity in the assembly and envelopment of end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL13\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and Urticaria Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, TSLP, Periostin, start_entity and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous Urticaria Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression KLRK1 and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute Urticaria at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of end_entity in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL15\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Upon vaccination, all immunized dogs presented strong and specific humoral responses with increased serum concentrations of IFN-, end_entity, IL7, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPS6\",\n",
       "                    \"target\": \"S6\",\n",
       "                    \"value\": \"Overall, phosphorylated p- AKT1, p-start_entity end_entity and p-4E-binding protein 1 4EBP1 expression levels were examined by immunohistochemistry in anogenital tumors both with and without positive telomerase activity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SQSTM1\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and end_entity Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, TSLP, Periostin, IL13 and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous end_entity Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression KLRK1 and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee start_entity Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute end_entity at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Comparison of the antigen-presenting capacity of aged Paroxysmal_nonkinesigenic_dyskinesia with young Paroxysmal_nonkinesigenic_dyskinesia revealed that Paroxysmal_nonkinesigenic_dyskinesias from aged subjects display reduced capacity to induce proliferation and IFN-gamma secretion in start_entity and end_entity T cells as compared with Paroxysmal_nonkinesigenic_dyskinesias from young subjects\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Additionally, we confirmed that EV71 infection induces robust expression of proinflammatory cytokines end_entity, start_entity, and IL1A and interferons IFNA1 and IFNA1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SCPEP1\",\n",
       "                    \"target\": \"p19\",\n",
       "                    \"value\": \"Here we report fluorescence quenching and electrophoretic mobility shift assays that probe siRNA binding by the dimeric RSS end_entity from Carnation Italian Ringspot Virus CIRV, as well as by human DICER1 and start_entity assembly complexes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PEA15\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"These include COVID-19 that cause severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, Middle East respiratory syndrome MERS, porcine epidemic end_entity start_entity and severe acute end_entity syndrome SADS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OCLN\",\n",
       "                    \"target\": \"TJP1\",\n",
       "                    \"value\": \"We conducted immunofluorescence IF staining for in situ identification of zonula start_entity end_entity proteins for TJ and CDH1 proteins for AJ in the small and large intestinal villous and crypt epithelium of nursing pigs infected with porcine epidemic diarrhea virus PEDV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA8\",\n",
       "                    \"target\": \"IL18R1\",\n",
       "                    \"value\": \"Candidate genes and regions chosen for this study were based on previously reported associations with response to immune stimulants, pathogens, or heat, including: TLR3, TLR7, MX, MHC-B major histocompatibility complex, gene complex, IFI27L2, SLC5A1, HSPB1, HSPA2, start_entity, IFRD1, end_entity, IL1R1, AP2A2, and TOLLIP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BAMBI\",\n",
       "                    \"target\": \"MCL1\",\n",
       "                    \"value\": \"The potential end_entity ligands are evaluated and computationally docked on to three conformation ensembles generated by normal mode analysis start_entity, molecular dynamics MD, and nuclear magnetic resonance NMR, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Korea failed in its risk communication during the early stage of the start_entity end_entity outbreak; consequently, it faced difficulties in managing end_entity, while disease-related worry increased\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"large number of viral and bacterial organisms are responsible for community-acquired end_entity start_entity which contributes to substantial burden on health management\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STK26\",\n",
       "                    \"target\": \"TRAF2\",\n",
       "                    \"value\": \"Real-time qPCR was performed to validate the expression of 6 selected genes RPS24, SARAF, SLC27A3, start_entity, end_entity and LRRC28, and the results of which were consistent with those from the microarray\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"The roles of start_entity T cells in end_entity have been clarified by either loss-of-function or gain-of-function methods, which have been carried out mainly in autoimmune and viral models of end_entity: experimental autoimmune encephalomyelitis and Theiler's murine encephalomyelitis virus infection, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Taken together, these data suggest that in acute RSV infection, start_entity helper lymphocytes and end_entity cytotoxic lymphocytes are primed to undergo apoptosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Publisher Summary start_entity, in particular by respiratory viruses, plays an important role in triggering exacerbations and has also been implicated in the etiology of asthma and chronic obstructive pulmonary disease end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Changes in PBMC cytokine mRNA levels were detected by a reverse transcription, semiquantitative polymerase chain reaction assay RT-sqPCR, assessing start_entity, IL4, end_entity, IL10, IL-12 and IFNA1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p24\",\n",
       "                    \"target\": \"p40\",\n",
       "                    \"value\": \"In the present study, reverse transcription, real-time PCR assays were established for the detection of BDV in the brain tissue from sheep and horses, using loci for the end_entity nucleoprotein and the start_entity phosphoprotein genes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"The same as severe acute respiratory syndrome COVID-19 SARS-CoV, 2019-nCov enters into host cells via cell receptor angiotensin converting enzyme end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity has been identified as the cause of the outbreak of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARK2\",\n",
       "                    \"target\": \"Angelman Syndrome\",\n",
       "                    \"value\": \"ngelman syndrome end_entity is a severe disorder of postnatal brain development caused by neuron-specific loss of the HECT homologous to E6AP carboxy terminus domain start_entity Ube3aE6AP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"MYD88\",\n",
       "                    \"value\": \"Phyllanthus extract induced interferon-beta IFN-, cyclooxygenase-2 COX-2, and interleukin-6 start_entity mRNA expression in HBV WT-transfected HepG2 cells, possibly via activation of extracellular signal-regulated kinases and c-jun N-terminal kinases and the induction of retinoic acid inducible gene-I, TLR3, end_entity, andor TNF receptor-associated factor 6 gene expression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERK\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, end_entity Department; EGF, Epidermal Growth Factor; start_entity, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LGALS3BP\",\n",
       "                    \"target\": \"Cone-Rod Dystrophy 1\",\n",
       "                    \"value\": \"Complementary exchanges of the respective cysteine-rich domains CRD between the ELR1 and murine HveA proteins revealed end_entity as the predominant determinant of functional start_entity binding to ELR1 and also to a chimeric murine HveA protein expressed on the surface of transfected Cf2Th cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cyclosporine\",\n",
       "                    \"target\": \"Eczema\",\n",
       "                    \"value\": \"1 Million South Korean Health-Care Records Gwang-Cheon Jang, Hyun-Hee Lee, Chang-Jong Lee, Huynsun Lim A314 Association of Recurrence Wheeze with Lung Function and Airway Inflammation in Preschool Children Ji-Eun Soh, Dae-Jin Song, Ji-Won Kwon, Hyung Young Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Gwang-Cheon Jang, Woo Kyung Kim, Young-Ho Jung, Soo-Jong Hong, Jung Yeon Shim A315 Mannan-Binding Lectin Serum Levels in Healthy Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A316 Rotanebuliser Prabhakarrao Pv, Ranjitha Nadendla A317 The Level of Serum Interleukin 13 and Interleukin 17A and Its Effect Factors in Children with Asthma Juan Fang, Jing Zhao A318 Is Vitamin D Insufficiency Also Involved in Childhood Asthma in South Korea? Dae-Jin Song, Sungchul Seo, Young Yoo, Yu-Ri Kim, Ji Tae Choung, Jee Hoo Lee A319 Collection of Nasal Secretions for Measurement of Local IgE: A Quest for the Best Method Margot Berings, Natalie De Ruyck, Claus Bachert, Philippe Gevaert, Gabrile Holtappels A320 The Role of Claudin 5 in a Murine Model of Asthma Pureun-Haneul Lee, Byeong-Gon Kim, Choon-Sik Park, George D Leikauf, An-Soo Jang A321 Claudin-4 in a Murine Model of Asthma: Modulation By Acrolein, a Highly Reactive Unsaturated Aldehyde Byeong-Gon Kim, Pureun-Haneul Lee, Choon-Sik Park, An-Soo Jang A322 Efficacy and Safety of Sublingual Immunotherapy in House Dust Mite Sensitized Children with Rhinitis,_Allergic Yang Park A323 The Association of Vitamine D Deficiency and Skeletal Muscle Dysfunction in Chronic Airway Disease Min-Su Sohn, Hyun Jung Jin, Dong-Won Lee, Jun-Hong Ahn, Jin Hong Chung A324 Bacteria Derived Extracellular Vesicles in Indoor Dust Is Closely Associated with Airway Disease and Lung_Neoplasms: Analysis of Indoor Dusts Microbiome and IgG Sensitization of Indoor Bacteria Derived Extracellular Vesicles Sae-in Kim, Han-Ki Park, Do-Yeon Kim, Mina RHOD, Jun-Pyo Choi, Yoon-Keun Kim A325 Clinical Care Program for Childhood Asthma CCP-Childhood Asthma; A Multidisciplinary Team Care at Samitivej International Children's Hospital Wasu Kamchaisatian, Thitikul Hiranras, Surinda Wongpun, Phornthip Chiraphorn, Anupan Tantachun, Wannipa Wongrassamee, Planee Vatanasurkitt, Naratip Somboonkul, Nattipat Juthacharoenwong, Surangkana Techapaitoon, Montri Tuchinda A326 Continuous B Cell Stimulation with CD40 Ligand Induce IgE Isotype Switching Jae Ho Lee, Sejin An A327 Effects of Interleukin-9 on Allergen-Specific Immunotherapy in a Mouse Model of Rhinitis,_Allergic Ji-Hyeon Shin, Soo Whan Kim, Si Won Kim, Jun Myung Kang, Boo-Young Kim, Byung-Guk Kim A328 Usefulness of Exhaled Nitric_Oxide for Evaluating Wheeze and Airway Hyperresponsiveness in Preschool Children Jung-Won Lee, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Jung Yeon Shim A329 Systemic start_entity Treatment in Hand end_entity Patients Kyung Ho Kim A330 Lipid Profiles and Adipokines in Korean Children with Dermatitis,_Atopic Young Yoo, Won Suck Yoon, Sungchul Seo, In Soon Kang, Jae Won Choi, Hye-Young Lim, Ji Tae Choung A331 Validation of Montelukast and Levocetirizine Combination Tablet Versus Individual Tablets in the Treatment of Moderate to Severe Persistent Rhinitis,_Allergic Among Adult Filipinos Seen at the Philippine General Hospital-Outpatient Department Michelle Buela A332 Efficacy of Makyokansekito on Treatment of Respiratory_Sounds Lower Respiratory_Tract_Infections in Children: A Retrospective Study of 68 Patients Koji Nishimura A333 Serum Eosinophilia and Total IgE Are Associated with the Risk of Allergic Sensitization and Allergic Symptoms in Two Years Follow-up, Respectively Sang Chul Park, Hyo Jin Chung, Chang-Hoon Kim, Ju Wan Kang, Seong-Chul Hong, Keun-Hwa Lee, Jaechun Lee, Hye-Sook Lee, Jeong Hong Kim A334 The Sensitization to Russian Thistle on Mongolian Patients Narantsetseg Logii A335 The Association Between Air Pollution, Allergic Sensitization to Inhalant Allergens and Airway Hyperresponsiveness in Ulaanbaatar, Mongolia Munkhbayarlakh Sonomjamts, Enkhbayar Bazarsad A336 Pre-Coseasonal Treatment with a 5-Grass Pollen Sublingual Tablet in Adults Demonstrated a Reduction on Asthma Symptoms in Runion Island Bashir Omarjee A337 Peak Expiratory Flow Rate Reference Values for Children Aged 5-14 Years Old in Beijing Urban Area Shuo TGM1 A338 Soybean Storage Proteins As the Main Allergen in a Patient with Food-Dependent Exercise-Induced Anaphylaxis Due to Tofu Miyuki Hayashi, Ruby Pawankar, Shingo Yamanishi, Toru Igarashi, Yasuhiko Itoh A339 A Study of Hypersensitivity Skin Prick Test with Weed Pollen Oyuntsatsral Batsaikhan, B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"end_entity phage-like particles end_entity start_entity are artificially constructed pseudo-viral particles derived from bacteriophage end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"For the non-SARS patients, cases in the validation cohort presented with less start_entity and coryza but more end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"USP14\",\n",
       "                    \"target\": \"USP5\",\n",
       "                    \"value\": \"Utilizing suicide inhibitors based on ubiquitin and ISG15, we have identified USP2, end_entity IsoT1, USP13 IsoT3, and start_entity as ISG15-reactive proteases, in addition to the bona fide ISG15-specific protease USP18 UBP43\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Noonan Syndrome\",\n",
       "                    \"target\": \"Noonan Syndrome 2\",\n",
       "                    \"value\": \"The non-structural proteins start_entity, end_entity, NS3NS3a play different key roles during the viral replication cycle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSD17B6\",\n",
       "                    \"target\": \"MAGT1\",\n",
       "                    \"value\": \"Site-directed mutagenesis analysis revealed that the start_entity CXXC active-site motif of end_entity or TUSC3 is essential for the glycosylation of LASV RNF130\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Allergic end_entity in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food start_entity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG start_entity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Immediate start_entity Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with start_entity end_entity; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal start_entity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for start_entity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PDE4B\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Upregulated genes included the immune regulatory molecules interleukin 1 IL-1, CIAS-1, end_entity alpha, start_entity, PTGS2, CXCL8, CXCL2, CCL4, ICAM-1, CD83, GOS-2, IER3 IER3, and TNFAIP3 A20\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"Noonan Syndrome 2\",\n",
       "                    \"value\": \"Moreover, specific mutations in core, start_entitys, EXOSC2 and NS5A reported to abolish viral assembly changed the subcellular localization of end_entity protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSB\",\n",
       "                    \"target\": \"CTSL\",\n",
       "                    \"value\": \"end_entity, start_entity, PLAU, CD44, have been noted to echo the hypothesis that increased tumor hypoxia leads to radiation resistance in cervical cancer during radiation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"IL4\",\n",
       "                    \"value\": \"We analyzed the changes in CD14, FCGR1A, CD80, CD163 and CD200R1 expression to evaluate macrophage phenotypes, and the changes in start_entity, IFN-g, end_entity, IL-17a and FoxP3 expression to evaluate T helper subsets using the FACS method\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NAA50\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": \"Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Akira Akasawa, Michihiro Hide, Hiroko Shizukawa A442 Evaluation of the Adherence Starts with Knowledge-20 ASK-20 to Inhaled Drug in Patients with Asthma Naoto Watanabe A443 The Epidemiology and Clinical Manifestation of Hmpv Infection in Children during Recent 4 Years: 2011-2014 Meeyong Shin, Myeong Sun Jang A444 Neutropenia Induced By Intravenous_Immunoglobulin Young-Hee Nam, Yeo Myeong Noh, Dong Sub Jeon, Hee-Joo Nam, start_entityg Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A445 A First Case of Lymphocytic Lung_Diseases,_Interstitial in Healthy Child Ji-in Jung, Ha-Su PSME3m, Hyun-a PSME3m, Jin-a Jung A446 Cytokine Production upon House Dust Mite Stimulation of Cord Blood Mononuclear Cells from Caesarean Section-Delivered Singaporean Infants Anne Goh, Rajeshwar Rao, Bindu Nandanan, Ruurd Van Elburg, Chua Mei Chien, Juandy Jo, Johan Garssen, Johan Garssen, Leon Knippels, Elena start_entitydalova, Wen Chin Chiang A447 Dress Syndrome with Acute Nephritis,_Interstitial Caused By Quinolone and Nonsteroidal Anti-Inflammatory Drugs Young-Hee Nam, Ji Young Juong, Soo Jin PSME3m, Eun Young PSME3m, Su Mi Lee, Young PSME3 Son, Hee-Joo Nam, PSME3-Ho PSME3m, Soo-Keol Lee A448 IL23A Roles in the Development of House Dust Mite Allergic Sensitization and Asthma Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Hyun Seung Lee, Yoon-Seok Chang, Jung-Won Park, start_entityg-Heon Cho, Kyung-up Min, Woo-Jung Song A449 Exposure Profile of Indoor Risk Factors in Dwellings of Children with Dermatitis,_Atopic Hyunwook Lim, Sungchul Seo, Ji Tae Choung, Young Yoo, Jun-Sik Park, Byung Kwan PSME3m A450 Epidemiological Characterization of Blood Eosinophils in the Elderly Population Ha Kyeong Won, Hye-Ryun Kang, Byung-Keun PSME3m, Sung Do Moon, Ju-Young PSME3m, So-Hee Lee, Woo-Jung Song, Heung Woo Park, Min-Koo Kang, Sun-Sin PSME3m, start_entityg-Heon Cho, Kyung-up Min, Yoon-Seok Chang, Kyoung Hee Sohn, Kyung-Mook PSME3m, PSME3-Woong PSME3m, Hak Chul Jang A451 Stevens-Johnson_Syndrome Caused By Methotrexate in the Treatment of Psoriasis Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, start_entityg Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A452 Genetic Determinants for Lung Function Growth in Asthma Children Ting Fan Leung, Man Fung Tang, Hing Yee Sy, Wa Cheong Chan, Wilson Wai start_entity Tam A453 The Power of Allergen Specific Ig E in the Classification of end_entity, Korean National Hanes 2010 Seung Kyu Chung, Sujin PSME3m, start_entityg Duk Hong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Hun-Jong Dhong, Jong in Jeong A454 Analysis of Allergen Immunotherapy Practice and Patients Knowledge and Attitude about Allergen Immunotherapy in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A455 Roles of Staphylococcal Enterotoxin B in House Dust Mite-Induced Acute Asthma Models Ji Won Lee, Mingyu Kang, Soon-Hee PSME3m A456 A Clinical Comparison of Drug_Hypersensitivity_Syndrome in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, start_entityg Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A457 The Beneficial Effect of Lactobacillus Gasseri PM-A0005 and Its Immunoregulatory Protein PMA5P40 on Milk-Induced Allergic Enteritis Yung-I Hou, Jiu-Yao Wang A458 Relationship Between Serum Folate Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Seol Jae Hee, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A459 Effects of Vitamin D in Patients with Chronic Rhinosinusitis Yuta Soma, So Watanabe, Ruby Pawankar, Ruby Pawankar, Harumi Suzaki, Harumi Suzaki, Hitome Kobayashi A460 Clinical Features of Systemic Dermatitis,_Contact from Ingestion of Rhus Young-Hee Nam, Chansun Park, Soo-Keol Lee A461 Sublingual Immunotherapy Efficacy in Patients with Dermatitis,_Atopic in Korea Jongrok Lee, Jooyoung Roh, Haryeong Ryu A462 Characteristics of Serious Drug-Related_Side_Effects_and_Adverse_Reactions in a Tertiary University Hospital Cheol-Woo PSME3m, Jae Hwa Cho, Mi Ra Eom, Ji Young Kang, Hye Gyeung Lee A463 Eyelid Dermatitis: Patch Test Results during a 15-Year Period in Korea and Evaluation of Metal Contents in Eye Shadows Hae Young Choi, Hye Jin Lee, Ju Yun Woo, Ji Yeon Byun, You Won Choi A464 Relationship Between Lipid Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A465 IL-32 in the Induced Sputum of Patients with Asthma Jae-Woo Kwon, Hun Soo Chang, Jeong-Seok Heo, Jong-Uk Lee, Jong-Sook Park, Eusom PSME3m, Soo Hyun PSME3m, Choon-Sik Park A466 Clinical Characteristics of Patients with Chromium Hypersensitivity in a Single University Hospital in Korea Hae Young Choi, Ji Yeon Byun, Ju Yun Woo, You Won Choi A467 Efficacy and Safety of Oral Acitretin in Chronic Hand Eczema Hyun-Ju Jin, Jin-Hwa Son, Jeong-Min PSME3m, Gun-Wook PSME3m, Je-Ho Mun, Margaret Song, Hyun-Chang Ko, Moon-Bum PSME3m, Hoon-Soo PSME3m, Byung Soo PSME3m A468 Atypical Antipsychotics and Anticholinergic Agents Mimicking Anaphylaxis Sheryl Van Nunen, Dinh Van Nguyen, Anthony Elias, Susannah Olivia Lauer A469 Introducing Reach Reliable Estimation of Dermatitis,_Atopic in ChildHood: Novel, Questionnaire-Based Diagnostic Criteria for Childhood Dermatitis,_Atopic Seung-Chul Lee, Ho-June Lee, Jung Min Bae A470 Comprehensive Assessment to Identify the Causative Factors in Oral Hypersensitivity Syndrome Emi Ono A471 Comparison of Interpretation Methods in Allergic Skin Test Sung-Hwa Dong, Tae Kyung Koh, Young Seok Byun, Sung Wan PSME3m, Joong-Saeng Jo, Chul Kwon, Kun Hee Lee A472 Refraining Aminophylline Use Increases Hospitalization Among Children with Acute Asthma: A 10-Years Retrospective Cohort Study Li-Fan Liu A473 The Prevalence and Risk Factors of Dermatitis,_Atopic from Nationwide Study for Korean School Students Sunghee Lee A474 Probiotic Recombination Protein Effect on Dermatitis,_Atopic Wei-Leng Chen, Jiu-Yao Wang A475 Allergic Sensitization Status in Various Inflammatory Skin_Diseases Youin Bae, Gyeong-Hun Park A476 Two Cases of Good's Syndrome: A Rare Acquired Immunologic_Deficiency_Syndromes Associated with Thymoma Suk Yeon PSME3m A477 IL23A Has a Role to Play in the Development of Asthma in Short-Term Cigarette Smoke Exposure-Induced House-Dust Mite Allergic Model Hyun Seung Lee, Woo-Jung Song, Mingyu Kang, Han-PSME3 Park, Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Hye-Young PSME3m, Kyung-up Min, start_entityg-Heon Cho, Ji-Won Lee, Boram Bae, Jung-Won Park A478 The Relationship Between the Relevance of Allergic Disease and the Value of Non-Specific IgE Yasuhiro Suzuki A479 Two Caces of Prawn Hypersensitivity in Adult Patients Ismet Bulut, Zeynep Ferhan Ozseker A480 Early Gut Bifidobacterium Breve and B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV1-17\",\n",
       "                    \"target\": \"TSLP\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva start_entity Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 end_entity downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, IL5, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C7orf49\",\n",
       "                    \"target\": \"PTH\",\n",
       "                    \"value\": \"start_entity confirmed that intermittent end_entity administration improved SAON after Hamartoma_Syndrome,_Multiple therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EGF\",\n",
       "                    \"target\": \"SPON1\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, Emergencies Department; start_entity, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, Thromboend_entity; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAX\",\n",
       "                    \"target\": \"Behcet Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity had the lowest turnaround time and highest throughput\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RNF130\",\n",
       "                    \"target\": \"Niemann-Pick Disease, Type C\",\n",
       "                    \"value\": \"This event allows cleaved start_entity start_entitycl to bind to Niemann-Pick C1 end_entity, its endosomal receptor\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food end_entity with Recurrence start_entity Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG end_entity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Immediate end_entity Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with end_entity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal end_entity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for end_entity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of start_entity Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of start_entity Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMOX1\",\n",
       "                    \"target\": \"OAS1\",\n",
       "                    \"value\": \"PR8 virus increased ROS1 production, Nrf2, start_entity, Mx1 and end_entity expression and Nrf2 translocation to the nucleus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAVS\",\n",
       "                    \"target\": \"RELA\",\n",
       "                    \"value\": \"More importantly, the endoribonuclease activity of nsp11 demonstrates the substrate specificity towards start_entity and DDX58 transcripts and proteins over end_entity and IRF3 in the context of gene transfection and overexpression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL-27\",\n",
       "                    \"target\": \"SNCG\",\n",
       "                    \"value\": \"In contrast, infected start_entity receptor deficient start_entityR mice, characterized by a drastic reduction of Tr1 cells, revealed that end_entity CD4 T cells in CLN remained unchanged but were specifically increased within the CNS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"During acute viral hepatitis, the intrahepatic tolerance sustained by immunosuppressive cytokines such as interleukin IL4, end_entity, transforming growth factor TGF- and prostaglandin start_entity PGstart_entity, produced by Kupffer cells KC, liver sinusoidal endothelial cells LSEC, natural killer NK T cells and natural regulatory T cells may be disturbed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"SAA1\",\n",
       "                    \"value\": \"CONCLUSION: A combination of start_entity, end_entity, PTX3 and properdin was able to identify children with a severe course of viral LRTI disease, even in children under 2 months of age\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL11\",\n",
       "                    \"target\": \"CXCL9\",\n",
       "                    \"value\": \"Human cells mounted vigorous cytokine TNF alpha TNF- and interleukin-6 IL6 and chemokine end_entity, CXCL10, and start_entity responses to H5N1 virus infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"NEAT1\",\n",
       "                    \"value\": \"HTNV infection activated end_entity transcription through the start_entityIRF7 pathway, whereas end_entity removed the transcriptional inhibitory effects of the splicing factor proline- and glutamine-rich protein SFPQ by relocating SFPQ to paraspeckles, thus promoting the expression of start_entity and DDX60\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PIK3CA\",\n",
       "                    \"target\": \"SRPK1\",\n",
       "                    \"value\": \"It was also observed that SOX2 knockdown decreased end_entity expression, which further led to the downregulation of start_entity and AKT1 expression levels in BCC cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Consequently, TNF--pre-treated cAT-MSCs further regulated colonic inflammatory cytokines such as interleukin IL-1, end_entity, and start_entity, and ameliorated DSS- or DNBS-induced colitis in mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DP1\",\n",
       "                    \"target\": \"HPGDS\",\n",
       "                    \"value\": \"Here we show that end_entity signaling through the D-prostanoid receptor 1 start_entity receptor is necessary for optimal microgliamacrophage activation and IFNA1 expression after infection with a neurotropic COVID-19\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"STING overexpression induced the start_entity response via the IRF3 and NF-B pathways and up-regulated the expression of end_entity and RSAD2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"SAA1\",\n",
       "                    \"value\": \"The AUCs of WBC, start_entity, and end_entity for predicting severe and critically severe COVID-19 were 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADAM10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma end_entitye end_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of start_entity and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Over a year after the emergence of this start_entity-end_entity start_entity MERS-CoV-it has caused 178 laboratory confirmed cases and 76 deaths The emergence of a second highly pathogenic start_entity within a decade highlights the importance of a coordinated global response incorporating reservoir surveillance, high-containment capacity with fundamental and applied research programs, and dependable communication pathways to ensure outbreak containment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV6-21\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi start_entity Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, IL5, end_entity, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"Interestingly, these recently recognized viruses include not only some with oncogenic potential hepatitis B virus, rhesus papillomavirus, cottontail rabbit papillomavirus but also many without this potential influenza virus, end_entity virus, tick-borne encephalitis virus, rabies virus, severe acute respiratory syndrome start_entity, human immunodeficiency virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H1\",\n",
       "                    \"target\": \"H5\",\n",
       "                    \"value\": \"METHODS: Nasal swabs were taken from 197 consenting piggery workers and 281 randomly selected pigs to determine the prevalence of Influenza-A start_entity, H3, end_entity using Reverse Transcriptase Polymerase Chain Reaction test gene M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ISG15\",\n",
       "                    \"target\": \"USP18\",\n",
       "                    \"value\": \"In contrast to other proteases of the ubiquitin-specific protease USP family, end_entity shows no reactivity towards ubiquitin but specifically deconjugates the interferon induced Ubl start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MRLN\",\n",
       "                    \"target\": \"NP\",\n",
       "                    \"value\": \"In this study, we inserted into a replication defective PanAd3 a transgene expressing a fusion protein of conserved influenza antigens nucleoprotein end_entity and matrix 1 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E4\",\n",
       "                    \"target\": \"Food Hypersensitivity\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of end_entity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene start_entity in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV and Middle East respiratory syndrome start_entity MERS-CoV, on the other hand, have strike humans in the past two decades as highly fatal human pathogens leading to considerable mortality and economic loss\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"New data from Wang and colleagues show that complement C3 suppresses the function of start_entity tumor-infiltrating T cells by inhibiting end_entity production, and targeting the complement receptors C3aR and C5aR enhances the antitumor activity of immune checkpoint blockade\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VDR\",\n",
       "                    \"target\": \"Acute Lung Injury\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of start_entity and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced end_entity Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERN1\",\n",
       "                    \"target\": \"XBP1\",\n",
       "                    \"value\": \"Furthermore, virus infection activated start_entity, another EREG stress sensor, thereby promoting the mRNA splicing of end_entity and resulting in the translation of transcription factor end_entitys\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C1\",\n",
       "                    \"target\": \"GSR\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and Urticaria Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, TSLP, Periostin, IL13 and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to start_entity inhibitor deficency start_entity-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous Urticaria Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression KLRK1 and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoend_entity GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute Urticaria at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"PBRM1\",\n",
       "                    \"value\": \"BALBc mice were immunized intramuscularly with a single vaccine based on start_entity, end_entity, or MRLN alone or a combination vaccine based on all three antigens and were then challenged with lethal doses of the heterologous influenza virus strain APR834 H1N1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"Newcastle Disease\",\n",
       "                    \"value\": \"To determine the role of the conserved leucines in the oligomeric structure and biological activity of the end_entity virus NDV fusion protein, the heptadic leucines at amino acids 481, 488, and 495 were changed individually and in combination to an start_entity residue\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPT\",\n",
       "                    \"target\": \"Alzheimer Disease\",\n",
       "                    \"value\": \"METHODS: We measured ACE-2 activity by fluorogenic peptide substrate assay in mid-frontal cortex Brodmann area 9 in a cohort of end_entity n 90 and age-matched non-demented controls n 59 for which we have previous data on ACE-1 activity, amyloid A level and start_entity pathology, as well as known ACE rs1799752 indel polymorphism, APOE APOE genotype, and cerebral amyloid angiopathy severity scores\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A4\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher start_entity Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of ADend_entity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, IL5, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn start_entity0 Danyoung classification 2015 update by digital end_entity endoscopic evaluation SUN-HOBrian Chang start_entity1 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li start_entity2 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi start_entity3 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu start_entity4 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim start_entity5 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won start_entity6 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TNFRSF11B\",\n",
       "                    \"value\": \"We measured the mRNA expression of cytokines with stimulatory IL-1, start_entity, and TNF- and inhibitory effects IL10 and IFN- on osteoclastogenesis, and the mRNA expression of the receptor activator of nuclear factor-kappaB ligand TNFSF11, end_entity OPG, and nVDR in RELN samples\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Measurements We prospectively studied 56 start_entity exacerbations, obtaining clinical data and paired end_entity and serum samples at baseline and exacerbation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD40LG\",\n",
       "                    \"value\": \"Extensive immunological analysis using polychromatic flow cytometry staining revealed that vaccinated, but not mock-vaccinated mice developed robust cellular immune responses as evidenced by up-regulation of start_entity end_entity IFNA1 T cells in vaccinated, but not mock-vaccinated mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pigmentary Disorder, Reticulate, with Systemic Manifestations\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and Allopurinol Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to Glatiramer_Acetate: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 Asthma Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent end_entity Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with end_entity Chellaa R A615 Study of Incidence of Severe Persistent end_entity in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent end_entity in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent end_entity in Central India Subir Jain A617 Dermatitis,_Atopic: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe Dermatitis,_Atopic Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of end_entity Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao start_entity Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, end_entity, Dermatitis,_Atopic, and Acute Upper Respiratory_Tract_Infections and Levels of Severity of Asthma in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in Eosinophilic_Esophagitis Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent Dermatitis,_Atopic Associated with Parasitic Infection Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and Asthma Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in Asthma, end_entity, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via ERK and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of Asthma Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of Anaphylaxis and Asthma Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe Dermatitis,_Atopic Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL12\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Using the murine end_entity model, experimental autoimmune encephalomyelitis EAE, we previously demonstrated that antagonism of the chemokine receptor ACKR3 blocks endothelial cell sequestration of start_entity, thereby enhancing the abluminal localization of CXCR4-expressing leukocytes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"DUSP4\",\n",
       "                    \"value\": \"start_entity memory T cells from individuals older than 65 y displayed increased and sustained transcription of the dual-specific phosphatase 4 end_entity that shortened expression of start_entity0-ligand start_entity0L and inducible T-cell costimulator ICOS both P 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Results showed that end_entity increased start_entity mRNA abundance and exhibited time-dependent effect for end_entity treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Halofuginone\",\n",
       "                    \"target\": \"HL\",\n",
       "                    \"value\": \"start_entity lactate end_entity is registered in several countries for the prevention of calf cryptosporidiosis, but the compound's utility in the presence of co-infection with other enteropathogens is not well understood\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAPDH\",\n",
       "                    \"target\": \"RPL35\",\n",
       "                    \"value\": \"start_entity and end_entity transcripts also declined over time\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SERPINC1\",\n",
       "                    \"target\": \"VWF\",\n",
       "                    \"value\": \"In addition, ALB, blood transfusion erythrocytes, granulocytes, and platelets, blood substitutes hemoglobin-based oxygen carriers, plasma products alpha1-antitrypsin, C1 esterase inhibitor concentrate, cryoprecipitate, and fresh frozen plasma, plasma substitutes etherified starches, and gelatin, globulins intravenous immunoglobulin, subcutaneous immunoglobulin, and anti-D immunoglobulin, coagulation proteins factor I, factor GCNT2, F7a, factor COX8A, factor IX, prothrombin complex concentrate, start_entity, and end_entityfactor COX8A concentrates, EPO and derivatives, THPO and receptor agonists, transmission of infectious agents through blood donation, and stem cells are reviewed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK14\",\n",
       "                    \"target\": \"MAPK8\",\n",
       "                    \"value\": \"HSV-2 infection increased the phosphorylation of end_entity and p38, and reduced ERK phosphorylation at 8 h postinfection in the host cells; BX-795 treatment inhibited HSV-2-induced activation of end_entity and start_entity as well as the phosphorylation of JUN and ATF-2, the downstream targets of end_entity and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and end_entity Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, TSLP, Periostin, IL13 and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous end_entity Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression KLRK1 and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial start_entity Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with start_entity when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute end_entity at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"PARP9\",\n",
       "                    \"value\": \"To determine the predictive value of nasopharyngeal start_entity sample testing for respiratory viruses RVs in suspected lower respiratory tract disease, 72 paired start_entity and bronchoalveolar lavage end_entity fluid specimen sets, mostly from transplant recipients or patients with hematologic malignancies, were analyzed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HLA-DRB1\",\n",
       "                    \"target\": \"Hereditary pancreatitis\",\n",
       "                    \"value\": \"The DE genes involved in the immune response included genes for inflammasomes RETN, S100A8, S100A9, S100A12, adhesion molecules CLDN3, VCAN, CD44, LGALS8, transcription factors ZBTB16, SLC39A14, CEBPD, CEBPB, acute-phase proteins and complement SAA1, LTF, end_entity, C3, differentiation genes for epithelial cells and keratinocytes TGM1, MS4A8, CSTA, and genes related to antigen processing and presentation HLA-B, start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Conclusions: Lymphopenia and start_entity may serve as the risk factors related to hepatic injury in patients with end_entity, which might be related to inflammatory cytokine storm in liver injury\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HACE1\",\n",
       "                    \"target\": \"TBK1\",\n",
       "                    \"value\": \"Further study indicated that start_entity acted downstream of MAVS and upstream of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD83\",\n",
       "                    \"target\": \"IER3\",\n",
       "                    \"value\": \"Upregulated genes included the immune regulatory molecules interleukin 1 IL-1, CIAS-1, TNF alpha, PDE4B, PTGS2, CXCL8, CXCL2, CCL4, ICAM-1, start_entity, GOS-2, end_entity end_entity, and TNFAIP3 A20\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PCBD2\",\n",
       "                    \"target\": \"TTN\",\n",
       "                    \"value\": \"Using qRT-PCR, when CSH2 and start_entity or EIF4G2, PSG4 and end_entity were silenced by RNAi, transcriptional levels of HBV s and x genes decreased or increased\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL13\",\n",
       "                    \"target\": \"Respiratory Sounds\",\n",
       "                    \"value\": \"Nataly Tataurshchikova A590 A Novel Biomarker for end_entity and Atopy in Early Infancy Eishika Dissanayake, Yuzaburo Inoue, Naoki Shimojo, Taiji Nakano A591 Prognostic Factors for Dermatitis,_Atopic in Spontaneously Born Babies from Low Socioeconomic Background Conny Tanjung A592 Higher IgE Antibody Levels Mediate Anti-Cancer Immunity in Transgenic KN1 Hyper-IgE Mice Erika Jensen-Jarolim, Judit Fazekas, Josef Singer, Anna Lukschal, Reinhard Horvat, Gertrude Achatz-Straussberger, Gernot Achatz A593 Fructooligosaccharides Intake during Pregnancy and Lactation Increases Gut Bifidobacterium and IL-27 in Breast Milk Yuji Fujita, Shuji Ikegami, Yoshitaka Nakamura, Yuzaburo Inoue, Naoki Shimojo, Yoichi Kohno, Shuichi Suzuki, Naoko Ozawa, Takayuki Kubota, Ken Nonaka, Osamu Ohara, Kentaro Masuda A594 Effect of Nintedanib on Asthma in Mouse Model Chin Kook Rhee, Sook Young Lee, Hwa Young Lee, Hea Yon Lee, Ji Young Kang, Sei Won Kim, Soon Seog Kwon, Young Kyoon Kim A595 Delayed Contrast Media Hypersensitivity after Coronary Angiography Gun-Woo Kim, Ju-Young Kim, Sang-Heon Cho, Hye-Ryun Kang, Hyo-Soo Kim, Jung Gyu Han, Jin Lee, Ji Young Lee, Ji Young Go, So Jung Park A596 Gene Expression Profiling in Patients with Chronic Idiopathic Urticaria Reveals Unique Gene Signature Distinct from Healthy Controls Julie Kim-Chang, Cassandra Love, Patricia Lugar A597 Failure to Recognize Lymphopenia in Newborn Leads to Undetectable Primary Immunologic_Deficiency_Syndromes Endah Citraresmi A598 The Concordance Between Lung Function Test and Indonesian Version of Childhood Asthma Control Test SLC25A20 Nastiti Kaswandani, Cynthia Utami, Mardjanis Said A599 Synergistic Interaction Between Bronchiolitis and PM10 Is Modified By start_entity Polymorphism on Asthma Development: Replication from Cheer Study Young-Ho Jung, Song-I Yang, Byoung-Ju Kim, Ji-Won Kwon, Hwan-Cheol Kim, Jong-Han Leem, Ju-Hee Seo, Hyung Young Kim, So-Yeon Lee, Ho-Jang Kwon, Hyo-Bin Kim, Hyun-Ju Cho A600 The Transcription Factor Ehf Is Involved in TGF-b-Induced Suppression of Fceri and c-Kit Expression and Fceri-Mediated Activation in C9orf9 Cells Susumu Yamazaki, Nobuhiro Nakano, Asuka Honjoh, Eisuke Inage, Yosuke Baba, Yoshikazu Ohtsuka, Toshiaki Shimizu A601 The Follow up of the Potential Immunosuppressant Effects of Marijuana MJA Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A602 Risk Factors of Allergen Sensitization at 3 Years: Results from the Gusto Study Evelyn Xiu Ling Loo, Anne Goh, Oon Hoe Teoh, Yiong Huak Chan, Seang Mei Saw, Kenneth Kwek, Peter D Gluckman, Keith M Godfrey, Hugo Van Bever, Yap Seng Chong, Bee Wah Lee, Lynette Shek, Alison Joanne Lee A603 IL6 Blockade As a Steroid-Sparing Treatment for Rhupus Patients Daniela Rossi A604 Examination of Late Pulmonary Drug_Toxicity in Children Treated for Malignancies Agnes Nemeth A605 Technical Validation of the Repurposing of a Personal Particle Sampler to Determine House Dust Mite Exposure in the Ambient Air Torsten Sehlinger, Karl-Christian Bergmann, Frank Goergen A606 Zinc Deficiency in Children with Severe Dermatitis,_Atopic: More Common Than Generally Thought Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"However, no acute worsening of the respiratory status was found, determined as the presence of fever and upper respiratory symptoms or a recent change in at least two of the following: end_entity volume or colour, start_entity intensity, increased malaise, increased dyspnea, loss of appetite, a decrease of FEV1 10 modified Fuchs criteria\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CADM1\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The end_entity COVID-19 MERS-CoV papain-like protease PLpro blocking loop 2 start_entity structure differs significantly from that of SARS-CoV PLpro, where it has been proven to play a crucial role in SARS-CoV PLpro inhibitor binding\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dehydrated Hereditary Stomatocytosis, Pseudohyperkalemia, and Perinatal Edema\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Conclusions Our results suggest that the end_entity outbreak was significantly associated with DAWV, and that DAAP, DARH and start_entity may also have influenced the end_entity outbreak to some extent\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Recurrence\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with end_entity Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Atopic start_entity of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic start_entity in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Atopic start_entity Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARG1\",\n",
       "                    \"target\": \"DDX60\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; start_entity, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; end_entity, DExDH-Box Helicase 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Autism Spectrum Disorder\",\n",
       "                    \"target\": \"Lung Injury\",\n",
       "                    \"value\": \"Lemessurier, Josepha Moore, Jeoung-Eun Park, Ae-Kyung Yi, ChiYoung Song, KafaitU Malik A383 Korean Profile in Childhood Asthma Severity Classification Dongin Suh, Ja Kyoung Kim, Hyeon-Jong Yang, Bong-Seong Kim, Youn Ho Shin, So-Yeon Lee, Geunhwa Park, Woo Kyung Kim, Hyo-Bin Kim, Heysung Baek, Dae Hyun Lim, Dae Hyun Lim, Jin Tack Kim A384 Prevalence of Food Sensitization, IgE-Mediated and Non-IgE-Mediated Food_Hypersensitivity Among Pediatric Patients Diagnosed with start_entity Aimee Lou Manalo Nano A385 Component-Resolved Diagnostic Study of Dermatophagoides Pteronyssinus Major Allergen Molecules in a Southern China Wenting Luo, Baoqing Sun A386 Risk Factors for Systemic and Local Reactions to Subcutaneous Allergen Immunotherapy Hikmet Tekin Nacaroglu, Semiha Bahceci Erdem, Ozlem Sumer, Sait Karaman, Canan Sule Unsal Karkiner, Suna Asilsoy, Ilker Gunay, Demet Can A387 Literature Review and Current Treatment Options for Cyclical Anaphylaxis Danielle Kiers A388 The Effect of Surfactant Protein D in Acute end_entity and Pulmonary_Fibrosis Induced By Bleomycin Hsu Han Yin, Jiu-Yao Wang A389 Activation of Endothelial Cells to Release HSP90AA1, an Activator of the Prekallikrein-High Molecular Weight Kininogen ATP12A Complex Allen Kaplan, Kusumam Joseph, Baby G\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic end_entity with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms end_entity in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity end_entity in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic start_entity in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"In addition, differential expression of cytokines within these pulmonary tissues were observed, including notable genes involved in the interferon IFNA1 pathway, such as Stat1, IFNA1 regulatory factor-1 IRF-1, interleukin-6 start_entity, CXCL8, and IL18, that are often characterized as elevated in end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P1\",\n",
       "                    \"target\": \"SLC10A3\",\n",
       "                    \"value\": \"lass of tripeptidyl transition state inhibitors containing a start_entity glutamine surrogate, a RPLP2 leucine, and a end_entity arylalanines, was found to potently inhibit Norwalk virus replication in enzyme and cell based assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The virus, which emerged in the Chinese city of Wuhan in December, is a start_entity and belongs to the same family as the pathogen that causes severe acute respiratory syndrome, or end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD28\",\n",
       "                    \"target\": \"MERTK\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab end_entity zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking start_entity signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-Aend_entityican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We generated a end_entity start_entity end_entity-CoV spike protein-expressing recombinant vaccinia virus RVV-S using highly attenuated strain LC16m8\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"CD19\",\n",
       "                    \"value\": \"RESULTS: Amplification of N and NP gene was detected in start_entity monocyte and end_entity B cell, significant increase in virus titre was also observed in these subsets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GBF1\",\n",
       "                    \"target\": \"RSAD2\",\n",
       "                    \"value\": \"Through analysis of the end_entity-interactome, we identified the Golgi brefeldin A-resistant guanine nucleotide exchange factor 1 start_entity as the cellular protein targeted by end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"CONCLUSIONS: This study has identified various pro-inflammatory cytokines and interferon-related genes such as MX1, RSAD2, CXCL10, CCL8, CCL5, KC, CCL2, end_entity, start_entity and IFNA1 in FCoV-positive cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AKT1S1\",\n",
       "                    \"target\": \"RPTOR\",\n",
       "                    \"value\": \"Immunoblotting confirmed GH-stimulated phosphorylation of all seven novel GH-dependent sites tested regulatory sites in proline-rich Akt substrate, 40 kDA start_entity, end_entity, ATP-citrate lyase, NaH exchanger-1, MYCN downstream regulated gene 1, and Shc\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"diarrhea\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Neonatal piglets infected with MRV-ZJ2013 displayed mild clinical signs such as poor appetite and soft feces, but end_entity and start_entity were not observed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"Arthritis, Rheumatoid\",\n",
       "                    \"value\": \"start_entity fluid from 40 of patients with end_entity was positive for a pathogenic microbe\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX60\",\n",
       "                    \"target\": \"EGF\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; start_entity, DExDH-Box Helicase 60; ED, Emergencies Department; end_entity, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"NR4A1\",\n",
       "                    \"value\": \"Here, we investigated a range of cell lines from different species for their susceptibility to infection by pseudotyped viruses Polycythemia_Vera bearing bat FOXRED1 andor end_entity start_entitys\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"Calves were fed pasteurized whole milk end_entity or fractionated colostrum replacer start_entity at birth d 0 and injected with vitamins according to treatment group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VDR\",\n",
       "                    \"target\": \"Pulmonary Eosinophilia\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of start_entity and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute end_entity Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"MSN\",\n",
       "                    \"value\": \"Migratory activity-related proteins, including plastin-2 LCP1, end_entity end_entity, lamin-B1 LMNB1, Ras GTPase-activating-like protein IQGAP1 and others, were identified in start_entity T cells and CD68 macrophages infiltrated to inflamed FT1DM islets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"HAP\",\n",
       "                    \"value\": \"Summary Community acquired COVID-19 start_entity, hospital-acquired COVID-19 end_entity and ventilator associated COVID-19 VAP are all associated with significant mortality and cause huge expense to health care services around the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Many intrahospital exposures, including aspiration, delayed resuscitation, high tidal volume mechanical start_entity and non critical use of transfusions may contribute or worsen end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B3GNT3\",\n",
       "                    \"target\": \"TRIM27\",\n",
       "                    \"value\": \"A further functional study indicated the role of Interferon-induced start_entity IFITM3, Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 CHCHD2, and Tripartite motif-containing protein 27 end_entity in inhibiting viral DNA replication and proliferation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BDNF\",\n",
       "                    \"target\": \"VEGFA\",\n",
       "                    \"value\": \"The decreased expression of inflammatory factors IL-1, IL6 and TNF- by Western blotting assay and ELISA, angiogenesis protein end_entity by Western blotting assay and other related proteins start_entity, NF-B, NOS2 and COX-2 by Western blotting assay in peri-tumour tissue indicated that AVNP2 could control tumour-associated inflammation, thus efficiently ameliorating the local inflammatory condition and, to some extent, inhibiting angiogenesis in C6-bearing rats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK8\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"A strong polar interaction was predicted between Thr-180 within the phosphorylation lip of end_entity and Gln-273 of nsP2, whereas, no such polar interaction was predicted for the phosphorylation lip of start_entity which indicates the differential roles of p-end_entity and p-start_entity during CHIKV infection in the host macrophages\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"Attention Deficit Disorder with Hyperactivity\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of end_entity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on start_entity, IL5, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"The end_entity domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor start_entity on the host cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL16\",\n",
       "                    \"target\": \"Tissue Adhesions\",\n",
       "                    \"value\": \"The signature's genes are: Interferon Stimulated Gene 15 ISG15, Interleukin 16 start_entity, 2,5-Oligoadenylate Synthetase Like OASL, and end_entity G Protein Coupled Receptor E5 ADGRE5\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"Distal Myopathies\",\n",
       "                    \"value\": \"In addition, replacement of the E2 end_entity by the anchor signal of start_entity or a GPI moiety abolished the formation of E1-E2 complexes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PPARA\",\n",
       "                    \"target\": \"PRKAA2\",\n",
       "                    \"value\": \"TSB andor TSF promoted phosphorylation of AMP-activated protein kinase end_entity and acetyl-coA carboxylase and start_entity upregulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pranlukast\",\n",
       "                    \"target\": \"Drug Eruptions\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed end_entity Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of start_entity Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MBL\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Objectives To assess associations between the functional polymorphisms G-2518A at the chemokine CC motif ligand 2 gene CCL2 and mannose binding lectin start_entity codon 54 variant AB and susceptibility to end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"TF\",\n",
       "                    \"value\": \"Thus, recognition of end_entity variants by start_entity could significantly impact the transition from acute to chronic infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C4A\",\n",
       "                    \"target\": \"LRRC23\",\n",
       "                    \"value\": \"The 13 HLA Class I supertypes are A1, A2, A3, A24, end_entity, NDUFA2, MRAP, B44, B58, B62, C1, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Exotic and emerging viral pathogens associated with high morbidity and mortality in humans are being identified annually with recent examples including Lujo virus in southern Africa, Severe end_entity with Thrombocytopenia Syndrome virus in China and a SARS-like start_entity in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"In particular, CDKN2A in MERS patients occurred considerably earlier after a median time to onset of 11 days end_entity 2,0 days as opposed to 20 days for start_entity, according to the literature\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Rather, the interplay between start_entity and end_entity subunits of spikes from the same viral origin might finally determine the avidity and specificity of virus attachment and thus viral host range\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"diarrhea\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"ute gastroenteritis, characterized by the onset of start_entity with or without end_entity, continues to be a major cause of morbidity and mortality in children in mostly resource-constrained nations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"G2\",\n",
       "                    \"target\": \"NDUFB6\",\n",
       "                    \"value\": \"Each virus vigorously induced an NK cell infiltrate into the peritoneal cavity and liver, causing some redistributions of NK cell subsets defined by monoclonal antibody mAb directed against Ly49A, end_entity, D, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"The spike S protein of severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome COVID-19 CoV, a type I transmembrane start_entity, consists of PSMD1 and end_entity domains responsible for virus binding and fusion, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"CD68\",\n",
       "                    \"value\": \"Using immunofluorescence and cell sorting techniques, we confirmed that human liver macrophages expressing start_entity and end_entity are highly responsive to IFN- ex vivo\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"We previously reported that the adaptive immune response plays an important protective role in MHV-1 infected resistant B6 mice and that both start_entity and end_entity T-cells play a significant role in the development of morbidity and lung pathology following intranasal MHV-infection of susceptible C3HHeJ and AJ mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SETD2\",\n",
       "                    \"target\": \"SRF\",\n",
       "                    \"value\": \"Additionally, we found evidence of interspecies variation in binding sites for several regulatory elements linked to NOS2 GATA-3, GATA-4, KLF6, end_entity, STAT-1, STAT-3, OLF-1 and start_entity across species, especially in African green monkeys relative to other species\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Polycythemia Vera\",\n",
       "                    \"value\": \"When compared to culture, the xTAG end_entity showed a sensitivity and specificity of 100 and 91, compared to MultiCode-PLx with 89 and 87, and ResPlex start_entity with 89 and 94, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Imiquimod\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"start_entity stimulates binding of several induction-specific nuclear complexes: i the NF-kappa B-specific complexes binding to the kappa B enhancer present in the promoters of all cytokine genes, but not in end_entity genes, and ii the complexes binding to the A4F1 site, 5'-GTAAAGAAAGT-3', conserved in the inducible element of end_entity genes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCR2\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"The results showed that end_entity decreased the expression levels of CXC-chemokine receptor CXCR1, start_entity and L-selectin SELL, and increased the expression of interleukin-8 CXCL8 by neutrophils\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a newly detected porcine start_entity causing serious vomiting and end_entity in piglets, especially newborn piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAP3K7\",\n",
       "                    \"target\": \"Carcinoma, Hepatocellular\",\n",
       "                    \"value\": \"Through a kinome siRNA library screening, we found that start_entity was a crucial gene for end_entity cell proliferation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"These data demonstrate that certain inflammatory stimuli TNF- and end_entity but not others start_entity and IL10 target USP18 expression and thus inhibit IFNA1 signaling\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome start_entity was first identified in 2003 when it caused an epidemic of fatal human start_entity cases that rapidly spread to multiple countries from an epicenter in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFI16\",\n",
       "                    \"target\": \"MB21D1\",\n",
       "                    \"value\": \"In recent years, the discovery of DNA sensing proteins, including cyclic GMPAMP synthase end_entity and gamma-interferon-inducible protein start_entity, has led to understanding of how cells evoke strong innate immune responses against incoming pathogens carrying DNA genomes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"LD\",\n",
       "                    \"value\": \"However, when weather is cold, dry, or extremely hot, empirically treating all start_entity patients for end_entity might contribute to excessive antimicrobial drug use at a population level\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"creatine kinase\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The highest leukocyte and neutrophil counts, lactate dehydrogenase, and start_entity; positive end-expiratory pressure; and use of corticosteroids, ribavirin, and intravenous immunoglobulin were higher in the end_entity group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MCOLN3\",\n",
       "                    \"target\": \"TPCN2\",\n",
       "                    \"value\": \"Accordingly, interactomes are compared and contrasted, and subsequently described in detail for TPCN1, end_entity, MCOLN1, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Diclofenac\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic end_entity with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and start_entity Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms end_entity in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity end_entity in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"IL5\",\n",
       "                    \"value\": \"Serum concentrations of RNASE3, end_entity, and start_entity were significantly elevated in virus-induced acute asthma cases compared with controls\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Toxicity\",\n",
       "                    \"target\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"value\": \"Nataly Tataurshchikova A590 A Novel Biomarker for Respiratory_Sounds and Atopy in Early Infancy Eishika Dissanayake, Yuzaburo Inoue, Naoki Shimojo, Taiji Nakano A591 Prognostic Factors for Dermatitis,_Atopic in Spontaneously Born Babies from Low Socioeconomic Background Conny Tanjung A592 Higher IgE Antibody Levels Mediate Anti-Cancer Immunity in Transgenic KN1 Hyper-IgE Mice Erika Jensen-Jarolim, Judit Fazekas, Josef Singer, Anna Lukschal, Reinhard Horvat, Gertrude Achatz-Straussberger, Gernot Achatz A593 Fructooligosaccharides Intake during Pregnancy and Lactation Increases Gut Bifidobacterium and IL-27 in Breast Milk Yuji Fujita, Shuji Ikegami, Yoshitaka Nakamura, Yuzaburo Inoue, Naoki Shimojo, Yoichi Kohno, Shuichi Suzuki, Naoko Ozawa, Takayuki Kubota, Ken Nonaka, Osamu Ohara, Kentaro Masuda A594 Effect of Nintedanib on Asthma in Mouse Model Chin Kook Rhee, Sook Young Lee, Hwa Young Lee, Hea Yon Lee, Ji Young Kang, Sei Won Kim, Soon Seog Kwon, Young Kyoon Kim A595 Delayed Contrast Media Hypersensitivity after Coronary Angiography Gun-Woo Kim, Ju-Young Kim, Sang-Heon Cho, Hye-Ryun Kang, Hyo-Soo Kim, Jung Gyu Han, Jin Lee, Ji Young Lee, Ji Young Go, So Jung Park A596 Gene Expression Profiling in Patients with Chronic Idiopathic Urticaria Reveals Unique Gene Signature Distinct from Healthy Controls Julie Kim-Chang, Cassandra Love, Patricia Lugar A597 Failure to Recognize Lymphopenia in Newborn Leads to Undetectable Primary end_entity Endah Citraresmi A598 The Concordance Between Lung Function Test and Indonesian Version of Childhood Asthma Control Test SLC25A20 Nastiti Kaswandani, Cynthia Utami, Mardjanis Said A599 Synergistic Interaction Between Bronchiolitis and PM10 Is Modified By IL13 Polymorphism on Asthma Development: Replication from Cheer Study Young-Ho Jung, Song-I Yang, Byoung-Ju Kim, Ji-Won Kwon, Hwan-Cheol Kim, Jong-Han Leem, Ju-Hee Seo, Hyung Young Kim, So-Yeon Lee, Ho-Jang Kwon, Hyo-Bin Kim, Hyun-Ju Cho A600 The Transcription Factor Ehf Is Involved in TGF-b-Induced Suppression of Fceri and c-Kit Expression and Fceri-Mediated Activation in C9orf9 Cells Susumu Yamazaki, Nobuhiro Nakano, Asuka Honjoh, Eisuke Inage, Yosuke Baba, Yoshikazu Ohtsuka, Toshiaki Shimizu A601 The Follow up of the Potential Immunosuppressant Effects of Marijuana MJA Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A602 Risk Factors of Allergen Sensitization at 3 Years: Results from the Gusto Study Evelyn Xiu Ling Loo, Anne Goh, Oon Hoe Teoh, Yiong Huak Chan, Seang Mei Saw, Kenneth Kwek, Peter D Gluckman, Keith M Godfrey, Hugo Van Bever, Yap Seng Chong, Bee Wah Lee, Lynette Shek, Alison Joanne Lee A603 IL6 Blockade As a Steroid-Sparing Treatment for Rhupus Patients Daniela Rossi A604 Examination of Late Pulmonary start_entity in Children Treated for Malignancies Agnes Nemeth A605 Technical Validation of the Repurposing of a Personal Particle Sampler to Determine House Dust Mite Exposure in the Ambient Air Torsten Sehlinger, Karl-Christian Bergmann, Frank Goergen A606 Zinc Deficiency in Children with Severe Dermatitis,_Atopic: More Common Than Generally Thought Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Overdose\",\n",
       "                    \"target\": \"Recurrence\",\n",
       "                    \"value\": \"Tsang, Ting Fan Leung A424 Clinical Significance of Increased VEGFA, TGF-21, and YKL-40, a Chitinase like Protein, in Serum of the Children with Asthma Yoon Young Jang, Hai Lee Chung, Seung Gook Lee, Ji Hyun Na, Jong Hoon Lee A425 Analysis of Follow-up Results of Mannitol Challenge Test in Asthma Patients Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A426 Analysis of 68 Oral Walnut Challenge Tests Mikita Yamamoto, Sakura Sato, Noriyuki Yanagida, Ayako Ogawa, Kanako Ogura, Kyohei Takahashi, Kenichi Nagakura, Shigehito Emura, Tomoyuki Asaumi, Katsuhito Iikura, Motohiro Ebisawa, Yu Okada A427 Effectiveness of Air Filters Intervention in Rhinitis,_Allergic Jiaying Luo, Xiao Lan, Baoqing Sun, Zhao Chen, Guiyuan Sun, Shimin Li, Jiaqing Hu A428 The Relationship Between Airway Hyperresponsiveness to Mannitol and Atopy in Asthma Children Woo-Hyeok Choi, Heysung Baek A429 Anaphylactoid Reactions to N-Acetylcysteine in the Treatment of Aacetaminophen start_entity Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, Sang Hee Kim Kim, Ye Suel Park, Soo-Keol Lee A430 Effect of Prenatal Maternal Distress and GSDMB Polymorphism on the Development of end_entity Respiratory_Sounds in Early Childhood: COCOA Study Yean Jung Choi, Si Hyeon Lee, Young-Ho Kim, Mi-Jin Kang, Hyun-Ju Cho, Eun Lee, Song-I Yang, Youn Ho Shin, Kangmo Ahn, Kyung Won Kim, Yoon Hee Kim, So-Yeon Lee, Hyoung Yoon Chang, In Ae Choi, Kyung-Sook Lee, Yee-Jin Shin A431 Vitamin D Level in Rhinitis,_Allergic: A Systemic Review and Meta-Analysis Yoon Hee Kim, Min Jung Kim, In Suk Sol, Seo Hee Yoon, Young a Park, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Yong Ju Lee A432 Implication of Inspiratory and Expiratory Resistance and Reactance in Children with Asthma In Suk Sol, Kyu-Earn Kim, Yoon Hee Kim, Min Jung Kim, Seo Hee Yoon, Yong Ju Lee, Kyung Won Kim, Young a Park, Myung Hyun Sohn A433 The Association of Asthma Predictive Index with Asthma in Preschool Children with end_entity Wheeze Sung Joo Park, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Yun Seok Yang, Jung Yeon Shim A434 Clinical Significance of Serum Total IgE Levels in Children with RSV-Associated Lower Respiratory Illness Yoon Young Jang, Hai Lee Chung, Ji Hye Kim, Hyun Seok Lee, Chang Ho Lee A435 Development of a Oak Pollen Emission and Transport Modeling Framework in South Korea Changbum Cho, Yun-Kyu Lim, Kyu Rang Kim, Mijin Kim, Baek-Jo Kim A436 Temperature, Humidity, and Air Pollution Affect Dermatitis,_Atopic Symptoms in Infants and Young Children Young-Min Kim, Youngshin Han, Jihyun Kim, Hae-Kwan Cheong, Byoung-Hak Jeon, Kangmo Ahn A437 Effects of Compound V on Pulmonary_Fibrosis Model ChuangYao Ming, Jiu-Yao Wang, YeYi Ling A438 Vitamin D Level and the Correlation with IgE in Children with Allergic Respiratory Diseases in Guangzhou China Huimin Huang, Baoqing Sun, Yun Chen, Peiyan Zheng, Nili Wei, Wenting Luo A439 Two Case Reports of Eosinophilic Gastroenteritis Associated with Allergic Disease Do Hyeong Lee, Gil-Soon Choi, Hee-Kyoo Kim, Han Su Park A440 Genome-Wide Association Study GWAS May Identify Common Genetic Variations Both in Immediate and Delayed Drug So-Young Park, Hyo-Jung Kim, Bomi Seo, Jung-Hyun Kim, Min-Gu Kim, Hyouk-Soo Kwon, You Sook Cho, Hee-Bom Moon, Tae-Bum Kim, Yoon Su Lee A441 Development of a Questionnaire for Secular Change of Dermatitis,_Atopic from Birth to 19-Year-Old\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GHITM\",\n",
       "                    \"target\": \"TFRC\",\n",
       "                    \"value\": \"Moreover, Severe_Acute_Respiratory_Syndrome and HIV infections dysregulate 4 genes ANXA3, GNS, HIST1H1C, RASA3 and 3 genes HBA1, end_entity, start_entity respectively that affect the ageing process\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Six months after discharge, new visits to the end_entity Room start_entity, use of systemic corticosteroids and adherence to the controller treatment were evaluated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Airway Obstruction\",\n",
       "                    \"target\": \"Molluscum Contagiosum\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized end_entity in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with start_entity and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"We have previously reported the synthesis of potent start_entity 3C-like protease 3CLpro inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GMIP\",\n",
       "                    \"target\": \"NEK9\",\n",
       "                    \"value\": \"Proteomic analyses of BGLF2-interacting proteins identified interactions with the NIMA-related protein kinase end_entity and GEM-interacting protein start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pranlukast\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food end_entity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of end_entity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk end_entity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of start_entity Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam end_entity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral end_entity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal end_entity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Cases of severe acute respiratory syndrome end_entity were investigated for end_entity start_entity end_entity-CoV through RNA tests, serologic response, and viral culture\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AGTR2\",\n",
       "                    \"target\": \"Ataxia Telangiectasia\",\n",
       "                    \"value\": \"Ang GCNT2I stimulates end_entity and start_entity receptors and its signaling pathway is similar to that of Ang GCNT2 but has a specific role on aldosterone stimulation in adrenal cortex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT2\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Among cats without end_entity, there were few differences between virus-positive and virus-negative MLNs; however, TLR9 and start_entity expression were higher with infection, suggesting a direct viral effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GATA3\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Quantitative real-time PCR was used to analyse intratonsillar gene expressions of IFN-, IFN-, IFN-, IL10, IL13, end_entity, IL-28, IFNL1, IL-37, TGF-, FOXP3, start_entity, RORC2 and Tbet\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACS\",\n",
       "                    \"target\": \"CALR\",\n",
       "                    \"value\": \"We therefore conducted this study to determine the burden of acute chest syndrome start_entity and describe its clinical and therapeutic aspects among Systemic_carnitine_deficiency children in Cameroon, a end_entity country\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"nucleotide variability in the sequence of the gene encoding for the transmembrane protein M of canine start_entity end_entity is described\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity infection stimulated the secretion of CXCL8 and start_entity by AECs plated on rat-tail collagen through EGFR activation likely by TGF- released from AECs and through c-Met activated by HGF secreted from lung fibroblasts\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Asthma\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and Allopurinol Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to Glatiramer_Acetate: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 end_entity Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent Rhinitis,_Allergic Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic end_entity Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic end_entity Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with Rhinitis,_Allergic Chellaa R A615 Study of Incidence of Severe Persistent Rhinitis,_Allergic in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A617 Dermatitis,_Atopic: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe Dermatitis,_Atopic Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of Rhinitis,_Allergic Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao Pigmentary_Disorder,_Reticulate,_with_Systemic_Manifestations Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, Rhinitis,_Allergic, Dermatitis,_Atopic, and Acute Upper Respiratory_Tract_Infections and Levels of Severity of end_entity in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in Eosinophilic_Esophagitis Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent Dermatitis,_Atopic Associated with Parasitic Infection Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and end_entity Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in end_entity, Rhinitis,_Allergic, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via ERK and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of end_entity Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of start_entity and end_entity Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe Dermatitis,_Atopic Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CIA\",\n",
       "                    \"target\": \"RELN\",\n",
       "                    \"value\": \"Here we investigated the effects and the mechanism of action of end_entity in collagen-induced arthritis start_entity rats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD80\",\n",
       "                    \"target\": \"GLS2\",\n",
       "                    \"value\": \"Our results showed that end_entity obviously increased the cell surface expression of start_entity, CD86, and MHCII molecules\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17A\",\n",
       "                    \"target\": \"IL4\",\n",
       "                    \"value\": \"Furthermore, ex vivo recall assays showed that CD4 T cells isolated from vaccinated IL10 mice compared to vaccinated wild-type mice produced significantly higher amounts of IL2, gamma interferon IFN-, end_entity, IL6, and start_entity in the presence of a coccidioidal antigen, indicating that IL10 suppresses Th1, Th2, and Th17 immunity to Coccidioides infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARK2\",\n",
       "                    \"target\": \"TRAT1\",\n",
       "                    \"value\": \"end_entity25 is a novel RBMS3 and a member of the Tripartite Motif end_entity family of start_entitys, which plays a pivotal role in the innate immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAPDH\",\n",
       "                    \"target\": \"TBP\",\n",
       "                    \"value\": \"In the study, using two different analysis programs, geNorm and NormFinder, we systematically evaluated the gene expression stability of six candidate reference genes start_entity, ACTB, B2M, RPL4, end_entity, and PPIA in samples of whole blood and PBMC with or without poly I:C stimulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR2\",\n",
       "                    \"target\": \"SIRPA\",\n",
       "                    \"value\": \"Phenotypic analysis identified these cells as bovine pDCs CD3 CD14 start_entity ITGAX NK TCR CD4 MHC GCNT2 CD45RB end_entity CD32\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Result The results demonstrated that BHT prevented sudden increase of start_entity, TNF-, ALT and SLC17A5, and liver damage induced by end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Korea failed in its risk communication during the early stage of the Middle East Respiratory end_entity start_entity outbreak; consequently, it faced difficulties in managing start_entity, while disease-related worry increased\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"p50\",\n",
       "                    \"value\": \"Furthermore, H2S decreased the expression levels of start_entity-, interleukin IL6, IL10, and CCL2, as well as the protein levels of end_entity, RELA, and p-RELA in the kidney of CRF rats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The successive emergence of highly pathogenic coronaviruses COVID-19 such as the Severe Acute Respiratory end_entity SARS-CoV in 2003 and the start_entity Coronavirus MERS-CoV in 2012 has stimulated a number of studies on the molecular biology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Cases with any codetection were more likely to present with fever; those with 2 virus detections had higher prevalence of start_entity; cases with virus and bacteria codetection were more likely to have start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cough\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced end_entity, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of start_entity in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic end_entity Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"This study aimed at investigating the global prevalence, biological and clinical characteristics of COVID-19, Wuhan China COVID-19, start_entity Coronavirus SARS-CoV, and Middle East Respiratory end_entity Coronavirus MERS-CoV infection outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RCVRN\",\n",
       "                    \"target\": \"Melanoma\",\n",
       "                    \"value\": \"As far as the retina is concerned Neoplasms Associated Retinal_Diseases and end_entity Associated Retinal_Diseases are well characterised clinically but a candidate autoantibody start_entity is only described in the former disorder\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Food Hypersensitivity\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of end_entity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with start_entity Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of start_entity Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe start_entity Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of start_entity Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe start_entity Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed start_entity, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CCL7\",\n",
       "                    \"value\": \"DCX recruitment was preceded by the up-regulation in the lung of the CCR2 ligands start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LE\",\n",
       "                    \"target\": \"RNF130\",\n",
       "                    \"value\": \"We found that while macropinocytotic uptake of filamentous EBOV viruslike particles VLPs expressing the EBOV glycoprotein end_entity occurs relatively quickly, VLPs only begin to enter the cytoplasm after a 30-min lag, considerably later than particles bearing the influenza hemagglutinin or end_entity from lymphocytic choriomeningitis virus, which enter through late endosomes start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK8\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Further investigations showed that PspA activated the extracellular signal-regulated kinase ERK, JUN N-terminal kinase start_entity, end_entity mitogen activated protein kinase MAPK and nuclear factor NF-B signaling pathways in human monocytes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PDI\",\n",
       "                    \"target\": \"TR\",\n",
       "                    \"value\": \"We previously found that overexpression of start_entity in rat pituitary tumor GH13 cells suppresses 3,3,5-triiodothyronine T3-stimulated growth hormone GH1 expression, suggesting the contribution of start_entity to the T3-mediated gene expression via thyroid hormone receptor end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCR3\",\n",
       "                    \"target\": \"PARP9\",\n",
       "                    \"value\": \"There were marked elevations in end_entity start_entity ligand concentrations during DAD\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL20\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"For example, in the absence of viral infection, CXCL10 mRNA, IFIH1 mRNA, CXCL10, IL4, IL13, CCL4, end_entity, start_entity and CCL24 were negatively associated with FVC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Result The results demonstrated that BHT prevented sudden increase of IL10, TNF-, ALT and start_entity, and liver damage induced by end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AKT1\",\n",
       "                    \"target\": \"TP53\",\n",
       "                    \"value\": \"Furthermore, AgNP-induced apoptosis was found dependent on the overproduction of reactive oxygen species ROS1 and affecting of MAPKs and start_entity signaling and DNA damage-mediated end_entity phosphorylation to advance HePG-2 cells apoptosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Recurrence\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": \"Tsang, Ting Fan Leung A424 Clinical Significance of Increased VEGFA, TGF-21, and YKL-40, a Chitinase like Protein, in Serum of the Children with Asthma Yoon Young Jang, Hai Lee Chung, Seung Gook Lee, Ji Hyun Na, Jong Hoon Lee A425 Analysis of Follow-up Results of Mannitol Challenge Test in Asthma Patients Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A426 Analysis of 68 Oral Walnut Challenge Tests Mikita Yamamoto, Sakura Sato, Noriyuki Yanagida, Ayako Ogawa, Kanako Ogura, Kyohei Takahashi, Kenichi Nagakura, Shigehito Emura, Tomoyuki Asaumi, Katsuhito Iikura, Motohiro Ebisawa, Yu Okada A427 Effectiveness of Air Filters Intervention in Allergic end_entity Jiaying Luo, Xiao Lan, Baoqing Sun, Zhao Chen, Guiyuan Sun, Shimin Li, Jiaqing Hu A428 The Relationship Between Airway Hyperresponsiveness to Mannitol and Atopy in Asthma Children Woo-Hyeok Choi, Heysung Baek A429 Anaphylactoid Reactions to N-Acetylcysteine in the Treatment of Aacetaminophen Overdose Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, Sang Hee Kim Kim, Ye Suel Park, Soo-Keol Lee A430 Effect of Prenatal Maternal Distress and GSDMB Polymorphism on the Development of start_entity Respiratory_Sounds in Early Childhood: COCOA Study Yean Jung Choi, Si Hyeon Lee, Young-Ho Kim, Mi-Jin Kang, Hyun-Ju Cho, Eun Lee, Song-I Yang, Youn Ho Shin, Kangmo Ahn, Kyung Won Kim, Yoon Hee Kim, So-Yeon Lee, Hyoung Yoon Chang, In Ae Choi, Kyung-Sook Lee, Yee-Jin Shin A431 Vitamin D Level in Allergic end_entity: A Systemic Review and Meta-Analysis Yoon Hee Kim, Min Jung Kim, In Suk Sol, Seo Hee Yoon, Young a Park, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Yong Ju Lee A432 Implication of Inspiratory and Expiratory Resistance and Reactance in Children with Asthma In Suk Sol, Kyu-Earn Kim, Yoon Hee Kim, Min Jung Kim, Seo Hee Yoon, Yong Ju Lee, Kyung Won Kim, Young a Park, Myung Hyun Sohn A433 The Association of Asthma Predictive Index with Asthma in Preschool Children with start_entity Wheeze Sung Joo Park, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Yun Seok Yang, Jung Yeon Shim A434 Clinical Significance of Serum Total IgE Levels in Children with RSV-Associated Lower Respiratory Illness Yoon Young Jang, Hai Lee Chung, Ji Hye Kim, Hyun Seok Lee, Chang Ho Lee A435 Development of a Oak Pollen Emission and Transport Modeling Framework in South Korea Changbum Cho, Yun-Kyu Lim, Kyu Rang Kim, Mijin Kim, Baek-Jo Kim A436 Temperature, Humidity, and Air Pollution Affect Dermatitis,_Atopic Symptoms in Infants and Young Children Young-Min Kim, Youngshin Han, Jihyun Kim, Hae-Kwan Cheong, Byoung-Hak Jeon, Kangmo Ahn A437 Effects of Compound V on Pulmonary_Fibrosis Model ChuangYao Ming, Jiu-Yao Wang, YeYi Ling A438 Vitamin D Level and the Correlation with IgE in Children with Allergic Respiratory Diseases in Guangzhou China Huimin Huang, Baoqing Sun, Yun Chen, Peiyan Zheng, Nili Wei, Wenting Luo A439 Two Case Reports of Eosinophilic Gastroenteritis Associated with Allergic Disease Do Hyeong Lee, Gil-Soon Choi, Hee-Kyoo Kim, Han Su Park A440 Genome-Wide Association Study GWAS May Identify Common Genetic Variations Both in Immediate and Delayed Drug So-Young Park, Hyo-Jung Kim, Bomi Seo, Jung-Hyun Kim, Min-Gu Kim, Hyouk-Soo Kwon, You Sook Cho, Hee-Bom Moon, Tae-Bum Kim, Yoon Su Lee A441 Development of a Questionnaire for Secular Change of Dermatitis,_Atopic from Birth to 19-Year-Old\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"IL1A\",\n",
       "                    \"value\": \"The aim of this prospective study was to evaluate heparinbinding protein HBP, LYZ, and the cytokines interleukin end_entity, IL6, start_entity, end_entity0 and TNF TNF in bronchoalveolar lavage fluid BALF as potential biomarkers for pulmonary infection in lungtransplanted patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"METHODS: In the PRISTINE end_entity treated with RIfampicin aTtenuates INflammation trial, a randomized, therapeutic controlled, exploratory study in patients with community-acquired pneumococcal start_entity, we looked at LTA release and inflammatory and clinical response during treatment with both rifampicin and -lactam compared with treatment with -lactam antibiotics only\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Connective Tissue Diseases\",\n",
       "                    \"target\": \"Obesity\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of end_entity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with start_entity Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy end_entity and Metabolically Unhealthy end_entity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"Noonan Syndrome\",\n",
       "                    \"value\": \"Influenza,_Human A virus non-structural protein 1 end_entity antagonizes interferon response through diverse strategies, particularly by inhibiting the activation of start_entity start_entity and IFN- transcription\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CR2\",\n",
       "                    \"value\": \"The IPC induced by CpG-ODN or plasmid DNA had a similar phenotype, expressing CD2 and start_entity and intermediate levels of MHC class GCNT2 and the myeloid marker SWC3, but not the markers of T and B cells or monocytes CD3, end_entity and CD14\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"The serum of dogs immunized with LJM17 also exhibited high levels of start_entity, end_entity, and IL18\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"USP33\",\n",
       "                    \"value\": \"Other genes unassociated to date with ARDSSARS include C1Qb, C5AR1, CASP3, CASP9, CD14, CD68, FGF7, HLA-DRA, IGF1, start_entity, MALAT1, MSR1, NFIL3, SLPI, end_entity, CLC, GBP1 and TAC1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EHF\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"value\": \"end_entity start_entity was first reported in 1976 with two concurrent outbreaks of acute viral hemorrhagic fever centered in Yambuku near the Ebola river, Democratic Republic of Congo, and in Nzara, Sudan\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The areas under the ROC curve AUC of WBC, CRP and start_entity in patients with end_entity were 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSIONS: The early transmission ability of start_entity is close to or slightly higher than end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD163\",\n",
       "                    \"target\": \"IFNL1\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; start_entity, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; end_entity, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The assay detected influenza A and B viruses; influenza A virus subtypes start_entity, H3, and H5 including subtype H5N1 of the Asian lineage; parainfluenza virus types 1, 2, 3, and 4; respiratory syncytial virus types A and B; adenovirus; metapneumovirus; rhinovirus; enterovirus; and end_entityes OC43, 229E, severe acute respiratory syndrome end_entity, NL63, and HKU1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSB\",\n",
       "                    \"target\": \"CTSL\",\n",
       "                    \"value\": \"Some peptidic natural products are inhibitors of the cysteine protease cathepsins such as E-64 isolated from Aspergillus, which is a start_entity inhibitor, or more recently the marine cyanobacterial metabolite gallinamide A which is a selective inhibitor of human end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"L9\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Based on the phylogenetic analysis of the hypervariable region of the PSMD1 subunit, all Korean Hepatolenticular_Degeneration strains clustered with the respiratory strain BSG, BCQ3994 and the enteric strain LY-138, while the Canadian BCQ calf end_entity and Hepatolenticular_Degeneration strains, and the American RBCV LSU, French EBCV F15 and avirulent VACC, start_entity, and Mebus strains clustered on a separate major branch\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neopterin\",\n",
       "                    \"target\": \"CFD\",\n",
       "                    \"value\": \"Conclusions start_entity concentrations were found significantly higher in end_entity patients compared with healthy controls and also with other viral infections P 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity acts as a protease and processes the large end_entity polyprotein for virus replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Following the 2003 the severe acute respiratory syndrome start_entity and the 2015 Middle East Respiratory end_entity MERS outbreak in South Korea, this research aims to explore and examine the factors influencing the response to infectious diseases, which encompasses both communicable and non-communicable diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Toluene\",\n",
       "                    \"target\": \"ADAM17\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of start_entity Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and end_entity in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCR3\",\n",
       "                    \"target\": \"S100A9\",\n",
       "                    \"value\": \"In particular, SIVmac239 infection elicited robust expression of CXCL10, a chemokine for start_entity cells, in CD14 CD16 monocytes and end_entity macrophages recently infiltrated in SLOs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"alanine \",\n",
       "                    \"value\": \"The homoplasmic conservative amino acid substitution valine to end_entity was identified in two myelopathic animals of haplotype start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP1A1\",\n",
       "                    \"target\": \"PHB\",\n",
       "                    \"value\": \"Accordingly, we observed a synergistic inhibitory effect on LCMV multiplication with a combination of start_entity and end_entity inhibitors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LRRC23\",\n",
       "                    \"target\": \"MRAP\",\n",
       "                    \"value\": \"The 13 HLA Class I supertypes are A1, A2, A3, A24, start_entity, NDUFA2, end_entity, B44, B58, B62, C1, and C4A\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAP1LC3A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Here we review current knowledge of end_entity induced membrane rearrangements and the involvement of autophagy or autophagy protein MAP1B light chain 3 start_entity in end_entity replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRB1\",\n",
       "                    \"target\": \"Sveinsson Chorioretinal Atrophy\",\n",
       "                    \"value\": \"The treatment of start_entity with l-arginine-NG-amine end_entity, a potent inhibitor of NO-producing enzymes, resulted in a marked accumulation of IFN-4 mRNA and, to a minor extent, of IFN- mRNA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Nasal Polyps\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with end_entity in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Atopic start_entity of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic start_entity in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Atopic start_entity Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": \"Alessandro Fiocchi, Maria Cristina Artesani, Paola Francalanci, Lamia Dahdah, Thomas Schreiner A487 Burden and Correlates of Cigarette Smoking and Respiratory Airway_Obstruction: An Observation in Urban Adult Population of West Bengal India Kaushik Chakraborty A488 Blood Eosinophils Could Predict Sputum Eosinophilia? : A Comparison Between Asthma and Non-Asthmatic Chronic Cough in the Elderly Ha Kyeong Won, Ju-Young Kim, Eun-Jung Jo, Kyoung Hee Sohn, Kyung-Mook Kim, Heung Woo Park, Yoon-Seok Chang, Sang-Heon Cho, Woo-Jung Song, Byung-Keun Kim A489 Complementary and Alternative Medicine for Allergic end_entity in Japan Syuji Yonekura, Yoshitaka Okamoto A490 Impact of Cognition_Disorders on Asthma Control Status in Elderly Asthmatics Gyu Young Hur, Young Min Ye, Joo-Hee Kim, Ki-Suck Jung, Junga Kim, Jae Jeong Shim, Hae-Sim Park A491 The Association Between Respiratory_Tract_Infections and Reactive Oxygen Stress Kazuhiro Sekimoto, Kazuko Sugai, Keiji Tsuchimoto, Hiromi Uehara, Masanori Ikeda A492 The Risk Factors and Lung Function of Current Allergic end_entity Due to Dust Mite Sensitization Euncho Chung, Kang Seo Park, Yean Jung Choi, Jeewon Park, Soo-Jong Hong, So Yeon Lee A493 Cloning and Expression of Recombinant Blomia Tropicalis Dust Mite Allergen Blo t 7 Alain Jacquet, Arun Buaklin, Nat Malainual A494 Seasonal Variations of Airborne Pollen in Bangalore, India Roopashree S A495 Pollen Observation and Use of Data Kyu Rang Kim, Mijin Kim, Changbum Cho, Baek-Jo Kim, Jae-Won Oh, Mae Ja Han A496 The Effect of Cord Serum 25-Hydroxyvitamin D 25OHD on the Development of Dermatitis,_Atopic in First 3 Years of Life : CALCOCO1 Study Hyun-Ju Cho, Youn Ho Shin, Eun Lee, Young-Ho Kim, Darae Lee, Mi-Jin Kang, Song-I Yang, Kangmo Ahn, Kyung Won Kim, Yoon Hee Kim, Hye-Sung Won, Soo Hyun Kim, Suk-Joo Choi, Young Han Kim, Jong Kwan Jun, Eun-Jin Kim, Jeom Gyu Lee, So-Yeon Lee, Soo-Jong Hong, Dongin Suh A497 Contribution of Stem Cell Factor AutocrineParacrine Mechanism to Aberrant Proliferation of C9orf9 Cells Yosuke Amagai, Akane Tanaka, Hiroshi Matsuda A498 A Randomized Dbpc Dose-Finding Multicenter Trial of Sublingual Immunotherapy SLIT Allergoid Tablets in House Dust Mites HDM Allergic Patients Ralph Msges, Pauline Dieterich, Anatoli Astvatsatourov, Christoph Hser, Jaswinder Singh, Kija Shah-Hosseini, Silke Allekotte, Enrico Compalati A499 Depression and start_entity in the Elderly: A Community Population Analysis Kyoung Hee Sohn, Woo-Jung Song, Byung-Keun Kim, Ju-Young Kim, Min Suk Yang, So-Hee Lee, Sae-Hoon Kim, Hye-Ryun Kang, Heung Woo Park, Sun-Sin Kim, Kyung-up Min, Sang-Heon Cho, Yoon-Seok Chang A500 The Integrated Analysis of Correlation Between Total IgE and Other Immunological Factors in Allergic Diseases Woo-Sung Chang, Ji-Hye Do, Yeon-Seop Kim, Dankyu Yoon, Hye-Sun Lim, Jeom-Kyu Lee, Eun-Jin Kim A501 Pattern of Allergic Diseases Among Military Servicemen Referred to a Clinical Immunologystart_entity Service in Singapore Bernard Thong, Yew Kuang Cheng, Jinfeng Hou, Khai Pang Leong, Justina Tan, Faith Chia, Grace Chan, Sze-Chin Tan, Teck Choon Tan, Chwee Ying Tang, Hiok Hee Chng A502 A Case of Rifampicin-Induced start_entity Diagnosed By the Lymphocyte Activation Test with Successful Desensitization Chan-Sun Park, Mi Yeoung Kim, Eun-Young Kim, Jae-Gook Shin, Jae-Hyeog Choi, Saegwang Park, Yeonye Kim A503 Analysis of Individual Case Safety Reports of Drug-Induced Anaphylaxis Based on Korea Adverse Event Reporting System Database Kyung-Hwan Lim, Jae Woo Jung, Mingyu Kang, Ju-Young Kim, Ju-Young Kim, Hyun Jeong Kim, Yeon-Ju Woo, Soo-Youn Jung, Hye-Ryun Kang, Hye-Ryun Kang A504 Impact of Processes Certification on the Liability of Anti-Dust Mites Bed Covers Thierry Pore, Nabile Boukhettala, Emeline Furon A505 Localisation Kinetics of Aluminium after Subcutaneous Injection in a Rat Model Alan David Bullimore, Matthew Heath, Simon Hewings, Murray Skinner A506 Periostin Levels in Exhaled Breath Condensate of Competitive Athletes, Asthmatics and Healthy Subjects - Associations with Outdoor Ambient Conditions Marcin Kurowski, Hubert Krysztofiak, Aleksandra Wardzynska, Marzanna Jarzebska, Janusz Jurczyk, Marek L\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CFH\",\n",
       "                    \"target\": \"GL\",\n",
       "                    \"value\": \"Combination of the two compounds using to dose levels were challenged with single doses of start_entity, end_entity and SI as well\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A2\",\n",
       "                    \"target\": \"CD163\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; end_entity, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLstart_entity, secretory Phospholipase start_entity; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTNNB1\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Moreover, expression levels of four representative proteins, start_entity, end_entity, GRB2 and PCNA, were further confirmed by western blot analysis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"The expression of start_entity, Mx1, and end_entity in lung tissues of NDV challenged chicken embryos from the outbred Kuroiler and Tanzanian local ecotype lines showed that their expression was several orders of magnitude higher in the Kuroiler than in the local ecotypes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PEA15\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Porcine epidemic end_entity start_entity is a lethal infectious disease in suckling piglets with symptoms including watery end_entity caused by start_entity virus start_entityV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SPR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The major biochemical and thermodynamic features of nucelocapsid protein of Severe_Acute_Respiratory_Syndrome end_entity Severe_Acute_Respiratory_SyndromeNP were characterized by use of non-denatured gel electrophoresis, size-exclusion chromatographic and surface plasmon resonance start_entity techniques\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAVS\",\n",
       "                    \"target\": \"TLR7\",\n",
       "                    \"value\": \"PS mutant viruses remained attenuated in start_entity and Toll-like receptor 7-knockout end_entity mice, two well-known RNA sensors for COVID-19, but virulence was restored in interferon alphabeta receptor-knockout IFNAR1 mice or in start_entity mice treated with IFNAR1-blocking antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC25A5\",\n",
       "                    \"target\": \"T1\",\n",
       "                    \"value\": \"Methods In patients undergoing coronary artery bypass graft CABG surgery with CPB, cerebral blood flow velocity CBFV and blood pressure BP were continuously recorded during 5-min preoperatively end_entity, after 24 h start_entity, and 7 days after procedure start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity, Immediate\",\n",
       "                    \"target\": \"Polyps\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal end_entity in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing start_entity Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IF\",\n",
       "                    \"target\": \"PORCN\",\n",
       "                    \"value\": \"Se evalu un total de 315 muestras respiratorias de nios menores de 6 aos con infecciones respiratorias agudas end_entity start_entity para 8 virus respiratorios y end_entity RT-PCR para rinovirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C3\",\n",
       "                    \"target\": \"C4A\",\n",
       "                    \"value\": \"Mice lacking either CD8A T cells, IFNA1 receptors, or complement components start_entity and end_entity showed no significant differences in the development of clinical signs by comparison with intact counterparts having the same genetic background\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"JUN\",\n",
       "                    \"value\": \"RESULTS: We showed that EV71 infection could activate both JNK12 and p38 MAPK in iDCs and phosphorylate their downstream transcription factors c-Fos and end_entity, which further promoted the production of start_entity, IL6, IL10, and TNF-\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity of these two start_entitys at the nonpermissive temperature for the ts helper virus resulted in replication and transcription of both start_entity RNAs but not in synthesis of the helper virus RNAs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"G10\",\n",
       "                    \"target\": \"PDIA6\",\n",
       "                    \"value\": \"Analysis sequencing revealed that field isolates were of G6 end_entity serotype and isolates from the dairy NCD samples were of start_entity P14 serotype\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Emergencies\",\n",
       "                    \"target\": \"Guillain-Barre Syndrome\",\n",
       "                    \"value\": \"An association with microcephaly and other birth defects as well as end_entity has led to a World Health Organization declaration of Zika virus as a Public Health start_entity of International Concern in February 2016\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Gastroenteritis\",\n",
       "                    \"target\": \"Wounds and Injuries\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver end_entity in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic start_entity in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute Lung end_entity Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"In this study, we found that macrophages, dendritic cells, neutrophils, and both end_entity and start_entity T cells recruited to Coccidioides posadasii-infected lungs of nonvaccinated and vaccinated mice contributed to the production of IL10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Psoriasis\",\n",
       "                    \"value\": \"Fal, Dorota Kiedik, Agnieszka Muszynska, Iwona Pirogowicz A523 Asthma Impact on Children with Food Induced Anaphylaxis Chikako Motomura, Masatoshi Wakatsuki, Yuko Akamine, Mihoko Iwata, Hiroshi Matsuzaki, Naohiko Taba, Yoko Murakami, Hiroshi Odajima A524 Case Reports of Stevens-Johnson_Syndrome and Stevens-Johnson_Syndrome-Stevens-Johnson_Syndrome in Lupus_Vulgaris_Erythematosus,_Systemic Reni Ghrahani A525 The Effectiveness of Oral Tolerance Induction for Wheat start_entity Using Two Different Intake Levels Yuri Takaoka A526 Association of Plasma Interleukin-25 Levels with Development of Aspirin Induced Airway Spasm in Asthma Jong-Uk Lee, Jeong-Seok Heo, Da-Jeong Bae, Hyun Ji Song, Choon-Sik Park, Jong-Sook Park A527 Transition of Allergic and Nonallergic Rhinitis after 2 Years in Korean Children: Preliminary Study Jae Hoon Cho, Ji Ho Choi A528 Early Onset of end_entity Arthritis,_Juvenile Budi Setiabudiawan, Fiska Febriana, Reni Ghrahani, Gartika Sapartini A529 Clinical Features of Immediate start_entity to Histamine H2 Antagonists and Their Cross Reactivity Chan-Sun Park, Young-Hee Nam, Mi Yeoung Kim, Gil-Soon Choi A530 Detection of Galacto-Oligosaccharide Specific IgE in Vitro Chiung-Hui Huang, Chiung-Hui Huang, Jian Yi Soh, Lynette Shek, Lynette Shek, Dianne J\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": \"The overall sensitivity and specificity, respectively, and 95 confidence interval start_entity; in parentheses for each panel were as follows: FilmArray end_entity, 84\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IQGAP1\",\n",
       "                    \"target\": \"LCP1\",\n",
       "                    \"value\": \"Migratory activity-related proteins, including plastin-2 end_entity, MSN MSN, lamin-B1 LMNB1, Ras GTPase-activating-like protein start_entity and others, were identified in CD8A T cells and CD68 macrophages infiltrated to inflamed FT1DM islets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KLK1\",\n",
       "                    \"target\": \"KLK5\",\n",
       "                    \"value\": \"Activation of the thrombolytic zymogens may therefore allow for both direct and indirect activation of the HA of human-adapted influenza viruses by end_entity and start_entity2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Small interference RNA siRNA was used to knockdown IFITM1, PLSCR1, end_entity, STAT2, IRF-7, and start_entity expression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CHM\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"We applied three different SARI case definitions end_entity based on Iend_entity-10 codes for discharge diagnoses of respiratory tract infections J09 - J22: basic end_entity Bend_entity, using only primary diagnoses; sensitive end_entity Send_entity, using primary and secondary diagnoses; timely end_entity start_entity, using only primary diagnoses of patients hospitalized up to one week\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"IL5\",\n",
       "                    \"value\": \"In addition, ribavirin treatment seemed also to promote the production of pro-inflammatory cytokines 4 days after cessation of treatment, although after 3 days of treatment ribavirin inhibited pro-inflammatory cytokine production in infected mice, significantly reducing the levels of the cytokines IL-1, end_entity end_entity, monocyte chemotactic protein-1 CCL2, and start_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AURKB\",\n",
       "                    \"target\": \"Sveinsson Chorioretinal Atrophy\",\n",
       "                    \"value\": \"start_entity rs2289590 CC genotype carriers had worse DFS than CA end_entity genotype carriers P 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NAGPA\",\n",
       "                    \"target\": \"NCL\",\n",
       "                    \"value\": \"Such RNAprotein interaction deprived end_entity of binding to upstream control element start_entity of the rRNA promoter, which resulted in start_entity DNA hypermethylation and subsequently perturbation of rRNA transcription\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Helicase\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box start_entity 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; end_entity, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neutrophil Chemotactic Response, Abnormal\",\n",
       "                    \"target\": \"Noonan Syndrome 5\",\n",
       "                    \"value\": \"These findings suggest that the 3' start_entity of JEV genomic RNA may form a replication complex together with Noonan_syndrome_3 and end_entity; this complex may be involved in JEV minus-strand RNA synthesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCND1\",\n",
       "                    \"target\": \"CCND3\",\n",
       "                    \"value\": \"MHV infection in quiescent 17Cl-1 cells prevented normal increases in Cdk4, Cdk6, start_entity, and end_entity levels after serum stimulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"CONCLUSIONS: This study has identified various pro-inflammatory cytokines and interferon-related genes such as MX1, RSAD2, CXCL10, CCL8, start_entity, KC, CCL2, end_entity, CSF2 and IFNA1 in FCoV-positive cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"RESULTS: Elevated levels of CXCL8, IL6, end_entity start_entity as well as CRP were associated with reduced time to post-traumatic sepsis in Cox regression analysis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Overall, this study provides evidence that the predicted MetYPCP domain of HEV ORF1 antagonises end_entity activation to modulate the start_entity response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypohidrosis\",\n",
       "                    \"target\": \"Lupus Vulgaris\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized start_entity ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory end_entity Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL1A\",\n",
       "                    \"target\": \"RPL32\",\n",
       "                    \"value\": \"To address this deficiency, high-throughput real time RT-PCR TaqMan assays were developed to measure the expression of fifteen immune mediators associated with the innate and adaptive immune responses IFNA1, IFNA1, IFNA1, start_entity, start_entity, IL2, IL4, IL6, CXCL8, start_entity0, start_entity2p40, start_entity7, Granzyme A, CCL2, TNF, as well as four endogenous housekeeping genes ATF4, HPRT1, GAPDH, end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ASAH1\",\n",
       "                    \"target\": \"TCF7\",\n",
       "                    \"value\": \", FOXP1, end_entity, and start_entity were validated in the independent cohort\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Purpura, Thrombocytopenic, Idiopathic\",\n",
       "                    \"target\": \"thrombocytopenia\",\n",
       "                    \"value\": \"Primary immune thrombocytopenic purpura start_entity remains a diagnosis of exclusion both from nonimmune causes of end_entity and immune end_entity that develops in the context of other disorders secondary immune end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OARD1\",\n",
       "                    \"target\": \"PARG\",\n",
       "                    \"value\": \"We further reveal that ADP-ribosylation of RNA mediated by PARP10 and TRPT1 can be efficiently reversed by several cellular ADP-ribosylhydrolases end_entity, start_entity, MACROD1, MACROD2 and ADPRHL2, as well as by MACROD-like hydrolases from VEEV and Severe_Acute_Respiratory_Syndrome viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of end_entity AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with end_entity and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial end_entity patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of end_entity Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of start_entity polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with end_entity and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in end_entity Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local end_entity CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of end_entity and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor end_entity and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"TRIM3\",\n",
       "                    \"value\": \"Furthermore, we provide evidence that bZIP60 and end_entity, products of the enzyme-substrate duet, rather than ERN1, are functionally replaceable to cope with start_entity stress in yeast\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"POU5F1\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"In addition, in ectoderm cerebrum and cerebellum, there was no significant methylation difference of start_entity gene exon 1 between low age and advanced age end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"PBRM1\",\n",
       "                    \"value\": \"RdRp consists of three subunits start_entity, end_entity and PB2 and binds both the highly conserved 3- and 5-ends of the VTRNA1-1 segment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"Sarcoma, Ewing\",\n",
       "                    \"value\": \"In the structural proteins, a total of two end_entity were identified, in the ORF3 and ORF4 minor start_entitys\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK9\",\n",
       "                    \"target\": \"MAVS\",\n",
       "                    \"value\": \"Mechanistically, end_entity recruits MAP2K7 onto mitochondria via its 3D domain, which subsequently phosphorylates start_entity and thus activates the apoptosis pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ESD\",\n",
       "                    \"target\": \"UBR5\",\n",
       "                    \"value\": \"Biochemical ACE and sACE2 activity, ACE concentration and echocardiographic parameters EF, left ventricular end-diastolic end_entity and end-systolic diameter start_entity and dPdt were measured\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MUC1\",\n",
       "                    \"target\": \"SOD2\",\n",
       "                    \"value\": \"Under IL6 trans-signaling conditions 36 genes were upregulated, including PLA2G2A, IL13RA1, start_entity, and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRR\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Compared to patients only infected at exacerbation, the re-infected children significantly exhibited lower levels of IFN- in plasma and end_entity at exacerbation associated with modifications in start_entity expression and function in blood mononuclear cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We demonstrate that the start_entity end_entity CoV and murine hepatitis virus MHV induce macropinocytosis, which occurs late during infection, is continuous, and is not associated with virus entry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD209\",\n",
       "                    \"target\": \"DCX\",\n",
       "                    \"value\": \"Here we describe a previously unrecognized mechanism of end_entity death in chronic HIV-1 infection, in which ligation of start_entity by gp120 sensitizes end_entity to undergo accelerated apoptosis in response to a variety of activation stimuli\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Unimmunized mice accumulated only low levels of T cells within the brain during fatal disease, whereas the brains of immunized mice contained higher levels of both T-cell subsets in response to challenge, with end_entity cells increased relative to the start_entity subset\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Nasal Polyps\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with end_entity in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut start_entity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"We have studied the production and release of infectious start_entity-particles in vaccinia-T7-polymerase recombinant virus-infected L cells that were transfected with five different plasmids expressing the synthetic start_entity RNA MIstart_entity-HD and the four structural proteins M, N, S, and E of the murine end_entity MHV-A59\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSG1\",\n",
       "                    \"target\": \"VEGFC\",\n",
       "                    \"value\": \"We did not observe induction of end_entity or PGF by start_entity in any of the cells tested\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"Respiratory Tract Infections\",\n",
       "                    \"value\": \"OBJECTIVES: To assess consistency between surveillance for respiratory viruses in outpatient and community settings using ILI surveillance from the Centers for Disease Control and Prevention Influenza,_Human Incidence Surveillance Project IISP and the Mobile Surveillance for Acute end_entity start_entity and Influenza,_HumanLike Illness in the Community MoSAIC Study\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL13\",\n",
       "                    \"target\": \"Milk Hypersensitivity\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and Urticaria Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, TSLP, Periostin, start_entity and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous Urticaria Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression KLRK1 and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of end_entity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute Urticaria at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cyclophosphamide\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Moniaga, Kenji Kabashima, Eung Ho Choi A199 Trends in oral food challenges in Japan: A six-year prospective study Noriyuki Yanagida, Sakura Sato, Chizuko Sugizaki, Motohiro Ebisawa A200 The Gut Microbiome in the Food Allergic Host Jamie Kiehm, Punita Ponda, Sherry Farzan, Jared Weiss, Claudia Elera, Catherine Destio, Cristina Sison, Annette Lee A201 Cord blood cytokines and maternal environmental exposure during pregnancy Soo Hyun Ri, Chang Hoon Lim A202 Rupatadine pharmacokinetics in Japanese healthy volunteers after single and repeated oral doses of 10, 20 and 40 mg Iaki Izquierdo Pulido, Jorg Taubel, Georg Ferber, Eva Santamaria Masdeu A203 A safe and effective method to desensitize patients with wheat allergy Alireza Khayatzadeh, Masoud Movahedi, Motohiro Ebisawa, Mohammad Gharagozlou A204 RNA Binding Protein Hur Regulates CD4 T Cell Differentiation and Is Required for Allergic Airway Inflammation and Normal IL2 Homeostasis Ulus Atasoy, Patsharaporn Techasintana, Matt Gubin, Jacqueline Glascock, Suzanne Ridenhour, Joseph Magee A205 Time Trends in the Epidemiology of Recurrence Respiratory_Sounds in Infants from South America Nelson Rosario Filho; Herberto Jose Chong Neto, Gustavo Falbo Wandalsen, Ana Caroline Dela Bianca, Carolina Aranda, Dirceu Sole, Javier Mallol, Luis Garcia-Marcos, Luis Garcia-Marcos A206 Successful start_entity Desensitization in a Pediatric Patient with Lupus_Vulgaris_Erythematosus,_Systemic Jennifer Toh, Yoomie Lee, Joyce Huang, Elina Jerschow, Jenny Shliozberg A207 The Fatty Acid Binding Protein Der p 13 Is a Minor House Dust Mite Allergen Able to Activate Innate Immunity Pattraporn Satitsuksanoa, Narissara Suratannon, Jongkonnee Wongpiyabovorn, Pantipa Chatchatee, Kiat Ruxrungtham, Alain Jacquet A208 Epidemiology of Stevens-Johnson end_entity and Toxic Epidemal Necrolysis: An Administrative Database Study Min Suk Yang; Jin Yong Lee, Ja Yeun Kim, Han-Ki Park, Ju-Young Kim, Woo-Jung Song, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Sang-Heon Cho, Kyung-up Min, Chang-Han Park, Suk-Il Chang, Sook-Hee Song A209 Regional Differences of Vitamin D and Food-Induced Anaphylaxis in Korea Si-Heon Kim, Gil-Soon Choi, Su-Chin Kim, Ji Hye Kim, Ga Young Ban, Yoo Seob Shin, Hae-Sim Park, Young Min Ye A210 Triggering Factors of Dermatitis,_Atopic By Severity Yoon Ha Hwang A211 Clinical Features of Drug-Related_Side_Effects_and_Adverse_Reactions of Monoclonal Antibodies in Korea Da Woon Sim, Kyung Hee Park, Kyung Hee Park, Hye Jung Park, Hye Jung Park, Jung-Won Park, Jung-Won Park, Jae-Hyun Lee, Jae-Hyun Lee A212 Food_Hypersensitivity with Eczema Is Associated with Reduced Growth in the First Four Years of Life Katrina Allen, Cara Beck, Jennifer Koplin, Melanie Matheson, Mimi Tang, Anne-Louise Ponsonby, Lyle Gurrin, Shyamali Dharmage, Melissa Wake, Vicki Mcwilliam A213 The Preliminary Study on Clinical Efficacy and Impact Factors of One Year's Dust Mite Specific Immunotherapy in Allergic Asthma and Rhinitis Children Sensitized to Dust Mite Xiaoying Liu, Jing Wang, Li Xiang, Qun Wang A214 Lipopolysaccharide Signaling through Toll- like Receptor 4 Could be Augmented By Dermatophagoides Farinae in the Human Middle Ear Epithelial Cell Ji-Eun Lee, Dong-Young Kim, Chae-Seo Rhee, Chae-Seo Rhee A215 Drug_Hypersensitivity in Pregnant Adolescents: Relation with Familial and Personal Atopy, and Substances Use Francisco Vazquez-Nava A216 Patients and Physicians Concept of Well-Controlled Asthma: Findings from Realise Asia Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, David Price, Glenn Neira, Jiangtao Lin A217 The Role of Vasoactive Intestinal Peptide in the Pathophysiology of Acute Asthma Olga Semernik A218 Comparison of Serum Cytokine Levels According to the Severity in Dermatitis,_Atopic Ha-Su Kim, Jin-a Jung, Ji-in Jung A219 The Different Influence on the Regulatory T Cell Response Between Subcutanous ImmnuotherapySCIT and Sublingual ImmunotherapySLIT in Children with Asthma Qing Miao, Li Xiang A220 Asthma State of Affairs in Asia: Seeing through Physicians' and Patients' Lenses Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, Jiangtao Lin, David Price A221 Identification of Aspirin Exacerbated Respiratory Disease AERD Phenotypes Using Two Step Cluster Analysis Hyun Young Lee, Hae-Sim Park, Young Min Ye, Su Chin Kim A222 Dusty Air Pollution Are Associated with an Increase Risk of Allergic Diseases in General Population Shokrollah Farrokhi, Mohammadkazem Gheiby A223 A Genome-Wide Association Study of Antituberculosis Drugs-Induced Hepatitis Sang-Heon Kim; Heung Woo Park, Sang-Hoon Kim, Young-Koo Jee A224 The Role of peroxiredoxin6 of Bronchial Epithelial Cells in Regulating Mitochondrial Function Under Oxidative Stress By Translocation,_Genetic to Outside Mitochondrial Membrane Sunjoo Park, Keun Ai Moon, Hyouk-Soo Kwon, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Kyoung Young Lee, Gyong Hwa Hong, Eun Hee Ha A225 Toxic and Adjuvant Effects of 3 Types of Silica Nanoparticles on Airway System Heejae Han, Hye Jung Park, Yoon Hee Park, Yoon-Jo Kim, Kangtaek Lee, Jung-Won Park, Jae-Hyun Lee A226 Procedure for Diagnostic and Selection of Immunotherapy Method for Children with Different Immunopathogenetic Phenotypes of Dermatitis,_Atopic Tatiana Slavyanskaya, Vladislava Derkach A227 Prediction of the Success of Our Desensitization Protocol with Symptoms and Results of a Skin Prick Test in Patients with Hypersensitivity to Platinum-Based Chemotherapy Hye Jung Park, Chein-Soo Hong, Jae-Hyun Lee, Jae-Hyun Lee, Sungryeol KIM, Sungryeol KIM, Kyung Hee Park, Kyung Hee Park, Choong-Kun Lee, Beodeul Kang, Seung-Hoon Beom, Sang Joon Shin, Minku Jung, Jung-Won Park, Jung-Won Park A228 Anti-Allergic Effect of Intralymphatic Injection of OVA-Flagelin Mixture in Mouse Model of Rhinitis,_Allergic Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo, Young-Jun Chung A229 Serum Periostin Level Is Higher in Respiratory Type of NSAID Hypersensitivity Than Cutaneous Type Mi-Ae Kim, Hae-Sim Park, Moon Gyeong Yoon, Young-Soo Lee, Ji Hye Kim, Ga Young Ban, Hye-Soo Yoo, Yoo Seob Shin, Young Min Ye, Dong-Ho Nahm A230 A Retrospective Analysis of Hypersensitivity Blood Testing in Beijing Children's Hospital in the Year of 2013: A Single-Center Research Qing Miao, Li Xiang A231 Role of Nrf2 in the Allergic Airway Inflammation Differ Between BALBc and C57BL6 Mice Ying-Ji Li, Takako Shimizu, Hirofumi Inagaki, Yukiyo Hirata, Hajime Takizawa, Arata Azuma, Masayuki Yamamoto, Tomoyuki Kawada A232 Effect of Human Mesenchymal Stem Cell on Neutrophilic Asthma Model Min-Gu Kim, Gyong Hwa Hong, Kyoung Young Lee, Eun Hee Ha, Keun Ai Moon, Sunjoo Park, Hyouk-Soo Kwon, Tae-Bum Kim, Hee-Bom Moon, You Sook Cho, Jung-Hyun Kim, Hyo-Jung Kim, So-Young Park, Bomi Seo A233 Immunomodulatory Effect of Tonsil Derived Mesenchymal Stem Cells in a Mouse Model of Rhinitis,_Allergic Ji-Hye Kim, Ramachandran Samivel, Eun-Hee Kim, Young-Jun Chung, Ji-Hun Mo A234 Alternative Therapy Such As Yoga May be a Low Cost Tool for Improving the Quality of Life of Patient's with Rhinitis,_Allergic and Asthma Soumya M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"MERS-CoV spike glycoprotein comprises start_entity and end_entity subunits, with the start_entity subunit being a primary target of neutralizing antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"In this study, we have expressed and purified severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome structural proteins and their fragments and developed indirect enzyme-linked immunosorbent assays ELISAs that detect antibodies against the Severe_Acute_Respiratory_Syndrome N, N1, N2, start_entity, ERMAP, end_entity, and M proteins as well as the human COVID-19 OC43 and 229E N proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"value\": \"BACKGROUND: Personal protective equipment PPE and strict infection control techniques are the primary methods by which healthcare workers HCW can avoid exposure during the treatment of patients with highly pathogenic infections such as end_entity EVD or the Coronavirus_Infections start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity end_entity-CoV spike is the largest known viral spike molecule, and shares a similar function with all class 1 viral fusion proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"To verify the whether IGEs suppress IAV replication in a Thyroid_cancer,_papillary-dependent manner, IAV RNA replication, expression of Thyroid_cancer,_papillary and the phosphorylation of eIF2 in A549 cells were detected; the levels of end_entity, Thyroid_cancer,_papillary and start_entity in mouse lung tissues were determined; and the activity of IAV polymerase was evaluated in Thyroid_cancer,_papillary-compromised cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD274\",\n",
       "                    \"target\": \"ERK\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; end_entity, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; start_entity, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADAM10\",\n",
       "                    \"target\": \"Familial paroxysmal dystonia\",\n",
       "                    \"value\": \"Incubation of cells with the end_entity- and -1-specific inhibitor Go6976, the end_entity 1 and 2-specific inhibitor ruboxistaurin, inhibitors of matrix metalloproteinases-2,-8, and -9, or an inhibitor of start_entity GI250423X had no effect on basal ACE2 shedding\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"1 Million South Korean Health-Care Records Gwang-Cheon Jang, Hyun-Hee Lee, Chang-Jong Lee, Huynsun Lim A314 Association of Recurrence Wheeze with Lung Function and Airway Inflammation in Preschool Children Ji-Eun Soh, Dae-Jin Song, Ji-Won Kwon, Hyung Young Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Gwang-Cheon Jang, Woo Kyung Kim, Young-Ho Jung, Soo-Jong Hong, Jung Yeon Shim A315 Mannan-Binding Lectin Serum Levels in Healthy Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A316 Rotanebuliser Prabhakarrao Pv, Ranjitha Nadendla A317 The Level of Serum Interleukin 13 and Interleukin 17A and Its Effect Factors in Children with Asthma Juan Fang, Jing Zhao A318 Is Vitamin D Insufficiency Also Involved in Childhood Asthma in South Korea? Dae-Jin Song, Sungchul Seo, Young Yoo, Yu-Ri Kim, Ji Tae Choung, Jee Hoo Lee A319 Collection of Nasal Secretions for Measurement of Local IgE: A Quest for the Best Method Margot Berings, Natalie De Ruyck, Claus Bachert, Philippe Gevaert, Gabrile Holtappels A320 The Role of Claudin 5 in a Murine Model of Asthma Pureun-Haneul Lee, Byeong-Gon Kim, Choon-Sik Park, George D Leikauf, An-Soo Jang A321 Claudin-4 in a Murine Model of Asthma: Modulation By Acrolein, a Highly Reactive Unsaturated Aldehyde Byeong-Gon Kim, Pureun-Haneul Lee, Choon-Sik Park, An-Soo Jang A322 Efficacy and Safety of Sublingual Immunotherapy in House Dust Mite Sensitized Children with end_entity Yang Park A323 The Association of Vitamine D Deficiency and Skeletal Muscle Dysfunction in Chronic Airway Disease Min-Su Sohn, Hyun Jung Jin, Dong-Won Lee, Jun-Hong Ahn, Jin Hong Chung A324 Bacteria Derived Extracellular Vesicles in Indoor Dust Is Closely Associated with Airway Disease and Lung_Neoplasms: Analysis of Indoor Dusts Microbiome and IgG Sensitization of Indoor Bacteria Derived Extracellular Vesicles Sae-in Kim, Han-Ki Park, Do-Yeon Kim, Mina RHOD, Jun-Pyo Choi, Yoon-Keun Kim A325 Clinical Care Program for Childhood Asthma CCP-Childhood Asthma; A Multidisciplinary Team Care at Samitivej International Children's Hospital Wasu Kamchaisatian, Thitikul Hiranras, Surinda Wongpun, Phornthip Chiraphorn, Anupan Tantachun, Wannipa Wongrassamee, Planee Vatanasurkitt, Naratip Somboonkul, Nattipat Juthacharoenwong, Surangkana Techapaitoon, Montri Tuchinda A326 Continuous B Cell Stimulation with CD40 Ligand Induce IgE Isotype Switching Jae Ho Lee, Sejin An A327 Effects of Interleukin-9 on Allergen-Specific Immunotherapy in a Mouse Model of end_entity Ji-Hyeon Shin, Soo Whan Kim, Si Won Kim, Jun Myung Kang, Boo-Young Kim, Byung-Guk Kim A328 Usefulness of Exhaled Nitric_Oxide for Evaluating Wheeze and Airway Hyperresponsiveness in Preschool Children Jung-Won Lee, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Jung Yeon Shim A329 Systemic Cyclosporine Treatment in Hand Eczema Patients Kyung Ho Kim A330 Lipid Profiles and Adipokines in Korean Children with Dermatitis,_Atopic Young Yoo, Won Suck Yoon, Sungchul Seo, In Soon Kang, Jae Won Choi, Hye-Young Lim, Ji Tae Choung A331 Validation of Montelukast and Levocetirizine Combination Tablet Versus Individual Tablets in the Treatment of Moderate to Severe Persistent end_entity Among Adult Filipinos Seen at the Philippine General Hospital-Outpatient Department Michelle Buela A332 Efficacy of Makyokansekito on Treatment of Respiratory_Sounds Lower Respiratory_Tract_Infections in Children: A Retrospective Study of 68 Patients Koji Nishimura A333 Serum Eosinophilia and Total IgE Are Associated with the Risk of Allergic Sensitization and Allergic Symptoms in Two Years Follow-up, Respectively Sang Chul Park, Hyo Jin Chung, Chang-Hoon Kim, Ju Wan Kang, Seong-Chul Hong, Keun-Hwa Lee, Jaechun Lee, Hye-Sook Lee, Jeong Hong Kim A334 The Sensitization to Russian Thistle on Mongolian Patients Narantsetseg Logii A335 The Association Between Air Pollution, Allergic Sensitization to Inhalant Allergens and Airway Hyperresponsiveness in Ulaanbaatar, Mongolia Munkhbayarlakh Sonomjamts, Enkhbayar Bazarsad A336 Pre-Coseasonal Treatment with a 5-Grass Pollen Sublingual Tablet in Adults Demonstrated a Reduction on Asthma Symptoms in Runion Island Bashir Omarjee A337 Peak Expiratory Flow Rate Reference Values for Children Aged 5-14 Years Old in Beijing Urban Area Shuo TGM1 A338 Soybean Storage Proteins As the Main Allergen in a Patient with Food-Dependent Exercise-Induced Anaphylaxis Due to Tofu Miyuki Hayashi, Ruby Pawankar, Shingo Yamanishi, Toru Igarashi, Yasuhiko Itoh A339 A Study of start_entity Skin Prick Test with Weed Pollen Oyuntsatsral Batsaikhan, B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Central Nervous System Infections\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Sections are divided into anatomic systems, including Bloodstream end_entity and end_entity of the Cardiovascular System, start_entity, Ocular end_entity, Soft Tissue end_entity of the Head and Neck, Upper Respiratory end_entity, Lower Respiratory Tract infections, end_entity of the Gastrointestinal Tract, Intraabdominal end_entity, Bone and Joint end_entity, Urinary Tract end_entity, Genital end_entity, and Skin and Soft Tissue end_entity; or into etiologic agent groups, including Tickborne end_entity, Viral Syndrome, and Blood and Tissue Parasite end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Analysis of the start_entity gene showed that isolate I110116 was genetically close to strain ckCHLJL140901, which belongs to the TW I genotype also known as lineage GI-7 based on the recent IBV classification, however the end_entity gene showed genetic diversity comparing to that of start_entity gene\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"TRIM25\",\n",
       "                    \"value\": \"Collectively, this study suggests that RSV Noonan_Syndrome interacts with end_entity and interferes with start_entity ubiquitination to suppress type-I interferon signaling\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Shock\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with start_entity Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of start_entity Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe start_entity Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylactic end_entity Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of start_entity Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe start_entity Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed start_entity, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Using time course experiments in whole peripheral blood mononuclear cell PBMC cultures, we show that TNF blockade maintained, rather than increased, end_entity cell frequencies in both CD4 and start_entity T cells following in vitro stimulation in a dose- and time-dependent manner\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Contact\",\n",
       "                    \"target\": \"Exanthema\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with start_entity Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug end_entity Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug end_entity with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDKN2A\",\n",
       "                    \"target\": \"CDKN2B\",\n",
       "                    \"value\": \"Semi-quantitative RT-PCR and Western blotting revealed that p17-expressing cells induced the expression of CDK inhibitor p21cip1waf1 in a time- and dose-dependent manner, but the transcripts of CDK inhibitor end_entity, start_entity, or p27kip were not altered\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AR\",\n",
       "                    \"target\": \"VDR\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal start_entity patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 end_entity gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT3\",\n",
       "                    \"target\": \"STAT6\",\n",
       "                    \"value\": \"SOAT11 belongs to the SOAT1 family of transcription factors, which comprises seven factors: SOAT11, SOAT12, start_entity, SOAT14, SOAT15A, SOAT15B and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Asthma\",\n",
       "                    \"value\": \"Kowalski A507 The Role of EIF2AK2 Pathway in Acute Exacerbation of Severe end_entity So Ri Kim, Yong Chul Lee, Dong Im Kim, Yang Keun Rhee, Heung Bum Lee, Seoung Ju Park, Yeong Hun Choe Choe, Seung Yong Park A508 Diversity of Clinical Manifestations and Treatment Responses for Hypereosinophilic_Syndrome Joo-Hee Kim, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A509 Effect of Dexamethasone in Th17 Cell Mediating Neutrophilic end_entity Nong Guang-Min, Jiang Min A510 Allergen Profile for end_entityRhinitis and Eczema Among Patients in North India: An Immunocap Allergen Specific IgE Antibodies Assay Based Study Nalin Nag A511 Clinical Profile of Rhinitis,_Allergic in Children in Jakarta Wahyuni Indawati A512 Preclinical Study on the Use of Micro Crystalline Tyrosine MCT Adjuvants in Hypersensitivity Immunotherapy Alan David Bullimore, Matthew Heath, Murray Skinner A513 Genetic Diversity of Filaggrin Mutation and Its Clinical Implication in East Asian Dermatitis,_Atopic Patients Seong Jun Seo, Won Jong Oh A514 Protein and MPL Adsorption Capacities for MCT in Candidate Therapeutic Formulations for Use in Immunotherapy, Compared Against Existing Adjuvants Alan David Bullimore, Murray Skinner, Matthew Heath, Andrew Bell A515 Interleukin-22 Gene Variation in Inflammatory_Bowel_Diseases Alireza Zarebidoki, Hournaz Hasanzadeh, Salman Sadeghzade, Nima Rezaei A516 Immunomodulatory Effects of Adipose-Derived Stem Cell Secretome in a Mouse Model of end_entity Kyu-Sup Cho A517 Diffuse Alveolar Hemorrhage with Positive Anti-Neutrophil Cytoplasmic Antibody in a Child : A Case Report Sung-Woo Kim, Moo-Young Oh A518 Clinical Analys the Serum CCL17 Levels As the Condition Index of Dermatitis,_Atopic in the Early Infancy Munemitsu Koizumi, Kazuyo Kuzume A519 An Analysis of the Filaggrin Gene Polymorphism in Korean Dermatitis,_Atopic Patients Kui Young Park, Won Jong Oh A520 A New Protocol for Wheat Oral Immunotherapy in Patients with start_entity Delara Babaie, Mohammad Nabavi, Fariborz Zandieh, Mehrdad Amir Moini, Zahra Chavoshzadeh, Hamideh Seifi, Mitra Sahragard, Mehrnaz Mesdaghi, Mohammad Hassan Bemanian A521 Clinical Characteristics of Filaggrin-Related Dermatitis,_Atopic Patients in Korea Sun Young Choi, Yeon a No A522 Early Hypersensitivity Diagnosis in Children - Self- Administered Questionnaire Vs Medical Verification Andrzej M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Carcinoma, Non-Small-Cell Lung\",\n",
       "                    \"target\": \"Chanarin-Dorfman Syndrome\",\n",
       "                    \"value\": \"Collectively, these findings highlight potential molecular mechanisms of end_entity chemotherapeutic activity and suggest that end_entity is an efficacious strategy in start_entity therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SOCS1\",\n",
       "                    \"target\": \"SOCS3\",\n",
       "                    \"value\": \"Real-time PCR revealed that the expression of the mandarin fish Mx, IRF-1, start_entity, and end_entity genes involved in the polyI:C-induced JakStat signaling pathway was impaired by the mCav-1 scaffolding domain peptide mSDP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OST\",\n",
       "                    \"target\": \"STT3A\",\n",
       "                    \"value\": \"Functional studies conducted by using CRISPR-Cas9-mediated knockouts showed that end_entity and STT3B, the two catalytically active isoforms of the start_entity complex, are essential for the propagation of the recombinant arenavirus rLCMVLASV glycoprotein precursor, mainly via affecting virus infectivity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIT1\",\n",
       "                    \"target\": \"IFIT3\",\n",
       "                    \"value\": \"IFIT2 and end_entity homodimers dissociate to form a more stable heterodimer that also associates with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like start_entityCLpro of the severe acute respiratory syndrome end_entity COVID-19 plays a vital role in virus maturation and is proposed to be a key target for drug design against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD274\",\n",
       "                    \"target\": \"Neoplasms\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; start_entity, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, end_entity Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"This cytokine inhibits class end_entity histocompatibility complex MHC molecules and inflammation in inflammatory diseases by suppressing MyD88 and subsequently IL-1, IL6, TNF and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"On the other hand, IFN-alpha induction was not markedly affected by monoclonal antibodies directed against other start_entity epitopes, against peplomer glycoprotein end_entity, or against nucleocapsid protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Infection with virulent biotypes of feline start_entity FCoV can result in the development of feline infectious peritonitis end_entity, a typically fatal immune mediated disease for which there is currently no effective antiviral treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL7\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Here we demonstrate that MCP-3start_entity is a significant chemokine produced by astrocytes, that basal monocyte migration may be facilitated by astrocyte-derived start_entity, that production of start_entity is rapidly increased by end_entity and thus likely plays a critical role in initiating neuroinvasion by SIVHIV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Newcastle Disease\",\n",
       "                    \"target\": \"Norrie disease\",\n",
       "                    \"value\": \"start_entity end_entity, caused by infections with virulent strains of start_entity virus end_entityV, is one of the most important infectious disease affecting wild, peridomestic, and domestic birds worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"TF\",\n",
       "                    \"value\": \"Using 14 unique poly-UUC sequences from HCV end_entity genomes recovered from acute-infection patients, we tested whether start_entity recognition and innate immune activation correlate with PAMP sequence characteristics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"RPLP2\",\n",
       "                    \"value\": \"To investigate the critical determinants recognized by start_entity, we performed site-directed mutagenesis on the P6 to end_entity residues at each of the three start_entity cleavage sites\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"To evaluate the effect of overexpression of chemokines on RABV infection, chemokines macrophage inflammatory protein 1 MIP-1, start_entity, and end_entity were individually cloned into the genome of attenuated RABV strain HEP-Flury\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM1\",\n",
       "                    \"target\": \"IFITM3\",\n",
       "                    \"value\": \"Here, through public data mining, episomal luciferase reporter assay and in vivo CRISPR-Cas9 genome editing, we identified an IFN-responsive enhancer located 35kb upstream of end_entity gene promoter upregulating the IFN-induced expression of start_entity, 2 and 3 genes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"In an effort to establish a screening program for high risk personal, the distribution of HLA class I and start_entity alleles in case and control groups was examined for the presence of an association to a genetic susceptibly or resistance to Severe_Acute_Respiratory_Syndrome end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Blockade of end_entity, IFNA1, IL-6R, or CD8A0CD8A6-mediated co-stimulation did not significantly regulate start_entity expression within CD4 or CD8A T cell subpopulations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"CXCR3\",\n",
       "                    \"value\": \"The recruited monocytes had higher expression of the activation marker MHCII on their surface as well as end_entity and CCR2; receptors for start_entity and CCL2, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"33 , fatigue or myalgia in 21patients 70 , nausea, vomiting or end_entity in 9 petients 30 , start_entity in 25 petients 83\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL2\",\n",
       "                    \"value\": \"OBJECTIVE: To investigate an association of variants in cytokine genes IL1A 889, IL1B 511, 3962, IL1R1 1970, IL1R1A 11100, IL4RA 1902, IL12 1188, IFNG 874, TGFB1 codon 10, codon 25, TNF 308, 238, end_entity 330, 166, IL4 1098, 590, 33, IL6 174, nt565, and start_entity 1082, 819, 592 between patients sensitive to dust mites and a control group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E3\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"HERC5 is the main cellular start_entity ligase that conjugates the IFN-induced protein end_entity to proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Additionally, one mAb recognized a neutralizing epitope located in the C-terminus of end_entity aa 13711377, while only one neutralizing mAb reacted against a region of the start_entity glycoprotein subunit aa 499600\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"IL18\",\n",
       "                    \"value\": \"Asymptomatic AMBP was characterized by a minimal immune response that was predominantly monocytic and lymphocytic, with limited lesions, and elevated urinary levels of IFN-, end_entity and start_entity P 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEACAM1\",\n",
       "                    \"target\": \"IL18\",\n",
       "                    \"value\": \"Expression of start_entity on NK cells was strongly enhanced by in vitro activation with interleukin-12 IL-12 and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"CXCL9\",\n",
       "                    \"value\": \"Human cells mounted vigorous cytokine TNF alpha TNF- and interleukin-6 IL6 and chemokine end_entity, start_entity, and CXCL11 responses to H5N1 virus infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"LYZ\",\n",
       "                    \"value\": \"Importantly, the host factors, such as up-regulated CCL23, IL-1, NOS2, start_entity, ACOD1, CH25H, NFKBIZ, end_entity and OASL were involved in the host defense response during the course of ALV-J infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"The ferret LECs were examined for their ability to respond to poly I:C TLR3 and RIG-1 ligand and other known TLR ligands as measured by production of proinflammatory cytokine IFNA1, IL6, IL10, Mx1, and TNF and chemokine start_entity, CCL20, and end_entity mRNAs using real time RT-PCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ginseng\",\n",
       "                    \"target\": \"Dermatitis, Contact\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with end_entity Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red start_entity KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red start_entity on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"During the first year of enhanced end_entity start_entity surveillance in England, 77 persons traveling from the Middle East had acute respiratory illness and were tested for the virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR5\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"The human immunodeficiency virus HIV Env binds to cell surfaceassociated receptor end_entity and coreceptor start_entity or CXCR4 by one of its two non-covalently associated subunits, gp120\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEBPA\",\n",
       "                    \"target\": \"XBP1\",\n",
       "                    \"value\": \"Despite representing unique signaling cascades, new data indicate that the UPR and NF-B pathways converge within the nucleus through ten major transcription factors TFs, namely activating transcription factor ATF4, ATF3, CCAATenhancer-binding protein start_entity homologous protein DDIT3, X-box-binding protein end_entity, ATF6 and the five NF-B subunits\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our results show that end_entity activates start_entity and EIF2AK3, leading to sustained eIF2 phosphorylation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TG\",\n",
       "                    \"target\": \"Herpes Simplex\",\n",
       "                    \"value\": \"end_entity virus type 1 HSV-specific CD8A T cells provide immunosurveillance of trigeminal ganglion start_entity neurons that harbor latent HSV-1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"IL2\",\n",
       "                    \"value\": \"Cytokine producing cells were predominantly single positive end_entity, start_entity, or TNF; triple-cytokine producing cells were relatively rare\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Paired sera from volunteers inoculated with one of the five recently isolated strains of human end_entity HCV, Alzheimer_Disease, GI, HO, start_entity, and CALR, none of which has been grown in tissue culture, or with strain OC38 were tested against end_entity antigens by enzyme-linked immunosorbent assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD40\",\n",
       "                    \"target\": \"Inflammation\",\n",
       "                    \"value\": \"1 Million South Korean Health-Care Records Gwang-Cheon Jang, Hyun-Hee Lee, Chang-Jong Lee, Huynsun Lim A314 Association of Recurrence Wheeze with Lung Function and Airway end_entity in Preschool Children Ji-Eun Soh, Dae-Jin Song, Ji-Won Kwon, Hyung Young Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Gwang-Cheon Jang, Woo Kyung Kim, Young-Ho Jung, Soo-Jong Hong, Jung Yeon Shim A315 Mannan-Binding Lectin Serum Levels in Healthy Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A316 Rotanebuliser Prabhakarrao Pv, Ranjitha Nadendla A317 The Level of Serum Interleukin 13 and Interleukin 17A and Its Effect Factors in Children with Asthma Juan Fang, Jing Zhao A318 Is Vitamin D Insufficiency Also Involved in Childhood Asthma in South Korea? Dae-Jin Song, Sungchul Seo, Young Yoo, Yu-Ri Kim, Ji Tae Choung, Jee Hoo Lee A319 Collection of Nasal Secretions for Measurement of Local IgE: A Quest for the Best Method Margot Berings, Natalie De Ruyck, Claus Bachert, Philippe Gevaert, Gabrile Holtappels A320 The Role of Claudin 5 in a Murine Model of Asthma Pureun-Haneul Lee, Byeong-Gon Kim, Choon-Sik Park, George D Leikauf, An-Soo Jang A321 Claudin-4 in a Murine Model of Asthma: Modulation By Acrolein, a Highly Reactive Unsaturated Aldehyde Byeong-Gon Kim, Pureun-Haneul Lee, Choon-Sik Park, An-Soo Jang A322 Efficacy and Safety of Sublingual Immunotherapy in House Dust Mite Sensitized Children with Rhinitis,_Allergic Yang Park A323 The Association of Vitamine D Deficiency and Skeletal Muscle Dysfunction in Chronic Airway Disease Min-Su Sohn, Hyun Jung Jin, Dong-Won Lee, Jun-Hong Ahn, Jin Hong Chung A324 Bacteria Derived Extracellular Vesicles in Indoor Dust Is Closely Associated with Airway Disease and Lung_Neoplasms: Analysis of Indoor Dusts Microbiome and IgG Sensitization of Indoor Bacteria Derived Extracellular Vesicles Sae-in Kim, Han-Ki Park, Do-Yeon Kim, Mina RHOD, Jun-Pyo Choi, Yoon-Keun Kim A325 Clinical Care Program for Childhood Asthma CCP-Childhood Asthma; A Multidisciplinary Team Care at Samitivej International Children's Hospital Wasu Kamchaisatian, Thitikul Hiranras, Surinda Wongpun, Phornthip Chiraphorn, Anupan Tantachun, Wannipa Wongrassamee, Planee Vatanasurkitt, Naratip Somboonkul, Nattipat Juthacharoenwong, Surangkana Techapaitoon, Montri Tuchinda A326 Continuous B Cell Stimulation with start_entity Ligand Induce IgE Isotype Switching Jae Ho Lee, Sejin An A327 Effects of Interleukin-9 on Allergen-Specific Immunotherapy in a Mouse Model of Rhinitis,_Allergic Ji-Hyeon Shin, Soo Whan Kim, Si Won Kim, Jun Myung Kang, Boo-Young Kim, Byung-Guk Kim A328 Usefulness of Exhaled Nitric_Oxide for Evaluating Wheeze and Airway Hyperresponsiveness in Preschool Children Jung-Won Lee, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Jung Yeon Shim A329 Systemic Cyclosporine Treatment in Hand Eczema Patients Kyung Ho Kim A330 Lipid Profiles and Adipokines in Korean Children with Dermatitis,_Atopic Young Yoo, Won Suck Yoon, Sungchul Seo, In Soon Kang, Jae Won Choi, Hye-Young Lim, Ji Tae Choung A331 Validation of Montelukast and Levocetirizine Combination Tablet Versus Individual Tablets in the Treatment of Moderate to Severe Persistent Rhinitis,_Allergic Among Adult Filipinos Seen at the Philippine General Hospital-Outpatient Department Michelle Buela A332 Efficacy of Makyokansekito on Treatment of Respiratory_Sounds Lower Respiratory_Tract_Infections in Children: A Retrospective Study of 68 Patients Koji Nishimura A333 Serum Eosinophilia and Total IgE Are Associated with the Risk of Allergic Sensitization and Allergic Symptoms in Two Years Follow-up, Respectively Sang Chul Park, Hyo Jin Chung, Chang-Hoon Kim, Ju Wan Kang, Seong-Chul Hong, Keun-Hwa Lee, Jaechun Lee, Hye-Sook Lee, Jeong Hong Kim A334 The Sensitization to Russian Thistle on Mongolian Patients Narantsetseg Logii A335 The Association Between Air Pollution, Allergic Sensitization to Inhalant Allergens and Airway Hyperresponsiveness in Ulaanbaatar, Mongolia Munkhbayarlakh Sonomjamts, Enkhbayar Bazarsad A336 Pre-Coseasonal Treatment with a 5-Grass Pollen Sublingual Tablet in Adults Demonstrated a Reduction on Asthma Symptoms in Runion Island Bashir Omarjee A337 Peak Expiratory Flow Rate Reference Values for Children Aged 5-14 Years Old in Beijing Urban Area Shuo TGM1 A338 Soybean Storage Proteins As the Main Allergen in a Patient with Food-Dependent Exercise-Induced Anaphylaxis Due to Tofu Miyuki Hayashi, Ruby Pawankar, Shingo Yamanishi, Toru Igarashi, Yasuhiko Itoh A339 A Study of Hypersensitivity Skin Prick Test with Weed Pollen Oyuntsatsral Batsaikhan, B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FKBP4\",\n",
       "                    \"target\": \"Noonan Syndrome\",\n",
       "                    \"value\": \"In this work, we demonstrate that in mosquito cells, but not in vertebrate cells, end_entity secretion takes place in association with the chaperone caveolin complex, a complex formed by caveolin-1 and the chaperones start_entity, CyA, and Cy40, which are in charge of cholesterol transport inside the cell\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Catenulatum Colonisation Differentially Modulate Eczema Risk in Children at High-Risk of Developing Allergic Disease Intan Hakimah Ismail, Robert Boyle, Paul Licciardi, Frances Oppedisano, Roy Robins-Browne, Mimi Tang A481 Effects of Chronic Repeated Exposure of Staphylococcal Enterotoxin B on Allergic Asthma Model in Mice Ji Won Lee, Hyun Seung Lee, Mingyu Kang, Da-Eun Park, Han-Ki Park, Soon-Hee Kim, Woo-Jung Song, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Chang-Han Park, Suk-Il Chang, Sook-Hee Song, Kyung-up Min, Sang-Heon Cho, Boram Bae A482 Skin Prick Test Result and Allergen Immunotherapy in Children with end_entity Grace Shieh A483 Role of Brp-39 in RSV-Induced Airway start_entity in Mice Min Jung Kim, Jung Yeon Hong, Seo Hee Yoon, Doo Hee Shim, In Suk Sol, Yoon Hee Kim, Mi Na Kim, Kyung Eun Lee, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Jae Myun Lee A484 Long-Term Outcomes of Twenty-Four Adults with Primary Immunologic_Deficiency_Syndromes from a Single Centre in Singapore Hiok Hee Chng A485 Breast Feeding Increases the Risk of Food Sensitization but Does Not Affect Food_Hypersensitivity in Young Children with Dermatitis,_Atopic Dong Chan Kim, Song-I Yang, Hae Ran Lee, An Deok Seo, So Yeon Lee A486 IgE Immunoadsorption Knocks Down Anaphylaxis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"01, headache 64 vs 72, malaise 64 vs 84, start_entity 86 vs 68, end_entity production 86 vs 60, sore throat 64 vs 80, and nasal congestion 93 vs 96\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Viremia, provirus and blood mRNA expression of interleukin IL-1, start_entity, end_entity, IL10, IL-12p40, Interferon- and Neoplasms Necrosis Factor- were monitored by Real-Time qPCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Intraabdominal Infections\",\n",
       "                    \"target\": \"Respiratory Tract Infections\",\n",
       "                    \"value\": \"Sections are divided into anatomic systems, including Bloodstream Infection and Infection of the Cardiovascular System, Central_Nervous_System_Eye_Infection Infection, Soft_Tissue_Infections of the Head and Neck, end_entity, Lower Respiratory Tract infections, Infection of the Gastrointestinal Tract, start_entity, Bone and Joint Infection, Urinary_Tract_Infections, Genital Infection, and Skin and Soft_Tissue_Infections; or into etiologic agent groups, including Tickborne Infection, Viral Syndrome, and Blood and Tissue Parasite Infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H2\",\n",
       "                    \"target\": \"Wheat Hypersensitivity\",\n",
       "                    \"value\": \"Fal, Dorota Kiedik, Agnieszka Muszynska, Iwona Pirogowicz A523 Asthma Impact on Children with Food Induced Anaphylaxis Chikako Motomura, Masatoshi Wakatsuki, Yuko Akamine, Mihoko Iwata, Hiroshi Matsuzaki, Naohiko Taba, Yoko Murakami, Hiroshi Odajima A524 Case Reports of Stevens-Johnson_Syndrome and Stevens-Johnson_Syndrome-Stevens-Johnson_Syndrome in Lupus_Vulgaris_Erythematosus,_Systemic Reni Ghrahani A525 The Effectiveness of Oral Tolerance Induction for end_entity Using Two Different Intake Levels Yuri Takaoka A526 Association of Plasma Interleukin-25 Levels with Development of Aspirin Induced Airway Spasm in Asthma Jong-Uk Lee, Jeong-Seok Heo, Da-Jeong Bae, Hyun Ji Song, Choon-Sik Park, Jong-Sook Park A527 Transition of Allergic and Nonallergic Rhinitis after 2 Years in Korean Children: Preliminary Study Jae Hoon Cho, Ji Ho Choi A528 Early Onset of Psoriasis Arthritis,_Juvenile Budi Setiabudiawan, Fiska Febriana, Reni Ghrahani, Gartika Sapartini A529 Clinical Features of Hypersensitivity,_Immediate to Histamine start_entity Antagonists and Their Cross Reactivity Chan-Sun Park, Young-Hee Nam, Mi Yeoung Kim, Gil-Soon Choi A530 Detection of Galacto-Oligosaccharide Specific IgE in Vitro Chiung-Hui Huang, Chiung-Hui Huang, Jian Yi Soh, Lynette Shek, Lynette Shek, Dianne J\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"Hemorrhagic Fever with Renal Syndrome\",\n",
       "                    \"value\": \"In Puumala virus-infected end_entity patients n 18, we report that the levels of start_entity- and start_entity- are similar, whereas the level of start_entity- type III start_entity is significantly decreased, during acute day of hospitalization compared to the convalescent phase\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"\\u00a0C-reactive protein\",\n",
       "                    \"value\": \"Performance to predict poor outcome in acute cough patients was compared with that of existing prediction rules, using the models' area under the receiver operator characteristic curve AUC, and any improvement obtained by including additional test results end_entity start_entity, blood urea nitrogen BUN, chest radiography, or aetiology was evaluated using the same methodology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"We describe a case of extremely severe respiratory failure due to concurrence of PAP and end_entity A H1N1 virus start_entity which resolved with the help of this procedure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Irrespective of the predominance of type I FCoV infection in Taiwan, type start_entity FCoV demonstrated a significantly higher correlation with end_entity p 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UPP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Background To collect disease information and provide data for early detection of epidemics, two surveillance systems were established for influenzalike illness ILI and unexplained end_entity start_entity in Wuxi, People's Republic of China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Marburg Virus Disease\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The committee determined that, given their potential to cause a public health emergency and the absence of efficacious drugs andor vaccines, there is an urgent need for accelerated RD for in no order of priority Hemorrhagic_Fever,_Crimean, Ebola virus and start_entity, Lassa_Fever, Coronavirus_Infections MERS and end_entity end_entity, Nipah and henipaviral diseases, Rift Valley fever and Zika virus disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COX8A\",\n",
       "                    \"target\": \"LEP\",\n",
       "                    \"value\": \"Our results indicate that first milk feeding after birth influenced whole-body energy expenditure but not FOX and start_entity in neonatal calves, and the absorption of colostral end_entity and ADIPOQ might affect INS sensitivity on d 1 of life\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"Hemorrhage\",\n",
       "                    \"value\": \"Kowalski A507 The Role of start_entity Pathway in Acute Exacerbation of Severe Asthma So Ri Kim, Yong Chul Lee, Dong Im Kim, Yang Keun Rhee, Heung Bum Lee, Seoung Ju Park, Yeong Hun Choe Choe, Seung Yong Park A508 Diversity of Clinical Manifestations and Treatment Responses for Hypereosinophilic_Syndrome Joo-Hee Kim, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A509 Effect of Dexamethasone in Th17 Cell Mediating Neutrophilic Asthma Nong Guang-Min, Jiang Min A510 Allergen Profile for AsthmaRhinitis and Eczema Among Patients in North India: An Immunocap Allergen Specific IgE Antibodies Assay Based Study Nalin Nag A511 Clinical Profile of Rhinitis,_Allergic in Children in Jakarta Wahyuni Indawati A512 Preclinical Study on the Use of Micro Crystalline Tyrosine MCT Adjuvants in Hypersensitivity Immunotherapy Alan David Bullimore, Matthew Heath, Murray Skinner A513 Genetic Diversity of Filaggrin Mutation and Its Clinical Implication in East Asian Dermatitis,_Atopic Patients Seong Jun Seo, Won Jong Oh A514 Protein and MPL Adsorption Capacities for MCT in Candidate Therapeutic Formulations for Use in Immunotherapy, Compared Against Existing Adjuvants Alan David Bullimore, Murray Skinner, Matthew Heath, Andrew Bell A515 Interleukin-22 Gene Variation in Inflammatory_Bowel_Diseases Alireza Zarebidoki, Hournaz Hasanzadeh, Salman Sadeghzade, Nima Rezaei A516 Immunomodulatory Effects of Adipose-Derived Stem Cell Secretome in a Mouse Model of Asthma Kyu-Sup Cho A517 Diffuse Alveolar end_entity with Positive Anti-Neutrophil Cytoplasmic Antibody in a Child : A Case Report Sung-Woo Kim, Moo-Young Oh A518 Clinical Analys the Serum CCL17 Levels As the Condition Index of Dermatitis,_Atopic in the Early Infancy Munemitsu Koizumi, Kazuyo Kuzume A519 An Analysis of the Filaggrin Gene Polymorphism in Korean Dermatitis,_Atopic Patients Kui Young Park, Won Jong Oh A520 A New Protocol for Wheat Oral Immunotherapy in Patients with Anaphylaxis Delara Babaie, Mohammad Nabavi, Fariborz Zandieh, Mehrdad Amir Moini, Zahra Chavoshzadeh, Hamideh Seifi, Mitra Sahragard, Mehrnaz Mesdaghi, Mohammad Hassan Bemanian A521 Clinical Characteristics of Filaggrin-Related Dermatitis,_Atopic Patients in Korea Sun Young Choi, Yeon a No A522 Early Hypersensitivity Diagnosis in Children - Self- Administered Questionnaire Vs Medical Verification Andrzej M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"ZBTB16\",\n",
       "                    \"value\": \"Here, we identified the PML zinc finger end_entity protein as a previously unrecognized component of the start_entity response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCX\",\n",
       "                    \"target\": \"IFNL2\",\n",
       "                    \"value\": \"We show that inactivated HHV-6B induced IFN-lambda1 IFNL1 but not IFN-lambda2 end_entity responses in plasmacytoid start_entity and that this induction was mediated through TLR9\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"value\": \"Moniaga, Kenji Kabashima, Eung Ho Choi A199 Trends in oral food challenges in Japan: A six-year prospective study Noriyuki Yanagida, Sakura Sato, Chizuko Sugizaki, Motohiro Ebisawa A200 The Gut Microbiome in the Food Allergic Host Jamie Kiehm, Punita Ponda, Sherry Farzan, Jared Weiss, Claudia Elera, Catherine Destio, Cristina Sison, Annette Lee A201 Cord blood cytokines and maternal environmental exposure during pregnancy Soo Hyun Ri, Chang Hoon Lim A202 Rupatadine pharmacokinetics in Japanese healthy volunteers after single and repeated oral doses of 10, 20 and 40 mg Iaki Izquierdo Pulido, Jorg Taubel, Georg Ferber, Eva Santamaria Masdeu A203 A safe and effective method to desensitize patients with wheat allergy Alireza Khayatzadeh, Masoud Movahedi, Motohiro Ebisawa, Mohammad Gharagozlou A204 RNA Binding Protein Hur Regulates CD4 T Cell Differentiation and Is Required for Allergic Airway Inflammation and Normal IL2 Homeostasis Ulus Atasoy, Patsharaporn Techasintana, Matt Gubin, Jacqueline Glascock, Suzanne Ridenhour, Joseph Magee A205 Time Trends in the Epidemiology of Recurrence Respiratory_Sounds in Infants from South America Nelson Rosario Filho; Herberto Jose Chong Neto, Gustavo Falbo Wandalsen, Ana Caroline Dela Bianca, Carolina Aranda, Dirceu Sole, Javier Mallol, Luis Garcia-Marcos, Luis Garcia-Marcos A206 Successful Cyclophosphamide Desensitization in a Pediatric Patient with Lupus_Vulgaris_Erythematosus,_Systemic Jennifer Toh, Yoomie Lee, Joyce Huang, Elina Jerschow, Jenny Shliozberg A207 The Fatty Acid Binding Protein Der p 13 Is a Minor House Dust Mite Allergen Able to Activate Innate Immunity Pattraporn Satitsuksanoa, Narissara Suratannon, Jongkonnee Wongpiyabovorn, Pantipa Chatchatee, Kiat Ruxrungtham, Alain Jacquet A208 Epidemiology of Stevens-Johnson_Syndrome and Toxic Epidemal Necrolysis: An Administrative Database Study Min Suk Yang; Jin Yong Lee, Ja Yeun Kim, Han-Ki Park, Ju-Young Kim, Woo-Jung Song, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Sang-Heon Cho, Kyung-up Min, Chang-Han Park, Suk-Il Chang, Sook-Hee Song A209 Regional Differences of Vitamin D and Food-Induced start_entity in Korea Si-Heon Kim, Gil-Soon Choi, Su-Chin Kim, Ji Hye Kim, Ga Young Ban, Yoo Seob Shin, Hae-Sim Park, Young Min Ye A210 Triggering Factors of Dermatitis,_Atopic By Severity Yoon Ha Hwang A211 Clinical Features of end_entity of Monoclonal Antibodies in Korea Da Woon Sim, Kyung Hee Park, Kyung Hee Park, Hye Jung Park, Hye Jung Park, Jung-Won Park, Jung-Won Park, Jae-Hyun Lee, Jae-Hyun Lee A212 Food_Hypersensitivity with Eczema Is Associated with Reduced Growth in the First Four Years of Life Katrina Allen, Cara Beck, Jennifer Koplin, Melanie Matheson, Mimi Tang, Anne-Louise Ponsonby, Lyle Gurrin, Shyamali Dharmage, Melissa Wake, Vicki Mcwilliam A213 The Preliminary Study on Clinical Efficacy and Impact Factors of One Year's Dust Mite Specific Immunotherapy in Allergic Asthma and Rhinitis Children Sensitized to Dust Mite Xiaoying Liu, Jing Wang, Li Xiang, Qun Wang A214 Lipopolysaccharide Signaling through Toll- like Receptor 4 Could be Augmented By Dermatophagoides Farinae in the Human Middle Ear Epithelial Cell Ji-Eun Lee, Dong-Young Kim, Chae-Seo Rhee, Chae-Seo Rhee A215 Drug_Hypersensitivity in Pregnant Adolescents: Relation with Familial and Personal Atopy, and Substances Use Francisco Vazquez-Nava A216 Patients and Physicians Concept of Well-Controlled Asthma: Findings from Realise Asia Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, David Price, Glenn Neira, Jiangtao Lin A217 The Role of Vasoactive Intestinal Peptide in the Pathophysiology of Acute Asthma Olga Semernik A218 Comparison of Serum Cytokine Levels According to the Severity in Dermatitis,_Atopic Ha-Su Kim, Jin-a Jung, Ji-in Jung A219 The Different Influence on the Regulatory T Cell Response Between Subcutanous ImmnuotherapySCIT and Sublingual ImmunotherapySLIT in Children with Asthma Qing Miao, Li Xiang A220 Asthma State of Affairs in Asia: Seeing through Physicians' and Patients' Lenses Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, Jiangtao Lin, David Price A221 Identification of Aspirin Exacerbated Respiratory Disease AERD Phenotypes Using Two Step Cluster Analysis Hyun Young Lee, Hae-Sim Park, Young Min Ye, Su Chin Kim A222 Dusty Air Pollution Are Associated with an Increase Risk of Allergic Diseases in General Population Shokrollah Farrokhi, Mohammadkazem Gheiby A223 A Genome-Wide Association Study of Antituberculosis Drugs-Induced Hepatitis Sang-Heon Kim; Heung Woo Park, Sang-Hoon Kim, Young-Koo Jee A224 The Role of peroxiredoxin6 of Bronchial Epithelial Cells in Regulating Mitochondrial Function Under Oxidative Stress By Translocation,_Genetic to Outside Mitochondrial Membrane Sunjoo Park, Keun Ai Moon, Hyouk-Soo Kwon, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Kyoung Young Lee, Gyong Hwa Hong, Eun Hee Ha A225 Toxic and Adjuvant Effects of 3 Types of Silica Nanoparticles on Airway System Heejae Han, Hye Jung Park, Yoon Hee Park, Yoon-Jo Kim, Kangtaek Lee, Jung-Won Park, Jae-Hyun Lee A226 Procedure for Diagnostic and Selection of Immunotherapy Method for Children with Different Immunopathogenetic Phenotypes of Dermatitis,_Atopic Tatiana Slavyanskaya, Vladislava Derkach A227 Prediction of the Success of Our Desensitization Protocol with Symptoms and Results of a Skin Prick Test in Patients with Hypersensitivity to Platinum-Based Chemotherapy Hye Jung Park, Chein-Soo Hong, Jae-Hyun Lee, Jae-Hyun Lee, Sungryeol KIM, Sungryeol KIM, Kyung Hee Park, Kyung Hee Park, Choong-Kun Lee, Beodeul Kang, Seung-Hoon Beom, Sang Joon Shin, Minku Jung, Jung-Won Park, Jung-Won Park A228 Anti-Allergic Effect of Intralymphatic Injection of OVA-Flagelin Mixture in Mouse Model of Rhinitis,_Allergic Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo, Young-Jun Chung A229 Serum Periostin Level Is Higher in Respiratory Type of NSAID Hypersensitivity Than Cutaneous Type Mi-Ae Kim, Hae-Sim Park, Moon Gyeong Yoon, Young-Soo Lee, Ji Hye Kim, Ga Young Ban, Hye-Soo Yoo, Yoo Seob Shin, Young Min Ye, Dong-Ho Nahm A230 A Retrospective Analysis of Hypersensitivity Blood Testing in Beijing Children's Hospital in the Year of 2013: A Single-Center Research Qing Miao, Li Xiang A231 Role of Nrf2 in the Allergic Airway Inflammation Differ Between BALBc and C57BL6 Mice Ying-Ji Li, Takako Shimizu, Hirofumi Inagaki, Yukiyo Hirata, Hajime Takizawa, Arata Azuma, Masayuki Yamamoto, Tomoyuki Kawada A232 Effect of Human Mesenchymal Stem Cell on Neutrophilic Asthma Model Min-Gu Kim, Gyong Hwa Hong, Kyoung Young Lee, Eun Hee Ha, Keun Ai Moon, Sunjoo Park, Hyouk-Soo Kwon, Tae-Bum Kim, Hee-Bom Moon, You Sook Cho, Jung-Hyun Kim, Hyo-Jung Kim, So-Young Park, Bomi Seo A233 Immunomodulatory Effect of Tonsil Derived Mesenchymal Stem Cells in a Mouse Model of Rhinitis,_Allergic Ji-Hye Kim, Ramachandran Samivel, Eun-Hee Kim, Young-Jun Chung, Ji-Hun Mo A234 Alternative Therapy Such As Yoga May be a Low Cost Tool for Improving the Quality of Life of Patient's with Rhinitis,_Allergic and Asthma Soumya M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OAS1\",\n",
       "                    \"target\": \"OAS3\",\n",
       "                    \"value\": \"Neither start_entity nor end_entity was exclusively responsible for the degradation of rRNA in macrophages stimulated with polyI:C, a synthetic surrogate for viral double-stranded dsRNA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dengue\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"These molecules are able to directly inhibit many viruses such as Human Immunologic_Deficiency_Syndromes Virus HIV, Hepatitis_C Virus HCV, start_entity Virus, Ebola Virus or Severe Acute Respiratory end_entity Coronavirus through binding to ERVW-1 N-glycans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NSP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"We demonstrated that nonstructural protein start_entity 6 of the avian end_entity, infectious bronchitis virus IBV, generates autophagosomes from the EREG\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"GCG\",\n",
       "                    \"value\": \"We also provide evidence of the roles of the start_entity substrates end_entity ZGLP1, VIP VIP and stromal cell-derived factor-1 SDF-1 in protection against oxidative stress through activation of the mitogen-activated protein kinase MAPK 12 and phosphatidylinositol 3'-kinase PI3KAkt signal transduction pathways\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AP-1\",\n",
       "                    \"target\": \"CD244\",\n",
       "                    \"value\": \"Specifically, we found a temporal and TBATA activation of nuclear factor NFB, activator protein start_entity, and interferon regulatory factor IRF-37 in infected end_entity cells at 12-, 24-, and 48-hrs post infection p\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV, a porcine enteropathogenic start_entity, causes lethal watery end_entity in piglets and results in large economic losses in many Asian and European countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD16\",\n",
       "                    \"target\": \"CX3CR1\",\n",
       "                    \"value\": \"Following transmigration or exposure to soluble CX3CL1, start_entity monocytes rapidly but transiently lost expression of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"NFKBIZ\",\n",
       "                    \"value\": \"Importantly, the host factors, such as up-regulated CCL23, IL-1, NOS2, start_entity, ACOD1, CH25H, end_entity, LYZ and OASL were involved in the host defense response during the course of ALV-J infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Doxycycline\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in end_entity t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: start_entity, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Reverse genetics systems established previously for serotype I and the less common serotype start_entity FCoVs were based on cell culture-adapted end_entityV strains which, however, were shown to be unsuitable for end_entity pathogenesis studies in vivo\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The search was limited to human studies, using the search terms end_entity, chronic bronchitis, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Considered a relative of severe acute respiratory syndrome end_entity and Middle East respiratory syndrome start_entity, COVID-19 is caused by a betacoronavirus named end_entity-CoV-2 that affects the lower respiratory tract and manifests as COVID-19 in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Respiratory Sounds\",\n",
       "                    \"value\": \"Tsang, Ting Fan Leung A424 Clinical Significance of Increased VEGFA, TGF-21, and YKL-40, a Chitinase like Protein, in Serum of the Children with Asthma Yoon Young Jang, Hai Lee Chung, Seung Gook Lee, Ji Hyun Na, Jong Hoon Lee A425 Analysis of Follow-up Results of Mannitol Challenge Test in Asthma Patients Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A426 Analysis of 68 Oral Walnut Challenge Tests Mikita Yamamoto, Sakura Sato, Noriyuki Yanagida, Ayako Ogawa, Kanako Ogura, Kyohei Takahashi, Kenichi Nagakura, Shigehito Emura, Tomoyuki Asaumi, Katsuhito Iikura, Motohiro Ebisawa, Yu Okada A427 Effectiveness of Air Filters Intervention in Rhinitis,_Allergic Jiaying Luo, Xiao Lan, Baoqing Sun, Zhao Chen, Guiyuan Sun, Shimin Li, Jiaqing Hu A428 The Relationship Between Airway Hyperresponsiveness to Mannitol and Atopy in Asthma Children Woo-Hyeok Choi, Heysung Baek A429 Anaphylactoid Reactions to N-Acetylcysteine in the Treatment of Aacetaminophen Overdose Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, Sang Hee Kim Kim, Ye Suel Park, Soo-Keol Lee A430 Effect of Prenatal Maternal Distress and GSDMB Polymorphism on the Development of Recurrence end_entity in Early Childhood: COCOA Study Yean Jung Choi, Si Hyeon Lee, Young-Ho Kim, Mi-Jin Kang, Hyun-Ju Cho, Eun Lee, Song-I Yang, Youn Ho Shin, Kangmo Ahn, Kyung Won Kim, Yoon Hee Kim, So-Yeon Lee, Hyoung Yoon Chang, In Ae Choi, Kyung-Sook Lee, Yee-Jin Shin A431 Vitamin D Level in Rhinitis,_Allergic: A Systemic Review and Meta-Analysis Yoon Hee Kim, Min Jung Kim, In Suk Sol, Seo Hee Yoon, Young a Park, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Yong Ju Lee A432 Implication of Inspiratory and Expiratory Resistance and Reactance in Children with Asthma In Suk Sol, Kyu-Earn Kim, Yoon Hee Kim, Min Jung Kim, Seo Hee Yoon, Yong Ju Lee, Kyung Won Kim, Young a Park, Myung Hyun Sohn A433 The Association of Asthma Predictive Index with Asthma in Preschool Children with Recurrence Wheeze Sung Joo Park, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Yun Seok Yang, Jung Yeon Shim A434 Clinical Significance of Serum Total IgE Levels in Children with RSV-Associated Lower Respiratory Illness Yoon Young Jang, Hai Lee Chung, Ji Hye Kim, Hyun Seok Lee, Chang Ho Lee A435 Development of a Oak Pollen Emission and Transport Modeling Framework in South Korea Changbum Cho, Yun-Kyu Lim, Kyu Rang Kim, Mijin Kim, Baek-Jo Kim A436 Temperature, Humidity, and Air Pollution Affect start_entity Symptoms in Infants and Young Children Young-Min Kim, Youngshin Han, Jihyun Kim, Hae-Kwan Cheong, Byoung-Hak Jeon, Kangmo Ahn A437 Effects of Compound V on Pulmonary_Fibrosis Model ChuangYao Ming, Jiu-Yao Wang, YeYi Ling A438 Vitamin D Level and the Correlation with IgE in Children with Allergic Respiratory Diseases in Guangzhou China Huimin Huang, Baoqing Sun, Yun Chen, Peiyan Zheng, Nili Wei, Wenting Luo A439 Two Case Reports of Eosinophilic Gastroenteritis Associated with Allergic Disease Do Hyeong Lee, Gil-Soon Choi, Hee-Kyoo Kim, Han Su Park A440 Genome-Wide Association Study GWAS May Identify Common Genetic Variations Both in Immediate and Delayed Drug So-Young Park, Hyo-Jung Kim, Bomi Seo, Jung-Hyun Kim, Min-Gu Kim, Hyouk-Soo Kwon, You Sook Cho, Hee-Bom Moon, Tae-Bum Kim, Yoon Su Lee A441 Development of a Questionnaire for Secular Change of start_entity from Birth to 19-Year-Old\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADI1\",\n",
       "                    \"target\": \"Short Stature, Idiopathic, X-Linked\",\n",
       "                    \"value\": \"Intravenous IV infusion of end_entity resulted in the acidification secondary to dilution, while AR and start_entity infusion inhibited acidification\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by these organisms typically occurs via percutaneous inoculation or inhalation of aerosols, and the most common manifestation is severe start_entity leading to fatal bacteremia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BRAF\",\n",
       "                    \"target\": \"Noonan syndrome 3\",\n",
       "                    \"value\": \"In this report, we found that the virulence protein end_entity interacts with start_entity, a key component of the MAPKERK pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"IFIH1\",\n",
       "                    \"value\": \"Furthermore, TGEV infection significantly upregulated mRNA expression of start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"2-kb defective interfering SLC4A1 RNA of the bovine end_entity, structurally a simple fusion of the genomic termini, contains a single contiguous open reading frame start_entity or 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E4\",\n",
       "                    \"target\": \"Shock\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylactic end_entity Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene start_entity in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL-22\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The significant antiviral activity of start_entity to curtail multiple enteric end_entity viruses in vitro suggests that pstart_entity could be a novel therapeutic against devastating viral end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPR50\",\n",
       "                    \"target\": \"H3\",\n",
       "                    \"value\": \"RESULTS: For each HA H1, H2, end_entity, H5, H7 and start_entity and NA N1, N2 and N7 molecular type chosen to be tested, 1 to 3 consensus sequences were computed and tiled on the microarray\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR4\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"In conclusion, OMT possesses anti-IAV and anti-inflammatory activities, the mechanism of action may be linked to its ability to inhibit IAV-induced activations of start_entity, end_entity MAPK, and NF-B pathways\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Polymorphisms in SLC11A1 SLC11A1, TLR2 TLR2, interleukin-6 IL6, end_entity alpha TNF-, interleukin-1 receptor antagonist IL-1RA, IL10, vitamin D receptor VDR, dendritic cell-specific ICAM-3-grabbing non-integrin CD209, start_entity start_entity, nucleotide oligomerization binding domain 2 NOD2, interferon-gamma IFN-, inducible nitric oxide synthase NOS2, mannose-binding lectin MBL and surfactant proteins A SFTPA1 have been reviewed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD40\",\n",
       "                    \"target\": \"CD80\",\n",
       "                    \"value\": \"Furthermore, WPCD could markedly up-regulate the expression levels of start_entity and end_entity on DCs in spleen and down-regulate the Treg frequency\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Peripheral lymphocytes, specifically start_entity T and B cells were significantly lower in aged monkeys pre- and post- end_entity, while neutrophil and monocyte numbers were not impacted by age or infection status\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lung transplantation\",\n",
       "                    \"value\": \"The objective of this study was to examine the relationship between serum ALB concentration and mortality in a large cohort of patients with idiopathic interstitial start_entity listed for end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDR2\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, start_entityon Hee Kim, In Suk Sol, Seo Hee start_entityon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of end_entity AR patients Ji Hye Kim, Hae-Sim Park, start_entityo Seob Shin, start_entityung Min Ye, Daehong Seo, Moon Gyeong start_entityon, start_entityung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, start_entityung-Mok Lee, start_entityung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga start_entityung Ban, Kumsun Cho, Seung-Hyun Kim, start_entityng Eun Kwon, Moon Gyeong start_entityon, Ji Hye Kim, start_entityo Seob Shin, start_entityung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with end_entity and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga start_entityung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, start_entityung Min Ye, start_entityo Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial end_entity patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga start_entityung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, start_entityng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo start_entityo, Moon Gyeong start_entityon, Ga start_entityung Ban, Ga start_entityung Ban, start_entityo Seob Shin, start_entityung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, start_entityng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, start_entityung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of end_entity Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, start_entityung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, start_entityung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, start_entityung-Ho Jung, Hyung start_entityung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, start_entityung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, start_entityo Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma start_entityrdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-start_entityung Kim, Jihyun Kim, Kangmo Ahn, start_entityungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo start_entityng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, start_entity Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with end_entity and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in end_entity Ji Won Seo, Jae Hoon Lee, Woo start_entityng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization start_entityo Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local end_entity start_entityung-Joo Ko, start_entityung Hyo Kim, Dae-start_entityung Kim, Tae start_entityung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu start_entitykooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of end_entity and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor end_entity and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"ADAM17\",\n",
       "                    \"value\": \"Western blot and immunohistochemistry identified ACE 60 kDa, start_entity 75 kDa, AT1R 43 kDa, REN 41 kDa, and end_entity 130 kDa in COS7\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD28\",\n",
       "                    \"target\": \"PIK3CA\",\n",
       "                    \"value\": \"These cells exhibit nearly complete loss of end_entity signaling downstream of the T-cell receptor TCR and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR2\",\n",
       "                    \"target\": \"MSR1\",\n",
       "                    \"value\": \"Persistent EAV infection is associated with moderate, multifocal lymphoplasmacytic ampullitis comprising clusters of B start_entity lymphocytes and significant infiltration of T CD3, CD4, CD8A, and CD25 lymphocytes, tissue macrophages, and dendritic cells Iba-1 and CD8A3, with a small number of tissue macrophages expressing CD163 and end_entity scavenger receptors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD16\",\n",
       "                    \"target\": \"CXCR3\",\n",
       "                    \"value\": \"In particular, SIVmac239 infection elicited robust expression of CXCL10, a chemokine for end_entity cells, in CD14 start_entity monocytes and S100A9 macrophages recently infiltrated in SLOs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AXIN1\",\n",
       "                    \"target\": \"TNFSF10\",\n",
       "                    \"value\": \"We conclude that CST5, start_entity and end_entity are worthy of further study in the context of a pre-hospital or pitch-side test to detect brain injury\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Highly significant decreases in haematocrit and start_entity levels and an increase in total bilirubin level were noted in both effusive and non-effusive end_entity, at first presentation and before death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"SACM1L\",\n",
       "                    \"value\": \"AiV RNA replication was inhibited by silencing cellular proteins known to be components of this pathway, OSBP, the start_entity membrane proteins VAPA and VAPB VAP-AB, the PI4P-phosphatase end_entity, and PI-transfer protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCR4\",\n",
       "                    \"target\": \"FGF2\",\n",
       "                    \"value\": \"We also evaluated protein levels of CCL2, CCR1, CCR2, CCL5, CCR5, CCR8, CXCL1, CXCR2, start_entity, end_entity, and VEGFA by ELISA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATF6\",\n",
       "                    \"target\": \"EIF2AK3\",\n",
       "                    \"value\": \"The UPR signaling pathways initiated by double-stranded RNA-activated protein kinase EIF2AK2 like EREG kinase end_entity, inositol requiring enzyme 1 ERN1, and start_entity start_entity are vital for tumor growth, aggressiveness, microenvironment remodeling, and resistance to cancer therapeutics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"Here, we describe methods for purification of end_entity, preparation, and culture of primary peripheral blood mononuclear cells PBMCs and NK-92 cells, assays for IL-12- and end_entity-dependent cytokine IFN- and start_entity secretion, and assays for initial intracellular signaling events triggered by extracellular end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"IMPORTANCE The subfamily Coronavirinae contains several notorious human and animal pathogens, including severe acute respiratory syndrome start_entity, Middle East respiratory syndrome start_entity, and porcine epidemic end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR4\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"ANPEP is co-internalized with start_entity, CD14 and dynamin into Rab5 early endosomes upon end_entity treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"AGTR1, start_entity, ENPEP, MME, and PRCP, which encode the Ataxia_Telangiectasia angiotensin GCNT2 receptor, angiotensin-converting enzyme, end_entity, MME, and PRCP, respectively, were also underexpressed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"SERPINA1\",\n",
       "                    \"value\": \"Regarding start_entity, only one PCV2-inoculated pig was positive day 7 end_entity; this pig was the only one in which viremia persisted until the end of the study\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL1\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Neutrophil migration to the inflammation area could be mediated largely by cytokines related to CD4 Th17 lymphocytes, because it has been shown that end_entity, IL17F and IL-22 act as inducers for CXCL8, start_entity, CXCL5, CSF3, and CSF2 secretion by epithelial cells of the airways\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IER3\",\n",
       "                    \"target\": \"TNFAIP3\",\n",
       "                    \"value\": \"Upregulated genes included the immune regulatory molecules interleukin 1 IL-1, CIAS-1, TNF alpha, PDE4B, PTGS2, CXCL8, CXCL2, CCL4, ICAM-1, CD83, GOS-2, start_entity start_entity, and end_entity A20\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"In summary, we have identified a new type of end_entity retention signal that may function to prevent unassembled start_entity subunits andor immature E2-start_entity dimers from reaching the Golgi complex, where they could interfere with viral assembly\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"JAK1\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Some of them are type I IFNA1-induced proteins, such as EIF2AK2 and DDX58, and some are the key regulators that are involved in IFNA1 signaling, such as start_entity and end_entity, implicating the role of ISG15 and its conjugates in type I IFNA1-mediated innate immune responses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP1\",\n",
       "                    \"target\": \"SLAMF7\",\n",
       "                    \"value\": \"However, when both end_entity and CLSTN2 were deleted in the presence of inactivated start_entity, the growth of the resulting mutant virus was partially compensated, comparable to that of the end_entity and CLSTN2 deletion mutant\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Enrico Compalati, Maurizio Marogna A374 The Positive Distribution Characteristics of 90 Food Specific IgG in Patients with Allergic Diseases Huimin Huang, Baoqing Sun, Mingyu BAI, Yiting Huo, Peiyan Zheng, Nili Wei, Wenting Luo A375 Evaluation of Serum Levels of Osteopontin As a Potential Biomarker of Immune Activation in Patients with Allergic Diseases Elisa Villa, Anand Andiappan, Rosalba Minisini, Olaf Rtzschke, Elena Boggio, Luca Gigliotti, Nausicaa Clemente, Annalisa Chiocchetti, Umberto Dianzani, Mario Pirisi A376 Prevalence of end_entity in 3-6-Year-Old preschool Children in Chiba City urban area, Japan Fumiya Yamaide, Syuji Yonekura, Naoki Shimojo, Yuzaburo Inoue, Yoshitaka Okamoto A377 Comparative Efficacy of Combination Nebulized Salbutamol and Fluticasone_Propionate and Nebulized Salbutamol in Children with Mild Moderate start_entity Attack Retno Asih Setyoningrum, Landia Setiawati, Sri Sumei, Deddy Iskandar A378 Characteristics of Children Hospitalized with start_entity in West Nusa Tenggara General Hospital Mataram Indonesia Indriyani Sang Ayu Kompiyang A379 Identification of Phenotypes in Aspergillosis,_Allergic_Bronchopulmonary Using Cluster Analysis Tsuyoshi Oguma, Jun Tanaka, Katsuyoshi Tomomatsu, Koichiro Asano A380 The Roles of Type 2 Innate Lymphoid Cells ILC2 in Chronic Rhinosinusitis Craniosynostoses Keisuke Uno, Yoshinori Matsuwaki, Kazuhiro Omura, Eika Hayashi, Norifumi Tatsumi, Hirohito Kita, Nobuyoshi Otori, Hiromi Kojima A381 Respiratory Symptoms, Signs and Spirometry Indexes Comparision in 7-12 Years Old Girls in Esfahan Metropolis and Its Far Suburb Mohammadreza Fatemi Khorasgani A382 Induction of Kruppel-like Transcription Factor KLF45 By Baker's Yeast Mannan in Human Bronchial Epithelial and Smooth Muscle Cells DukheeBetty Lew, KimS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNMD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The combined use of serological tests and start_entity significantly improved the detection rate of nonbacterial infectious agents in patients with severe end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"5 cells and primary murine hepatocytes with Van_der_Woude_syndrome and TNF-, but not end_entity or start_entity, led to upregulated USP18 expression and induced an IFN- refractory state, which was reversed by USP18 knockdown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Multivariable regression analyses were conducted to compare the viruses for clinical outcomes including ICU admission, start_entity, end_entity, length of stay and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD209\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Activation of ERK pathway by HCV end_entity through start_entity provides useful information for understanding cellular receptor-mediated signaling\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"MB21D1\",\n",
       "                    \"value\": \"Stimulator of interferon gene STING plays an important role in the end_entity cGAS-mediated activation of type I start_entity responses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"haemolytica treatment produced significantly greater inductions 10-fold of several inflammation associated genes, such as CXCL2, end_entity, IL-1, e-selectin, and start_entity, than to BHV-1 alone\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Peripheral blood mononuclear cells PBMC isolated from these pigs responded to PRRSV exposure with a limited increase in their expression of the Th1 immune markers, IFNG, end_entity-alpha and interleukin-15 IL15, and a reduction in the quantity of mRNAs encoding the innate and inflammatory proteins, IL1B, CXCL8 and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pranlukast\",\n",
       "                    \"target\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of end_entity Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of start_entity Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD44\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Infectivity-neutralizing start_entity and hemagglutinin-inhibiting HAI antibodies induced by RBCV infections were monitored in sequential serum samples collected from cattle during a naturally evolving and experimentally monitored epizootic of shipping fever end_entity SFP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Mucolipidoses\",\n",
       "                    \"target\": \"Neuraminidase 1 deficiency\",\n",
       "                    \"value\": \"start_entity end_entityI or inclusion cell disease I-cell disease is a rarely occurring autosomal recessive lysosomal enzyme-targeting disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pranlukast\",\n",
       "                    \"target\": \"Exanthema\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug end_entity Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug end_entity with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of start_entity Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL15\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"High systemic levels of type-II interferon IFN- and also of a group of mediators involved in the development of T-helper 17 CXCL8, IL9, IL17A, end_entity and T-helper 1 TNF-, start_entity, IL-12p70 responses were exclusively found in hospitalized patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FARP1\",\n",
       "                    \"target\": \"MAPRE2\",\n",
       "                    \"value\": \"To validate the best candidate genes, we performed quantitative RT-PCR on a subset of 10 genes TRAP1, DECR1, FPGS, start_entity, end_entity, PEX16, GINS2, CRY2, CSNK1G2 and A4GALT, 4 commonly employed reference genes GAPDH, ACTB, B2M and HMBS and PPIB, previously reported to be stably expressed in blood\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchitis\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Chronic start_entity with Radio Contrast Media end_entity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, IL5, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"Demyelinating Diseases\",\n",
       "                    \"value\": \"end_entity was most severe following viral control by wt start_entity T cells but was independent of macrophage infiltration\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Terazosin\",\n",
       "                    \"target\": \"FGF4\",\n",
       "                    \"value\": \"Methods Four primary outcome measures, namely the quality of life QOL, maximum urine flow ratio UFR, International Prostate Symptom Score IPSS and prostate volumes, as well as four urethra-related and 35 non-urethra-related symptoms, were investigated to evaluate the effects on 31 BPH patients subjected to WM start_entity Hydrochloride Hytrin, TCHH and 30 cases to TCM herbal Saxifrage tablet, end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Comparisons were made with start_entity infection data from another case-control study on bacterialviral end_entity at Shenyang Chest Hospital\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP2\",\n",
       "                    \"target\": \"TBK1\",\n",
       "                    \"value\": \"Intriguing enough, results of start_entity overexpression system and MHV-A59 infection system proved that start_entity formed an inactive complex with end_entity and IRF3 in the cytoplasm and the presence of start_entity stabilized the hypo-phosphorylated IRF3-end_entity complex in a dose-dependent manner\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL8\",\n",
       "                    \"target\": \"RSAD2\",\n",
       "                    \"value\": \"CONCLUSIONS: This study has identified various pro-inflammatory cytokines and interferon-related genes such as MX1, end_entity, CXCL10, start_entity, CCL5, KC, CCL2, CXCL8, CSF2 and IFNA1 in FCoV-positive cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Epidemics of infectious diseases such as end_entity, H1N1, and start_entity threaten public health, particularly in large cities such as Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"NPIPB3\",\n",
       "                    \"value\": \"Conclusion The overexpression of end_entity restored the start_entity- responses in Severe_Acute_Respiratory_Syndrome-CoV ORF6 expressing cells, indicating that the interaction of Severe_Acute_Respiratory_Syndrome CoV ORF6 and end_entity reduced Type I start_entity antagonism by Severe_Acute_Respiratory_Syndrome-CoV ORF6\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MPO\",\n",
       "                    \"target\": \"THBD\",\n",
       "                    \"value\": \"The brochoalveolar lavage fluid of infected macrophage-depleted mice exhibited elevated protein content, T1-, end_entity, matrix metalloproteinase-9, and start_entity activities indicating augmented alveolar-capillary damage, compared to neutrophil-depleted animals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Development of vaccines is essential for the prevention of future recurrences of severe acute respiratory syndrome end_entity, caused by the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL5\",\n",
       "                    \"target\": \"TSPAN7\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura end_entity Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, start_entity and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, start_entity, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Moniaga, Kenji Kabashima, Eung Ho Choi A199 Trends in oral food challenges in Japan: A six-year prospective study Noriyuki Yanagida, Sakura Sato, Chizuko Sugizaki, Motohiro Ebisawa A200 The Gut Microbiome in the Food Allergic Host Jamie Kiehm, Punita Ponda, Sherry Farzan, Jared Weiss, Claudia Elera, Catherine Destio, Cristina Sison, Annette Lee A201 Cord blood cytokines and maternal environmental exposure during pregnancy Soo Hyun Ri, Chang Hoon Lim A202 Rupatadine pharmacokinetics in Japanese healthy volunteers after single and repeated oral doses of 10, 20 and 40 mg Iaki Izquierdo Pulido, Jorg Taubel, Georg Ferber, Eva Santamaria Masdeu A203 A safe and effective method to desensitize patients with wheat allergy Alireza Khayatzadeh, Masoud Movahedi, Motohiro Ebisawa, Mohammad Gharagozlou A204 RNA Binding Protein Hur Regulates CD4 T Cell Differentiation and Is Required for Allergic Airway Inflammation and Normal start_entity Homeostasis Ulus Atasoy, Patsharaporn Techasintana, Matt Gubin, Jacqueline Glascock, Suzanne Ridenhour, Joseph Magee A205 Time Trends in the Epidemiology of Recurrence Respiratory_Sounds in Infants from South America Nelson Rosario Filho; Herberto Jose Chong Neto, Gustavo Falbo Wandalsen, Ana Caroline Dela Bianca, Carolina Aranda, Dirceu Sole, Javier Mallol, Luis Garcia-Marcos, Luis Garcia-Marcos A206 Successful Cyclophosphamide Desensitization in a Pediatric Patient with Lupus_Vulgaris_Erythematosus,_Systemic Jennifer Toh, Yoomie Lee, Joyce Huang, Elina Jerschow, Jenny Shliozberg A207 The Fatty Acid Binding Protein Der p 13 Is a Minor House Dust Mite Allergen Able to Activate Innate Immunity Pattraporn Satitsuksanoa, Narissara Suratannon, Jongkonnee Wongpiyabovorn, Pantipa Chatchatee, Kiat Ruxrungtham, Alain Jacquet A208 Epidemiology of Stevens-Johnson_Syndrome and Toxic Epidemal Necrolysis: An Administrative Database Study Min Suk Yang; Jin Yong Lee, Ja Yeun Kim, Han-Ki Park, Ju-Young Kim, Woo-Jung Song, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Sang-Heon Cho, Kyung-up Min, Chang-Han Park, Suk-Il Chang, Sook-Hee Song A209 Regional Differences of Vitamin D and Food-Induced Anaphylaxis in Korea Si-Heon Kim, Gil-Soon Choi, Su-Chin Kim, Ji Hye Kim, Ga Young Ban, Yoo Seob Shin, Hae-Sim Park, Young Min Ye A210 Triggering Factors of Dermatitis,_Atopic By Severity Yoon Ha Hwang A211 Clinical Features of Drug-Related_Side_Effects_and_Adverse_Reactions of Monoclonal Antibodies in Korea Da Woon Sim, Kyung Hee Park, Kyung Hee Park, Hye Jung Park, Hye Jung Park, Jung-Won Park, Jung-Won Park, Jae-Hyun Lee, Jae-Hyun Lee A212 Food_Hypersensitivity with Eczema Is Associated with Reduced Growth in the First Four Years of Life Katrina Allen, Cara Beck, Jennifer Koplin, Melanie Matheson, Mimi Tang, Anne-Louise Ponsonby, Lyle Gurrin, Shyamali Dharmage, Melissa Wake, Vicki Mcwilliam A213 The Preliminary Study on Clinical Efficacy and Impact Factors of One Year's Dust Mite Specific Immunotherapy in Allergic Asthma and Rhinitis Children Sensitized to Dust Mite Xiaoying Liu, Jing Wang, Li Xiang, Qun Wang A214 Lipopolysaccharide Signaling through Toll- like Receptor 4 Could be Augmented By Dermatophagoides Farinae in the Human Middle Ear Epithelial Cell Ji-Eun Lee, Dong-Young Kim, Chae-Seo Rhee, Chae-Seo Rhee A215 Drug_Hypersensitivity in Pregnant Adolescents: Relation with Familial and Personal Atopy, and Substances Use Francisco Vazquez-Nava A216 Patients and Physicians Concept of Well-Controlled Asthma: Findings from Realise Asia Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, David Price, Glenn Neira, Jiangtao Lin A217 The Role of Vasoactive Intestinal Peptide in the Pathophysiology of Acute Asthma Olga Semernik A218 Comparison of Serum Cytokine Levels According to the Severity in Dermatitis,_Atopic Ha-Su Kim, Jin-a Jung, Ji-in Jung A219 The Different Influence on the Regulatory T Cell Response Between Subcutanous ImmnuotherapySCIT and Sublingual ImmunotherapySLIT in Children with Asthma Qing Miao, Li Xiang A220 Asthma State of Affairs in Asia: Seeing through Physicians' and Patients' Lenses Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, Jiangtao Lin, David Price A221 Identification of Aspirin Exacerbated Respiratory Disease AERD Phenotypes Using Two Step Cluster Analysis Hyun Young Lee, Hae-Sim Park, Young Min Ye, Su Chin Kim A222 Dusty Air Pollution Are Associated with an Increase Risk of Allergic Diseases in General Population Shokrollah Farrokhi, Mohammadkazem Gheiby A223 A Genome-Wide Association Study of Antituberculosis Drugs-Induced Hepatitis Sang-Heon Kim; Heung Woo Park, Sang-Hoon Kim, Young-Koo Jee A224 The Role of peroxiredoxin6 of Bronchial Epithelial Cells in Regulating Mitochondrial Function Under Oxidative Stress By Translocation,_Genetic to Outside Mitochondrial Membrane Sunjoo Park, Keun Ai Moon, Hyouk-Soo Kwon, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Kyoung Young Lee, Gyong Hwa Hong, Eun Hee Ha A225 Toxic and Adjuvant Effects of 3 Types of Silica Nanoparticles on Airway System Heejae Han, Hye Jung Park, Yoon Hee Park, Yoon-Jo Kim, Kangtaek Lee, Jung-Won Park, Jae-Hyun Lee A226 Procedure for Diagnostic and Selection of Immunotherapy Method for Children with Different Immunopathogenetic Phenotypes of Dermatitis,_Atopic Tatiana Slavyanskaya, Vladislava Derkach A227 Prediction of the Success of Our Desensitization Protocol with Symptoms and Results of a Skin Prick Test in Patients with Hypersensitivity to Platinum-Based Chemotherapy Hye Jung Park, Chein-Soo Hong, Jae-Hyun Lee, Jae-Hyun Lee, Sungryeol KIM, Sungryeol KIM, Kyung Hee Park, Kyung Hee Park, Choong-Kun Lee, Beodeul Kang, Seung-Hoon Beom, Sang Joon Shin, Minku Jung, Jung-Won Park, Jung-Won Park A228 Anti-Allergic Effect of Intralymphatic Injection of OVA-Flagelin Mixture in Mouse Model of end_entity Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo, Young-Jun Chung A229 Serum Periostin Level Is Higher in Respiratory Type of NSAID Hypersensitivity Than Cutaneous Type Mi-Ae Kim, Hae-Sim Park, Moon Gyeong Yoon, Young-Soo Lee, Ji Hye Kim, Ga Young Ban, Hye-Soo Yoo, Yoo Seob Shin, Young Min Ye, Dong-Ho Nahm A230 A Retrospective Analysis of Hypersensitivity Blood Testing in Beijing Children's Hospital in the Year of 2013: A Single-Center Research Qing Miao, Li Xiang A231 Role of Nrf2 in the Allergic Airway Inflammation Differ Between BALBc and C57BL6 Mice Ying-Ji Li, Takako Shimizu, Hirofumi Inagaki, Yukiyo Hirata, Hajime Takizawa, Arata Azuma, Masayuki Yamamoto, Tomoyuki Kawada A232 Effect of Human Mesenchymal Stem Cell on Neutrophilic Asthma Model Min-Gu Kim, Gyong Hwa Hong, Kyoung Young Lee, Eun Hee Ha, Keun Ai Moon, Sunjoo Park, Hyouk-Soo Kwon, Tae-Bum Kim, Hee-Bom Moon, You Sook Cho, Jung-Hyun Kim, Hyo-Jung Kim, So-Young Park, Bomi Seo A233 Immunomodulatory Effect of Tonsil Derived Mesenchymal Stem Cells in a Mouse Model of end_entity Ji-Hye Kim, Ramachandran Samivel, Eun-Hee Kim, Young-Jun Chung, Ji-Hun Mo A234 Alternative Therapy Such As Yoga May be a Low Cost Tool for Improving the Quality of Life of Patient's with end_entity and Asthma Soumya M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPL32\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"To address this deficiency, high-throughput real time RT-PCR TaqMan assays were developed to measure the expression of fifteen immune mediators associated with the innate and adaptive immune responses IFNA1, IFNA1, IFNA1, IL1A, IL1A, IL2, IL4, IL6, CXCL8, IL1A0, IL1A2p40, IL1A7A, Granzyme A, CCL2, end_entity, as well as four endogenous housekeeping genes ATF4, HPRT1, GAPDH, start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NR3C2\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"Twenty-eight newborn Holstein heifer calves from the university herd and 8 newborn Holstein heifer calves from a commercial herd were blocked by birth and herd into 1 of 4 treatments: conventional 20 crude protein end_entity, 20 fat milk replacer start_entity; treatment C with 1 or without 0 human visitation, or a higher plane of start_entity nutrition 28 end_entity, 20 fat regimen treatment A with 1 or 0 without human visitation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Enteropathogenic porcine epidemic end_entity virus PEDV and porcine deltastart_entity PDCoV, members of the start_entity family, account for the majority of lethal watery end_entity in neonatal pigs in the past decade\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MIF\",\n",
       "                    \"target\": \"\\u00a0C-reactive protein\",\n",
       "                    \"value\": \"A multiplex immunoassay measuring soluble urokinase-type PLG activator suPAR and soluble triggering receptor expressed on myeloid cells sTREM-1 and macrophage migration inhibitory factor start_entity was used in parallel with standard measurements of end_entity CRP, procalcitonin Porphyria_Cutanea_Tarda, and neutrophils\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OAS1\",\n",
       "                    \"target\": \"OAS3\",\n",
       "                    \"value\": \"This latter characteristic, which might be crucial for a versatile inhibitor, was observed in compounds interacting with the residues Asp75, Asp77, Gln229, and Tyr230 in start_entity, and their equivalents in OAS2 and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"African Swine Fever\",\n",
       "                    \"target\": \"Bluetongue\",\n",
       "                    \"value\": \"Moreover mixed nucleic acid of 10 insect-borne pathogens, including end_entity virus, Epizootic hemorrhagic disease virus of deer, Coxiella burnetii, start_entity virus, West Nile fever virus, Borrelia burgdorferi, vesicular stomatitis virus, Rift Valley fever virus, Ebola virus and Schmalenberg's disease virus, and 3000 clinical samples were tested for practicability\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR2\",\n",
       "                    \"target\": \"CXCL1\",\n",
       "                    \"value\": \"ELISA results showed that end_entity, CCL2, start_entity, CCR5, CCR8, and CXCR4 protein levels were decreased in brainstem at the age of 6 months\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Mehdi Adeli, Shaza Ali Mohammed Elhassan, Caroline Beck A372 Prevalence and Clinical Characteristics of Local Rhinitis,_Allergic in Children Min Sun Na, Heysung Baek, Seung Jin Lee, Ji Hyeon Baek, Jungwon Yoon, Sun Hee Choi, Young-Ho Jung, Youn Ho Shin, Man Yong Han A373 House Dust Mites Sublingual Immunotherapy Can Influence the Long-Term Evolution of Severe start_entity and the Progression to Respiratory end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"LGALS3BP\",\n",
       "                    \"value\": \"Cleavage of the start_entity protein results in two different end_entity species, 90A and 90B L\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"In mouse studies, Cap-AuNP-immunized mice displayed a high production of interleukin IL4, end_entity, and interferon-, suggesting that Cap-AuNPs can effectively activate CD4 and start_entity T cells and balance Th1 and Th2 cellular responses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RBMS3\",\n",
       "                    \"target\": \"SBS\",\n",
       "                    \"value\": \"STAU2, like STAU1, is a double-stranded start_entity that interacts directly with the ATP-dependent RNA helicase up-frameshift 1 UPF1 to reduce the half-life of Strudwick_syndrome targets that form an end_entity by either intramolecular or intermolecular base-pairing\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MCT\",\n",
       "                    \"target\": \"Asthma\",\n",
       "                    \"value\": \"Kowalski A507 The Role of EIF2AK2 Pathway in Acute Exacerbation of Severe end_entity So Ri Kim, Yong Chul Lee, Dong Im Kim, Yang Keun Rhee, Heung Bum Lee, Seoung Ju Park, Yeong Hun Choe Choe, Seung Yong Park A508 Diversity of Clinical Manifestations and Treatment Responses for Hypereosinophilic_Syndrome Joo-Hee Kim, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A509 Effect of Dexamethasone in Th17 Cell Mediating Neutrophilic end_entity Nong Guang-Min, Jiang Min A510 Allergen Profile for end_entityRhinitis and Eczema Among Patients in North India: An Immunocap Allergen Specific IgE Antibodies Assay Based Study Nalin Nag A511 Clinical Profile of Rhinitis,_Allergic in Children in Jakarta Wahyuni Indawati A512 Preclinical Study on the Use of Micro Crystalline Tyrosine start_entity Adjuvants in Hypersensitivity Immunotherapy Alan David Bullimore, Matthew Heath, Murray Skinner A513 Genetic Diversity of Filaggrin Mutation and Its Clinical Implication in East Asian Dermatitis,_Atopic Patients Seong Jun Seo, Won Jong Oh A514 Protein and MPL Adsorption Capacities for start_entity in Candidate Therapeutic Formulations for Use in Immunotherapy, Compared Against Existing Adjuvants Alan David Bullimore, Murray Skinner, Matthew Heath, Andrew Bell A515 Interleukin-22 Gene Variation in Inflammatory_Bowel_Diseases Alireza Zarebidoki, Hournaz Hasanzadeh, Salman Sadeghzade, Nima Rezaei A516 Immunomodulatory Effects of Adipose-Derived Stem Cell Secretome in a Mouse Model of end_entity Kyu-Sup Cho A517 Diffuse Alveolar Hemorrhage with Positive Anti-Neutrophil Cytoplasmic Antibody in a Child : A Case Report Sung-Woo Kim, Moo-Young Oh A518 Clinical Analys the Serum CCL17 Levels As the Condition Index of Dermatitis,_Atopic in the Early Infancy Munemitsu Koizumi, Kazuyo Kuzume A519 An Analysis of the Filaggrin Gene Polymorphism in Korean Dermatitis,_Atopic Patients Kui Young Park, Won Jong Oh A520 A New Protocol for Wheat Oral Immunotherapy in Patients with Anaphylaxis Delara Babaie, Mohammad Nabavi, Fariborz Zandieh, Mehrdad Amir Moini, Zahra Chavoshzadeh, Hamideh Seifi, Mitra Sahragard, Mehrnaz Mesdaghi, Mohammad Hassan Bemanian A521 Clinical Characteristics of Filaggrin-Related Dermatitis,_Atopic Patients in Korea Sun Young Choi, Yeon a No A522 Early Hypersensitivity Diagnosis in Children - Self- Administered Questionnaire Vs Medical Verification Andrzej M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"value\": \"Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Akira Akasawa, Michihiro Hide, Hiroko Shizukawa A442 Evaluation of the Adherence Starts with Knowledge-20 ASK-20 to Inhaled Drug in Patients with Asthma Naoto Watanabe A443 The Epidemiology and Clinical Manifestation of Hmpv Infection in Children during Recent 4 Years: 2011-2014 Meeyong Shin, Myeong Sun Jang A444 Neutropenia Induced By Intravenous_Immunoglobulin Young-Hee Nam, Yeo Myeong Noh, Dong Sub Jeon, Hee-Joo Nam, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A445 A First Case of Lymphocytic Lung_Diseases,_Interstitial in Healthy Child Ji-in Jung, Ha-Su PSME3m, Hyun-a PSME3m, Jin-a Jung A446 Cytokine Production upon House Dust Mite Stimulation of Cord Blood Mononuclear Cells from Caesarean Section-Delivered Singaporean Infants Anne Goh, Rajeshwar Rao, Bindu Nandanan, Ruurd Van Elburg, Chua Mei Chien, Juandy Jo, Johan Garssen, Johan Garssen, Leon Knippels, Elena NAA50dalova, Wen Chin Chiang A447 Dress Syndrome with Acute Nephritis,_Interstitial Caused By Quinolone and Nonsteroidal Anti-Inflammatory Drugs Young-Hee Nam, Ji Young Juong, Soo Jin PSME3m, Eun Young PSME3m, Su Mi Lee, Young PSME3 Son, Hee-Joo Nam, PSME3-Ho PSME3m, Soo-Keol Lee A448 IL23A Roles in the Development of House Dust Mite Allergic Sensitization and Asthma Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Hyun Seung Lee, Yoon-Seok Chang, Jung-Won Park, NAA50g-Heon Cho, Kyung-up Min, Woo-Jung Song A449 Exposure Profile of Indoor Risk Factors in Dwellings of Children with Dermatitis,_Atopic Hyunwook Lim, Sungchul Seo, Ji Tae Choung, Young Yoo, Jun-Sik Park, Byung Kwan PSME3m A450 Epidemiological Characterization of Blood Eosinophils in the Elderly Population Ha Kyeong Won, Hye-Ryun Kang, Byung-Keun PSME3m, Sung Do Moon, Ju-Young PSME3m, So-Hee Lee, Woo-Jung Song, Heung Woo Park, Min-Koo Kang, Sun-Sin PSME3m, NAA50g-Heon Cho, Kyung-up Min, Yoon-Seok Chang, Kyoung Hee Sohn, Kyung-Mook PSME3m, PSME3-Woong PSME3m, Hak Chul Jang A451 end_entity Caused By Methotrexate in the Treatment of Psoriasis Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A452 Genetic Determinants for Lung Function Growth in Asthma Children Ting Fan Leung, Man Fung Tang, Hing Yee Sy, Wa Cheong Chan, Wilson Wai NAA50 Tam A453 The Power of Allergen Specific Ig E in the Classification of Rhinitis, Korean National Hanes 2010 Seung Kyu Chung, Sujin PSME3m, NAA50g Duk Hong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Hun-Jong Dhong, Jong in Jeong A454 Analysis of Allergen Immunotherapy Practice and Patients Knowledge and Attitude about Allergen Immunotherapy in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A455 Roles of Staphylococcal Enterotoxin B in House Dust Mite-Induced Acute Asthma Models Ji Won Lee, Mingyu Kang, Soon-Hee PSME3m A456 A Clinical Comparison of Drug_Hypersensitivity_Syndrome in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee PSME3m PSME3m, Ye Suel Park, Soo-Keol Lee A457 The Beneficial Effect of Lactobacillus Gasseri PM-A0005 and Its Immunoregulatory Protein PMA5P40 on Milk-Induced Allergic Enteritis Yung-I Hou, Jiu-Yao Wang A458 Relationship Between Serum Folate Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Seol Jae Hee, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A459 Effects of Vitamin D in Patients with Chronic Rhinosinusitis Yuta Soma, So Watanabe, Ruby Pawankar, Ruby Pawankar, Harumi Suzaki, Harumi Suzaki, Hitome Kobayashi A460 Clinical Features of Systemic Dermatitis,_Contact from Ingestion of Rhus Young-Hee Nam, Chansun Park, Soo-Keol Lee A461 Sublingual Immunotherapy Efficacy in Patients with Dermatitis,_Atopic in Korea Jongrok Lee, Jooyoung Roh, Haryeong Ryu A462 Characteristics of Serious Drug-Related_Side_Effects_and_Adverse_Reactions in a Tertiary University Hospital Cheol-Woo PSME3m, Jae Hwa Cho, Mi Ra Eom, Ji Young Kang, Hye Gyeung Lee A463 Eyelid Dermatitis: Patch Test Results during a 15-Year Period in Korea and Evaluation of Metal Contents in Eye Shadows Hae Young Choi, Hye Jin Lee, Ju Yun Woo, Ji Yeon Byun, You Won Choi A464 Relationship Between Lipid Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong PSME3m, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho PSME3m, Namsoo Chang A465 IL-32 in the Induced Sputum of Patients with Asthma Jae-Woo Kwon, Hun Soo Chang, Jeong-Seok Heo, Jong-Uk Lee, Jong-Sook Park, Eusom PSME3m, Soo Hyun PSME3m, Choon-Sik Park A466 Clinical Characteristics of Patients with Chromium Hypersensitivity in a Single University Hospital in Korea Hae Young Choi, Ji Yeon Byun, Ju Yun Woo, You Won Choi A467 Efficacy and Safety of Oral Acitretin in Chronic Hand start_entity Hyun-Ju Jin, Jin-Hwa Son, Jeong-Min PSME3m, Gun-Wook PSME3m, Je-Ho Mun, Margaret Song, Hyun-Chang Ko, Moon-Bum PSME3m, Hoon-Soo PSME3m, Byung Soo PSME3m A468 Atypical Antipsychotics and Anticholinergic Agents Mimicking Anaphylaxis Sheryl Van Nunen, Dinh Van Nguyen, Anthony Elias, Susannah Olivia Lauer A469 Introducing Reach Reliable Estimation of Dermatitis,_Atopic in ChildHood: Novel, Questionnaire-Based Diagnostic Criteria for Childhood Dermatitis,_Atopic Seung-Chul Lee, Ho-June Lee, Jung Min Bae A470 Comprehensive Assessment to Identify the Causative Factors in Oral Hypersensitivity Syndrome Emi Ono A471 Comparison of Interpretation Methods in Allergic Skin Test Sung-Hwa Dong, Tae Kyung Koh, Young Seok Byun, Sung Wan PSME3m, Joong-Saeng Jo, Chul Kwon, Kun Hee Lee A472 Refraining Aminophylline Use Increases Hospitalization Among Children with Acute Asthma: A 10-Years Retrospective Cohort Study Li-Fan Liu A473 The Prevalence and Risk Factors of Dermatitis,_Atopic from Nationwide Study for Korean School Students Sunghee Lee A474 Probiotic Recombination Protein Effect on Dermatitis,_Atopic Wei-Leng Chen, Jiu-Yao Wang A475 Allergic Sensitization Status in Various Inflammatory Skin_Diseases Youin Bae, Gyeong-Hun Park A476 Two Cases of Good's Syndrome: A Rare Acquired Immunologic_Deficiency_Syndromes Associated with Thymoma Suk Yeon PSME3m A477 IL23A Has a Role to Play in the Development of Asthma in Short-Term Cigarette Smoke Exposure-Induced House-Dust Mite Allergic Model Hyun Seung Lee, Woo-Jung Song, Mingyu Kang, Han-PSME3 Park, Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Hye-Young PSME3m, Kyung-up Min, NAA50g-Heon Cho, Ji-Won Lee, Boram Bae, Jung-Won Park A478 The Relationship Between the Relevance of Allergic Disease and the Value of Non-Specific IgE Yasuhiro Suzuki A479 Two Caces of Prawn Hypersensitivity in Adult Patients Ismet Bulut, Zeynep Ferhan Ozseker A480 Early Gut Bifidobacterium Breve and B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"KRT8\",\n",
       "                    \"value\": \"Administration of exogenous TGF- to 6 end_entity mice leads to reduced numbers of ITGAM AMs, decreased type I start_entity signaling activity and loss of the protective phenotype during influenza infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis\",\n",
       "                    \"value\": \"Here, we have systematically studied the impact of minor differences in start_entity composition on cellular stress responses and viability by using highly similar polyalkylcyanoacrylate end_entity particles\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD40\",\n",
       "                    \"target\": \"CD86\",\n",
       "                    \"value\": \"The results indicate that microglia lines can be persistently infected with TMEV and that infection significantly upregulates the expression of cytokines involved in innate immunity TNF alpha, interleukin-6 IL6, IL18, and, most importantly, type I interferons along with upregulation of major histocompatibility complex class GCNT2, IL-12, and various costimulatory molecules CD80, end_entity, start_entity, and ICAM-1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"SIGNIFICANCE AND IMPACT start_entity THE STUDY: The noncoding upstream and downstream flanks of end_entity genomes allow for rapid classification of novel Betaend_entity species and correct identification of genetic relationships\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilic Esophagitis\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and Allopurinol Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to Glatiramer_Acetate: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 Asthma Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent end_entity Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with end_entity Chellaa R A615 Study of Incidence of Severe Persistent end_entity in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent end_entity in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent end_entity in Central India Subir Jain A617 Dermatitis,_Atopic: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe Dermatitis,_Atopic Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of end_entity Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao Pigmentary_Disorder,_Reticulate,_with_Systemic_Manifestations Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, end_entity, Dermatitis,_Atopic, and Acute Upper Respiratory_Tract_Infections and Levels of Severity of Asthma in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in start_entity Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent Dermatitis,_Atopic Associated with Parasitic Infection Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and Asthma Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in Asthma, end_entity, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via ERK and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of Asthma Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of Anaphylaxis and Asthma Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe Dermatitis,_Atopic Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GFAP\",\n",
       "                    \"target\": \"IGKV1D-37\",\n",
       "                    \"value\": \"Both start_entity only and start_entity, end_entity astrocytes were also increased in the spinal cord at 1 WPI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"SLPI\",\n",
       "                    \"value\": \"Other genes unassociated to date with ARDSSARS include C1Qb, C5AR1, CASP3, CASP9, start_entity, CD68, FGF7, HLA-DRA, IGF1, IRF3, MALAT1, MSR1, NFIL3, end_entity, USP33, CLC, GBP1 and TAC1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Carney Complex\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"CONCLUSIONS: end_entity in adult patients with relapsed Burkitt_Lymphoma are common after CD19 start_entity T-cell therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL1RA\",\n",
       "                    \"target\": \"TGFB1\",\n",
       "                    \"value\": \"OBJECTIVE: To investigate an association of variants in cytokine genes IL1A 889, IL1B 511, 3962, IL1R1 1970, start_entity 11100, IL4RA 1902, IL12 1188, IFNG 874, end_entity codon 10, codon 25, TNF 308, 238, IL2 330, 166, IL4 1098, 590, 33, IL6 174, nt565, and IL10 1082, 819, 592 between patients sensitive to dust mites and a control group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK1\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"MAP3K1 potently activated CRTC1, and this activation was independent of downstream effectors MEK1MEK2, start_entity, MAPK8, end_entity, protein kinase A, and calcineurin\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"RESULTS: In Daejeon, a end_entity patient the index case was hospitalized at Hospital A in the first week of illness and was transferred to Hospital B because of start_entity progression in the second week of illness, where he received a bronchoscopic examination and nebulizer therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"IRF1\",\n",
       "                    \"value\": \"Further validation showed that ISR2, 8, and 12 expression mimics that of their neighboring genes GBP1, end_entity, and start_entity, respectively, all related to the IFNA1 response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; ARG1, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; FCER1G, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; start_entity, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; end_entity, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"However, in comparison with the end_entity group, the degree of lung injury was reduced in start_entity mice that were treated with PDTC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPR50\",\n",
       "                    \"target\": \"H5\",\n",
       "                    \"value\": \"The simple analysis step and objective results that can be obtained within 15min indicate that this QD-LFIAS is a highly efficient test that can be used to monitor and prevent both Influenza,_Human A virus subtypes end_entity and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL8\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"CONCLUSIONS: This study has identified various pro-inflammatory cytokines and interferon-related genes such as MX1, RSAD2, CXCL10, start_entity, CCL5, KC, CCL2, CXCL8, CSF2 and end_entity in FCoV-positive cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PTX3\",\n",
       "                    \"target\": \"VDR\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum start_entity levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 end_entity gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C1\",\n",
       "                    \"target\": \"C2\",\n",
       "                    \"value\": \"According to a genotyping method developed previously for HCoV-OC43, BCoVs and BCoVs-like are distributed on three main sub-clusters named start_entity, end_entity, and C3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIT5\",\n",
       "                    \"target\": \"OASL\",\n",
       "                    \"value\": \"We used real-time PCR to confirm upregulation of a subset of these antiviral genes including MX1, EIF2AK2, start_entity, end_entity, IFNB1, and downregulation of the influenza matrix gene\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria, Erythropoietic\",\n",
       "                    \"value\": \"end_entity, selamectin and mefloquine hydrochloride are potential drugs for treating start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OAS3\",\n",
       "                    \"target\": \"OASL\",\n",
       "                    \"value\": \"Further analysis of selection on the OAS family in primates, which comprises OAS1, OAS2, start_entity and end_entity, suggests a hypothesis where gene duplications and domain fusion events result in paralogs that provide another means of escaping pathogen inhibitors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2RA\",\n",
       "                    \"target\": \"SFTPB\",\n",
       "                    \"value\": \"We performed whole-exome sequence analysis in a family affected by infantile-onset PAP with hypogammaglobulinemia without causative mutations in genes associated with PAP: end_entity, SFTPC, ABCA3, start_entity, CSF2RB, and GATA2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"In the present study, we identified at least two epitopes at amino acid residues 412419 epitope I and 434446 epitope end_entity, located downstream of the hypervariable region I within the HCV start_entity protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC6A3\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"end_entity increased the expression levels of Nurr1, TH, DOPA decarboxylase, start_entity, and vesicular monoamine transporter 2 via extracellular signal-regulated kinase phosphorylation in differentiated PC12 cells and the mouse SNPC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VHLL\",\n",
       "                    \"target\": \"Equine Infectious Anemia\",\n",
       "                    \"value\": \"3, also detected other genogroup GCNT2 start_entitys by end_entity but did not block any start_entity interactions with carbohydrate ligands\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome COVID-19 SARS-CoV papain-like protease PLPro reportedly inhibits the production of type I interferons IFNs and pro-inflammatory cytokines in Toll-like receptor 3 end_entity and retinoic acid-inducible gene 1 start_entity pathways\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PPIA\",\n",
       "                    \"target\": \"SPR\",\n",
       "                    \"value\": \"imple protocol for generating a highly stable and active surface plasmon resonance end_entity sensor surface of recombinant human hexahistidine start_entity His-CypA is described\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MRLN\",\n",
       "                    \"target\": \"PA\",\n",
       "                    \"value\": \"Moreover, three amino acid substitutions in end_entity P224S, PB2 E72D, and start_entity A128T were identified in intra-duck variations p518-L vs p518-S, whereas other changes in HA N170D, NA I56T, and NP Y289H were present in inter-duck variations DV518 vs DV413\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HLA-B\",\n",
       "                    \"target\": \"HLA-DRB1\",\n",
       "                    \"value\": \"The DE genes involved in the immune response included genes for inflammasomes RETN, S100A8, S100A9, S100A12, adhesion molecules CLDN3, VCAN, CD44, LGALS8, transcription factors ZBTB16, SLC39A14, CEBPD, CEBPB, acute-phase proteins and complement SAA1, LTF, Hereditary_pancreatitis, C3, differentiation genes for epithelial cells and keratinocytes TGM1, MS4A8, CSTA, and genes related to antigen processing and presentation start_entity, end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity CoV-2 start_entity caused the Corona Virus_Diseases 2019 start_entity cases in China has become a public health emergency of international concern PHEIC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRAF2\",\n",
       "                    \"target\": \"USP25\",\n",
       "                    \"value\": \"Mechanistically, end_entity deubiquitinated retinoic acid-inducible gene I DDX58, tumornecrosis factor TNF receptor-associated factor 2 start_entity, and TRAF6 to inhibit DDX58-like receptor-mediated IFNA1 signaling\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA2\",\n",
       "                    \"target\": \"SLC5A1\",\n",
       "                    \"value\": \"Candidate genes and regions chosen for this study were based on previously reported associations with response to immune stimulants, pathogens, or heat, including: TLR3, TLR7, MX, MHC-B major histocompatibility complex, gene complex, IFI27L2, end_entity, HSPB1, start_entity, HSPA8, IFRD1, IL18R1, IL1R1, AP2A2, and TOLLIP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"govgenomevirusesvariation and includes modules for seven viral groups: influenza virus, end_entity virus, West Nile virus, Ebolavirus, MERS start_entity, Rotavirus A and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bjornstad syndrome\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Mice deficient in T and B cells due to genetic deficiency in the RAG1 Rag1 were given end_entity intraperitoneally on Day 15 of gestation and found to be susceptible to end_entity-induced start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Enrollment criteria were the presence of a start_entity and the ability to produce a end_entity sample\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYP4F3\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the Guangzhou cohort study, after adjusting for age and sex, two AHSG SNPs and one start_entity SNP were found to be associated with end_entity susceptibility: rs2248690 adjusted odds ratio AOR 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Here we investigated immunocompromised adults with suspected Pneumocystis jirovecii end_entity start_entity for new respiratory viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity is also the receptor for the end_entity COVID-19 end_entity-CoV, a group GCNT2 COVID-19\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cholera\",\n",
       "                    \"target\": \"Giardiasis\",\n",
       "                    \"value\": \"start_entity, Leptospirosis, end_entity remain an important cause of morbidity and mortality, especially in low-income countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AKT1\",\n",
       "                    \"target\": \"PICK1\",\n",
       "                    \"value\": \"Tertiary structure along with binding sites was obtained, and visualized CHRAN7 protein have interaction with CHRNA1 protein family along with JAK2, start_entity, end_entity protein that are involved in neurological disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"While end_entity production by CD8A T cells was limited primarily to the time of acute effector function, start_entity T cells continued to produce end_entity throughout infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Tissue sections were stained with haematoxylin and eosin start_entity, and in situ reverse transcriptase polymerase chain reaction RTPCR on lung sections was performed using end_entity coronavirus-specific primers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"E1\",\n",
       "                    \"value\": \"Fusion of the end_entity transmembrane and cytoplasmic regions, but not analogous domains from two control membrane proteins, to the ectodomains of G and start_entity proteins caused the resulting chimeras to be retained in the EREG\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P1\",\n",
       "                    \"target\": \"RPLP2\",\n",
       "                    \"value\": \"28-nucleotide mRNA pseudoknot that overlaps the start_entity and end_entity genes of sugarcane yellow leaf virus ScYLV stimulates 1 ribosomal frameshifting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RH\",\n",
       "                    \"target\": \"Ataxia Telangiectasia\",\n",
       "                    \"value\": \"Two potential surrogates were evaluated in this study; transmissible gastroenteritis virus TGEV and mouse hepatitis virus MHV were used to determine effects of end_entity and start_entity on the survival of coronaviruses on stainless steel\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"We have previously reported that an open reading frame start_entity 1a-specific proteinase of the picornavirus 3C proteinase group is involved in processing of the end_entity infectious bronchitis virus IBV 1a1b polyprotein, leading to the formation of a mature viral protein of 100 kDa\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"IGKV1-16\",\n",
       "                    \"value\": \"We also demonstrated that co-administration of vectors expressing BPV-1 end_entity andor L2 DNA with CRTE7 DNA led to the generation of end_entityL2-specific start_entity T cell immune responses and end_entity-specific neutralizing antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPA33\",\n",
       "                    \"target\": \"Asthma\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 end_entity Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: end_entity index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh start_entity Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, IL5, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"alanine \",\n",
       "                    \"value\": \"The serum levels of TNF- TNF-, interleukin start_entity, 10 and immunoglobulin IgG, IgA, and IgM were determined by enzyme-linked immunosorbent assay ELISA; end_entity aminotransferase ALT and aspartate_aminotransferase SLC17A5 were tested by biochemical methods\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Development of anti-severe acute respiratory syndrome associated start_entity end_entity-CoV agents is pivotal to prevent the reemergence of the life-threatening disease, end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Seung Jin Lee, Bo Seon Seo, Ji Hyeon Baek, Kyung Suk Lee, Young-Ho Jung, Hye Mi Jee, Youn Ho Shin, Man Yong Han, Mi-Ae Kim A415 The Association of Exhaled Nitric_Oxide and Airway Hyperresponsiveness in Patients with and without Asthma Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A416 Effects of Air Pollution on end_entity in Korea Jisun Park A417 Exhaled Nitric_Oxide in Korean Children with end_entity Seung Hyun Moon A418 A Questionnaire of Children with Asthma or Asthma and end_entity Rong Jun Lin, Ren Zheng Guan A419 A Case of Trimebutine-Induced Morbilliform Skin Exanthema Gyeong Yul Park, Hyun-Sun Yoon A420 Comparison of Methacholine and Mannitol to Predict Exercise-Induced Bronchoconstriction in Children with Asthma Woo-Hyeok Choi, Heysung Baek A421 Different Inflammatory Mechanisms of Human Metapneumovirus and Respiratory Syncytial Virus Jin-Sung Park, Eunmi Kwon, Zac Callaway, Chang-Keun Kim, Takao Fujisawa A422 Sputum Microbiota in Chinese Adults with Eosinophilic Versus Non-Eosinophilic Asthma Qingling Zhang, Rihuang Qiu, Naijian Li, Zhaowei Yang, Jing Li, Kian Fan Chung, Nanshan Zhong A423 Which Clinical Features Are Useful in Predicting Presence of Staphylococcus Aureus colonizationInfection in Childhood start_entity? Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPT\",\n",
       "                    \"target\": \"Androgen-Insensitivity Syndrome\",\n",
       "                    \"value\": \"Thus, disruption in the end_entity barrier may allow start_entity to diffuse freely back into the somatodendritic compartment and potentially lead to Neurotoxicity_Syndromes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AGTR2\",\n",
       "                    \"target\": \"Ataxia Telangiectasia\",\n",
       "                    \"value\": \"Receptors for angiotensin peptides, including end_entity and start_entity receptors, are distributed in a characteristic pattern throughout the brain, with many of these sites behind the bloodbrain barrier\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD40\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"The cultured monocyte-derived DCX and also freshly-isolated CD209 blood DCX that were exposed to either cross-linked recombinant gp120 or immune-complex gp120 in HIV serum underwent considerable apoptosis after start_entity ligation or exposure to bacterial lipopolysaccharide end_entity or pro-inflammatory cytokines such as TNF and IL-1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK3\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"start_entity and IRE1XBP1 in the unfolded protein response differentially regulate the expression of CXCL10 and CCL2 likely through modulation of end_entity stress-induced NF-B RelA and STAT3 activation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"The Marfan_Syndrome inhibited the production of some cytokines IL-1, IL-1, end_entity, and IL6, chemokines CCL5, CCL22, CXCL1, CXCL5 and CXCL8 and prostaglandin start_entity but did not alter the production of IL-1225, CCL2 and CCL20\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BDNF\",\n",
       "                    \"target\": \"NOS2\",\n",
       "                    \"value\": \"The decreased expression of inflammatory factors IL-1, IL6 and TNF- by Western blotting assay and ELISA, angiogenesis protein VEGFA by Western blotting assay and other related proteins start_entity, NF-B, end_entity and COX-2 by Western blotting assay in peri-tumour tissue indicated that AVNP2 could control tumour-associated inflammation, thus efficiently ameliorating the local inflammatory condition and, to some extent, inhibiting angiogenesis in C6-bearing rats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Metabolic Syndrome X\",\n",
       "                    \"target\": \"Obesity\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of end_entity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of start_entity with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy end_entity and Metabolically Unhealthy end_entity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"typhimurium induced mobilization of end_entity and end_entity TCR T cells in the epithelium and start_entity and end_entity T cells in the lamina propria reflecting an inflammatory process that was attenuated by IgY\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Moniaga, Kenji Kabashima, Eung Ho Choi A199 Trends in oral food challenges in Japan: A six-year prospective study Noriyuki Yanagida, Sakura Sato, Chizuko Sugizaki, Motohiro Ebisawa A200 The Gut Microbiome in the Food Allergic Host Jamie Kiehm, Punita Ponda, Sherry Farzan, Jared Weiss, Claudia Elera, Catherine Destio, Cristina Sison, Annette Lee A201 Cord blood cytokines and maternal environmental exposure during pregnancy Soo Hyun Ri, Chang Hoon Lim A202 Rupatadine pharmacokinetics in Japanese healthy volunteers after single and repeated oral doses of 10, 20 and 40 mg Iaki Izquierdo Pulido, Jorg Taubel, Georg Ferber, Eva Santamaria Masdeu A203 A safe and effective method to desensitize patients with wheat allergy Alireza Khayatzadeh, Masoud Movahedi, Motohiro Ebisawa, Mohammad Gharagozlou A204 RNA Binding Protein Hur Regulates CD4 T Cell Differentiation and Is Required for Allergic Airway Inflammation and Normal IL2 Homeostasis Ulus Atasoy, Patsharaporn Techasintana, Matt Gubin, Jacqueline Glascock, Suzanne Ridenhour, Joseph Magee A205 Time Trends in the Epidemiology of Recurrence start_entity in Infants from South America Nelson Rosario Filho; Herberto Jose Chong Neto, Gustavo Falbo Wandalsen, Ana Caroline Dela Bianca, Carolina Aranda, Dirceu Sole, Javier Mallol, Luis Garcia-Marcos, Luis Garcia-Marcos A206 Successful Cyclophosphamide Desensitization in a Pediatric Patient with Lupus_Vulgaris_Erythematosus,_Systemic Jennifer Toh, Yoomie Lee, Joyce Huang, Elina Jerschow, Jenny Shliozberg A207 The Fatty Acid Binding Protein Der p 13 Is a Minor House Dust Mite Allergen Able to Activate Innate Immunity Pattraporn Satitsuksanoa, Narissara Suratannon, Jongkonnee Wongpiyabovorn, Pantipa Chatchatee, Kiat Ruxrungtham, Alain Jacquet A208 Epidemiology of Stevens-Johnson_Syndrome and Toxic Epidemal Necrolysis: An Administrative Database Study Min Suk Yang; Jin Yong Lee, Ja Yeun Kim, Han-Ki Park, Ju-Young Kim, Woo-Jung Song, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Sang-Heon Cho, Kyung-up Min, Chang-Han Park, Suk-Il Chang, Sook-Hee Song A209 Regional Differences of Vitamin D and Food-Induced Anaphylaxis in Korea Si-Heon Kim, Gil-Soon Choi, Su-Chin Kim, Ji Hye Kim, Ga Young Ban, Yoo Seob Shin, Hae-Sim Park, Young Min Ye A210 Triggering Factors of Dermatitis,_Atopic By Severity Yoon Ha Hwang A211 Clinical Features of Drug-Related_Side_Effects_and_Adverse_Reactions of Monoclonal Antibodies in Korea Da Woon Sim, Kyung Hee Park, Kyung Hee Park, Hye Jung Park, Hye Jung Park, Jung-Won Park, Jung-Won Park, Jae-Hyun Lee, Jae-Hyun Lee A212 Food_Hypersensitivity with Eczema Is Associated with Reduced Growth in the First Four Years of Life Katrina Allen, Cara Beck, Jennifer Koplin, Melanie Matheson, Mimi Tang, Anne-Louise Ponsonby, Lyle Gurrin, Shyamali Dharmage, Melissa Wake, Vicki Mcwilliam A213 The Preliminary Study on Clinical Efficacy and Impact Factors of One Year's Dust Mite Specific Immunotherapy in Allergic Asthma and Rhinitis Children Sensitized to Dust Mite Xiaoying Liu, Jing Wang, Li Xiang, Qun Wang A214 Lipopolysaccharide Signaling through Toll- like Receptor 4 Could be Augmented By Dermatophagoides Farinae in the Human Middle Ear Epithelial Cell Ji-Eun Lee, Dong-Young Kim, Chae-Seo Rhee, Chae-Seo Rhee A215 Drug_Hypersensitivity in Pregnant Adolescents: Relation with Familial and Personal Atopy, and Substances Use Francisco Vazquez-Nava A216 Patients and Physicians Concept of Well-Controlled Asthma: Findings from Realise Asia Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, David Price, Glenn Neira, Jiangtao Lin A217 The Role of Vasoactive Intestinal Peptide in the Pathophysiology of Acute Asthma Olga Semernik A218 Comparison of Serum Cytokine Levels According to the Severity in Dermatitis,_Atopic Ha-Su Kim, Jin-a Jung, Ji-in Jung A219 The Different Influence on the Regulatory T Cell Response Between Subcutanous ImmnuotherapySCIT and Sublingual ImmunotherapySLIT in Children with Asthma Qing Miao, Li Xiang A220 Asthma State of Affairs in Asia: Seeing through Physicians' and Patients' Lenses Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, Jiangtao Lin, David Price A221 Identification of Aspirin Exacerbated Respiratory Disease AERD Phenotypes Using Two Step Cluster Analysis Hyun Young Lee, Hae-Sim Park, Young Min Ye, Su Chin Kim A222 Dusty Air Pollution Are Associated with an Increase Risk of Allergic Diseases in General Population Shokrollah Farrokhi, Mohammadkazem Gheiby A223 A Genome-Wide Association Study of Antituberculosis Drugs-Induced Hepatitis Sang-Heon Kim; Heung Woo Park, Sang-Hoon Kim, Young-Koo Jee A224 The Role of peroxiredoxin6 of Bronchial Epithelial Cells in Regulating Mitochondrial Function Under Oxidative Stress By Translocation,_Genetic to Outside Mitochondrial Membrane Sunjoo Park, Keun Ai Moon, Hyouk-Soo Kwon, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Kyoung Young Lee, Gyong Hwa Hong, Eun Hee Ha A225 Toxic and Adjuvant Effects of 3 Types of Silica Nanoparticles on Airway System Heejae Han, Hye Jung Park, Yoon Hee Park, Yoon-Jo Kim, Kangtaek Lee, Jung-Won Park, Jae-Hyun Lee A226 Procedure for Diagnostic and Selection of Immunotherapy Method for Children with Different Immunopathogenetic Phenotypes of Dermatitis,_Atopic Tatiana Slavyanskaya, Vladislava Derkach A227 Prediction of the Success of Our Desensitization Protocol with Symptoms and Results of a Skin Prick Test in Patients with Hypersensitivity to Platinum-Based Chemotherapy Hye Jung Park, Chein-Soo Hong, Jae-Hyun Lee, Jae-Hyun Lee, Sungryeol KIM, Sungryeol KIM, Kyung Hee Park, Kyung Hee Park, Choong-Kun Lee, Beodeul Kang, Seung-Hoon Beom, Sang Joon Shin, Minku Jung, Jung-Won Park, Jung-Won Park A228 Anti-Allergic Effect of Intralymphatic Injection of OVA-Flagelin Mixture in Mouse Model of end_entity Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo, Young-Jun Chung A229 Serum Periostin Level Is Higher in Respiratory Type of NSAID Hypersensitivity Than Cutaneous Type Mi-Ae Kim, Hae-Sim Park, Moon Gyeong Yoon, Young-Soo Lee, Ji Hye Kim, Ga Young Ban, Hye-Soo Yoo, Yoo Seob Shin, Young Min Ye, Dong-Ho Nahm A230 A Retrospective Analysis of Hypersensitivity Blood Testing in Beijing Children's Hospital in the Year of 2013: A Single-Center Research Qing Miao, Li Xiang A231 Role of Nrf2 in the Allergic Airway Inflammation Differ Between BALBc and C57BL6 Mice Ying-Ji Li, Takako Shimizu, Hirofumi Inagaki, Yukiyo Hirata, Hajime Takizawa, Arata Azuma, Masayuki Yamamoto, Tomoyuki Kawada A232 Effect of Human Mesenchymal Stem Cell on Neutrophilic Asthma Model Min-Gu Kim, Gyong Hwa Hong, Kyoung Young Lee, Eun Hee Ha, Keun Ai Moon, Sunjoo Park, Hyouk-Soo Kwon, Tae-Bum Kim, Hee-Bom Moon, You Sook Cho, Jung-Hyun Kim, Hyo-Jung Kim, So-Young Park, Bomi Seo A233 Immunomodulatory Effect of Tonsil Derived Mesenchymal Stem Cells in a Mouse Model of end_entity Ji-Hye Kim, Ramachandran Samivel, Eun-Hee Kim, Young-Jun Chung, Ji-Hun Mo A234 Alternative Therapy Such As Yoga May be a Low Cost Tool for Improving the Quality of Life of Patient's with end_entity and Asthma Soumya M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and Allopurinol Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to Glatiramer_Acetate: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 Asthma Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent Allergic end_entity Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with Allergic end_entity Chellaa R A615 Study of Incidence of Severe Persistent Allergic end_entity in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent Allergic end_entity in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent Allergic end_entity in Central India Subir Jain A617 start_entity: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe start_entity Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of Allergic end_entity Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao Pigmentary_Disorder,_Reticulate,_with_Systemic_Manifestations Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, Allergic end_entity, start_entity, and Acute Upper Respiratory_Tract_Infections and Levels of Severity of Asthma in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in Eosinophilic_Esophagitis Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent start_entity Associated with Parasitic Infection Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and Asthma Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in Asthma, Allergic end_entity, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via ERK and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of Asthma Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of Anaphylaxis and Asthma Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe start_entity Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult start_entity and end_entity Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in start_entity Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of start_entity: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with start_entity and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe start_entity Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly start_entitys Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's start_entity : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric start_entity Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of start_entity-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity start_entity Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of end_entity Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled start_entity in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of start_entitys As an Endotype for Refractory start_entity Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of start_entity in an Ovalbumin-Specific Mouse Model of Allergic start_entity Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with start_entity Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in start_entity Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for start_entity in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAP1LC3A\",\n",
       "                    \"target\": \"RGN\",\n",
       "                    \"value\": \"The MNV end_entity was marked by the microtubule-associated-protein-1-light-chain-3 start_entity conjugation system of autophagy and then targeted by immunity-related GTPases IRGs and guanylate binding proteins GBPs upon their induction by IFNG\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"IFITM2\",\n",
       "                    \"value\": \"High levels of 20 end_entity expression could be detected in start_entity T cells and in monocytes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAL\",\n",
       "                    \"target\": \"KD\",\n",
       "                    \"value\": \"Other studies from Japan suggested the role of CD40LG in the pathogenesis of start_entity, and this might help explain the excessive number of males affected with end_entity but cannot be reproduced by Taiwanese population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CASP8AP2\",\n",
       "                    \"target\": \"Neural Tube Defects\",\n",
       "                    \"value\": \"Here, we determined crystal structures of start_entity end_entity and found that it forms a coiled-coil dimer\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SOCS1\",\n",
       "                    \"target\": \"SOCS3\",\n",
       "                    \"value\": \"Notably, the expression levels of the negative regulators of SOAT1 activation, start_entity and end_entity, were not altered by Noonan_Syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Since it has been reported that the HIV-1 protease inhibitors can be used as anti-SARS drugs by tegarting SARS-CoV start_entity, we choose six approved anti-HIV-1 drugs to investigate their binding interactions between start_entity, and to evaluate their potential to become clinical drugs for the new end_entity end_entity COVID19 caused by end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GLS2\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"Results: We found that rs10513846 start_entity genotype was associated with older age end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SN\",\n",
       "                    \"target\": \"Harlequin type ichthyosis\",\n",
       "                    \"value\": \"The groups immunized with the CL antigen having an HA titer of 4000 or 16 000 produced hemagglutination inhibition end_entity antibody titers of 320 and serum neutralizing start_entity antibody titers of 1280\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Secreted end_entity was found to contain both O-linked and N-linked complex glycans, whereas secreted start_entity retained virus neutralization and hemagglutination epitopes, suggesting the possibility of using soluble RV antigens as subunit vaccines and for serodiagnostic purposes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A1\",\n",
       "                    \"target\": \"MRAP\",\n",
       "                    \"value\": \"The 13 HLA Class I supertypes are start_entity, A2, A3, A24, LRRC23, NDUFA2, end_entity, B44, B58, B62, C1, and C4A\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Salmonella Infections\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Diarrhea due to start_entity is an important cause of neonatal calf end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"PDCD1\",\n",
       "                    \"value\": \"The checkpoint receptor end_entity suppresses the functionality of virus-specific start_entity T cells during chronic infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C7\",\n",
       "                    \"target\": \"CCDC88A\",\n",
       "                    \"value\": \"According to the phylogenetic analysis, the following nine PBV assortment types are proposed: C1:GI, C2:end_entity, C4A:GI, C4A:GV, C5:GI, start_entity:GI, C8:end_entity, C8:GV and C8:GII\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"By Feb 27th, 2020, the outbreak of COVID-19 caused 82623 confirmed cases and 2858 deaths globally, more than end_entity end_entity 8273 cases, 775 deaths and start_entity MERS 1139 cases, 431 deaths caused in 2003 and 2013 respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IQGAP1\",\n",
       "                    \"target\": \"SAMHD1\",\n",
       "                    \"value\": \"Proteins involved in successive signaling in innateadaptive immunity were identified, including SAM domain and Huntington_Disease domain-containing protein 1 end_entity, Ras GTPase-activating-like protein start_entity, proteasome activator complex subunit 1 PSME1, HLA class I histocompatibility antigen HLA-C, and STAT1-alphabeta STAT1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"BACKGROUND: Patients with community acquired end_entity start_entity caused by viruses can develop severe complications, which result in hospitalization and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"FASLG\",\n",
       "                    \"value\": \"The levels of start_entity, TNF-, IFN-, and end_entity transcripts in AMs in all groups with dual inoculation of PCV2 and PRRSV were significantly increased regardless of the infection orders as compared with infection by PCV2 alone or PRRSV alone\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"CXCR4\",\n",
       "                    \"value\": \"The purpose of this project was to evaluate the expression of representative pro-TNF-, IFN-, IL-1, IL2, IL6, IL-12p35, IL-12p40, IL18, and start_entity and anti-inflammatory cytokines IL4, IL5, and IL10; TNFRSF4, a secondary co-stimulatory molecule expressed on activated T cells FIV primary receptor; the chemokine receptor end_entity FIV co-receptor; SDF-1, the chemokine ligand to end_entity; and FIV gag in trophoblasts from early-and late-term pregnancy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"We further demonstrate that the receptor-binding domains of end_entity S and SARS-CoV S bind with similar affinities to human start_entity, which correlates with the efficient spread of end_entity among humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CBARP\",\n",
       "                    \"target\": \"SLC5A5\",\n",
       "                    \"value\": \"CONCLUSION: Although more patients with bilateral pneumonias were hospitalized in IS, start_entity was not different between IS and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"In contrast, 7 Th1 epitope-containing peptides were identified in the end_entity domain of type start_entity FIPV, and no linear immunodominant antibody-binding epitope was contained in any of these peptides\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BSG\",\n",
       "                    \"target\": \"Arthritis, Rheumatoid\",\n",
       "                    \"value\": \"RT-PCR showed that the expressions of start_entity, MMP-2 and MMP-9 mRNA was higher in end_entity FLS than in osteoarthritis FLS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PML\",\n",
       "                    \"target\": \"Leukoencephalopathy, Progressive Multifocal\",\n",
       "                    \"value\": \"JC virus JCV is a human polyomavirus that can emerge from a latent state to cause the cytolytic destruction of oligodendrocytes in the brain resulting in the fatal demyelinating disease, end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"If new mutants of end_entity start_entity do initiate another epidemic, administration of prophylactic antibodies to risk groups may supplement the stringent isolation procedures that contained the first end_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL18\",\n",
       "                    \"value\": \"Plasma concentrations of inflammatory cytokines tumour necrosis factor TNF-, interleukin IL6, end_entity and chemokine CCL2 in patients with diabetic nephropathy DN were significantly higher than control subjects, while start_entity, CXCL8, CXCL9, CXCL10 and ADIPOQ concentrations of DN were significantly higher than patients without diabetic nephropathy NDN and control subjects all P 005\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NLRP3\",\n",
       "                    \"target\": \"Noonan Syndrome\",\n",
       "                    \"value\": \"The end_entity RNA-binding domain basic residues 38 and 41 and TRIM25-binding domain acidic residues 96 and 97 are important for suppression of start_entity inflammasome-mediated IL-1 secretion\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AGTR1\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"start_entity, ACE, ENPEP, MME, and PRCP, which encode the Ataxia_Telangiectasia angiotensin GCNT2 receptor, angiotensin-converting enzyme, end_entity, MME, and PRCP, respectively, were also underexpressed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CHAC1\",\n",
       "                    \"target\": \"PRH1\",\n",
       "                    \"value\": \"Moreover, the end_entity virulence factors Van_der_Woude_syndrome and flagellin were shown to induce start_entity expression in cells from patients without Cystic_Fibrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD25\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"In addition, a proportion of intraepithelial end_entity T cells from acutely infected calves coexpressed start_entity, whereas there was an absence of coexpressed start_entity on end_entity T cells from control calves\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"VEGFA\",\n",
       "                    \"value\": \"The concentrations of interleukins IL-1 receptor antagonist Ra, IL2, start_entity, CXCL8, IL10, IL-12p40, granulocyte-macrophage colony-stimulating factor CSF2, monocyte chemotactic protein-1 CCL2, macrophage inflammatory protein-1b MIP-1b, end_entity end_entity, TNF TNF- and viral load cycle threshold Ct were measured in the dengue virus type 2-infected mononuclear cells at 6 h, 24 h, 48 h, and 72 h post-infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neoplasms\",\n",
       "                    \"target\": \"Wounds and Injuries\",\n",
       "                    \"value\": \"RESULTS: The panel reviewed and evaluated all available evidence to list and rank 1highest priority the top four main public health issues: 1 Cardiovascular disease accounted for more than 25 of deaths in 2010; 2 end_entity caused 17 of mortality for all age groups in 2010; 3 start_entity accounted for 10 of all deaths in 2010, and the incidence of all cancers is projected to double by 2020; and 4 Respiratory disorders were the second most common non-fatal condition in 2010\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNL1\",\n",
       "                    \"target\": \"IL13\",\n",
       "                    \"value\": \"The expression of 10 cytokines and 4 transcription factors IFN-, IFN-, IFN-, IL10, end_entity, IL17A, IL-28, start_entity, IL-37, TGF-, FOXP3, GATA3, RORC2 and Tbet were studied from tonsil tissue by quantitative PCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"MALAT1\",\n",
       "                    \"value\": \"Other genes unassociated to date with ARDSSARS include C1Qb, C5AR1, CASP3, CASP9, start_entity, CD68, FGF7, HLA-DRA, IGF1, IRF3, end_entity, MSR1, NFIL3, SLPI, USP33, CLC, GBP1 and TAC1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"In this study chimeric proteins containing the ectodomain of start_entity or CD8A fused to the C-terminal hydrophobic sequence of E1 were shown to be localized in the end_entity, indicating that the Distal_Myopathies of E1 is also a signal for end_entity localization\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CHAF1A\",\n",
       "                    \"target\": \"PRCP\",\n",
       "                    \"value\": \"The rubella virus RUB nonstructural Netherton_Syndrome protease is a papain-like cysteine protease end_entity located in the Netherton_Syndrome-protein open reading frame Netherton_SyndromeP-ORF that cleaves the Netherton_SyndromeP-ORF translation product at a single site to produce two products, start_entity the N-terminal product and CANX the C-terminal product\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"VEGFA\",\n",
       "                    \"value\": \"The concentrations of interleukins IL-1 receptor antagonist Ra, IL2, IL6, CXCL8, IL10, IL-12p40, granulocyte-macrophage colony-stimulating factor CSF2, monocyte chemotactic protein-1 CCL2, macrophage inflammatory protein-1b MIP-1b, end_entity end_entity, start_entity TNF- and viral load cycle threshold Ct were measured in the dengue virus type 2-infected mononuclear cells at 6 h, 24 h, 48 h, and 72 h post-infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"LIF\",\n",
       "                    \"value\": \"Quercetin at concentrations up to 50 M significantly inhibited the production of NO, IL6, CCL2, CXCL10, CCL5, start_entity, CSF3, TNF-, end_entity, LIX, and VEGFA as well as calcium release in dsRNA 50 gmL of polyinosinic-polycytidylic acid-induced RAW 264\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Fever\",\n",
       "                    \"target\": \"Mumps\",\n",
       "                    \"value\": \"DCVMN members presented their progress in developing novel Hexavalent, Meningitis,_Pneumococcal Conjugate Vaccine, Shigella, end_entity, Rotavirus, Yellow start_entity, Poliomyelitis, Hepatitis_E and Dengue vaccines, and a novel monoclonal antibody cocktail for post-bite prophylaxis against rabies infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and start_entity end_entity are two coronaviruses with demonstrated potential to generate significant nosocomial outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B1\",\n",
       "                    \"target\": \"IGKV5-2\",\n",
       "                    \"value\": \"5 ml 4 times, group start_entity 5 ml 2 times, and group end_entity 5 ml 4 times; the time interval among the injection was 5 days, and the structural changes of FHC were the observed using 50100200 light microscope; the modified Mankin pathological scoring was also performed for the evaluation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Montelukast\",\n",
       "                    \"target\": \"CD40\",\n",
       "                    \"value\": \"1 Million South Korean Health-Care Records Gwang-Cheon Jang, Hyun-Hee Lee, Chang-Jong Lee, Huynsun Lim A314 Association of Recurrence Wheeze with Lung Function and Airway Inflammation in Preschool Children Ji-Eun Soh, Dae-Jin Song, Ji-Won Kwon, Hyung Young Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Gwang-Cheon Jang, Woo Kyung Kim, Young-Ho Jung, Soo-Jong Hong, Jung Yeon Shim A315 Mannan-Binding Lectin Serum Levels in Healthy Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A316 Rotanebuliser Prabhakarrao Pv, Ranjitha Nadendla A317 The Level of Serum Interleukin 13 and Interleukin 17A and Its Effect Factors in Children with Asthma Juan Fang, Jing Zhao A318 Is Vitamin D Insufficiency Also Involved in Childhood Asthma in South Korea? Dae-Jin Song, Sungchul Seo, Young Yoo, Yu-Ri Kim, Ji Tae Choung, Jee Hoo Lee A319 Collection of Nasal Secretions for Measurement of Local IgE: A Quest for the Best Method Margot Berings, Natalie De Ruyck, Claus Bachert, Philippe Gevaert, Gabrile Holtappels A320 The Role of Claudin 5 in a Murine Model of Asthma Pureun-Haneul Lee, Byeong-Gon Kim, Choon-Sik Park, George D Leikauf, An-Soo Jang A321 Claudin-4 in a Murine Model of Asthma: Modulation By Acrolein, a Highly Reactive Unsaturated Aldehyde Byeong-Gon Kim, Pureun-Haneul Lee, Choon-Sik Park, An-Soo Jang A322 Efficacy and Safety of Sublingual Immunotherapy in House Dust Mite Sensitized Children with Rhinitis,_Allergic Yang Park A323 The Association of Vitamine D Deficiency and Skeletal Muscle Dysfunction in Chronic Airway Disease Min-Su Sohn, Hyun Jung Jin, Dong-Won Lee, Jun-Hong Ahn, Jin Hong Chung A324 Bacteria Derived Extracellular Vesicles in Indoor Dust Is Closely Associated with Airway Disease and Lung_Neoplasms: Analysis of Indoor Dusts Microbiome and IgG Sensitization of Indoor Bacteria Derived Extracellular Vesicles Sae-in Kim, Han-Ki Park, Do-Yeon Kim, Mina RHOD, Jun-Pyo Choi, Yoon-Keun Kim A325 Clinical Care Program for Childhood Asthma CCP-Childhood Asthma; A Multidisciplinary Team Care at Samitivej International Children's Hospital Wasu Kamchaisatian, Thitikul Hiranras, Surinda Wongpun, Phornthip Chiraphorn, Anupan Tantachun, Wannipa Wongrassamee, Planee Vatanasurkitt, Naratip Somboonkul, Nattipat Juthacharoenwong, Surangkana Techapaitoon, Montri Tuchinda A326 Continuous B Cell Stimulation with end_entity Ligand Induce IgE Isotype Switching Jae Ho Lee, Sejin An A327 Effects of Interleukin-9 on Allergen-Specific Immunotherapy in a Mouse Model of Rhinitis,_Allergic Ji-Hyeon Shin, Soo Whan Kim, Si Won Kim, Jun Myung Kang, Boo-Young Kim, Byung-Guk Kim A328 Usefulness of Exhaled Nitric_Oxide for Evaluating Wheeze and Airway Hyperresponsiveness in Preschool Children Jung-Won Lee, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Jung Yeon Shim A329 Systemic Cyclosporine Treatment in Hand Eczema Patients Kyung Ho Kim A330 Lipid Profiles and Adipokines in Korean Children with Dermatitis,_Atopic Young Yoo, Won Suck Yoon, Sungchul Seo, In Soon Kang, Jae Won Choi, Hye-Young Lim, Ji Tae Choung A331 Validation of start_entity and Levocetirizine Combination Tablet Versus Individual Tablets in the Treatment of Moderate to Severe Persistent Rhinitis,_Allergic Among Adult Filipinos Seen at the Philippine General Hospital-Outpatient Department Michelle Buela A332 Efficacy of Makyokansekito on Treatment of Respiratory_Sounds Lower Respiratory_Tract_Infections in Children: A Retrospective Study of 68 Patients Koji Nishimura A333 Serum Eosinophilia and Total IgE Are Associated with the Risk of Allergic Sensitization and Allergic Symptoms in Two Years Follow-up, Respectively Sang Chul Park, Hyo Jin Chung, Chang-Hoon Kim, Ju Wan Kang, Seong-Chul Hong, Keun-Hwa Lee, Jaechun Lee, Hye-Sook Lee, Jeong Hong Kim A334 The Sensitization to Russian Thistle on Mongolian Patients Narantsetseg Logii A335 The Association Between Air Pollution, Allergic Sensitization to Inhalant Allergens and Airway Hyperresponsiveness in Ulaanbaatar, Mongolia Munkhbayarlakh Sonomjamts, Enkhbayar Bazarsad A336 Pre-Coseasonal Treatment with a 5-Grass Pollen Sublingual Tablet in Adults Demonstrated a Reduction on Asthma Symptoms in Runion Island Bashir Omarjee A337 Peak Expiratory Flow Rate Reference Values for Children Aged 5-14 Years Old in Beijing Urban Area Shuo TGM1 A338 Soybean Storage Proteins As the Main Allergen in a Patient with Food-Dependent Exercise-Induced Anaphylaxis Due to Tofu Miyuki Hayashi, Ruby Pawankar, Shingo Yamanishi, Toru Igarashi, Yasuhiko Itoh A339 A Study of Hypersensitivity Skin Prick Test with Weed Pollen Oyuntsatsral Batsaikhan, B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BMP2\",\n",
       "                    \"target\": \"Atherosclerosis\",\n",
       "                    \"value\": \"The expression of start_entity start_entity, RUNX family transcription factor 2 RUNX2, alkaline phosphatase end_entity, BGLAP OC and ARNTL in BMSCs was evaluated by reverse transcription-quantitative PCR and western blotting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"To address this deficiency, high-throughput real time RT-PCR TaqMan assays were developed to measure the expression of fifteen immune mediators associated with the innate and adaptive immune responses IFNA1, IFNA1, IFNA1, IL1A, IL1A, IL2, IL4, end_entity, CXCL8, IL1A0, IL1A2p40, IL1A7A, Granzyme A, start_entity, TNF, as well as four endogenous housekeeping genes ATF4, HPRT1, GAPDH, RPL32\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX1\",\n",
       "                    \"target\": \"RTCB\",\n",
       "                    \"value\": \"Moreover, endogenous hCLE fractionates in protein complexes together with start_entity, end_entity and FAM98B and silencing of hCLE down-regulates their nuclear and cytosolic accumulation levels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BAAT\",\n",
       "                    \"target\": \"Asthma\",\n",
       "                    \"value\": \"Won Suck Yoon A399 Case Report of Near-Fatal end_entity Due to Snail Hypersensitivity in a House Dust Mite-Allergic Adult Jean-Pierre L'huillier, Jean-Eric Autegarden, Catherine Bertrand, Dominique Tardy A400 Relationship Between Gut Microbiota in the First 3 Months of Life and Infant Immune Function at Age 12 Months Intan Hakimah Ismail, Mimi Tang, Paul Licciardi, Frances Oppedisano, Robert Boyle, Roy Robins-Browne A401 A Pediatric Case of Food-Dependent Exercise-Induced Anaphylaxis Due to Spice Hypersensitivity Hisako Yagi, Harumi Koyama, Yutaka Nishida, Takumi Takizawa, Hirokazu Arakawa A402 Correlations Between Objective Severity Score and Each of the Subjective Severity Intensity in Dermatitis,_Atopic Hong Kyu Kang, Hemin Lee, Jungsoo Lee, Jung U Shin, Kwang Hoon Lee, Kwang Hoon Lee, Howard Chu, Chang Ook Park A403 Barrier Related Gene Mutations in Dermatitis,_Atopic Na Young Yoon, Hyeyoung Lee, Seong Jun Seo, Eunhee Choi, Hye-Young Wang, Minyoung Jung, Eung Ho Choi, Dong Hye Kim A404 Clinical Utility of Basophil Activation Test start_entity in the Diagnosis of Drug Induced Anaphylaxis Joo-Hee KimYoung-Sook Jang, Jeong-Hee Choi, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A405 Feeding Shapes the Colonization of Gut Microbiota and Associated with Total IgE in Infant Mi-Jin KangDongin Suh, Eun Lee, Kil Yong Choi, Young-Ho Jung, Song-I Yang, Bong-Soo Kim, Ha-Jung Kim, Juneyoung Koh, Hyun-Jin Kim, Kangmo Ahn, Youn Ho Shin, Hyun-Ju Cho, Byoung-Ju Kim, Young-Ho Kim, Yean Jung A406 CD8T Cell-Intrinsic Smad4 Suppresses Th2 Responses in the Pathogenesis of Dermatitis,_Contact Mizuko Mamura, Jeong-Hwan Yoon, Susumu Nakae, Inkyu Lee, Isao Matsumoto, Takayuki Sumida, Jin Soo Han, Katsuko Sudo, Ji Hyeon Ju A407 Immune-Modulatory Genomic Properties Differentiate Gut Microbiotas of Infants with and without Eczema Gaik Chin Yap, Wen Tso Liu, Seungdae Oh, Pei Ying Hong, Chiung Hui Huang, Marion Aw, Lynette Shek, Bee Wah Lee A408 The Effect of Medication in OSA Patients with Rhinitis,_Allergic Young Seok Byun, Sung Wan Kim, Tae Kyung Koh, Joong-Saeng Jo, Kun Hee Lee, Chul Kwon, Sung-Hwa Dong A409 A Case of Generalized Pustular Psoriasis Mimicking Acute_Generalized_Exanthematous_Pustulosis Myung Shin Kim, Chansun Park A410 Anaphylaxis Caused By Gummy Jelly Ingestion: A Case Report Han Seok Cho, Min-Ju Kim, Min Ji Kim, Young Ok Park, Hye Yeong Lee, Hee Seong Kim, Eun Lee, Hyun-Ju Cho, Jinho Yu, Soo-Jong Hong, Keum Hee Hwang A411 Serum Folliculin As a Novel Biomarker for end_entity Jung-Hyun Kim, You Sook Cho, Sae-Hoon Kim, Hyouk-Soo Kwon, Mira Yoo, Hyo-Jung Kim, So-Young Park, Bomi Shin, So Young Park, Bomi Seo, Min-Gu Kim, Hee-Bom Moon, Jin-Ah Park, Tae-Bum Kim, Jaemoon Lee A412 Corticosteroid Nasal Irrigations after Endoscopic Fistula Surgery in the Management of Chronic Rhinosinusitis with end_entity Jin Hyeok Jeong, Tae Wook Kang, Han Seok Yoo, Yong Hee Cho, Seok Hyun Cho, Kyung Rae Kim A413 Capsaicin Injection in Neonatal Period Potentiates Intensity and Duration of Dermatitis,_Atopic of Rats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BAG6\",\n",
       "                    \"target\": \"TWF1\",\n",
       "                    \"value\": \"end_entity cells endogenously contain high levels of G1 but low levels of start_entity, C6orf47, and GPANK1 were detected by Q-PCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMBS\",\n",
       "                    \"target\": \"RPS9\",\n",
       "                    \"value\": \"While NormFinder analysis ranked the genes as: UXT RPS23 RPL4 end_entity EEF1A1 start_entity ACTB 2M GAPDH RPS15\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"TRPV1\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of end_entity in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of start_entity polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR7\",\n",
       "                    \"target\": \"CD80\",\n",
       "                    \"value\": \"We found that the messenger RNA mRNA expression of cell surface molecules CD40, end_entity, CD83, and start_entity and cytokines IFN-, IL6, and IL10 of HD11 cells was up-regulated following GLS2 exposure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAP2K1\",\n",
       "                    \"target\": \"MAP2K2\",\n",
       "                    \"value\": \"Interestingly, a specific knockdown of start_entity with siRNAs caused a marked inhibition of viral titers, viral proteins and virus-induced cytopathic effect CPE, whereas silencing end_entity had little effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"The International Society for start_entity and other Respiratory end_entity held its 6th Antiviral Group isirv-AVG conference in Rockville, Maryland, November 1315, 2018\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARG1\",\n",
       "                    \"target\": \"FCER1G\",\n",
       "                    \"value\": \"nnAbbreviationsAHR, airway hyperresponsiveness; start_entity, Arginase 1, CSF3, Colony Stimulating Factor 3; CD38, Cluster of Differentiation 38; CD163, Cluster of Differentiation 163; cDCs, conventional or myeloid dendritic cells; DDX60, DExDH-Box Helicase 60; ED, Emergencies Department; EGF, Epidermal Growth Factor; ERK, Extracellular signal-Regulated Kinase; end_entity, Fc Fragment Of IgE Receptor Ig; HMBS, Hydroxymethylbilane Synthase; IFNg, Interferon Gamma; IFNL1, Interferon Lambda 1; IL-1R2, Interleukin 1 Receptor Type 2; IRF7, Interferon Regulatory Factor 7; ISG15, Interferon-stimulated gene 15; IFIH1, Melanoma Differentiation-Associated protein 5; MX1, Myxovirus Resistance Protein 1; NAD, nicotinamide adenine dinucleotide; NCR1, Natural cytotoxicity triggering receptor 1; OSM, Oncostatin M; CD274, Programmed Death-Ligand 1; PPIA, Peptidylprolyl Isomerase A; PPIB Peptidylprolyl Isomerase B; RSAD2, Radical S-adenosyl methionine domain-containing protein 2; RSV, respiratory syncytial virus; RT-qPCR, quantitative reverse transcription PCR; RV, rhinovirus; sPLA2, secretory Phospholipase A2; TGFb, Transforming Growth Factor beta; THBS1, ThromboSPON1; TNF, Neoplasms Necrosis Factor; TLR2, Toll-like Receptor 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MN\",\n",
       "                    \"target\": \"Harlequin type ichthyosis\",\n",
       "                    \"value\": \"Sera were tested for antibody to vaccine antigens and AH1N1pdm09 by hemagglutination inhibition end_entity, microneutralization start_entity, nucleoprotein-based ELISA and HA1-based microarray assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Arthritis\",\n",
       "                    \"target\": \"Spasm\",\n",
       "                    \"value\": \"Fal, Dorota Kiedik, Agnieszka Muszynska, Iwona Pirogowicz A523 Asthma Impact on Children with Food Induced Anaphylaxis Chikako Motomura, Masatoshi Wakatsuki, Yuko Akamine, Mihoko Iwata, Hiroshi Matsuzaki, Naohiko Taba, Yoko Murakami, Hiroshi Odajima A524 Case Reports of Stevens-Johnson_Syndrome and Stevens-Johnson_Syndrome-Stevens-Johnson_Syndrome in Lupus_Vulgaris_Erythematosus,_Systemic Reni Ghrahani A525 The Effectiveness of Oral Tolerance Induction for Wheat Hypersensitivity Using Two Different Intake Levels Yuri Takaoka A526 Association of Plasma Interleukin-25 Levels with Development of Aspirin Induced Airway end_entity in Asthma Jong-Uk Lee, Jeong-Seok Heo, Da-Jeong Bae, Hyun Ji Song, Choon-Sik Park, Jong-Sook Park A527 Transition of Allergic and Nonallergic Rhinitis after 2 Years in Korean Children: Preliminary Study Jae Hoon Cho, Ji Ho Choi A528 Early Onset of Psoriasis Juvenile Idiopathic start_entity Budi Setiabudiawan, Fiska Febriana, Reni Ghrahani, Gartika Sapartini A529 Clinical Features of Hypersensitivity,_Immediate to Histamine H2 Antagonists and Their Cross Reactivity Chan-Sun Park, Young-Hee Nam, Mi Yeoung Kim, Gil-Soon Choi A530 Detection of Galacto-Oligosaccharide Specific IgE in Vitro Chiung-Hui Huang, Chiung-Hui Huang, Jian Yi Soh, Lynette Shek, Lynette Shek, Dianne J\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Structure analysis of the spike S protein of this new virus showed that its S protein only binds weakly to the start_entity2 receptor on human cells whereas the human Severe_Acute_Respiratory_Syndrome end_entity exhibits strongly affinity to the start_entity receptor\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"Nail-Patella Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Four sampling techniques commonly are used for antemortem identification of pathogens from cattle with bovine respiratory disease BRD: the nasal swab Netherton_Syndrome, guarded nasopharyngeal swab end_entity, bronchoalveolar lavage start_entity, and transtracheal wash TTW\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PIK3CA\",\n",
       "                    \"target\": \"TNS1\",\n",
       "                    \"value\": \"Western blot analyses were applied to determine the expression levels of Lymphoma,_B-Cell-2 BCL2, B-cell associated X protein Bax, phosphatase and end_entity homolog PTEN, phosphorylated phosphoinositide 3-kinase start_entity and AKT1 MARK2 1 Akt\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"G2\",\n",
       "                    \"target\": \"MPZL2\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and Urticaria Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, TSLP, Periostin, IL13 and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous Urticaria Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of start_entity Vaccine on the Gene Expression NKstart_entityD and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, end_entity Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute Urticaria at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD69\",\n",
       "                    \"value\": \"In the present study, we found that without any stimulation, start_entity T cells in pleural fluid cells PFCs from patients with TBP expressed significantly higher levels of end_entity than PBMCs from patients with tuberculosis TB or healthy donors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CXCL9\",\n",
       "                    \"value\": \"Coinciding with the increase, selective chemokines including start_entity, CCL3, CCL5, end_entity, and CXCL10 were elevated in the anterior segment of the HSV-1-infected CXCR3 mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity mitogen-activated protein kinase MAPK and its downstream targets are activated in end_entity COVID-19 end_entity-CoV-infected Vero E6 cells and activation of start_entity MAPK enhances the cytopathic effects of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Increased start_entity and Ang end_entity are poor prognostic factors for severe COVID-19\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"Noonan Syndrome 5\",\n",
       "                    \"value\": \"Here we demonstrate the ability of JEV end_entity to interfere with the dsRNA-induced nuclear translocation of start_entity and NF-B by competitively inhibiting the interaction of start_entity and NF-B with nuclear transport proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"Distal Myopathies\",\n",
       "                    \"value\": \"In this study chimeric proteins containing the ectodomain of start_entity or CD8A fused to the C-terminal hydrophobic sequence of E1 were shown to be localized in the EREG, indicating that the end_entity of E1 is also a signal for EREG localization\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF5\",\n",
       "                    \"target\": \"IRF7\",\n",
       "                    \"value\": \"In contrast to IRF3, neither the IFNA1 master regulator end_entity nor any of the related transcription factors IRF2, start_entity, and IRF9 were bound by SFSV NSs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These variables signaled a deterioration in respiratory function and could be indicators of developing pneumothorax during mechanical start_entity in the end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Inflammation\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with start_entity Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of start_entity Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe start_entity Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of start_entity Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe start_entity Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic end_entity in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed start_entity, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"IFIH1\",\n",
       "                    \"value\": \"Infection of macrophages with N15m1, which expresses an unstable nsp15, or N15m3, which expresses a catalysis-deficient nsp15, activated end_entity, start_entity, and the OASRNase L system, resulting in an early, robust induction of type I IFNA1, start_entity-mediated apoptosis, and RNA degradation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM1\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Lastly, neutralizing antibody against end_entityAR12 and knockdown of STAT1STAT2 completely suppressed start_entity, PLSCR1, p-STAT1, and p-STAT2 expression in the resistant cells, thus confirming the involvement of the canonical end_entity signaling pathway in driving the overexpression of start_entity and other interferon-stimulated genes ISGs in the resistant cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KPNA3\",\n",
       "                    \"target\": \"KPNA4\",\n",
       "                    \"value\": \"Furthermore, overexpression of start_entity and end_entity restored the activity of IRF3 and NF-B and increased the production of IFN- in NS5-expressing or JEV-infected cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSTA\",\n",
       "                    \"target\": \"HLA-DRB1\",\n",
       "                    \"value\": \"The DE genes involved in the immune response included genes for inflammasomes RETN, S100A8, S100A9, S100A12, adhesion molecules CLDN3, VCAN, CD44, LGALS8, transcription factors ZBTB16, SLC39A14, CEBPD, CEBPB, acute-phase proteins and complement SAA1, LTF, Hereditary_pancreatitis, C3, differentiation genes for epithelial cells and keratinocytes TGM1, MS4A8, start_entity, and genes related to antigen processing and presentation HLA-B, end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL1\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Also, they can produce proinflammatory cytokines, such as TNF, GIF, IL6, IL-12p70, and end_entity; other chemokines, such as start_entity, CCL2, CCL5, CXCL1, CXCL8, CXCL10, and CX3CL1; and the growth factors granulocytemacrophage colony-stimulating factor CSF2 and granulocyte colony-stimulating factor CSF3 to induce and recruit inflammatory cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADI1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Human adenoviruses HAdVs are highly contagious pathogens causing acute respiratory disease start_entity, such as community-acquired end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"RELN significantly increased food intake and weight gain of CIA rats without any observable adverse effect; ameliorated joint erythema and swelling; inhibited immune cell infiltration, bone erosion and osteophyte formation in joints; reduced joint protein expression levels of TLR4, phospho-TAK1, phospho-NF-B RELA, phospho-c-Jun and phospho-IRF3; lowered levels of inflammatory factors TNF-, end_entity, IL-1, IL17A and start_entity in sera and TNF-, end_entity, IL-1 and IL17A in joints; elevated serum IL10 level; reinvigorated activities of antioxidant SOD, CAT and GSH-Px in the liver and serum; reduced Th17 cell proportions in splenocytes; inhibited splenocyte proliferation and activation; and lowered serum IgG level\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Emerging respiratory COVID-19es such as the Severe Acute Respiratory end_entity COVID-19 SARS-CoV and start_entity COVID-19 MERS-CoV pose potential biological threats to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DHX58\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"Innate immune reaction is initially activated by conserved pathogen-associated molecular patterns, pattern recognition receptors, retinoic acid-inducible gene I, IFIH1, start_entity, and toll-like receptors TLRs such as end_entity and TLR7\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA5\",\n",
       "                    \"target\": \"autoimmunity\",\n",
       "                    \"value\": \"METHODS: Replicate nonbiased discovery assays indicated that end_entity to glucose regulated protein 78 start_entity, an endoplasmic reticulum chaperone and cell surface signaling receptor, is present in many smokers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ABCC4\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric end_entity Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with Connective_Tissue_Diseases Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent end_entity in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with end_entity Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus Bronchiolitis Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in end_entity Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute Bronchiolitis Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 start_entity gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with end_entity Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of end_entity Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Etiology of EA end_entity are mainly infectious, viral rhinovirus, influenzae or parainfluenzae virus, start_entity, adenovirus and respiratory syncytial virus or bacterial Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p115\",\n",
       "                    \"target\": \"Diarrhea 5, With Tufting Enteropathy, Congenital\",\n",
       "                    \"value\": \"Upon treatment with brefeldin A, both the E and end_entity proteins redistributed to punctate structures that colocalized with the Golgi matrix proteins GOLGA2 and start_entity instead of being localized to the endoplasmic reticulum like Golgi glycosylation enzymes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF3\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"RESULTS: The results showed that IFN-, end_entity TNF-, granulocyte colony-stimulating factor start_entity, interferon- IFN-, macrophage inflammatory protein MIP-1, interleukin-6 IL6, IL10, interferon-inducible protein CXCL10, monocyte chemoattractant protein CCL2 were significantly higher in SFTS patients than in healthy persons p 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"The two end_entitys, GP23 and GP18090 are designated start_entity and E2, respectively; the inner core protein, VP50, is designated N\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Reporter assays demonstrated that the NiV and HeV N proteins NiV-N and HeV-N, respectively dose-dependently suppressed both type I and type start_entity end_entity responses and that the inhibitory effect was mediated by their core domains\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDK4\",\n",
       "                    \"target\": \"LMOD1\",\n",
       "                    \"value\": \"Nevertheless, overexpression of cyclin end_entity or a CDKN2A-resistant form of start_entity or knockdown of CDKN2A in the human TERT-immortalized NPE cell lines could counteract the EBV-induced growth arrest and senescence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The start_entity gene has 1,620 nucleotides and encoded a polypeptide of 540 amino acids with typical end_entity cleavage recognition sites of HRRR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL17\",\n",
       "                    \"target\": \"Dermatitis, Atopic\",\n",
       "                    \"value\": \"Kowalski A507 The Role of EIF2AK2 Pathway in Acute Exacerbation of Severe Asthma So Ri Kim, Yong Chul Lee, Dong Im Kim, Yang Keun Rhee, Heung Bum Lee, Seoung Ju Park, Yeong Hun Choe Choe, Seung Yong Park A508 Diversity of Clinical Manifestations and Treatment Responses for Hypereosinophilic_Syndrome Joo-Hee Kim, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A509 Effect of Dexamethasone in Th17 Cell Mediating Neutrophilic Asthma Nong Guang-Min, Jiang Min A510 Allergen Profile for AsthmaRhinitis and Eczema Among Patients in North India: An Immunocap Allergen Specific IgE Antibodies Assay Based Study Nalin Nag A511 Clinical Profile of Rhinitis,_Allergic in Children in Jakarta Wahyuni Indawati A512 Preclinical Study on the Use of Micro Crystalline Tyrosine MCT Adjuvants in Hypersensitivity Immunotherapy Alan David Bullimore, Matthew Heath, Murray Skinner A513 Genetic Diversity of Filaggrin Mutation and Its Clinical Implication in East Asian end_entity Patients Seong Jun Seo, Won Jong Oh A514 Protein and MPL Adsorption Capacities for MCT in Candidate Therapeutic Formulations for Use in Immunotherapy, Compared Against Existing Adjuvants Alan David Bullimore, Murray Skinner, Matthew Heath, Andrew Bell A515 Interleukin-22 Gene Variation in Inflammatory_Bowel_Diseases Alireza Zarebidoki, Hournaz Hasanzadeh, Salman Sadeghzade, Nima Rezaei A516 Immunomodulatory Effects of Adipose-Derived Stem Cell Secretome in a Mouse Model of Asthma Kyu-Sup Cho A517 Diffuse Alveolar Hemorrhage with Positive Anti-Neutrophil Cytoplasmic Antibody in a Child : A Case Report Sung-Woo Kim, Moo-Young Oh A518 Clinical Analys the Serum start_entity Levels As the Condition Index of end_entity in the Early Infancy Munemitsu Koizumi, Kazuyo Kuzume A519 An Analysis of the Filaggrin Gene Polymorphism in Korean end_entity Patients Kui Young Park, Won Jong Oh A520 A New Protocol for Wheat Oral Immunotherapy in Patients with Anaphylaxis Delara Babaie, Mohammad Nabavi, Fariborz Zandieh, Mehrdad Amir Moini, Zahra Chavoshzadeh, Hamideh Seifi, Mitra Sahragard, Mehrnaz Mesdaghi, Mohammad Hassan Bemanian A521 Clinical Characteristics of Filaggrin-Related end_entity Patients in Korea Sun Young Choi, Yeon a No A522 Early Hypersensitivity Diagnosis in Children - Self- Administered Questionnaire Vs Medical Verification Andrzej M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EGF\",\n",
       "                    \"target\": \"Atherosclerosis\",\n",
       "                    \"value\": \"The interactions between recombinant partial fibulin7 FBLN7; including two start_entity start_entity domains and end_entity were confirmed by Far-western blotting and colocalization\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATS\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"This study aimed to describe real-life microbiological testing of adults hospitalised with community-acquired COVID-19 CAP and to assess concordance with the 2007 end_entity Society of America IDSAAmerican Thoracic Society start_entity and 2011 European Respiratory Society ERS CAP guidelines\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL4\",\n",
       "                    \"value\": \"Main findings included differences in T helper Th type cytokine responses in various brain regions, particularly the cortex, with respect to end_entity, start_entity, and IL17A levels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD81\",\n",
       "                    \"target\": \"E1\",\n",
       "                    \"value\": \"The mutant library was probed, by a high-throughput flow cytometry-based assay, for binding with the co-receptor start_entity, and a panel of 13 human and mouse monoclonal antibodies mAbs that target continuous and discontinuous epitopes of end_entity, E2, and the end_entityE2 complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"IL-27\",\n",
       "                    \"value\": \"end_entity functions through end_entityR and has been shown to have potent anti-tumor activity via activation of a variety of immune components, including anti-tumor start_entity T cell responses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PFDN1\",\n",
       "                    \"target\": \"YARS\",\n",
       "                    \"value\": \"Using this method, three genes end_entity, EIF3D, and start_entity were selected as candidate RGs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C4B\",\n",
       "                    \"target\": \"IGKV5-2\",\n",
       "                    \"value\": \"end_entity is accomplished by transcription of the corresponding start_entity genes in germline configuration using a single VDJ on the same chromosome 12\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAP\",\n",
       "                    \"target\": \"RBP4\",\n",
       "                    \"value\": \"We identified the following differentially expressed host-specific proteins within sera from OSCC patients: leucine-rich 2-glycoprotein LRG1, alpha-1-B-glycoprotein ABG, CLU CLU, PRO2044, HP start_entity, complement C3c C3, proapolipoprotein A1 proapo-A1, and retinol-binding protein 4 precursor end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BCR\",\n",
       "                    \"target\": \"IL-21\",\n",
       "                    \"value\": \"By introducing these genes into peripheral blood memory B cells and culturing these cells with factors produced by follicular helper T cells, CD40LG and end_entity, we convert them to highly proliferating, cell surface start_entity positive, Ig-secreting B cells with features of GC B cells including expression of AICDA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AKAP7\",\n",
       "                    \"target\": \"ENPP1\",\n",
       "                    \"value\": \"Whereas synthesis is mediated by the 2-5 oligoadenylate synthetase family of enzymes, degradation seems to be orchestrated by multiple enzyme nucleases including PDE12, the end_entity and the start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"The IBV-specific antibody levels, as well as the percentages of start_entity and end_entity T lymphocytes, were detected within 28 days post-vaccination dpv\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C6orf47\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"On all TmPVs, start_entity sequences were located in the non-coding region near putative end_entity binding sites\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL13\",\n",
       "                    \"target\": \"CXCL9\",\n",
       "                    \"value\": \"Decreased CNS antiviral antibody was associated with lower expression of mRNAs for B-cell attracting chemokines end_entity, CXCL10 and start_entity and fewer B cells in the CNS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CLSTN2\",\n",
       "                    \"target\": \"MYOZ3\",\n",
       "                    \"value\": \"Replicons containing individual deletions of start_entity, repeated start_entity Rstart_entity, end_entity, or Rend_entity were viable, but their RNA replication was dramatically compromised\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NAC\",\n",
       "                    \"target\": \"PORCN\",\n",
       "                    \"value\": \"El papel de los virus respiratorios VR en el paciente infectado end_entity el virus de la inmunodeficiencia humana VIH que presenta una neumona adquirida en la comunidad start_entity es poco conocido\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Vulgaris\",\n",
       "                    \"target\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"value\": \"Moniaga, Kenji Kabashima, Eung Ho Choi A199 Trends in oral food challenges in Japan: A six-year prospective study Noriyuki Yanagida, Sakura Sato, Chizuko Sugizaki, Motohiro Ebisawa A200 The Gut Microbiome in the Food Allergic Host Jamie Kiehm, Punita Ponda, Sherry Farzan, Jared Weiss, Claudia Elera, Catherine Destio, Cristina Sison, Annette Lee A201 Cord blood cytokines and maternal environmental exposure during pregnancy Soo Hyun Ri, Chang Hoon Lim A202 Rupatadine pharmacokinetics in Japanese healthy volunteers after single and repeated oral doses of 10, 20 and 40 mg Iaki Izquierdo Pulido, Jorg Taubel, Georg Ferber, Eva Santamaria Masdeu A203 A safe and effective method to desensitize patients with wheat allergy Alireza Khayatzadeh, Masoud Movahedi, Motohiro Ebisawa, Mohammad Gharagozlou A204 RNA Binding Protein Hur Regulates CD4 T Cell Differentiation and Is Required for Allergic Airway Inflammation and Normal IL2 Homeostasis Ulus Atasoy, Patsharaporn Techasintana, Matt Gubin, Jacqueline Glascock, Suzanne Ridenhour, Joseph Magee A205 Time Trends in the Epidemiology of Recurrence Respiratory_Sounds in Infants from South America Nelson Rosario Filho; Herberto Jose Chong Neto, Gustavo Falbo Wandalsen, Ana Caroline Dela Bianca, Carolina Aranda, Dirceu Sole, Javier Mallol, Luis Garcia-Marcos, Luis Garcia-Marcos A206 Successful Cyclophosphamide Desensitization in a Pediatric Patient with Systemic start_entity Erythematosus Jennifer Toh, Yoomie Lee, Joyce Huang, Elina Jerschow, Jenny Shliozberg A207 The Fatty Acid Binding Protein Der p 13 Is a Minor House Dust Mite Allergen Able to Activate Innate Immunity Pattraporn Satitsuksanoa, Narissara Suratannon, Jongkonnee Wongpiyabovorn, Pantipa Chatchatee, Kiat Ruxrungtham, Alain Jacquet A208 Epidemiology of end_entity and Toxic Epidemal Necrolysis: An Administrative Database Study Min Suk Yang; Jin Yong Lee, Ja Yeun Kim, Han-Ki Park, Ju-Young Kim, Woo-Jung Song, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Sang-Heon Cho, Kyung-up Min, Chang-Han Park, Suk-Il Chang, Sook-Hee Song A209 Regional Differences of Vitamin D and Food-Induced Anaphylaxis in Korea Si-Heon Kim, Gil-Soon Choi, Su-Chin Kim, Ji Hye Kim, Ga Young Ban, Yoo Seob Shin, Hae-Sim Park, Young Min Ye A210 Triggering Factors of Dermatitis,_Atopic By Severity Yoon Ha Hwang A211 Clinical Features of Drug-Related_Side_Effects_and_Adverse_Reactions of Monoclonal Antibodies in Korea Da Woon Sim, Kyung Hee Park, Kyung Hee Park, Hye Jung Park, Hye Jung Park, Jung-Won Park, Jung-Won Park, Jae-Hyun Lee, Jae-Hyun Lee A212 Food_Hypersensitivity with Eczema Is Associated with Reduced Growth in the First Four Years of Life Katrina Allen, Cara Beck, Jennifer Koplin, Melanie Matheson, Mimi Tang, Anne-Louise Ponsonby, Lyle Gurrin, Shyamali Dharmage, Melissa Wake, Vicki Mcwilliam A213 The Preliminary Study on Clinical Efficacy and Impact Factors of One Year's Dust Mite Specific Immunotherapy in Allergic Asthma and Rhinitis Children Sensitized to Dust Mite Xiaoying Liu, Jing Wang, Li Xiang, Qun Wang A214 Lipopolysaccharide Signaling through Toll- like Receptor 4 Could be Augmented By Dermatophagoides Farinae in the Human Middle Ear Epithelial Cell Ji-Eun Lee, Dong-Young Kim, Chae-Seo Rhee, Chae-Seo Rhee A215 Drug_Hypersensitivity in Pregnant Adolescents: Relation with Familial and Personal Atopy, and Substances Use Francisco Vazquez-Nava A216 Patients and Physicians Concept of Well-Controlled Asthma: Findings from Realise Asia Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, David Price, Glenn Neira, Jiangtao Lin A217 The Role of Vasoactive Intestinal Peptide in the Pathophysiology of Acute Asthma Olga Semernik A218 Comparison of Serum Cytokine Levels According to the Severity in Dermatitis,_Atopic Ha-Su Kim, Jin-a Jung, Ji-in Jung A219 The Different Influence on the Regulatory T Cell Response Between Subcutanous ImmnuotherapySCIT and Sublingual ImmunotherapySLIT in Children with Asthma Qing Miao, Li Xiang A220 Asthma State of Affairs in Asia: Seeing through Physicians' and Patients' Lenses Sang-Heon Cho, Jaewon Jeong, Diahn-Warng Perng, Jiangtao Lin, David Price A221 Identification of Aspirin Exacerbated Respiratory Disease AERD Phenotypes Using Two Step Cluster Analysis Hyun Young Lee, Hae-Sim Park, Young Min Ye, Su Chin Kim A222 Dusty Air Pollution Are Associated with an Increase Risk of Allergic Diseases in General Population Shokrollah Farrokhi, Mohammadkazem Gheiby A223 A Genome-Wide Association Study of Antituberculosis Drugs-Induced Hepatitis Sang-Heon Kim; Heung Woo Park, Sang-Hoon Kim, Young-Koo Jee A224 The Role of peroxiredoxin6 of Bronchial Epithelial Cells in Regulating Mitochondrial Function Under Oxidative Stress By Translocation,_Genetic to Outside Mitochondrial Membrane Sunjoo Park, Keun Ai Moon, Hyouk-Soo Kwon, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Kyoung Young Lee, Gyong Hwa Hong, Eun Hee Ha A225 Toxic and Adjuvant Effects of 3 Types of Silica Nanoparticles on Airway System Heejae Han, Hye Jung Park, Yoon Hee Park, Yoon-Jo Kim, Kangtaek Lee, Jung-Won Park, Jae-Hyun Lee A226 Procedure for Diagnostic and Selection of Immunotherapy Method for Children with Different Immunopathogenetic Phenotypes of Dermatitis,_Atopic Tatiana Slavyanskaya, Vladislava Derkach A227 Prediction of the Success of Our Desensitization Protocol with Symptoms and Results of a Skin Prick Test in Patients with Hypersensitivity to Platinum-Based Chemotherapy Hye Jung Park, Chein-Soo Hong, Jae-Hyun Lee, Jae-Hyun Lee, Sungryeol KIM, Sungryeol KIM, Kyung Hee Park, Kyung Hee Park, Choong-Kun Lee, Beodeul Kang, Seung-Hoon Beom, Sang Joon Shin, Minku Jung, Jung-Won Park, Jung-Won Park A228 Anti-Allergic Effect of Intralymphatic Injection of OVA-Flagelin Mixture in Mouse Model of Rhinitis,_Allergic Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo, Young-Jun Chung A229 Serum Periostin Level Is Higher in Respiratory Type of NSAID Hypersensitivity Than Cutaneous Type Mi-Ae Kim, Hae-Sim Park, Moon Gyeong Yoon, Young-Soo Lee, Ji Hye Kim, Ga Young Ban, Hye-Soo Yoo, Yoo Seob Shin, Young Min Ye, Dong-Ho Nahm A230 A Retrospective Analysis of Hypersensitivity Blood Testing in Beijing Children's Hospital in the Year of 2013: A Single-Center Research Qing Miao, Li Xiang A231 Role of Nrf2 in the Allergic Airway Inflammation Differ Between BALBc and C57BL6 Mice Ying-Ji Li, Takako Shimizu, Hirofumi Inagaki, Yukiyo Hirata, Hajime Takizawa, Arata Azuma, Masayuki Yamamoto, Tomoyuki Kawada A232 Effect of Human Mesenchymal Stem Cell on Neutrophilic Asthma Model Min-Gu Kim, Gyong Hwa Hong, Kyoung Young Lee, Eun Hee Ha, Keun Ai Moon, Sunjoo Park, Hyouk-Soo Kwon, Tae-Bum Kim, Hee-Bom Moon, You Sook Cho, Jung-Hyun Kim, Hyo-Jung Kim, So-Young Park, Bomi Seo A233 Immunomodulatory Effect of Tonsil Derived Mesenchymal Stem Cells in a Mouse Model of Rhinitis,_Allergic Ji-Hye Kim, Ramachandran Samivel, Eun-Hee Kim, Young-Jun Chung, Ji-Hun Mo A234 Alternative Therapy Such As Yoga May be a Low Cost Tool for Improving the Quality of Life of Patient's with Rhinitis,_Allergic and Asthma Soumya M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"IFIH1\",\n",
       "                    \"value\": \"start_entity and end_entity receptors are key sensors of pathogen-associated molecular pattern PAMP-containing viral RNA and transduce downstream signals to activate an antiviral and immunomodulatory response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTTN\",\n",
       "                    \"target\": \"DOK1\",\n",
       "                    \"value\": \"Hakai acts through its phosphotyrosine-binding HYB domain, which bears a dimeric fold that recognizes the phosphotyrosine motifs of E-cadherin, start_entity, end_entity, and other Src substrates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KCNQ1\",\n",
       "                    \"target\": \"TMIE\",\n",
       "                    \"value\": \"We therefore designed Affymetrix resequencing microarrays capable of resequencing 13 genes mutated in SNHL GJB2, GJB6, CDH23, KCNE1, start_entity, MYO7A, OTOF, PDS, MYO6, SLC26A5, end_entity, TMPRSS3, Usher_syndrome,_type_1C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome end_entity papain-like protease start_entity is a DUB that cleaves ISG15, a two-domain Ub-like protein, and Lys48-linked polyUb chains, releasing diUbLys48 products\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Finally, we discuss STING antagonism in the start_entityes end_entity start_entity and human start_entity NL63, which disrupt K63-linked polyubiquitination and dimerisation of STING both of which are required for STING-mediated activation of IRF-3 via their papain-like proteases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD274\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"METHODS: Wild-type WT and start_entity mice were infected with a gliatropic COVID-19 and end_entity T cells depleted to specifically block T helper function in the CNS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MBP\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"To investigate antigenic cross-reactivity at the molecular level, 155 long-term T-cell clones NOG-Related-Symphalangism_Spectrum_Disorder were derived from 32 end_entity patients by in vitro selection with start_entity, proteolipid protein PLP or HCoV strains 229E and OC43\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"STAT3\",\n",
       "                    \"value\": \"In contrast to EIF2AK3, knockdown of XBP1, which is activated by IRE1-mediated splicing, robustly enhanced TG-induced start_entity and CCL2 expression and phosphorylation of NF-B RelA and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"start_entity metabolizes ANG end_entity to ANG-17, which may have antagonistic effects to ANG end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Interpretation The GLS-5300 end_entity start_entity vaccine was well tolerated with no vaccine-associated serious adverse events\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL26\",\n",
       "                    \"target\": \"IL13\",\n",
       "                    \"value\": \"Cluster 2 had 10 asthmatic patients and 17 patients with Pulmonary_Disease,_Chronic_Obstructive with increased blood and sputum eosinophil counts, type 2 mediators IL5, end_entity, CCL13, CCL17, and start_entity, and proportions of the bacterial phylum Bacteroidetes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The purpose of this study was to evaluate the changes in the serum concentrations of HP Hp, serum amyloid A SAA1 and IgG, IgA in calves with diarrhea caused by rotavirus, end_entity, Escherichia coli start_entity and Eimeria species\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EDN2\",\n",
       "                    \"target\": \"IL16\",\n",
       "                    \"value\": \"Functional analysis of the microarray data revealed a significant upregulation of genes involved in important biological processes such as inflammation TNF-, CXCL8, Tlr-2, IL-1, CXCL2, CSF2, vascular functions VEGFA, start_entity and leukocyte migration ICAM1, end_entity during a co-infection with BHV-1 and M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC2A5\",\n",
       "                    \"target\": \"SLC5A1\",\n",
       "                    \"value\": \"This study was conducted to evaluate the effects of Yupingfeng polysaccharides YP supplementation on growth performance and expression of end_entity, SLC2A2 and start_entity in Qingyuan partridge chicken\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Toxicity\",\n",
       "                    \"target\": \"Lymphopenia\",\n",
       "                    \"value\": \"Nataly Tataurshchikova A590 A Novel Biomarker for Respiratory_Sounds and Atopy in Early Infancy Eishika Dissanayake, Yuzaburo Inoue, Naoki Shimojo, Taiji Nakano A591 Prognostic Factors for Dermatitis,_Atopic in Spontaneously Born Babies from Low Socioeconomic Background Conny Tanjung A592 Higher IgE Antibody Levels Mediate Anti-Cancer Immunity in Transgenic KN1 Hyper-IgE Mice Erika Jensen-Jarolim, Judit Fazekas, Josef Singer, Anna Lukschal, Reinhard Horvat, Gertrude Achatz-Straussberger, Gernot Achatz A593 Fructooligosaccharides Intake during Pregnancy and Lactation Increases Gut Bifidobacterium and IL-27 in Breast Milk Yuji Fujita, Shuji Ikegami, Yoshitaka Nakamura, Yuzaburo Inoue, Naoki Shimojo, Yoichi Kohno, Shuichi Suzuki, Naoko Ozawa, Takayuki Kubota, Ken Nonaka, Osamu Ohara, Kentaro Masuda A594 Effect of Nintedanib on Asthma in Mouse Model Chin Kook Rhee, Sook Young Lee, Hwa Young Lee, Hea Yon Lee, Ji Young Kang, Sei Won Kim, Soon Seog Kwon, Young Kyoon Kim A595 Delayed Contrast Media Hypersensitivity after Coronary Angiography Gun-Woo Kim, Ju-Young Kim, Sang-Heon Cho, Hye-Ryun Kang, Hyo-Soo Kim, Jung Gyu Han, Jin Lee, Ji Young Lee, Ji Young Go, So Jung Park A596 Gene Expression Profiling in Patients with Chronic Idiopathic Urticaria Reveals Unique Gene Signature Distinct from Healthy Controls Julie Kim-Chang, Cassandra Love, Patricia Lugar A597 Failure to Recognize end_entity in Newborn Leads to Undetectable Primary Immunologic_Deficiency_Syndromes Endah Citraresmi A598 The Concordance Between Lung Function Test and Indonesian Version of Childhood Asthma Control Test SLC25A20 Nastiti Kaswandani, Cynthia Utami, Mardjanis Said A599 Synergistic Interaction Between Bronchiolitis and PM10 Is Modified By IL13 Polymorphism on Asthma Development: Replication from Cheer Study Young-Ho Jung, Song-I Yang, Byoung-Ju Kim, Ji-Won Kwon, Hwan-Cheol Kim, Jong-Han Leem, Ju-Hee Seo, Hyung Young Kim, So-Yeon Lee, Ho-Jang Kwon, Hyo-Bin Kim, Hyun-Ju Cho A600 The Transcription Factor Ehf Is Involved in TGF-b-Induced Suppression of Fceri and c-Kit Expression and Fceri-Mediated Activation in C9orf9 Cells Susumu Yamazaki, Nobuhiro Nakano, Asuka Honjoh, Eisuke Inage, Yosuke Baba, Yoshikazu Ohtsuka, Toshiaki Shimizu A601 The Follow up of the Potential Immunosuppressant Effects of Marijuana MJA Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A602 Risk Factors of Allergen Sensitization at 3 Years: Results from the Gusto Study Evelyn Xiu Ling Loo, Anne Goh, Oon Hoe Teoh, Yiong Huak Chan, Seang Mei Saw, Kenneth Kwek, Peter D Gluckman, Keith M Godfrey, Hugo Van Bever, Yap Seng Chong, Bee Wah Lee, Lynette Shek, Alison Joanne Lee A603 IL6 Blockade As a Steroid-Sparing Treatment for Rhupus Patients Daniela Rossi A604 Examination of Late Pulmonary start_entity in Children Treated for Malignancies Agnes Nemeth A605 Technical Validation of the Repurposing of a Personal Particle Sampler to Determine House Dust Mite Exposure in the Ambient Air Torsten Sehlinger, Karl-Christian Bergmann, Frank Goergen A606 Zinc Deficiency in Children with Severe Dermatitis,_Atopic: More Common Than Generally Thought Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"Non-alcoholic Fatty Liver Disease\",\n",
       "                    \"value\": \"CONCLUSIONS: Our results give evidence that elevated expression of start_entity in the liver promotes end_entity and INS resistance\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADAM17\",\n",
       "                    \"target\": \"INS\",\n",
       "                    \"value\": \"The aim of the present study was to determine the effect of end_entity on ACE2 shedding and start_entity in type 1 diabetic Akita mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD44\",\n",
       "                    \"target\": \"S100A9\",\n",
       "                    \"value\": \"The DE genes involved in the immune response included genes for inflammasomes RETN, S100A8, end_entity, S100A12, adhesion molecules CLDN3, VCAN, start_entity, LGALS8, transcription factors ZBTB16, SLC39A14, CEBPD, CEBPB, acute-phase proteins and complement SAA1, LTF, Hereditary_pancreatitis, C3, differentiation genes for epithelial cells and keratinocytes TGM1, MS4A8, CSTA, and genes related to antigen processing and presentation HLA-B, HLA-DRB1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EDEM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Together with the observation that EAV-induced DMVs are also positive for EREG degradation-enhancing -mannosidase-like 1 start_entity, our data suggested that this virus, similarly to the distantly-related mouse hepatitis end_entity, hijacks the EREG-derived membranes of EDEMosomes to ensure its efficient replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MUC5AC\",\n",
       "                    \"target\": \"MUC5B\",\n",
       "                    \"value\": \"Quantitative trait locus QTL mapping identified distinct, trans protein QTL for start_entity chromosome 13 and end_entity chromosome 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Multiple Sclerosis\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"end_entitys have long been implicated as triggers of autoimmune diseases, including multiple sclerosis start_entity, a central nervous system CNS inflammatory demyelinating disorder\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Corticosteroid reduced CXCL8, start_entity and end_entity concentrations from 58 days after treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MEFV\",\n",
       "                    \"target\": \"NLRP3\",\n",
       "                    \"value\": \"Considering that inflammasome activation and IL-1 induction by macrophages are key players for an appropriate T cell response, we investigated the relevance of NLR start_entity domain-containing 3 end_entity and caspase-111 to elucidate their roles in the induction of different T cell phenotypes and the relationship with parasite load and hepatic inflammation during T\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCND1\",\n",
       "                    \"target\": \"CDK4\",\n",
       "                    \"value\": \"Nevertheless, overexpression of start_entity or a CDKN2A-resistant form of end_entity or knockdown of CDKN2A in the human TERT-immortalized NPE cell lines could counteract the EBV-induced growth arrest and senescence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ZBTB1\",\n",
       "                    \"target\": \"ZBTB17\",\n",
       "                    \"value\": \"A number of DEGs, including start_entity7 end_entity, heat shock protein 90 kDa , member 1 HSP90B1 and major histocompatibility complex, class GCNT2, Diabetic_Retinopathy were identified\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ESR1\",\n",
       "                    \"target\": \"PLAUR\",\n",
       "                    \"value\": \"There is also evidence that several asthma candidate genes may contribute to decline in lung function, including ADAM33, end_entity, VEGFA, IL13, CHI3L1, TSLP, GSDMB, TGFB1, POSTN, start_entity and ARG2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C7orf49\",\n",
       "                    \"target\": \"SPARC\",\n",
       "                    \"value\": \"Dynamic start_entity showed a significant decrease in the perfusion index 'maximum enhancement' in the end_entity rabbits P 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COX8A\",\n",
       "                    \"target\": \"MYO10\",\n",
       "                    \"value\": \"Microfilament depolymerizing drugs and silencing expression of end_entityI-2 gene, but not myosin start_entity genes, also inhibited TuMV intercellular movement\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"In vitro infection of naive splenocytes induced B-cell- dependent secretion of end_entity and start_entity, whereas IFN-gamma and IL2 were produced only by cells that had been primed in vivo\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"NEDD4\",\n",
       "                    \"value\": \"This start_entity ubiquitination is dependent upon the presence of a PPxY motif within start_entity and the WW domain-containing region of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cystic Fibrosis\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Among inherited diseases, cystic fibrosis start_entity is the major disorder associated with bronchiectasis, while acquired conditions frequently featuring bronchiectasis include post-infective bronchiectasis and chronic obstructive pulmonary disease end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRH1\",\n",
       "                    \"target\": \"Cystic Fibrosis\",\n",
       "                    \"value\": \"Our results suggest that CHAC1 is involved in the regulation of inflammation in bronchial cells during start_entity infection and may explain the excessive inflammation present in the respiratory tracts of patients with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"DUSP1\",\n",
       "                    \"value\": \"Meanwhile, IBV has developed a strategy to counteract the induction of IL6 and start_entity by inducing the expression of dual-specificity phosphatase 1 end_entity, a negative regulator of the p38 MAPK, in order to limit the production of an excessive amount of IL6 and start_entity in the infected cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BAAT\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Won Suck Yoon A399 Case Report of Near-Fatal Asthma Due to Snail Hypersensitivity in a House Dust Mite-Allergic Adult Jean-Pierre L'huillier, Jean-Eric Autegarden, Catherine Bertrand, Dominique Tardy A400 Relationship Between Gut Microbiota in the First 3 Months of Life and Infant Immune Function at Age 12 Months Intan Hakimah Ismail, Mimi Tang, Paul Licciardi, Frances Oppedisano, Robert Boyle, Roy Robins-Browne A401 A Pediatric Case of Food-Dependent Exercise-Induced Anaphylaxis Due to Spice Hypersensitivity Hisako Yagi, Harumi Koyama, Yutaka Nishida, Takumi Takizawa, Hirokazu Arakawa A402 Correlations Between Objective Severity Score and Each of the Subjective Severity Intensity in Dermatitis,_Atopic Hong Kyu Kang, Hemin Lee, Jungsoo Lee, Jung U Shin, Kwang Hoon Lee, Kwang Hoon Lee, Howard Chu, Chang Ook Park A403 Barrier Related Gene Mutations in Dermatitis,_Atopic Na Young Yoon, Hyeyoung Lee, Seong Jun Seo, Eunhee Choi, Hye-Young Wang, Minyoung Jung, Eung Ho Choi, Dong Hye Kim A404 Clinical Utility of Basophil Activation Test start_entity in the Diagnosis of Drug Induced Anaphylaxis Joo-Hee KimYoung-Sook Jang, Jeong-Hee Choi, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A405 Feeding Shapes the Colonization of Gut Microbiota and Associated with Total IgE in Infant Mi-Jin KangDongin Suh, Eun Lee, Kil Yong Choi, Young-Ho Jung, Song-I Yang, Bong-Soo Kim, Ha-Jung Kim, Juneyoung Koh, Hyun-Jin Kim, Kangmo Ahn, Youn Ho Shin, Hyun-Ju Cho, Byoung-Ju Kim, Young-Ho Kim, Yean Jung A406 CD8T Cell-Intrinsic Smad4 Suppresses Th2 Responses in the Pathogenesis of Dermatitis,_Contact Mizuko Mamura, Jeong-Hwan Yoon, Susumu Nakae, Inkyu Lee, Isao Matsumoto, Takayuki Sumida, Jin Soo Han, Katsuko Sudo, Ji Hyeon Ju A407 Immune-Modulatory Genomic Properties Differentiate Gut Microbiotas of Infants with and without Eczema Gaik Chin Yap, Wen Tso Liu, Seungdae Oh, Pei Ying Hong, Chiung Hui Huang, Marion Aw, Lynette Shek, Bee Wah Lee A408 The Effect of Medication in OSA Patients with end_entity Young Seok Byun, Sung Wan Kim, Tae Kyung Koh, Joong-Saeng Jo, Kun Hee Lee, Chul Kwon, Sung-Hwa Dong A409 A Case of Generalized Pustular Psoriasis Mimicking Acute_Generalized_Exanthematous_Pustulosis Myung Shin Kim, Chansun Park A410 Anaphylaxis Caused By Gummy Jelly Ingestion: A Case Report Han Seok Cho, Min-Ju Kim, Min Ji Kim, Young Ok Park, Hye Yeong Lee, Hee Seong Kim, Eun Lee, Hyun-Ju Cho, Jinho Yu, Soo-Jong Hong, Keum Hee Hwang A411 Serum Folliculin As a Novel Biomarker for Asthma Jung-Hyun Kim, You Sook Cho, Sae-Hoon Kim, Hyouk-Soo Kwon, Mira Yoo, Hyo-Jung Kim, So-Young Park, Bomi Shin, So Young Park, Bomi Seo, Min-Gu Kim, Hee-Bom Moon, Jin-Ah Park, Tae-Bum Kim, Jaemoon Lee A412 Corticosteroid Nasal Irrigations after Endoscopic Fistula Surgery in the Management of Chronic Rhinosinusitis with Asthma Jin Hyeok Jeong, Tae Wook Kang, Han Seok Yoo, Yong Hee Cho, Seok Hyun Cho, Kyung Rae Kim A413 Capsaicin Injection in Neonatal Period Potentiates Intensity and Duration of Dermatitis,_Atopic of Rats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCND3\",\n",
       "                    \"target\": \"IGHD2-15\",\n",
       "                    \"value\": \"After analyzing the cellular proteins involving in regulation of cell cycle progression, we demonstrated that ORF7a expression was correlated with a significant reduction of start_entity level of mRNA transcription and expression, and phosphorylation of retinoblastoma Rb protein at ser795 and ser809811, not with the expression of CCNLMOD1, end_entity, cdk4 and cdk6 in EPHA3 293 cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR5\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"In particular, CXCR3 was found to be elevated on an increasing number of cells over the time course of infection, and it was the primary chemokine receptor expressed at 60 days post infection Quite different expression kinetics were observed for CXCR5, start_entity, and CCR7, which were elevated on the highest number of cells early during infection and decreased by 14, 30, and 60 days post infection Correspondingly, elevated levels of CXCL9, end_entity, and CXCL13, as well as CCL5, were found within the brains of infected animals, and only low levels of CCL3 and CCL19 were detected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"Necrosis\",\n",
       "                    \"value\": \"Viremia, provirus and blood mRNA expression of interleukin IL-1, IL4, IL6, start_entity, IL-12p40, Interferon- and Neoplasms end_entity Factor- were monitored by Real-Time qPCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neoplasms\",\n",
       "                    \"target\": \"Viremia\",\n",
       "                    \"value\": \"end_entity, provirus and blood mRNA expression of interleukin IL-1, IL4, IL6, IL10, IL-12p40, Interferon- and start_entity Necrosis Factor- were monitored by Real-Time qPCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Sequencing analysis of the S end_entity portion, start_entity, ORF4 and ORF5 genes of BCoV isolates associated with different clinical syndromes indicated that neither insertions or deletions could explain their distinct tropism\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSME3\",\n",
       "                    \"target\": \"Neutropenia\",\n",
       "                    \"value\": \"Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Akira Akasawa, Michihiro Hide, Hiroko Shizukawa A442 Evaluation of the Adherence Starts with Knowledge-20 ASK-20 to Inhaled Drug in Patients with Asthma Naoto Watanabe A443 The Epidemiology and Clinical Manifestation of Hmpv Infection in Children during Recent 4 Years: 2011-2014 Meeyong Shin, Myeong Sun Jang A444 end_entity Induced By Intravenous_Immunoglobulin Young-Hee Nam, Yeo Myeong Noh, Dong Sub Jeon, Hee-Joo Nam, NAA50g Hee start_entitym start_entitym, Ye Suel Park, Soo-Keol Lee A445 A First Case of Lymphocytic Lung_Diseases,_Interstitial in Healthy Child Ji-in Jung, Ha-Su start_entitym, Hyun-a start_entitym, Jin-a Jung A446 Cytokine Production upon House Dust Mite Stimulation of Cord Blood Mononuclear Cells from Caesarean Section-Delivered Singaporean Infants Anne Goh, Rajeshwar Rao, Bindu Nandanan, Ruurd Van Elburg, Chua Mei Chien, Juandy Jo, Johan Garssen, Johan Garssen, Leon Knippels, Elena NAA50dalova, Wen Chin Chiang A447 Dress Syndrome with Acute Nephritis,_Interstitial Caused By Quinolone and Nonsteroidal Anti-Inflammatory Drugs Young-Hee Nam, Ji Young Juong, Soo Jin start_entitym, Eun Young start_entitym, Su Mi Lee, Young start_entity Son, Hee-Joo Nam, start_entity-Ho start_entitym, Soo-Keol Lee A448 IL23A Roles in the Development of House Dust Mite Allergic Sensitization and Asthma Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Hyun Seung Lee, Yoon-Seok Chang, Jung-Won Park, NAA50g-Heon Cho, Kyung-up Min, Woo-Jung Song A449 Exposure Profile of Indoor Risk Factors in Dwellings of Children with Dermatitis,_Atopic Hyunwook Lim, Sungchul Seo, Ji Tae Choung, Young Yoo, Jun-Sik Park, Byung Kwan start_entitym A450 Epidemiological Characterization of Blood Eosinophils in the Elderly Population Ha Kyeong Won, Hye-Ryun Kang, Byung-Keun start_entitym, Sung Do Moon, Ju-Young start_entitym, So-Hee Lee, Woo-Jung Song, Heung Woo Park, Min-Koo Kang, Sun-Sin start_entitym, NAA50g-Heon Cho, Kyung-up Min, Yoon-Seok Chang, Kyoung Hee Sohn, Kyung-Mook start_entitym, start_entity-Woong start_entitym, Hak Chul Jang A451 Stevens-Johnson_Syndrome Caused By Methotrexate in the Treatment of Psoriasis Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee start_entitym start_entitym, Ye Suel Park, Soo-Keol Lee A452 Genetic Determinants for Lung Function Growth in Asthma Children Ting Fan Leung, Man Fung Tang, Hing Yee Sy, Wa Cheong Chan, Wilson Wai NAA50 Tam A453 The Power of Allergen Specific Ig E in the Classification of Rhinitis, Korean National Hanes 2010 Seung Kyu Chung, Sujin start_entitym, NAA50g Duk Hong, Hyo Yeol start_entitym Hyo Yeol start_entitym, Hun-Jong Dhong, Jong in Jeong A454 Analysis of Allergen Immunotherapy Practice and Patients Knowledge and Attitude about Allergen Immunotherapy in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Soo-Keol Lee A455 Roles of Staphylococcal Enterotoxin B in House Dust Mite-Induced Acute Asthma Models Ji Won Lee, Mingyu Kang, Soon-Hee start_entitym A456 A Clinical Comparison of Drug_Hypersensitivity_Syndrome in a Single Tertiary Hospital in Korea Young-Hee Nam, Dong Sub Jeon, Hee-Joo Nam, Yeo Myeong Noh, NAA50g Hee start_entitym start_entitym, Ye Suel Park, Soo-Keol Lee A457 The Beneficial Effect of Lactobacillus Gasseri PM-A0005 and Its Immunoregulatory Protein PMA5P40 on Milk-Induced Allergic Enteritis Yung-I Hou, Jiu-Yao Wang A458 Relationship Between Serum Folate Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong start_entitym, Seol Jae Hee, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho start_entitym, Namsoo Chang A459 Effects of Vitamin D in Patients with Chronic Rhinosinusitis Yuta Soma, So Watanabe, Ruby Pawankar, Ruby Pawankar, Harumi Suzaki, Harumi Suzaki, Hitome Kobayashi A460 Clinical Features of Systemic Dermatitis,_Contact from Ingestion of Rhus Young-Hee Nam, Chansun Park, Soo-Keol Lee A461 Sublingual Immunotherapy Efficacy in Patients with Dermatitis,_Atopic in Korea Jongrok Lee, Jooyoung Roh, Haryeong Ryu A462 Characteristics of Serious Drug-Related_Side_Effects_and_Adverse_Reactions in a Tertiary University Hospital Cheol-Woo start_entitym, Jae Hwa Cho, Mi Ra Eom, Ji Young Kang, Hye Gyeung Lee A463 Eyelid Dermatitis: Patch Test Results during a 15-Year Period in Korea and Evaluation of Metal Contents in Eye Shadows Hae Young Choi, Hye Jin Lee, Ju Yun Woo, Ji Yeon Byun, You Won Choi A464 Relationship Between Lipid Levels and Risks of Allergic and Respiratory Diseases in Early Childhood: The Mothers and Children's Environmental Health Study Ja Hyeong start_entitym, Eun-Hee Ha, Hyesook Park, Mina Ha, Yun-Chul Hong, Yangho start_entitym, Namsoo Chang A465 IL-32 in the Induced Sputum of Patients with Asthma Jae-Woo Kwon, Hun Soo Chang, Jeong-Seok Heo, Jong-Uk Lee, Jong-Sook Park, Eusom start_entitym, Soo Hyun start_entitym, Choon-Sik Park A466 Clinical Characteristics of Patients with Chromium Hypersensitivity in a Single University Hospital in Korea Hae Young Choi, Ji Yeon Byun, Ju Yun Woo, You Won Choi A467 Efficacy and Safety of Oral Acitretin in Chronic Hand Eczema Hyun-Ju Jin, Jin-Hwa Son, Jeong-Min start_entitym, Gun-Wook start_entitym, Je-Ho Mun, Margaret Song, Hyun-Chang Ko, Moon-Bum start_entitym, Hoon-Soo start_entitym, Byung Soo start_entitym A468 Atypical Antipsychotics and Anticholinergic Agents Mimicking Anaphylaxis Sheryl Van Nunen, Dinh Van Nguyen, Anthony Elias, Susannah Olivia Lauer A469 Introducing Reach Reliable Estimation of Dermatitis,_Atopic in ChildHood: Novel, Questionnaire-Based Diagnostic Criteria for Childhood Dermatitis,_Atopic Seung-Chul Lee, Ho-June Lee, Jung Min Bae A470 Comprehensive Assessment to Identify the Causative Factors in Oral Hypersensitivity Syndrome Emi Ono A471 Comparison of Interpretation Methods in Allergic Skin Test Sung-Hwa Dong, Tae Kyung Koh, Young Seok Byun, Sung Wan start_entitym, Joong-Saeng Jo, Chul Kwon, Kun Hee Lee A472 Refraining Aminophylline Use Increases Hospitalization Among Children with Acute Asthma: A 10-Years Retrospective Cohort Study Li-Fan Liu A473 The Prevalence and Risk Factors of Dermatitis,_Atopic from Nationwide Study for Korean School Students Sunghee Lee A474 Probiotic Recombination Protein Effect on Dermatitis,_Atopic Wei-Leng Chen, Jiu-Yao Wang A475 Allergic Sensitization Status in Various Inflammatory Skin_Diseases Youin Bae, Gyeong-Hun Park A476 Two Cases of Good's Syndrome: A Rare Acquired Immunologic_Deficiency_Syndromes Associated with Thymoma Suk Yeon start_entitym A477 IL23A Has a Role to Play in the Development of Asthma in Short-Term Cigarette Smoke Exposure-Induced House-Dust Mite Allergic Model Hyun Seung Lee, Woo-Jung Song, Mingyu Kang, Han-start_entity Park, Da-Eun Park, Hye-Ryun Kang, Heung Woo Park, Yoon-Seok Chang, Hye-Young start_entitym, Kyung-up Min, NAA50g-Heon Cho, Ji-Won Lee, Boram Bae, Jung-Won Park A478 The Relationship Between the Relevance of Allergic Disease and the Value of Non-Specific IgE Yasuhiro Suzuki A479 Two Caces of Prawn Hypersensitivity in Adult Patients Ismet Bulut, Zeynep Ferhan Ozseker A480 Early Gut Bifidobacterium Breve and B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VTRNA1-1\",\n",
       "                    \"target\": \"viral RNA transcription\",\n",
       "                    \"value\": \"A unique feature of ZBTB25 in the regulation of viral replication is its dual transcription functions, namely, promoting end_entity through binding to the U-rich region of start_entity and suppressing cellular interferon production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FH\",\n",
       "                    \"target\": \"alanine aminotransferase\",\n",
       "                    \"value\": \"METHODS: Msr1-deficient Msr1 mice and their wild-type WT littermates were infected with mouse hepatitis virus strain-A59 MHV-A59 to induce start_entity, and the levels of tissue damage, serum end_entity, inflammatory cytokines and C5 C5 were measured and compared\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDH23\",\n",
       "                    \"target\": \"OTOF\",\n",
       "                    \"value\": \"We therefore designed Affymetrix resequencing microarrays capable of resequencing 13 genes mutated in SNHL GJB2, GJB6, start_entity, KCNE1, KCNQ1, MYO7A, end_entity, PDS, MYO6, SLC26A5, TMIE, TMPRSS3, Usher_syndrome,_type_1C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"SLPI\",\n",
       "                    \"value\": \"Other genes unassociated to date with ARDSSARS include C1Qb, C5AR1, CASP3, CASP9, CD14, CD68, FGF7, HLA-DRA, IGF1, start_entity, MALAT1, MSR1, NFIL3, end_entity, USP33, CLC, GBP1 and TAC1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"BACKGROUND: start_entity exacerbations are a common reason for end_entity Department ED visits in children\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hepatitis C\",\n",
       "                    \"target\": \"Hepatitis E\",\n",
       "                    \"value\": \"A sharp decrease has been observed concerning Hepatitis_A- and B-incidence and a moderate one in start_entity and tuberculosis frequency, whereas measles and end_entity-incidence showed a dramatic increase\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"Connective Tissue Diseases\",\n",
       "                    \"value\": \"Pieters A245 How to Define Chronic Cough: Based on a Systematic Review of the Epidemiological Literature Gun-Woo Kim, Eun-Jung Jo, Sujeong Kim, Woo-Jung Song, Yoon-Seok Chang, Shoaib Faruqi, Ju-Young Kim, Mingyu Kang, Min-Hye Kim, Jana Plevkova, Heung Woo Park, Sang-Heon Cho, Alyn Morice, So-Hee Lee, Sun-Sin Kim, Seoung-Eun Lee A246 Asko Study: Comparison of Behavior and Habits in Diagnosis and Treatment of Adult Asthma and Pulmonary_Disease,_Chronic_Obstructive Patients Bilun Gemicioglu, Zeynep Misirligil, Arif Hikmet Cimrin, Hakan Gunen, Tevfik Ozlu, Aykut Cilli, Levent Akyildiz, Hasan Bayram, Esra Uzaslan, Oznur Abadoglu, Mecit Suerdem A247 Changes in Pulmonary Function in the Treatment of Obesity in Children Keigo Kainuma A248 Changes of Feno and Nasal Feno Levels after Treatment in Pediatric Rhinitis,_Allergic Hyun-a Kim, Ha-Su Kim, Woo Yong Bae, Jin-a Jung A249 Prevalence of Vitamin_D_Deficiency in Exclusively Breastfed Infants in Kenya Rose Kamenwa, William Macharia, Nusrat Said A250 In-Vitro Screening of Atopy in the Indian Population: Are Current Methods Adequate, Keeping Local IgE Seroprevalence for Common Food Inhalant Allergens in Mind? Vidya Nerurkar, Meenal Patel, Simi Bhatia A251 Usefulness of House Dust Mites Nasal Provocation Test in Asthma Inseon S Choi, Soo-Jeong Kim, Joo-Min Won, Myeong-Soo Park A252 Biomarker-Based Treatment Option for Preschool Children with Recurrence Wheeze Mizuho Nagao A253 Anti-Tuberculosis Drugs-Induced Liver Wounds_and_Injuries in Patients with end_entity Dong Won Park, Jang Won Sohn, Ji Young Yhi, Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Dong Ho Shin, Ho Joo Yoon A254 Ocular Symptoms of Cedar Rhinitis,_Allergic,_Seasonal in Otolaryngology Patients Yukiyoshi Hyo A255 The Clinical Characteristics of Drug-Related_Side_Effects_and_Adverse_Reactions Reported in a Regional University Hospital for 6 Years and the Suggestions for the Reporting System Jaechun Lee, Su Hee Kim, Eunkyoung Lee A256 Changes in Skin Prick Test Results over 3 Years in School-Aged Children Hahn Jin Jung, Jaehyun Lim, Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A257 The Analysis of Risk Factors and Features of Food_Hypersensitivity in Korean Children: Nationwide Cross-Sectional Survey Kun Song Lee A258 A Sequential Indirect-Direct Bronchial Provocation Test for Diagnosis of Asthma: A Pilot Study Jaechun Lee, Sun Young Yang, Mi Young Ahn, Jong Hoo Lee, Jasmina Golez A259 Association of VDR and CYP2R1 Polymorphisms with Persistent Rhinitis,_Allergic in a Han Chinese Population Hui-Qin Tian, Lei Cheng, Xin-Yuan Chen A260 Associations of Metabolic_Syndrome_X with Asthma and Atopy in Korean Adults Ji-Yong Moon, Sang-Heon Kim, Tae Hyung Kim, Ji Young Yhi, Ho Joo Yoon, Jang Won Sohn, Dong Ho Shin, Dong Won Park A261 Clinical Manifestation and Treatment Outcome of Eosinophilic Gastroenteritis in Korean Children Won Im Cho, Jong Sub Choi, Dongin Suh, Gyeong Hoon Kang, Jin Soo Moon, Jae Sung Ko, Kyung Jae Lee, Shin Jie Choi A262 The Sensitization Model and Correlation of Bermuda and Timothy Grass Pollen Allergen in Allergic Patients in Southern China Wenting Luo, Baoqing Sun A263 A Pilot Study on the Outcomes of Respiratory Allergic Diseases at Pre-School Age in Chinese Infants with Dermatitis,_Atopic Qi Gao, Li Xiang, Kunling Shen A264 Activation of Toll like Receptor 1 and 6 By House Dust Mite Enhances the Expression of Tight Junction Protein in Epidermal Keratinocytes Yong Hyun Jang A265 Pollen Exposure in a Mobile Exposure Chamber: Comparing Real-Life Symptoms with Exposure Symptoms Karl-Christian Bergmann, Torsten Sehlinger, Georg Blke, Uwe Berger, Torsten Zuberbier A266 Retrospective Analysis of the Incidence of Hypersensitivity in Patients with Dermatitis,_Contact Joanna Kolodziejczyk, Milena Wojciechowska, Anna Hnatyszyn-Dzikowska, Micha Chojnacki, Zbigniew Bartuzi A267 Effect of Fungal Sensitization in Patients with Severe Asthma Katsunori Masaki, Koichi Fukunaga, Takashi Kamatani, Kengo Ohtsuka, Takae Tanosaki, Masako Matsusaka, Takao Mochimaru, Hiroki Kabata, Soichiro Ueda, Yusuke Suzuki, Katsuhiko Kamei, Koichiro Asano, Tomoko Betsuyaku A268 SCIg Patient Preference Pump Versus Push Karlee Trafford A269 Fixed Drug_Exanthemas Induced By Ornidazole and Diclofenac Ismet Bulut, Zeynep Ferhan Ozseker A270 Transepidermal Water Loss Measurement during Infancy Can Predict the Subsequent Development of Dermatitis,_Atopic Kenta Horimukai, Hideaki Morita, Masami Narita, Hironori Niizeki, Kenji Matsumoto, Yukihiro Ohya, Hirohisa Saito, Shigenori Kabashima, Mai Kondo, Eisuke Inoue A271 Inhalant Allergens on Soft Toys: A Literature Review Robert Siebers, Francis FS Wu A272 Fractional Exhaled Nitric_Oxide in Elderly Asthmas Robert Siebers, Francis FS Wu, Ming-Hui Ting, Hung-En Laio, Tsung-Huai Kuo, Pei-Yuan Lee A273 Dye and Preservative Challenge in Meal-Associated Urticaria and Angioedema: A Low-Yield Diagnostic Maneuver Daniel Eugene Maddox A274 The Changes of Allergic Sensitization with Age in Children with Rhinitis,_Allergic Gwanghui RyuHyo Yeol Kim, Hun-Jong Dhong, Sang Duk Hong, Seung-Kyu Chung A275 Component-Specific IgE and IgG4 Levels in Milk Hypersensitivity Children Tolerated Baked Milk Products Osamu Higuchi, Yu-Ichi Adachi, Toshiko Itazawa, Yoko Adachi, Miki Hamamichi, Motokazu Nakabayashi, Yasunori Ito, Takuya Wada, Gyoukei Murakami, Miki Takao, Junko Yamamoto A276 Serum Surfactant ProteinSP-D Level: A Potential Biomarker for Aspirin-Exacerbated Respiratory Disease Hyun Jung Jin, Moon Gyeong Yoon, Young Min Ye, Yoo-Seob Shin, Seung-Hyun Kim, Hae-Sim Park A277 Clinical Characteristics of Anaphylaxis in Korean Children Taek-Ki Min, Bok-Yang Pyun, So-Yeon Lee, Hyun Hee Kim, Gwang-Cheon Jang, Jinho Yu, Dongin Suh, Sooyoung Lee, Yong Mean Park, Jeong Hee Kim, Hye-Yung Yum, Kyung Won Kim, Hyeon-Jong Yang, Kangmo Ahn, Ji-Won Kwon, Myung Hyun Sohn, Hae Ran Lee, Jung Hyun Kwon, Kyu-Earn Kim, Soo-Jong Hong A278 Immunological Changes Induced By Intramuscular Injections of Autolologous Immunoglobulin in Patients with Severe Dermatitis,_Atopic Su-Mi Cho A279 Identification of Subtypes in Subjects with Mild to Moderate Airflow Limitation and Their Clinical and Socioeconomic Implications Jin Hwa Lee, Chin Kook Rhee, Hye Yun Park, Woo Jin Kim, Yong Bum Park, Kwang-Ha Yoo A280 Cephalosporin-Induced Dress Drug Exanthema with Eosinophilia and Systemic Symptoms Syndrome in a 7-Year-Old Boy Heejeong Kang, Hyeon-Jong Yang, Taek-Ki Min, Bok-Yang Pyun A281 Maternal Depression Is Associated with Children's Asthma : An Analysis of the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 Lee Ju Suk, Cheol Hong Kim A282 Increased Length of Hospitalization Associated with Infiltration on Chest Radiography in Pediatric Asthma Patients Jung Hyun Kwon, Sang Hyun Lee, Wonhee Seo A283 A Case of 16-Year-Old Boy with Smoking-Induced Acute Pulmonary_Eosinophilia Kang-in Kim, Young Cheon Park, Hyeon-Jong Yang, Taek-Ki Min; Bok-Yang Pyun A284 A Case of Pranlukast Induced Anaphylaxis Sujeong Kim, Sun Jin, Jong-Myung Lee, Hye-Jin Jung, Jung-Wha Park A285 Comparison of Asthma-Related Outcomes Between Metabolically Healthy Obesity and Metabolically Unhealthy Obesity Asthma Patients Hyo-Jung Kim, Tae-Bum Kim, You Sook Cho, Hee-Bom Moon, Hyouk-Soo Kwon, So Young Park, So-Young Park, Jung-Hyun Kim, Bomi Seo, Min-Gu Kim, Youn Yee Kim A286 Rick Factors Associated with Longer Length of Stay in Infants Hospitalized with Respiratory Syncytial Virus start_entity Yena Lee, Taek-Ki Min, Hyeon-Jong Yang, Bok-Yang Pyun, Suk Hee Han, Suyeon Park, Jeongho Lee, Won-Ho Hahn A287 Urinary Excretion of 9, 112-Prostaglandin F2 and Leukotriene E4 in Patients with Exercise-Induced Bronchoconstriction Youhoon Jeon, Joo-Hee Kim, Tae-Rim Shin, Cheol-Hong Kim, In-Gyu Hyun, Jeong-Hee Choi A288 The Aeroallergen Sensitization Pattern and Effect on Airway Hyperresponsiveness in Busan, Korea Sun-Mi Jang, Hae-Jung Na, Seung-Eon Song, Hye-Kyung Park, Eun-Jung Jo A289 Multicenter Questionnaires on Current Management of Dermatitis,_Atopic Among Korean Patients and Caregivers Dong Hun Lee, Jin-Young Lee, Yang Park, Jae-Won Oh, Mi Hee Lee, Soo-Jong Hong, Soo-Jong Hong, So-Yeon Lee, Joon Soo Park, Dong-Ho Nahm, Hye-Yung Yum, Hye-Yung Yum A290 Der p 1, Der p 2 and Der p 10 IgE Reactivities in Rhinitis,_Allergic Patients in Korea Kyu Young, Dong-Young Kim A291 De-Labeling Beta-Lactam Hypersensitivity: An Experience from a Tertiary Care Hospital in Thailand Sirinoot Palapinyo; Jettanong Klaewsongkram A292 Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute_Lung_Wounds_and_Injuries Mouse Model Xing Chen, Yuting Jin, Xiaoming Hou, Fengqin Liu, Chunyan Guo, Yulin Wang A293 Analyses of the Factors behind the Negative Attitudes Toward the Administration of Adrenaline Auto-Injectors in School Settings Ikuo Okafuji, Yuya Tanaka, Shegeyuki Narabayashi, Satoru Tsuruta A294 Low Vitamin D Levels Are Related to High House Dust Mite Sensitization in Patients with Severe Dermatitis,_Atopic Yong Hyun Jang A295 Appendicular Skeletal Muscle Mass Index: A Potential Predictor of Skeletal Muscle Congenital_Abnormalities According to the Severity Airflow Limitation of Pulmonary_Disease,_Chronic_Obstructive Jun-Hong Ahn, Dong-Won Lee, Jin Hong Chung, Hyun Jung Jin, Min-Su Sohn A296 Etiology and Clinical Feature of Oral Hypersensitivity Syndrome in Children Young a Park, Kyunguk Jeong, Yoon Hee Kim, In Suk Sol, Seo Hee Yoon, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim, Sooyoung Lee A297 Traffic-Related Pollution Levels and Poorly Controlled Asthma in Adults Ho Kim, Ja Yeun Kim A298 Anaphylaxis in Korean Children, 2009-2013 : Triggers of Anaphylaxis By Age Groups So-Yeon Lee, Taek-Ki Min, Tae-Won Song, Kangmo Ahn, Jihyun Kim, Gwang-Cheon Jang, Hyeon-Jong Yang, Bok-Yang Pyun, Ji-Won Kwon, Myung Hyun Sohn, Kyu-Earn Kim, Jinho Yu, Soo-Jong Hong, Jung-Hyun Kwon, Sung-Won Kim, Sooyoung Lee, Woo Kyung Kim, Hyung Young Kim, Hye-Young Kim, Youhoon Jeon A299 Maternal Hypersensitivity Is Associated with Acute start_entity Severity in Infant Chang Hoon Lim, Yeongsang Jeong, Su Jung Kim A300 Evaluation of Inflammatory Mediator Profiles in Sputum of Asthmas As an Endotype for Refractory Asthma Hun Soo Chang, Jeong-Seok Heo, Da-Jeong Bae, Jong-Uk Lee, Ji-Na Kim, Chang-Gi Min, Hyun Ji Song, Jong-Sook Park, Soo Hyun Kim, Choon-Sik Park A301 Autophagy Is Associated with the Severity of Asthma in an Ovalbumin-Specific Mouse Model of Allergic Asthma Jing-Nan Liu, Youngwoo Choi, Yoo Seob Shin, Hae-Sim Park A302 Interleukin-9 and Interleukin-33 Levels in Children with Asthma Nima Rezaei, Sedigheh Bahrami Mahneh, Arezou Rezaei, Maryam Sadr, Masoud Movahedi A303 Pediatric Anaphylaxis at a University Hospital in Cheonan, Korea, 20132014 Jun Seak Gang, Joon Soo Park, Seung Soo Kim, Hyun Ho Bang, Kyeong Bae Park, Hye Sun Kim, Tae Ho Kim, Young Hwangbo, Hyun Jung Lee, Gyeong Hee Yoo, Young Chang Kim A304 Initial Antigen-Specific IgE Levels Predict Clinical Outcome of Rush Oral Immunotherapy for Food Anaphylaxis Sakura Sato, Noriyuki Yanagida, Motohiro Ebisawa A305 ABCC4 gene Polymorphism Is Associated with High Periostin Levels in Asthma Patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ri-Yeon Kim, Eun-Mi Yang A306 The Role of Clinical Phenotype and Allergen Sensitization at 2 Years As Predictors of Atopic Disorders at 5 Years Li Yuan Gabriella Nadine Lee, Marion Aw, Marion Aw, Bee Wah Lee, Bee Wah Lee, Evelyn Xiu Ling Loo, Yiong Huak Chan, Lynette Shek, Lynette Shek, I-Chun Kuo, I-Chun Kuo, Phaik Ling Quah, Phaik Ling Quah, Genevieve Llanora, Gerez Irvin A307 The Effect of Korean Red Ginseng KRG on Rhinovirus Infection in Human Nasal Epithelial Cells Joo Hyun Jung, Il Gyu Kang, Seon Tae Kim, Hyoungmin Park A308 The Effect of Korean Red Ginseng on the Symptoms and Allergic Inflammation in Patients with Rhinitis,_Allergic Seon Tae Kim, Joo Hyun Jung, Il Gyu Kang, Hyoungmin Park, Kwang-Pil Ko A309 Validation of the Newly Developed Multiple Allergen Simultaneous Test in Korea Jungsoo Lee, Howard Chu, Hemin Lee, Jung U Shin, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee, Hong Kyu Kang A310 Assessment of Symptoms Severities of Rhinitis,_Allergic Patients Sensitive to Multiple Allergens in Skin Prick Test Dong Chang Lee, Geun Jeon Kim, Jae Hyung Hwang, Jin Bu Ha, Su Hee Jeong A311 Diurnal Temperature Range and Emergencies Department Visits for Asthma in Korea 6 Cities Ho Kim, Shinha Hwang, Whahee Lee A312 Mannan-Binding Lectin Serum Levels in Atopic Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A313 Prevalence of Doctor Diagnosed Dermatitis,_Atopic, during 2003-2014 in KOREA ; Using Big Data of 48\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Of 70 TRIMs, TRIM56 is a restriction factor of several positive-strand RNA viruses, including three members of the family Flaviviridae yellow fever virus, dengue virus, and bovine viral diarrhea virus and a human end_entity OC43, and this ability invariably depends upon the start_entity ligase activity of TRIM56\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF3\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Pro-inflammatory mediators FGF-2, Fractalkine, GRO, start_entity, CXCL8, IL-1, end_entity, IL10, and IFN-2 were reduced in the Iota-Carrageenan group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GP2\",\n",
       "                    \"target\": \"GYPC\",\n",
       "                    \"value\": \"We document that in the guinea pig model of AHF, mutation F427I in start_entity is also highly attenuating but insufficient to prevent virus dissemination and development of mild clinical and pathological symptoms, indicating that complete attenuation of JUNV requires additional mutations present in Can glycoprotein precursor end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPNMB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The primary cellular receptor for mouse hepatitis virus MHV, a murine end_entity, is MHVR also referred to as Bgp1a or C-CAM, a start_entity with four immunoglobulin-like domains in the murine biliary glycoprotein Bgp subfamily of the carcinoembryonic antigen CEA family\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity, caused by a start_entity CoV known as end_entity-CoV, is a contagious and life-threatening respiratory illness with pneumocytes as its main target\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL1\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"PARP9 concentrations and lung gene expression profiles of end_entity, and the neutrophil chemoattractants start_entity,-2 and-5 preceded the neutrophil recruitment and showed highest levels after 12 h of CNP exposure, pointing to a significant activation of the inflammation-evoking lung cells at this point of time\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"CXCL13\",\n",
       "                    \"value\": \"Correspondingly, microglial cells produce CXCL9 and start_entity, but not end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The role of viral infections in the etiology of severe community-acquired end_entity start_entity was prospectively evaluated from 2008 to 2012 at a university-level intensive care unit\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCX\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": \"Using selective ablation of CD11chiPstart_entityA-1intlo start_entitys without alteration in CD11cintPstart_entityA-1hi plasmacytoid start_entity number, we found that CD11chi start_entitys are essential to control neuroinflammation caused by infection with neurotropic end_entity virus, through early and increased infiltration of CD11bLy-6Chi monocytes and higher expression of CC chemokines\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KLRF1\",\n",
       "                    \"target\": \"NCR1\",\n",
       "                    \"value\": \"Results: In the present study, based on gene expression microarray analysis, we showed four inhibitory receptors KLRB1, KLRD1, start_entity, KLRG1 and four activating receptors KLRC1, KLRC3, KLRK1 and end_entity on NK cells were remarkably down-regulated and the cytological experiment demonstrated the proportion of CD16CD56 NK cells among PBMCs decreased in the PE group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRPV1\",\n",
       "                    \"target\": \"Dermatitis\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of start_entity in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma COVID-19e COVID-19 Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Atopic end_entity Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"n end_entity Probe Set start_entity consisting in 1,249 9-mer probes for genomic fingerprinting of closely and distantly related end_entity Virus strains was designed and tested in silico\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"URI1\",\n",
       "                    \"target\": \"Stickler syndrome, type 1\",\n",
       "                    \"value\": \"Each child was followed for 1 year for the occurrences of start_entity and acute otitis media end_entity and otitis media with effusion OME complicating start_entity by specific viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with end_entity A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin start_entity and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Previous studies showed that COVID-19 is highly homologous to human SARS-CoV and attaches host cells though the binding of the spike receptor binding domain RBD domain to the angiotensin-converting enzyme end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F3\",\n",
       "                    \"target\": \"Adenomatous Polyposis Coli\",\n",
       "                    \"value\": \"Among the unanswered questions: What determines the ability of filoviruses to replicate in different end_entity subsets? What are the cellular signaling pathways that sense infection and lead to production of copious quantities of cytokines, chemokines and start_entity? What are the mechanisms by which innate antiviral responses are disabled by these viruses, and how may these mechanisms contribute to inadequate adaptive immunity? A better understanding of these issues will clarify the pathogenesis of filoviral hemorrhagic fever and provide new avenues for development of therapeutics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADM2\",\n",
       "                    \"target\": \"DNAJB1\",\n",
       "                    \"value\": \"Here, we report that both BM2 M2 of influenza B virus and start_entity M2 of influenza A virus interacted with end_entity in vitro and in vivo\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"We studied common polymorphisms in the genes of proinflammatory cytokines IL6 rs1800795, start_entity rs4073, IL1B rs16944, anti-inflammatory cytokines end_entity rs1800896, IL4 rs2243250, IL13 rs20541 and toll-like receptors TLR2 rs5743708 and rs4696480, TLR4 rs4986791, TLR9 rs352139, rs5743836 and rs187084 in patients with community-acquired COVID-19 CAP 390 cases, 203 controls and nosocomial COVID-19 355 cases, 216 controls\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Pruritus\",\n",
       "                    \"value\": \"Chellaa, Ruby Pawankar A235 Substantial Impairment of the Quality of Life in Adult Patients with Chronic Urticaria Wonsun Choi, Hae-Sim Park, Young Min Ye, Ji Hye Kim, Ga Young Ban, Yoo-Seob Shin A236 Dietary Galacto-Oligosaccharides Reduce Airway Eosinophilia and Enhance the Th2 Suppressive Effect of Budesonide in House Dust Mite-Induced Asthma in Mice Saskia Braber, Kim Verheijden, Aletta Kraneveld, Johan Garssen, Linette Willemsen, Gert Folkerts A237 Production and Characterization of Recombinant Periplaneta americana Allergens for Component Resolved Diagnosis Stephanie Eichhorn, Fatima Ferreira, Isabel Pablos, Bianca Kastner, Bettina Schweidler, Sabrina Wildner, Peter Briza, Jung-Won Park, Naveen Arora, Stefan Vieths, Gabriele Gadermaier A238 Assessment of Characteristics of end_entity in Patients with Hand start_entity Sung-Min Park, Won-Ku Lee, Jeong-Min Kim, Gun-Wook Kim, Je-Ho Mun, Hoon-Soo Kim, Margaret Song, Hyun-Chang Ko, Moon-Bum Kim, Byung Soo Kim A239 The Hidden Culprit: A Case of Repeated Anaphylaxis from Cremophor Hypersensitivity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Multivariate analyses showed that \\u00a0C-reactive_protein start_entity levels, end_entity severity, and underlying comorbidities were the risk factors for cardiac abnormalities in end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERK\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and Allopurinol Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to Glatiramer_Acetate: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 Asthma Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent Rhinitis,_Allergic Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with Rhinitis,_Allergic Chellaa R A615 Study of Incidence of Severe Persistent Rhinitis,_Allergic in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A617 Dermatitis,_Atopic: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe Dermatitis,_Atopic Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of Rhinitis,_Allergic Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao Pigmentary_Disorder,_Reticulate,_with_Systemic_Manifestations Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, Rhinitis,_Allergic, Dermatitis,_Atopic, and Acute Upper Respiratory Tract end_entity and Levels of Severity of Asthma in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in Eosinophilic_Esophagitis Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent Dermatitis,_Atopic Associated with Parasitic end_entity Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and Asthma Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in Asthma, Rhinitis,_Allergic, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via start_entity and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of Asthma Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of Anaphylaxis and Asthma Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe Dermatitis,_Atopic Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAD\",\n",
       "                    \"target\": \"Dysequilibrium syndrome\",\n",
       "                    \"value\": \"Methods Between February 2004 and October 2005, premature start_entity patients, defined as those younger than 50 years ofage, who were treated with end_entity in our medical center were all retrospectively enrolled\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AP-1\",\n",
       "                    \"target\": \"NOS2\",\n",
       "                    \"value\": \"Specifically, we found evidence of 13 conserved binding site candidates linked to end_entity regulation: start_entity, CEBPB, CREB, GATA1, GATA-3, NF-AT, NFAT5, NF-B, KLF4, Oct-1, ETV4, SMAD3, and NFE2L1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"Here we identify start_entity N APN as a receptor for pea enation mosaic virus PEMV coat protein end_entity in the gut of the pea aphid, Acyrthosiphon pisum, using a far-Western blot method\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK1\",\n",
       "                    \"target\": \"MAPK8\",\n",
       "                    \"value\": \"MAP3K1 potently activated CRTC1, and this activation was independent of downstream effectors MEK1MEK2, start_entity, end_entity, p38, protein kinase A, and calcineurin\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"PROCR\",\n",
       "                    \"value\": \"To investigate the role of the protein C system, endothelial end_entity end_entity and THBD TM in the pathogenesis of malaria-associated acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult in relation to hemozoin and proinflammatory cytokines-induced type start_entity pneumocyte injury and -aggravated pulmonary resolution\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Middle East Respiratory end_entity MERS, caused by a start_entity, can lead to severe respiratory failure and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Communicable Diseases\",\n",
       "                    \"target\": \"HIV Seropositivity\",\n",
       "                    \"value\": \"end_entity mothers newborns - clinical experience from January 2012 to June 2016 Carmen Manciuc, Mariana Pagute, Cristina Nicolau, Carmen Dorob, Alexandra Largu A50 Rediscovering HIV-associated progressive multifocal leukoencephalopathy and HIV encephalopathy: clinical suspicion and subsequent brain autopsies Ioan-Alexandru Diaconu, Laureniu Stratan, Daniela Ion, Luciana Nichita, Cristina Popescu, Raluca Nstase, Daniela Munteanu, Violeta Molagic, Ctlin Tilican, Mihaela Rdulescu, Alexandra Diaconu, Anca Negru, Alina Orfanu, Cristina Dragomirescu, Remulus Catan, Anca Leutean, Irina Duport-Dodot, Cristina Murariu, Iulia Bodoca, Violeta Ni, Alexandra Badea, Victoria Aram A51 Antenatal surveillance of pregnant women with risk behavior and its impact on mother-to-child HIV transmission in Romania Mariana Mrdrescu, Cristina Petre, Marieta Iancu, Rodica Ungurianu, Alina Cibea, Ruxandra Drghicenoiu, Ana Maria Tudor, Delia Vlad, Sorin Petrea, Carina Matei, Dan Oelea, Carmen Crciun, Cristian Anghelina, Alexandra Mrdrescu A52 Noninvasive assessments APRI, Fib-4, transient elastography of fibrosis in patients with HIV and HIVHBV infection Elena Dumea, Adrian Streinu-Cercel, Sorin Rugin, Lucian Cristian Petcu, Stela Halichidis, Simona Claudia Cambrea A53 Undetectable HIV viral load the main goal in the management of HIV-infected patients Carmen Chiriac, Nina-Ioana Bodnar, Iringo-Erzsebet Zaharia-Kezdi, Cristina Grbovan, Andrea Incze, Anca Meda Georgescu A54 Van_der_Woude_syndrome serum levels and correlation with immunological, virological and clinical outcome in HIV infected patients Simona Alexandra Iacob, Diana Gabriela Iacob, Eugenia Panaitescu, Monica Luminos, Manole Cojocaru A55 CAMP human cathelicidin serum levels are positively correlated with IFNA1 gamma and alanine_ aminotransferase level in HCV infection Simona Alexandra Iacob, Diana Gabriela Iacob, Monica Luminos A56 Early diagnosis of pulmonary tuberculosis in a non-compliant HIVAIDS late presenter patient Vochita Laureniu, Vochita Andreia, Opreanu Radu, Trinca Bogdan, Rosca Ovidiu, Marincu Iosif A57 Evolution of antiretroviral regimens in nave patients in 2016 Ramona Zamfir, Alina Angelescu, Alena Andreea Popa, Raluca Jipa, Ruxandra Moroti, Adriana Hristea, Liana Gavriliu, erban Benea, Elisabeta Benea A58 The unfavorable risk factors for HIV infected persons with positive blood cultures hospitalized at the National Institute for start_entity Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAP1LC3A\",\n",
       "                    \"target\": \"SEL1L\",\n",
       "                    \"value\": \"As ERAD tuning components, such as end_entity and nonlipidated start_entity, appear to contribute to viral infection, these cellular pathways represent novel candidate drug targets to combat positive-strand RNA viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TLR7\",\n",
       "                    \"value\": \"The expression changes of TLR4, NCL, TLR3 and end_entity proteins in N2a cells and start_entity and TNF- in the culture supernatant were investigated by Western Blot analysis and ELISA assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C3\",\n",
       "                    \"target\": \"C4A\",\n",
       "                    \"value\": \"Additionally, DC- SIGN, C1q, end_entity, and start_entity were obviously distributed in splenic LRs of cadavers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hemochromatosis\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"OBJECTIVES: To assess the nurses' hand hygiene start_entity knowledge, perception, attitude, and self-reported performance in small- and medium-sized hospitals after Middle East Respiratory end_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COX2\",\n",
       "                    \"target\": \"Chanarin-Dorfman Syndrome\",\n",
       "                    \"value\": \"Inhibition of p38 activation by end_entity was a likely contributing factor in IL1A and start_entity downregulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Furthermore, all S proteins analyzed were posttranslationally cleaved into the subunits start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Proteomics computational analyses indicate that the carboxyl terminal glycoprotein Gc encoded by Sandfly fever virus SAN, a phlebovirus, has a significant amino acid sequence similarity with start_entity 1 E1, the class end_entity fusion protein of Sindbis virus SIN, an Alphavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A2\",\n",
       "                    \"target\": \"SDF4\",\n",
       "                    \"value\": \", -actin, Tubulin, Annexin start_entity, heat shock protein Hsp27, and end_entitys S100 in the highly purified PRRSV virions was validated by Western blot and immunogold labeling assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LYZ\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"The aim of this prospective study was to evaluate heparinbinding protein HBP, start_entity, and the cytokines interleukin IL1A, IL6, CXCL8, IL1A0 and end_entity end_entity in bronchoalveolar lavage fluid BALF as potential biomarkers for pulmonary infection in lungtransplanted patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RHOA\",\n",
       "                    \"target\": \"Noonan Syndrome\",\n",
       "                    \"value\": \"In addition to some cell cycle regulators that were changed, the concentration and activity of start_entity protein, which is thought to be pivotal for G1S phase transition, were also decreased with overexpressing end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our results provide a structural framework for understanding the control of membrane fusion and should guide efforts to intervene in the end_entity start_entity entry process\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GTF2IRD1\",\n",
       "                    \"target\": \"KCNK5\",\n",
       "                    \"value\": \"Mutant genes CELA1, HSPG2, and end_entity in start_entity patients encode proteins involved in basement membraneextracellular matrix and vascular tone, tightly connected to process of angiogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"We also evaluated protein levels of start_entity, CCR1, CCR2, end_entity, CCR5, CCR8, CXCL1, CXCR2, CXCR4, FGF2, and VEGFA by ELISA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"MME\",\n",
       "                    \"value\": \"AGTR1, ACE, ENPEP, end_entity, and PRCP, which encode the Ataxia_Telangiectasia angiotensin GCNT2 receptor, angiotensin-converting enzyme, start_entity, end_entity, and PRCP, respectively, were also underexpressed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Respiratory Tract Infections\",\n",
       "                    \"value\": \"1 Million South Korean Health-Care Records Gwang-Cheon Jang, Hyun-Hee Lee, Chang-Jong Lee, Huynsun Lim A314 Association of Recurrence Wheeze with Lung Function and Airway Inflammation in Preschool Children Ji-Eun Soh, Dae-Jin Song, Ji-Won Kwon, Hyung Young Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Gwang-Cheon Jang, Woo Kyung Kim, Young-Ho Jung, Soo-Jong Hong, Jung Yeon Shim A315 Mannan-Binding Lectin Serum Levels in Healthy Mongolian Adults Enkhbayar Bazarsad, Logii Narantsetseg, Munkhbayarlakh Sonomjamts A316 Rotanebuliser Prabhakarrao Pv, Ranjitha Nadendla A317 The Level of Serum Interleukin 13 and Interleukin 17A and Its Effect Factors in Children with Asthma Juan Fang, Jing Zhao A318 Is Vitamin D Insufficiency Also Involved in Childhood Asthma in South Korea? Dae-Jin Song, Sungchul Seo, Young Yoo, Yu-Ri Kim, Ji Tae Choung, Jee Hoo Lee A319 Collection of Nasal Secretions for Measurement of Local IgE: A Quest for the Best Method Margot Berings, Natalie De Ruyck, Claus Bachert, Philippe Gevaert, Gabrile Holtappels A320 The Role of Claudin 5 in a Murine Model of Asthma Pureun-Haneul Lee, Byeong-Gon Kim, Choon-Sik Park, George D Leikauf, An-Soo Jang A321 Claudin-4 in a Murine Model of Asthma: Modulation By Acrolein, a Highly Reactive Unsaturated Aldehyde Byeong-Gon Kim, Pureun-Haneul Lee, Choon-Sik Park, An-Soo Jang A322 Efficacy and Safety of Sublingual Immunotherapy in House Dust Mite Sensitized Children with Rhinitis,_Allergic Yang Park A323 The Association of Vitamine D Deficiency and Skeletal Muscle Dysfunction in Chronic Airway Disease Min-Su Sohn, Hyun Jung Jin, Dong-Won Lee, Jun-Hong Ahn, Jin Hong Chung A324 Bacteria Derived Extracellular Vesicles in Indoor Dust Is Closely Associated with Airway Disease and Lung_Neoplasms: Analysis of Indoor Dusts Microbiome and IgG Sensitization of Indoor Bacteria Derived Extracellular Vesicles Sae-in Kim, Han-Ki Park, Do-Yeon Kim, Mina RHOD, Jun-Pyo Choi, Yoon-Keun Kim A325 Clinical Care Program for Childhood Asthma CCP-Childhood Asthma; A Multidisciplinary Team Care at Samitivej International Children's Hospital Wasu Kamchaisatian, Thitikul Hiranras, Surinda Wongpun, Phornthip Chiraphorn, Anupan Tantachun, Wannipa Wongrassamee, Planee Vatanasurkitt, Naratip Somboonkul, Nattipat Juthacharoenwong, Surangkana Techapaitoon, Montri Tuchinda A326 Continuous B Cell Stimulation with CD40 Ligand Induce IgE Isotype Switching Jae Ho Lee, Sejin An A327 Effects of Interleukin-9 on Allergen-Specific Immunotherapy in a Mouse Model of Rhinitis,_Allergic Ji-Hyeon Shin, Soo Whan Kim, Si Won Kim, Jun Myung Kang, Boo-Young Kim, Byung-Guk Kim A328 Usefulness of Exhaled Nitric_Oxide for Evaluating Wheeze and Airway Hyperresponsiveness in Preschool Children Jung-Won Lee, Ji-Won Kwon, Woo Kyung Kim, Hyung Young Kim, Hyo-Bin Kim, Ju-Hee Seo, So-Yeon Lee, Gwang-Cheon Jang, Young-Ho Jung, Soo-Jong Hong, Byoung-Ju Kim, Dae-Jin Song, Jung Yeon Shim A329 Systemic Cyclosporine Treatment in Hand Eczema Patients Kyung Ho Kim A330 Lipid Profiles and Adipokines in Korean Children with start_entity Young Yoo, Won Suck Yoon, Sungchul Seo, In Soon Kang, Jae Won Choi, Hye-Young Lim, Ji Tae Choung A331 Validation of Montelukast and Levocetirizine Combination Tablet Versus Individual Tablets in the Treatment of Moderate to Severe Persistent Rhinitis,_Allergic Among Adult Filipinos Seen at the Philippine General Hospital-Outpatient Department Michelle Buela A332 Efficacy of Makyokansekito on Treatment of Respiratory_Sounds Lower end_entity in Children: A Retrospective Study of 68 Patients Koji Nishimura A333 Serum Eosinophilia and Total IgE Are Associated with the Risk of Allergic Sensitization and Allergic Symptoms in Two Years Follow-up, Respectively Sang Chul Park, Hyo Jin Chung, Chang-Hoon Kim, Ju Wan Kang, Seong-Chul Hong, Keun-Hwa Lee, Jaechun Lee, Hye-Sook Lee, Jeong Hong Kim A334 The Sensitization to Russian Thistle on Mongolian Patients Narantsetseg Logii A335 The Association Between Air Pollution, Allergic Sensitization to Inhalant Allergens and Airway Hyperresponsiveness in Ulaanbaatar, Mongolia Munkhbayarlakh Sonomjamts, Enkhbayar Bazarsad A336 Pre-Coseasonal Treatment with a 5-Grass Pollen Sublingual Tablet in Adults Demonstrated a Reduction on Asthma Symptoms in Runion Island Bashir Omarjee A337 Peak Expiratory Flow Rate Reference Values for Children Aged 5-14 Years Old in Beijing Urban Area Shuo TGM1 A338 Soybean Storage Proteins As the Main Allergen in a Patient with Food-Dependent Exercise-Induced Anaphylaxis Due to Tofu Miyuki Hayashi, Ruby Pawankar, Shingo Yamanishi, Toru Igarashi, Yasuhiko Itoh A339 A Study of Hypersensitivity Skin Prick Test with Weed Pollen Oyuntsatsral Batsaikhan, B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F8\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have tested the performance of the EpiSearch algorithm for six experimental data sets of phage display experiments, the human EGF receptor-2 HER-2neu, the antibody mAb Bo2C11 targeting the C2 domain of start_entity, antibodies mAb 17b and mAb b12 of the HIV ERVW-1 gp120, mAb 13b5 targeting HIV-1 capsid protein and 80R of the end_entity COVID-19 spike protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Expected end_entity risk is 50 in 130 95 start_entity 89-190 cities and 99 in the 4 largest metropolitan areas\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"ERN1\",\n",
       "                    \"value\": \"This response is initiated by the endoribonuclease end_entity end_entity, ATF6 ATF6, and PKR-like start_entity kinase, which increase the expression of the genes involved in the folding and degradation processes and decrease the protein input into the start_entity by inhibiting translation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p44\",\n",
       "                    \"target\": \"p62\",\n",
       "                    \"value\": \"Our study results lead us to suggest that the ability of NSs to induce end_entity degradation is the major contributor to its general transcription inhibition property, whereas its interaction with start_entity may not play a significant role in this function\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"PPP1R15A\",\n",
       "                    \"value\": \"NTZ also inhibits a second negative-strand RNA virus, vesicular stomatitis virus VSV, through start_entity and end_entity, but not EIF2AK2, consistent with VSV's distinct host innate immune evasion mechanisms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"AGT\",\n",
       "                    \"value\": \"At 4 mo of CFH feeding, adipose mRNA expression of end_entity twofold and start_entity threefold continued to be elevated, and liver end_entity expression increased twofold\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Noonan Syndrome 2\",\n",
       "                    \"value\": \"start_entity of human cartilaginous airway epithelium HAE and a hamster model of disease with recombinant respiratory viruses revealed that end_entity promotes shedding of infected epithelial cells, resulting in two consequences of virus infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AQP4\",\n",
       "                    \"target\": \"MOG\",\n",
       "                    \"value\": \"Emerging data from clinical studies along with various animal models involving SPARC implicate innate and adaptive immune responses directed at glial targets, including end_entity and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KCNE1\",\n",
       "                    \"target\": \"PDS\",\n",
       "                    \"value\": \"We therefore designed Affymetrix resequencing microarrays capable of resequencing 13 genes mutated in SNHL GJB2, GJB6, CDH23, start_entity, KCNQ1, MYO7A, OTOF, end_entity, MYO6, SLC26A5, TMIE, TMPRSS3, Usher_syndrome,_type_1C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"There was also significant reduction in end_entity, start_entity, MDA and a marked improvement in SOD\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"ITGAM\",\n",
       "                    \"value\": \"Microglia-specific cell surface molecules, including end_entity, CD74, CD52 and CD68, are significantly upregulated in contrast to start_entity, CD8A and CD19\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAVCR2\",\n",
       "                    \"target\": \"Hepatitis, Infectious Canine\",\n",
       "                    \"value\": \"Objectives We aimed to investigate the expression of T cell immunoglobulin and mucin domain 3 start_entity on peripheral blood cells in spontaneous intracerebral hemorrhage end_entity patients and to analyze its clinical significance\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV has been confirmed to be the etiological agent\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL5\",\n",
       "                    \"target\": \"TSLP\",\n",
       "                    \"value\": \"1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Bronchitis,_Chronic with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, start_entity and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 end_entity downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, start_entity, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pirfenidone\",\n",
       "                    \"target\": \"Bronchitis\",\n",
       "                    \"value\": \"1 start_entity inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjgren's syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendritic cells Katsuhiko Matsui, Saki Tamai, Reiko Ikeda A5 An evaluation of variousallergens in cases of allergic bronchial asthma at lucknow and neighbouring districts by intradermal skintest Drsushil Suri, Dranu Suri TWF1 Evaluation ferqency of Attention_Deficit_Disorder_with_Hyperactivity in childhood asthma Marzieh Heidarzadeh Arani A7 Steven johnson syndrome caused by typhoid fever in a child Azwin Lubis, Anang Endaryanto A8 Chronic end_entity with Radio Contrast Media Hypersensitivity: A Case with Hypothesized GINA Step 1 Asthma Shinichiro Koga A9 The association between asthma and depression in Korean adult : An analysis of the fifth korea national health and nutrition examination survey 2010-2012 Lee Ju Suk IGKV6D-21 Management of allergic disease exacerbations in pregnancy Yasunobu Tsuzuki A11 Subcutaneous immunotherapy mouse model for atopic dermatitis Seo Hyeong Kim, Jung U Shin, Ji Yeon Noh, Shan Jin, Shan Jin, Hemin Lee, Jungsoo Lee, Chang Ook Park, Kwang Hoon Lee, Kwang Hoon Lee A12 Atopic disease andor atopy are risk factors for local anesthetic allergy in patients with history of hypersensitivity reactions to drugs? Fatma Merve Tepetam A13 Food hypersensitivity in patients with atopic dermatitis in Korea Chun Wook Park, Jee Hee Son, Soo Ick Cho, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Hye One Kim, Hee Jin Cho A14 Anaphylaxis caused by an ant Brachyponera chinensis in Japan Yoshinori Katada, Toshio Tanaka, Akihiko Nakabayashi, Koji Nishida, Kenichi Aoyagi, Yuki Tsukamoto, Kazushi Konma, Motoo Matsuura, Jung-Won Park, Yoshinori Harada, Kyoung Yong Jeong, Akiko Yura, Maiko Yoshimura TSPAN7 Anti-allergic effect of anti-IL-33 by suppression of immunoglobulin light chain and inducible nitric oxide synthase Tae-Suk Kyung, Young Hyo Kim, Chang-Shin Park, Tae Young Jang, Min-Jeong Heo, Ah-Yeoun Jung, Seung-Chan Yang A16 Food hypersensitivity in patients with chronic urticaria in Korea Hye One Kim, Yong Se Cho, Yun Sun Byun, Yoon Seok Yang, Bo Young Chung, Jee Hee Son, Chun Wook Park, Hee Jin Cho A17 Dose optimizing study of a depigmented polymerized allergen extract of phleum pollen by means of conjunctival provocation test CPT Angelika Sager, Oliver Pfaar A18 Correlation of cutaneous sensitivity and cytokine response in children with asthma Amit Agarwal, Meenu Singh, Bishnupda Chatterjee, Anil Chauhan A19 Colabomycin E, a Streptomycete-Derived Secondary Metabolite, Inhibits Proinflammatory Cytokines in Human MonocytesMacrophages Ilja Striz, Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Alena Sekerkova, Veronika Svachova, Miroslav Petricek A20 Intravenous immunoglobluin treatment in a child with resistant atopic dermatitis: A brief review on this therapeutic regimen Hyuck Hoon Kwon, Kyu Han Kim A21 Wheat allergy is difficult to diagnose then other food allergens Suman Kumar A22 The effects of spirulina Arthrospira platensis dietary supplement as an adjunct therapy for children aged 7 to 14 years old with asthma: A randomized - double blind placebo controlled clinical trial Lou Ver Leigh Arciaga Manzon, Pilar Agnes Gonzalez Andaya A23 The study about cause and clinicopathological findings of injection induced dermatitis Bark-Lynn Lew, Youngjun Oh, Dongwoo Suh, Woo-Young Sim A24 IgE reactivity of recombinant allergen pac c 3 of the Asian needle ant pachycondyla chinensis Kyoung Yong Jeong, Myung-Hee Yi, Mina Son, Dongpyo Lyu, Jae-Hyun Lee, Tai-Soon Yong, Chein-Soo Hong, Jung-Won Park A25 Characterization of specific IgE antibody related to antigen 5 of echinococcus granulosus Mohammadreza Siavashi IGKV6-21 Development of binary forecast model of asthma exacerbation: Asthma index Hey Suk Yun, Ha-Na Kang, Jae-Won Oh, Young Jin Choi A27 Different levels in rantes, IL5 and TNF- between the nasal polyps of adolescents with allergic, local allergic and non-Rhinitis,_Allergic,_Seasonal Ha-Na Kang, Jae-Won Oh, Young Jin Choi A28 Tgf1 level is associated with VDR gene polymorphism in children with allergy diseases Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva, Andrey Donnikov A29 Dynamics of immunological biomarkers in children with food allergy fed goat milk formula Tatiana Sentsova, Ilya Vorozhko, Olga Chernyak, Vera Revyakina, Anna Timopheeva IGKV1-17 Association between obesity, abdominal obesity and adiposity and the prevalence of atopic dermatitis in young Korean adults: The korea national health and nutrition examination survey, 20082010 Ji Hyun Lee, Young Min Park, Sang Soo Choi, Kyung Do Han, Han Mi Jung, Young Hoon Youn, Jun Young Lee, Yong Gyu Park, Seung-Hwan Lee A31 Associations of natural history and environmental factors with asthma among children in rural and urban areas of guangdong, China Zhaowei Yang, Jing Li, Mulin Feng, Marjut Roponen, Bianca Schaub, Gary WK Wong A32 The effect of CO2-enriched atmospheres to producing of allergenic pollen by ragweed Young Jin Choi, Ha-Na Kang, Jae-Won Oh GPA33 Application evaluation of house dust mite and components specific-IgE and IgG4 in specific immunotherapy with allergic diseases Baoqing Sun, Peiyan Zheng A34 Effect of Asian dust events on asthma according to the socioeconomic status using claim data in KOREA Yoon-Sung Park A35 TSLP downregulates human -defensin 2 through STAT3-dependent pathway in keratinocytes Sang Wook Son A36 Effects of anti-IgE on IL4, IL5, IL17A, and CD19,20,200 in a case of netherton syndrome SPINK5 mutation Arzu Didem Yalcin, Sukran Kose, Kemal Kiraz A37 Augmentation of ARG1 expression exacerbates airway inflammation in murine asthma models Jin-Young Lee, Sehyo Yune, Jae-Won Paeng, Mi-Jung Oh, Byung-Jae Lee, Dong-Chull Choi, Young Hee Lim, Kyoung Won Ha A38 Caregivers of children with no food allergy their experiences and perception of the condition Kiwako Yamamoto-Hanada, Masami Narita, Masaki Futamura, Yukihiro Ohya A39 Evaluation of Drug Provocation Tests in Korean Children: A Single Center Experience Jihyun Kim, Jinwha Choi, Kwanghoon Kim, Jaehee Choi, Kangmo Ahn A40 Danyoung classification 2015 update by digital Huntington_Disease endoscopic evaluation SUN-HOBrian Chang A41 Effect on quality of life of the mixed house dust miteweed pollen extract immunotherapy in polysensitized patients Lisha Li A42 Ambient desert dust and allergic symptoms: A time series analysis from a national birth cohort JECS Kumiko Tsuji Kanatani, Yu-Ichi Adachi A43 Individuals Allergic to Cow's Milk Should be Vigilant When Consuming Beef Because It May be Injected Beef Shigeyuki Narabayashi, Ikuo Okafuji, Yuya Tanaka, Satoru Tsuruta, Nobue Takamatsu A44 Quality of life of chronic rhinosinusitis patients with or without nasal polyps in Korea Soo Whan Kim, Do Hyun Kim A45 House dust mite sensitization and exacerbation of asthma in the fall in children Jong-Seo Yoon, Jin Tack Kim, Hwan Soo Kim, Yoon Hong Chun, Hyun Hee Kim, Sul Mui Won A46 Evidence-based health advice for childhood eczema and household pets Kam Lun E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"HAVCR2\",\n",
       "                    \"value\": \"Furthermore, end_entity expression on peripheral start_entity T cells was negatively correlated with the inflammatory response, the disease severity and the outcome of Hepatitis,_Infectious_Canine patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"Necrosis\",\n",
       "                    \"value\": \"Neoplasms end_entity Factor receptor-associated factor-3 TRAF3 is a central mediator important for inducing type I interferon start_entity production in response to intracellular double-stranded RNA dsRNA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL20\",\n",
       "                    \"target\": \"CCL4\",\n",
       "                    \"value\": \"While an additive effect could be observed for end_entity, CCL14, start_entity, and IL15, a distinct synergistic up-regulatory effect was observed for IL6, CCL5 and TNF- after co-infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CASP3\",\n",
       "                    \"target\": \"PARP1\",\n",
       "                    \"value\": \"In contrast, here we demonstrated apoptosis induction in human lung epithelial carcinoma A549, human hepatocarcinoma and Vero cells upon infection with the attenuated Candid1 strain of, JUNV as determined by phosphatidylserine PS translocation, Caspase 3 start_entity activation, Poly ADP-ribose polymerase end_entity cleavage andor chromosomal DNA fragmentation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Previous studies have described the general pathology in the lungs of end_entity patients and have identified some of the cell types infected by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CASP1\",\n",
       "                    \"target\": \"IFI16\",\n",
       "                    \"value\": \"end_entity and start_entity are coded by p53-regulated genes which led us to investigate regulation of NLRP1, NLRX1, STING, IFIT1 and IFIT3 in p53-dependent mode\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FKBP11\",\n",
       "                    \"target\": \"IFITM5\",\n",
       "                    \"value\": \"In this study, we investigated the role played by S-palmitoylation of end_entity in its interaction with start_entity in the cells, because this interaction is a key process for the gene expression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COX8A\",\n",
       "                    \"target\": \"Spherocytosis, Type 1\",\n",
       "                    \"value\": \"Introduction Beriate P was first introduced in Germany in 1990 as factor start_entity Fstart_entity:C end_entity Behring and subsequent product improvements yielded an albumin-free formulation with a specific activity of approximately 170IUmg protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TF\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Levels of mRNA of IL-1, end_entity, and musfiblp were greater and more persistent in BALBcJ than in AJ macrophages, whereas the levels and kinetics of IL-1, end_entity, and start_entity mRNA following Van_der_Woude_syndrome stimulation were identical in macrophages from both strains of mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Three out of eight experimental calves developed severe end_entity and the lesions in the small and large intestines were similar to those reported for start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EDEM1\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"MHV infection causes accumulation of start_entity and OS9, another short-living end_entity chaperone, in the DMVs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"TBP\",\n",
       "                    \"value\": \"Taken together, based on the expression of CD69, we found a direct quantitative and qualitative method to detect and evaluate the in vivo generated MTB-specific polyfunctional start_entity T cells in PFCs from patients with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"WDR11\",\n",
       "                    \"target\": \"Diabetic Retinopathy\",\n",
       "                    \"value\": \"The 13 HLA Class GCNT2 end_entity supertypes are end_entity1, end_entity3, end_entity4, end_entity6, end_entity7, end_entity8, end_entity9, start_entity, end_entity12, end_entity13, end_entity14, end_entity15, and end_entity16\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"One year after the occurrence of the first case of infection by the end_entity start_entity MERS-CoV there is no clear consensus on the best treatment to propose\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": \"Kowalski A507 The Role of EIF2AK2 Pathway in Acute Exacerbation of Severe Asthma So Ri Kim, Yong Chul Lee, Dong Im Kim, Yang Keun Rhee, Heung Bum Lee, Seoung Ju Park, Yeong Hun Choe Choe, Seung Yong Park A508 Diversity of Clinical Manifestations and Treatment Responses for Hypereosinophilic_Syndrome Joo-Hee Kim, Sunghoon Park, Young Il Hwang, Seung Hun Jang, Ki-Suck Jung A509 Effect of Dexamethasone in Th17 Cell Mediating Neutrophilic Asthma Nong Guang-Min, Jiang Min A510 Allergen Profile for AsthmaRhinitis and Eczema Among Patients in North India: An Immunocap Allergen Specific IgE Antibodies Assay Based Study Nalin Nag A511 Clinical Profile of end_entity in Children in Jakarta Wahyuni Indawati A512 Preclinical Study on the Use of Micro Crystalline Tyrosine MCT Adjuvants in Hypersensitivity Immunotherapy Alan David Bullimore, Matthew Heath, Murray Skinner A513 Genetic Diversity of Filaggrin Mutation and Its Clinical Implication in East Asian Dermatitis,_Atopic Patients Seong Jun Seo, Won Jong Oh A514 Protein and MPL Adsorption Capacities for MCT in Candidate Therapeutic Formulations for Use in Immunotherapy, Compared Against Existing Adjuvants Alan David Bullimore, Murray Skinner, Matthew Heath, Andrew Bell A515 Interleukin-22 Gene Variation in Inflammatory_Bowel_Diseases Alireza Zarebidoki, Hournaz Hasanzadeh, Salman Sadeghzade, Nima Rezaei A516 Immunomodulatory Effects of Adipose-Derived Stem Cell Secretome in a Mouse Model of Asthma Kyu-Sup Cho A517 Diffuse Alveolar Hemorrhage with Positive Anti-Neutrophil Cytoplasmic Antibody in a Child : A Case Report Sung-Woo Kim, Moo-Young Oh A518 Clinical Analys the Serum CCL17 Levels As the Condition Index of Dermatitis,_Atopic in the Early Infancy Munemitsu Koizumi, Kazuyo Kuzume A519 An Analysis of the Filaggrin Gene Polymorphism in Korean Dermatitis,_Atopic Patients Kui Young Park, Won Jong Oh A520 A New Protocol for Wheat Oral Immunotherapy in Patients with start_entity Delara Babaie, Mohammad Nabavi, Fariborz Zandieh, Mehrdad Amir Moini, Zahra Chavoshzadeh, Hamideh Seifi, Mitra Sahragard, Mehrnaz Mesdaghi, Mohammad Hassan Bemanian A521 Clinical Characteristics of Filaggrin-Related Dermatitis,_Atopic Patients in Korea Sun Young Choi, Yeon a No A522 Early Hypersensitivity Diagnosis in Children - Self- Administered Questionnaire Vs Medical Verification Andrzej M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"target\": \"Alzheimer Disease\",\n",
       "                    \"value\": \"The amyloid precursor protein APP, that plays a critical role in the development of senile plaques in APP end_entity, and the gp41 ERVW-1 of the human immunodeficiency virus HIV, the causative agent of the acquired immunodeficiency syndrome start_entity, are single-spanning type-1 transmembrane TM glycoproteins with the ability to form homo-oligomers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"T1\",\n",
       "                    \"value\": \"Our start_entity, V1, and end_entity endonuclease mappings, together with UV melting analysis, clearly indicate that this sequence element of the HIV-1 mRNA frameshift site forms a stem-loop structure, not a pseudoknot structure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"HSP90B1\",\n",
       "                    \"value\": \"A number of DEGs, including zinc finger and BTBD17 ZBTB17, heat shock protein 90 kDa , member 1 end_entity and major histocompatibility complex, class start_entity, Diabetic_Retinopathy were identified\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"MAVS\",\n",
       "                    \"value\": \"Reovirus activates start_entity and end_entity for phosphorylation of IRF3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity and Middle-East respiratory syndrome MERS start_entity, which caused 2003 end_entity outbreak in China and 2014 MERS outbreak in the Middle East, belong to the start_entity family\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNFRSF1A\",\n",
       "                    \"target\": \"TNFRSF1B\",\n",
       "                    \"value\": \"METHODOLOGYPRINCIPAL FINDINGS: Ten SNPs in TNF, LTA, start_entity and end_entity were genotyped in samples of patients with severe sepsis n 432, sepsis n 384 and healthy controls n 624\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALK\",\n",
       "                    \"target\": \"Neoplasms\",\n",
       "                    \"value\": \"Here, we employ a bioinformatics method, Prediction of T Cell Epitopes for end_entity Therapy, to analyze sequencing data from neuroblastoma patients and identify a recurrent anaplastic lymphoma kinase mutation start_entity R1275Q that leads to two high affinity neoepitopes when expressed in complex with common HLA alleles\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK1\",\n",
       "                    \"target\": \"Spherocytosis, Type 1\",\n",
       "                    \"value\": \"Heat shock end_entity, another activator of start_entity, also induced eIF2 phosphorylation and SGs in cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bietti Crystalline Dystrophy\",\n",
       "                    \"target\": \"Hepatitis\",\n",
       "                    \"value\": \"This review takes a closer look at T-cell exhaustion in chronic viruses known to cause human disease: EpsteinBarr virus EBV, end_entity start_entity virus HBVHCVHDV, human herpesvirus 8 HHV-8, human immunodeficiency virus HIV, human T-cell leukemia virus type I HTLV-I, human papillomavirus HPV, herpes simplex virus-12 HSV-12, and VaricellaZoster virus VZV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypohidrosis\",\n",
       "                    \"target\": \"Recurrence\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with end_entity Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory_Tract_Infections Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus Infection-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing Hypersensitivity,_Immediate Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized start_entity ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Allopurinol\",\n",
       "                    \"target\": \"Esophagitis\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and start_entity Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to Glatiramer_Acetate: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 Asthma Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent Rhinitis,_Allergic Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with Rhinitis,_Allergic Chellaa R A615 Study of Incidence of Severe Persistent Rhinitis,_Allergic in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A617 Dermatitis,_Atopic: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera MITF Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe Dermatitis,_Atopic Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of Rhinitis,_Allergic Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao Pigmentary_Disorder,_Reticulate,_with_Systemic_Manifestations Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, Rhinitis,_Allergic, Dermatitis,_Atopic, and Acute Upper Respiratory_Tract_Infections and Levels of Severity of Asthma in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in Eosinophilic end_entity Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent Dermatitis,_Atopic Associated with Parasitic Infection Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and Asthma Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in Asthma, Rhinitis,_Allergic, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via ERK and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of Asthma Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of Anaphylaxis and Asthma Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe Dermatitis,_Atopic Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DOCK11\",\n",
       "                    \"target\": \"TBATA\",\n",
       "                    \"value\": \"This study has demonstrated that the glycan array prepared from the start_entity slide is more homogeneous with better end_entity control compared with the commonly used glycan array prepared from the N-hydroxysuccinimide-activated glass slide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TSLP\",\n",
       "                    \"target\": \"Nasal Polyps\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and Urticaria Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, start_entity, Periostin, IL13 and IL-33 in end_entity Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous Urticaria Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression KLRK1 and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 Chlorhexidine anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute Urticaria at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P1\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"The end_entity produced in Nicotiana benthamiana leaves from a subviral RNA termed LONG, which expresses a truncated polyprotein that lacks start_entity and Hend_entityro, together with Hend_entityro supplied in trans, was assembled into virus-like particles and remained stable after in vitro incubation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"IRF3\",\n",
       "                    \"value\": \"We also found that PDCoV infection significantly suppresses the activation of IFN- promoter stimulated by end_entity or its upstream molecules DDX58, start_entity, MAVS, TBK1, IKK in the DDX58 signaling pathway, but does not counteract its activation by the constitutively active mutant of end_entity end_entity5D\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNL1\",\n",
       "                    \"target\": \"IFNL3\",\n",
       "                    \"value\": \"Type I IFNs are appreciated to be important in several viral and bacterial diseases, while the recently identified type III IFNs start_entity, IFNL2, end_entity, IFNL4 have been studied primarily in the context of viral infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Burkitt Lymphoma\",\n",
       "                    \"target\": \"Sarcoma, Kaposi\",\n",
       "                    \"value\": \"The role of cyclooxygenase-2 COX-2, its lipid metabolite prostaglandin E2 PGE2, and Eicosanoid EPO receptors EPO; 1-4 underlying the proinflammatory mechanistic aspects of start_entity, nasopharyngeal carcinoma, cervical cancer, prostate cancer, colon cancer, and end_entity KS is an active area of investigation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ABCB11\",\n",
       "                    \"target\": \"FXR2\",\n",
       "                    \"value\": \"Emodin also had a notable effect on rat primary hepatocytes experiment, rat pathological manifestation, start_entity, FXR1, and end_entity positive staining in liver tissues and the test of liver function\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CASP3\",\n",
       "                    \"target\": \"FCGR3B\",\n",
       "                    \"value\": \"Genetic studies have identified several susceptibility genes for KD and its sequelae in different ethnic populations, including FCGR2A, CD40, ITPKC, FAM167A-BLK and start_entity, as well as genes influencing response to intravenous immunoglobulin IVIG and aneurysm formation such as end_entity, and transforming growth factor TGF pathway genes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"IL18\",\n",
       "                    \"value\": \"RESULTS: Serum lactate dehydrogenase, end_entity, and ferritin concentrations were significantly higher in Group start_entity than in Groups I, start_entityI, IV, and V and were significantly higher in Group B than in Group A\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIT1\",\n",
       "                    \"target\": \"IFIT3\",\n",
       "                    \"value\": \"Site-directed mutagenesis revealed a C-terminal YxxxL motif in start_entity that mediates its association with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"membrane oxygenation\",\n",
       "                    \"value\": \"29 patients 69 were transported with extracorporeal end_entity support, while 13 patients 31 were transported with conventional start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Independent of virulence variations they are separated into two different types, type I, the original FCoV, and type start_entity, which is closely related to canine COVID-19 end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity, Immediate\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Delsing, Bee Wah Lee, Bee Wah Lee, Si Hui Goh, Wen Chin Chiang, Wenyin Loh A531 The Association Between Serum Vitamin D Levels and Allergic Diseases in Elementary Schoolchildren Hea-Kyoung Yang, Ji Young Lee, Minji PSME3m, Kangmo Ahn, Jihyun PSME3m, Young-Min PSME3m, Hye-Young PSME3m, Yong Mean Park, Woo Kyung KIM, So-Yeon Lee A532 Serum Levels Specific IgE to Shock,_Septic Toxin Type 1 in Eosinophilic Chronic Rhinosinusitis with Nasal_Polypss in Korean Jongin Jeong, Sang Duk Hong, Seung Kyu Chung, Hun-Jong Dhong, Hyo Yeol PSME3m Hyo Yeol PSME3m, Sujin KIM A533 Impacts of Rhizosphere Cleaning Effects of Potted Indoor Plants on the Symptoms and Stress of Students with Rhinitis,_Allergic in Newly Built Schools Yong-Won Lee, Hana Bak, Hye-Rim Son, Si-Eun Lee, Kwang-Jin PSME3m, Young-Wook Lim, Ho-Hyun PSME3m A534 A Case of Multiple Food_Hypersensitivity with Recurrence Anaphylaxis Successively Controlled By Omalizumab Mi-Ae PSME3m, Man Yong Han, Young-Ho Jung, Hye Mi Jee, Seung Jin Lee, Kyung Suk Lee A535 Bepotastine-Induced Urticaria, Cross-Reactive with Other Antihistamines Jasmina Golez, Jaechun Lee, Eunkyoung Lee A536 Role of SLC26a4 in Ozone - Induced Airway Reactivity and Inflammation Da-Jeong Bae, Chang-Gi Min, Jong-Uk Lee, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, An-Soo Jang A537 PAR2-Antagonist Suppresses Protease-Induced Allergic Inflammation Mediated By Degradation of Lung Epithelial Tight Junction and Generation of ROS1 Young-Joon PSME3m, Bok Kyoung Jung, Seung-Hwa Lee, Mi-Jin Kang, Sekyoo Jeong, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Song-I Yang, Seo Hee PSME3m, Soo-Jong Hong A538 Novel Anti-IL-4Ra Nanocarrier Approach for the Efficient Control of Lung Tissue Inflammation during Asthma Rabih Halwani, Saleh Al Muhsen, Asma Sultana, Achraf Al-Faraj, Rosan Kanana, Sibtain Afzal, Roaa Al Kufaidi A539 Clinical Factors for Improved Allergen Reactivities Induced By Subcutaneous Allergen Specific Immunotherapy with House Dust Mites during 1 Year Period Hee-Kyoo PSME3m, Chul-Ho Oak, Gil-Soon Choi, Ye-Jin Moon, Eun-Kee Park A540 Cytokine Gene Polymorphisms in Iranian Patients with PSME3dney Acute Rejection Alireza Zarebidoki, Mina Abrari, Ali Akbar Amirzargar A541 Phthalate Exposure and Obesity in Dermatitis,_Atopic of Korean Children and Adolescents Ju-Hee Seo, Mina Ha, Soo-Jong Hong A542 Which Drives Chronicity of Cough in Adults: Based on the Knhanes 2010-2012 Mingyu Kang, Byung-Ha Cho, Han-PSME3 Park, Han-PSME3 Park, Kyung-Mook PSME3m, Chang-Han Park, Heung Woo Park, Heung Woo Park, Yoon-Seok Chang, Yoon-Seok Chang, Yoon-Seok Chang, Sook-Hee Song, Mi-Kyeong PSME3m, Mi-Kyeong PSME3m, Sang-Heon Cho, Suk-Il Chang, Kyung-up Min, Kyung-up Min, Alyn Morice A543 Elevated Airway CD45RO Memory Cells in Respiratory_Sounds Children with Lower Respiratory end_entity Jungi Choi, Yusok Han, Jin-Sung Park, Eunmi Kwon, Chang-Keun PSME3m A544 Quality of Life in Obesity Children with or without Atopic Disease Gartika Sapartini A545 Relation of Human microRNA in Sputum of Asthma with Influenza,_Human A Virus end_entity-Induced Exacerbation Ji-Na PSME3m, Seungwoo Shin, Hun Soo Chang, Eun-Young Shim, Ji Ah Jun, Hyeonju Lee, Jong-Sook Park, Choon-Sik Park A546 Aeropolinologic Monitoring and Distribution of Allergoallergens in Western Georgia Revaz Sepiashvili, Darejan Khachapuridze, Sofio Gamkrelidze, Manana Chikhladze A547 Extracorporeal Membrane Oxygenation As Emergencies Treatment for Patients with Near-Fatal Status_Asthmaticus Seung-Eun Lee, Yun-Seong PSME3m, Doo-Soo Jeon, Woo-Hyun Cho, Hye-Ju Yeo, Seong-Hoon Yoon, Seung-Hyun PSME3m A548 Relationship of S100calcium Binding Protein A9 with Neutophilic Inflammation in Murine Asthma Model Taehyeong Lee, Hyun Ji Song, Choon-Sik Park, Ji Ah Jun, Jong-Sook Park A549 Whole-Exome Sequencing of Aatopic Dermatitis in Korean Childhood Dankyu Yoon, Yeon-Seop PSME3m, Woo-Sung Chang, Mi-Jin Kang, Soo-Jong Hong, Jeom-Kyu Lee, Eun-Jin PSME3m A550 A Case of Generalized Molluscum_Contagiosum in an Adult Patient with Severe Dermatitis,_Atopic Minkee Park A551 Discovery of Putative Macadamia Nut Allergens By Patient IgE Binding and a Label-Free Shotgun Proteomics Approach Nanju Alice Lee, Johanna Rost, Sridevi Muralidharan, Dianne Campbell, Sam Mehr A552 Anti-Fcri Antibody Inhibits Allergic March in Mice By Suppressing Th17 Pathway Via Suppression of Fcri-Mediated C9orf9 Cells Activation Seung-Hwa Lee, Seon-Joo Yoon, Ha-Jung PSME3m, Eun Lee, Song-I Yang, Young-Ho Jung, Ho-Sung Yu, Hee-Suk PSME3m, Yeon Hee Park, So-Yeon Lee, Jun-Sung Park A553 Clinical Characteristics and the Associated Factors of ATG Hypersensitivity Reaction Ha Kyeong Won, Min-Koo Kang, Sung Do Moon, Byung-Keun PSME3m, Ju-Young PSME3m, Sang-Heon Cho, Hye-Ryun Kang, Ji-Su Shim, Soo Jie Chung A554 Reference Value and Utility of Total Serum Immunoglobulin E in Korean Schoolchildren Jaehee Choi, Kangmo Ahn, Kwanghoon PSME3m, Jihyun PSME3m, Jiyoung Lee A555 Two-Step Prescreening Skin Testing May be Useful for Reducing start_entity Reaction to Nonionic Contrast Media: Results of 7-Year Period in a Secondary Hospital Bo Bae Park, In Young Nho, Chang-Han Park, Jang Min PSME3m, Suk-Il Chang A556 Prevalence of Allergic Sensitization in Patients with Hypersensitivity Rhinitis; Gwangju, Jeonnam State Study Sun Kyung PSME3m, Hyung Chae Yang, Kwang Il Nam A557 Analysis of IgE Binding Components of Walnut in Korean Children Effect of Cooking Methods on the Allergenicity of Walnut Proteins Jeongmin Lee, Jeongmin Lee, Sooyoung Lee, Kyunguk Jeong, Se-Ah Jeon A558 Assessment of Autonomic Nervous Function in Subjects with Cholinergic Urticaria Associated with Acquired Idiopathic Generalized Hypohidrosis ALPK3 Fujiwara, Shoko Shindo, Hiroyuki Murota, Mayuko Tahara, Aya Takahashi, Ichiro Katayama A559 Interleukin 1 Beta in Sputum of Patients with Asthma: Relation with Airway_Obstruction and Neutrophilc Inflammation Jae Woo Jung, Hyun Ji Song, Taehyeong Lee, An-Soo Jang, Jong-Sook Park, Hun Soo Chang, Choon-Sik Park, Byoung Whui Choi A560 Interleukin 8 in Sputum of Patients with Asthma: Relation with Neutrophilc Inflammation and Exacerbation Min-Hye PSME3m, Da-Jeong Bae, Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Jong-Sook Park, An-Soo Jang, Hun Soo Chang, Young Joo Cho, Choon-Sik Park A561 Prostaglandin E2 and Transforming Growth Factor-2 Play a Critical Role in Suppression of Allergic Airway Inflammation By Adipose-Derived Stem Cells Sue Jean Mun A562 Inhalation of Fine Particles PSME3ll Alveolar Macrophages to Release IL-1alpha That Promote Inducible Bronchus-Associated Lymphoid Tissue iBALT Formation Etsushi Kuroda, Koji Ozasa, Ken Ishii A563 Association Between Smoking and Allergic Diseases in the Korean Adult General Population Sunmi PSME3m, Gyeong-Hun Park A564 Relationship of S100 Calcium Binding Protein A9 with Inflammasome Activation in Murine Asthma Model Hyun Ji Song, Taehyeong Lee, Ji Ah Jun, Hun Soo Chang, Jong-Sook Park, Choon-Sik Park A565 Cluster Analysis of Asthma Phenotypes to Predict Exacerbation in Korean Population Mi-Ae PSME3m, Seungwoo Shin, Jong-Sook Park, Hun Soo Chang, You Sook Cho, Hae-Sim Park, Choon-Sik Park A566 Effect of AG490 on the Expression of TH17 CELLS and Tregs in the MOUSE MODEL of Neutrophilic Asthma Zhang Min A567 Association Between the Clinical Characteristics and Disease Severity in Hospitalized Bronchiolitis Patients Younger Than Two Years Old Seo Hee Yoon, In Suk Sol, Young a Park, Yoon Hee PSME3m, Min Jung PSME3m, Kyung Won PSME3m, Myung Hyun Sohn, Kyu-Earn PSME3m A568 Comparison Between House Dust Mite and Aspergillosis Sensitization in Patients with High Level of Tige Wu Shiquan A569 The Prevalence of Metal Hypersensitivity in the Patients with Orthodontic Appliance Yongwon Lee, Hana Bak A570 Component Resolved Diagnosis and Single Nucleotide Polymorphism Analyses: Towards the Development of Specific Immunotherapy for Hypersensitivity Maricar Wisco Ching, John Donnie Ramos A571 Clinical Features of Anaphylaxis Caused By Peanut, Tree Nuts and Seeds in Children and Adolescents: Multi-Center Study with 126 Patients Kyunguk Jeong, Sooyoung Lee, Kangmo Ahn, Myung Hyun Sohn, Kyung Won PSME3m, So-Yeon Lee, Tae Won Song, Youhoon Jeon, Jihyun PSME3m, Taek PSME3 Min, Kyu-Earn PSME3m, Bok-Yang Pyun, Hyeon-Jong Yang, Hae Ran Lee, Youngmin Ahn, Ji-Won Kwon, Dae Hyun Lim, Jeong Hee PSME3m, Dongin Suh, Hyung Young PSME3 A572 A Report of Two Cases of Anaphylaxis Caused By Perilla Seed in Children Kyunguk Jeong, Byeong Sub Park, Sooyoung Lee, Se-Ah Jeon, Kyu Jung Park A573 Prenatal Fine Particulate Matter Affects Respiratory_Sounds in Children with TLR4 Polymorphism: CALCOCO1 Study Song-I Yang, Eun Lee, Hyun-Ju Cho, Young-Ho PSME3m, Mi-Jin Kang, Yean Jung Choi, PSME3l Yong Choi, Youn Ho Shin, Kangmo Ahn, Kyung Won PSME3m, Byoung-Ju PSME3m, So-Yeon Lee, Eun-Jin K A574 Intensified B Lymphocyte Depletion IBLD without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus_Vulgaris_Nephritis LN: a 4-Year Observation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"JUN\",\n",
       "                    \"target\": \"TAX1BP1\",\n",
       "                    \"value\": \"end_entity deficiency augments virus-induced activation of proapoptotic start_entity N-terminal kinase MAPK8 signaling\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Glatiramer Acetate\",\n",
       "                    \"target\": \"MITF\",\n",
       "                    \"value\": \"Ehlayel, Abdul Bari Bener A607 Strong Association Between HLA-B5801 Allele and Allopurinol Induced Severe Cutaneous Adverse Reactions in Vietnamese Hieu Chi Chu, Nga Thi Quynh Do, Dinh Van Nguyen, Ha Thi Thu Nguyen, Huong Thi Minh Le, Sheryl Van Nunen, Christopher Vidal, Suran Fernando A608 Successful Rapid Desensitization to start_entity: Report of 2 Cases Fotis Psarros, Ekaterini Syrigou, Ekaterini Politi, Spyridon Chrysoulakis A609 Asthma Exacerbations Seasonal Variation in Two Perennial Phenotypes during Twenty Years 1995-2014: House Dust Mite Monosensitized and Non Atopic Patients Dimitrios Vourdas, Konstantinos Petalas A610 Occupational Hypersensitivity to Fungal Spores Among the Farmers of Paddy Fields in West Bengal, India: An Aeromycological and Immunological Approach Mouli SAHA, Kashinath Bhattacharya A611 Study of Efficacy of Sublingual Immunotherapy SLIT in Cases of Severe Persistent Rhinitis,_Allergic Subir Jain A612 Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Pathway Mesenchymal Stem Cells Suppress Pneumonia and Airway_Remodeling in Chronic Asthma Rat Model Via PI3KAkt Signaling Xiaolian Song, Haiyan Lin A613 Development of Allergen ELISA Kits for Dust Mites, Pollen, and Pet Dander Kyohei Nishikawa, Takashi Shimada, Hiroshi Yasueda, Tadao Enomoto, Daisuke Aizawa, Takayoshi Kobayashi A614 Yoga As a Lifestyle Modification to Improve the Quality of Life in Smokers with Rhinitis,_Allergic Chellaa R A615 Study of Incidence of Severe Persistent Rhinitis,_Allergic in Different Age Groups,Sex Prevalance and Type of Allergen Aeroallergen or Food Allergen Responsible for Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A616 Causative Allergens in Cases of Severe Persistent Rhinitis,_Allergic in Central India Subir Jain A617 Dermatitis,_Atopic: A New Data on the Mechanisms of Chronic Pruritus Marina Yudina A618 The Efficacy and Safety of Peanut Oral Immunotherapy in High-Dose with Predicting Factors Ishaq M, Sameera end_entity Khan, Imran Khan, Sabeen Khan A619 Evaluation of Long-Term Prognosis and Topical Corticosteroid Usage after One Year of Proactive Treatment for Children with Moderate-to-Severe Dermatitis,_Atopic Mayako Saito A620 Hypersensitivity Symptoms in the First Two Months of Life Nurul Iman Nilam Sari A621 Factors Related to the Seasonal Variation of Rhinitis,_Allergic Jae Young Kim, Jaechul Song, Inah Kim, Kyeong Joon Lee, Soo Jin Park, Soo Yong Roh A622 Allergic Risk Survey in Lao Children at out-Patient Department, Children's Hospital, Vientiane Capital, Lao Pigmentary_Disorder,_Reticulate,_with_Systemic_Manifestations Somxay Billamay A623 Correlation Between Food_Hypersensitivity, Aeroinhalant Hypersensitivity, Rhinitis,_Allergic, Dermatitis,_Atopic, and Acute Upper Respiratory_Tract_Infections and Levels of Severity of Asthma in Pediatric Medicine Department Saiful Anwar Hospital Indonesia Muchammad Fahrul Udin A624 Comparative Study of Pine, Oak, and Ginkgo Pollen Counts in Korea during Last Four Years Mae Ja Han, Jae-Won Oh, Kyu Rang Kim, Baek-Jo Kim A625 Effectiveness of Hypersensitivity-Test Directed Elimination Diets in Eosinophilic_Esophagitis Jorge A Mazza, Jason Kangeun Ko, David JT Huang A626 Comparison of Cut-Off Values and Probability Curves for Egg Specific IgE in Diagnosis of Egg_Hypersensitivity in Young Children Kanae Furuya, Keigo Kainuma, Takahiro Ito, Mizuho Nagao, Takao Fujisawa, Junya Hirayama, Yu Kuwahara A627 A Case of Persistent Dermatitis,_Atopic Associated with Parasitic Infection Rosanna Qualizza, Cristoforo Incorvaia, Anna Maraschini A628 Aeroallergenic Profile of Indoor Allergens and Their Clinical Relevance in Hypersensitivity and Asthma Patients in Saudi Arabia Syed Mohammed Hasnain, Abdulrahman Al-Frayh A629 Oral Exposure to the Amino Acid Glycine Inhibits the Onset of Allergic Disorders Anita Hartog, Jacqueline Bastiaans, Reinilde Loonstra, Lieke Rutten, Lucien Harthoorn, Jeroen Van Bergenhenegouwen, Johan Garssen, Johan Garssen A630 Cough As a Key Symptom in Asthma, Rhinitis,_Allergic, Pulmonary_Disease,_Chronic_Obstructive and Rhinosinusitis and Its Impact in Korea Kwang-Ha Yoo, Sang-Heon Cho, AG Ghoshal, Abdul Razak Bin Abdul Muttalif, Horng- Chyuan Lin, Sanguansak Thanaviratananich, Shalini Bagga, Rab Faruqi, Santwona Baidya, Colman Taylor, De Yun Wang, Hae-Ryun Ahn, Soon-Kwan Hong, Jong-Woong Kim, Gui-Hyun Nam, Mee-Ja Kim, Jae-Kyoung Park A631 Cysteine Protease Allergen Def f 1 Induces Th2 Cytokines in Mouse Bone Marrow Derived Basophils Via ERK and MAPK8 Dependent Pathways Myung-Hee Yi, Kyoung Yong Jeong, Ju-Yeong Kim, Tai-Soon Yong A632 Novel Multiple Hypersensitivity Testing Kit Using Parallel Lines Array PLA Technology Bum Joon Kim, Hs Joo, Kj Lim, Jae-Hyun Lee, Jung-Won Park, Kh Yoon, DHDDS Choi A633 Quantitative Rapid Kit for Human Immunoglobulin Hanseung Joo, Bum Joon Kim, Kj Lim, MJ KIM, DHDDS Choi, Kh Yoon A634 Total IgE Measurement By Protia Hypersensitivity-Q: Comparison Study with Immunocap Bum Joon Kim, Hanseung Joo, Woo Sang Jung, Kj Lim, DHDDS Choi A635 Prevalence and Risk Factors of Asthma Among Korean Farmers Ji-Hoon Lee, Soon-Chan Kwon, Soo-Jin Lee, Soo Yong Roh, Hogil Kim, Kyeong Joon Lee A636 Dietary Intake and Perceived Immune Status in Young Dutch Women Aurora Van De Loo, Amanda Fernstrand, Johan Garssen, Joris Verster A637 The Effects of Antihistamine Drugs on on-Road Driving Performance Aurora Van De Loo, Johan Garssen, Joris Verster A638 Grass Is Guilty: A Case of Anaphylaxis and Asthma Status in the Same Time in an Individual Jasmina Golez A639 Cyclic Gamp-AMPcGAMP Induces Allergic Inflammation Koji Ozasa, Etsushi Kuroda, Ken Ishii, Ken Ishii A640 Role of Omalizumab in the Setting of Recalcitrate Dermatitis with Extremely Elevated IgE Levels Muhammad Imran, Selina Gierer, John Martinez A641 Follow-up Study on the Natural History of Prawn Hypersensitivity Lydia Wong, Bee Wah Lee, Gaik Chin Yap, Genevieve Llanora, Bernard Thong, Lynette Shek A642 Protein-Losing Dermopathy Impairing Growth in Children with Severe Dermatitis,_Atopic Mohammad S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Chlorhexidine\",\n",
       "                    \"target\": \"KLRK1\",\n",
       "                    \"value\": \"Pieters A151 Clinical significance between the allergic test and serum RNASE3 Boo-Young PSME3m, Soo Whan PSME3m A152 Hydroclorothiazide-induced acute non-cardiogenic pulmonary edema Ramon Lleonart A153 A Synbiotic Mixture of ScgosLcfos and Bifidobacterium Breve M-16V Is Able to Restore the Delayed Colonization of Bifidobacterium Observed in C-Section Delivered Infants Christophe Lay, Kaouther Benamor, Chua Mei Chen, Jan Knol, Charmaine Chew, Voranush Chongsrisawat, Anne Goh, Wen Chin Chiang, Rajeshwar Rao, Surasith Chaithongwongwatthana, Nipon Khemapech A154 Atopic characteristics of patients with asthma-COPD overlap syndrome Ji Young Yhi, Sang-Heon PSME3m, Dong Won Park, Ji-Yong Moon, Tae Hyung PSME3m, Jang Won Sohn, Dong Ho Shin, Ho Joo Yoon, Seok Hyun Cho A155 Perceptions and practices of severe asthma and asthma-COPD overlap syndrome among specialists: A questionnaire survey Sang-Heon PSME3m, Ji-Yong Moon, Jae-Hyun Lee, Ga Young Ban, Sujeong PSME3m, Mi-Ae PSME3m, Joo-Hee PSME3m, Min-Hye PSME3m, Chan-Sun Park, Hyouk-Soo Kwon, Jae-Woo Kwon, Jae Woo Jung, Hye-Ryun Kang, Jong-Sook Park, Tae-Bum PSME3m, Heung Woo Park, You Sook Cho, Kwang-Ha Yoo, Yeon-Mok Oh A156 A case of surgical diagnosed eosinophilic enteritis with intussusception in adult patient Sang-Rok Lee A157 Reference values of total IgE in estonian children Kaja Julge, Maire Vasar, Tiia Voor, Tiina Rebane A158 A case of eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis Yu Jin PSME3m, Sang Min Lee, Shin Myung Kang, Sojeong PSME3m, Sun Young Kyung, Sung Hwan Jeong, Jeong-Woong Park, Hyunjung Hwang, Yong Han Seon, Sanghui Park, Sang Pyo Lee A159 Associations Between Communicable_Diseases and Urticaria Marius Iordache A160 Sleep in infants in korea finding of bisq survey Yeongsang Jeong, Sohee Eun, Byung Min Choi, Ji Tae Choung, Wonhee Seo A161 Increased Expression of Filaggrin, TSLP, Periostin, IL13 and IL-33 in Nasal_Polyps Liang Zhang, Ruby Pawankar, Manabu Nonaka, Miyuki Hayashi, Shingo Yamanishi, Harumi Suzaki, Yasuhiko Itoh, So Watanabe, Hitome Kobayashi A162 Asymptomatic bacteruria increases the risk of edematous attacks in patients with hereditary angioedema due to C1 inhibitor deficency C1-INH-HAE Zsuzsanna Zotter, Henriette Farkas, Lilian Varga, Nora Veszeli, Eva Imreh, Gabor Kovacs, Marsel Nallbani A163 Gastric Erosions Cause Spontaneous Urticaria Independent of Helicobacter Pylori Semen Zheleznov, Galina Urzhumtseva, Natalia Petrova, Zhanna Sarsaniia, Nikolai Didkovskii, Torsten Zuberbier A164 The Effect of G2 Vaccine on the Gene Expression end_entity and Receptor Presenting on the Surface of NK Cells in Peripheral Blood Nader Dashti Gerdabi, Ali Khodadadi, Zahra Abdoli, Mehri Ghafourian, Mohammad Ali Assarehzadegan, Khodayar Ghorban A165 Ethnic differences in lifetime prevalence and indoor environmental factors for childhood eczema Hyo-Bin PSME3m, Hui Zhou, Jeong Hee PSME3m, Rima Habre, Theresa Bastain, Frank Gilliland A166 A case of methazolamide-induced toxic epidermal necrolysis Jong-Wook Bae, Kyu-Hyung Han, Young-Koo Jee, Misoo Choi, Seung-Phil Hong, Seung-Hyun PSME3m A167 Inflammatory responses of human adipose-tissue derived stem cells to Van_der_Woude_syndrome and nanoparticles Hee-Kyoo PSME3m, Gil-Soon Choi, Jeonghoon Heo, Young-Ho PSME3m, Eun-Kee Park A168 Analysis of 71 Cashew Nut Oral Challenge Tests Takashi Inoue, PSME3yotake Ogura, Noriyuki Yanagida, Hirotoshi Unno, Kenichi Nagakura, Tetsuharu Manabe, Tomoyuki Asaumi, Sakura Sato, Yu Okada, Motohiro Ebisawa A169 Fungal sensitization is associated with asthma exacerbation Min-Gu PSME3m, You Sook Cho, Tae-Bum PSME3m, Hee-Bom Moon, Jung-Hyun PSME3m, Hyo-Jung PSME3m, So-Young Park, Bomi Seo, Hyouk-Soo Kwon, Jaemoon Lee, Taehoon Lee SQSTM1 Individual therapeutic patient education and consultation in children with atopic dermatitis Hye-Soo Yoo, Jieun PSME3m, Inok PSME3m, Haejin PSME3m, Younhee Chang, Hae-Sim Park, Sooyoung Lee A171 Utility of Alpha-Lactalbumin Specific IgE Levels Using Immulite 2000 3gHypersensitivity in Predicting Clinical Severity of Milk Hypersensitivity Kazuyo Kuzume, Munemitsu Koizumi, Koji Nishimura, Michiko Okamoto A172 Isoniazidrifampicin-specific t-cell responses in patients with anti-tuberculosis induced dress syndrome Seung-Hyun PSME3m, Young Min Ye, Gyu Young Hur, Hae-Sim Park, Sang-Heon PSME3m, Young-Koo Jee A173 Genetic biomarkers associated with aspirin-exacerbated respiratory disease AERD phenotype based on genome-wide association study Seung-Hyun PSME3m, Hyunna Choi, Young Min Ye, Hae-Sim Park A174 Assessment of ORAL drug provocation test in the diagnosis of NON-steroidal ANTI-inflammatory drugs hypersensitivity Bui TNIP1 Khanh, Hieu Chi Chu, Nguyen Nhu Nguyet, Nguyen Hoang Phuong A175 Korean treatment guideline of atopic dermatitis Joo Young Roh, Hyun Jeong PSME3m, Jung Eun PSME3m, Bark-Lynn Lew, Kyung Ho Lee, Seung-Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, PSME3 Beom Suhr, Seung Chul Lee, Hyun-Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park A176 Systemic side reaction of subcutaneous immunotherapySCIT for perennial Rhinitis,_Allergic,_Seasonal Kun Hee Lee, Sung Wan PSME3m A177 Clinical baseline characteristics of Asian patients suffering from refractory chronic spontaneous urticaria CSU in three phase 3 omalizumab clinical trials Chia-Yu CHU, Derrick Aw, Young-Min Ye, Giovanni Bader, Fabrizio Dolfi, Nathalie Oliveira A178 A metagenomic approach through t-RFLP to the microbiome of asthma Jae Chol Choi, Jae Woo Jung, Hye-Ryun Kang, PSME3jeong PSME3m, Byoung Whui Choi A179 Clinical characteristics and ten-year trend of peripheral blood eosinophilia among health screening program recipients at a tertiary hospital of South Korea Jong Wook Shin, Jae Woo Jung, Jae Chol Choi, In Won Park, Byoung Whui Choi, Jae Yeol PSME3m A180 The prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic Korean adults Jin-Young Lee, Kyoung Won Ha, Yun-Jin Jeung, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jung Oh, Young Hee Lim A181 Cutaneous Drug_Hypersensitivity Reaction in Korean Children: An Analysis of KAERS Database on 2012-2013 Eui Jun Lee, Dongin Suh, Sung-Il Woo, Hwa Jin Cho, Eun Hee Chung, Soo Youn Chung A182 Comparison of clinical characteristics, quality of life and sleep in patients with Rhinitis,_Allergic,_Seasonal when categorised as sneezers and runners and blockers Kamal Gera, Ashok Shah A183 Role of s-nitrosoGSR GSNOR in the murine strain differences of airway hyperresponsiveness Jin-Young Lee, Kyoung Won Ha, Mi-Jung Oh, Young Hee Lim, Sehyo Yune, Jae-Won Paeng, Mi-Jin Jang, Byung-Jae Lee, Dong-Chull Choi A184 Protection from airway bronchoconstriction by gsno Jin-Young Lee, Mi-Jin Jang, Jae-Won Paeng, Yun-Jin Jeung, Young Hee Lim, Mi-Jung Oh, Kyoung Won Ha, Byung-Jae Lee, Dong-Chull Choi, Sehyo Yune A185 Does EIA-targeted asthma treatment improve daily physical activity of children? Takahiro Ito A186 Respiratory_Sounds as a clue to the diagnosis of cough variant asthma and nonasthmatic eosinophilic bronchitis Jihye PSME3m, Jin-Young Lee, Sehyo Yune, Byung-Jae Lee, Dong-Chull Choi, Mi-Jin Jang, Jae-Won Paeng, Young Eun PSME3m, Young Nam PSME3m, Yongseok Lee A187 Antagonism of microRNA-21 suppressed the airway inflammation in a mouse model of bronchial asthma Hwa Young Lee, Sook Young Lee, Soon Seog Kwon, Young Kyoon PSME3m, Chin Kook Rhee, Sei Won PSME3m, Hea Yon Lee, Joon Young Choi, In Kyoung PSME3m A188 start_entity anaphylaxis: A report of two cases Jose Antonio Navarro, Maria Ascension Aranzabal, Alejandro Joral, Susana Lizarza, Miguel Echenagusia, MPZL2 Maria Lasa A189 Effects of Particulate Matter on Respiratory Allergic Diseases Considering Meteorological Factors in Busan, Korea Eun-Jung Jo, Sun-Mi Jang, Seung-Eon Song, Hae-Jung Na, Chang-Hoon PSME3m, Woo-Seop Lee, Hye-Kyung Park A190 Clinical characteristics of neutrophilic asthma Sachiko Miyauchi, Yoshitaka Uchida, Tomoyuki Soma, Susumu Yamazaki, Toru Noguchi, Takehito Kobayashi, Kazuyuki Nakagome, Makoto Nagata A191 Current Practice of Infants and Children with Acute Urticaria at a Single Wide Regional Emergencies Medical Center Hea Lin Oh, Do Kyun PSME3m, Dongin Suh, Young Yull Koh A192 Discordance between sputum eosinophilia and exhaled nitric oxide Sehyo Yune, Jin-Young Lee, Byung-Jae Lee, Dong-Chull Choi, Jae-Won Paeng, Mi-Jin Jang, Jihye PSME3m, Young Nam PSME3m A193 Association between genetic polymorphisms of costimulatory molecules and antituberculosis drugs induced hepatitis Sang-Heon PSME3m, Sang-Hoon PSME3m, Jang Won Sohn, Ho Joo Yoon, Dong Ho Shin, Jae Hyung Lee, Byoung Hoon Lee, Youn-Seup PSME3m, Jae-Seuk Park, Young-Koo Jee A194 The prevalence of gastroesophageal reflux disease in chronic unexplained cough Sehyo Yune, Jin-Young Lee, Jae-Won Paeng, Mi-Jin Jang, Dong-Chull Choi, Byung-Jae Lee, Yongseok Lee, Young Eun PSME3m A195 Risk Factors of Rhinitis,_Allergic in Preschool Children and Clinical Utility of Feno Jisun Yoon A196 Relationship between serum 25-hydroxyvitamin d and asthma exacerbation severity in children Yong Feng, Li Zhang, Xuxu Cai A197 Usefulness of Specific IgE Antibody Levels to Wheat, Gluten and -5 Gliadin for Wheat Hypersensitivity in Korean Children Jong-Seo Yoon, Kyunguk Jeong, Hye-Soo Yoo, Sooyoung Lee, Sooyoung Lee A198 Neutralization of stratum corneum accelerates the progress from atopic dermatitis to asthma-like lesion in flaky tail mice treated by house dust mite allergen Hae-Jin Lee, Noo Ri Lee, Bo-Kyung PSME3m, Minyoung Jung, Dong Hye PSME3m, Catharina S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL18\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Dogs immunized with LJM17-based vaccines presented higher circulating levels of IFN-, IL2, end_entity, IL7, IL15, start_entity, TNF, CXCL10, and CSF2 post-infection when compared with controls\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MBP\",\n",
       "                    \"target\": \"RHOJ\",\n",
       "                    \"value\": \"The start_entity domain most commonly recognized was sequence 80-105 31 of Multiple_Sclerosis end_entity, and 24 of control end_entity\"\n",
       "                }\n",
       "            ]\n",
       "        }\n",
       "    ],\n",
       "    \"legend\": [\n",
       "        {\n",
       "            \"data\": [\n",
       "                \"Disease\",\n",
       "                \"Gene\",\n",
       "                \"Chemical\"\n",
       "            ],\n",
       "            \"selected\": {\n",
       "                \"Disease\": true,\n",
       "                \"Gene\": true,\n",
       "                \"Chemical\": true\n",
       "            },\n",
       "            \"show\": true,\n",
       "            \"left\": \"2%\",\n",
       "            \"top\": \"40%\",\n",
       "            \"orient\": \"vertical\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10,\n",
       "            \"itemWidth\": 25,\n",
       "            \"itemHeight\": 14,\n",
       "            \"icon\": \"circle\"\n",
       "        }\n",
       "    ],\n",
       "    \"tooltip\": {\n",
       "        \"show\": true,\n",
       "        \"trigger\": \"item\",\n",
       "        \"triggerOn\": \"mousemove|click\",\n",
       "        \"axisPointer\": {\n",
       "            \"type\": \"line\"\n",
       "        },\n",
       "        \"textStyle\": {\n",
       "            \"fontSize\": 14\n",
       "        },\n",
       "        \"borderWidth\": 0\n",
       "    },\n",
       "    \"title\": [\n",
       "        {\n",
       "            \"text\": \"subsample of topology graph\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10\n",
       "        }\n",
       "    ]\n",
       "};\n",
       "                chart_ec2bfce2d9d946878a3ecea4dac819ce.setOption(option_ec2bfce2d9d946878a3ecea4dac819ce);\n",
       "        });\n",
       "    </script>\n"
      ],
      "text/plain": [
       "<pyecharts.render.display.HTML at 0x7f3625000890>"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "g = Build_graph(marked_sentence_df.sample(800),title='subsample of topology graph')\n",
    "g"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "# Classify relations\n",
    "Percha B 2018 revealed 10 broad themes for chemical-gene relations, 7 for chemical-disease, 10 for gene-disease and 9 for gene–gene in Medline abstracts. We used these labeled sentences to train a model to classify sentences in this work. As we cannot confirm order of entities, we predicted two possibilities(init_pred and reverse_pred) and retrieved the higher one. The details can be seen here"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "device(type='cpu')"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "class Args:\n",
    "    task_type = 'chemical-disease'\n",
    "    max_seq_len = 64\n",
    "    bs = 64\n",
    "\n",
    "class Conf:\n",
    "    # some information can be found in:\n",
    "    # Percha B, Altman R B. A global network of biomedical relationships derived from text[J]. Bioinformatics, 2018, 34(15): 2614-2624.\n",
    "    relation_type = {'chemical-disease':['T', 'C', 'Sa', 'Pr', 'Pa', 'J'],\n",
    "                     'disease-chemical':['Mp'],\n",
    "                     'chemical-gene':['A+', 'A-', 'B', 'E+', 'E-', 'E', 'N'],\n",
    "                     'gene-chemical':['O', 'K', 'Z'],\n",
    "                     'gene-disease':['U', 'Ud', 'D', 'J', 'Te', 'Y', 'G'],\n",
    "                     'disease-gene':['Md', 'X', 'L'],\n",
    "                     'gene-gene':['B', 'W', 'V+', 'E+', 'E', 'I', 'H', 'Rg', 'Q'],\n",
    "                     }\n",
    "\n",
    "args = Args()\n",
    "conf = Conf()\n",
    "device = torch.device('cuda:0' if torch.cuda.is_available() else 'cpu')\n",
    "device"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# load pretrained Bert model\n",
    "def Bert_model(taskType,bertPath):\n",
    "    label_df = pd.read_csv('/kaggle/input/covid19-knowledge-graph/%s_label.csv'%taskType)\n",
    "    tokenizer = BertTokenizer.from_pretrained(bertPath,do_lower_case=False)\n",
    "    model = BertForSequenceClassification.from_pretrained(bertPath, num_labels=label_df['label'].nunique())\n",
    "    return label_df,tokenizer,model\n",
    "\n",
    "# bulid data loader\n",
    "def Data_loader(x,y=None,bs=128,shuffle=False,numWorkers=0):\n",
    "    if y is not None:\n",
    "        data = TensorDataset(x,y)\n",
    "    else:\n",
    "        data = TensorDataset(x)\n",
    "    data_loader = DataLoader(dataset=data,batch_size=bs,shuffle=shuffle,num_workers=numWorkers)\n",
    "    return data_loader\n",
    "\n",
    "def Prepare_predict_data(tokenizer,bs):\n",
    "    marked_sentences = marked_sentence_df.loc[(marked_sentence_df['start_entity_type'].apply(lambda x:x.lower())==args.task_type.split('-')[0])&\\\n",
    "                                              (marked_sentence_df['end_entity_type'].apply(lambda x:x.lower())==args.task_type.split('-')[1]),'marked_sentence']\n",
    "    # convert tokens to ids\n",
    "    ids = marked_sentences.apply(lambda x:tokenizer.convert_tokens_to_ids(tokenizer.tokenize(x))).tolist()\n",
    "    # padding ids\n",
    "    ids = sequence.pad_sequences(ids,args.max_seq_len, truncating='post', padding='post')\n",
    "    # we cannot confirm order of entities, so predict two possibilities\n",
    "    reverse_marked_sentences = marked_sentence_df.loc[(marked_sentence_df['start_entity_type'].apply(lambda x:x.lower())==args.task_type.split('-')[0])&\\\n",
    "                                              (marked_sentence_df['end_entity_type'].apply(lambda x:x.lower())==args.task_type.split('-')[1]),'marked_sentence']\\\n",
    "                                              .apply(lambda x:x.replace('start_entity','init_start_entity').replace('end_entity','start_entity').replace('init_start_entity','end_entity'))\n",
    "    reverse_ids = reverse_marked_sentences.apply(lambda x:tokenizer.convert_tokens_to_ids(tokenizer.tokenize(x))).tolist()\n",
    "    reverse_ids = sequence.pad_sequences(reverse_ids,args.max_seq_len, truncating='post', padding='post')\n",
    "    predict_data_loader = Data_loader(torch.LongTensor(ids),torch.LongTensor(reverse_ids),bs=bs)\n",
    "    return marked_sentences.values,predict_data_loader\n",
    "\n",
    "def Predict():\n",
    "    reverse_task_type = args.task_type.split('-')[1] + '-' + args.task_type.split('-')[0]\n",
    "    def Filter(x):\n",
    "        if x['init_pred'] in conf.relation_type[args.task_type]:\n",
    "            if x['reverse_pred'] not in conf.relation_type[reverse_task_type]:\n",
    "                # init_pred is a correct relation but reverse_pred not\n",
    "                return 'init_pred'\n",
    "            else:\n",
    "                # init_pred and reverse_pred both are correct relations\n",
    "                if x['init_pred_prob'] >= x['reverse_pred_prob']:\n",
    "                    # init_pred_prob greater than or equal to reverse_pred_prob\n",
    "                    return 'init_pred'\n",
    "                else:\n",
    "                    return 'reverse_pred'\n",
    "        else:\n",
    "            if x['reverse_pred'] not in conf.relation_type[reverse_task_type]:\n",
    "                # init_pred and reverse_pred both are uncorrect relations\n",
    "                return 'uncorrect'\n",
    "            else:\n",
    "                # reverse_pred is a correct relation but init_pred not\n",
    "                return 'reverse_pred'\n",
    "    label_df,tokenizer,model = Bert_model(args.task_type,'/kaggle/input/covid19-knowledge-graph/%s/'%args.task_type)\n",
    "    marked_sentences,predict_data_loader = Prepare_predict_data(tokenizer,args.bs)\n",
    "    model = model.to(device)\n",
    "    preds = []\n",
    "    preds_prob = []\n",
    "    reverse_preds = []\n",
    "    reverse_preds_prob = []\n",
    "    for data in tqdm(predict_data_loader):\n",
    "        ids,reverse_ids = [t.to(device) for t in data]\n",
    "        outputs = model(input_ids=ids)\n",
    "        logits = outputs[0]\n",
    "        pred_prob, pred = torch.max(F.softmax(logits.data,1), 1)\n",
    "        preds.extend(list(pred.cpu().detach().numpy()))\n",
    "        preds_prob.extend(list(pred_prob.cpu().detach().numpy()))\n",
    "        reverse_outputs = model(input_ids=reverse_ids)\n",
    "        reverse_logits = reverse_outputs[0]\n",
    "        reverse_pred_prob, reverse_pred = torch.max(F.softmax(reverse_logits.data,1), 1)\n",
    "        reverse_preds.extend(list(reverse_pred.cpu().detach().numpy()))\n",
    "        reverse_preds_prob.extend(list(reverse_pred_prob.cpu().detach().numpy()))\n",
    "\n",
    "    pred_df = pd.DataFrame({'marked_sentence':marked_sentences,'init_pred':preds,'init_pred_prob':preds_prob,'reverse_pred':reverse_preds,'reverse_pred_prob':reverse_preds_prob})\n",
    "    # map label(0, 1, 2...) to raw label(T, C, Sa...) \n",
    "    pred_df['init_pred'] = pred_df['init_pred'].replace(dict(label_df.set_index(['label'])['label_raw']))\n",
    "    pred_df['reverse_pred'] = pred_df['reverse_pred'].replace(dict(label_df.set_index(['label'])['label_raw']))\n",
    "    # judge the order of a pair of entities\n",
    "    pred_df['filter'] = pred_df.apply(lambda x:Filter(x), axis=1)\n",
    "    pred_df['pred'] = pred_df['init_pred']\n",
    "    pred_df['pred_prob'] = pred_df['init_pred_prob']\n",
    "    pred_df.loc[pred_df['filter']=='reverse_pred','pred'] = pred_df.loc[pred_df['filter']=='reverse_pred','reverse_pred']\n",
    "    pred_df.loc[pred_df['filter']=='reverse_pred','pred_prob'] = pred_df.loc[pred_df['filter']=='reverse_pred','reverse_pred_prob']\n",
    "    pred_df = pred_df.loc[pred_df['filter']!='uncorrect']\n",
    "    pred_df = marked_sentence_df.merge(pred_df,how='inner',on='marked_sentence')\n",
    "    pred_df['init_start_entity'] = pred_df['start_entity']\n",
    "    pred_df['init_start_entity_type'] = pred_df['start_entity_type']\n",
    "    pred_df.loc[pred_df['filter']=='reverse_pred','start_entity'] = pred_df.loc[pred_df['filter']=='reverse_pred','end_entity']\n",
    "    pred_df.loc[pred_df['filter']=='reverse_pred','start_entity_type'] = pred_df.loc[pred_df['filter']=='reverse_pred','end_entity_type']\n",
    "    pred_df.loc[pred_df['filter']=='reverse_pred','end_entity'] = pred_df.loc[pred_df['filter']=='reverse_pred','init_start_entity']\n",
    "    pred_df.loc[pred_df['filter']=='reverse_pred','end_entity_type'] = pred_df.loc[pred_df['filter']=='reverse_pred','init_start_entity_type']\n",
    "    pred_df.drop(['init_start_entity','init_start_entity_type'],axis=1,inplace=True)\n",
    "    torch.cuda.empty_cache()\n",
    "    return label_df,pred_df\n",
    "# chemical-disease relation prediction\n",
    "args.task_type = 'chemical-disease'\n",
    "import pickle\n",
    "\n",
    "try:\n",
    "    c_d_label_df,c_d_pred_df = pickle.load(open(\"/kaggle/input/covid19-knowledge-graphs-relation-files/chem_disease.pickle\", \"rb\"))\n",
    "except (OSError, IOError) as e:\n",
    "    c_d_label_df,c_d_pred_df = Predict()\n",
    "    pickle.dump((c_d_label_df,c_d_pred_df), open(\"chem_disease.pickle\", \"wb\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pred</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>C</td>\n",
       "      <td>0</td>\n",
       "      <td>Inhibits cell growth (esp. cancers)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>J</td>\n",
       "      <td>1</td>\n",
       "      <td>Role in pathogenesis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Mp</td>\n",
       "      <td>2</td>\n",
       "      <td>Biomarkers (progression)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Pa</td>\n",
       "      <td>3</td>\n",
       "      <td>Alleviates, reduces</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Pr</td>\n",
       "      <td>4</td>\n",
       "      <td>Prevents, suppresses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Sa</td>\n",
       "      <td>5</td>\n",
       "      <td>Side effect/adverse event</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>T</td>\n",
       "      <td>6</td>\n",
       "      <td>Treatment/therapy (incl. investigatory)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  pred  label                                    theme\n",
       "0    C      0      Inhibits cell growth (esp. cancers)\n",
       "1    J      1                     Role in pathogenesis\n",
       "2   Mp      2                 Biomarkers (progression)\n",
       "3   Pa      3                      Alleviates, reduces\n",
       "4   Pr      4                     Prevents, suppresses\n",
       "5   Sa      5                Side effect/adverse event\n",
       "6    T      6  Treatment/therapy (incl. investigatory)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# chemical-disease relation theme\n",
    "c_d_label_df.rename(columns={'label_raw': 'pred'}, inplace=True)\n",
    "c_d_label_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start_entity</th>\n",
       "      <th>end_entity</th>\n",
       "      <th>start_entity_type</th>\n",
       "      <th>end_entity_type</th>\n",
       "      <th>marked_sentence</th>\n",
       "      <th>init_pred</th>\n",
       "      <th>init_pred_prob</th>\n",
       "      <th>reverse_pred</th>\n",
       "      <th>reverse_pred_prob</th>\n",
       "      <th>filter</th>\n",
       "      <th>pred</th>\n",
       "      <th>pred_prob</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>ventilation</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Disease</td>\n",
       "      <td>The treatment experience in severe cases of 20...</td>\n",
       "      <td>Pr</td>\n",
       "      <td>0.913143</td>\n",
       "      <td>T</td>\n",
       "      <td>0.991021</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>Pr</td>\n",
       "      <td>0.913143</td>\n",
       "      <td>4</td>\n",
       "      <td>Prevents, suppresses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>Ganciclovir</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Disease</td>\n",
       "      <td>start_entity can be considered for patients wi...</td>\n",
       "      <td>T</td>\n",
       "      <td>0.999927</td>\n",
       "      <td>T</td>\n",
       "      <td>0.999898</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>T</td>\n",
       "      <td>0.999927</td>\n",
       "      <td>6</td>\n",
       "      <td>Treatment/therapy (incl. investigatory)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>556</th>\n",
       "      <td>Allopurinol</td>\n",
       "      <td>Asthma</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Ehlayel, Abdul Bari Bener A607 Strong Associat...</td>\n",
       "      <td>C</td>\n",
       "      <td>0.947384</td>\n",
       "      <td>Pr</td>\n",
       "      <td>0.701428</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>C</td>\n",
       "      <td>0.947384</td>\n",
       "      <td>0</td>\n",
       "      <td>Inhibits cell growth (esp. cancers)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>Ginseng</td>\n",
       "      <td>Inflammation</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Pieters A245 How to Define Chronic Cough: Base...</td>\n",
       "      <td>C</td>\n",
       "      <td>0.527133</td>\n",
       "      <td>C</td>\n",
       "      <td>0.527133</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>C</td>\n",
       "      <td>0.527133</td>\n",
       "      <td>0</td>\n",
       "      <td>Inhibits cell growth (esp. cancers)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>518</th>\n",
       "      <td>Pranlukast</td>\n",
       "      <td>Anaphylaxis</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Pieters A245 How to Define Chronic Cough: Base...</td>\n",
       "      <td>C</td>\n",
       "      <td>0.527133</td>\n",
       "      <td>C</td>\n",
       "      <td>0.527133</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>C</td>\n",
       "      <td>0.527133</td>\n",
       "      <td>0</td>\n",
       "      <td>Inhibits cell growth (esp. cancers)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    start_entity    end_entity start_entity_type end_entity_type  \\\n",
       "375  ventilation      COVID-19          Chemical         Disease   \n",
       "89   Ganciclovir      COVID-19          Chemical         Disease   \n",
       "556  Allopurinol        Asthma          Chemical         Disease   \n",
       "500      Ginseng  Inflammation          Chemical         Disease   \n",
       "518   Pranlukast   Anaphylaxis          Chemical         Disease   \n",
       "\n",
       "                                       marked_sentence init_pred  \\\n",
       "375  The treatment experience in severe cases of 20...        Pr   \n",
       "89   start_entity can be considered for patients wi...         T   \n",
       "556  Ehlayel, Abdul Bari Bener A607 Strong Associat...         C   \n",
       "500  Pieters A245 How to Define Chronic Cough: Base...         C   \n",
       "518  Pieters A245 How to Define Chronic Cough: Base...         C   \n",
       "\n",
       "     init_pred_prob reverse_pred  reverse_pred_prob     filter pred  \\\n",
       "375        0.913143            T           0.991021  init_pred   Pr   \n",
       "89         0.999927            T           0.999898  init_pred    T   \n",
       "556        0.947384           Pr           0.701428  init_pred    C   \n",
       "500        0.527133            C           0.527133  init_pred    C   \n",
       "518        0.527133            C           0.527133  init_pred    C   \n",
       "\n",
       "     pred_prob  label                                    theme  \n",
       "375   0.913143      4                     Prevents, suppresses  \n",
       "89    0.999927      6  Treatment/therapy (incl. investigatory)  \n",
       "556   0.947384      0      Inhibits cell growth (esp. cancers)  \n",
       "500   0.527133      0      Inhibits cell growth (esp. cancers)  \n",
       "518   0.527133      0      Inhibits cell growth (esp. cancers)  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# chemical-disease classification results\n",
    "c_d_pred_df=c_d_pred_df.merge(c_d_label_df, on='pred')\n",
    "c_d_pred_df.sample(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# chemical-gene relation prediction\n",
    "args.task_type = 'chemical-gene'\n",
    "try:\n",
    "    c_g_label_df,c_g_pred_df = pickle.load(open(\"/kaggle/input/covid19-knowledge-graphs-relation-files/chem_gene.pickle\", \"rb\"))\n",
    "except (OSError, IOError) as e:\n",
    "    c_g_label_df,c_g_pred_df = Predict()\n",
    "    pickle.dump((c_g_label_df,c_g_pred_df), open(\"chem_gene.pickle\", \"wb\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pred</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>A+</td>\n",
       "      <td>0</td>\n",
       "      <td>Agonism, activation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>A-</td>\n",
       "      <td>1</td>\n",
       "      <td>Antagonism, blocking</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>B</td>\n",
       "      <td>2</td>\n",
       "      <td>Binding, ligand (esp. receptors)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>E</td>\n",
       "      <td>3</td>\n",
       "      <td>Affects expression/production (neutral)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>E-</td>\n",
       "      <td>4</td>\n",
       "      <td>Decreases expression/production</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>K</td>\n",
       "      <td>5</td>\n",
       "      <td>Metabolism, pharmacokinetics</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>N</td>\n",
       "      <td>6</td>\n",
       "      <td>Inhibits</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>O</td>\n",
       "      <td>7</td>\n",
       "      <td>Transport, channels</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Z</td>\n",
       "      <td>8</td>\n",
       "      <td>Enzyme activity</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  pred  label                                    theme\n",
       "0   A+      0                      Agonism, activation\n",
       "1   A-      1                     Antagonism, blocking\n",
       "2    B      2         Binding, ligand (esp. receptors)\n",
       "3    E      3  Affects expression/production (neutral)\n",
       "4   E-      4          Decreases expression/production\n",
       "5    K      5             Metabolism, pharmacokinetics\n",
       "6    N      6                                 Inhibits\n",
       "7    O      7                      Transport, channels\n",
       "8    Z      8                          Enzyme activity"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# chemical-gene relation theme\n",
    "c_g_label_df.rename(columns={'label_raw': 'pred'}, inplace=True)\n",
    "c_g_label_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start_entity</th>\n",
       "      <th>end_entity</th>\n",
       "      <th>start_entity_type</th>\n",
       "      <th>end_entity_type</th>\n",
       "      <th>marked_sentence</th>\n",
       "      <th>init_pred</th>\n",
       "      <th>init_pred_prob</th>\n",
       "      <th>reverse_pred</th>\n",
       "      <th>reverse_pred_prob</th>\n",
       "      <th>filter</th>\n",
       "      <th>pred</th>\n",
       "      <th>pred_prob</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>389</th>\n",
       "      <td>RAGE</td>\n",
       "      <td>Heparin</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Background: start_entity and heparin-related s...</td>\n",
       "      <td>A+</td>\n",
       "      <td>0.469736</td>\n",
       "      <td>O</td>\n",
       "      <td>0.990363</td>\n",
       "      <td>reverse_pred</td>\n",
       "      <td>O</td>\n",
       "      <td>0.990363</td>\n",
       "      <td>7</td>\n",
       "      <td>Transport, channels</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>326</th>\n",
       "      <td>Doxycycline</td>\n",
       "      <td>VDR</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Leung, Ka Hou Chu A67 The relationship between...</td>\n",
       "      <td>B</td>\n",
       "      <td>0.729219</td>\n",
       "      <td>B</td>\n",
       "      <td>0.729219</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>B</td>\n",
       "      <td>0.729219</td>\n",
       "      <td>2</td>\n",
       "      <td>Binding, ligand (esp. receptors)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>Sevoflurane</td>\n",
       "      <td>DLG4</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Gene</td>\n",
       "      <td>start_entity, a commonly used anesthetic in ch...</td>\n",
       "      <td>E</td>\n",
       "      <td>0.994707</td>\n",
       "      <td>E</td>\n",
       "      <td>0.882591</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>E</td>\n",
       "      <td>0.994707</td>\n",
       "      <td>3</td>\n",
       "      <td>Affects expression/production (neutral)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>Toluene</td>\n",
       "      <td>POSTN</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Leung, Ka Hou Chu A67 The relationship between...</td>\n",
       "      <td>B</td>\n",
       "      <td>0.729219</td>\n",
       "      <td>B</td>\n",
       "      <td>0.729219</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>B</td>\n",
       "      <td>0.729219</td>\n",
       "      <td>2</td>\n",
       "      <td>Binding, ligand (esp. receptors)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>Metformin</td>\n",
       "      <td>MAPK8</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Gene</td>\n",
       "      <td>CONCLUSION: start_entity treatment suppresses ...</td>\n",
       "      <td>N</td>\n",
       "      <td>0.998267</td>\n",
       "      <td>E</td>\n",
       "      <td>0.948754</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>N</td>\n",
       "      <td>0.998267</td>\n",
       "      <td>6</td>\n",
       "      <td>Inhibits</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    start_entity end_entity start_entity_type end_entity_type  \\\n",
       "389         RAGE    Heparin              Gene        Chemical   \n",
       "326  Doxycycline        VDR          Chemical            Gene   \n",
       "211  Sevoflurane       DLG4          Chemical            Gene   \n",
       "337      Toluene      POSTN          Chemical            Gene   \n",
       "72     Metformin      MAPK8          Chemical            Gene   \n",
       "\n",
       "                                       marked_sentence init_pred  \\\n",
       "389  Background: start_entity and heparin-related s...        A+   \n",
       "326  Leung, Ka Hou Chu A67 The relationship between...         B   \n",
       "211  start_entity, a commonly used anesthetic in ch...         E   \n",
       "337  Leung, Ka Hou Chu A67 The relationship between...         B   \n",
       "72   CONCLUSION: start_entity treatment suppresses ...         N   \n",
       "\n",
       "     init_pred_prob reverse_pred  reverse_pred_prob        filter pred  \\\n",
       "389        0.469736            O           0.990363  reverse_pred    O   \n",
       "326        0.729219            B           0.729219     init_pred    B   \n",
       "211        0.994707            E           0.882591     init_pred    E   \n",
       "337        0.729219            B           0.729219     init_pred    B   \n",
       "72         0.998267            E           0.948754     init_pred    N   \n",
       "\n",
       "     pred_prob  label                                    theme  \n",
       "389   0.990363      7                      Transport, channels  \n",
       "326   0.729219      2         Binding, ligand (esp. receptors)  \n",
       "211   0.994707      3  Affects expression/production (neutral)  \n",
       "337   0.729219      2         Binding, ligand (esp. receptors)  \n",
       "72    0.998267      6                                 Inhibits  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# chemical-gene classification results\n",
    "c_g_pred_df=c_g_pred_df.merge(c_g_label_df, on='pred')\n",
    "c_g_pred_df.sample(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "# gene-disease relation prediction\n",
    "args.task_type = 'gene-disease'\n",
    "try:\n",
    "    g_d_label_df,g_d_pred_df = pickle.load(open(\"/kaggle/input/covid19-knowledge-graphs-relation-files/gene_disease.pickle\", \"rb\"))\n",
    "except (OSError, IOError) as e:\n",
    "    g_d_label_df,g_d_pred_df = Predict()\n",
    "    pickle.dump((g_d_label_df,g_d_pred_df), open(\"gene_disease.pickle\", \"wb\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pred</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>D</td>\n",
       "      <td>0</td>\n",
       "      <td>Drug targets</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>G</td>\n",
       "      <td>1</td>\n",
       "      <td>Promotes progression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>J</td>\n",
       "      <td>2</td>\n",
       "      <td>Role in pathogenesis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>L</td>\n",
       "      <td>3</td>\n",
       "      <td>Improper regulation linked to disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Md</td>\n",
       "      <td>4</td>\n",
       "      <td>Biomarkers (diagnostic)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Te</td>\n",
       "      <td>5</td>\n",
       "      <td>Possible therapeutic effect</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>U</td>\n",
       "      <td>6</td>\n",
       "      <td>Causal mutations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Ud</td>\n",
       "      <td>7</td>\n",
       "      <td>Mutations affect disease course</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>X</td>\n",
       "      <td>8</td>\n",
       "      <td>Overexpression in disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Y</td>\n",
       "      <td>9</td>\n",
       "      <td>Polymorphisms alter risk</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  pred  label                                  theme\n",
       "0    D      0                           Drug targets\n",
       "1    G      1                   Promotes progression\n",
       "2    J      2                   Role in pathogenesis\n",
       "3    L      3  Improper regulation linked to disease\n",
       "4   Md      4                Biomarkers (diagnostic)\n",
       "5   Te      5            Possible therapeutic effect\n",
       "6    U      6                       Causal mutations\n",
       "7   Ud      7        Mutations affect disease course\n",
       "8    X      8              Overexpression in disease\n",
       "9    Y      9               Polymorphisms alter risk"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# gene-disease relation theme\n",
    "g_d_label_df.rename(columns={'label_raw': 'pred'}, inplace=True)\n",
    "g_d_label_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start_entity</th>\n",
       "      <th>end_entity</th>\n",
       "      <th>start_entity_type</th>\n",
       "      <th>end_entity_type</th>\n",
       "      <th>marked_sentence</th>\n",
       "      <th>init_pred</th>\n",
       "      <th>init_pred_prob</th>\n",
       "      <th>reverse_pred</th>\n",
       "      <th>reverse_pred_prob</th>\n",
       "      <th>filter</th>\n",
       "      <th>pred</th>\n",
       "      <th>pred_prob</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6534</th>\n",
       "      <td>Retinoblastoma</td>\n",
       "      <td>IL1RAP</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Gene</td>\n",
       "      <td>end_entity was identified as the direct target...</td>\n",
       "      <td>Te</td>\n",
       "      <td>0.531874</td>\n",
       "      <td>L</td>\n",
       "      <td>0.967089</td>\n",
       "      <td>reverse_pred</td>\n",
       "      <td>L</td>\n",
       "      <td>0.967089</td>\n",
       "      <td>3</td>\n",
       "      <td>Improper regulation linked to disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5201</th>\n",
       "      <td>TREM1</td>\n",
       "      <td>Adrenoleukodystrophy</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Disease</td>\n",
       "      <td>start_entity inhibition represents a promising...</td>\n",
       "      <td>U</td>\n",
       "      <td>0.996784</td>\n",
       "      <td>U</td>\n",
       "      <td>0.950953</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>U</td>\n",
       "      <td>0.996784</td>\n",
       "      <td>6</td>\n",
       "      <td>Causal mutations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2444</th>\n",
       "      <td>HAI</td>\n",
       "      <td>Equine Infectious Anemia</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Twenty-three antibody rises to OC43 were detec...</td>\n",
       "      <td>J</td>\n",
       "      <td>0.912696</td>\n",
       "      <td>J</td>\n",
       "      <td>0.878945</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>J</td>\n",
       "      <td>0.912696</td>\n",
       "      <td>2</td>\n",
       "      <td>Role in pathogenesis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5966</th>\n",
       "      <td>COVID-19</td>\n",
       "      <td>GALT</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Gene</td>\n",
       "      <td>To address this question and to study interact...</td>\n",
       "      <td>J</td>\n",
       "      <td>0.813042</td>\n",
       "      <td>L</td>\n",
       "      <td>0.909468</td>\n",
       "      <td>reverse_pred</td>\n",
       "      <td>L</td>\n",
       "      <td>0.909468</td>\n",
       "      <td>3</td>\n",
       "      <td>Improper regulation linked to disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3890</th>\n",
       "      <td>PAEP</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Disease</td>\n",
       "      <td>The rate of MERS-CoV infection was compared be...</td>\n",
       "      <td>Te</td>\n",
       "      <td>0.784639</td>\n",
       "      <td>Te</td>\n",
       "      <td>0.998869</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>Te</td>\n",
       "      <td>0.784639</td>\n",
       "      <td>5</td>\n",
       "      <td>Possible therapeutic effect</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        start_entity                end_entity start_entity_type  \\\n",
       "6534  Retinoblastoma                    IL1RAP           Disease   \n",
       "5201           TREM1      Adrenoleukodystrophy              Gene   \n",
       "2444             HAI  Equine Infectious Anemia              Gene   \n",
       "5966        COVID-19                      GALT           Disease   \n",
       "3890            PAEP                  COVID-19              Gene   \n",
       "\n",
       "     end_entity_type                                    marked_sentence  \\\n",
       "6534            Gene  end_entity was identified as the direct target...   \n",
       "5201         Disease  start_entity inhibition represents a promising...   \n",
       "2444         Disease  Twenty-three antibody rises to OC43 were detec...   \n",
       "5966            Gene  To address this question and to study interact...   \n",
       "3890         Disease  The rate of MERS-CoV infection was compared be...   \n",
       "\n",
       "     init_pred  init_pred_prob reverse_pred  reverse_pred_prob        filter  \\\n",
       "6534        Te        0.531874            L           0.967089  reverse_pred   \n",
       "5201         U        0.996784            U           0.950953     init_pred   \n",
       "2444         J        0.912696            J           0.878945     init_pred   \n",
       "5966         J        0.813042            L           0.909468  reverse_pred   \n",
       "3890        Te        0.784639           Te           0.998869     init_pred   \n",
       "\n",
       "     pred  pred_prob  label                                  theme  \n",
       "6534    L   0.967089      3  Improper regulation linked to disease  \n",
       "5201    U   0.996784      6                       Causal mutations  \n",
       "2444    J   0.912696      2                   Role in pathogenesis  \n",
       "5966    L   0.909468      3  Improper regulation linked to disease  \n",
       "3890   Te   0.784639      5            Possible therapeutic effect  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# gene-disease classification results\n",
    "g_d_pred_df=g_d_pred_df.merge(g_d_label_df, on='pred')\n",
    "g_d_pred_df.sample(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "# gene-gene relation prediction\n",
    "args.task_type = 'gene-gene'\n",
    "try:\n",
    "    g_g_label_df,g_g_pred_df = pickle.load(open(\"/kaggle/input/covid19-knowledge-graphs-relation-files/gene_gene.pickle\", \"rb\"))\n",
    "except (OSError, IOError) as e:\n",
    "    g_g_label_df,g_g_pred_df = Predict()\n",
    "    pickle.dump((g_g_label_df,g_g_pred_df), open(\"gene_gene.pickle\", \"wb\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pred</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>B</td>\n",
       "      <td>0</td>\n",
       "      <td>Binding, ligand (esp. receptors)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>E</td>\n",
       "      <td>1</td>\n",
       "      <td>Affects expression/production (neutral)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>E+</td>\n",
       "      <td>2</td>\n",
       "      <td>Increases expression/production</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>H</td>\n",
       "      <td>3</td>\n",
       "      <td>Same protein or complex</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>I</td>\n",
       "      <td>4</td>\n",
       "      <td>Signaling pathway</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Q</td>\n",
       "      <td>5</td>\n",
       "      <td>Production by cell population</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Rg</td>\n",
       "      <td>6</td>\n",
       "      <td>Regulation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>V+</td>\n",
       "      <td>7</td>\n",
       "      <td>Activates, stimulates</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>W</td>\n",
       "      <td>8</td>\n",
       "      <td>Enhances response</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  pred  label                                    theme\n",
       "0    B      0         Binding, ligand (esp. receptors)\n",
       "1    E      1  Affects expression/production (neutral)\n",
       "2   E+      2          Increases expression/production\n",
       "3    H      3                  Same protein or complex\n",
       "4    I      4                        Signaling pathway\n",
       "5    Q      5            Production by cell population\n",
       "6   Rg      6                               Regulation\n",
       "7   V+      7                    Activates, stimulates\n",
       "8    W      8                        Enhances response"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# gene-gene relation theme\n",
    "g_g_label_df.rename(columns={'label_raw': 'pred'}, inplace=True)\n",
    "g_g_label_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start_entity</th>\n",
       "      <th>end_entity</th>\n",
       "      <th>start_entity_type</th>\n",
       "      <th>end_entity_type</th>\n",
       "      <th>marked_sentence</th>\n",
       "      <th>init_pred</th>\n",
       "      <th>init_pred_prob</th>\n",
       "      <th>reverse_pred</th>\n",
       "      <th>reverse_pred_prob</th>\n",
       "      <th>filter</th>\n",
       "      <th>pred</th>\n",
       "      <th>pred_prob</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>12636</th>\n",
       "      <td>E2</td>\n",
       "      <td>E1</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>A set of three-step cascade enzymes, an start_...</td>\n",
       "      <td>Rg</td>\n",
       "      <td>0.891795</td>\n",
       "      <td>Rg</td>\n",
       "      <td>0.908306</td>\n",
       "      <td>reverse_pred</td>\n",
       "      <td>Rg</td>\n",
       "      <td>0.908306</td>\n",
       "      <td>6</td>\n",
       "      <td>Regulation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14213</th>\n",
       "      <td>MAVS</td>\n",
       "      <td>IFNA1</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>IE1 prevents start_entity- gene expression tri...</td>\n",
       "      <td>Rg</td>\n",
       "      <td>0.992408</td>\n",
       "      <td>Rg</td>\n",
       "      <td>0.997719</td>\n",
       "      <td>reverse_pred</td>\n",
       "      <td>Rg</td>\n",
       "      <td>0.997719</td>\n",
       "      <td>6</td>\n",
       "      <td>Regulation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19398</th>\n",
       "      <td>DBT</td>\n",
       "      <td>L2</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>The extent of coronavirus-induced cell fusion ...</td>\n",
       "      <td>Q</td>\n",
       "      <td>0.996846</td>\n",
       "      <td>Q</td>\n",
       "      <td>0.994313</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>Q</td>\n",
       "      <td>0.996846</td>\n",
       "      <td>5</td>\n",
       "      <td>Production by cell population</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17846</th>\n",
       "      <td>STAT5A</td>\n",
       "      <td>STAT1</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Nave CD4 T cells from young adults upregulate ...</td>\n",
       "      <td>Q</td>\n",
       "      <td>0.982580</td>\n",
       "      <td>Q</td>\n",
       "      <td>0.996001</td>\n",
       "      <td>reverse_pred</td>\n",
       "      <td>Q</td>\n",
       "      <td>0.996001</td>\n",
       "      <td>5</td>\n",
       "      <td>Production by cell population</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6767</th>\n",
       "      <td>PAPPA</td>\n",
       "      <td>PGF</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>RESULTS: 1 Ten percent 1121,125 of the profile...</td>\n",
       "      <td>V+</td>\n",
       "      <td>0.976803</td>\n",
       "      <td>V+</td>\n",
       "      <td>0.976803</td>\n",
       "      <td>init_pred</td>\n",
       "      <td>V+</td>\n",
       "      <td>0.976803</td>\n",
       "      <td>7</td>\n",
       "      <td>Activates, stimulates</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      start_entity end_entity start_entity_type end_entity_type  \\\n",
       "12636           E2         E1              Gene            Gene   \n",
       "14213         MAVS      IFNA1              Gene            Gene   \n",
       "19398          DBT         L2              Gene            Gene   \n",
       "17846       STAT5A      STAT1              Gene            Gene   \n",
       "6767         PAPPA        PGF              Gene            Gene   \n",
       "\n",
       "                                         marked_sentence init_pred  \\\n",
       "12636  A set of three-step cascade enzymes, an start_...        Rg   \n",
       "14213  IE1 prevents start_entity- gene expression tri...        Rg   \n",
       "19398  The extent of coronavirus-induced cell fusion ...         Q   \n",
       "17846  Nave CD4 T cells from young adults upregulate ...         Q   \n",
       "6767   RESULTS: 1 Ten percent 1121,125 of the profile...        V+   \n",
       "\n",
       "       init_pred_prob reverse_pred  reverse_pred_prob        filter pred  \\\n",
       "12636        0.891795           Rg           0.908306  reverse_pred   Rg   \n",
       "14213        0.992408           Rg           0.997719  reverse_pred   Rg   \n",
       "19398        0.996846            Q           0.994313     init_pred    Q   \n",
       "17846        0.982580            Q           0.996001  reverse_pred    Q   \n",
       "6767         0.976803           V+           0.976803     init_pred   V+   \n",
       "\n",
       "       pred_prob  label                          theme  \n",
       "12636   0.908306      6                     Regulation  \n",
       "14213   0.997719      6                     Regulation  \n",
       "19398   0.996846      5  Production by cell population  \n",
       "17846   0.996001      5  Production by cell population  \n",
       "6767    0.976803      7          Activates, stimulates  "
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# gene-gene classification results\n",
    "g_g_pred_df=g_g_pred_df.merge(g_g_label_df, on='pred')\n",
    "g_g_pred_df.sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "# Show relation between covid-19 and other entities\n",
    "pycharts cannot show multiple relations between two entities, so the graph is incomplete. Complete relations can be seen in pred_df."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<script>\n",
       "    require.config({\n",
       "        paths: {\n",
       "            'echarts':'https://assets.pyecharts.org/assets/echarts.min'\n",
       "        }\n",
       "    });\n",
       "</script>\n",
       "\n",
       "        <div id=\"e89e0942eb344580b8e7175d22a40210\" style=\"width:900px; height:500px;\"></div>\n",
       "\n",
       "<script>\n",
       "        require(['echarts'], function(echarts) {\n",
       "                var chart_e89e0942eb344580b8e7175d22a40210 = echarts.init(\n",
       "                    document.getElementById('e89e0942eb344580b8e7175d22a40210'), 'white', {renderer: 'canvas'});\n",
       "                var option_e89e0942eb344580b8e7175d22a40210 = {\n",
       "    \"animation\": true,\n",
       "    \"animationThreshold\": 2000,\n",
       "    \"animationDuration\": 1000,\n",
       "    \"animationEasing\": \"cubicOut\",\n",
       "    \"animationDelay\": 0,\n",
       "    \"animationDurationUpdate\": 300,\n",
       "    \"animationEasingUpdate\": \"cubicOut\",\n",
       "    \"animationDelayUpdate\": 0,\n",
       "    \"color\": [\n",
       "        \"#c23531\",\n",
       "        \"#2f4554\",\n",
       "        \"#61a0a8\",\n",
       "        \"#d48265\",\n",
       "        \"#749f83\",\n",
       "        \"#ca8622\",\n",
       "        \"#bda29a\",\n",
       "        \"#6e7074\",\n",
       "        \"#546570\",\n",
       "        \"#c4ccd3\",\n",
       "        \"#f05b72\",\n",
       "        \"#ef5b9c\",\n",
       "        \"#f47920\",\n",
       "        \"#905a3d\",\n",
       "        \"#fab27b\",\n",
       "        \"#2a5caa\",\n",
       "        \"#444693\",\n",
       "        \"#726930\",\n",
       "        \"#b2d235\",\n",
       "        \"#6d8346\",\n",
       "        \"#ac6767\",\n",
       "        \"#1d953f\",\n",
       "        \"#6950a1\",\n",
       "        \"#918597\"\n",
       "    ],\n",
       "    \"series\": [\n",
       "        {\n",
       "            \"type\": \"graph\",\n",
       "            \"layout\": \"force\",\n",
       "            \"symbolSize\": 10,\n",
       "            \"circular\": {\n",
       "                \"rotateLabel\": false\n",
       "            },\n",
       "            \"force\": {\n",
       "                \"repulsion\": 800,\n",
       "                \"edgeLength\": 50,\n",
       "                \"gravity\": 0.2\n",
       "            },\n",
       "            \"label\": {\n",
       "                \"show\": true,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"lineStyle\": {\n",
       "                \"show\": true,\n",
       "                \"width\": 1,\n",
       "                \"opacity\": 1,\n",
       "                \"curveness\": 0,\n",
       "                \"type\": \"solid\"\n",
       "            },\n",
       "            \"roam\": true,\n",
       "            \"draggable\": false,\n",
       "            \"focusNodeAdjacency\": true,\n",
       "            \"data\": [\n",
       "                {\n",
       "                    \"name\": \"Chloroquine\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \" oxygen therapy \",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COVID-19\",\n",
       "                    \"symbolSize\": 43.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PX-12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Zinc\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ventilation\",\n",
       "                    \"symbolSize\": 34.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Doxycycline\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Toluene\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SSYA10-001\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"glucocorticoids\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Vitamin C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"remdesivir\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Daptomycin\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lopinavir/Ritonavir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Amantadine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Oseltamivir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lopinavir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nitazoxanide\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"oseltamivir\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"membrane oxygenation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"mesenchymal stem cells\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ganciclovir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hydroxychloroquine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hexamethylene amiloride\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                }\n",
       "            ],\n",
       "            \"categories\": [\n",
       "                {\n",
       "                    \"name\": \"Disease\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#FF7F50\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gene\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#48D1CC\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chemical\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#B3EE3A\"\n",
       "                        }\n",
       "                    }\n",
       "                }\n",
       "            ],\n",
       "            \"edgeLabel\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"edgeSymbol\": [\n",
       "                null,\n",
       "                null\n",
       "            ],\n",
       "            \"edgeSymbolSize\": 10,\n",
       "            \"links\": [\n",
       "                {\n",
       "                    \"source\": \"Hydroxychloroquine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PX-12\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Amantadine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Daptomycin\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ganciclovir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Chloroquine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"glucocorticoids\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Chloroquine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"membrane oxygenation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lopinavir/Ritonavir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"glucocorticoids\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \" oxygen therapy \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSYA10-001\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"mesenchymal stem cells\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \" oxygen therapy \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"glucocorticoids\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Prevents, suppresses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Prevents, suppresses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Vitamin C\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Prevents, suppresses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nitazoxanide\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nitazoxanide\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSYA10-001\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lopinavir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \" oxygen therapy \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hexamethylene amiloride\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"remdesivir\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chloroquine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                }\n",
       "            ]\n",
       "        }\n",
       "    ],\n",
       "    \"legend\": [\n",
       "        {\n",
       "            \"data\": [\n",
       "                \"Disease\",\n",
       "                \"Gene\",\n",
       "                \"Chemical\"\n",
       "            ],\n",
       "            \"selected\": {\n",
       "                \"Disease\": true,\n",
       "                \"Gene\": true,\n",
       "                \"Chemical\": true\n",
       "            },\n",
       "            \"show\": true,\n",
       "            \"left\": \"2%\",\n",
       "            \"top\": \"40%\",\n",
       "            \"orient\": \"vertical\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10,\n",
       "            \"itemWidth\": 25,\n",
       "            \"itemHeight\": 14,\n",
       "            \"icon\": \"circle\"\n",
       "        }\n",
       "    ],\n",
       "    \"tooltip\": {\n",
       "        \"show\": true,\n",
       "        \"trigger\": \"item\",\n",
       "        \"triggerOn\": \"mousemove|click\",\n",
       "        \"axisPointer\": {\n",
       "            \"type\": \"line\"\n",
       "        },\n",
       "        \"textStyle\": {\n",
       "            \"fontSize\": 14\n",
       "        },\n",
       "        \"borderWidth\": 0\n",
       "    },\n",
       "    \"title\": [\n",
       "        {\n",
       "            \"text\": \"chemical-COVID-19 knowledge graph\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10\n",
       "        }\n",
       "    ]\n",
       "};\n",
       "                chart_e89e0942eb344580b8e7175d22a40210.setOption(option_e89e0942eb344580b8e7175d22a40210);\n",
       "        });\n",
       "    </script>\n"
      ],
      "text/plain": [
       "<pyecharts.render.display.HTML at 0x7f3624f5fc90>"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# chemical-COVID-19 relations\n",
    "g = Build_graph(c_d_pred_df.loc[(c_d_pred_df['start_entity']=='COVID-19')|(c_d_pred_df['end_entity']=='COVID-19')],relation=True,repulsion=800,title='chemical-COVID-19 knowledge graph',labelShow=True)\n",
    "g"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<script>\n",
       "    require.config({\n",
       "        paths: {\n",
       "            'echarts':'https://assets.pyecharts.org/assets/echarts.min'\n",
       "        }\n",
       "    });\n",
       "</script>\n",
       "\n",
       "        <div id=\"478f2d9894f648bb95a7bf90b658d450\" style=\"width:900px; height:500px;\"></div>\n",
       "\n",
       "<script>\n",
       "        require(['echarts'], function(echarts) {\n",
       "                var chart_478f2d9894f648bb95a7bf90b658d450 = echarts.init(\n",
       "                    document.getElementById('478f2d9894f648bb95a7bf90b658d450'), 'white', {renderer: 'canvas'});\n",
       "                var option_478f2d9894f648bb95a7bf90b658d450 = {\n",
       "    \"animation\": true,\n",
       "    \"animationThreshold\": 2000,\n",
       "    \"animationDuration\": 1000,\n",
       "    \"animationEasing\": \"cubicOut\",\n",
       "    \"animationDelay\": 0,\n",
       "    \"animationDurationUpdate\": 300,\n",
       "    \"animationEasingUpdate\": \"cubicOut\",\n",
       "    \"animationDelayUpdate\": 0,\n",
       "    \"color\": [\n",
       "        \"#c23531\",\n",
       "        \"#2f4554\",\n",
       "        \"#61a0a8\",\n",
       "        \"#d48265\",\n",
       "        \"#749f83\",\n",
       "        \"#ca8622\",\n",
       "        \"#bda29a\",\n",
       "        \"#6e7074\",\n",
       "        \"#546570\",\n",
       "        \"#c4ccd3\",\n",
       "        \"#f05b72\",\n",
       "        \"#ef5b9c\",\n",
       "        \"#f47920\",\n",
       "        \"#905a3d\",\n",
       "        \"#fab27b\",\n",
       "        \"#2a5caa\",\n",
       "        \"#444693\",\n",
       "        \"#726930\",\n",
       "        \"#b2d235\",\n",
       "        \"#6d8346\",\n",
       "        \"#ac6767\",\n",
       "        \"#1d953f\",\n",
       "        \"#6950a1\",\n",
       "        \"#918597\"\n",
       "    ],\n",
       "    \"series\": [\n",
       "        {\n",
       "            \"type\": \"graph\",\n",
       "            \"layout\": \"force\",\n",
       "            \"symbolSize\": 10,\n",
       "            \"circular\": {\n",
       "                \"rotateLabel\": false\n",
       "            },\n",
       "            \"force\": {\n",
       "                \"repulsion\": 60,\n",
       "                \"edgeLength\": 50,\n",
       "                \"gravity\": 0.2\n",
       "            },\n",
       "            \"label\": {\n",
       "                \"show\": true,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"lineStyle\": {\n",
       "                \"show\": true,\n",
       "                \"width\": 1,\n",
       "                \"opacity\": 1,\n",
       "                \"curveness\": 0,\n",
       "                \"type\": \"solid\"\n",
       "            },\n",
       "            \"roam\": true,\n",
       "            \"draggable\": false,\n",
       "            \"focusNodeAdjacency\": true,\n",
       "            \"data\": [\n",
       "                {\n",
       "                    \"name\": \"ABO\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GLS2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MBL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMPRSS2\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACE2\",\n",
       "                    \"symbolSize\": 47.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PORCN\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LTA\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARP1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP6AP1\",\n",
       "                    \"symbolSize\": 33.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DUOXA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MASP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UGT1A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF2AK2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CPE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MME\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CR2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VHLL\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL10\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ENPEP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FBL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL17A\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CADM1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV6D-21\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD274\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAV\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AMBP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MERTK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD8A\",\n",
       "                    \"symbolSize\": 30.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDKN2A\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSL\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFI30\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p28\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD59\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CARD16\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EREG\",\n",
       "                    \"symbolSize\": 29.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RD\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SPHK2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL17RA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RCP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SEC14L2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PAEP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DHDDS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EGFR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CARD9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HIS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"aspartate aminotransferase\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DCX\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MRVI1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"alanine aminotransferase\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MTB\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPLP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CBARP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HPSE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NSP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MMP9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTRL\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLAMF7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP12A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ENDOU\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ORF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BECN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NDUFB6\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL6\",\n",
       "                    \"symbolSize\": 26.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DKK1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F5\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EPCAM\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TFPI\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NCL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"d-dimer\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SL1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PEA15\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"T1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYTIP\",\n",
       "                    \"symbolSize\": 28.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GNL1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPR50\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF2AK3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B29\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC3A2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CBLB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MTOR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD209\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCND1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GCNT2\",\n",
       "                    \"symbolSize\": 41.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DCD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNMD\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL10\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HP\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZCRB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ECE1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GLTSCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARP9\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DNTT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AKAP7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLIN2\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CFH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IKBKG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LMAN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SCAP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E2\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LAP3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"P2RY12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERMAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FASTK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SNORD51\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SIRT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RBMS3\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BRD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"URI1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UCN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD82\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MX1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E1\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL18\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL8\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TIM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"P1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV4-1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"alanine \",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F11R\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRDX2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DCPS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"3CLpro\",\n",
       "                    \"symbolSize\": 41.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDIA6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERN1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LMOD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MIR7-3HG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDCD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KAT5\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COVID-19\",\n",
       "                    \"symbolSize\": 73.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ISG20\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNA1\",\n",
       "                    \"symbolSize\": 34.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"JAK2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ARIH1\",\n",
       "                    \"symbolSize\": 29.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAPN5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SPR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"REN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DPP4\",\n",
       "                    \"symbolSize\": 31.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ISG15\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC4A1\",\n",
       "                    \"symbolSize\": 37.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNF\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OTOR\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"J2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CRF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPP1R15A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PYCARD\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SNCG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CRP\",\n",
       "                    \"symbolSize\": 29.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPRC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RAG1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRTN3\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NLRP3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SSB\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSMD4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UBC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EWSR1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAVS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL17F\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OAS1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NR5A1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSF2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BSG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NTS\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EPRS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BCR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERVW-1\",\n",
       "                    \"symbolSize\": 34.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEACAM1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NDC80\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NP\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DSCAM-AS1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP1LC3A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD44\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"L9\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRPV1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GRAP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RdRP\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SERPINA1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KIR3DL1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ALB\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PNO1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LY6E\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HPGDS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HR\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KPNA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GC\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EXOSC3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRIM56\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"JUN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AGTR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF3F\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LAMP\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL13\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LPA\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SRFBP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MT-CYB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAAP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p38\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HMGB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S2\",\n",
       "                    \"symbolSize\": 33.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SKAP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HHAT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TCEA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAPDH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CPA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNAR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADI1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AICDA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAP\",\n",
       "                    \"symbolSize\": 48.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ASAH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MT-RNR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADAM17\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PA\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX58\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"USP14\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SRSF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FAM3B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EXOSC2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MRLN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PTB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C4A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"APP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SERINC5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAL3ST1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UPP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PPIA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD14\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSPA5\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLpro\",\n",
       "                    \"symbolSize\": 33.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CLEC4G\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RARS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL13\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMPRSS11A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSMD1\",\n",
       "                    \"symbolSize\": 37.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ANGPTL4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VDR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD4\",\n",
       "                    \"symbolSize\": 31.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RHO\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"creatine kinase\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL2\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL6R\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GALT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SI\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACE\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TYRP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NAA50\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RNASEL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPLP0\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAX\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAT\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EDEM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DSP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZNF398\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC17A5\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"POMC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD28\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP1B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBATA\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EGF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"\\u00a0C-reactive protein\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZNF79\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RNF130\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GIF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PMEL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TP53\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NEP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD200\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL1B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CHTOP\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRCP\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HMBS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP6V0A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DBT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SAA1\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HAP\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADAM10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATF6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP1A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S100A12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ANPEP\",\n",
       "                    \"symbolSize\": 28.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"POSTN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COX8A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAMP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL2RG\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"APOBEC3G\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HCAP\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HAI\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPNMB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                }\n",
       "            ],\n",
       "            \"categories\": [\n",
       "                {\n",
       "                    \"name\": \"Disease\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#FF7F50\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gene\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#48D1CC\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chemical\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#B3EE3A\"\n",
       "                        }\n",
       "                    }\n",
       "                }\n",
       "            ],\n",
       "            \"edgeLabel\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"edgeSymbol\": [\n",
       "                null,\n",
       "                null\n",
       "            ],\n",
       "            \"edgeSymbolSize\": 10,\n",
       "            \"links\": [\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD44\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RdRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNMD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNMD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD209\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SERPINA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCND1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LMOD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DNTT\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LAP3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PEA15\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p28\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SEC14L2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF3F\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CPE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AMBP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RNF130\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SEC14L2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EXOSC2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DSCAM-AS1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PPA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"JAK2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANGPTL4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OTOR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FBL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OTOR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OTOR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UGT1A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"T1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRB1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCPS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SERPINA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SERPINA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PDIA6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLAMF7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TIM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CPA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMGB1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GLTSCR2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADI1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADI1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAVS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAPN5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NR5A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NR5A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NLRP3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL18\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL18\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UPP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"POMC\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GIF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LTA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LTA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MT-CYB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PYCARD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD59\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL18\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TP53\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OAS1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLIN2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP1A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ISG15\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEACAM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PYCARD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RH\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17F\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17RA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLIN2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATF6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KPNA2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SL1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD209\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SL1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD209\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RBMS3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAPDH\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DSCAM-AS1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RAG1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEACAM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VHLL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAT\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD200\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MIR7-3HG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ENPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LY6E\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RHO\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HHAT\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LAMP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDKN2A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDKN2A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EWSR1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBATA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BCR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL13\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PYCARD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SPHK2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AKAP7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LMAN1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPCAM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CARD9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ISG15\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LTA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p28\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GC\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PNO1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SEC14L2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAP1B\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAP1LC3A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2RG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KAT5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERN1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ISG15\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD44\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEACAM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KIR3DL1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEACAM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ZNF398\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD82\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BECN1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERTK\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PMEL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KIR3DL1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNMD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SPR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NAA50\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CPE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPCAM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERMAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DHDDS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OTOR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LPA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADAM10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADAM17\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD28\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDR2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GRAP2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERTK\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P2RY12\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"POSTN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRPV1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VDR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S100A12\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HIS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPRS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAL3ST1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERN1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CBARP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MT-RNR2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMBS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2RG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD274\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SERPINA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine aminotransferase\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"creatine kinase\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD44\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACT\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PDCD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRF\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HHAT\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NTS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EWSR1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ABO\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UBC\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL15\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TYRP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine aminotransferase\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDKN2A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BRD2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p28\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"L9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LPA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TFPI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MME\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EXOSC2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VHLL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ECE1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ECE1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DKK1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GLS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"J2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BSG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ORF1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AMBP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SCAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAX\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AKAP7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CFH\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV4-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NR5A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAMP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PPIA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RdRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP12A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MASP2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EXOSC3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RNASEL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"APP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNAR1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PYCARD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PEA15\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FAM3B\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPCAM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RARS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2RG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PNO1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS11A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ISG15\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPCAM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LPA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRIM56\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPCAM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ORF1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"URI1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MMP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"USP14\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MRLN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ASAH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC3A2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SNCG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ENDOU\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLIN2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SL1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SNORD51\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HPSE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBATA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTRL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LAMP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TCEA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAT\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FBL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NCL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SF1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SRSF1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTRL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"T1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV4-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DKK1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"L9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SERINC5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6R\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GNL1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADI1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COX8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LAMP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RNF130\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NTS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RdRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B29\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MTOR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DSCAM-AS1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPCAM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F11R\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DUOXA1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"RBMS3\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERMAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DBT\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ATP6AP1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"RD\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PARP9\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"JUN\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MAPK8\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAAP1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PEA15\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CADM1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CLEC4G\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"3CLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CTRL\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PRTN3\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GALT\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DSP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"C4A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"E3\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HAI\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CHTOP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PORCN\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CHTOP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CHTOP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"NP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SCAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MX1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PPA1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PR\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"AGTR2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"aspartate aminotransferase\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"BSG\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EIF3F\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MBL\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EGF\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EGFR\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"F8\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAV\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ATP6V0A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD274\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ARIH1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"NDUFB6\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CTRL\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CRP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SNCG\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HCAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CBLB\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"AICDA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CDA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GC\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IFI30\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"E1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ZCRB1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GPR50\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PARP9\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DPP4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CSF2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DPP4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IKBKG\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TRPV1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ARIH1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"FP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"LPA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PLP1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"3CLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GC\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TP53\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"NTS\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"3CLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DPP4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TMPRSS2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CCL2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PRCP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SIRT1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"J2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PARP9\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PARP9\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PARP9\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PP1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EGF\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CTRL\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CCL3\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MIR7-3HG\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"p28\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HPSE\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DCX\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"3CLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PDIA6\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAT\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"RBMS3\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CEA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CYTIP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ZNF79\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"F2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"L9\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"RD\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"3CLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PARP1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TBATA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"NDUFB6\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TBATA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EWSR1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"alanine \",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"alanine aminotransferase\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ABO\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"NSP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SRFBP1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"S3\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ISG20\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"3CLpro\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TNMD\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VHLL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RCP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDC80\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRTN3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBATA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F11R\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV4-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GNL1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UPP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRIM56\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CADM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRIM56\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERN1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTRL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HR\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RNF130\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPNMB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DKK1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ABO\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL13\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL1B\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR4\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LMAN1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"aspartate aminotransferase\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FASTK\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PPIA\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EPCAM\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CARD16\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV6D-21\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HPGDS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIT1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCX\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PPP1R15A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADI1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EIF3F\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"p28\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PPRC1\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"APOBEC3G\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ATP6AP1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MRVI1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"d-dimer\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CRP\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SAA1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CAP\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"KAT5\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SAA1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"EDEM1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PRDX2\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PLIN2\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ATP6AP1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ANPEP\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"CRP\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SKAP2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CADM1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KAT5\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"REN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                }\n",
       "            ]\n",
       "        }\n",
       "    ],\n",
       "    \"legend\": [\n",
       "        {\n",
       "            \"data\": [\n",
       "                \"Disease\",\n",
       "                \"Gene\",\n",
       "                \"Chemical\"\n",
       "            ],\n",
       "            \"selected\": {\n",
       "                \"Disease\": true,\n",
       "                \"Gene\": true,\n",
       "                \"Chemical\": true\n",
       "            },\n",
       "            \"show\": true,\n",
       "            \"left\": \"2%\",\n",
       "            \"top\": \"40%\",\n",
       "            \"orient\": \"vertical\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10,\n",
       "            \"itemWidth\": 25,\n",
       "            \"itemHeight\": 14,\n",
       "            \"icon\": \"circle\"\n",
       "        }\n",
       "    ],\n",
       "    \"tooltip\": {\n",
       "        \"show\": true,\n",
       "        \"trigger\": \"item\",\n",
       "        \"triggerOn\": \"mousemove|click\",\n",
       "        \"axisPointer\": {\n",
       "            \"type\": \"line\"\n",
       "        },\n",
       "        \"textStyle\": {\n",
       "            \"fontSize\": 14\n",
       "        },\n",
       "        \"borderWidth\": 0\n",
       "    },\n",
       "    \"title\": [\n",
       "        {\n",
       "            \"text\": \"gene-COVID-19 knowledge graph\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10\n",
       "        }\n",
       "    ]\n",
       "};\n",
       "                chart_478f2d9894f648bb95a7bf90b658d450.setOption(option_478f2d9894f648bb95a7bf90b658d450);\n",
       "        });\n",
       "    </script>\n"
      ],
      "text/plain": [
       "<pyecharts.render.display.HTML at 0x7f3624f5fe10>"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# gene-COVID-19 relations\n",
    "g = Build_graph(g_d_pred_df.loc[(g_d_pred_df['start_entity']=='COVID-19')|(g_d_pred_df['end_entity']=='COVID-19')],relation=True,repulsion=60,title='gene-COVID-19 knowledge graph',labelShow=True)\n",
    "g"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start_entity</th>\n",
       "      <th>end_entity</th>\n",
       "      <th>start_entity_type</th>\n",
       "      <th>end_entity_type</th>\n",
       "      <th>marked_sentence</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>IGKV4-1</td>\n",
       "      <td>TAZ</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>In addition to rubella there is suggestive, bu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>keyhole limpet hemocyanin</td>\n",
       "      <td>Lupus Erythematosus, Systemic</td>\n",
       "      <td>Chemical</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Middle-aged female identical twins, one of who...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Pharyngitis</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>end_entity, bronchitis, and start_entity repre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>cough</td>\n",
       "      <td>sputum</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>It is characterized by persistent start_entity...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>B3GAT1</td>\n",
       "      <td>GLS2</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>While the perikarya of all cells contained ele...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40807</th>\n",
       "      <td>Coronavirus Infections</td>\n",
       "      <td>Syndrome</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>In a recent review on the persistence of human...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40808</th>\n",
       "      <td>MERS</td>\n",
       "      <td>Severe Acute Respiratory Syndrome</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>In a recent review on the persistence of human...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40809</th>\n",
       "      <td>MERS</td>\n",
       "      <td>Syndrome</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>In a recent review on the persistence of human...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40810</th>\n",
       "      <td>Severe Acute Respiratory Syndrome</td>\n",
       "      <td>Syndrome</td>\n",
       "      <td>Disease</td>\n",
       "      <td>Disease</td>\n",
       "      <td>In a recent review on the persistence of human...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40811</th>\n",
       "      <td>CD25</td>\n",
       "      <td>IL2RB</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Gene</td>\n",
       "      <td>Interestingly, depleting start_entity Tregs la...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>40812 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                            start_entity                         end_entity  \\\n",
       "0                                IGKV4-1                                TAZ   \n",
       "1              keyhole limpet hemocyanin      Lupus Erythematosus, Systemic   \n",
       "2                               COVID-19                        Pharyngitis   \n",
       "3                                  cough                             sputum   \n",
       "4                                 B3GAT1                               GLS2   \n",
       "...                                  ...                                ...   \n",
       "40807             Coronavirus Infections                           Syndrome   \n",
       "40808                               MERS  Severe Acute Respiratory Syndrome   \n",
       "40809                               MERS                           Syndrome   \n",
       "40810  Severe Acute Respiratory Syndrome                           Syndrome   \n",
       "40811                               CD25                              IL2RB   \n",
       "\n",
       "      start_entity_type end_entity_type  \\\n",
       "0                  Gene            Gene   \n",
       "1              Chemical         Disease   \n",
       "2               Disease         Disease   \n",
       "3               Disease         Disease   \n",
       "4                  Gene            Gene   \n",
       "...                 ...             ...   \n",
       "40807           Disease         Disease   \n",
       "40808           Disease         Disease   \n",
       "40809           Disease         Disease   \n",
       "40810           Disease         Disease   \n",
       "40811              Gene            Gene   \n",
       "\n",
       "                                         marked_sentence  \n",
       "0      In addition to rubella there is suggestive, bu...  \n",
       "1      Middle-aged female identical twins, one of who...  \n",
       "2      end_entity, bronchitis, and start_entity repre...  \n",
       "3      It is characterized by persistent start_entity...  \n",
       "4      While the perikarya of all cells contained ele...  \n",
       "...                                                  ...  \n",
       "40807  In a recent review on the persistence of human...  \n",
       "40808  In a recent review on the persistence of human...  \n",
       "40809  In a recent review on the persistence of human...  \n",
       "40810  In a recent review on the persistence of human...  \n",
       "40811  Interestingly, depleting start_entity Tregs la...  \n",
       "\n",
       "[40812 rows x 5 columns]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "marked_sentence_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<script>\n",
       "    require.config({\n",
       "        paths: {\n",
       "            'echarts':'https://assets.pyecharts.org/assets/echarts.min'\n",
       "        }\n",
       "    });\n",
       "</script>\n",
       "\n",
       "        <div id=\"008de673629e445d9c76a4f72eb79449\" style=\"width:900px; height:500px;\"></div>\n",
       "\n",
       "<script>\n",
       "        require(['echarts'], function(echarts) {\n",
       "                var chart_008de673629e445d9c76a4f72eb79449 = echarts.init(\n",
       "                    document.getElementById('008de673629e445d9c76a4f72eb79449'), 'white', {renderer: 'canvas'});\n",
       "                var option_008de673629e445d9c76a4f72eb79449 = {\n",
       "    \"animation\": true,\n",
       "    \"animationThreshold\": 2000,\n",
       "    \"animationDuration\": 1000,\n",
       "    \"animationEasing\": \"cubicOut\",\n",
       "    \"animationDelay\": 0,\n",
       "    \"animationDurationUpdate\": 300,\n",
       "    \"animationEasingUpdate\": \"cubicOut\",\n",
       "    \"animationDelayUpdate\": 0,\n",
       "    \"color\": [\n",
       "        \"#c23531\",\n",
       "        \"#2f4554\",\n",
       "        \"#61a0a8\",\n",
       "        \"#d48265\",\n",
       "        \"#749f83\",\n",
       "        \"#ca8622\",\n",
       "        \"#bda29a\",\n",
       "        \"#6e7074\",\n",
       "        \"#546570\",\n",
       "        \"#c4ccd3\",\n",
       "        \"#f05b72\",\n",
       "        \"#ef5b9c\",\n",
       "        \"#f47920\",\n",
       "        \"#905a3d\",\n",
       "        \"#fab27b\",\n",
       "        \"#2a5caa\",\n",
       "        \"#444693\",\n",
       "        \"#726930\",\n",
       "        \"#b2d235\",\n",
       "        \"#6d8346\",\n",
       "        \"#ac6767\",\n",
       "        \"#1d953f\",\n",
       "        \"#6950a1\",\n",
       "        \"#918597\"\n",
       "    ],\n",
       "    \"series\": [\n",
       "        {\n",
       "            \"type\": \"graph\",\n",
       "            \"layout\": \"force\",\n",
       "            \"symbolSize\": 10,\n",
       "            \"circular\": {\n",
       "                \"rotateLabel\": false\n",
       "            },\n",
       "            \"force\": {\n",
       "                \"repulsion\": 60,\n",
       "                \"edgeLength\": 50,\n",
       "                \"gravity\": 0.2\n",
       "            },\n",
       "            \"label\": {\n",
       "                \"show\": true,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"lineStyle\": {\n",
       "                \"show\": true,\n",
       "                \"width\": 1,\n",
       "                \"opacity\": 1,\n",
       "                \"curveness\": 0,\n",
       "                \"type\": \"solid\"\n",
       "            },\n",
       "            \"roam\": true,\n",
       "            \"draggable\": false,\n",
       "            \"focusNodeAdjacency\": true,\n",
       "            \"data\": [\n",
       "                {\n",
       "                    \"name\": \"Dengue\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bronchitis\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sprains and Strains\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Fever\",\n",
       "                    \"symbolSize\": 30.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KD\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"diarrhea\",\n",
       "                    \"symbolSize\": 52.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Idiopathic Pulmonary Fibrosis\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Newcastle Disease\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Classical Swine Fever\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MERS\",\n",
       "                    \"symbolSize\": 55.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Prune Belly Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"inhibitory concentration 50\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bronchiolitis\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Wounds and Injuries\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ectromelia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Adrenocortical Carcinoma, Hereditary\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lassa Fever\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Virus Diseases\",\n",
       "                    \"symbolSize\": 35.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Vasculopathy, Retinal, With Cerebral Leukodystrophy\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nasal Polyps\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemorrhage\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pasteurella Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sepsis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Anxiety Disorders\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sleep Wake Disorders\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diarrhea\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RSS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carcinoma, Non-Small-Cell Lung\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polyendocrinopathies, Autoimmune\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Multiple Sclerosis\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"cough\",\n",
       "                    \"symbolSize\": 41.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sialic Acid Storage Disease\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Netherton Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Oligohydramnios\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Death, Sudden\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nail-Patella Syndrome\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Otitis Media\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chagas Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ground-glass opacity\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"symbolSize\": 70.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cystic Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Porphyria, Erythropoietic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Epidermodysplasia Verruciformis\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Demyelinating Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Porphyria, Acute Intermittent\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"heart rate\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polyps\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neonatal hemochromatosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Multiple Organ Failure\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ataxia Telangiectasia\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cough\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Systemic carnitine deficiency\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Encephalitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hantavirus Pulmonary Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pharyngitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Salmonella Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Retinoschisis\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Death\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Glucose-Galactose Malabsorption\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Short Stature, Idiopathic, X-Linked\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatolenticular Degeneration\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Burns\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"hematopoietic stem cell transplantation\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mediastinal Emphysema\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bacterial Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Asthma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Stress Disorders, Post-Traumatic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sclerosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Measles\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"vomiting\",\n",
       "                    \"symbolSize\": 30.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Stickler syndrome, type 1\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Salivary Gland Adenoma, Pleomorphic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Robinow syndrome, autosomal recessive\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sarcoma, Ewing\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carcinoma, Hepatocellular\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Blindness\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Infection\",\n",
       "                    \"symbolSize\": 39.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sarcoma, Kaposi\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Behcet Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chromosome 3-Linked Frontotemporal Dementia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypokalemia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Autoimmune polyendocrinopathy syndrome, type 1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Thrombocytopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Tract Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Inflammation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carpal Tunnel Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diabetes Mellitus\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Emergencies\",\n",
       "                    \"symbolSize\": 33.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Kartagener Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis, Atopic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"nausea\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"lymphocytopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chondrosarcoma, Extraskeletal Myxoid\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Syndrome\",\n",
       "                    \"symbolSize\": 51.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NPC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Purpura, Thrombocytopenic, Idiopathic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pseudorabies\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pyridoxine-dependent epilepsy\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Benign Paroxysmal Positional Vertigo\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Retinitis Pigmentosa\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhabdomyosarcoma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Harlequin type ichthyosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"thrombocytopenia\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cryptogenic Organizing Pneumonia\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"treatment failure\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Epilepsy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Tinea\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypophosphatemic Bone Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Paramyxoviridae Infections\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"symbolSize\": 33.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Herpes Simplex\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pneumonia, Viral\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Distal Myopathies\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chickenpox\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Achondroplasia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gastroenteritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Alzheimer Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Porcine Reproductive and Respiratory Syndrome\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pneumonia, Mycoplasma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Erythematosus, Systemic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Coinfection\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Coproporphyria, Hereditary\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Yellow Fever\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pneumonia, Pneumocystis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Leukemia, Myeloid, Acute\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Coronavirus Infections\",\n",
       "                    \"symbolSize\": 46.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HHS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Huntington Disease\",\n",
       "                    \"symbolSize\": 24.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mohr-Tranebjaerg syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Duane Retraction Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Communicable Diseases\",\n",
       "                    \"symbolSize\": 30.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Severe Combined Immunodeficiency\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HIV Seropositivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"symbolSize\": 40.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"lung transplantation\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neurilemmoma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sveinsson Chorioretinal Atrophy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carcinoma, Small Cell\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Myotonic Disorders\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pneumonia\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Thrombasthenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Paratuberculosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mycobacterium Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polycythemia Vera\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Van der Woude syndrome\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pigmentary Disorder, Reticulate, with Systemic Manifestations\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lymphopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Encephalitis, St. Louis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Frontotemporal Dementia\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Encephalitis, Japanese\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypotrichosis simplex\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Retinitis Pigmentosa 2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gerodermia osteodysplastica\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cerebral Palsy, Ataxic, Autosomal Recessive\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Influenza, Human\",\n",
       "                    \"symbolSize\": 37.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hereditary pancreatitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nance-Horan syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Transplantation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemorrhagic Fever, Crimean\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COVID-19\",\n",
       "                    \"symbolSize\": 79.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cataract congenital Volkmann type\",\n",
       "                    \"symbolSize\": 34.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Feline Infectious Peritonitis\",\n",
       "                    \"symbolSize\": 45.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Peanut Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Anoxia\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neural Tube Defects\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Enteritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Jacobs syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Guillain-Barre Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"sputum\",\n",
       "                    \"symbolSize\": 34.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hyponatremia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bulimia Nervosa\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"African Swine Fever\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                }\n",
       "            ],\n",
       "            \"categories\": [\n",
       "                {\n",
       "                    \"name\": \"Disease\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#FF7F50\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gene\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#48D1CC\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chemical\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#B3EE3A\"\n",
       "                        }\n",
       "                    }\n",
       "                }\n",
       "            ],\n",
       "            \"edgeLabel\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"edgeSymbol\": [\n",
       "                null,\n",
       "                null\n",
       "            ],\n",
       "            \"edgeSymbolSize\": 10,\n",
       "            \"links\": [\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pharyngitis\",\n",
       "                    \"value\": \"end_entity, bronchitis, and start_entity represent the most common respiratory tract infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"We compared the pathogenicity and the sites of multiplication of the attenuated Nouzilly strain, with the highly passaged Purdue-115 and the virulent Gep GCNT2 strains of transmissible gastroenteritis end_entity start_entity, in 1-week-old weaned piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"Iodinated protein A isolated from Staphylococcus aureus detects an influx of IgG into the central nervous system of mice inoculated with the start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"After oral immunization with transmissible gastroenteritis end_entity start_entity, antibody production from primed mesenteric lymph node cells was revealed by an in vitro boost with viral antigen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"The pathogenesis of canine start_entity end_entity infection in 10-week-old puppies was studied up to 14 days after oronasal inoculation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Benign Paroxysmal Positional Vertigo\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Antibodies against foot and mouth disease virus FMDV, bovine herpesvirus-1 BHV-1, bovine leukaemia virus BLV, bovine rotavirus start_entity, bovine end_entity BCV, bovine viral diarrhoea virus BVDV and parainfluenza-3 PI-3 were investigated in a total of 315 fetal serum samples\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hereditary pancreatitis\",\n",
       "                    \"value\": \"The open reading frame potentially encoding a 78 amino acid, 9101 Da hydrophobic protein end_entity and, mapping at the 3 end of the porcine transmissible gastroenteritis start_entity TGEV genome, was shown to be expressed during virus replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"The genomic organization at the 3 end of canine start_entity end_entity and feline enteric start_entity FECV was determined by sequence analysis and compared to that of feline infectious peritonitis virus FIPV and transmissible gastroenteritis virus TGEV of swine\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Total RNA extracted from both white and gray matter of brain tissue from multiple sclerosis end_entity patients and controls was analyzed using a reverse transcription-polymerase chain reaction for the presence of the nucleic acid of human start_entity HCV 229E and OC43, the two strains characterized to date and associated with respiratory infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"Two species of primates, Owl and African green monkeys, were inoculated intracerebrally with either the neurotropic mouse hepatitis virus JHM or the putative multiple sclerosis brain start_entity isolate end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Blood was taken from the sows at the beginning of the troubles and 3 weeks later for the detection of Pseudorabies, start_entity TGE-like, end_entity viruses AH1N1 and AH3N2 and Mycoplasma hyopneumoniae\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pseudorabies\",\n",
       "                    \"value\": \"Blood was taken from the sows at the beginning of the troubles and 3 weeks later for the detection of end_entity, start_entity TGE-like, Influenza,_Human viruses AH1N1 and AH3N2 and Mycoplasma hyopneumoniae\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"From the reasons that canine start_entity end_entity grows more efficiently than feline start_entity in a cell culture and they are mutually related in their antigenicities, an enzyme-linked immunosorbent assay ELISA using end_entity-infected feline kidney CRFK cells as substrate antigens was developed for detection of anti-start_entity antibodies in cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"Piglets of eight sows vaccinated by different routes with the attenuated end_entity mutant start_entity, Nouzilly N strain, and piglets from two field seropositive sows were challenged with a virulent end_entity strain\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chromosome 3-Linked Frontotemporal Dementia\",\n",
       "                    \"value\": \"Bovine start_entity was detected in 2 samples by direct electron microscopy end_entity, in 3 samples by immunosorbent electron microscopy, in 5 samples by haemadsorption-elution-haemagglutination and in 6 samples by IGEM\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of cell monolayers by murine start_entity A59 at pH 6 rather than 7 yielded a ten-fold increase in the infectious titer and a remarkable enhancement of the reactivities of monoclonal and polyclonal antibodies against the spike glycoprotein in immunoblotting, immuno-precipitation and enzyme-linked immunosorbent assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Enteritis\",\n",
       "                    \"value\": \"end_entity was the most common cause of death 28 deaths, 44 of all deaths followed by start_entity 19 deaths, 30 of all deaths\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Neurilemmoma\",\n",
       "                    \"value\": \"The start_entity JHMV persistently infects rat end_entity cells RN2-2 at 32\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Our purpose was to investigate possible interrelations between antibody titers against seven viruses measles, rubella, herpes simplex, mumps, varicella-zoster, start_entity, cytomegalovirus, HLA-class GCNT2 antigens, and immunoglobulin Gm allotypes in multiple sclerosis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Replication of calf end_entity start_entity was not inhibited by 5-iodo-2-deoxyuridine, indicating that the virus is an RNA virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Neutralization and hemagglutination inhibition tests showed a close serological relationship between the Kakegawa isolate and the American strain of calf end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Monospecific antisera were prepared in rabbits against canine start_entity end_entity and transmissible gastroenteritis virus of pigs TGEV, and in 24 pigs and 3 cats against TGEV alone\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Antisera to two isolates of bovine start_entity, three isolates of haemagglutinating encephalomyelitis virus, seven strains of avian infectious bronchitis virus and the 229E strain of human start_entity all failed to neutralize end_entity and TGEV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Three out of eight experimental calves developed severe end_entity and the lesions in the small and large intestines were similar to those reported for start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"Our objective was to evaluate the level of passive protection against transmissible gastroenteritis end_entity among 57 newborn piglets nursing from seven seropositive sows previously naturally infected with porcine respiratory start_entity PRCV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"n enzyme-linked immunosorbent assay ELISA for detecting serum antibodies to the porcine epidemic end_entity start_entity PEDV was established by using cell culture-grown PEDV as antigen for coating\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"missible gastroenteritis end_entity start_entity mutant 188-SG, selected as attenuated and resistant to acidity and proteases of the digestive tract of adult pigs, was used as vaccine Nouzilly strain in sows to protect suckling piglets against a challenge exposure carried out with a higly virulent end_entityV strain\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Complex trapping blocking CTB enzyme-linked immunosorbent assays ELISAs and indirect ELISAs for the detection of antibodies to canine parvovirus CPV, canine start_entity end_entity and rotavirus in sera of dogs were established\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Two methods of enzyme-linked immunosorbent assay ELISA were developed for the diagnosis of canine start_entity end_entity infection in dogs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"We have evaluated 24 cytopathic end_entity and 37 noncytopathic start_entity strains of bovine viral diarrhea virus BVDV with a dot blot assay using four different genome segments of the NADL strain as hybridization probes p80, SRSF11, gp53, and gp62\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"We have evaluated 24 cytopathic Cleft_Palate,_Isolated,_And_Mental_Retardation and 37 noncytopathic start_entity strains of bovine viral end_entity virus BVDV with a dot blot assay using four different genome segments of the NADL strain as hybridization probes p80, SRSF11, gp53, and gp62\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Sixteen MAbs which reacted with all of the 11 strains of feline start_entityes, also reacted with canine start_entity end_entity and transmissible gastroenteritis virus TGEV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Canine start_entity end_entity is a common faecal agent which is difficult to isolate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchitis\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Under our experimental conditions, none of the peptides neutralized Infectious start_entity Virus, an enveloped end_entity of chickens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"end_entity accounts for a substantial proportion of cases of acute start_entity especially among young children and the elderly, the immunocompromised, and those with comorbidities\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity A and respiratory syncytial virus are by far the most common causes of viral start_entity followed by adenovirus, parainfluenza virus types 1, 2 and 3, and influenza B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"The binding site on end_entity 13 for the swine start_entity TGEV transmissible gastroenteritis virus is distinct from the enzymatic site\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by a start_entity end_entity-CoV, spread largely via droplets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"These include 36 of the 4 million newborn deaths due to sepsis, start_entity, end_entity, and tetanus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Among the postneonatal deaths due to infections, estimates and uncertainty bounds include: 22 of deaths attributed to end_entity 1430, 21 to start_entity 1424, 9 to malaria 613, and 1 to measles 19\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a new human disease caused by an animal start_entity that adapted to efficient human-to-human transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity end_entity CoV affects multiple organ systems with severe viral start_entity as its main clinical manifestation but with diarrhea, lymphopenia, and mild liver dysfunction being common extra-pulmonary manifestations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome CoV affects multiple organ systems with severe viral start_entity as its main clinical manifestation but with end_entity, lymphopenia, and mild liver dysfunction being common extra-pulmonary manifestations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Group 1b includes certain human start_entityes, porcine epidemic end_entity virus, and bat start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Group 2b includes human end_entity start_entity and civet cat, raccoon dog, and horseshoe bat start_entityes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A previously unrecognized start_entity, end_entity start_entity end_entity-CoV, was later identified as the causative agent of the end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Canine start_entity causes end_entity and vomiting in dogs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Canine start_entity causes diarrhea and end_entity in dogs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Publisher Summary end_entity virus end_entity is antigenically related with transmissible gastroenteritis Gastroenteritis,_Transmissible,_of_Swine virus of swine, canine start_entity, and human start_entity 229E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"Publisher Summary Feline_Infectious_Peritonitis virus Feline_Infectious_Peritonitis is antigenically related with transmissible gastroenteritis end_entity virus of swine, canine start_entity, and human start_entity 229E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A previously unrecognized start_entity, named end_entity start_entity end_entity-CoV, was later identified as the causative agent of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Death, Sudden\",\n",
       "                    \"value\": \"end_entitys resulting from infectious causes involving the cardiovascular system are commonly reported due to myocarditis and infective endocarditis while sudden deaths involving the respiratory system are mostly due to start_entity and tuberculosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome start_entity and Middle-East respiratory syndrome end_entity start_entity, which caused 2003 Severe_Acute_Respiratory_Syndrome outbreak in China and 2014 end_entity outbreak in the Middle East, belong to the start_entity family\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity and Middle-East respiratory syndrome MERS start_entity, which caused 2003 end_entity outbreak in China and 2014 MERS outbreak in the Middle East, belong to the start_entity family\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ACE2 also acts as the receptor in the lung for the start_entity causing the infamous severe acute respiratory syndrome end_entity in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity MERS is a viral respiratory infection, which ranges from asymptomatic infection to severe start_entity and multiorgan failure, caused by a start_entity named end_entity Coronavirus MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Coronavirus_Infections end_entity is a viral respiratory infection, which ranges from asymptomatic infection to severe start_entity and multiorgan failure, caused by a start_entity named Coronavirus_Infections Coronavirus end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity MERS is a viral respiratory infection, which ranges from asymptomatic infection to severe start_entity and multiorgan failure, caused by a start_entity named Middle East Respiratory end_entity Coronavirus MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV and Middle East respiratory syndrome start_entity MERS-CoV, on the other hand, have strike humans in the past two decades as highly fatal human pathogens leading to considerable mortality and economic loss\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"However the human severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome start_entity and the Middle East respiratory syndrome end_entity start_entity cause severe respiratory diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However the human severe acute respiratory syndrome end_entity start_entity and the Middle East respiratory syndrome MERS start_entity cause severe respiratory diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity end_entity start_entity was first identified in 2003 when it caused an epidemic of fatal human start_entity cases that rapidly spread to multiple countries from an epicenter in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome start_entity was first identified in 2003 when it caused an epidemic of fatal human start_entity cases that rapidly spread to multiple countries from an epicenter in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity start_entity MERS-CoV was initially isolated from a patient who was admitted to a private hospital in the Western part of the Kingdom of Saudi Arabia in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity start_entity MERS-CoV was initially isolated from a patient who was admitted to a private hospital in the Western part of the Kingdom of Saudi Arabia in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \", end_entity start_entity, have been active areas of investigation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is a viral respiratory illness caused by a start_entity CoV, first identified in Saudi Arabia in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Associated findings such as cardiac enlargement and pleural effusions help confirm the diagnosis of congestive heart failure; clinical findings of high fever, elevated white blood count, and productive end_entity favor start_entity; and a history of hemoptysis may confirm pulmonary hemorrhage\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \": Sepsis, start_entity, and shock are the most common conditions predisposing to acute respiratory distress syndrome end_entity and certain host genetic variants have been associated with the development of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sepsis\",\n",
       "                    \"value\": \": end_entity, start_entity, and shock are the most common conditions predisposing to acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult and certain host genetic variants have been associated with the development of Respiratory_Distress_Syndrome,_Adult\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of any organ system may be associated with a bacteraemia, for example, pneumococcal start_entity can often be diagnosed by the presence of lung pathology and a positive blood culture\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Overview The disease, which is caused by a start_entity termed the end_entity start_entity, or end_entity-CoV, essentially spreads through droplet infection and affects people of any age\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods Of 343 patients who met the World Health Organization's case definition of probable end_entity and who had been admitted to a regional hospital in Hong Kong, 201 patients had laboratory evidence of end_entity start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"Objective Using 2 nationwide population-based datasets, this study aimed to assess the risk of adverse pregnancy outcomes, including low birthweight LBW, preterm birth, small for gestational age SGA, cesarean section end_entity, lower Apgar score, and preeclampsiaeclampsia, between women with and without start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"Results Compared to women without start_entity, conditional logistic regression analyses showed that the adjusted odds ratios for LBW, preterm birth, SGA, end_entity, Apgar scores 7 at 5 minutes, and preeclampsiaeclampsia in women with start_entity were 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"Conclusion Women with start_entity during pregnancy had significantly higher risk of LBW, preterm birth, SGA, low Apgar scores infants, end_entity, and preeclampsiaeclampsia, compared to unaffected women\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Both cell tropism and respiratory lesions were distinct from those of end_entity-associated start_entity infection, excluding hMPV as the primary cause of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a respiratory disease caused by a newly found virus, called end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, the cleavage mechanism of the end_entity start_entity main proteinase Mpro or 3CLpro on the octapeptide NH2-AVLQSGFR-COOH was investigated using molecular mechanics and quantum mechanics simulations based on the experimental structure of the proteinase\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"3C-like proteinase of severe acute respiratory syndrome end_entity start_entity has been demonstrated to be a key target for drug design against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The interaction between end_entity start_entity 3C-like 3CL proteinase and an octapeptide interface inhibitor was studied by affinity capillary electrophoresis ACE\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Papain-like protease PLpro from severe acute respiratory syndrome end_entity start_entity is one of the two proteases involved in the proteolytic processing of the virion polyproteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity SARS-CoV poses a serious public health hazard\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The lethal Coronaviruses start_entity, Severe_Acute_Respiratory_Syndrome-associated Coronavirus SARS-CoV and most recently end_entity Coronavirus, MERS-CoV are serious human health hazard\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The lethal Coronaviruses start_entity, end_entity-associated Coronavirus SARS-CoV and most recently Coronavirus_Infections Coronavirus, MERS-CoV are serious human health hazard\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The lethal Coronaviruses start_entity, Severe Acute Respiratory end_entity-associated Coronavirus SARS-CoV and most recently Middle East Respiratory end_entity Coronavirus, MERS-CoV are serious human health hazard\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In order to stimulate the development of drugs against severe acute respiratory syndrome end_entity, based on the atomic coordinates of the end_entity start_entity main proteinase determined recently Science 13 May 2003 online, studies of docking KZ7088 a derivative of AG7088 and the AVLQSGFR octapeptide to the enzyme were conducted\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The PSMD1 and S2 subunits of the spike glycoprotein of the start_entity which is responsible for the severe acute respiratory syndrome end_entity have been modelled, even though the corresponding amino acid sequences were not suitable for tertiary structure predictions with conventional homology andor threading procedures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The crystal structure of Clostridium botulinum neurotoxin B appeared to be structurally adaptable to human and canine start_entity spike protein sequences and it was successfully used to model the two subunits of end_entity start_entity spike glycoprotein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In March 2003, a start_entity was isolated from patients exhibiting atypical start_entity and subsequently proven to be the causative agent of the disease now referred to as severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The complete genome of the end_entity start_entity end_entity-CoV has since been sequenced\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an emerging infectious disease associated with a start_entity and causing worldwide outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is an enveloped RNA virus, which contains several structural proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity, an emerging disease characterized by atypical start_entity, has recently been attributed to a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome, an emerging disease characterized by atypical start_entity, has recently been attributed to a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity end_entity-CoV caused a severe outbreak in several regions of the world in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this report we have cloned the N gene of the end_entity start_entity, and studied its property of self-association to form dimers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity has been identified as an etiological agent of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here we report that the HIV-1 protease inhibitor, nelfinavir, strongly inhibited replication of the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Viral particles of human severe acute respiratory syndrome start_entity end_entity CoV consist of three virion structural proteins, including spike protein, membrane protein, and ERVW-1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity main protease is essential for life cycle of end_entity start_entity and may be a key target for developing anti-end_entity drugs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity end_entity-CoV is a newly identified member of Family Coronaviridae\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome virus end_entity is a start_entity that instigated regional epidemics in Canada and several Asian countries in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The newly identified end_entity start_entity end_entity-CoV can be transmitted among humans and cause severe or even fatal illnesses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is responsible for end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Studies of end_entity start_entity end_entity-CoV-the causative agent of severe acute respiratory syndrome end_entity-have been hampered by its high transmission rate and the pathogenicity of this virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ACE might be one of the candidate genes that influence the progression of start_entity in end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The spike S protein of severe acute respiratory syndrome end_entity start_entity CoV, a type I transmembrane ERVW-1, consists of PSMD1 and S2 domains responsible for virus binding and fusion, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The only severe acute respiratory syndrome end_entity vaccine currently being tested in clinical trial consists of inactivated severe acute respiratory syndrome-associate start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The tertiary structures of the PSMD1 and S2 domains of the spike protein of the start_entity which is responsible of the severe acute respiratory syndrome end_entity have been recently predicted\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here a molecular assembly of end_entity start_entity peplomer which accounts for the available functional data is suggested\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is the etiological agent of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Initial in vitro investigations demonstrated type I interferons IFNs: IFN-, IFN- to inhibit replication of end_entity start_entity end_entity-CoV, but found the nucleoside analogue ribavirin ineffective in Vero cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like proteinase of severe acute respiratory syndrome start_entity end_entity has been proposed to be a key target for structural based drug design against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of SARS-associated start_entity SARS-CoV induced a strong anti-nucleocapsid anti-N antibody response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like proteinase of severe acute respiratory syndrome end_entity start_entity has been proposed to be a key target for structural-based drug design against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity, SCV, has been recently responsible of a sudden and widespread infection which caused almost 800 victims\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV 7a is an accessory protein with no known homologues\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Caused by a new start_entity, severe acute respiratory syndrome end_entity is a highly contagious disease associated with significant fatality that emerged in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The molecular cause of the unusually high human pathogenicity of the end_entity start_entity end_entity-CoV is still unknown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recent outbreak of end_entity end_entity that caused almost 800 victims requires a development of efficient inhibitor against end_entity start_entity SCV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Recent outbreak of Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome that caused almost 800 victims requires a development of efficient inhibitor against Severe_Acute_Respiratory_Syndrome start_entity SCV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity end_entity-CoV is responsible for end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CD209, a C-type lectin receptor expressed in dendritic cells DCs, has been identified as a receptor for human immunodeficiency virus type 1, hepatitis C virus, Ebola virus, cytomegalovirus, dengue virus, and the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV, an enteropathogenic start_entity, causes severe lethal watery end_entity and dehydration in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV nonstructural protein nsp16 functions as a methyltransferase, to methylate mRNA cap-0 structure at the ribose 2-O position of the first nucleotide to form cap-1 structures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity is caused by a start_entity, and one of its components, a viral helicase, is emerging as a promising target for the development of chemical end_entity inhibitors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the following review, we describe the characterization, family classification, and kinetic movement mechanisms of the end_entity start_entity SCV helicase-nsP13\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Exposure to canine start_entity end_entity, canine herpesvirus CHV, and Leptospira was rare\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A highly virulent feline start_entity epidemic in African cheetahs, a disease model for human end_entity, illustrates the critical role of ancestral population genetic variation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity which causes severe acute respiratory syndrome end_entity is a virulent and highly contagious organism\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"Recent molecular evidence points to end_entity viruses arising from their start_entity counterparts by recombination events that include the insertion of host RNA andor the duplication of viral RNA sequences\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"Virtually all end_entity and start_entity viruses cause only mild, transient clinical symptoms in healthy adult animals and stimulate a protective immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"thrombocytopenia\",\n",
       "                    \"value\": \"Additionally, we evaluate if end_entity is associated with severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"thrombocytopenia\",\n",
       "                    \"value\": \"A meta-analysis was performed, with calculation of weighted mean difference WMD of platelet number in start_entity patients with or without severe disease and odds ratio OR of end_entity for severe form of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"thrombocytopenia\",\n",
       "                    \"value\": \"In the four studies n1427 which reported data on rate of end_entity, a low platelet count was associated with over fivefold enhanced risk of severe start_entity OR, 5\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a highly infectious disease caused by a start_entity, and has become pandemic within a short period of time\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity n 7, hMPV n 7, and RSV n 5 accounted for most viral infections; other infections included rhinovirus n 4, parainfluenza n 3, start_entity n 4, and adenovirus n 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Conclusions end_entitys are common in adults with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Study objectives: end_entity end_entity is a rapidly progressive disease caused by a start_entity CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Nail-Patella Syndrome\",\n",
       "                    \"value\": \"Study objectives To report the efficacy and findings of a large-scale preventive screening program for severe acute respiratory syndrome-associated start_entity SARS-CoV using amplification of the virus from a nasopharyngeal swab end_entity obtained from the health-care workers HCWs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Virus_Diseases appeared to have no effect on subsequent readmissions or mortality rate over a study period of 1 year Conclusion end_entity A and two less-attended viruses, start_entity OC43 and rhinovirus, were the common etiologic agents in patients hospitalized with AECOPD in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"end_entity appeared to have no effect on subsequent readmissions or mortality rate over a study period of 1 year Conclusion Influenza,_Human A and two less-attended viruses, start_entity OC43 and rhinovirus, were the common etiologic agents in patients hospitalized with AECOPD in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Conclusions Community-acquired start_entity is common among patients hospitalized for an acute exacerbation of end_entity and is generally manifested by more severe clinical and laboratory parameters\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods Surviving end_entity patients were seen at least twice within 3 months after discharge and underwent end_entity-associated start_entity end_entity-CoV IgG antibody testing, pulmonary function testing, and chest radiography andor high-resolution CT HRCT examinations at Chinese PLA General Hospital\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"end_entity attributed to potentially antibiotic-resistant bacteria is associated with an increased risk for 90-day readmission, whereas culture-negative start_entity is associated with lower risk for 90-day readmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"A small number of viral agents lead to acute FRI, respiratory failure, and end_entity: seasonal influenza, avian influenza, start_entity associated with severe end_entity, respiratory syncytial virus, adenovirus, varicella, human metapneumovirus, and hantavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria, Acute Intermittent\",\n",
       "                    \"value\": \"Study objectives: To report on our experience with acute interstitial start_entity end_entity in which patients underwent early diagnostic procedures and received mechanical ventilation with a lung-protective strategy and early institution of immunosuppressive therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"The diagnosis of acute bronchitis should be made only when there is no clinical or radiographic evidence of start_entity, and the common cold, acute asthma, or an exacerbation of end_entity have been ruled out as the cause of cough\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The diagnosis of acute bronchitis should be made only when there is no clinical or radiographic evidence of start_entity, and the common cold, acute asthma, or an exacerbation of Pulmonary_Disease,_Chronic_Obstructive have been ruled out as the cause of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cryptogenic Organizing Pneumonia\",\n",
       "                    \"value\": \"There were two with respiratory bronchiolitis, one with panbronchiolitis, one patient with bronchiolitis obliterans organizing start_entity end_entity, and six with acute inflammatory bronchiolitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cryptogenic Organizing Pneumonia\",\n",
       "                    \"value\": \"One patient had bronchiolitis as well as organizing start_entity end_entity that responded favorably to corticosteroid treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Despite recent progress in identifying and analyzing the start_entity that is responsible for it, few reports have addressed the clinical complications of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity associated start_entity main protease SARS-CoV Mpro has been proposed as a prime target for anti-SARS drug development\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"p38 mitogen-activated protein kinase MAPK and its downstream targets are activated in end_entity start_entity end_entity-CoV-infected Vero E6 cells and activation of p38 MAPK enhances the cytopathic effects of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV encodes a highly basic nucleocapsid N protein of 422 amino acids\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-CoV is a newly identified start_entity that causes severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The nucleocapsid N protein of end_entity start_entity end_entityCoV is a major structural component of virions, which appears to be a multifunctional protein involved in viral RNA replication and translation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have employed NMR to investigate the structure of end_entity start_entity nucleocapsid protein dimer\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The pathogenesis of severe acute respiratory syndrome start_entity end_entity-CoV is an important issue for treatment and prevention of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The enzymatic activity of the end_entity start_entity main proteinase dimer was characterized by a sensitive, quantitative assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The new, fluorogenic substrate, Ala-Arg-Leu-Gln-NH2-Rhodamine, contained a severe acute respiratory syndrome start_entity end_entity CoV main proteinase consensus cleavage sequence and Rhodamine 110, one of the most detectable compounds known, as the reporter group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity 8b is one of the putative accessory proteins of the severe acute respiratory syndrome-associated start_entity end_entity-CoV with unknown functions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, we demonstrated that, among five accessory proteins of end_entity start_entity end_entity-CoV tested, 3aX1 and 7aX4 were capable of activating nuclear factor kappa B NF-B and JUN N-terminal kinase MAPK8, and significantly enhanced CXCL8 CXCL8 promoter activity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background Aims : end_entity end_entity is a recently emerged infection from a start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity has been described as a rapidly progressive, sometimes fatal start_entity with a case fatality rate of 7\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Frontotemporal Dementia\",\n",
       "                    \"value\": \"Ireland, and real-time multiplex polymerase chain reaction end_entity, Respiratory pathogens, multiplex Fast Trade Kit, Malta for detection of influenza virus H1N1, B, rhinovirus, parainfluenza virus, adenovirus, respiratory syncytial virus, human parechovirus, bocavirus, metapneumovirus, and human start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anoxia\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity oxygen saturation 96 and increased work of breathing are signs most associated with community-acquired end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"The screened bacterial pathogens included Streptococcus start_entitye, Staphylococcus aureus, Methicillin-resistant Stphylococcus aureus MRSA, Escherichia coli, Klebsiella start_entitye, Pseudomonas aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia, Haemophilus influenzae, Legionella pneumophila, Mycoplasma end_entity, Chlamydia start_entity, and Mycobacterium tuberculosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia, Mycoplasma\",\n",
       "                    \"value\": \"The screened bacterial pathogens included Streptococcus start_entitye, Staphylococcus aureus, Methicillin-resistant Stphylococcus aureus MRSA, Escherichia coli, Klebsiella start_entitye, Pseudomonas aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia, Haemophilus influenzae, Legionella pneumophila, end_entity, Chlamydia start_entity, and Mycobacterium tuberculosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity was confirmed with a reverse transcriptasepolymerase chain reaction test and by immunohistochemical demonstration of start_entity antigen in the affected tissues, including the left testicle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Summary end_entity is a multisystemic disease of domestic and exotic cats caused by a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Important differences are the presence of multinucleated giant cells and intra-alveolar fibrosis in end_entity and more fulminant necrotizing and haemorrhagic start_entity in H5N1 influenza\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline start_entity FCoV antigen was identified immunohistochemically in ocular macrophages, consistent with a diagnosis of feline infectious peritonitis end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Summary end_entity end_entity is an almost invariably fatal feline start_entity FCoV-induced disease thought to arise from a combination of viral mutations and an overexuberant immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatolenticular Degeneration\",\n",
       "                    \"value\": \"BSTRACT Winter dysentery end_entity is a contagious disease caused by bovine start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatolenticular Degeneration\",\n",
       "                    \"value\": \"These findings highlight the important negative consequences of end_entity, and should motivate actions to prevent between-herd spread of bovine start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"This was especially apparent for numerous cases of necrotizing enteritis and typhlitis cecal inflammation that were variously categorized as end_entity and start_entity by treatment-based diagnoses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Paratuberculosis\",\n",
       "                    \"value\": \"Sufficient literature was available to assess mastitis in cows, and scours, cryptosporidiosis, end_entity, start_entity, immunity, and mortality in calves\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Our objective was to study the effects of start_entity cumulative incidence, 25, end_entity 29, umbilical infection 14, and umbilical hernia 15 on BW and height gains during the first 3 mo of life\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"as the immunodominant fragment of Spike S protein of severe acute respiratory syndrome end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"urate assessment of neutralizing antibody activities is important either for patients infected with end_entity end_entity or for animals and volunteers immunized with the experimental vaccines against the end_entity associated start_entity SCV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"urate assessment of neutralizing antibody activities is important either for patients infected with Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome or for animals and volunteers immunized with the experimental vaccines against the Severe_Acute_Respiratory_Syndrome associated start_entity SCV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The agent responsible for the recent severe acute respiratory syndrome end_entity outbreak is a previously unidentified start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"While there is a wealth of epidemiological studies, little if any molecular characterization of end_entity start_entity SCoV proteins has been carried out\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The main peptidase Mpro from the start_entity CoV causing severe acute respiratory syndrome end_entity is one of the most attractive molecular targets for the development of anti-end_entity agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome end_entity start_entity virus non-structural protein 15 is a Mn2-dependent endoribonuclease with specificity for cleavage at uridylate residues\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity main proteinase Mpro is a key enzyme in the processing of the viral polyproteins and thus an attractive target for the discovery of drugs directed against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Rapid elucidation of neutralizing antibody epitopes on emerging viral pathogens like severe acute respiratory syndrome end_entity start_entity CoV or highly pathogenic avian influenza H5N1 virus is of great importance for rational design of vaccines against these viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emerging disease end_entity is caused by a start_entity that encodes several unusual RNA-processing enzymes, including non-structural protein 15 Nsp15, a hexameric endoribonuclease that preferentially cleaves at uridine residues\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"As a key enzyme in the viral life-cycle, the main protease Mpro is most attractive for drug design targeting the end_entity start_entity end_entity-CoV, the etiological agent responsible for the outbreak of severe acute respiratory syndrome end_entity in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity main peptidase end_entity-CoV Mpro plays an essential role in the life-cycle of the virus and is a primary target for the development of anti-end_entity agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like main peptidase 3CLpro is a viral polyprotein processing enzyme essential for the viability of the end_entity start_entity SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The 3C-like main peptidase 3CLpro is a viral polyprotein processing enzyme essential for the viability of the Severe Acute Respiratory end_entity start_entity SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The epidemic outbreak of severe acute respiratory syndrome end_entity in 2003 was caused by a start_entity CoV, designated end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The crystal structure of Nsp9 of human start_entity HCoV 229E reveals a novel disulfide-linked homodimer, which is very different from the previously reported Nsp9 dimer of end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Paramyxoviridae Infections\",\n",
       "                    \"value\": \"end_entity type 2 infection appeared to be next most likely to be associated with wheezing, followed by start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Early interventions within 1week after the epidemic onset, for instance, including the initial government announcement to the public about the list of hospitals exposed to end_entity start_entity end_entity-CoV, show a promising means to reduce the size 71 and duration 35 of the end_entity epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Much concern has arisen regarding serious epidemics due to the end_entity MERS start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Much concern has arisen regarding serious epidemics due to the Coronavirus_Infections end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Much concern has arisen regarding serious epidemics due to the Middle East Respiratory end_entity MERS start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSION The clinical picture of our patients presenting with hospital-acquired end_entity revealed atypical start_entity associated with lymphopenia, elevated serum levels of LDH, rapid clinical deterioration, and lack of response to empirical antibiotic therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis, St. Louis\",\n",
       "                    \"value\": \"Abstract The recent onset of epidemics caused by viruses such as Ebola, Marburg, Nipah, Lassa, start_entity, West-Nile encephalitis, end_entity, human immunodeficiency virus, dengue, yellow fever and Venezuelan hemorrhagic fever alerts about the risk these agents represent for the global health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Also it is important to consider new pathogens, as Asia has seen the emergence of end_entity start_entity, avian influenza virus, Nipah virus and others in recent years\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Aims The severe acute respiratory syndrome end_entity caused a large outbreak of atypical start_entity in Beijing, China from early March 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In situ RTPCR detected end_entity start_entity RNA in type GCNT2 alveolar cells, interstitial cells and bronchiolar epithelial cells from all three patients Conclusions Severe immunological damage in lung tissue is responsible for the clinical features of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Uniform polymeric nanoparticles with various morphologies of projection coronas like the viruses in the end_entity group have been formed by the self-organization of macromolecular chains polymerizing in a dispersion system of styrene St, acrylonitrile start_entity and polyethylene glycol monomethoxymonomethacrylate PEGm in a polar solvent waterethanol\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of end_entity was identified as a start_entity, the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"In three of the end_entity cats, start_entity isolates with both intact 3c genes as well as 7b genes of full length could also be detected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Here we infected porcine precision-cut lung slices with porcine respiratory start_entity and two end_entity A viruses to analyze if co-infection with these viruses may enhance disease outcome in swine\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"With the aim to contribute to fill this diagnostic gap, a total of 61 effusions from cats with suspected effusive end_entity were collected intra-vitam for detection of feline start_entity FCoV antibodies and RNA by means of indirect immunofluorescence IIF assay and real-time RT-PCR qRT-PCR, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a feline start_entity FCoV-induced fatal disease in wild and domestic cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis start_entity TGEV is enteropathogenic start_entity that causes end_entity in pigs, and is associated with high morbidity and mortality in sucking piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"The start_entity of end_entity and wasting disease VWD was isolated from some three-week-old pigs which had moderate, rising antibody titres\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"G7088 was identified as a good starting point for modification, leading to an efficient and bio-available inhibitor for the end_entity start_entity main proteinase end_entity-CoV Mpro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with start_entity results in the accumulation of genomic-sized mRNA and six to eight subgenomic mRNAs that make up a 3 coterminal nested-set structure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Laboratory analysis showed that the etiologic agent for end_entity is a new type of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The etiological agent of severe acute respiratory syndrome end_entity has been identified as a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an acute respiratory tract infectious disease that is associated with a new start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV administered intranasally and intratracheally to rhesus, cynomolgus and African Green monkeys AGM replicated in the respiratory tract but did not induce illness\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome is caused by a start_entity Severe_Acute_Respiratory_Syndrome-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of severe acute respiratory syndrome end_entity has been identified as a new type of start_entity, end_entity-associated start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Inactivated severe acute respiratory syndrome-associated start_entity end_entity-CoV has been tested as a candidate vaccine against the re-emergence of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ecreted, glycosylated polypeptide containing amino acids 14 to 762 of the end_entity start_entity end_entity-CoV spike protein and a polyhistidine tag was expressed in recombinant baculovirus-infected insect cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The RNA-dependent RNA polymerase RdRp of end_entity start_entity end_entity-CoV is essential for viral replication and a potential target for anti-end_entity drugs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"lthough the recent end_entity start_entity end_entity-CoV that appeared in 2002 has now been contained, the possibility of re-emergence of end_entity-CoV remains\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We developed an attenuated VSV recombinant VSV-S expressing the end_entity start_entity end_entity-CoV spike S protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, we show that CLEC4G enhances infection driven by filovirus glycoproteins RNF130 and the S protein of end_entity start_entity, but does not interact with human immunodeficiency virus type-1 and hepatitis C virus ERVW-1s\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: end_entity end_entity is an emerging infection caused by a start_entity known as end_entity-CoV, characterized by an over-exuberant immune response with lung lymphomononuclear cells infiltration and proliferation that may account for tissue damage more than the direct effect of viral replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the present study, we analyzed the spectrum of immune responses of mice to three different forms of the end_entity start_entity nucleocapsid N: 1 exogenous recombinant protein N-GST with Freund's adjuvant; 2 DNA encoding unmodified N as an endogenous cytoplasmic protein pN; and 3 DNA encoding N as a LAMP-1 chimera targeted to the lysosomal MHC GCNT2 compartment p-LAMP-N\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by a start_entity, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"FECV is more similar to feline start_entity, porcine transmissible gastroenteritis virus, and canine start_entity than to porcine epidemic end_entity virus and human start_entity 229E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Although the start_entity CoV S glycoproteins share membership in this class of ERVW-1s, cleavage to generate the respective PSMD1 and S2 subunits appears absent in a subset of CoV species, including that responsible for the severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The nucleocapsid N protein is a structural component of severe acute respiratory syndrome end_entity start_entity end_entity-CoV and can induce antibody responses in end_entity patients during infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Development of an effective vaccine for severe acute respiratory syndrome end_entity remains to be a priority to prevent possible re-emergence of end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have previously shown that the E protein from end_entity start_entity SARS-CoV forms cation-selective ion channels in planar lipid bilayers Wilson, L\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"We have previously shown that the E protein from Severe Acute Respiratory end_entity start_entity SARS-CoV forms cation-selective ion channels in planar lipid bilayers Wilson, L\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity E protein forms cation-selective ion channels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interferons IFNs inhibit severe acute respiratory syndrome start_entity end_entity-CoV replication and might be valuable for end_entity treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The spike S protein of end_entity start_entity end_entity-CoV is responsible for viral binding with ACE2 molecules\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with the SARS-associated start_entity SARS-CoV induces an atypical pulmonary disease with a high lethality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of fibroblasts with the murine hepatitis start_entity MHV and SARS-start_entity SARS-CoV did not result in nuclear translocation of interferon-regulatory factor 3 IRF3, a key transcription factor involved in IFNA1 induction, and induction of IFNA1 mRNA transcription\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Furthermore, MHV and end_entity could not prevent IFNA1 induction by poly I:C or Sendai virus, suggesting that these start_entity do not inactivate IRF3-mediated transcription regulation, but apparently prevent detection of replicative RNA by cellular sensory molecules\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Long-term protection from end_entity start_entity infection conferred by a single immunization with an attenuated VSV-based vaccine\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ngiotensin converting enzyme 2 ACE2 is the receptor that severe acute respiratory syndrome start_entity end_entity-CoV utilizes for target cell entry and, therefore, plays an important role in end_entity pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Therefore, the role of cholesterol for end_entity can be assigned to the S protein and is unaffected by other start_entity proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The receptor-binding domain RBD on spike protein of severe acute respiratory syndrome-associated start_entity SARS-CoV is the main region interacting with the viral receptor-ACE2 and is a useful target for induction of neutralizing antibodies against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is an invariably fatal disease of cats caused by systemic infection with a feline start_entity FCoV termed feline infectious peritonitis virus end_entityV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like protease of end_entity start_entity end_entity-CoV 3CLpro is vital for end_entity-CoV replication and is a promising drug target\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV belongs to the family Coronaviridae, was first identified during 2002-2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity start_entity SARS-CoV belongs to the family Coronaviridae, was first identified during 2002-2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Structure probing confirmed the existence of these hairpins in the group I Human start_entity-229E and the group GCNT2 end_entity start_entity SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The recent identification of a novel human start_entity responsible of a end_entity-like illness in the Middle-East a decade after the end_entity pandemic, demonstrates that reemergence of a end_entity-like start_entity from an animal reservoir remains a credible threat\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The objective of the present work was to identify, using end_entity start_entity end_entity-CoV mouse infection models, immune factors responsible for clearing of the virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a highly enteropathogenic start_entity of swine that causes acute enteritis with high mortality in nursery piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Noonan Syndrome 6\",\n",
       "                    \"value\": \"Accessory proteins are genus-specific for start_entity, and two putative accessory proteins, end_entity and NS7, are predicted to be encoded by PDCoV; however, this remains to be confirmed experimentally\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV is a porcine enteric start_entity which causes lethal severe watery end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchitis\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Here we studied the antiviral effect of recombinant chicken rcMBL against Infectious start_entity Virus IBV, a highly contagious end_entity of chicken\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with start_entity rearranges the host cell membrane to assemble a replicationtranscription complex in which replication of the viral genome and transcription of viral mRNA occur\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline start_entity FCoV is an etiological agent that causes a benign enteric illness and the fatal systemic disease feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV is an inefficient inducer of interferon IFNA1 response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The value of antibody tests based on these peptides in differentiating between the enteric and end_entity forms of feline start_entity infection remains to be determined\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine enteric alphastart_entity SeACoV, also known as swine acute end_entity syndrome start_entity SADS-CoV, belongs to the species Rhinolophus bat start_entity HKU2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine acute end_entity syndrome start_entity SADS-CoV is a newly identified enteric alphastart_entity that causes fatal end_entity in newborn piglets in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is an emerging enteropathogenic start_entity that causes serious vomiting and end_entity in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is an emerging enteropathogenic start_entity that causes serious end_entity and diarrhea in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Since Sialic_Acid_Storage_Disease and DKK1 were isolated by inoculation of multiple sclerosis end_entity central nervous system CNS tissue into mice or cultured mouse cells, it is important to determine their relationships to other murine and human start_entity isolates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"Since end_entity and DKK1 were isolated by inoculation of multiple sclerosis Multiple_Sclerosis central nervous system CNS tissue into mice or cultured mouse cells, it is important to determine their relationships to other murine and human start_entity isolates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Serologically, a distinction has been made between type I and GCNT2 FCoVs, the latter of which more closely resemble canine start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity virus FIPV strains from six cats and three different geographic areas were compared genetically with feline enteric start_entity FECV isolates obtained from cats inhabiting the same environments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emergence of a previously unknown start_entity infection, end_entity end_entity, demonstrated that fecally contaminated liquid droplets are a potential vehicle for the spread of a respiratory virus to large numbers of people\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The emergence of a previously unknown start_entity infection, Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome, demonstrated that fecally contaminated liquid droplets are a potential vehicle for the spread of a respiratory virus to large numbers of people\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To assess potential risks from this pathway, there is a need for surrogates for end_entity start_entity to provide representative data on viral survival in contaminated water\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an infectious condition caused by the end_entity-associated start_entity end_entity-CoV, a new member in the family Coronaviridae\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Immunohistochemical and in situ hybridization assays demonstrated evidence of SARS-associated start_entity end_entity in various respiratory epithelial cells, predominantly type GCNT2 pneumocytes, and in alveolar macrophages in the lung\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary The pathology of 2 zoonotic human viral infections that recently emerged, severe acute respiratory syndrome end_entity due to start_entity end_entity-CoV and avian influenza A subtype H5N1, is reviewed and compared based on the literature and the cases examined by the authors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity associated start_entity persists in the lung up to the second month, whereas H5N1 persists in the lung up to the third week\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity associated start_entity disseminates to blood, urine, feces, gastrointestinal tract, and liver\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Apoptosis may play a role in the pathogenesis of end_entity associated start_entity infection in the thyroid gland\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interest in this viral family has intensified in the past few years as a result of the identification of a newly emerged start_entity as the causative agent of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and end_entity MERS are the most severe start_entity CoV-associated diseases in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and Coronavirus_Infections end_entity are the most severe start_entity CoV-associated diseases in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity and Coronavirus_Infections MERS are the most severe start_entity CoV-associated diseases in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome and Middle East Respiratory end_entity MERS are the most severe start_entity CoV-associated diseases in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"New data suggest that HCoV-229E may actually be transferred from dromedary camels similar to Middle East respiratory syndrome end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"This scenario provides important ecological parallels to the present prepandemic pattern of host associations of the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background end_entity end_entity is a newly emerged infection from a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3D jury system has predicted the methyltransferase fold for the nsp13 protein of the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"For this article, afebrile start_entity is defined as a pneumonitis with the following: 1 Acute or subacute onset 2 Lack of fever or low-grade fever 102F 3 Clinical signs suggestive of a pulmonary process such as end_entity, tachypnea, or mild to moderate respiratory distress 4 Infiltrates on chest radiographs such as perihilar or interstitial infiltrates 5 Lack of evidence of on acute pyogenic bacterial process such as a normal or only mildly elevated white blood cell count and no response to -lactam antibiotics such as amoxicillin or cephalosporins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interpretation A start_entity was isolated from patients with end_entity that might be the primary agent associated with this disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The network has identified a new start_entity, consistently detected in samples of end_entity patients from several countries, and conclusively named it as the causative agent of end_entity; the strain is unlike any other known member of the genus Coronavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Findings end_entity and start_entity initially improved but 64 85 patients developed recurrent fever after a mean of 8\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Background The cause of severe acute respiratory syndrome end_entity has been identified as a new start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We assessed the antiviral potential of ribavirin, 6-azauridine, pyrazofurin, mycophenolic acid, and glycyrrhizin against two clinical isolates of start_entity FFM-1 and FFM-2 from patients with end_entity admitted to the clinical centre of Frankfurt University, Germany\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Background The worldwide outbreak of severe acute respiratory syndrome end_entity is associated with a newly discovered start_entity, end_entity-associated start_entity end_entityCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interpretation Replication in end_entity-CoV-infected macaques of start_entity similar to that in human beings with end_entity, combined with the high prevalence of end_entity in end_entity patients, fulfill the criteria required to prove that end_entity-CoV is the primary cause of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Effective antiviral agents are needed to treat severe acute respiratory syndrome-associated start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Background An epidemic of severe acute respiratory syndrome end_entity has been associated with an outbreak of atypical start_entity originating in Guangdong Province, People's Republic of China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A start_entity, end_entity start_entity CoV, was isolated from specimens from three patients with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Alterations in the end_entity start_entity genome are unlikely to have caused the distinctive clinical features of the Amoy Gardens patients, and these results highlight the importance of non-viral genomic factors in this outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary The causative agent of severe acute respiratory syndrome end_entity has been identified as a new type of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Background end_entity end_entity is a newly emerged disease caused by a start_entity end_entity-CoV, which spread globally in early 2003, affecting over 30 countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Starting point Yi Guan and colleagues Science 2003; 302: 27678 recently reported the isolation of severe acute respiratory syndrome end_entity start_entity CoV from Himalayan palm civets Paguna larvata in wet markets in Shenzen, southern China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary end_entity end_entity is thought to be caused by a start_entity, end_entity-associated start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We studied viral shedding of end_entity start_entity to improve diagnosis and infection control\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"355 45 specimens of nasopharyngeal aspirates and 150 28 of faeces were positive for end_entity start_entity RNA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Background The outbreak of severe acute respiratory syndrome end_entity in 2002 was caused by a previously unknown start_entity-end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods We expressed the complete end_entity start_entity envelope spike S protein from a recombinant attenuated parainfluenza virus BHPIV3 that is being developed as a live attenuated, intranasal paediatric vaccine against human parainfluenza virus type 3 HPIV3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"After challenge with end_entity start_entity, all monkeys in the control group shed end_entity start_entity, with shedding lasting 58 days\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary end_entity start_entity continues to cause sporadic cases of severe acute respiratory syndrome end_entity in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"No active or passive immunoprophylaxis for disease induced by end_entity start_entity is available\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We investigated prophylaxis of end_entity start_entity infection with a neutralising human monoclonal antibody in ferrets, which can be readily infected with the virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Prophylactic administration of the monoclonal antibody at 10 mgkg reduced replication of end_entity start_entity in the lungs of infected ferrets by 33 logs 95 Cl 2640 logs; p0001, completely prevented the development of end_entity start_entity-induced macroscopic lung pathology p0013, and abolished shedding of virus in pharyngeal secretions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The data generated in this animal model show that administration of a human monoclonal antibody might offer a feasible and effective prophylaxis for the control of human end_entity start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": \"Findings Clinical samples tested negative for IgM antibodies to end_entity, West Nile, dengue, and measles viruses, and for RNA of start_entity, paramyxovirus, enterovirus, and influenza viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Summary Background Human infection with a start_entity named end_entity start_entity MERS-CoV was first identified in Saudi Arabia and the Middle East in September, 2012, with 44 laboratory-confirmed cases as of May 23, 2013\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Summary Background Human infection with a start_entity named Middle East Respiratory end_entity start_entity MERS-CoV was first identified in Saudi Arabia and the Middle East in September, 2012, with 44 laboratory-confirmed cases as of May 23, 2013\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Moreover, -PGA 2000 kDa displayed an antiviral activity against end_entity start_entity and hepatitis C virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV is an economically significant start_entity that can cause severe end_entity in pigs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"The Winthrop-University Hospital end_entity Division's diagnostic weighted point score system for swine influenza H1N1 start_entity is based on key clinical and laboratory features\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Early in the pandemic, the Winthrop-University Hospital end_entity Division developed a diagnostic weighted point score system to diagnose H1N1 start_entity clinically in RIDT-negative adults\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"The end_entity Division's diagnostic swine flu triad was used effectively as the pandemic progressed, and was not only useful in correctly diagnosing probable H1N1 start_entity in hospitalized adults with negative RIDTs, but was also in ruling out mimics of swine influenza, e\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Conclusion Clinicians can use the Winthrop-University Hospital end_entity Division's Diagnostic swine influenza triad to make a rapid clinical diagnosis of probable H1N1 start_entity in hospitalized adult patients with negative RIDTs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Objective Accordingly, a diagnostic weighted point score system was developed for H1N1 start_entity patients, based on RT-PCR positivity by the end_entity Division at Winthrop-University Hospital\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Swine influenza start_entity presents as an influenza-like illness ILI with dry end_entity, fever 102F and myalgias\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"In our experience, the best way to differentiate H1N1 from ILIs or other bacterial CAPs is through the Winthrop-University Hospital end_entity Division's diagnostic weighted point score system for H1N1 start_entity or its rapid simplified version, ie, the diagnostic swine influenza triad\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a newly emerging infectious disease caused by a start_entity end_entity-CoV, which has overwhelmed more than 30 countries claiming nearly 8400 cases with over 800 fatalities\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity end_entity causes lung failure characterized by atypical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Massive aggregations of macrophages are frequently detected in afflicted lungs of patients with severe acute respiratory syndrome-associated start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a major enteric pathogen of the start_entity family that causes extensive mortality among piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is an emerging swine start_entity causing end_entity and intestinal damage in nursing piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"We described retrospectively eight cases of sepsis from start_entity of various microbiological aetiologies including two due to Severe_Acute_Respiratory_Syndrome, compared their end_entity concentrations and provided further descriptors of Severe_Acute_Respiratory_Syndrome as a viral start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We described retrospectively eight cases of sepsis from start_entity of various microbiological aetiologies including two due to end_entity, compared their Porphyria_Cutanea_Tarda concentrations and provided further descriptors of end_entity as a viral start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"Like any viral start_entity, patients with Severe_Acute_Respiratory_Syndrome had low end_entity levels in contrast to bacterial or fungal start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Like any viral start_entity, patients with end_entity had low Porphyria_Cutanea_Tarda levels in contrast to bacterial or fungal start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"In the setting of start_entity with a finding of low end_entity, testing for Severe_Acute_Respiratory_Syndrome should be considered, especially if there is a positive travel or contact history\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the setting of start_entity with a finding of low Porphyria_Cutanea_Tarda, testing for end_entity should be considered, especially if there is a positive travel or contact history\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"During a Severe_Acute_Respiratory_Syndrome epidemic, we also strongly advocate isolating all suspected community acquired start_entity with a low end_entity level\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"During a end_entity epidemic, we also strongly advocate isolating all suspected community acquired start_entity with a low Porphyria_Cutanea_Tarda level\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Case reports single or case series with details on their treatment and outcome in the English literature can be reviewed for start_entity caused by human or avian influenza A virus 50 patients, varicella zoster virus 120, adenovirus 29, hantavirus 100 and end_entity start_entity end_entity-CoV 841\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Conclusion Bacterial co-infection was frequent in influenza A H1N1 start_entity, with end_entity and increased platelet count as the main predictors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We compare and contrast the clinical presentation, laboratory diagnosis and management of infection due to this start_entity and that of end_entity start_entity despite the paucity of published information on the former\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Since 70 of all emerging infectious pathogens came from animals, the emergence of this novel virus may represent another instance of interspecies jumping of betastart_entity from animals to human similar to the group A start_entity OC43 possibly from a bovine source in the 1890s and the group B end_entity start_entity in 2003 from bat to civet and human\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chondrosarcoma, Extraskeletal Myxoid\",\n",
       "                    \"value\": \"Summary Objectives A severe acute respiratory syndrome SARS-like disease due to a novel betastart_entity, human start_entity end_entity HCoV-end_entity, has emerged recently\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Virus detection rates exceeded 50 in patients with exacerbation of asthma 58, acute bronchitis and Influenza-like-illness 64, and ranged from 30 to 50 in patients with an exacerbation of end_entity 38, community acquired start_entity 36 and congestive cardiac failure 31\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Bacterial detection was relatively frequent in patients with exacerbation of end_entity and start_entity 25 and 33 respectively but was uncommon in all other groups\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Summary Background After the 2015 Middle East respiratory syndrome end_entity outbreak in Korea, prediction of start_entity development and progression to respiratory failure was emphasized in control of end_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Second ACE2 was identified as an essential receptor for the end_entity start_entity that causes severe acute lung failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is an immune-mediated disease of domestic and exotic felides infected with feline start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"As end_entity is an immune-mediated disease, treatment is mainly aimed at controlling the immune response triggered by the infection with the feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Treatment of primary tracheal epithelial cells with lipopolysaccharide end_entity or infection with canine respiratory start_entity led to decreased expression of CBD103 and CBD108, while cells infected with canine parainfluenza virus had lower levels of CBD1 and CBD108\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a fatal, immune-augmented, and progressive viral disease of cats associated with feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To create a novel trial vaccine and evaluate its potency, we attempted to generate a end_entity inactivated vaccine using end_entity start_entity end_entity-CoV strain F69 treated with formaldehyde and mixed with AlOH3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a highly infectious disease caused by a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of the human astrocytic cell line U-373MG by the OC43 strain of human start_entity caused an upregulation of IL6, TNF-, and CCL2 mRNA expression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Demyelinating Diseases\",\n",
       "                    \"value\": \"end_entity following infection of mice with the neurotropic start_entity mouse hepatitis virus strain JHM MHV is immune-mediated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Indeed, murine start_entity MHV infection provides a well-known experimental model for end_entity studies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Stickler syndrome, type 1\",\n",
       "                    \"value\": \"end_entity and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Detection of HCoV-229E and HCoV-OC43 in clinical specimens is possible using this method: 348 respiratory specimens 202 end_entity and 146 nasal aspirates were tested with this RT-PCR-hybridization and 12 human start_entity are detected 3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome end_entity epidemic originating from China in 2002 was caused by a previously uncharacterized start_entity that could be identified by specific RT-PCR amplification\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a life-threatening disease caused by a start_entity termed end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity-associated human start_entity end_entity-HCoV is a newly described, emerging virus conclusively established as the etiologic agent of the severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity, a life-threatening disease, is caused by the newly identified virus end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The test was applied to 1075 feline blood samples 424 from healthy, 651 from sick cats suspected of end_entity and returned 46 of the diseased cats as positive for feline start_entity mRNA in their peripheral blood cells; of the healthy cats, 5 tested positive\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The recombinant nucleocapsid protein rNP of severe acute respiratory syndrome end_entity start_entity end_entity-CoV was expressed in a baculovirus system\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The transmission of severe acute respiratory syndrome-associated start_entity end_entity-CoV is associated with close contact to end_entity patients and droplet secretions of those patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Cell lines were engineered to constitutively express an enhanced green fluorescent protein EGFP and used to detect 1 antiviral potency in end_entity tests; 2 antiviral specificity in tests using the porcine start_entity transmissible gastroenteritis virus TGEV; and 3 cytotoxicity in the same assays without virus challenge\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"pture enzyme-enhanced chemiluminescence immunoassay ECLIA based on three specific monoclonal antibodies to detect the nucleocapsid N protein of severe acute respiratory syndrome end_entity associated start_entity end_entity-CoV in the serial serum samples from end_entity patients was developed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a recently discovered viral disease, characterized by fever, cough, acute fibrinous start_entity and high infectivity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome is a recently discovered viral disease, characterized by fever, end_entity, acute fibrinous start_entity and high infectivity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Specific pathogen-free SEC14L2 chickens were immunized with inactivated end_entity start_entity and their eggs were harvested at regular intervals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"All these data suggest that the anti-end_entity start_entity IgY could be a new useful biological product for specific antiviral therapy against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome start_entity SARS-CoV nucleocapsid protein NP is one of the predominant antigenic protein and the most abundant shed antigen throughout the end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Rhabdomyosarcoma\",\n",
       "                    \"value\": \"In end_entity cells, MadinDarbyCanine-kidney cells and in an undefined monkey kidney cell line some replication was observed but massive exponential rise in virus yield lacked The results will lead to an improved routine diagnostic algorithm for the detection of the human start_entity NL63\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The major concern for severe acute respiratory syndrome end_entity, caused by the end_entity-associated start_entity end_entity-CoV, is the lack of diagnostic and therapeutic agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"By using an infectious cloning system developed recently for the avian start_entity infectious bronchitis virus IBV, the enhanced green fluorescent protein EGFP gene, the firefly luciferase gene and several host and viral genes EIF3F, Severe_Acute_Respiratory_Syndrome ORF6, end_entity virus 1 core protein gene were inserted into various positions of the IBV genome, and the effects on gene expression, virus recovery, and stability in cell culture were studied\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"By using an infectious cloning system developed recently for the avian start_entity infectious bronchitis virus IBV, the enhanced green fluorescent protein EGFP gene, the firefly luciferase gene and several host and viral genes EIF3F, end_entity ORF6, Dengue virus 1 core protein gene were inserted into various positions of the IBV genome, and the effects on gene expression, virus recovery, and stability in cell culture were studied\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The assay was specific in that it did not amplify other porcine viruses including porcine parvovirus, porcine circovirus type 1, porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, classical swine fever virus, swine transmissible gastroenteritis start_entity, and porcine epidemic end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Neonatal calf end_entity is a multi-etiology syndrome of cattle and direct detection of the two major agents of the syndrome, group A rotavirus and Bovine start_entity BCoV is hampered by their fastidious growth in cell culture\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Cell clones expressed interferon beta in response to polyI:C stimulation and supported the replication of four different viruses, namely, vesicular stomatitis virus VSV, porcine epidemic end_entity start_entity PED-CoV, Middle-East respiratory syndrome start_entity MERS-CoV and herpes simplex virus HSV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Results This work examines the available strategies for overcoming the obstacles of assembling the long and complex RNA genomes of start_entityes and reports one-step construction of an infectious clone system for the end_entity start_entity MERS-CoV by homologous recombination in S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Results This work examines the available strategies for overcoming the obstacles of assembling the long and complex RNA genomes of start_entityes and reports one-step construction of an infectious clone system for the Middle East Respiratory end_entity start_entity MERS-CoV by homologous recombination in S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The Feline start_entity FCoV is the etiological agent of feline infectious peritonitis end_entity, a lethal disease of felids\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a recently identified start_entity in the genus Deltastart_entity that can cause enteric disease including end_entity, vomiting, dehydration and mortality in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a recently identified start_entity in the genus Deltastart_entity that can cause enteric disease including diarrhea, end_entity, dehydration and mortality in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"In pigs, the newly emerged porcine deltacoronavirus PDCoV and re-emerged porcine epidemic end_entity virus PEDV reported in the US and Asia, as well as the discovery of novel start_entity in wild bats or birds, has necessitated development of improved detection and control measures for these start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine acute end_entity syndrome start_entity SADS-CoV is a start_entity which was first reported in southern China in 2017\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Clinical detection of Middle East respiratory syndrome end_entity start_entity end_entity-CoV in patients is achieved using genetic diagnostic methods, such as real-time RT-PCR assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The BRDC multiplex PCR-microarray assay was able to detect and differentiate four bacteria Mannheimia haemolytica, Histophilus somni, Pasteurella multocida, and Mycoplasma bovis and five viruses bovine parainfluenza virus-3, bovine respiratory syncytial virus, bovine herpesvirus-1, bovine start_entity BCoV, and bovine viral end_entity virus BVDV associated with BRDC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"0 101 copiesL with no cross-reactions with classical swine fever virus, porcine and respiratory syndrome virus NA, porcine and respiratory syndrome virus EU, transmissible gastroenteritis start_entity, foot and mouth disease virus, porcine epidemic end_entity virus S-INDEL and non-S-INDEL, swine influenza virus subtype H1N1, porcine circovirus type 2, seneca valley virus, porcine parvovirus, porcine deltastart_entity and rotavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine acute end_entity syndrome start_entity SADS-CoV is a start_entity which was associated with severe end_entity disease in pigs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The conserved target sequences directed to classical swine fever virus CSFV, porcine reproductive and respiratory syndrome virus PRRSV, porcine epidemic end_entity virus PEDV and transmissible gastroenteritis start_entity TGEV were selected based on alignments of genomic sequences and then specific primers were designed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a highly pathogenic enteric start_entity causing lethal watery end_entity in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"diagnostic test for canine start_entity end_entity infection based on a nested polymerase chain reaction n-PCR assay was developed and tested using the following start_entity strains: end_entity USDA strain, end_entity 4593, field strain, feline infectious peritonitis virus FIPV, field strain, trasmissible gastroenteritis virus TGEV, Purdue strain, bovine start_entity BCV, 9WBL-77 strain, infectious bronchitis virus IBV, M-41 strain and fecal samples of dogs with end_entity enteritis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"The results of polymerase chain reaction PCR and nested polymerase chain reaction n-PCR assays for the diagnosis of canine start_entity end_entity infection, and the comparison with other diagnostic techniques, such as electron microscopy EM and virus isolation using A-72 cell line are reported\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity end_entity-CoV has been identified as the causal agent of a new emerging disease: severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Based on molecular modeling techniques we constructed a rational 3D model of ORF3 in end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This report describes the application of real-time PCR for testing antivirals against highly pathogenic viruses such as Lassa virus, end_entity start_entity and Ebola virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The compounds also inhibited replication of end_entity start_entity and Ebola virus in analogous assays, although to a lesser extent than Lassa virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Serious outbreaks of severe acute respiratory syndrome end_entity, caused by the newly discovered start_entity end_entity-CoV, occurred between late 2002 and early 2003 and there is an urgent need for effective antiviral agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A start_entity was identified as the aetiological agent of end_entity and the 30kb viral genome was deciphered with unprecedented speed in a coordinated manner by the global community\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Mohr-Tranebjaerg syndrome\",\n",
       "                    \"value\": \"More than 200 Chinese medicinal herb extracts were screened for antiviral activities against Severe_Acute_Respiratory_Syndrome-associated start_entity SARS-CoV using 3-4,5-dimethylthiazol-2-yl-5-3-carboxymethoxyphenyl-2-4-sulfophenyl-2H-tetrazolium inner salt end_entity assay for virus-induced cytopathic effect CPE\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"More than 200 Chinese medicinal herb extracts were screened for antiviral activities against end_entity-associated start_entity SARS-CoV using 3-4,5-dimethylthiazol-2-yl-5-3-carboxymethoxyphenyl-2-4-sulfophenyl-2H-tetrazolium inner salt Mohr-Tranebjaerg_syndrome assay for virus-induced cytopathic effect CPE\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"new disease, the severe acute respiratory distress syndrome end_entity, caused by the end_entity start_entity end_entity-CoV, emerged at the beginning of 2003 and rapidly spread throughout the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an emerging infectious disease caused by a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome start_entity end_entity CoV genome has 14 potential open reading frames ORFs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of severe acute respiratory syndrome end_entity has been identified as a start_entity, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a fatal disease in domestic and nondomestic felids caused by feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In addition, tylophorine compounds strongly reduced cytopathic effect in Vero 76 cells induced by human severe acute respiratory syndrome start_entity end_entity CoV, with EC50 values ranging from less than 5 to 340nM\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The open-reading-frame 3a of end_entity start_entity end_entity-CoV had been demonstrated previously to form a cation-selective channel that may become expressed in the infected cell and is then involved in virus release\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity main protease end_entity-CoV Mpro is essential for the replication of the virus and regarded as a major antiviral drug target\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In vitro infection of Vero E6 cells by end_entity start_entity end_entity-CoV is blocked by hexapeptide Tyr-Lys-Tyr-Arg-Tyr-Leu\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This article introduces a series of invited papers in Antiviral Research marking the 10th anniversary of the outbreak of severe acute respiratory syndrome end_entity, caused by a start_entity that emerged in southern China in late 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The recent emergence of another start_entity causing severe disease, Middle East respiratory syndrome end_entity, in humans, has made it clear that start_entityes pose a major threat to human health, and that more research is urgently needed to elucidate their replication mechanisms, identify potential drug targets, and develop effective countermeasures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this series, experts in many different aspects of start_entity replication and disease will provide authoritative, up-to-date reviews of the following topics: clinical management and infection control of end_entity; reservoir hosts of start_entityes; receptor recognition and cross-species transmission of end_entity-CoV; end_entity-CoV evasion of innate immune responses; structures and functions of individual coronaviral proteins; anti-start_entity drug discovery and development; and the public health legacy of the end_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Lessons learned from the Severe_Acute_Respiratory_Syndrome epidemic will be especially important in responding to the current emergence of another highly pathogenic human start_entity, the agent of Middle East respiratory syndrome end_entity, and to the recently emerging H7N9 influenza A virus in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Lessons learned from the end_entity epidemic will be especially important in responding to the current emergence of another highly pathogenic human start_entity, the agent of Middle East respiratory syndrome MERS, and to the recently emerging H7N9 influenza A virus in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We first present an overview of the available studies on bat start_entity, with details on their chiropteran hosts, then comparatively analyze the increase in bat CoV studies and novel genomic sequences obtained since the end_entity pandemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our previous work showed that end_entity start_entity end_entity-CoV non-structural protein 14 represents a structurally novel and unique guanine-N7-methyltransferase N7-MTase that is able to functionally complement yeast cellular N7-MTase\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Middle-East Respiratory end_entity start_entity MERS-CoV causes severe acute start_entity and renal failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These differences are the likely reason for reduced in vitro peptide hydrolysis and deubiquitinating activities of the MERS-CoV PLpro, compared to the homologous enzyme from the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The huge RNA genome of end_entity start_entity comprises a number of open reading frames that code for a total of eight accessory proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": \"Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, start_entity, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, end_entity virus and human immunodeficiency virus in cell culture assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"With the recent emergence of end_entity start_entity in humans and the outbreak of devastating porcine epidemic diarrhea start_entity in swine, therapeutic intervention is urgently needed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"With the recent emergence of Middle East Respiratory end_entity start_entity in humans and the outbreak of devastating porcine epidemic diarrhea start_entity in swine, therapeutic intervention is urgently needed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"With the recent emergence of Coronavirus_Infections start_entity in humans and the outbreak of devastating porcine epidemic end_entity start_entity in swine, therapeutic intervention is urgently needed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"lthough feline start_entity FCoV causes feline infectious peritonitis end_entity, which is a fatal infectious disease, there are no effective therapeutic medicines or vaccines\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV, which causes high morbidity and mortality in piglets, is an enteropathogenic start_entity with economic importance\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our data suggest that Hiltonol treatment of end_entity in mice leads to substantial prophylactic and therapeutic effects and could be used for treatment of other virus disease such as those caused by MERS-CoV a related start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity MERS is a highly lethal pulmonary infection caused by a start_entity CoV, MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Coronavirus_Infections end_entity is a highly lethal pulmonary infection caused by a start_entity CoV, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity MERS is a highly lethal pulmonary infection caused by a start_entity CoV, MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Over 12 years have elapsed since severe acute respiratory syndrome end_entity triggered the first global alert for start_entity infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Virus transmission in humans was quickly halted by public health measures and human infections of end_entity start_entity end_entity-CoV have not been observed since\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The work on SARS-CoV widens our knowledge on the epidemiology, pathophysiology and immunology of start_entityes and may shed light on end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV causes severe acute respiratory illness with fever, end_entity and shortness of breath\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"inhibitory concentration 50\",\n",
       "                    \"value\": \"As presented here, our peptidomimetic inhibitors of enterovirus 3Cpro 6b, 6c and 6d inhibited 3CLpro of MERS-CoV and severe acute respiratory syndrome start_entity SARS-CoV with end_entity values ranging from 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"In this study, we found that recombinant mature pIL-22 mpIL-22 inhibited the infection of multiple end_entity viruses, including alpha start_entity, porcine epidemic end_entity virus PEDV, transmissible gastroenteritis virus TGEV, and porcine rotavirus PoRV, in the intestinal porcine epithelial cell line J2 IPEC-J2 cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The three-dimensional structures of domains in the N-terminal two thirds of Nsp3 have been investigated by X-ray crystallography andor nuclear magnetic resonance NMR spectroscopy since the outbreaks of end_entity start_entity SARS-CoV in 2003 as well as Middle-East Respiratory Syndrome start_entity MERS-CoV in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The three-dimensional structures of domains in the N-terminal two thirds of Nsp3 have been investigated by X-ray crystallography andor nuclear magnetic resonance NMR spectroscopy since the outbreaks of Severe Acute Respiratory end_entity start_entity SARS-CoV in 2003 as well as Middle-East Respiratory end_entity start_entity MERS-CoV in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV emerged in southern China in late 2002 and caused a global outbreak with a fatality rate around 10 in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity Coronavirus MERS-CoV has emerged as a start_entity infection of humans in the past 5 years\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity Coronavirus MERS-CoV has emerged as a start_entity infection of humans in the past 5 years\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a start_entity CoV discovered in the 1970s that infects the intestinal tract of pigs, resulting in end_entity and vomiting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine epidemic diarrhea virus PEDV is a start_entity CoV discovered in the 1970s that infects the intestinal tract of pigs, resulting in diarrhea and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine enteric start_entityes SECoVs, including porcine epidemic end_entity virus PEDV, swine acute end_entity syndrome start_entity SADS-CoV, and porcine deltastart_entity PDCoV have emerged and been prevalent in pig populations in China for the last several years\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Moreover, A9 exhibited potent antiviral activity against the replication of various start_entity, including murine hepatitis virus MHV, porcine epidemic end_entity virus PEDV and feline infectious peritonitis virus FIPV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The second objective was to determine whether the serostatus seropositiveseronegative of seven respiratory pathogens bovine respiratory syncytial virus BRSV, parainfluenzavirus-3, bovine start_entity BCV, bovine herpesvirus-1, bovine viral end_entity virus, Mannheimia haemolytica and Mycoplasma bovis of these arrival serum samples could be associated with the risk of having BRD\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porcine Reproductive and Respiratory Syndrome\",\n",
       "                    \"value\": \"Four diseases were included in the BBN: Porcine reproductive and respiratory syndrome end_entity, a prevalent endemic aerosol pathogen, Swine influenza SI a viral respiratory aerosol pathogen, Mycoplasma start_entity MP an endemic respiratory disease spread by close contact and aerosol and Swine dysentery Sialic_Acid_Storage_Disease an enteric disease which is re-emerging in North America\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"Four diseases were included in the BBN: Porcine reproductive and respiratory syndrome Porcine_Reproductive_and_Respiratory_Syndrome, a prevalent endemic aerosol pathogen, Swine influenza SI a viral respiratory aerosol pathogen, Mycoplasma start_entity MP an endemic respiratory disease spread by close contact and aerosol and Swine dysentery end_entity an enteric disease which is re-emerging in North America\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Bovine respiratory syncytial virus BRSV and bovine start_entity BCV are responsible for respiratory disease and end_entity in cattle worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a novel porcine enteric start_entity that causes end_entity, vomiting and dehydration in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a novel porcine enteric start_entity that causes diarrhea, end_entity and dehydration in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Health data including date of initial treatment and number of treatments were collected for the diseases end_entity, omphalitis, septicemia and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Cumulative incidences of mortality and occurrence of end_entity, omphalitis, septicemia and start_entity were 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatolenticular Degeneration\",\n",
       "                    \"value\": \"Bovine start_entity isolates associated with recent outbreaks of respiratory disease in Ontario and Quebec dairy farms were compared to reference strains known to be responsible for neonatal calf diarrhea NCD or winter dysentery end_entity of adult cattle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Bovine start_entity isolates associated with recent outbreaks of respiratory disease in Ontario and Quebec dairy farms were compared to reference strains known to be responsible for neonatal calf end_entity NCD or winter dysentery Hepatolenticular_Degeneration of adult cattle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatolenticular Degeneration\",\n",
       "                    \"value\": \"In the present study, we analyzed the S glycoprotein gene to characterize 10 winter dysentery end_entity start_entity strains circulated in Korea during 20022003 and compared the nucleotide nt and deduced amino acid aa sequences with the other known BCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatolenticular Degeneration\",\n",
       "                    \"value\": \"The phylogenetic analysis of the entire S glycoprotein gene revealed that the aa sequences of all Korean end_entity strains were more homologous to each other and were very closely related to respiratory bovine start_entity RBCV strain BSG and enteric bovine start_entity EBCV strain LY-138, but were distinct from the other known BCoVs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity CoV has been described in association with cases of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-CoV 3a protein was a unique protein of end_entity start_entity end_entity-CoV, which was identified in end_entity-CoV infected cells and end_entity patients' specimen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of severe acute respiratory syndrome end_entity has been identified as end_entity-associated start_entity end_entity-CoV, but the prophylactic treatment of end_entity-CoV is still under investigation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity CoV has recently been identified as the aetiological agent of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Differences in nuclearnucleolar localization properties of N from other members of start_entity family suggest a unique function for N, which may play an important role in the pathogenesis of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This article focuses on frameshifting in two human pathogens, the retrovirus human immunodeficiency virus type 1 HIV-1 and the start_entity responsible for severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Viral evasion of innate immunity, hypercytokinemia and systemic immunopathology in the end_entity start_entity end_entity CoV infected host have been suggested as possible mechanisms for the cause of severe pathology and morbidity in end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Open reading frame 9b ATP6AP1 9b encodes a 98 amino acid group-specific protein of severe acute respiratory syndrome end_entity start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this review, we summarize the researches on animal reservoirs of the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Cats infected with virulent feline start_entity which causes feline infectious peritonitis end_entity usually succumb to disease despite high antibody concentrations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity virus FIPV was presumed to arise from mutations in the 3c of a ubiquitous and largely nonpathogenic feline enteric start_entity FECV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"In order to confirm these assumptions, 27 fecal and 32 end_entity start_entity isolates were obtained from resident or adopted cats from a large metropolitan shelter during 20082009 and their 3ac, E, and M genes sequenced\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Forty percent of start_entity isolates from end_entity tissues had an intact 3c gene, while 60 had mutations that truncated the gene product\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Coronaviruses are the etiological agents of respiratory and enteric diseases in humans and livestock, exemplified by the life-threatening severe acute respiratory syndrome end_entity caused by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"More than a decade after the emergence of severe acute respiratory syndrome start_entity SARS-CoV in 20022003 the occurrence of a novel CoV termed Middle East respiratory syndrome end_entity CoV challenges researchers and public health authorities\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The recent outbreak of Middle East respiratory syndrome end_entity start_entity end_entity-CoV infection has led to more than 800 laboratory-confirmed end_entity cases with a high case fatality rate 35, posing a serious threat to global public health and calling for the development of effective and safe therapeutic and prophylactic strategies to treat and prevent end_entity-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The successive emergence of highly pathogenic coronaviruses start_entity such as the Severe_Acute_Respiratory_Syndrome SARS-CoV in 2003 and the end_entity Coronavirus MERS-CoV in 2012 has stimulated a number of studies on the molecular biology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The successive emergence of highly pathogenic coronaviruses start_entity such as the end_entity SARS-CoV in 2003 and the Coronavirus_Infections Coronavirus MERS-CoV in 2012 has stimulated a number of studies on the molecular biology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The successive emergence of highly pathogenic coronaviruses start_entity such as the Severe Acute Respiratory end_entity SARS-CoV in 2003 and the Middle East Respiratory end_entity Coronavirus MERS-CoV in 2012 has stimulated a number of studies on the molecular biology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In 2012 in Jordan, infection by a start_entity CoV caused the first known cases of Middle East respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity is often a lower respiratory tract disease associated with fever, cough, breathing difficulties, start_entity that can progress to acute respiratory distress syndrome, multiorgan failure and death among more than a third of those infected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"MERS is often a lower respiratory tract disease associated with fever, end_entity, breathing difficulties, start_entity that can progress to acute respiratory distress syndrome, multiorgan failure and death among more than a third of those infected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Now we know that many of these terrible diseases are caused by viruses originated from bats Table 1, such as Ebola virus, Marburg, Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome-CoV, end_entity start_entity end_entity-CoV, Nipah virus NiV and Hendra virus HeV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Now we know that many of these terrible diseases are caused by viruses originated from bats Table 1, such as Ebola virus, Marburg, end_entity start_entity end_entity-CoV, MERS start_entity MERS-CoV, Nipah virus NiV and Hendra virus HeV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a newly discovered enterotropic swine start_entity that causes enteritis and end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV, a start_entity discovered more than 40 years ago, regained notoriety recently by its devastating outbreaks in East Asia and the Americas, causing substantial economic losses to the swine husbandry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity CoV papain-like protease PLpro reportedly induced the production of TGF-1 through p38 MAPKSTAT3-meidated Egr-1-dependent activation Sci\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is an emerging pathogenic start_entity that causes a significant economic burden to the swine industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV, a newly discovered enteric start_entity, is a causative agent of severe clinical end_entity and intestinal pathological damage in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Human start_entity NL63 HCoV-NL63, one of the main circulating HCoVs worldwide, causes respiratory tract illnesses like runny nose, end_entity, bronchiolitis and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"wine acute end_entity syndrome start_entity SADS-CoV that causes severe end_entity in suckling piglets was identified in Southern China in 2017\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"The gene encoding the spike S protein from two geographically distinct strains American and British of canine start_entity end_entity was cloned and sequenced\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Moreover, the sequence similarity between end_entity isolates and the feline start_entity, feline infectious peritonitis virus FIPV was comparable\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"To gain insight into the genetic relationships among six canine start_entity end_entity strains, the variable region of the spike S protein gene was sequenced\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Publisher Summary end_entity end_entity is caused by a start_entity CoV, end_entityCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Transgenic cauliflower plants cv Early Snowball were obtained in similar procedure and have shown detectable amounts of end_entity start_entity spike-protein end_entity-CoV PSMD1 in floret tissue of mature curd\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Focused efforts by several international laboratories have resulted in the sequencing of the genome of the causative agent of severe acute respiratory syndrome end_entity, start_entity end_entity-CoV, in record time\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hypophosphatemic Bone Disease\",\n",
       "                    \"value\": \"We analyzed the mechanisms by which end_entity 2 primes innate antiviral immunity and polarized activation of macrophage-like THP-1 cells using the receptor-binding domain RBD of Middle East respiratory syndrome start_entity MERS-CoV spike protein S RBD as a model antigen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity epidemic, which began in the Fall of 2002, was related to the exotic food industry in southern China, initially involving disproportionate numbers of animal handlers, chefs, and caterers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Between 13 March and 23 June, 38 patients with probable and suspected end_entity, 90 patients with non-end_entity start_entity, and 510 patients without start_entity were admitted into our unit\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However, only limited data were available to demonstrate their efficacy against end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Aside from Ebola, other trends in the infection prevention and control literature covered in this article include end_entity MERS start_entity, universal versus targeted interventions, faecal microbiota transplantation, whole genome sequencing, carbapenem-resistant Enterobacteriaceae, and some aspects of environmental science\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Aside from Ebola, other trends in the infection prevention and control literature covered in this article include Coronavirus_Infections end_entity start_entity, universal versus targeted interventions, faecal microbiota transplantation, whole genome sequencing, carbapenem-resistant Enterobacteriaceae, and some aspects of environmental science\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Aside from Ebola, other trends in the infection prevention and control literature covered in this article include Middle East Respiratory end_entity MERS start_entity, universal versus targeted interventions, faecal microbiota transplantation, whole genome sequencing, carbapenem-resistant Enterobacteriaceae, and some aspects of environmental science\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The evaluation of adults with an acute end_entity illness or a presumptive diagnosis of uncomplicated acute bronchitis should focus on ruling out serious illness, particularly start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Study objective On March 13, 2003, Singapore physicians were alerted about an outbreak of atypical start_entity that became known as severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The World Health Organization recommended the use of household disinfectants, which have not been previously tested against end_entity start_entity end_entity-CoV, to disinfect potentially contaminated environmental surfaces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The purpose was to define the potential targets for anti-end_entity drugs in the structural proteins from human end_entity related start_entity end_entity-CoV while knowing little about the functional sites and possible mutations in these proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The cleavage mechanism of severe acute respiratory syndrome end_entity start_entity main proteinase Mpro or 3CLpro for the octapeptide AVLQSGFR is studied using molecular mechanics MM and quantum mechanics RPL10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Stimulated by the binding mechanism of end_entity-CoV Mpro with the octapeptide AVLQSGFR reported recently as well as the Chou's distorted key theory, we synthesized the octapeptide AVLQSGFR for conducting various biochemical experiments to investigate the antiviral potential of the octapeptide against end_entity start_entity BJ-01\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The results demonstrate that, compared with other compounds reported so far, AVLQSGFR is the most active in inhibiting replication of the end_entity start_entity, and that no detectable toxicity is observed on Vero cells under the condition of experimental concentration\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"The Spanish Societies of Intensive and Critical Care SEMICYUC, end_entity and Clinical Microbiology SEIMC and Pulmonology and Thoracic Surgery SEPAR have produced these evidence-based Guidelines for the management of community acquired start_entity in Adults\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A year later, in November 2002, severe acute respiratory syndrome end_entity suddenly appeared as atypical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity AH1N1pdm09-related start_entity and other complications were associated with increased morbidity and mortality among hospitalized patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"inhibitory concentration 50\",\n",
       "                    \"value\": \"We have further showed that the peptidomimetic inhibitor, Cbz-AVLQ-CN, has broad-spectrum inhibition against 3CLpro from human start_entity strains 229E, NL63, OC43, HKU1, and infectious bronchitis virus, with end_entity values ranging from 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The screening of antitrypanosomal and antiviral activities of 5-3-naphthalen-2-yl-5-aryl-4,5-dihydropyrazol-1-yl-thiazolidine-2,4-diones was carried out with the promising influence of the mentioned compounds on Trypanosoma brucei, but minimal effect on end_entity start_entity and influenza types A and B viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"For example, consideration should be given to the development of a vaccine that will protect across regional strains of end_entity, as the newly emergent start_entity end_entity-start_entity end_entity-CoV is proving to be variable and may be mutating in response to immune pressure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity caused by a newly identified start_entity end_entity-CoV remains a threat to cause epidemics as evidenced by recent sporadic cases in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ELISA, Western-blotting and neutralization assay detected specific antibody against end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The DNA vaccine contained a plasmid encoding the end_entity start_entity end_entity-CoV S protein under the control of the human CMV promoter and intron A\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Different forms of end_entity start_entity end_entity-CoV spike protein-based vaccines for generation of neutralizing antibody response against end_entity-CoV were compared using a mouse model\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods The cultures of end_entity start_entity end_entity-CoV BJ-01 strain infected Vero cells were inactivated with -propiolactone\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The recombinant nucleocapsid rN protein of the start_entity CoV responsible for severe acute respiratory syndrome end_entity was cloned and expressed in Escherichia coli, extracted from cell lysates containing 6M urea, then purified by Ni2-affinity chromatography\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We studied the immunogenicity of an anti-end_entity subunit vaccine comprised of the fragment of the end_entity start_entity end_entity-CoV spike protein amino acids 318510 S318510 containing the receptor-binding domain\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We generated a end_entity start_entity end_entity-CoV spike protein-expressing recombinant vaccinia virus RVV-S using highly attenuated strain LC16m8\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Development of effective vaccines against severe acute respiratory syndrome end_entity start_entity end_entity-CoV is still a priority in prevention of re-emergence of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome start_entity nucleocapsid protein end_entity-CoV N is one of the major targets for end_entity vaccine due to its high potency in triggering immune responses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In our previous study, immunization of mice with severe acute respiratory syndrome start_entity end_entity CoV spike S DNA vaccine could induce both humoral and cellular immunity in response to a pool of entire overlapping S peptides\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a serious infectious disease caused by the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"For vaccine-induced enhanced susceptibility to infection with certain viruses like feline start_entity, end_entity virus, and feline immunodeficiency virus, it has been shown that antibody-dependent enhancement ADE plays an important role\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We investigated whether the surface-linked liposomal peptide was applicable to a vaccine based on cytotoxic T lymphocytes CTLs against severe acute respiratory syndrome end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"new type of start_entity has been identified as the causative agent underlying end_entity MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"new type of start_entity has been identified as the causative agent underlying Coronavirus_Infections end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"new type of start_entity has been identified as the causative agent underlying Middle East Respiratory end_entity MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The end_entity start_entity end_entity-CoV has spread in the Middle East, but cases originating in the Middle East have also occurred in the European Union and the USA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"For admissions between 022007 and 032012 chest radiographs were interpreted for the presence of WHO primary endpoint start_entity and nasopharyngeal swabs were analysed by PCR for the presence of end_entity A or B, RSV and rhinovirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"end_entity virus of mice PVM infection of BALBc mice induces bronchiolitis leading to a fatal start_entity in a dose-dependent manner, closely paralleling the development of severe disease during human respiratory syncytial virus infection in man, and is thus a recognised model in which to study the pathogenesis of pneumoviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human start_entity, end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"In this paper, the precepts of vaccine discovery and advancement through pre-clinical and clinical assessment are discussed in the context of the recent Ebola virus, end_entity start_entity MERS-CoV, and Zika virus outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In this paper, the precepts of vaccine discovery and advancement through pre-clinical and clinical assessment are discussed in the context of the recent Ebola virus, Middle East Respiratory end_entity start_entity MERS-CoV, and Zika virus outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Since 2010, the porcine epidemic end_entity start_entity PEDV has caused significant damage to the global pork industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity vaccine effectiveness IVE against laboratory-confirmed influenza start_entity was estimated by a test-negative design\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Murine antisera with neutralising activity for the start_entity causative of Middle East respiratory syndrome end_entity were induced by immunisation of Balbc mice with the receptor binding domain RBD of the viral Spike protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The murine antisera induced were fully-neutralising in vitro for two separate clinical strains of the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a highly infective disease caused by a newly identified start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity virus and start_entity epidemics or pandemics have occurred in succession worldwide throughout the early 21st century\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The major biochemical and thermodynamic features of nucelocapsid protein of end_entity start_entity end_entityNP were characterized by use of non-denatured gel electrophoresis, size-exclusion chromatographic and surface plasmon resonance SPR techniques\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"foetus infection of the colon, cecum and ileum with concurrent feline enteric start_entity FCoV and feline panleukopenia virus FPV in a 3-month-old Bengal kitten with an 8-day history of end_entity, diarrhoea, failure to thrive and coughing\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity CoV spread from China to more than 30 countries, causing severe outbreaks of atypical start_entity and over 800 deaths worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Of which a quarter are lower respiratory tract: acute bronchitis, exacerbation of end_entity or bronchiectasis and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"Patients with Healthcare Associated end_entity HCAP and nosocomial start_entity NP have a higher risk of infection by multiresistant microorganisms MMR and increased morbidity and mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"The most frequent respiratory infections in emergencies, acute bronchitis, end_entity flares, bronchiectasis and start_entity, are analyzed in this protocol\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Two examples of viral diseases that have emerged from areas of high incidence of chloroquine-resistant malaria are start_entity from HIV and Severe_Acute_Respiratory_Syndrome from end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Two examples of viral diseases that have emerged from areas of high incidence of chloroquine-resistant malaria are Acquired_Immunodeficiency_Syndrome from HIV and end_entity from start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the case of end_entity, the start_entity appears to have accessed a new niche where it proves to be lethal to its host\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Direct infestation of lymphocytes, neutrophils and macrophages by end_entity start_entity CoV has been debated as a cause of lymphopenia, but there is no convincing data\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity A and B, and many unrelated viruses including rhinovirus, RSV, adenovirus, metapneumovirus and start_entity share the same seasonality, since these viral acute respiratory tract infections vARIs are much more common in winter than summer\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"1M, but lacked inhibitory activity toward HIV-1 integrase and end_entity start_entity proteinase\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Bovine start_entity BCoV is a viral enteric pathogen associated with calf end_entity worldwide being, in Argentina, mostly detected in dairy husbandry systems\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The outbreak of atypical start_entity, referred to as severe acute respiratory syndrome end_entity, has spread to many countries in the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Frontotemporal Dementia\",\n",
       "                    \"value\": \", Ireland, and real-time multiplex polymerase chain reaction end_entity, Respiratory pathogens, multiplex Fast Trade Kit, Malta for detection of influenza virus H1N1, B, rhinovirus, parainfluenza virus, adenovirus, respiratory syncytial virus, human parechovirus, bocavirus, metapneumovirus, and human start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatolenticular Degeneration\",\n",
       "                    \"value\": \"Infection models were developed for adult cows and for young calves using the same strain of bovine start_entity BCV, which for the first time allows experimental reproduction of winter dysentery end_entity in seronegative lactating cows\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity models were developed for adult cows and for young calves using the same strain of bovine start_entity BCV, which for the first time allows experimental reproduction of winter dysentery Hepatolenticular_Degeneration in seronegative lactating cows\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline start_entity FCoV genomic RNA was detected consistently in this study in biologic samples from adult cats, kittens suffering from end_entity, and their siblings\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity virus FIPV is a start_entity that causes sporadic fatal disease in cats characterized by vasculitis, granulomatous inflammation and effusive pleuritisperitonitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Independent of virulence variations they are separated into two different types, type I, the original FCoV, and type GCNT2, which is closely related to canine start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"From long-term observations of several hundred known individuals, the only clinical sign in hyenas consistent with those described for start_entity infections in dogs and cats was end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Phylogenetic analysis of end_entity start_entity isolates based on the spike gene and protein sequence using Neighbor-Joining, maximum likelihood and Bayesian inference methods indicated that a recent human end_entity-CoV isolate was closer to some human end_entity-CoV isolates from earlier epidemic phase than to the end_entity-CoV-like viruses isolated from wild animals during previous epidemic phase\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"9 samples also tested positive for other enteric pathogens including the bovine start_entity, bovine viral end_entity virus, bovine torovirus, bovine groups A, B and C rotaviruses, bovine enteric Nebraska-like calicivirus and Escherichia coli\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The outcomes of feline start_entity FCoV infection vary greatly from asymptomatic or mild enteric infection to fatal feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Canine start_entity end_entity and canine parainfluenza virus CPIV titers were not detected in all serum samples\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Clinical disease was characterized firstly by abundant purulent nasal discharges and end_entity, progressing to sinusitis, dyspnea, symptoms of start_entity and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Infection with virulent biotypes of feline start_entity FCoV can result in the development of feline infectious peritonitis end_entity, a typically fatal immune mediated disease for which there is currently no effective antiviral treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with virulent biotypes of feline start_entity FCoV can result in the development of feline infectious peritonitis Feline_Infectious_Peritonitis, a typically fatal immune mediated disease for which there is currently no effective antiviral treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Interferon gamma IFN- plays an important role in cell mediated responses against mutated feline start_entity strains FCoV involved in the pathogenesis of feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"All the positive dogs presented end_entity and were found to be infected by CaKV alone or in mixed infections with canine start_entity CCoV andor canine parvovirus type 2 CPV-2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Samples were tested by a panel of multiplex PCR assays for 11 enteric pathogens: bovine rotavirus group A BRV-A, bovine start_entity BCoV, bovine viral end_entity virus BVDV, bovine enterovirus BEV, bovine norovirus BNoV, Nebovirus, bovine torovirus BToV Salmonella spp\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis start_entity TGEV is an enteropathogenic start_entity that causes end_entity in pigs, which is correlated with high morbidity and mortality in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity, a feline start_entity FCoV induced disease, is almost invariably fatal with median life expectancy measured in days\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Virulent biotypes of feline start_entity FCoV, commonly referred to as feline infectious peritonitis virus end_entityV, can result in the development of feline infectious peritonitis end_entity, a typically fatal immune mediated disease for which there is currently no effective antiviral treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The aim of this study is to reveal infection dynamics of bovine respiratory syncytial virus BRSV, bovine parainfluenza virus type 3 PI-3, bovine herpesvirus 1 BHV-1, bovine viral end_entity virus BVDV, bovine adenovirus type 3 BAV-3 and bovine start_entity BCoV, which are important viral pathogens of respiratory disease complex in ruminants\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Bovine start_entity BCoV is an important viral pathogen associated with neonatal calf end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The aim of the study was to estimate in population of free-living wild boar in the Czech Republic the prevalence of enteric viral pathogens, namely rotavirus groups A and C RVA and RVC, porcine reproductive and respiratory syndrome virus PRRSV, and members of family Coronaviridae transmissible gastroenteritis virus TGEV, porcine epidemic end_entity virus PEDV, porcine respiratory start_entity PRCV, and porcine hemagglutination encephalomyelitis virus PHEV and Picornaviridae,teschovirus A PTV, sapelovirus A PSV, and enterovirus G EV-G\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is an emerging swine start_entity that causes end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity PEA15, caused by an alpha start_entity, is a highly contagious disease and causes high morbidity and mortality in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a common and highly lethal start_entity disease of domestic cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a newly identified swine enteropathogenic start_entity that causes watery end_entity in piglets and results in significant economic losses to the pig industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine enteric start_entity CoV is an important group of pathogens causing end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"At least four kinds of swine enteric start_entity have been identified, including transmissible gastroenteritis virus TGEV, porcine epidemic end_entity virus PEDV, porcine deltacoronavirus PDCoV, and the emerging HKU2-like porcine enteric alphacoronavirus PEAV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine enteric alphastart_entity PEAV is a newly identified swine enteropathogenic start_entity that causes watery end_entity in newborn piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a highly fatal disease caused by a virulent feline start_entity in domestic and wild cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"We have previously reported the synthesis of potent start_entity 3C-like protease 3CLpro inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Harlequin type ichthyosis\",\n",
       "                    \"value\": \"Antigenic differences were observed among the isolates in a one-way hemagglutination-inhibition end_entity test using a polyclonal antiserum against the Mebus bovine start_entity isolate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Small world network models have been effective in capturing the variable behaviour of reported case data of the end_entity start_entity outbreak in Hong Kong during 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Conclusions end_entity CoV virus may have a specific pattern in chest X-ray and CT developing a single or multiple opacities progressing into a widespread multifocal bilateral patches of ground glass opacities or confluent consolidation resembling organizing start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background end_entity end_entity is a life-threatening form of start_entity caused by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Saururaceae HC was shortlisted by Chinese scientists to tackle end_entity problem as it is conventionally used to treat start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"im of the study end_entity end_entity is a life-threatening disease caused by the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Epidermodysplasia Verruciformis\",\n",
       "                    \"value\": \"Les prlvements taient ensuite analyss par RT-PCR multiplex au CHU de Marseille pour vrification des rsultats et recherche d'autres virus adnovirus, entrovirus end_entity, parainfluenzavirus PIV, influenzavirus, virus respiratoire syncitial VRS, mtapneumovirus hMPV, rhinovirus et start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Results Respiratory tract infections, ENT infections, influenza, pyogenic start_entity, whooping end_entity, and tuberculosis are most frequently observed during the Hajj\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Autoimmune polyendocrinopathy syndrome, type 1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Results Mean age of patients was 71 67;76 years, Sstart_entityI was 42 28;53, end_entity severity index 159 139;182 vs 73 40\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Systemic carnitine deficiency\",\n",
       "                    \"value\": \"Background Differentiating acute chest syndrome ACS from community-acquired start_entity CAP is challenging in adults presenting with major sickle cell disease end_entity semiological similarity, rare microbiological documentation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Patients and methods 54 patients presented by symptoms and sign of severe community acquired start_entity who were admitted to respiratory care unit of Alhussein, Al-Azhar University Hospital from August 2015 to March 2016 were subjected to full clinical examination, chest X ray, complete blood picture, sputum and blood culture, PCR for suspected cases of end_entity H1N1 and MERS, treatment, follow up, data collections and statistical analysis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Patients and methods 54 patients presented by symptoms and sign of severe community acquired start_entity who were admitted to respiratory care unit of Alhussein, Al-Azhar University Hospital from August 2015 to March 2016 were subjected to full clinical examination, chest X ray, complete blood picture, sputum and blood culture, PCR for suspected cases of Influenza,_Human H1N1 and end_entity, treatment, follow up, data collections and statistical analysis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Patients and methods 54 patients presented by symptoms and sign of severe community acquired start_entity who were admitted to respiratory care unit of Alhussein, Al-Azhar University Hospital from August 2015 to March 2016 were subjected to full clinical examination, chest X ray, complete blood picture, end_entity and blood culture, PCR for suspected cases of Influenza,_Human H1N1 and MERS, treatment, follow up, data collections and statistical analysis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a newly described infection affecting, in most individuals, the lungs with progressive severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome is a newly described infection affecting, in most individuals, the lungs with progressive severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It has been tested on a small series of chest radiographs with minimal end_entity start_entity and provided 88 sensitivity with 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Among 35 patients 22 men, 13 women; median age: 48 years, 25 demonstrated abnormal opacity on CXR end_entity start_entity, whereas no abnormality was detected in 10 patients end_entity upper respiratory tract infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"The etiology of community-acquired start_entity CAP is determined in less than half of the patients based on cultures of end_entity and blood plus testing urine for the antigens of Streptococcus start_entitye and Legionella pneumophila\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Behcet Syndrome\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The goal of the study was to adapt our Middle East respiratory syndrome end_entity MERS-CoV lab-developed test LDT to 3 Sample to Result S2R systems: start_entity MAX start_entity, ELITe InGenius ELITechGroup, and ARIES Luminex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Microbiological tests included blood and end_entity cultures, PCR for bacterial and viral pathogens, antigen test for Streptococcus start_entitye and the influenza virus, and antibody detection of Mycoplasma start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Infectious end_entity in calves is most commonly associated with enterotoxigenic Escherichia coli, Cryptosporidium parvum, rotavirus, start_entity, or some combination of these pathogens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"A vanadium substituted polyoxotungstate, PM-1001 has antiviral activity against FluV A, RSV, parainfluenza virus PfluV type 2, end_entity fiver virus, HIV-1 and Severe_Acute_Respiratory_Syndrome start_entity in vitro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A vanadium substituted polyoxotungstate, PM-1001 has antiviral activity against FluV A, RSV, parainfluenza virus PfluV type 2, Dengue fiver virus, HIV-1 and end_entity start_entity in vitro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Infectious agent The severe acute respiratory syndrome end_entity is a febrile start_entity initially observed in China at the end of 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Summary The acute respiratory distress syndrome end_entity can be induced by viral diseases, with two virus types being responsible: respiratory viruses that cause community-acquired viral start_entity and Herpesviridae that cause nosocomial viral start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Apart from these pandemic viruses, respiratory viruses are rarely responsible for viral start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Among Herpesviridae, herpes simplex virus HSV and cytomegalovirus CMV are the two viruses causing nosocomial viral start_entity that can evolve into end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Ganciclovir can be considered for patients with end_entity and histology- or cytology-proven CMV start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Etiology of EA end_entity are mainly infectious, viral rhinovirus, influenzae or parainfluenzae virus, start_entity, adenovirus and respiratory syncytial virus or bacterial Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Differential diagnoses of AE end_entity include infectious start_entity, pneumothorax, acute heart failure and pulmonary embolism\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"L'tude par PCR des prlvements naso-pharyngs prcoces 36e heure la recherche du start_entity associ au end_entity sera ngative\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Early 36 hours PCR studies of naso-pharyngeal washings were negative for the start_entity associated with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Case report We report a case of acute respiratory distress syndrome end_entity complicating severe EBV start_entity and requiring prolonged artificial ventilation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Conclusion end_entity can complicate EBV start_entity in an immuno-competent subject\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"The histologic pattern of Acute Fibrinous and Organizing end_entity AFOP, described by Beasley in 2002, is characterized by the existence of intraalveolar fibrin in the form of fibrin balls and diffuse organizing start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinoschisis\",\n",
       "                    \"value\": \"previous report demonstrated that intracerebrally inoculated start_entity produced CNS disease in two species of primates Murray end_entity, Cai G-Y, Hoel K, et al\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinoschisis\",\n",
       "                    \"value\": \"Four Owl monkeys Aotus trivirgatus were inoculated intranasally and ocularly and four were inoculated intravenously with start_entity JHM OMp1 Murray end_entity, Cai G-Y, Hoel K, et al\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"OBJECTIVES The aims of this study were to test the following hypotheses: stigma and hardiness exert both direct effects on mental health and also indirect mediated effects on mental health through stress in nurses working at a government-designated hospital during a end_entity start_entity MERS-CoV epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"OBJECTIVES The aims of this study were to test the following hypotheses: stigma and hardiness exert both direct effects on mental health and also indirect mediated effects on mental health through stress in nurses working at a government-designated hospital during a Middle East Respiratory end_entity start_entity MERS-CoV epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Patients with positive results of either reverse transcriptasepolymerase chain reaction or antibody to end_entity start_entity were defined as end_entity cases and others with negative results as control cases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"During the last three decades or so, many efforts have been made to study the protein cleavage sites by some disease-causing enzyme, such as HIV human immunodeficiency virus protease and end_entity severe acute respiratory syndrome start_entity main proteinase\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The bipolar depressed group also had elevated levels of antibodies to the nucleocapsid protein of the end_entity strain of start_entity, while elevated levels of these antibodies were not found in the other groups\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"AVNP2 inactivates viruses, such as the H1N1 and H5N1influenza viruses and even the end_entity start_entity, while it inhibits bacteria, such as MRSA and E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"nucleotide variability in the sequence of the gene encoding for the transmembrane protein M of canine start_entity end_entity is described\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The detection limit of this assay was 8 copies per reaction, and there was no cross-reactivity with other bovine infectious viruses such as bovine viral end_entity virus, infectious bovine rhinotracheitis virus, bovine respiratory syncytial virus, bovine start_entity, bovine parainfluenza virus type 3, bovine vesicular stomatitis virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is caused by the end_entity virus end_entityV, a highly virulent mutant form of feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"This article reviews the diagnosis and management of start_entity in the emergency department and highlights dilemmas in diagnostic testing, use of blood and end_entity cultures, hospital admission decisions, infection control, quality measures for start_entity care, and empiric antimicrobial therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The most common pathogens causing end_entity in neonatal camelids are start_entity, Escherichia coli E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Herpes Simplex\",\n",
       "                    \"value\": \"Our work includes synthetic peptides deduced from amino acid sequences of immunodominant linear epitopes, such as the T7 phage capsid protein, end_entity virus glycoprotein D, c-myc protein and three domains of the Human start_entity 229E polymerase polyprotein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"ute Fibrinous and Organizing end_entity AFOP is a disease with histopathological pattern characterized by the presence of intra-alveolar fibrin in the form of fibrin balls and organizing start_entity represented by inflammatory myofibroblastic polyps\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The purpose of our study was to survey the prevalence of the end_entity start_entity CoV in a community adjacent to Kaohsiung CGMH and collect demographic data, including basic information about health status, household, and possible risk factors for end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"BackgroundPurpose Serum soluble triggering receptor expressed on myeloid cells-1 sTREM-1, a detector of acute inflammatory response to microbial products and a good marker for diagnosing sepsis and start_entity, has not yet been described as a predictor for infection or a prognostic factor in patients with acute respiratory distress syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Originally considered to be restricted to humans, it is now clear that HEV and HEV-like viruses have several animal reservoirs with complex ecology and genetic diversity, as exemplified by the recent discovery of HEV in dromedaries, a previously underestimated reservoir of zoonotic viruses prior to the emergence of end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Originally considered to be restricted to humans, it is now clear that HEV and HEV-like viruses have several animal reservoirs with complex ecology and genetic diversity, as exemplified by the recent discovery of HEV in dromedaries, a previously underestimated reservoir of zoonotic viruses prior to the emergence of Middle East Respiratory end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a zoonotic infectious disease caused by a start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"treatment failure\",\n",
       "                    \"value\": \"The use of non-invasive ventilation in patients with community-acquired start_entity is controversial since this is associated with high rates of end_entity, compared with other causes of severe acute respiratory failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Research on end_entity start_entity end_entity CoV demonstrated that this virus belongs to the same family of viruses, the Coronaviridae that causes the common cold, with some important differences\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Idiopathic Pulmonary Fibrosis\",\n",
       "                    \"value\": \"Objectives To elucidate the frequency of virus infections in patients with end_entity or non-end_entity ILDs including idiopathic interstitial start_entity IIP or connective tissue disease CTD-associated start_entity, and its influence on their short-term mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Ionic gold is bound to a 30-mer sequence of the end_entity severe acute respiratory syndrome virus, responsible for the atypical start_entity, using sodium aurothiomalate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In order to enhance the sensitivity of conventional immunoassay technology for the detection of end_entity start_entity end_entity-CoV nucleocapsid protein N protein, we developed a localized surface plasmon coupled fluorescence LSPCF fiber-optic biosensor that combines sandwich immunoassay with the LSP technique\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity was identified as the pathogen of a global outbreak of end_entity severe acute respiratory syndrome in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The availability of structures of end_entity start_entity macromolecules has enabled the elucidation of their important functions, such as mediating the fusion of viral and host cellular membranes, and in replication and transcription\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Vasculopathy, Retinal, With Cerebral Leukodystrophy\",\n",
       "                    \"value\": \"Results end_entity infections in cancer patients may lead to start_entity in approximately 30 of the cases, with an associated mortality of around 25\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \", HIV, AIDS-virus and end_entity start_entity tend to be more fatal? The paper concludes that the cell fractal geometry of viruses is the key\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Bioactivity assay results in vitro tests demonstrated that some of these compounds are potent and selective inhibitors against end_entity start_entity 3CL protease with inhibitory_concentration_50 values ranging from 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"inhibitory concentration 50\",\n",
       "                    \"value\": \"Bioactivity assay results in vitro tests demonstrated that some of these compounds are potent and selective inhibitors against Severe_Acute_Respiratory_Syndrome start_entity 3CL protease with end_entity values ranging from 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Additionally, isatin 4o exhibited more potent inhibition for end_entity start_entity protease than for other proteases including papain, chymotrypsin, and trypsin\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity main protease, Mpro, is considered a major target for drugs suitable to combat start_entity infections including the severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like protease 3CLpro of severe acute respiratory syndrome-associated start_entity end_entity-CoV is one of the most promising targets for discovery of drugs against end_entity, because of its critical role in the viral life cycle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"On the basis of our previous study on antiviral agents against the severe acute respiratory syndrome end_entity start_entity, a series of nucleoside analogues whose 5-hydroxyl groups are masked by various protective groups such as carboxylate, sulfonate, and ether were synthesized and evaluated to develop novel anti-hepatitis C virus HCV agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like main proteinase of the severe acute respiratory syndrome end_entity start_entity, end_entity-CoV Mpro, is widely considered to be a major drug target for the development of anti-end_entity treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity is a highly infectious upper respiratory tract disease caused by SARS-CoV, a previously unidentified human start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like 3CL protease of the severe acute respiratory syndrome end_entity start_entity is a key enzyme for the virus maturation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the second example, the interaction of epoxide inhibitors with the main protease of the end_entity start_entity was investigated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity led to a life-threatening form of atypical start_entity in late 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The development of new therapeutic agents against the start_entity causing end_entity MERS is a continuing imperative\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The development of new therapeutic agents against the start_entity causing Coronavirus_Infections end_entity is a continuing imperative\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The development of new therapeutic agents against the start_entity causing Middle East Respiratory end_entity MERS is a continuing imperative\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Worldwide cooperative efforts to understand the biology of the end_entity start_entity have already born significant fruit\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Entry of end_entity start_entity into its target cell requires large-scale structural transitions in the viral spike S glycoprotein in order to induce fusion of the virus and cell membranes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our results provide a structural framework for understanding the control of membrane fusion and should guide efforts to intervene in the end_entity start_entity entry process\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here we report the crystal structure of ORF-9b, an alternative open reading frame within the nucleocapsid N gene from the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have also shown that griffithsin is a potent inhibitor of the start_entity responsible for severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"paper in this issue of Structure reports the crystal structure of griffithsin, a lectin from red algae, and demonstrates its ability to bind and neutralize the end_entity start_entity, providing a link in understanding the evolution of lectins in this family\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pyridoxine-dependent epilepsy\",\n",
       "                    \"value\": \"We previously showed that murine start_entity MHV accessory protein ns2, a 2H phosphoesterase superfamily member, is a phosphodiesterase end_entity that cleaves 2,5-oligoadenylates 2-5A thereby preventing activation of RNase L Zhao et al\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Th1 and Th2 response downregulation, high expression of inflammatory cytokines, and high viral load may contribute to lung inflammation, severe infection, the evolution of start_entity and end_entity, and a higher case fatality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In many instances these outbreaks have been newly emerging end_entity start_entity, re-emerging Ebola virus, Zika virus or zoonotic avian influenza H5N1 virus infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, we have expressed and purified severe acute respiratory syndrome end_entity structural proteins and their fragments and developed indirect enzyme-linked immunosorbent assays ELISAs that detect antibodies against the end_entity N, N1, N2, PSMD1, ERMAP, S2, and M proteins as well as the human start_entity OC43 and 229E N proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It has been known that end_entity start_entity end_entityCoV is a novel human start_entity and is responsible for end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Belonging to one of the major proteins associated with end_entityCoV, end_entity 3C-like protease end_entity3CLpro functions as a cysteine protease engaging in the proteolytic cleavage of the viral precursor polyprotein to a series of functional proteins required for start_entity replication and is considered as an appealing target for designing anti-end_entity agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV proteins belong to a large group of proteins that is difficult to express in traditional expression systems\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Newcastle Disease\",\n",
       "                    \"value\": \"The best inducer found was end_entity virus NDV, followed by two start_entityes porcine TGEV and a bovine start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity has been identified as the cause of the outbreak of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary end_entity end_entity is caused by a newly emerged start_entity that infected more than 8000 individuals and resulted in more than 800 fatalities in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity main proteinase is a prime target for antiviral therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary The main proteinase Mpro of the severe acute respiratory syndrome end_entity start_entity is a principal target for the design of anticoronaviral compounds\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"hematopoietic stem cell transplantation\",\n",
       "                    \"value\": \"lloimmune lung syndromes allo-LS, including idiopathic start_entity syndrome, bronchiolitis obliterans syndrome, and bronchiolitis obliterans organizing start_entity, are severe complications after end_entity HSCT\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"hematopoietic stem cell transplantation\",\n",
       "                    \"value\": \"Epidemiologic data about coronaviruses start_entity and human bocavirus HBoV in the setting of allogeneic end_entity allo-HSCT are scarce\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"value\": \"BSTRACT Our current knowledge of idiopathic start_entity syndrome end_entity predates improved specificity in the diagnosis of end_entity and advances in hematopoietic cell transplantation HCT and critical care practices\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Serum protein electrophoresis and the concentration of HP Hp, serum amyloid A SAA1, 1-acid glycoprotein AGP, IgG and IgM were evaluated in cats exposed to feline start_entity FCoV and in cats with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The aim of this study was to quantify and compare interferon- IFN- concentrations in the serum of clinically normal cats infected with feline start_entity FCoV with its concentration in the sera and effusions of cats with feline infectious peritonitis end_entity, a disease associated with infection with a mutated form of FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"How can a ubiquitous and largely non-pathogenic enteric start_entity transform into a highly lethal pathogen? What are the interactions between host and virus that determine both disease form wet or dry and outcome death or resistance? Why is it so difficult, and perhaps impossible, to develop a vaccine for end_entity? What role do genetics play in disease susceptibility? This review will explore research conducted over the last 5 years that attempts to answer these and other questions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Feline enteric start_entity 88, Giardia 56, Clostridium perfringens 49, and Tritrichomonas foetus 39 were most common in cats with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Benign Paroxysmal Positional Vertigo\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Faecal specimens from 1283 calves were scored as liquid, semi-solid or solid, and analysed for bovine rotavirus start_entity and end_entity BCV, enterotoxigenic K99 Escherichia coli K99, Salmonella spp\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Although end_entity has been associated with 30 case fatality in human beings, end_entity start_entity end_entity-CoV infection in dromedaries is usually asymptomatic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Pathogenic bacteria Mannheimia haemolytica Mh, Pasteurella multocida Pm, Histophilus somni Hs, and Mycoplasma bovis and a range of viruses bovine respiratory syncytial virus, bovine start_entity, bovine parainfluenza virus type 3, bovine viral end_entity virus and bovine herpesvirus type 1 are associated with this complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a newly emerging and highly infectious form of atypical start_entity with a high rate of transmission, especially among health care workers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a progressive, fatal, predominantly Arthus-type immune-mediated disease that is triggered when cats are infected with a mutant enteric start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"In this work we describe the tissue distribution of fAGPrP during end_entity, and its relationship with feline start_entity FCoV and myeloid cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"In August 2002, scientists and veterinarians from all over the world met in Scotland to discuss feline start_entity FCoV and feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"There are four outcomes to feline start_entity FCoV infection: the development of feline infectious peritonitis end_entity, which is immune-mediated, subclinical infection, development of healthy lifelong carriers and a small minority of cats who resist infection Addie and Jarrett, Veterinary Record 148 2001 649\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity virus FIPV is a start_entity that induces a fatal systemic disease mediated by an inappropriate immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"This report describes a clinical case of feline infectious peritonitis end_entity with multisystemic involvement, including multiple nodular cutaneous lesions, in a cat that was co-infected with feline start_entity and feline immunodeficiency virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Natural feline start_entity FCoV infection has been shown to not only induce intestinal infection with viral shedding, but also systemic infection which either remains without clinical signs or leads to feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Therefore, the purpose of this study was to quantitatively assess feline start_entity FCoV RNA loads in haemolymphatic tissues of healthy, long-term FCoV-infected cats and cats with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"In this study, the cytokine profiles of clinically healthy cats naturally infected with feline start_entity FCoV, of cats with feline infectious peritonitis end_entity and of specific pathogen-free SEC14L2 cats were investigated in whole blood using a traditional reverse-transcriptase polymerase chain reaction RT-PCR assay and a semi-quantitative method of analysis based on computerised quantification of positive bands\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Blood samples were tested for feline start_entity FCoV messenger RNA mRNA by an reverse transcriptase-polymerase chain reaction RT-PCR assay which has previously been described to have a high specificity in the diagnosis of clinical end_entity Simons PSMD4, Vennema H, Rofina JE, Pol JM, Horzinek MC, Rottier PJM, Egberink CFH 2005 A mRNA PCR for the diagnosis of feline infectious peritonitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline start_entity FCoV varies greatly from causing subclinical or mild enteric infections to fatal feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Saudi Arabian Ministry of Health implemented a pro-active surveillance programme for Middle East respiratory syndrome end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Topics include management outside hospital, management inside hospital including community-acquired start_entity CAP, acute exacerbations of end_entity AEend_entity, acute exacerbations of bronchiectasis and prevention\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BSTRACT Serum levels of IgG, IgM and IgA against severe acute respiratory distress syndrome end_entity-associated start_entity end_entity-CoV were detected serially with the use of immunofluorescent antibody assays in 30 patients with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We evaluated the prevalence of end_entity start_entity CoV immunoglobulin Ig G in HCWs exposed to end_entity patients and calculated the incidence of end_entity-affected cases in HCWs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity virus, human parainfluenza viruses and human respiratory syncytial virus as well as human rhinovirus, human start_entity and human metapneumovirus were detected significantly more frequently in LRTI patients than in controls\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This study describes the assessment of the antiviral potential of nitric oxide NO against end_entity start_entity end_entity-CoV strain Frankfurt-1 replicating in African Green Monkey Vero E6 cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Introduction end_entity end_entity caused large outbreaks of atypical start_entity in 2003, with the largest localized outbreak occurring in Beijing, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The end_entity start_entity MERS-CoV has been detected in a number of countries in the Middle East and Europe with an apparently high mortality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Middle East Respiratory end_entity start_entity MERS-CoV has been detected in a number of countries in the Middle East and Europe with an apparently high mortality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It is phylogenetically related to the end_entity start_entity and has also been associated with severe respiratory illness as well as nosocomial transmission in healthcare settings\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"It is possible that these might be active against the related end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"A large proportion of end_entity patients who die have a range of pulmonary pathology ranging from start_entity to adult respiratory distress syndrome with multi-organ failure, compounded by co-morbidities, reflecting a precarious balance of interactions between the host-immune system and end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Summary end_entity due to the Middle East respiratory syndrome start_entity MERS-CoV is widespread\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The vast majority of viral respiratory infections in pilgrims returning home have been due to seasonal influenza viruses, rhinoviruses, and other known start_entityes distinct from the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"value\": \"The emergence of severe acute respiratory syndrome start_entity SARS-CoV and Middle East respiratory syndrome start_entity MERS-CoV, and more recently end_entity, has highlighted the risks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Over the past few decades new zoonotic infectious diseases of humans caused by pathogens arising from animal reservoirs have included West Nile virus, Yellow fever virus, Ebola virus, Nipah virus, Lassa_Fever virus, Hanta virus, Dengue virus, Rift Valley fever virus, Hemorrhagic_Fever,_Crimean virus, severe acute respiratory syndrome start_entity, highly pathogenic avian influenza viruses, end_entity Coronavirus, and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"Over the past few decades new zoonotic infectious diseases of humans caused by pathogens arising from animal reservoirs have included West Nile virus, Yellow fever virus, Ebola virus, Nipah virus, Lassa_Fever virus, Hanta virus, end_entity virus, Rift Valley fever virus, Hemorrhagic_Fever,_Crimean virus, severe acute respiratory syndrome start_entity, highly pathogenic avian influenza viruses, Coronavirus_Infections Coronavirus, and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Over the past few decades new zoonotic infectious diseases of humans caused by pathogens arising from animal reservoirs have included West Nile virus, Yellow fever virus, Ebola virus, Nipah virus, Lassa end_entity virus, Hanta virus, Dengue virus, Rift Valley fever virus, Hemorrhagic_Fever,_Crimean virus, severe acute respiratory syndrome start_entity, highly pathogenic avian influenza viruses, Coronavirus_Infections Coronavirus, and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Crimean\",\n",
       "                    \"value\": \"Over the past few decades new zoonotic infectious diseases of humans caused by pathogens arising from animal reservoirs have included West Nile virus, Yellow fever virus, Ebola virus, Nipah virus, Lassa_Fever virus, Hanta virus, Dengue virus, Rift Valley fever virus, end_entity virus, severe acute respiratory syndrome start_entity, highly pathogenic avian influenza viruses, Coronavirus_Infections Coronavirus, and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lassa Fever\",\n",
       "                    \"value\": \"Over the past few decades new zoonotic infectious diseases of humans caused by pathogens arising from animal reservoirs have included West Nile virus, Yellow fever virus, Ebola virus, Nipah virus, end_entity virus, Hanta virus, Dengue virus, Rift Valley fever virus, Hemorrhagic_Fever,_Crimean virus, severe acute respiratory syndrome start_entity, highly pathogenic avian influenza viruses, Coronavirus_Infections Coronavirus, and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Over the past few decades new zoonotic infectious diseases of humans caused by pathogens arising from animal reservoirs have included West Nile virus, Yellow fever virus, Ebola virus, Nipah virus, Lassa_Fever virus, Hanta virus, Dengue virus, Rift Valley fever virus, Hemorrhagic_Fever,_Crimean virus, severe acute respiratory syndrome start_entity, highly pathogenic avian influenza viruses, Middle East Respiratory end_entity Coronavirus, and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"The host factors associated with high CFR were pre-existing start_entity, smoking history, an incubation period of less than 5 days, leukocytosis, abnormal renal function at diagnosis, and respiratory symptoms such as end_entity and dyspnea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"This study investigated the association of macrolides with 90-day mortality and end_entity start_entity CoV RNA clearance in critically ill patients with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To define the dynamics of the immune spectrum in end_entity, serum levels of cytokines, chemokines, immunoglobulins, complement and specific antibodies against end_entity-associated start_entity end_entity-CoV were assayed by enzyme-linked immunosorbent assay ELISA, and phenotypes of peripheral lymphocytes were analyzed by flow cytometry in 95 end_entity-infected patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity, the severe acute respiratory syndrome end_entity start_entity end_entity-CoV, was identified as the causative agent of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Little information is available on persistent infection of severe acute respiratory syndrome end_entity start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Porcine respiratory start_entity PRCV potentiates respiratory disease and proinflammatory cytokine production in the lungs upon intratracheal inoculation with lipopolysaccharide end_entity at 1day of infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To develop reagents for early diagnosis and therapeutic drugs against end_entity-associated start_entity end_entity-CoV, a large 3109 immunized human antibody library was constructed from peripheral blood mononuclear cells from six end_entity convalescent patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In addition, ACE2 has functions independent of the RAS: ACE2 is the receptor for the end_entity start_entity and ACE2 is essential for expression of neutral amino acid transporters in the gut\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The geographic spread and rapid increase in the cases of Middle East respiratory syndrome end_entity caused by a start_entity end_entity-CoV during the past two months have raised concern about its pandemic potential\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"To evaluate host susceptibility factors to Middle East respiratory syndrome start_entity end_entity-CoV infection, we conducted a retrospective cohort study from the single largest exposure event of the 2015 Korean end_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The recent emergence of the end_entity start_entity in the human population in 2003, with an ensuing global epidemic affecting more than 8000 individuals with a case fatality of about 10, underlines the fact that respiratory viral infections of humans may originate in animals, and that many different influenza A viruses also occur naturally in animal reservoirs, representing a constant threat of zoonotic infections of humans and ensuing global pandemics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The advent of severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome in the 21st century and the recent outbreak of Middle-East respiratory syndrome end_entity highlight the importance of coronaviruses start_entity as human pathogens, emphasizing the need for development of novel antiviral strategies to combat acute respiratory infections caused by start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The advent of severe acute respiratory syndrome end_entity in the 21st century and the recent outbreak of Middle-East respiratory syndrome MERS highlight the importance of coronaviruses start_entity as human pathogens, emphasizing the need for development of novel antiviral strategies to combat acute respiratory infections caused by start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The worldwide epidemic of severe acute respiratory syndrome end_entity in 2003 was caused by a start_entity called end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity epidemic prompted a variety of studies on multiple aspects of the start_entity replication cycle, yielding both rapid identification of the entry mechanisms of end_entity-CoV into host cells and valuable structural and functional information on end_entity-CoV proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: The etiologic agent of severe acute respiratory syndrome end_entity is a recently identified, positive single-stranded RNA ssRNA start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: A start_entity was recently identified as the aetiological agent of end_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Background: A start_entity was recently identified as the aetiological agent of Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Little more than one week later, three research groups from this WHO-coordinated network simultaneously found evidence of a hitherto unknown start_entity in end_entity patients, using different approaches\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by a start_entity termed end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To detect false negative results due to PCR inhibitors or faulty RNA extraction, we have further modified this one step RT-PCR assay for simultaneous detection of severe acute respiratory syndrome end_entity start_entity CoV and 18S ribosomal RNA rRNA as an internal positive control\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity has been associated with a worldwide outbreak of atypical start_entity referred to as end_entity SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"start_entity has been associated with a worldwide outbreak of atypical start_entity referred to as Severe Acute Respiratory end_entity SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Commercial antiviral agents and pure chemical compounds extracted from traditional Chinese medicinal herbs were screened against 10 clinical isolates of end_entity start_entity by neutralisation tests with confirmation by plaque reduction assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: end_entity end_entity is caused by infection with end_entity-associated start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: The protocols of WHO network laboratories facilitated development of rapid diagnosis for end_entity start_entity CoV using reverse transcription RT-PCR assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: end_entity start_entity has been identified as the cause of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To confirm an infection with the new start_entity end_entity-CoV causing the severe acute respiratory syndrome end_entity diagnostic assays for detection of end_entity-CoV specific antibody are necessary\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Evidence for the potential benefits of PIs against the end_entity start_entity end_entity-CoV is provided by empirical clinical studies, in vivo viral inhibition assays and computational simulations of the docking of these compounds to the active site of the main end_entity-CoV protease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background The spike glycoprotein S gene of the severe acute respiratory syndrome-associated start_entity end_entity-CoV has been useful in analyzing the molecular epidemiology of the 2003 end_entity outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Objectives In order to find drugs that treat start_entity infections, including end_entity, we screened traditional medicinal herbal extracts and evaluated their antiviral activities on start_entity replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Following the identification of severe acute respiratory syndrome end_entity associated start_entity, two other newly detected start_entityes, NL63 and HKU1, have been linked to respiratory disease in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Objective To describe the clinical, laboratorial, and radiological characteristics of adenovirus start_entity and detect the type and diversity of human adenoviruses that caused acute respiratory distress syndrome end_entity in Beijing\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Background Middle East respiratory syndrome start_entity MERS-CoV is an emerging start_entity involved in severe acute respiratory distress syndrome end_entity and rapid renal failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity 55 and end_entity 13 were the most frequent clinical diagnosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity Coronavirus MERS CoV may cause severe start_entity with significant morbidity and mortality, particularly in patients with multiple comorbid condition\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Coronavirus_Infections Coronavirus end_entity CoV may cause severe start_entity with significant morbidity and mortality, particularly in patients with multiple comorbid condition\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity Coronavirus MERS CoV may cause severe start_entity with significant morbidity and mortality, particularly in patients with multiple comorbid condition\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"value\": \"MERS CoV start_entity has not been previously reported in patients with Human end_entity Virus HIV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity CoV start_entity has not been previously reported in patients with Human Immunologic_Deficiency_Syndromes Virus HIV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Herein, we report a case of end_entity CoV start_entity with a successful outcome in a patient recently diagnosed with HIV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Background end_entity start_entity MERS-CoV is an emerging pathogen that causes lower respiratory tract infection in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Background Middle East Respiratory end_entity start_entity MERS-CoV is an emerging pathogen that causes lower respiratory tract infection in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Background The emergence of end_entity start_entity MERS-CoV has prompted enhanced surveillance for respiratory infections among pilgrims returning from the Hajj, one of the largest annual mass gatherings in the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Background The emergence of Middle East Respiratory end_entity start_entity MERS-CoV has prompted enhanced surveillance for respiratory infections among pilgrims returning from the Hajj, one of the largest annual mass gatherings in the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The manifestation of influenza C virus infection in young children was observed acute respiratory illness, such as fever, rhinorrhea, and end_entity, but no start_entity or severe respiratory illness\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinoschisis\",\n",
       "                    \"value\": \"According to the virus, a viral isolation technique, immunofluorescence assays IFA or both were used for the detection of rhinovirus, enterovirus, respiratory syncytial end_entity virus, adenovirus, start_entity 229E, influenza and parainfluenza virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinoschisis\",\n",
       "                    \"value\": \"Polymerase chain reaction PCR assays were used for the detection of rhinovirus, enterovirus, end_entity virus, adenovirus, start_entity 229E and OC43, Chlamydia pneumoniae and Mycoplasma pneumoniae\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The outbreak of severe acute respiratory syndrome end_entity in 2002 affected thousands of people and an efficient diagnostic system is needed for accurate detection of end_entity start_entity end_entity CoV to prevent or limit future outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ACE2, a close homologue of ACE, functions as a negative regulator of the angiotensin system and was identified as a key receptor for end_entity severe acute respiratory syndrome start_entity infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Three research groups within a World Health Organization WHO-coordinated network have independently and simultaneously shown that a start_entity is linked to end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The cause of end_entity was identified as a start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A start_entity was later identified in patients with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The detection of the virus in these patients, its absence in healthy controls or other patients with atypical start_entity, and the reproduction of a similar disease in a relevant animal model fulfilled Koch's postulates for implicating this start_entity as the causal agent of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Subsequent studies have indicated that the end_entity start_entity is of animal origin, that its precursor is still present in animal populations within the region, and that live-animal markets in southern China may have provided the animal-human interphase that allowed this precursor virus to adapt to human-human transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary The novel severe acute respiratory syndrome end_entity start_entity caused severe disease and heavy economic losses before apparently coming under complete control\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Because end_entity start_entity RNA can be detected in the stool of some individuals for at least 9 weeks, recurrence of end_entity from persistently shedding human or animal reservoirs is biologically plausible\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary The causative agent of severe acute respiratory syndrome end_entity, which affected over 8000 individuals worldwide and was responsible for over 700 deaths in the 20022003 outbreak, is a start_entity that was unknown before the outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Summary end_entity with either influenza A H5N1 virus in 1997 or avian influenza A H7N9 virus in 2013 caused severe start_entity that did not respond to typical or atypical antimicrobial treatment, and resulted in high mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Summary Background Middle East respiratory syndrome end_entity is a new human disease caused by a start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Summary Background Middle East respiratory syndrome end_entity start_entity causes a highly fatal lower-respiratory tract infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"This study WRAIR-2274 assessed the safety, tolerability, and immunogenicity of the GLS-5300 end_entity start_entity DNA vaccine in healthy adults\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Interpretation The GLS-5300 end_entity start_entity vaccine was well tolerated with no vaccine-associated serious adverse events\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The data support further development of the GLS-5300 vaccine, including additional studies to test the efficacy of GLS-5300 in a region endemic for end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The sequential determination of crystal structures of the end_entity start_entity spike receptor-binding domain RBD in complex with its cellular receptor or neutralizing antibody opened a door for the design and development of antiviral competitive inhibitors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Subsequently, we applied such a method for prediction of T-cell epitopes in end_entity start_entity end_entity-CoV S, N and M proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"If new mutants of end_entity start_entity do initiate another epidemic, administration of prophylactic antibodies to risk groups may supplement the stringent isolation procedures that contained the first end_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome start_entity and end_entity start_entity MERS were never isolated in Hajj pilgrims\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome start_entity and Coronavirus_Infections start_entity end_entity were never isolated in Hajj pilgrims\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity and Coronavirus_Infections start_entity MERS were never isolated in Hajj pilgrims\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity start_entity and Middle East Respiratory end_entity start_entity MERS were never isolated in Hajj pilgrims\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Background Since the initial description of end_entity Coronavirus MERS-CoV, we adopted a systematic process of screening patients admitted with community acquired start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Background Since the initial description of Middle East Respiratory end_entity Coronavirus MERS-CoV, we adopted a systematic process of screening patients admitted with community acquired start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The clinical presentation of end_entity varied from asymptomatic to severe bilateral start_entity, depending on the case definition and surveillance strategies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Introduction An epidemic of Coronavirus Disease 2019 start_entity began in December 2019 in China leading to a Public Health end_entity of International Concern PHEIC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recombinant fragments of S proteins from the end_entity end_entity start_entity SARA-CoV were generated and used in a Western blot WB assay that was compared to a commercial end_entity ELISA method\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Recombinant fragments of S proteins from the Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome start_entity SARA-CoV were generated and used in a Western blot WB assay that was compared to a commercial Severe_Acute_Respiratory_Syndrome ELISA method\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Patients without pathogens isolated were less likely to have purulent end_entity and crepitations on chest auscultation, compared with those with start_entity caused by identified pathogens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a newly recognised and highly contagious respiratory infection caused by a new strain of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The pathophysiology of end_entity appears to be related to immunological dysregulation in response to the start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A start_entity CoV was identified as its aetiological agent and its genome was sequenced within months of the World Health Organisation issuing a global threat on end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Children are susceptible to infection by end_entity-associated start_entity end_entity-CoV but the clinical picture of end_entity is milder than in adults\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Mycobacterium Infections\",\n",
       "                    \"value\": \"end_entity should be included in the differential diagnosis for ocular, respiratory, and gastrointestinal diseases; in particular, it should be differentiated from systemic start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We find that the end_entity start_entity, bacteria and yeast are completely inactivated in 5 min on Ag catalyst surface and in 20 min on Cu catalyst surface at room temperature in air\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The origins and evolutionary history of the end_entity end_entity start_entity end_entity-CoV remain an issue of uncertainty and debate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The origins and evolutionary history of the Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome-CoV remain an issue of uncertainty and debate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a respiratory disease caused by a zoonotic start_entity CoV named end_entity-CoV SCoV, which rapidly swept the globe after its emergence in rural China during late 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome is a respiratory disease caused by a zoonotic start_entity CoV named Severe_Acute_Respiratory_Syndrome-CoV SCoV, which rapidly swept the globe after its emergence in rural China during late 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The nsp1 protein of the highly pathogenic end_entity start_entity suppresses host protein synthesis, including genes involved in the innate immune system\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However, synthesis of host immune and non-immune proteins was inhibited by nsp1 proteins at both transcriptional and translational levels, similar to end_entity start_entity nsp1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However, nsp1 may not be the key determinant of viral pathogenicity, or the factor used by the end_entity start_entity to evade host innate immunity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the case of the emergence of end_entity Coronavirus SARS-CoV, several studies have shown start_entity diversity in bats as well as the existence of end_entity in apparently healthy bats, suggesting that bats may be a crucial host in the genesis of this disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In the case of the emergence of Severe Acute Respiratory end_entity Coronavirus SARS-CoV, several studies have shown start_entity diversity in bats as well as the existence of Severe_Acute_Respiratory_Syndrome in apparently healthy bats, suggesting that bats may be a crucial host in the genesis of this disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Canine start_entity CCoV is an etiologic agent of end_entity in dogs and is known to have spread worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline and canine start_entityes FCoV and CCoV, respectively are common pathogens of cats and dogs sometimes leading to lethal infections named feline infectious peritonitis end_entity and canine pantropic start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Bats are the natural reservoirs of severe acute respiratory syndrome start_entity end_entity-CoV which caused the outbreak of human end_entity in 20022003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Shortly after its emergence in southern China in 20022003, end_entity start_entity end_entity-CoV was confirmed to be the cause of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Shortly after its emergence in southern China in 20022003, Severe Acute Respiratory end_entity start_entity Severe_Acute_Respiratory_Syndrome-CoV was confirmed to be the cause of Severe_Acute_Respiratory_Syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"The presence of underlying disease states such as chronic obstructive pulmonary disease end_entity or other organ system disease further increases the likelihood of developing severe start_entity in the elderly population, and the frail elderly, particularly when institutionalized in chronic care facilities, are at high risk for developing severe and recurrent start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Finally, the most recent viral pathogen involved in respiratory disease is a newly discovered start_entity, the SARS-CoV which was responsible for the worldwide outbreak of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Finally, the most recent viral pathogen involved in respiratory disease is a newly discovered start_entity, the SARS-CoV which was responsible for the worldwide outbreak of Severe Acute Respiratory end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BackgroundPurpose end_entity start_entity SARS-CoV proteins including ORF6 inhibit Type I interferon IFNA1 signaling\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a newly described infectious disease caused by a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome is a newly described infectious disease caused by a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is the etiological agent of end_entity disease, which has ever severely menaced humans from the end of 2002 to June 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This summary discusses recent advances in start_entity research that will facilitate the identification of crucial molecular targets for the rational design of end_entity therapeutics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Levy Place, Box 1198, New York, NY 10029, USA When the end_entity start_entity came dramatically to attention as a fatal and potentially pandemic respiratory disease, the scientific response was swift and effective\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity start_entity cases notified in the Middle East region since the identification of the virus in 2012 have displayed variations in time and across geography\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Abstract end_entity is a fatal disease of felidae due to a feline start_entity, occurring mainly in kittens between 6 months and 2 years\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Abstract A new respiratory illness, designated as atypical start_entity, produces in 20 of the cases a much more serious disease termed severe acute respiratory syndrome end_entity, which can be fatal in 5 of the cases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hantavirus Pulmonary Syndrome\",\n",
       "                    \"value\": \"These emerging respiratory viruses are represented by the henipaviruses Hendra and Nipah viruses, the New World hantaviruses associated with the end_entity, the start_entity responsible for the Severe_Acute_Respiratory_Syndrome SARS-CoV, and the avian influenza virus H5N1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These emerging respiratory viruses are represented by the henipaviruses Hendra and Nipah viruses, the New World hantaviruses associated with the Hantavirus_Pulmonary_Syndrome, the start_entity responsible for the end_entity SARS-CoV, and the avian influenza virus H5N1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"These emerging respiratory viruses are represented by the henipaviruses Hendra and Nipah viruses, the New World hantaviruses associated with the Hantavirus Pulmonary end_entity, the start_entity responsible for the Severe Acute Respiratory end_entity SARS-CoV, and the avian influenza virus H5N1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the history of start_entityes, several examples of variations of tropism have been described, and have as consequences the emergence of a new infection start_entity associated with end_entity, porcine respiratory start_entity, or a new expression of the clinical presentation of the infection fatal infectious peritonitis in cats and ferrets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"l'instar des paramyxovirus et des virus end_entity, les start_entity doivent tre surveills pour leur risque d'mergence dans la population humaine partir d'un rservoir animal\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"SUMMARY Background end_entity end_entity is a new respiratory tract infectious disease caused by the highly contagious start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Summary end_entity MERS start_entity is the most recent among the Coronaviridae family to jump species and infect humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Summary Coronavirus_Infections end_entity start_entity is the most recent among the Coronaviridae family to jump species and infect humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Summary Middle East Respiratory end_entity MERS start_entity is the most recent among the Coronaviridae family to jump species and infect humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Therefore, this study aims to explore what healthcare providers, who survived start_entity infection, have experienced as a end_entity patient and how the infection affected their relationship with their colleagues\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Methods Samples from 749 patients with suspected Middle East respiratory start_entity who presented to Johns Hopkins Aramco Healthcare facilities in the Eastern Province of Saudi Arabia were tested reflexively for influenza AH1N1 2009 by the Ministry of Health using the RealTime ready end_entity AH1N1 Detection Set for real-time PCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The precise mechanism of severe acute respiratory syndrome end_entity, which is caused by end_entity-associated start_entity end_entity-CoV, is still unclear\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Furthermore, we determined which SARS-CoV structural protein for the prior rVV-immunization is responsible for the severe start_entity after the end_entity as observed in the rVV-NMES-immunized mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"At 9 days after end_entity, the rVV-N-immunized mice show more severe start_entity than in other groups\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These results suggest that an excessive host immune response against the N protein of SARS-CoV is involved in severe start_entity caused by end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity, henipaviruses and filoviruses are zoonotic RNA viruses that use bats as their reservoir\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Bats are being increasingly recognized as an important reservoir of zoonotic viruses of different families, including end_entity start_entity, Nipah virus, Hendra virus and Ebola virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Emerging zoonotic pathogens, for example, end_entity start_entity, avian influenza viruses, Coxiella, and Francisella, would have pandemic potential were they to acquire efficient human-to-human transmissibility\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These include end_entity start_entity, Hendra virus and Nipah virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In addition, it has been suspected that ebolaviruses and end_entity start_entity are also linked to bats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV, porcine deltacoronavirus PDCoV, and swine acute end_entity syndrome-coronavirus SADS-CoV are emergingreemerging coronaviruses start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Toona sinensis TS, which is also known as Cedrela sinensis, belongs to Meliaceae family, the compounds identified from this TS leaves possess a wide range of biologic functions, such as hypoglycemic effects, antiLDL glycative activity, antioxidant activities, and inhibition of sudden acute respiratory syndrome end_entity start_entity replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TS\",\n",
       "                    \"value\": \"Toona sinensis end_entity, which is also known as Cedrela sinensis, belongs to Meliaceae family, the compounds identified from this end_entity leaves possess a wide range of biologic functions, such as hypoglycemic effects, antiLDL glycative activity, antioxidant activities, and inhibition of sudden acute respiratory syndrome Severe_Acute_Respiratory_Syndrome start_entity replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Summary Purpose end_entity department ED nurses suffer from persistent stress after experiencing the traumatic event of exposure to Middle East respiratory syndrome start_entity MERS-CoV, which can subsequently lead to burnout\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity end_entity-CoV, a member of the Coronaviridae family, is the causative pathogen for end_entity that is characterized by high fever, start_entity, acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult, as well as extrapulmonary manifestations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV, a member of the Coronaviridae family, is the causative pathogen for MERS that is characterized by high fever, start_entity, acute respiratory distress syndrome end_entity, as well as extrapulmonary manifestations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"Resumo O padro histolgico de end_entity Aguda Fibrinosa e Organizante AFOP Acute Fibrinous And Organizing end_entity, descrito PORCN Beasley em 2002, caracteriza-se pela existncia de fibrina intra-alveolar sob a forma de bolas de fibrina e start_entity organizativa difusa\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"Abstract The histologic pattern of Acute Fibrinous and Organizing end_entity AFOP, described by Beasley in 2002, is characterized by the existence of intra alveolar fibrin in the form of fibrin balls and diffuse organizing start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Methods Results were compared from community surveys measuring health care-seeking for start_entity defined as: 1 end_entity and difficulty breathing for 2days; or, 2 provider-diagnosed start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sprains and Strains\",\n",
       "                    \"value\": \"end_entity of human start_entity HCoV, namely HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1, primarily infect the upper respiratory and gastrointestinal tracts and are the most common cause of non-rhinovirus-induced common cold in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"We identified start_entity episodes and collected blood, nasopharyngeal swabs, and induced end_entity specimens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"We used multiplex real-time PCR to detect pathogens in nasopharyngeal swabs and induced end_entity of start_entity cases and in nasopharyngeal swabs of age-matched and site-matched controls\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Development of anti-severe acute respiratory syndrome associated start_entity end_entity-CoV agents is pivotal to prevent the reemergence of the life-threatening disease, end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Frontotemporal Dementia\",\n",
       "                    \"value\": \"Ireland, and realtime multiplex polymerase chain reaction end_entity, Respiratory pathogens, multiplex Fast Trade Kit, Malta for detection of influenza virus H1N1, B, rhinovirus, parainfluenza virus, adenovirus, respiratory syncytial virus, human parechovirus, bocavirus, metapneumovirus, and human start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome start_entity end_entity CoV is a start_entity first recognized in 2012 and is associated with severe respiratory disease in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ground-glass opacity\",\n",
       "                    \"value\": \"Conclusion The imaging features of severe start_entity caused by human infected avian influenza H7N9 include obvious end_entity and pulmonary consolidation, mainly at lower lobes and dorsal of lungs, with rapid changes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"end_entity was the main clinical manifestation of this patient, and the primary imaging findings were basically the same as viral start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Differential imaging diagnosis on the basis of epidemiological and experimental pathogen detection is helpful for clinical diagnosis of end_entity, even in distinguishing from Severe_Acute_Respiratory_Syndrome and start_entity caused by H7N9 avian influenza\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Differential imaging diagnosis on the basis of epidemiological and experimental pathogen detection is helpful for clinical diagnosis of MERS, even in distinguishing from end_entity and start_entity caused by H7N9 avian influenza\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis, St. Louis\",\n",
       "                    \"value\": \"The recent onset of epidemics caused by viruses such as Ebola, Marburg, Nipah, Lassa, start_entity, West-Nile encephalitis, end_entity, human immunodeficiency virus, dengue, yellow fever and Venezuelan haemorrhagic fever alerts about the risk these agents represent for the global health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"Transmissible gastroenteritis end_entity is a highly contagious enteric disease of swine, which became infrequent with the appearance of porcine respiratory start_entity PRCV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome end_entity is a lethal zoonosis caused by end_entity start_entity end_entity-CoV and poses a significant threat to public health worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The beginning of 2020 has seen the emergence of start_entity outbreak caused by a start_entity, end_entity Coronavirus 2 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The beginning of 2020 has seen the emergence of start_entity outbreak caused by a start_entity, Severe Acute Respiratory end_entity Coronavirus 2 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Organ Failure\",\n",
       "                    \"value\": \"We recently reported in Intensive Care Medicine the imaging changes of acute stage from a case of 75-year-old male patient with severe start_entity combined acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult, septic shock, and multiple organ disfunction syndrome end_entity who had a history of 10-year hypertension and 1-year diabetes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"We recently reported in Intensive Care Medicine the imaging changes of acute stage from a case of 75-year-old male patient with severe start_entity combined acute respiratory distress syndrome end_entity, septic shock, and multiple organ disfunction syndrome Multiple_Organ_Failure who had a history of 10-year hypertension and 1-year diabetes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Under the assumptions that the imported case is representative of the patients in China, and that the start_entity is similarly transmissible to the end_entity start_entity, the probability that an imported case is followed by sustained human-to-human transmission is 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome end_entity related start_entity start_entity sequences isolated in China and around the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Based on phylogeny, taxonomy and established practice, the CSG recognizes this virus as forming a sister clade to the prototype human and bat severe acute respiratory syndrome start_entityes SARS-CoVs of the species end_entity-related start_entity, and designates it as start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"BACKGROUND: The ongoing new start_entity start_entity Corona end_entity 2019, start_entity outbreak is spreading in China, but it has not yet reached its peak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Within last 17 years two widespread epidemics of severe acute respiratory syndrome end_entity occurred in China, which were caused by related coronaviruses start_entity: end_entity-CoV and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Genome sequencing found the genetic sequence of start_entity homologous to that of end_entity-Associated Coronavirus SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"Hemodialysis end_entity patients had a high rate of infection transmission and mortality during the middle east respiratory syndrome start_entity MERS-CoV outbreak in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ground-glass opacity\",\n",
       "                    \"value\": \"The start_entity start_entity basically showed a multifocal or unifocal involvement of end_entity GGO, sometimes with consolidation and fibrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Similar to such other start_entityes as those causing the Middle East respiratory syndrome end_entity and severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, the new start_entity was reported to spread via natural aerosols from human-to-human\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Similar to such other start_entityes as those causing the Middle East respiratory syndrome MERS and severe acute respiratory syndrome end_entity, the new start_entity was reported to spread via natural aerosols from human-to-human\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In order to assess the potential of the Wuhan start_entity to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of Severe_Acute_Respiratory_Syndrome, end_entity, and other start_entity infections on pregnant women and their infants\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In order to assess the potential of the Wuhan start_entity to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of end_entity, MERS, and other start_entity infections on pregnant women and their infants\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV and Middle East respiratory syndrome start_entity MERS-CoV are two highly transmissible and pathogenic viruses that emerged in humans at the beginning of the 21st century\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The person-to-person transmission routes of start_entity included direct transmission, such as end_entity, sneeze, droplet inhalation transmission, and contact transmission, such as the contact with oral, nasal, and eye mucous membranes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"6 start_entity outbreak coincides similar to end_entity with Chinese new year during which the Chinese travel extensively, increasing chances for transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This virus is genetically similar to end_entity start_entity and bat end_entity-like start_entityes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The primer and probe sets were designed to react with this start_entity and its closely related viruses, such as end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"RESULTS: Using RNA extracted from cells infected by end_entity start_entity as a positive control, these assays were shown to have a dynamic range of at least seven orders of magnitude 2x10-4-2000 TCID50reaction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"We used the serial intervals SI of infection caused by two other well-known coronaviruses CoV, Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and end_entity MERS start_entity, as approximations of the unknown SI for start_entity to estimate R0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We used the serial intervals SI of infection caused by two other well-known coronaviruses CoV, Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and Coronavirus_Infections end_entity start_entity, as approximations of the unknown SI for start_entity to estimate R0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We used the serial intervals SI of infection caused by two other well-known coronaviruses CoV, end_entity end_entity and Coronavirus_Infections MERS start_entity, as approximations of the unknown SI for start_entity to estimate R0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"We used the serial intervals SI of infection caused by two other well-known coronaviruses CoV, Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome and Middle East Respiratory end_entity MERS start_entity, as approximations of the unknown SI for start_entity to estimate R0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HHS\",\n",
       "                    \"value\": \"With increasing numbers of cases of start_entity disease 2019 start_entity globally and in the United States, Health and Human Services end_entity Secretary Alex Azar declared a national public health emergency on January 31\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity 2 start_entity emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Objective To describe the clinical characteristics and outcomes in patients with start_entity who developed acute respiratory distress syndrome end_entity or died\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"These were start_entityes such as the Severe_Acute_Respiratory_Syndrome start_entity SARSCoV in 20022003, the end_entity start_entity MERSCoV with occasional outbreaks since 2012 or influenza viruses like the H1N1 pandemic in 20092010\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These were start_entityes such as the end_entity start_entity SARSCoV in 20022003, the Coronavirus_Infections start_entity MERSCoV with occasional outbreaks since 2012 or influenza viruses like the H1N1 pandemic in 20092010\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"These were start_entityes such as the Severe Acute Respiratory end_entity start_entity SARSCoV in 20022003, the Middle East Respiratory end_entity start_entity MERSCoV with occasional outbreaks since 2012 or influenza viruses like the H1N1 pandemic in 20092010\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"he time of writing this commentary February 2020, the start_entity start_entity epidemic has already resulted in more fatalities compared with the Severe_Acute_Respiratory_Syndrome and end_entity start_entity epidemics combined\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"he time of writing this commentary February 2020, the start_entity start_entity epidemic has already resulted in more fatalities compared with the end_entity and MERS start_entity epidemics combined\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This idea is based on observations that the angiotensin-converting enzyme 2 ACE2 very likely serves as the binding site for start_entity, the strain implicated in the current start_entity epidemic, similarly to strain end_entity-CoV implicated in the 2002-2003 end_entity epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The virus termed Severe_Acute_Respiratory_SyndromeCoV2 shares 88 sequence identity to two start_entityes found in bats, batSLCoVZC45 and batSLCoVZXC21, 79 identity with the Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome start_entity and 50 identity with Middle Eastern Respiratory Syndrome end_entity start_entity 4\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The virus termed end_entityCoV2 shares 88 sequence identity to two start_entityes found in bats, batSLCoVZC45 and batSLCoVZXC21, 79 identity with the end_entity end_entity start_entity and 50 identity with Middle Eastern Respiratory Syndrome MERS start_entity 4\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The virus termed Severe_Acute_Respiratory_SyndromeCoV2 shares 88 sequence identity to two start_entityes found in bats, batSLCoVZC45 and batSLCoVZXC21, 79 identity with the Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome start_entity and 50 identity with Middle Eastern Respiratory end_entity MERS start_entity 4\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In 2003, the end_entity start_entity SARSCoV outbreak in Toronto highlighted this very real vulnerability, where busy emergency departments, delays in isolation, and improper personal protective equipment PPE use fueled the spread of disease in several hospitals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In 2003, the Severe Acute Respiratory end_entity start_entity SARSCoV outbreak in Toronto highlighted this very real vulnerability, where busy emergency departments, delays in isolation, and improper personal protective equipment PPE use fueled the spread of disease in several hospitals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Taking advantage of all the genomic information currently available, we constructed a phylogenetic tree including also representatives of other coronaviridae, such as Bat start_entity BCoV and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"However, based on our analysis of a larger dataset available so far, we find there is no observable difference between the incubation time for start_entity, Severe_Acute_Respiratory_Syndrome and end_entity, highlighting the need for larger and well annotated datasets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However, based on our analysis of a larger dataset available so far, we find there is no observable difference between the incubation time for start_entity, end_entity and MERS, highlighting the need for larger and well annotated datasets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Based on the advice of the International Health Regulations end_entity Committee and the fact that to date 24 other countries also reported cases, the WHO Director-General declared that the outbreak of start_entity constitutes a Public Health end_entity of International Concern on 30 January 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"On February 11, 2020, the WHO officially named the disease caused by the start_entity as Corona end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In this review, we discuss the literature on the efficacy of LPV in vitro and in vivo, especially in patients with Severe_Acute_Respiratory_Syndrome and end_entity, so that we might clarify the potential for the use of LPV in patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this review, we discuss the literature on the efficacy of LPV in vitro and in vivo, especially in patients with end_entity and MERS, so that we might clarify the potential for the use of LPV in patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Conclusion end_entity and cough are the most common symptoms in patients with start_entity infection, and most of these patients have abnormal chest CT examination\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Conclusion Fever and end_entity are the most common symptoms in patients with start_entity infection, and most of these patients have abnormal chest CT examination\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The case fatality rate of patients with start_entity infection is lower than that of Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and end_entity MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The case fatality rate of patients with start_entity infection is lower than that of Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and Coronavirus_Infections end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The case fatality rate of patients with start_entity infection is lower than that of end_entity end_entity and Coronavirus_Infections MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The case fatality rate of patients with start_entity infection is lower than that of Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome and Middle East Respiratory end_entity MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Finally, could this outbreak of start_entity be caused by a start_entity that was different from those causing end_entity or Middle East respiratory syndrome MERS3? This article is protected by copyright\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity Coronavirus 2 start_entity cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity Coronavirus 2 start_entity cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"The emergence and spread of 2019 Novel Coronavirus-Infected end_entity start_entity from Wuhan, China, it has spread globally\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Neonatal hemochromatosis\",\n",
       "                    \"value\": \"In this article, we present an effort to compile and analyze epidemiological outbreak information on start_entity based on the several open datasets on Novel Corona Virus 2019 provided by the Johns Hopkins University, World Health Organization WHO, Chinese Center for Disease Control and Prevention CDC, National Health Commission end_entity, and DXY\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"By Feb 27th, 2020, the outbreak of start_entity caused 82623 confirmed cases and 2858 deaths globally, more than Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome 8273 cases, 775 deaths and end_entity MERS 1139 cases, 431 deaths caused in 2003 and 2013 respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"By Feb 27th, 2020, the outbreak of start_entity caused 82623 confirmed cases and 2858 deaths globally, more than Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome 8273 cases, 775 deaths and Coronavirus_Infections end_entity 1139 cases, 431 deaths caused in 2003 and 2013 respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"By Feb 27th, 2020, the outbreak of start_entity caused 82623 confirmed cases and 2858 deaths globally, more than end_entity end_entity 8273 cases, 775 deaths and Coronavirus_Infections MERS 1139 cases, 431 deaths caused in 2003 and 2013 respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"By Feb 27th, 2020, the outbreak of start_entity caused 82623 confirmed cases and 2858 deaths globally, more than Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome 8273 cases, 775 deaths and Middle East Respiratory end_entity MERS 1139 cases, 431 deaths caused in 2003 and 2013 respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Limited epidemiological and clinical data suggest that the disease spectrum of start_entity may differ from Severe_Acute_Respiratory_Syndrome or end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Limited epidemiological and clinical data suggest that the disease spectrum of start_entity may differ from end_entity or MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We summarize latest literatures on genetic, epidemiological, and clinical features of start_entity in comparison to Severe_Acute_Respiratory_Syndrome and end_entity and emphasize special measures on diagnosis and potential interventions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We summarize latest literatures on genetic, epidemiological, and clinical features of start_entity in comparison to end_entity and MERS and emphasize special measures on diagnosis and potential interventions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity SARS-like start_entity sequences were identified in two separate cDNA pools\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In this study, a fundamental knowledge gap question is to be resolved by evaluating the differences in biological and pathogenic aspects of start_entity and the changes in start_entity in comparison with the two prior major COV epidemics, Severe_Acute_Respiratory_Syndrome and end_entity coronaviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, a fundamental knowledge gap question is to be resolved by evaluating the differences in biological and pathogenic aspects of start_entity and the changes in start_entity in comparison with the two prior major COV epidemics, end_entity and MERS coronaviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"METHODS: The genome composition, nucleotides analysis, codon usage indices, relative synonymous codons usage RESU and effective number of codons ENc were analysed in the four structural genes; Spike S, Envelope E, membrane M, and Nucleocapsid N genes, and two of the most important non-structural genes comprising RNA-dependent RNA polymerase RdRP and main protease Mpro of start_entity, Beta-CoV from pangolins, bat Severe_Acute_Respiratory_Syndrome, end_entity and Severe_Acute_Respiratory_Syndrome start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS: The genome composition, nucleotides analysis, codon usage indices, relative synonymous codons usage RESU and effective number of codons ENc were analysed in the four structural genes; Spike S, Envelope E, membrane M, and Nucleocapsid N genes, and two of the most important non-structural genes comprising RNA-dependent RNA polymerase RdRP and main protease Mpro of start_entity, Beta-CoV from pangolins, bat end_entity, MERS and end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"start_entity structural proteins showed 5-20 lower ENc values, compared with Severe_Acute_Respiratory_Syndrome, bat Severe_Acute_Respiratory_Syndrome and end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity structural proteins showed 5-20 lower ENc values, compared with end_entity, bat end_entity and MERS start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Pangolin Beta-CoV showed little differences with start_entity ENc values, compared with Severe_Acute_Respiratory_Syndrome, bat Severe_Acute_Respiratory_Syndrome and end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Pangolin Beta-CoV showed little differences with start_entity ENc values, compared with end_entity, bat end_entity and MERS CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"CONCLUSION: Extreme bias and lower ENc values of start_entity, especially in Spike, Envelope and Mpro genes, are suggestive for higher gene expression efficiency, compared with Severe_Acute_Respiratory_Syndrome, bat Severe_Acute_Respiratory_Syndrome and end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSION: Extreme bias and lower ENc values of start_entity, especially in Spike, Envelope and Mpro genes, are suggestive for higher gene expression efficiency, compared with end_entity, bat end_entity and MERS start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Blindness\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"8 kcalmol when it docks in the catalytic pocket of end_entity RdRp by using the start_entity Docking server\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"9 reported the clinical characteristics of nine pregnant women with laboratory-confirmed start_entity in the third trimester, which comprised mainly fever and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Crimean\",\n",
       "                    \"value\": \"In this study, 19 important zoonotic diseases were reported among Iranian camels including listeriosis, leptospirosis, plague, Q fever, brucellosis, campylobacteriosis, tuberculosis, pasteurellosis, clostridiosis, salmonellosis, Escherichia coli infections, rabies, camelpox, Middle East respiratory syndrome start_entity, end_entity, echinococcosis, cryptosporidiosis, toxoplasmosis and dermatophytosis, most of which belong to bacterial, viral, parasitic and fungal pathogens, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome end_entity is the second novel zoonotic disease infecting humans caused by start_entity CoV in this century\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"In addition, novel pathogens including zoonotic start_entityes like the agents causing Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome, end_entity MERS and the 2019 start_entity 2019 nCoV are still being identified\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In addition, novel pathogens including zoonotic start_entityes like the agents causing Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome, Coronavirus_Infections end_entity and the 2019 start_entity 2019 nCoV are still being identified\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In addition, novel pathogens including zoonotic start_entityes like the agents causing end_entity end_entity, Coronavirus_Infections MERS and the 2019 start_entity 2019 nCoV are still being identified\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In addition, novel pathogens including zoonotic start_entityes like the agents causing Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome, Middle East Respiratory end_entity MERS and the 2019 start_entity 2019 nCoV are still being identified\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a start_entity that can cause vomiting and watery end_entity in pigs and death in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a start_entity that can cause end_entity and watery diarrhea in pigs and death in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"All 12 cases of the 2019-nCoV-infected patients developed start_entity and half of them developed acute respiratory distress syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS: Historical records on prevention and treatment of infections in CM classics, clinical evidence of CM on the prevention of severe acute respiratory syndrome end_entity and H1N1 influenza, and CM prevention programs issued by health authorities in China since the start_entity outbreak were retrieved from different databases and websites till 12 February, 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSIONS: Based on historical records and human evidence of end_entity and H1N1 influenza prevention, Chinese herbal formula could be an alternative approach for prevention of start_entity in high-risk population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"The disease is mild in most people; in some usually the elderly and those with comorbidities, it may progress to start_entity, acute respiratory distress syndrome end_entity and multi organ dysfunction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Although understanding of the start_entity virus is evolving, lessons learned from prior infectious disease challenges such as end_entity will hopefully improve our state of readiness regardless of the number of cases we eventually manage in Canada\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Although understanding of the start_entity virus is evolving, lessons learned from prior infectious disease challenges such as Severe Acute Respiratory end_entity will hopefully improve our state of readiness regardless of the number of cases we eventually manage in Canada\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The sequences of spike glycoprotein of start_entity and end_entity start_entity end_entity-CoV were used for the comparison\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"0 based on cryo-EM structure of the end_entity start_entity spike glycoprotein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ground-glass opacity\",\n",
       "                    \"value\": \"Subsequently, the patient was diagnosed with start_entity according to the diagnostic criteria 2 as follows 1: the positive result of start_entity nucleic acid detection 2; a history of short stay in Wuhan within 14 days; and 3 symptoms of fever, and multiple patchy areas of end_entity on CT scan\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Notably, start_entity nucleic acid was still detected in end_entity from the patient although negative result of throat swab detection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Hospital-associated transmission is an important route of spreading the 2019 start_entity start_entity infection and start_entity Corona end_entity 2019, start_entity 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Healthcare workers HCWs are at high risk while combating start_entity at the very frontline, and nosocomial outbreaks among HCWs are not unusual in similar settings; the 2003 severe acute respiratory syndrome end_entity outbreak led to over 966 HCW infections with 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Sanofi will build on work on a vaccine against end_entity, another start_entity that circulated in the early 2000s\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Existing antivirals and knowledge gained from the Severe_Acute_Respiratory_Syndrome and end_entity outbreaks gain traction as the fastest route to fight the current start_entity epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Existing antivirals and knowledge gained from the end_entity and MERS outbreaks gain traction as the fastest route to fight the current start_entity epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"The outbreak of 2019-start_entity disease start_entity that is caused by start_entity has spread rapidly in China, and has developed to be a Public Health end_entity of International Concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity 2 start_entity infects host cells through ACE2 receptors, leading to start_entity disease COVID-19-related start_entity, while also causing acute myocardial injury and chronic damage to the cardiovascular system\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Bats have been recognized as one of the most important reservoirs for emerging viruses and the transmission of a start_entity that originated in bats to humans via intermediate hosts was responsible for the high-impact emerging zoonosis, severe acute respiratory syndrome end_entity 2-10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity nonstructural protein 13 SCV nsP13, a superfamily 1 helicase, plays a central role in viral RNA replication through the unwinding of duplex RNA and DNA with a 5' single-stranded tail in a 5' to 3' direction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV is the causative agent of a respiratory disease with a high case fatality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"previously unknown start_entity was isolated from the end_entity of a 60-year-old man who presented with acute start_entity and subsequent renal failure with a fatal outcome in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Remdesivir GS-5734 effectively inhibited end_entity start_entity end_entity-CoV replication in vitro, and showed efficacy against Severe_Acute_Respiratory_Syndrome SARS-CoV in a mouse model\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Remdesivir GS-5734 effectively inhibited MERS start_entity MERS-CoV replication in vitro, and showed efficacy against end_entity SARS-CoV in a mouse model\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Remdesivir GS-5734 effectively inhibited MERS start_entity MERS-CoV replication in vitro, and showed efficacy against Severe Acute Respiratory end_entity SARS-CoV in a mouse model\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Learning from the roles of civet in Severe_Acute_Respiratory_Syndrome and camel in end_entity, hunting for the animal source of start_entity and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Learning from the roles of civet in end_entity and camel in MERS, hunting for the animal source of start_entity and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"World Health Organization has declared the ongoing outbreak of start_entity disease 2019 start_entity a Public Health end_entity of International Concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"As with Severe_Acute_Respiratory_Syndrome, the end_entity start_entity remains viable as an aerosol and on surfaces for long periods of time at low relative humidity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"As with end_entity, the MERS start_entity remains viable as an aerosol and on surfaces for long periods of time at low relative humidity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the face of a potential pandemic of start_entity, we suggest sustainable and scalable control measures developed based on lessons learned from end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The end_entity Coronavirus 2 start_entity first broke out in Wuhan China and subsequently spread worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The Severe Acute Respiratory end_entity Coronavirus 2 start_entity first broke out in Wuhan China and subsequently spread worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We draw on Taiwan's end_entity experience to argue that a modified form of Traffic Control Bundling protects health care worker safety and by extension strengthens overall start_entity epidemic control\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Conclusions start_entity appears to show frequent fever, dry end_entity, and increase of inflammatory cytokines, and induced a mortality rate of 7\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Utilizing the Centers for Disease Control and Prevention CDC, USA website, and a comprehensive review of PubMed literature, we obtained information regarding clinical signs and symptoms, treatment and diagnosis, transmission methods, protection methods and risk factors for end_entity MERS, Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Utilizing the Centers for Disease Control and Prevention CDC, USA website, and a comprehensive review of PubMed literature, we obtained information regarding clinical signs and symptoms, treatment and diagnosis, transmission methods, protection methods and risk factors for Coronavirus_Infections end_entity, Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Utilizing the Centers for Disease Control and Prevention CDC, USA website, and a comprehensive review of PubMed literature, we obtained information regarding clinical signs and symptoms, treatment and diagnosis, transmission methods, protection methods and risk factors for Coronavirus_Infections MERS, end_entity end_entity and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Utilizing the Centers for Disease Control and Prevention CDC, USA website, and a comprehensive review of PubMed literature, we obtained information regarding clinical signs and symptoms, treatment and diagnosis, transmission methods, protection methods and risk factors for Middle East Respiratory end_entity MERS, Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Compared with Severe_Acute_Respiratory_Syndrome and end_entity, start_entity has spread more rapidly, due in part to increased globalization and the focus of the epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Compared with end_entity and MERS, start_entity has spread more rapidly, due in part to increased globalization and the focus of the epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria, Erythropoietic\",\n",
       "                    \"value\": \"end_entity, selamectin and mefloquine hydrochloride are potential drugs for treating start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria, Erythropoietic\",\n",
       "                    \"value\": \"Our results strongly suggest that end_entity is a wide-spectrum inhibitor of pan-betacoronavirus, and clinical trial of end_entity for treatment of start_entity infection is warranted\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"OBJECTIVE: To investigate the clinical and CT features associated with severe and critical Corona end_entity 2019 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The clinical factors of age 50 years old, comorbidities, dyspnea, chest pain, end_entity, expectoration, decreased lymphocytes and increased inflammation indicators were risk factors for severecritical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"In West China Hospital, end_entity Department ED undertook the mission of clinical reception, primary diagnosis, and interim treatment for the suspected cases of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Coronavirus Disease 2019 start_entity caused by end_entity Coronavirus -2 start_entity infection has been widely spread\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Coronavirus Disease 2019 start_entity caused by Severe Acute Respiratory end_entity Coronavirus -2 start_entity infection has been widely spread\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Allergic diseases, asthma and end_entity are not risk factors for start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS: Based on the susceptible-exposed-infected-removed SEIR compartment model and the assumption that the infectious cases with symptoms occurred before 26 January, 2020 are resulted from free propagation without intervention, we estimate the basic reproduction number of start_entity according to the reported confirmed cases and suspected cases, as well as the theoretical estimated number of infected cases by other research teams, together with some epidemiological determinants learned from the severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSIONS: The early transmission ability of start_entity is close to or slightly higher than end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"African Swine Fever\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Summary The interplay of simultaneous end_entity, start_entity, and avian influenza emergencies on global health and industries is constantly evolving and difficult to predict, and therefore warrants further scrutiny\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Crimean\",\n",
       "                    \"value\": \"Background Emerging viruses like severe acute respiratory syndrome start_entity SARS-CoV, end_entity virus CCHFV and Nipah virus NiV have been identified to pose a potential threat to transfusion safety\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This week, the cumulative death toll surpassed 1000, compared with the more than 800 killed by another start_entity in the 200203 outbreaks of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ngiotensin-converting enzyme 2 ACE2 is the cellular receptor for end_entity start_entity end_entity-CoV and the new start_entity start_entity that is causing the serious epidemic start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Nance-Horan syndrome\",\n",
       "                    \"value\": \"What you need to knowConsider covid-19 infection in anyone with cough, fever, or breathlessness who has had contact with someone with covid-19, or has returned from a high risk area in the 14 days before the onset of symptomsEvery effort should be made to avoid in-person assessment of patients with possible covid-19 in primary careGP surgeries should plan ahead and develop clear protocols for managing possible cases, including isolation procedures, personal protective equipment, seeking specialist advice, and decontaminationIf covid-19 infection is suspected in someone attending the practice, isolate the patient in a room away from other patients and staff, close the door, and ask the patient to call end_entity 111The guidance may change so it is essential to look at the latest guidance online box 1The UK recorded its first confirmed case of acute respiratory infection due to start_entity disease 2019 covid-19 on 31 January 2020 and responded by quarantining at-risk individuals to contain the spread of infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"What you need to knowConsider covid-19 infection in anyone with end_entity, fever, or breathlessness who has had contact with someone with covid-19, or has returned from a high risk area in the 14 days before the onset of symptomsEvery effort should be made to avoid in-person assessment of patients with possible covid-19 in primary careGP surgeries should plan ahead and develop clear protocols for managing possible cases, including isolation procedures, personal protective equipment, seeking specialist advice, and decontaminationIf covid-19 infection is suspected in someone attending the practice, isolate the patient in a room away from other patients and staff, close the door, and ask the patient to call Nance-Horan_syndrome 111The guidance may change so it is essential to look at the latest guidance online box 1The UK recorded its first confirmed case of acute respiratory infection due to start_entity disease 2019 covid-19 on 31 January 2020 and responded by quarantining at-risk individuals to contain the spread of infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Nance-Horan syndrome\",\n",
       "                    \"value\": \"In a letter sent on 8 March, seen by The BMJ, end_entity England and end_entity Improvement's strategic incident director for start_entity, Keith Willett, has ordered regional primary care and public health directors to set up a 24 hour, seven day a week service to manage patients in the community\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"OBJECTIVES: This study aimed to assess the affective and cognitive risk perceptions in the general population of Middle East respiratory syndrome end_entity during the 2015 end_entity start_entity end_entity-CoV outbreak in South Korea and the influencing factors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Conclusions Patients with fever andor end_entity and with conspicuous ground grass opacity lesions in the peripheral and posterior lungs on CT images combined with normal or decreased white blood cells and a history of epidemic exposure are highly suspected of start_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The clinical symptoms of start_entity patients include fever, end_entity, fatigue and a small population of patients appeared gastrointestinal infection symptoms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"he world is witnessing the epidemic of start_entity, a disease caused by a start_entity, start_entity, emerging genetics and clinical evidences suggest a similar path to those of Severe_Acute_Respiratory_Syndrome and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"he world is witnessing the epidemic of start_entity, a disease caused by a start_entity, start_entity, emerging genetics and clinical evidences suggest a similar path to those of end_entity and MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Several clinical, genetic and epidemiological features of start_entity resemble end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Neural Tube Defects\",\n",
       "                    \"value\": \"Mouse hepatitis start_entity MHV is the only known start_entity that uses the N-terminal domain end_entity of its spike to recognize a protein receptor, CEACAM1a\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"UNSTRUCTURED Background: From December 2019, the 2019 Novel Coronavirus start_entity end_entity broke out in Wuhan, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Though similar to end_entity, the start_entity outbreak has several differences\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Because similar pulmonary syndromes have been reported from other strains of the start_entity family, our aim is to review the lessons from imaging studies obtained during severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome and Middle East respiratory syndrome end_entity outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Because similar pulmonary syndromes have been reported from other strains of the start_entity family, our aim is to review the lessons from imaging studies obtained during severe acute respiratory syndrome end_entity and Middle East respiratory syndrome MERS outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The review of experiences with the end_entity and Severe_Acute_Respiratory_Syndrome outbreaks will help us better understand the role of the radiologist in combating the outbreak of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The review of experiences with the MERS and end_entity outbreaks will help us better understand the role of the radiologist in combating the outbreak of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Human start_entity infections can induce not only mild to severe respiratory diseases, but also inflammation, high fever, end_entity, acute respiratory tract infection and dysfunction of internal organs that may lead to death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity is similar to end_entity start_entity SARS-CoV virus in its pathogenicity, clinical spectrum, and epidemiology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"start_entity is similar to Severe Acute Respiratory end_entity start_entity SARS-CoV virus in its pathogenicity, clinical spectrum, and epidemiology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Comparison of the genome sequences of start_entity, SARS-CoV, and end_entity start_entity MERS-CoV showed that start_entity has a better sequence identity with SARS-CoV compared to MERS CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Comparison of the genome sequences of start_entity, SARS-CoV, and Coronavirus_Infections start_entity end_entity-CoV showed that start_entity has a better sequence identity with SARS-CoV compared to end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Comparison of the genome sequences of start_entity, SARS-CoV, and Middle East Respiratory end_entity start_entity MERS-CoV showed that start_entity has a better sequence identity with SARS-CoV compared to MERS CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"This study aimed at investigating the global prevalence, biological and clinical characteristics of start_entity, Wuhan China start_entity, Severe_Acute_Respiratory_Syndrome Coronavirus SARS-CoV, and end_entity Coronavirus MERS-CoV infection outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This study aimed at investigating the global prevalence, biological and clinical characteristics of start_entity, Wuhan China start_entity, end_entity Coronavirus SARS-CoV, and Coronavirus_Infections Coronavirus MERS-CoV infection outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"This study aimed at investigating the global prevalence, biological and clinical characteristics of start_entity, Wuhan China start_entity, Severe Acute Respiratory end_entity Coronavirus SARS-CoV, and Middle East Respiratory end_entity Coronavirus MERS-CoV infection outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The major clinical manifestations in start_entity infections start_entity, MERS-CoV, and end_entity CoV are fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, dyspnea, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The major clinical manifestations in start_entity infections start_entity, MERS-CoV, and Severe_Acute_Respiratory_Syndrome CoV are fever, chills, end_entity, shortness of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, dyspnea, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The major clinical manifestations in start_entity infections start_entity, MERS-CoV, and Severe_Acute_Respiratory_Syndrome CoV are fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, end_entity, confusion, dyspnea, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The molecular docking results indicate that, the 3CLpro of start_entity has a higher binding affinity for all the studied inhibitors than its end_entity homologue\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with start_entity can spread from person to person, and in the earliest phase of the outbreak the basic reproductive number was estimated to be around 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Therefore, although Severe_Acute_Respiratory_Syndrome, end_entity, and start_entity are all the result of coronaviral infections, the causes of the coronaviruses differ dramatically in their transmissibility\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Therefore, although end_entity, MERS, and start_entity are all the result of coronaviral infections, the causes of the coronaviruses differ dramatically in their transmissibility\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"start_entity is compared with two related start_entity epidemics, Severe_Acute_Respiratory_Syndrome and end_entity, in terms of the number of reported human infections, deaths, countries, major country clusters, timelines, and the likelihood of discovering a safe, effective, and approved vaccine\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity is compared with two related start_entity epidemics, end_entity and MERS, in terms of the number of reported human infections, deaths, countries, major country clusters, timelines, and the likelihood of discovering a safe, effective, and approved vaccine\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a highly virulent re-emerging enteric start_entity that causes acute end_entity, dehydration, and up to 100 mortality in neonatal suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Coronaviruses start_entity are RNA viruses that have become a major public health concern since the end_entity-CoV SARS-CoV outbreak in 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Objective: To construct and evaluate a diagnosis process for 2019-Corona end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"end_entity was cured in 2 patients, and one patient died of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Carcinoma, Non-Small-Cell Lung\",\n",
       "                    \"value\": \"During the epidemic of start_entity, We recommended that patients with advanced end_entity should be treated as outpatients as possible at the nearest medical center; Patients who need to be hospitalized for antitumor treatment should be excluded from start_entity infection; More intensive attention should be paid to identification of start_entity-related symptoms and adverse reactions caused by the malignancy or antitumor treatments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"According to the Diagnosis and Treatment of New Coronavirus end_entity 6th edition of the National Health Commission of the People's Republic of China, a new guideline for the diagnosis and treatment of 2019 start_entity infection suitable for the military first trial version was established\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Epidemiological data showed that the older patients with chronic commodities were at high risk of the involvement of the severe and critical type of start_entity, especially patients with chronic obstructive pulmonary disease end_entity resulting in high mortalities\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Once infected with start_entity, it would be life-threatening for the end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Carpal Tunnel Syndrome\",\n",
       "                    \"value\": \"Based on these considerations, the Pulmonary_Disease,_Chronic_Obstructive Group of the Chinese Thoracic Society end_entity and the Pulmonary_Disease,_Chronic_Obstructive working Committee of the Chinese Association of Chest Physicians Jacobs_syndrome altogether drafted the instruction for medical management and prevention of Pulmonary_Disease,_Chronic_Obstructive during the start_entity epidemic period for the healthcare practitioner and patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Jacobs syndrome\",\n",
       "                    \"value\": \"Based on these considerations, the Pulmonary_Disease,_Chronic_Obstructive Group of the Chinese Thoracic Society Carpal_Tunnel_Syndrome and the Pulmonary_Disease,_Chronic_Obstructive working Committee of the Chinese Association of Chest Physicians end_entity altogether drafted the instruction for medical management and prevention of Pulmonary_Disease,_Chronic_Obstructive during the start_entity epidemic period for the healthcare practitioner and patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Based on these considerations, the end_entity Group of the Chinese Thoracic Society Carpal_Tunnel_Syndrome and the end_entity working Committee of the Chinese Association of Chest Physicians Jacobs_syndrome altogether drafted the instruction for medical management and prevention of end_entity during the start_entity epidemic period for the healthcare practitioner and patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ground-glass opacity\",\n",
       "                    \"value\": \"For imaging features, both groups had end_entity and thickening of interlobular septum, but the ratio of central and gradient distribution was higher in patients with heart failure than that in patients with start_entity 47 vs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"NPC\",\n",
       "                    \"value\": \"This guideline is applicable to the health protection requirements of large indoor stadiums which are reconstructed as treatment sites for the start_entity end_entity patients with mild symptoms during the outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Conclusions: end_entity was the main symptom at the early phase of start_entity in Tianjin, and the local cluster cases accounted for high proportion in confirmed start_entity cases reported in Tianjin\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Since December 2019, Corona end_entity start_entity, a new emerging infection disease occurred in Wuhan, has spread in 27 countries and regions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Conclusions: The prevention and control strategies for start_entity 2010 are more effective compared to that of end_entity 2003, and the emergency response procedures are worth to be evaluated and summarized\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In this review, we analyzed a total of 10 literatures on the sampling methods of upper respiratory tract related to infectious diseases such as severe acute respiratory syndrome start_entity Severe_Acute_Respiratory_Syndrome, middle east respiratory syndrome start_entity end_entity, and influenza A H1N1, which were spread worldwide in past years\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this review, we analyzed a total of 10 literatures on the sampling methods of upper respiratory tract related to infectious diseases such as severe acute respiratory syndrome start_entity end_entity, middle east respiratory syndrome start_entity MERS, and influenza A H1N1, which were spread worldwide in past years\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"China has formally included the start_entity in the statutory notification and control system for infectious diseases according to the Law of the People's Republic of China on the Prevention and Treatment of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Burns\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity Department is also confronted with risk of infection by the end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Corona end_entity 2019 start_entity has seriously affected the treatment of patients and social stability\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The Corona Virus_Diseases 2019 start_entity outbroke in Wuhan, China in December 2019 and the severe acute respiratory syndrome end_entity outbroke in Guangzhou, China in 2003 were caused by highly pathogenic coronaviruses with high homology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"The Corona end_entity 2019 start_entity outbroke in Wuhan, China in December 2019 and the severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome outbroke in Guangzhou, China in 2003 were caused by highly pathogenic coronaviruses with high homology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"According to current observations, start_entity is weaker than end_entity in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme ACE2, which is consistent with the receptor end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Methods: All start_entity cases reported through February 11, 2020 were extracted from China's end_entity Information System\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"end_entity, cough, myalgia, weakness, dyspnea and imagings may be helpful for the early detection of start_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Fever, end_entity, myalgia, weakness, dyspnea and imagings may be helpful for the early detection of start_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The article provides the pulmonary rehabilitation PR methods in the principle of 4S simple, safe, satisfy, save for patients with start_entity caused by the start_entity, shows how to establish a ventilative and convectional PR environment to prevent the spread of virus through droplets, how to guide the patients to carry out PR, how to carry out respiratory muscle training, effective end_entity, expectoration, sneeze, general exercise, digestive function rehabilitation and psychological rehabilitation, and how to clean and disinfect the PR environment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with 2019 Novel Coronavirus start_entity is mainly transmitted by respiratory droplets, airborne transmission and direct contact\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"The New Coronavirus end_entity start_entity, also named as start_entity by WHO on Feb 11 2020, is now causing a severe public health emergency in China since\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Combination of Ribavirin and Interferon- is recommended by the 5th edition National Health Commission's Regimen Revised Edition because of the effect on end_entity, and the effectiveness of Lopinavir/Ritonavir and Remdisivir needs to be confirmed by randomized controlled trial RCT, given the situation of no specific antivirus drug on start_entity is unavailable\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Combination of Ribavirin and Interferon- is recommended by the 5th edition National Health Commission's Regimen Revised Edition because of the effect on end_entity Coronavirus_Infections, and the effectiveness of Lopinavir/Ritonavir and Remdisivir needs to be confirmed by randomized controlled trial RCT, given the situation of no specific antivirus drug on start_entity is unavailable\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Combination of Ribavirin and Interferon- is recommended by the 5th edition National Health Commission's Regimen Revised Edition because of the effect on MERS Middle East Respiratory end_entity, and the effectiveness of Lopinavir/Ritonavir and Remdisivir needs to be confirmed by randomized controlled trial RCT, given the situation of no specific antivirus drug on start_entity is unavailable\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"The outbreak of a start_entity infection can lead to 15 30 patients developing into acute respiratory distress syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"World Health Organization WHO announced that the outbreaks of the start_entity have constituted a Public Health end_entity of International Concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"end_entity after surgery must be carefully differentiated whether it's caused by post-surgery abdominal infectioninflammation or start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"1, 2 However, two start_entityes have previously caused significant outbreaks associated with more severe disease: the end_entity start_entity in 20022003 and the Middle East respiratory syndrome start_entity that emerged in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"4, 5 Early studies using data before the institution of public health interventions in China suggest that end_entityCoV2 is as transmissible as end_entity start_entity and probably more transmissible than influenza viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSION: This work provides additional evidence for a median incubation period for start_entity of approximately 5 days, similar to end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"According to the latest start_entity national management plan and the actual situation, the Working Group for the Prevention and Control of Neonatal start_entity end_entity in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics puts forward recommendations for the prevention and control of start_entity infection in neonates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"As the National Clinical Research Center for end_entity, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for start_entity inZhejiang Province\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Following the end_entity outbreak, 5 additional start_entityes have been discovered in humans, most recently the start_entity start_entity, believed to have originated in Wuhan, Hubei Province, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lymphocytopenia\",\n",
       "                    \"value\": \"In conclusion, leukopenia, end_entity and eosinophil cytopenia are more common in start_entity patients than those in non- start_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"There is a spectrum of clinical features from mild to severe life threatening disease with major complications like severe start_entity, end_entity, acute cardiac injury and septic shock\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Subsequently, the task of experts of the International Committee on Taxonomy of Viruses ICTV termed it the start_entity virus as it is very similar to the one that caused the end_entity outbreak end_entity-CoVs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity SCoV is the etiological agent of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Wounds and Injuries\",\n",
       "                    \"value\": \"In order to standardize the emergency treatment and the infection prevention and control of severe trauma patients with hidden infection, suspected or confirmed infection of start_entity, end_entity Surgery Branch of Chinese Medical Doctors' Association organized this expert consensus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"lthough the epidemic outbreak of Corona end_entity 2019 start_entity restricted freecoming and going of people, it was inevitable that fracture patients, elderly ones with low-energy fracture in part ICU lar, sought medical attention\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"n outbreak of start_entity caused by end_entity Coronavirus 2 SARS-CoV-2infection has spread to children\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"n outbreak of start_entity caused by Severe Acute Respiratory end_entity Coronavirus 2 SARS-CoV-2infection has spread to children\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The new virus spreads much more readily than the one that caused severe acute respiratory syndrome, or end_entity also a start_entity, and has infected more than ten times the number of people who contracted end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"The start_entity outbreak declared a Public Health end_entity of International Concern on 30 January 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"However, the mortality rate of start_entity is lower than that of other coronaviruses diseases such as Severe_Acute_Respiratory_Syndrome or end_entity and other viruses like HIV and Ebola\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However, the mortality rate of start_entity is lower than that of other coronaviruses diseases such as end_entity or MERS and other viruses like HIV and Ebola\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Polyendocrinopathies, Autoimmune\",\n",
       "                    \"value\": \"Citing the growing threat of the start_entity, the American Physical Society end_entity, the 55,000 member professional society for physicists and researchers in associated fields, cancelled its largest meeting of the year just 34 hours before it was supposed to begin\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"start_entity, like previous severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome and Middle East respiratory syndrome end_entity, is also caused by start_entity infection, and acute kidney injury AKI is one of the important complications of the disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity, like previous severe acute respiratory syndrome end_entity and Middle East respiratory syndrome MERS, is also caused by start_entity infection, and acute kidney injury AKI is one of the important complications of the disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Otitis Media\",\n",
       "                    \"value\": \"011, y en el marco del Reglamento Sanitario Internacional -RSI-2005, y ante la situacin epidemiolgica PORCN el nuevo start_entity start_entity, declarada como emergencia en salud pblica de imPORCNtancia internacional ESPII PORCN la Organizacin Mundial de la Salud end_entity el da 30 de enero del ao en curso: imparten instrucciones sobre las acciones que los destinatarios de esta circular deben observar para la vigilancia activa, preparacin y toma de medidas de contencin para una eventual introduccin del virus en el territorio nacional\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"A recent study on another type of start_entity infection, end_entity MERS, investigated its relationship with diabetes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"A recent study on another type of start_entity infection, Coronavirus_Infections end_entity, investigated its relationship with diabetes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"A recent study on another type of start_entity infection, Middle East Respiratory end_entity MERS, investigated its relationship with diabetes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"1 Announcement, which incorporated the start_entity start_entity into the Class B infectious diseases according to the Law on Prevention and Control of end_entity, but the disease should be adopted the management of Class A infectious diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"On January 20, 2020,the Chinese health authorities upgraded the start_entity to a Class B infectious disease in the Law of the People's Republic of China on the Prevention and Treatment of end_entity , and considered it as Class A infectious diseases in disease control and prevention\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In February 2020 the nature of the start_entity outbreak is still slowly coming into focus but it appears to be acting more like bad pandemic influenza efficient spread, overall lower mortality than like end_entity less efficient spread, overall higher mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Otitis Media\",\n",
       "                    \"value\": \"SSB Organizacin Mundial de Salud end_entity inform la ocurrencia de casos de Infeccin Respiratoria Aguda Grave MRVI1 causada PORCN un nuevo start_entity start_entity en Wuhan China, desde la ltima semana de diciembre de 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"The World Health Organization WHO reported the occurrence of cases of Acute Respiratory end_entity Severe MRVI1 caused by a new start_entity start_entity in Wuhan, China, since last week December 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Tract Infections\",\n",
       "                    \"value\": \"The World Health Organization WHO reported the occurrence of cases of Acute end_entity Severe MRVI1 caused by a new start_entity start_entity in Wuhan, China, since last week December 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Objective Conduct comprehensive analysis of the regulatory requirement of ethical review regarding to the response of public health emergency, illustrate particular ethical review and ethical administration strategies for start_entity end_entity Research\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Conclusions The ethical review approval criteria of start_entity emergency research should take into full consideration of its urgency to make sure efficient and high quality initial review, meanwhile, more attention should be paid on continuing ethical review and ethical consultation during the whole life-circle of start_entity end_entity Research\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Conclusions The start_entity patients mostly present with fever and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"Conclusion Severity of start_entity was associated with underlying disease, symptoms, site of involvement, \\u00a0C-reactive_protein, d-dimer, end_entity 3 T lymphocyte count, end_entity 4 T lymphocyte count, and end_entity 8 T lymphocyte count\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Objective To analyze the CT manifestations of the 2019 start_entity start_entity start_entity combined with severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome and Middle East respiratory syndrome end_entity literature review, and to summarize the characteristics of CT imaging, so as to improve the ability of rapid and accurate diagnosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Objective To analyze the CT manifestations of the 2019 start_entity start_entity start_entity combined with severe acute respiratory syndrome end_entity and Middle East respiratory syndrome MERS literature review, and to summarize the characteristics of CT imaging, so as to improve the ability of rapid and accurate diagnosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Methods CT manifestations of two confirmed cases of start_entity were reported, meanwhile the literatures on Severe_Acute_Respiratory_Syndrome and end_entity imaging performance were reviewed and summarized\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods CT manifestations of two confirmed cases of start_entity were reported, meanwhile the literatures on end_entity and MERS imaging performance were reviewed and summarized\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Results The two cases of start_entity were both in acute stage, the CT imaging showed multiple and scattered ground-glass_opacity GGO in both lungs, which is similar to the CT performance of Severe_Acute_Respiratory_Syndrome and end_entity in acute stage\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Results The two cases of start_entity were both in acute stage, the CT imaging showed multiple and scattered ground-glass_opacity GGO in both lungs, which is similar to the CT performance of end_entity and MERS in acute stage\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ground-glass opacity\",\n",
       "                    \"value\": \"Results The two cases of start_entity were both in acute stage, the CT imaging showed multiple and scattered end_entity GGO in both lungs, which is similar to the CT performance of Severe_Acute_Respiratory_Syndrome and MERS in acute stage\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Conclusions The CT features of 2019 start_entity start_entity are similar to Severe_Acute_Respiratory_Syndrome and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Conclusions The CT features of 2019 start_entity start_entity are similar to end_entity and MERS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lymphocytopenia\",\n",
       "                    \"value\": \"Conclusions Epidemic history of contact, fever, start_entity signs of chest CT, normal or decreased count of WBC and end_entity are the clinical basis for diagnosis of the disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Oligohydramnios\",\n",
       "                    \"value\": \"end_entity was detected in only one case at 37 5 weeks, which was 7 d after the diagnosis of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anxiety Disorders\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Methods From February 2nd to 16th, 2020, 106 end_entity patients were anonymously investigated for their mental health status using onlinequestionnaires including Patient Health Questionnaire-9, Generalized start_entity Scale-7, Patient Health Questionnaire-15 scales\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"end_entity was the first symptom in 49 84 of 58 patients with start_entity, and fever was the first symptom in both severe and critical start_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The incidence of end_entity in severe 25 36, 69 and critical 6 9, 67 start_entity patients was higher than that in general 20 58, 34\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"Among them 205 cases were start_entity infected patients, including 186 cases confirmed with nucleic acid test and 19 cases diagnosed by clinical symptoms and CT characteristics according to 'the New Coronavirus end_entity Control Protocol 5th edition'\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"GICA and ELISA were used to detect start_entity IgM in 71 serum, including 5 influenza A virus end_entity A IgM positive serum, 5 influenza B virus end_entity B IgM positive serum, 5 Mycoplasma start_entity MP IgM positive serum, 5 Legionella pneumophila LPA IgM positive serum, 29 rheumatoid factor RF IgM positive serum, 5 hypertension patients serum, 5 diabetes mellitus patients serum, 6 human immunodeficiency virus HIV infection patients serum and 6 Corona Virus_Diseases 2019 start_entity patients serum\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"GICA and ELISA were used to detect start_entity IgM in 71 serum, including 5 influenza A virus Influenza,_Human A IgM positive serum, 5 influenza B virus Influenza,_Human B IgM positive serum, 5 Mycoplasma start_entity MP IgM positive serum, 5 Legionella pneumophila LPA IgM positive serum, 29 rheumatoid factor RF IgM positive serum, 5 hypertension patients serum, 5 diabetes mellitus patients serum, 6 human immunodeficiency virus HIV infection patients serum and 6 Corona end_entity 2019 start_entity patients serum\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity should be pay close attention in start_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Objective To investigate the role of epidemiological history in the screening of Corona end_entity 2019 start_entity in fever clinic, to improve the efficiency in fever clinic and reduce the incidence of cross infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Conclusions The manifestation of digestive system of hospitalized start_entity patients in Wuhan is significant, the ratio of patients with end_entity and abnormal aminotransferase level is high\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Results end_entitys modelling based on multi-source information has become the main research trend, and the published mathematical models of start_entity epidemic need to be improved in terms of accuracy and scalability\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Objective: To analyze application fields of 5G communication technology in Corona end_entity 2019 start_entity epidemic prevention and control, and build a 5G intelligent medical service system for start_entity epidemic prevention and control in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Salivary Gland Adenoma, Pleomorphic\",\n",
       "                    \"value\": \"Since this is going to be a post about the start_entity, let's start off with this end_entity: wash your hands\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Summary One patient with a complaint of intermittent end_entity, vomiting for 6 days, fever with shortness of breath for half a day was referred to the Department of Critical Medicine, Wuhan Children's Hospital, and was diagnosed with neonatal severe start_entity start_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Summary One patient with a complaint of intermittent diarrhea, end_entity for 6 days, fever with shortness of breath for half a day was referred to the Department of Critical Medicine, Wuhan Children's Hospital, and was diagnosed with neonatal severe start_entity start_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The International Committee on Viral Classification named the virus 'end_entity Coronavirus 2' start_entity, and the WHO named the start_entity it causes 'Coronavirus Disease 2019' start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The International Committee on Viral Classification named the virus 'Severe Acute Respiratory end_entity Coronavirus 2' start_entity, and the WHO named the start_entity it causes 'Coronavirus Disease 2019' start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"These measures include 1 wearing an efficient mask an N95 mask; 2 always performing hand hygiene before and after examining a patient; 3 wearing sterile gloves when entering a patientrsquo;s room and touching a patient; 4 wearing a gown when contact is expected with items and environmental surfaces surrounding a patient or when the patient is incontinent or has end_entity or a surgical or other invasive wound with oozing fluid; 5 cleaning and disinfecting ophthalmic equipment and correctly handling medical waste after examination to prevent transmission to patients who are subsequently examined; 6 wearing goggles and a disposable mask to cover the front and sides of the face before touching a patient, as the virus could spread through the ocular surface; 7 performing the relevant screening for start_entity start_entity for regular patients who have conjunctivitis and respiratory symptoms at the same time; 8 prohibiting the use of infected patients as potential donors for corneal transplants and temporarily adding donor start_entity screening to the medical standard of the eye bank during the outbreak; and 9 for the purposes of scientific research, diagnosis, and other special needs, packing, shipping, and transporting collected specimens according to the relevant dangerous biological goods regulations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"People who infected by the start_entity may suffer from fever and end_entity, some may gradually appear breathing difficulties and other serious manifestations, some severe patients may have acute respiratory distress syndrome and septic shock leading to death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The virus, which emerged in the Chinese city of Wuhan in December, is a start_entity and belongs to the same family as the pathogen that causes severe acute respiratory syndrome, or end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Dalton's unexpected moment in the media spotlight came as Deborah Birx, the White House's start_entity response coordinator, and Anthony Fauci, head of the National Institute of Hypersensitivity and end_entity, stepped to the White House lectern to describe a new set of guidelines that the U\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Dalton's unexpected moment in the media spotlight came as Deborah Birx, the White House's start_entity response coordinator, and Anthony Fauci, head of the National Institute of end_entity and Communicable_Diseases, stepped to the White House lectern to describe a new set of guidelines that the U\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSION: Resolution of pneumonitis is delayed in some patients during end_entity recovery and may be associated with delayed clearance of start_entity, Complete resolution may occur by 90 days or later\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV, cause of the life-threatening atypical start_entity, infects many organs, such as lung, liver and immune organ, and induces parenchyma cells apoptosis and necrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Severe Acute Respiratory end_entity start_entity SARS-CoV, cause of the life-threatening atypical start_entity, infects many organs, such as lung, liver and immune organ, and induces parenchyma cells apoptosis and necrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is caused by a newly discovered start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The entry of the end_entity start_entity SCV into cells is initiated by binding of its spike ERVW-1 S to a receptor, ACE2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity, a recent epidemic human disease, is caused by a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Cellular localization of severe acute respiratory syndrome start_entity end_entity-CoV in the lungs of patients with end_entity is important in confirming the etiological association of the virus with disease as well as in understanding the pathogenesis of the disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Adequate animal models are required to study the underlying pathogenesis of SARS-associated start_entity end_entity and to develop effective vaccines and therapeutics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity start_entity end_entity-CoV is the etiologic agent of the severe acute respiratory syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Experimental animal data show that protection against severe acute respiratory syndrome start_entity end_entity with human monoclonal antibodies mAbs is feasible\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Host genetic factors may play a role in susceptibility and resistance to end_entity associated start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: It is believed that animal-to-human transmission of severe acute respiratory syndrome end_entity start_entity CoV is the cause of the end_entity outbreak worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Most of the individuals infected with end_entity start_entity end_entity-CoV spontaneously recovered without clinical intervention\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity caused a large outbreak of start_entity in Beijing, China, in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity end_entity-CoV spike is the largest known viral spike molecule, and shares a similar function with all class 1 viral fusion proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The pathogenesis of end_entity start_entity CoV remains poorly understood\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lupus Erythematosus, Systemic\",\n",
       "                    \"value\": \"We report a case of systemic lupus erythematosus end_entity in a 44-year old Caucasian woman complicated with start_entity and severe respiratory failure requiring ICU treatment and mechanical ventilation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, we adopted a mammalian two-hybrid system to screen the genome-wide intraviral protein-protein interactions of end_entity start_entity end_entity-CoV and therefrom revealed a number of novel interactions which could be partly confirmed by in vitro biochemical assays\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"BACKGROUND: end_entity start_entity causes high mortality every year, and pandemic episodes kill millions of people\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"During an outbreak of severe acute respiratory syndrome end_entity in March 2003, hybridization to this microarray revealed the presence of a previously uncharacterized start_entity in a viral isolate cultivated from a end_entity patient\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity start_entity main proteinase end_entity CoVMpro is an important enzyme for the replication of end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Severe_Acute_Respiratory_Syndrome start_entity main proteinase Severe_Acute_Respiratory_Syndrome CoVMpro is an important enzyme for the replication of Severe Acute Respiratory end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A functional screen identifies the hepatitis C virus NS34A and the end_entity start_entity SARS-CoV nonstructural protein NSP15 as inhibitors of MAVS-induced apoptosis, possibly as a method of immune evasion\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"A functional screen identifies the hepatitis C virus NS34A and the Severe Acute Respiratory end_entity start_entity SARS-CoV nonstructural protein NSP15 as inhibitors of MAVS-induced apoptosis, possibly as a method of immune evasion\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"As the downstream protein of MBL, variants of the MBL-associated serine protease-2 MASP2 gene may be associated with end_entity start_entity end_entity in the same population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"In this study, we describe end_entity levels overtime and their relationship with bacterial infection in chronic obstructive pulmonary disease Pulmonary_Disease,_Chronic_Obstructive critically ill patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"In this study, we describe Porphyria_Cutanea_Tarda levels overtime and their relationship with bacterial infection in chronic obstructive pulmonary disease end_entity critically ill patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"All consecutive end_entity patients admitted for start_entity between September 2005 and September 2006 were included\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"25 gL previously proposed for non severe lower respiratory tract infection to predict the probability of a bacterial infection in severe end_entity patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Further studies testing procalcitonin-based antibiotic strategies are needed in end_entity patients with severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity, caused by the start_entity end_entity-CoV, is an acute infectious disease with significant mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The spike S protein is a major structural glycoprotein of start_entity CoV, the causal agent of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have tested the performance of the EpiSearch algorithm for six experimental data sets of phage display experiments, the human EGF receptor-2 HER-2neu, the antibody mAb Bo2C11 targeting the C2 domain of F8, antibodies mAb 17b and mAb b12 of the HIV ERVW-1 gp120, mAb 13b5 targeting HIV-1 capsid protein and 80R of the end_entity start_entity spike protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Prune Belly Syndrome\",\n",
       "                    \"value\": \"CR2 targeting complement inhibitors are used to treat mouse influenza viral start_entity model, with end_entity treatment group as the control\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity end_entity-CoV open reading frame 7a ATP6AP1 7a encodes a 122 amino acid accessory protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Murine start_entity, mouse hepatitis virus MHV infection of the mouse, provides animal models for the study of central nervous system disease, including encephalitis and demyelinating diseases such as end_entity and for hepatitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sclerosis\",\n",
       "                    \"value\": \"Murine start_entity, mouse hepatitis virus MHV infection of the mouse, provides animal models for the study of central nervous system disease, including encephalitis and demyelinating diseases such as Multiple end_entity and for hepatitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity often caused severe end stage lung disease and organizing phase diffuse alveolar damage, especially in the elderly\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"No amplification was achieved for uninfected cells, or cells infected with Newcastle_Disease virus NDV, canine parvovirus CPV, canine start_entity end_entity, rabies virus RV, or canine adenovirus CAV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Newcastle Disease\",\n",
       "                    \"value\": \"No amplification was achieved for uninfected cells, or cells infected with end_entity virus NDV, canine parvovirus CPV, canine start_entity Cataract_congenital_Volkmann_type, rabies virus RV, or canine adenovirus CAV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porcine Reproductive and Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity virus end_entityV replicates mainly in porcine alveolar macrophages PAMs and dendritic cells DCs and develops persistent infections, antibody-dependent enhancement ADE, interstitial start_entity and immunosuppression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity-associated start_entity SARS-CoV spreads rapidly and has a high case-mortality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"CONCLUSIONSSIGNIFICANCE: end_entity continues to be a major public health challenge in young children in China, and estimates of start_entity incidence and mortality vary widely\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSIONS: VIGOR is a user friendly web-based genome annotation program for five different viral agents, influenza, rotavirus, rhinovirus, start_entity and end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"BACKGROUND: The domestic cat has offered enormous genomic potential in the veterinary description of over 250 hereditary disease models as well as the occurrence of several deadly feline viruses feline leukemia virus -- FeLV, feline end_entity -- FECV, feline immunodeficiency virus - FIV that are homologues to human scourges cancer, Severe_Acute_Respiratory_Syndrome, and start_entity respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The domestic cat has offered enormous genomic potential in the veterinary description of over 250 hereditary disease models as well as the occurrence of several deadly feline viruses feline leukemia virus -- FeLV, feline start_entity -- FECV, feline immunodeficiency virus - FIV that are homologues to human scourges cancer, end_entity, and Acquired_Immunodeficiency_Syndrome respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We further demonstrate that replication of infectious end_entity start_entity end_entity-CoV and entry mediated by the end_entity-CoV spike S protein are restricted by IFITM proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Coronaviruses such as severe acute respiratory syndrome end_entity start_entity SCoV and mouse hepatitis virus A59 MHV-A59 have evolved strategies to disable the innate immune system for productive replication and spread of infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"One start_entity strain was isolated from brain tissues of ten piglets with evident clinical manifestations of vomiting, end_entity and dyskinesia in Jilin province in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"One start_entity strain was isolated from brain tissues of ten piglets with evident clinical manifestations of end_entity, diarrhea and dyskinesia in Jilin province in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The inhibitory effect of LiCl was also observed with porcine epidemic end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Idiopathic Pulmonary Fibrosis\",\n",
       "                    \"value\": \"The histopathology of DAD is considered to represent end stage phenomenon in acutely behaving interstitial start_entitys, such as acute interstitial start_entity Porphyria,_Acute_Intermittent and acute exacerbations of idiopathic pulmonary fibrosis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria, Acute Intermittent\",\n",
       "                    \"value\": \"The histopathology of DAD is considered to represent end stage phenomenon in acutely behaving interstitial start_entitys, such as acute interstitial start_entity end_entity and acute exacerbations of idiopathic pulmonary fibrosis Idiopathic_Pulmonary_Fibrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity nsp16 protein is a S-adenosylmethionine-dependent nucleoside-2-O-methyltransferase only active in the presence of its activating partner nsp10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Severe Acute Respiratory end_entity start_entity nsp16 protein is a S-adenosylmethionine-dependent nucleoside-2-O-methyltransferase only active in the presence of its activating partner nsp10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We found several proteins that could interact with the nucleocapsid protein of the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Molecular clock analysis using various gene loci revealed that the time of most recent common ancestor of humancivet end_entity related start_entity to be 19992002, with estimated substitution rate of 4104 to 2102 substitutions per site per year\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV encodes two S-adenosyl-L-methionine SAM-dependent methyltransferases MTase which sequentially methylate the RNA cap at guanosine-N7 and ribose 2-O positions, catalyzed by nsp14 N7-MTase and nsp16 2-O-MTase, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SCoV nonstructural protein nsp 1, a potent inhibitor of host gene expression, possesses a unique mode of action: it binds to 40S ribosomes to inactivate their translation functions and induces host mRNA degradation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The causative agent of severe acute respiratory syndrome, end_entity start_entity end_entity-CoV genome encodes several unique group specific accessory proteins with unknown functions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"new human start_entity responsible for severe acute respiratory syndrome end_entity was identified in 2003, which raised concern about start_entityes as agents of serious infectious disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline and canine start_entityes are widespread among dog and cat populations, sometimes leading to the fatal diseases known as feline infectious peritonitis end_entity and pantropic canine start_entity infection in cats and dogs, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The better stability of end_entity start_entity at low temperature and low humidity environment may facilitate its transmission in community in subtropical area such as Hong Kong during the spring and in air-conditioned environments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here we show that human start_entity HCoV NL63 and severe acute respiratory syndrome end_entity CoV papain-like proteases PLP antagonize innate immune signaling mediated by STING stimulator of interferon genes, also known as MITAERISMYPS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a zoonotic disease caused by end_entity-related start_entity end_entity-CoV that emerged in 2002 to become a global health concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"RESULTS: From a compendium of 12 studies that included responses to influenza A subtype H5N1, reconstructed 1918 influenza A virus, and end_entity start_entity, we used meta-analysis to derive multiple gene expression signatures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"For this paper, we chose Bombyx mori cypovirus 1 BmCPV-1 interactions with midgut cells from silkworm, and severe acute respiratory syndrome end_entity associated start_entity interactions with Vero E6 cells, as examples to demonstrate the response of eukaryotic cells to two different types of virus from our previous studies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Because of a concern for reemergence or a deliberate release of the end_entity start_entity, vaccine development was initiated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"The start_entity E protein is a small membrane protein with a single predicted hydrophobic domain end_entity, and has a poorly defined role in infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Detection of bovine viral end_entity virus at necropsy was associated with chronic start_entity and pleuritis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The feline infectious peritonitis virus end_entityV is a member of the feline start_entity family that causes end_entity, which is incurable and fatal in cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our understanding of how antibodies are generated and function could help develop effective vaccines and antibody-based therapeutics against viruses such as HIV-1, end_entity start_entity end_entity CoV, and Hendra and Nipah viruses henipaviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis\",\n",
       "                    \"value\": \"METHODS: end_entity induced by a gliatropic murine start_entity was used as a model to assess the direct contributions of neutrophils, IFN- and IL17A to virus-induced mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Early recognition of end_entity modified risk factors and avoidance of aggravating factors during hospital stay such as nonprotective mechanical ventilation, multiple blood products transfusions, positive fluid balance, ventilator-associated start_entity, and gastric aspiration can help decrease its incidence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Besides being a common threat to farm animals and poultry, start_entity CoV was responsible for the human severe acute respiratory syndrome end_entity epidemic in 20024\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anoxia\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity was more frequent among end_entity cases involving influenza odds ratio, 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Entry of end_entity start_entity SARS-CoV and its envelope fusion with host cell membrane are controlled by a series of complex molecular mechanisms, largely dependent on the viral ERVW-1 Spike S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Entry of Severe Acute Respiratory end_entity start_entity SARS-CoV and its envelope fusion with host cell membrane are controlled by a series of complex molecular mechanisms, largely dependent on the viral ERVW-1 Spike S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"We report here a case of a 39-year-old patient presenting with fever, end_entity, and interstitial opacities on CT scan diagnosed as a nonsevere hMPV start_entity 11 years after a renal transplantation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Vasculopathy, Retinal, With Cerebral Leukodystrophy\",\n",
       "                    \"value\": \"mixed infections for human metapneumovirus hMPV as compared to adenovirus ADV, four types of start_entity end_entity, parainfluenza virus PIV, RSV, and enterovirusrhinovirus ERV in Alberta, Canada\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In 20022003, the outbreak of severe acute respiratory syndrome end_entity, due to a newly discovered start_entity, the end_entity-associated start_entity end_entity-CoV; led to a new awareness of the medical importance of the Coronaviridae family\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"BACKGROUND: end_entity A virus IAV infection primarily targets respiratory epithelial cells and produces clinical outcomes ranging from mild upper respiratory infection to severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Following the successful cloning of receptor for end_entity start_entity a few years ago, Dr\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"BACKGROUND: end_entity virus FIPV and feline enteric start_entity FECV are two important start_entityes of domestic cat worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is an emerging infectious disease caused by the start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lassa Fever\",\n",
       "                    \"value\": \"Notably, infection mediated by the entry proteins of end_entity virus, influenza A virus and Severe_Acute_Respiratory_Syndrome start_entity was largely unaffected by TIM1 expression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Notably, infection mediated by the entry proteins of Lassa_Fever virus, influenza A virus and end_entity start_entity was largely unaffected by TIM1 expression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"OBJECTIVE: In order to investigate the clinical and epidemiological rules of severe acute respiratory syndrome end_entity, rates and levels end_entity start_entity end_entity-CoV IgG antibodies of the patients and community populations from several areas were detected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"To evaluate the most controversial issue concerning current feline start_entity FCoV virology, the coexisting hypotheses of the intrahost and interhost origins of feline infectious peritonitis virus end_entityV in regard to the pathogenesis of feline infectious peritonitis end_entity, this study aimed to assess the molecular diversity of the membrane gene FCoVs in 190 samples from 10 cats with signs of end_entity and in 5 faecal samples from cats without signs of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"In C57Bl6 mice, intravenous administration of 5pppRNA protected animals from a lethal challenge with H1N1 end_entity, reduced virus titers in mouse lungs and protected animals from virus-induced start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"n epidemic of end_entity end_entity led to the identification of an associated start_entity, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"n epidemic of Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome led to the identification of an associated start_entity, Severe_Acute_Respiratory_Syndrome-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"By investigating a recently identified regulatory element upstream of the end_entity start_entity end_entity-CoV 1 frameshifting site, it is shown that a minimal functional element with hairpin forming potential is sufficient to down-regulate1 frameshifting activity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV membrane M proteins are capable of self-assembly and release in the form of membrane-enveloped vesicles, and of forming virus-like particles VLPs when coexpressed with SARS-CoV nucleocapsid N protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The outbreaks of emerging infectious diseases caused by pathogens such as end_entity start_entity, H5N1, H1N1, and recently H7N9 influenza viruses, have been associated with significant mortality and morbidity in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a fatal disease caused by feline start_entity FCoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Transmissible gastroenteritis start_entity TGEV is an enteropathogenic start_entity that causes end_entity in pigs, which is correlated with high morbidity and mortality in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"93, along with attendant cases with Possible end_entity adds either cough, sputum, feverchillsnight sweats, dyspnea or pleuritic chest pain or with end_entity-in-Plan adds start_entity stated as a likely diagnosis by the provider\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"93, along with attendant cases with Possible Pneumonia adds either end_entity, sputum, feverchillsnight sweats, dyspnea or pleuritic chest pain or with Pneumonia-in-Plan adds start_entity stated as a likely diagnosis by the provider\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"93, along with attendant cases with Possible Pneumonia adds either cough, end_entity, feverchillsnight sweats, dyspnea or pleuritic chest pain or with Pneumonia-in-Plan adds start_entity stated as a likely diagnosis by the provider\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The Severe_Acute_Respiratory_Syndrome-associated start_entity SARS-CoV epidemic in 20022003, and the recent emergence of end_entity start_entity MERS-CoV in April 2012, emphasize the high probability of future zoonotic HCoV emergence causing severe and lethal human disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity-associated start_entity SARS-CoV epidemic in 20022003, and the recent emergence of Coronavirus_Infections start_entity MERS-CoV in April 2012, emphasize the high probability of future zoonotic HCoV emergence causing severe and lethal human disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Severe Acute Respiratory end_entity-associated start_entity SARS-CoV epidemic in 20022003, and the recent emergence of Middle East Respiratory end_entity start_entity MERS-CoV in April 2012, emphasize the high probability of future zoonotic HCoV emergence causing severe and lethal human disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Ferrets are widely used as a small animal model for a number of viral infections, including influenza A virus and end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"In 2012, a novel CoV end_entity start_entity; MERS-CoV emerged, causing 49 human cases thus far, of which 23 had a fatal outcome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In 2012, a novel CoV Middle East Respiratory end_entity start_entity; MERS-CoV emerged, causing 49 human cases thus far, of which 23 had a fatal outcome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Similar pathogens, including human rhinovirus, respiratory syncytial virus, influenza virus, parainfluenza virus, and start_entity, are also frequently detected during exacerbation of asthma andor end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by these organisms typically occurs via percutaneous inoculation or inhalation of aerosols, and the most common manifestation is severe start_entity leading to fatal bacteremia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Little is known about the biology of the emerging human group c betastart_entity, end_entity start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Little is known about the biology of the emerging human group c betastart_entity, Middle East Respiratory end_entity start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We illustrate the power of these methods by: 1 identifying the sites explaining end_entity start_entity differences between human, bat and palm civet samples; 2 showing how cross species jumps of rabies virus among bat populations can be readily identified; and 3 de novo identification of likely functional influenza host discriminant markers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of the CNS central nervous system with a sublethal neurotropic start_entity JHMV induces a vigorous inflammatory response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is a lethal immune-mediated disease caused by feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"n emerging respiratory infectious disease with high mortality, Middle East respiratory syndrome end_entity, is caused by a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"FINDINGS: We show that bat DPP4 genes have been subject to significant adaptive evolution, suggestive of a long-term arms-race between bats and end_entity related start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis\",\n",
       "                    \"value\": \"end_entity is one of the leading causes of morbidity and mortality among young and newborn animals and is often caused by multiple intestinal infections, with rotavirus and bovine start_entity BCoV being the main viral causes in cattle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The disease is characterized by severe pyrexia, oculo-nasal discharge, start_entity, necrosis and ulceration of the mucous membrane and inflammation of the gastro-intestinal tract leading to severe end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"One year after the occurrence of the first case of infection by the end_entity start_entity MERS-CoV there is no clear consensus on the best treatment to propose\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"One year after the occurrence of the first case of infection by the Middle East Respiratory end_entity start_entity MERS-CoV there is no clear consensus on the best treatment to propose\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Whereas severe acute respiratory syndrome end_entity start_entity end_entity-CoV is associated with severe disease, human start_entity HKU1 HCoV-HKU1 commonly circulates in the human populations causing generally milder illness\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The porcine epidemic end_entity virus PEDV, start_entity nucleocapsid N protein, plays important roles in the process of virus replication and cellular infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The microorganisms that for decades have been associated with enteritis and end_entity in suckling piglets are: rotavirus A, start_entity, enterotoxigenic Escherichia coli ETEC, Clostridium perfringens type C, Cryptosporidium spp\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Likewise, advanced age correlated with more adverse disease outcomes following severe acute respiratory syndrome start_entity end_entity in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The end_entity start_entity end_entity-CoV 3a protein functions as an ion channel, induces apoptosis and is important for viral pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"BACKGROUND: end_entity caused by canine parvovirus, canine distemper virus and canine start_entity are an important cause of mortality and morbidity in dogs worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Six studies enrolled adult patients who were either hospitalized or admitted to end_entity Departments with suspicion of start_entity and 4 studies enrolled critically-ill adult patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Recent evidence suggests that a mutation in the spike protein gene of feline start_entity FCoV, which results in an amino acid change from methionine to leucine at position 1058, may be associated with feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV M co-expression with either N or E is sufficient for producing virus-like particles VLPs, although at a lower level compared to M, N and E co-expression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is an immune-mediated, highly lethal disease caused by feline start_entity FCoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"BACKGROUND: Lung ultrasound has been shown to identify in real-time, various pathologies of the lung such as start_entity, viral start_entity, and acute respiratory distress syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pasteurella Infections\",\n",
       "                    \"value\": \"These infectious respiratory disorders are divided into two groups: the diseases of upper respiratory tract, namely, nasal myiasis and enzootic nasal tumors, and diseases of lower respiratory tract, namely, peste des petits ruminants PPR, parainfluenza, end_entity, Ovine progressive start_entity, mycoplasmosis, caprine arthritis encephalitis virus, caseous lymphadenitis, verminous start_entity, and many others\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: The first documented case of end_entity start_entity MERS-CoV occurred in 2012, and outbreaks have continued ever since, mainly in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The first documented case of Middle East Respiratory end_entity start_entity MERS-CoV occurred in 2012, and outbreaks have continued ever since, mainly in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"Multivariate logistic regression analysis was performed to identify risk factors associated with severe pneumococcal start_entity, defined as severity with the end_entity Severity Index PSI score 91\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is a fatal disease caused by feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"METHODS: We conducted a prospective, single-center observational study of start_entity with end_entity in immunocompetent adults admitted to our respiratory ICU\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity, caused by feline start_entity FCoV infection, is a highly lethal disease without effective therapy and prevention\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV engages and regulates several innate immune response pathways during infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Recruits with rhinovirus had higher percentages of start_entity, end_entity, shortness of breath, congestion, end_entity, less fever and longer time to seeking care and were more likely to be male compared to those in the nounknown pathogen group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The new epidemic end_entity MERS is caused by a type of human start_entity called MERS-CoV which has global fatality rate of about 30\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The new epidemic Coronavirus_Infections end_entity is caused by a type of human start_entity called end_entity-CoV which has global fatality rate of about 30\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The new epidemic Middle East Respiratory end_entity MERS is caused by a type of human start_entity called MERS-CoV which has global fatality rate of about 30\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"BACKGROUND: end_entity with bovine respiratory syncytial virus BRSV and bovine start_entity BoCV are endemic to the cattle populations in most countries, causing respiratory andor enteric disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Porcine Epidemic end_entity virus PEDV is a highly transmissible start_entity that causes a severe enteric disease that is particularly deadly for neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity virus B, enterovirus, respiratory syncytial virus, human start_entity and parainfluenza virus 4 were rarely detected 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"A total of 39,756 children with one or more symptoms, including fever, end_entity, sore throat, tonsillitis, pharyngitis, herpangina, start_entity, and bronchiolitis, were enrolled in the study\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"BACKGROUND: end_entity is a fatal disease of cats caused by infection with feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Canine influenza virus CIV subtype H3N2 is a newly identified, highly contagious respiratory pathogen that causes end_entity, start_entity and other respiratory symptoms in dogs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In 2001, this led to the discovery of human metapneumovirus hMPV and soon following that the outbreak of end_entity start_entity SARS-CoV promoted an increased interest in coronavirology and the latter discovery of human start_entity HCoV NL63 and HCoV-HKU1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In 2001, this led to the discovery of human metapneumovirus hMPV and soon following that the outbreak of Severe Acute Respiratory end_entity start_entity SARS-CoV promoted an increased interest in coronavirology and the latter discovery of human start_entity HCoV NL63 and HCoV-HKU1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity start_entity MERS-CoV represents the most recent outbreak of a completely novel respiratory virus, which occurred in Saudi Arabia in 2012 and presents a significant threat to human health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity start_entity MERS-CoV represents the most recent outbreak of a completely novel respiratory virus, which occurred in Saudi Arabia in 2012 and presents a significant threat to human health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Classical Swine Fever\",\n",
       "                    \"value\": \"PCR was used to identify the pathogen and we tested for eight viruses HEV, Porcine reproductive and respiratory syndrome virus, PCV2, end_entity, Porcine epidemic diarrhea virus, Transmissible gastroenteritis start_entity, Porcine parvovirus and Pseudorabies virus that are prevalent in Chinese pig farms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pseudorabies\",\n",
       "                    \"value\": \"PCR was used to identify the pathogen and we tested for eight viruses HEV, Porcine reproductive and respiratory syndrome virus, PCV2, Classical_Swine_Fever, Porcine epidemic diarrhea virus, Transmissible gastroenteritis start_entity, Porcine parvovirus and end_entity virus that are prevalent in Chinese pig farms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"PCR was used to identify the pathogen and we tested for eight viruses HEV, Porcine reproductive and respiratory syndrome virus, PCV2, Classical_Swine_Fever, Porcine epidemic end_entity virus, Transmissible gastroenteritis start_entity, Porcine parvovirus and Pseudorabies virus that are prevalent in Chinese pig farms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"A total of 968 serum samples were tested including samples with confirmed infection with PDCoV, porcine epidemic end_entity virus PEDV, transmissible gastroenteritis virus or porcine respiratory start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Compared to pathogen-free patients, the patients with pathogens were older and non-atopic and had later onset of disease, lower FeNO levels, lower IgE titers, and a higher incidence of comorbid sinusitis, end_entity, or start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Compared to stable outpatients, asthma exacerbation inpatients had a higher incidence of smoking and comorbid sinusitis, end_entity, or start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A previous study identified the compound ML188, also termed 16R, as an inhibitor of the end_entity start_entity SARS-CoV 3CLpro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"A previous study identified the compound ML188, also termed 16R, as an inhibitor of the Severe Acute Respiratory end_entity start_entity SARS-CoV 3CLpro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: Bats are reservoirs for a diverse range of coronaviruses start_entity, including those closely related to human pathogens such as Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome CoV and end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Bats are reservoirs for a diverse range of coronaviruses start_entity, including those closely related to human pathogens such as end_entity end_entity CoV and Coronavirus_Infections CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Bats are reservoirs for a diverse range of coronaviruses start_entity, including those closely related to human pathogens such as Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome CoV and Middle East Respiratory end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"BACKGROUND: start_entity obliterans organizing end_entity Cryptogenic_Organizing_Pneumonia is a type of diffuse interstitial lung disease characterized by the pathology of fibroblastic plugs in the lumens of the respiratory bronchioles, alveolar ducts, and alveoli\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cryptogenic Organizing Pneumonia\",\n",
       "                    \"value\": \"BACKGROUND: Bronchiolitis obliterans organizing start_entity end_entity is a type of diffuse interstitial lung disease characterized by the pathology of fibroblastic plugs in the lumens of the respiratory bronchioles, alveolar ducts, and alveoli\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV causes high fever, end_entity, acute respiratory tract infection and multiorgan dysfunction that may eventually lead to the death of the infected individuals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity with canine start_entity, canine kobuvirus, and canine bocavirus were identified\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Ten pathogens in the highest priority group Borrelia, calicivirus, Campylobacter, Echinococcus multilocularis, hepatitis C virus, HIV, respiratory syncytial virus, SARS- and end_entity start_entity, tick-borne encephalitis virus and varicella-zoster virus did not have any surveillance of typing results\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pigmentary Disorder, Reticulate, with Systemic Manifestations\",\n",
       "                    \"value\": \"Of the 18 pathogens analyzed, four were detected with a positive detection rate end_entity 5: influenza A virus IAV respiratory syncytial virus RSV Mycoplasma pneumoniae MP human start_entity HCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is a novel infectious disease caused by a start_entity end_entity-CoV first reported in Saudi Arabia in September 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"The most frequent diagnoses were influenza-associated start_entity 62 , bronchitisbronchiolitis 32 , secondary bacterial start_entity 26 , and end_entity 21\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle-East Respiratory end_entity start_entity MERS-CoV was identified to cause severe respiratory infection in humans since 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The first known cases of Middle East respiratory syndrome end_entity, associated with infection by a start_entity CoV, occurred in 2012 in Jordan but were reported retrospectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In humans, end_entity is mostly known as a lower respiratory tract LRT disease involving fever, cough, breathing difficulties and start_entity that may progress to acute respiratory distress syndrome, multiorgan failure and death in 20 to 40 of those infected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"In humans, MERS is mostly known as a lower respiratory tract LRT disease involving fever, end_entity, breathing difficulties and start_entity that may progress to acute respiratory distress syndrome, multiorgan failure and death in 20 to 40 of those infected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Compared to severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, another sometimes- fatal zoonotic start_entity disease that has since disappeared, end_entity progresses more rapidly to respiratory failure and acute kidney injury it also has an affinity for growth in kidney cells under laboratory conditions, is more frequently reported in patients with underlying disease and is more often fatal\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Compared to severe acute respiratory syndrome end_entity, another sometimes- fatal zoonotic start_entity disease that has since disappeared, MERS progresses more rapidly to respiratory failure and acute kidney injury it also has an affinity for growth in kidney cells under laboratory conditions, is more frequently reported in patients with underlying disease and is more often fatal\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Bovine start_entity is a primary cause of neonatal calf end_entity worldwide, and is also associated with acute end_entity in adult cattle during the winter season\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity start_entity SARS-CoV caused a global panic due to its high morbidity and mortality during 2002 and 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity results from mutations in the viral genome during a common feline enteric start_entity FECV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emergence of both end_entity and Middle East Respiratory syndrome start_entity as well as the yearly circulation of four common start_entity highlights the importance of elucidating the different mechanisms employed by these viruses to evade the host immune response, determine their tropism and identify antiviral compounds\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The emergence of both Severe Acute Respiratory end_entity and Middle East Respiratory syndrome start_entity as well as the yearly circulation of four common start_entity highlights the importance of elucidating the different mechanisms employed by these viruses to evade the host immune response, determine their tropism and identify antiviral compounds\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity 3C-like proteinase end_entity-3CLpro, which is the main proteinase of the end_entity start_entity, is essential to the virus life cycle\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Several start_entityes, such as end_entity-related start_entity SARS-CoV and Middle East respiratory syndrome-related start_entity MERS-CoV, are of medical importance, with high mortality rates and, in the case of SARS-CoV, significant pandemic potential\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Other start_entityes, such as Porcine epidemic end_entity virus and Avian start_entity, are important livestock pathogens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: end_entity start_entity MERS-CoV is a viral respiratory disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Middle East Respiratory end_entity start_entity MERS-CoV is a viral respiratory disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"CONCLUSIONS: end_entity start_entity MERS-CoV known to cause severe acute respiratory illness associated with a high risk of mortality Various factors may have contributed to the successful outcome of this patient such as young age, presentation during the last stages of pregnancy, and possible differences in immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"CONCLUSIONS: Middle East Respiratory end_entity start_entity MERS-CoV known to cause severe acute respiratory illness associated with a high risk of mortality Various factors may have contributed to the successful outcome of this patient such as young age, presentation during the last stages of pregnancy, and possible differences in immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"0C and at least one of the following: end_entity, sore throat, tachypnea, difficulty breathing, abnormal breath sounds on auscultation, sputum production, hemoptysis, chest pain, or chest radiograph consistent with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"0C and at least one of the following: cough, sore throat, tachypnea, difficulty breathing, abnormal breath sounds on auscultation, end_entity production, hemoptysis, chest pain, or chest radiograph consistent with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The reporting and monitoring of swine enteric start_entity diseases SECD, including porcine epidemic end_entity virus and porcine delta start_entity, in the United States have been challenging because of the initial absence of a regulatory framework and the emerging nature of these diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Wildlife trade can facilitate zoonotic disease transmission and represents a threat to human health and economies in Asia, highlighted by the 2003 end_entity start_entity outbreak, where a Chinese wildlife market facilitated pathogen transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The receptors for porcine sapelovirus PSV, which causes end_entity, start_entity, polioencephalomyelitis, and reproductive disorders in pigs, remains largely unknown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline enteric start_entity FECV causes inapparent or mild enteritis in cats, but a highly fatal disease, called feline infectious peritonitis end_entity, can arise through mutation of FECV to end_entity virus end_entityV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a highly transmissible start_entity that causes a severe enteric disease particularly in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Consistently, the mAbs exhibited no obvious cross-reactivity with NPs derived from other related viruses, including end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Middle Eastern Respiratory end_entity start_entity MERS-CoV is a poorly understood disease with no known treatments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gerodermia osteodysplastica\",\n",
       "                    \"value\": \"To investigate the antiviral activity of graphene oxide end_entity sheets and end_entity sheets with silver particles end_entity-Ag against enveloped and non-enveloped viruses, feline start_entity FCoV with an envelope and infectious bursal disease virus IBDV without an envelope were chosen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a start_entity that infects pigs and can have mortality rates approaching 100 in piglets, causing serious economic impact\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity virus end_entityV is highly virulent and responsible for the highly fatal disease feline infectious peritonitis end_entity, whereas feline enteric start_entity FECV is widespread among the feline population and typically causes asymptomatic infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV papain-like protease PLPro reportedly inhibits the production of type I interferons IFNs and pro-inflammatory cytokines in Toll-like receptor 3 TLR3 and retinoic acid-inducible gene 1 DDX58 pathways\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity-Coronavirus MERS-CoV is a start_entity discovered in 2012 and is responsible for acute respiratory syndrome in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dermatitis\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Atopic end_entity Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dermatitis, Atopic\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with end_entity Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut end_entity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Inflammation\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Lung end_entity Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Nasal Polyps\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with end_entity in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Peanut Hypersensitivity\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with end_entity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced end_entity Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Polyps\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal end_entity in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of end_entity from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of end_entity AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with end_entity and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial end_entity patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of end_entity Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with end_entity and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in end_entity Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local end_entity CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of end_entity and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor end_entity and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sleep Wake Disorders\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between sputum PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 end_entitys in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Leung, Ka Hou Chu A67 The relationship between end_entity PTX3 levels and childhood asthma Hee Seon Lee, Kyung Eun Lee, Jung Yeon Hong, Mi Na Kim, Min Jung Kim, CDR2on Hee Kim, In Suk Sol, Seo Hee CDR2on, Kyung Won Kim, Myung Hyun Sohn, Kyu-Earn Kim A68 The role of local antibody responses in the nasal inflammation of Rhinitis,_Allergic,_Seasonal AR patients Ji Hye Kim, Hae-Sim Park, CDR2o Seob Shin, CDR2ung Min Ye, Daehong Seo, Moon Gyeong CDR2on, CDR2ung Mok Lee A69 A case of ofloxacin-induced anaphylaxis by non-IgE, but specific IgG4-mediated responses Daehong Seo, Ji Hye Kim, CDR2ung-Mok Lee, CDR2ung Min Ye, Hae-Sim Park A70 Serum LTE4 metabolite as a biomarker for aspirin exacerbated respiratory disease Ga CDR2ung Ban, Kumsun Cho, Seung-Hyun Kim, CDR2ng Eun Kwon, Moon Gyeong CDR2on, Ji Hye Kim, CDR2o Seob Shin, CDR2ung Min Ye, Dong-Ho Nahm, Hae-Sim Park A71 Local and systemic reactions of dust mite subcutaneous immunotherapy SCIT among children in a tertiary care hospital Pilar Agnes Gonzalez Andaya A72 Effects of carboxymethyl glucan CM-glucan in children with Rhinitis,_Allergic,_Seasonal and asthma: A randomized controlled trial Pilar Agnes Gonzalez Andaya A73 Autophagy mechanisms in patients with severe asthma: A new therapeutic target Ga CDR2ung Ban, Chang Gyu Jung, Seung-Ihm Lee, Duy Le Pham, Dong-Hyeon Suh, Eun-Mi Yang, CDR2ung Min Ye, CDR2o Seob Shin, Hae-Sim Park A74 Aggravation of airway inflammation and hypperresponsiveness following nasal challenge with dermatophagoides pteronyssinus in perennial Rhinitis,_Allergic,_Seasonal patients without symptoms of asthma Wan Jun Wang, MO Xian, Yan Qing Xie, Jing Ping Zheng, Jing Li A75 Serum 25-hydroxyvitamin d in early childhood is non-linearly associated with allergy Emma Merike Savilahti, Outi Mkitie, Anna Kaarina Kukkonen, Sture Andersson, Heli Viljakainen, Erkki Savilahti, Mikael Kuitunen A76 Fric test in dermographism Kiran Godse A77 Neutrophil autophagy and extracellular trap could contribute to asthma severity Duy Le Pham, Ga CDR2ung Ban, Seung-Hyun Kim, Eun-Mi Yang, Hae-Sim Park, Ji-Ho Lee, CDR2ng-Joon Chwae A78 Redox Modulation for the Treatment of Toluene Diisocyanates-Induced Pneumonia Li-Ming Chin, Chi-Chang Shieh A79 A case of occupational asthma and rhinitis with anaphylaxis to Korean ginseng and sanyak Ji Hye Kim, Hye-Soo CDR2o, Moon Gyeong CDR2on, Ga CDR2ung Ban, Ga CDR2ung Ban, CDR2o Seob Shin, CDR2ung Min Ye, Hae-Sim Park A80 Factors of influencing epidermal permeability barrier defects in atopic dermatitis children Myong Soon Sung, Jin Uck Choi, Sung Won Kim, CDR2ng Jin Hwang A81 Innate type 2 response to aspergillusfumigatus in a murine model of atopic dermatitis-like skin inflammation Arum Park, Eun Lee, Song-I Yang, Hyun-Ju Cho, Jinho Yu A82 Activin a receptor 1C may implicate in the development of sensitive skin Dong Hun Lee, Eun Ju Kim, Yeon Kyung Kim, Eun Jin Doh, Hee Chul Eun, Jin Ho Chung, CDR2ung Mee Lee, Seon Pil Jin A83 Genetic association and eQTL analyses of genes associated with allergy in atopicnon-atopic asthma Xingnan Li, Naftali Kaminski, Sally Wenzel, Eugene Bleecker, Deborah Meyers A84 Gastroscope feature and clinical characteristics in 172 cases of children with henoch-schonlein purpura Zeng Huasong A85 The role of TRPV1 in CD4 t cell mediated inflammatory response of Rhinitis,_Allergic,_Seasonal Ji-Hun Mo, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Jun-Sang Bae, CDR2ung-Jun Chung, Dae Woo Kim A86 A Phenotype of Rhinitis from School Children Is Associated with the Development of Bronchial Hyperresponsiveness Eun Lee, Si Hyeon Lee, CDR2ung-Ho Kim, Hyun-Ju Cho, Ho-Sung Yu, Mi-Jin Kang, Song-I Yang, CDR2ung-Ho Jung, Hyung CDR2ung Kim, Ju-Hee Seo, Byoung-Ju Kim, Hyo-Bin Kim, So-Yeon Lee, Ho-Jang Kwon, Soo-Jong Hong A87 Increased basal activation status was noted in adult anaphylaxis patients Sailesh Palikhe, Hae-Sim Park, Seung-Hyun Kim, Ji Hye Kim, Eun-Mi Yang A88 Clinical values of interferon-gamma enzyme-linked immunospot assays for management of antibiotic hypersensitivity in hospitalized patients Suda Sibunruang, Jettanong Klaewsongkram A89 VDR gene polymorphism and 25-hydroxy vitamin d levels in children with food allergy Tatiana Sentsova, Ilya Vorozhko, Anna Timopheeva, Olga Chernyak, Vera Revyakina, Andrey Sokolnikov A90 An analysis of 145 oral almond challenge tests Makoto Nisihino, Yu Okada, Noriyuki Yanagida, Motohiro Ebisawa, Sakura Sato, Kiyotake Ogura, Tomoyuki Asaumi, Kenichi Nagakura, Tetsuharu Manabe, Hirotoshi Unno A91 Effect of creatine supplementation in fish allergenic potential; A proteomics study Pedro M Rodrigues, Denise Schrama, Gadija Mohamed, Lizex Hsselmann, Lizex Hsselmann, Bongani Ndimba A92 Flagellin modulates the function of invariant NKT cells via dendritic cells in asthma patients Jae-Uoong Shim, CDR2ung Il Koh, Joon Haeng Rhee, Ji-Ung Jeong A93 Clinical and subclinical manifestations of allopurinol induced severe cutaneous adverse reactions in Vietnam Dinh Van Nguyen, Hieu Chi Chu, Mui Thi Tran, Christopher Vidal, Suran Fernando, Sheryl Van Nunen, Sy Van Than A94 Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Mulin Feng, Jing Li A95 Periostin is a novel biomarker in eosinophilic nasal polyps of chronic rhinosinusitis Dong-Kyu Kim, Seung-No Hong, Kyoung Mi Eun, Hong Ryul Jin, Dae Woo Kim A96 Dominance of Th1-response in children with refractory mycoplasma start_entitye start_entity Jun Bao, Yi-Xiao Bao A97 Studies on the role of CD14 polymorphism among pollen and mold induced asthmatics of kolkata, India Sanjoy Podder, Goutam Kumar, Shampa Dutta, Amlan Ghosh A98 House dust mite allergy Indian perspective Goutam Kumar Saha, Sanjoy Podder, Salil Kumar Gupta A99 Increased expression of purinergic P2RY12 receptor and cysteinyl leukotriene receptors in the lung tissue of a mouse model of allergic asthma TuHoang Kim Trinh, CDR2o Seob Shin, Hae-Sim Park, Jing-Nan Liu, Duy Le Pham A100 Autologous serum skin test in chronic idiopathic urticaria - relationship with autoimmune markers and disease severity Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim A101 Anxiety and depression levels in severe asthma patients treated with omalizumab MERTK zbudak, Fatih zer A102 Economic burden of refractory chronic spontaneous urticaria on Kuwait health system GRAP2 Al-Ahmad, Maryam Alowayesh, Norman Carroll A103 IgE-mediated maize allergy in India: A 28 kd protein responsible for food-induced allergic reaction Anand Bahadur Singh A104 Liposomal encapsulation of house dust mite allergens and dexamethasone modulates allergic response in a murine model of asthma CDR2rdanis Prez-Llano, Mara Del Carmen Luzardo Lorenzo, Wendy Ramrez Gonzlez, Carlos Calcines Cruz, Rady Laborde Quintana, Alain Morejn, Virgilio Bourg, Maril Hechavarra Stoker A105 Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells for Eosinophilic Rhinosinusitis with Nasal_Polyps in a Mouse Model Jun-Sang Bae, Ramachandran Samivel, Eun-Hee Kim, Ji-Hye Kim, Ji-Hun Mo A106 Second line treatments of dermographic urticaria refractory to antihistamines Keiko Hanaoka, Michihiro Hide, Akio Tanaka, Makiko Hiragun, Mikio Kawai A107 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Hypersensitivity Kwanghoon Kim, Kwanghoon Kim, Hye-CDR2ung Kim, Jihyun Kim, Kangmo Ahn, CDR2ungshin Han A108 Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema Gun-Wook Kim, Hyun-Chang Ko, Byung Soo Kim, Moon-Bum Kim, Margaret Song A109 Identification of an IgG1-mediated anaphylaxis marker and its application in evaluating the antigenicity of infant formulas Takeshi Matsubara, Hiroshi Iwamoto, Yuki Nakazato, Kazuyoshi Namba, Yasuhiro Takeda A110 Nitric oxide as a screening tool for evaluation of postoperative state of chronic rhinosinusitis Jae Hoon Lee, Woo CDR2ng Bae A111 Comparison of different medical treatment options for crswnp: Doxycycline, methylprednisolone, mepolizumab, omalizumab Els De Schryver, Lien Calus, Philippe Gevaert, Thibaut Van Zele, Claus Bachert A112 Successful treatment of steroid resistant asthma model by blocking CD28 signal Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, CDR2 Iijima, Akemi Abe-Ohtomo, Hiroaki Hayashi, Kentaroh Watai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi A113 Serum POSTN levels was not associated with Rhinitis,_Allergic,_Seasonal and allergic sensitization in Korean children Ju Wan Kang, Jeong Hong Kim, Jeong Hong Kim, Keun-Hwa Lee, Hye-Sook Lee, Seong-Chul Hong, Jaechun Lee A114 Roles of ADAM10 and ADAM17 in Rhinitis,_Allergic,_Seasonal Ji Won Seo, Jae Hoon Lee, Woo CDR2ng Bae A115 Mechanism of oral and topical polyprenol action in atopic dermatitis Ivans Sergejs Kuznecovs, Galina Kuznecova A116 Technical and clinical validation of a mobile chamber for allergen exposure tests Karl-Christian Bergmann, Torsten Zuberbier, Joseph Salame, Torsten Sehlinger, Georg Blke A117 The association between serum lead level and total immunoglobulin e according to allergic sensitization CDR2o Suk Kim, Jung Hyun Chang, Jeong Hong Kim, Ju Wan Kang A118 Clinical and laboratory characteristics of nasal obstruction dominant allergic sensitization Seung-No Hong, Doo Hee Han, Chae-Seo Rhee A119 Nasal provocation test is useful for the diagnoses of allergic, non- allergic, and local Rhinitis,_Allergic,_Seasonal CDR2ung-Joo Ko, CDR2ung Hyo Kim, Dae-CDR2ung Kim, Tae CDR2ung Jang A120 Aspirin facilitates the intestinal absorption and oral sensitization of food allergens in rats Tomoharu CDR2kooji, Taiki Hirano, Hiroaki Matsuo EIF1 Gestational Secondhand Smoke Exposure Could Affect Maternal n-Glycosylation and Cause Filaggrin Loss in Children with Dermatitis,_Atopic Galina Kuznecova, Ivans Sergejs Kuznecovs A122 Allergen specific immunotherapy in the treatment of Rhinitis,_Allergic,_Seasonal and asthma--a randomized prospective study from kashmir valley-north of India Roohi Rasool Wani, Shafia Alam Syed, Ghulam Hassan, Ayaz Gul, Saniya Nissar, Zaffar Amin Shah A123 Sleep_Wake_Disorderss in latin-AMERTKican children with asthma andor Rhinitis,_Allergic,_Seasonal and normal controls Marilyn Urrutia Pereira, Carmen Fernandez, Dirceu Sole, Herberto Jose Chong Neto, Veronica Acosta, Alfonso Mario Cepeda, Mirta Alvarez Castello, Claudia Almendarez, Jose Santos Lozano Saenz, Juan C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: The end_entity start_entity MERS-CoV is an emerging respiratory pathogen with a high mortality rate and no specific treatments available to date\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The Middle East Respiratory end_entity start_entity MERS-CoV is an emerging respiratory pathogen with a high mortality rate and no specific treatments available to date\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: The Middle East respiratory syndrome end_entity associated start_entity has been imported via travelers into multiple countries around the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The successful application of the effective distance model to predict end_entity importations, particularly when computationally intensive large-scale transmission models may not be immediately applicable could have been benefited from the particularly low transmissibility of the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"A literature review found more than 40 types of diseases that have presented with paving patterns in the lung-predominantly pulmonary alveolar proteinosis, viral start_entity, exogenous lipoid start_entity, bacterial start_entity, pulmonary alveolar microlithiasis, interstitial start_entity, end_entity, squalene aspiration start_entity, radiation pneumonitis, drug-induced pneumonitis, pulmonary leptospirosis, pulmonary hemorrhage, and pulmonary nocardiosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"RESULTS: To investigate the prevalence of PDCoV in this region and compare its activity to other enteric disease of swine caused by porcine epidemic end_entity virus PEDV, transmissible gastroenteritis start_entity TGEV, and porcine rotavirus group C Rota C, 390 fecal samples were collected from swine of various ages from 15 swine farms with reported end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity start_entity MERS-CoV has repeatedly caused outbreaks in the Arabian Peninsula\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity start_entity MERS-CoV has repeatedly caused outbreaks in the Arabian Peninsula\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Paramyxoviridae Infections\",\n",
       "                    \"value\": \"Seventeen percent of the start_entity positive samples were also positive for other respiratory viruses, such as Respiratory Syncytial Virus RSV, end_entity 2 and 3, and Rhinovirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This dichotomy is exemplified by CTSL CTSL, which helps Hendra virus and end_entity start_entity to invade cells, but is essential for survival in mice with mycoplasma start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity start_entity MERS is an emerging infectious disease in the Arabian Peninsula\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Coronavirus_Infections start_entity end_entity is an emerging infectious disease in the Arabian Peninsula\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity start_entity MERS is an emerging infectious disease in the Arabian Peninsula\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We examined the incubation period distribution of end_entity start_entity infection for cases in South Korea and in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bacterial Infections\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 start_entity in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired end_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chickenpox\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 end_entity complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of end_entity Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for end_entity Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Ectromelia\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation end_entity Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Epilepsy\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, end_entity Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Guillain-Barre Syndrome\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe end_entity occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HIV Seropositivity\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an end_entity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 end_entity infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 Tinea incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 end_entity 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Tinea\",\n",
       "                    \"value\": \"Matei Bal in 2015 Alena-Andreea Popa, Georgeta Ducu, Daniela Camburu, Alina Cozma, Manuela Podani, Roxana Dumitriu, Liana Gavriliu, erban Benea, Elisabeta Benea A59 Epidemiological aspects of HIV infection in Oltenia region Andreea Cristina Stoian, Florentina Dumitrescu, Augustin Cupa, Lucian Giubelan, Irina Niculescu, Loredana Ionescu, Livia Dragonu A60 HIV risk behaviors and prevalence among patients in methadone maintenance therapy MMT from Arena center, Bucharest Adrian Octavian Abagiu, Loredana Nicoleta Stoica, Catrinel Blaga, Archontis Koulosousas, Roxana tefnescu, Alice Atomoaie, Florentina Paraschiv, Florin Matache Duna A61 Therapeutic options in a case of severe psoriasis associated with both HIV infection and hepatitis C virus previously treated with fumaric acid esters Rodica Olteanu, Roxana Ion, Alexandra Zota, Isra Ennour Jaballah, Lara Mahfoud, Georgeta Preda, Magda Constantin A62 Prevalence of autoantibodies against gangliosides in asymptomatic HIV-infected patients Ilinca Nicolae, Corina Daniela Ene, Mdlina Irina Mitran, Vasile Benea, Mircea Tampa, Simona Roxana Georgescu A63 Subclinical inflammation in HIV-infected patients undergoing antiretroviral therapy a cross sectional study Iulia Cristina Bodoca, Cristina Murariu, Ctlin Tilican, Victoria Aram, Cristina Popescu, Daniela Munteanu, Mihaela Rdulescu, Violeta Molagic, Raluca Nstase, Alina Orfanu, Anca Leutean, Remulus Catan, Anca Negru, Adrian Streinu-Cercel, Sorin Aram A64 Severe Guillain-Barre_Syndrome occurring after chickenpox with favorable evolution Iuliana CAramngiu, Ovidiu Rosca, Monica Cialma, Radu Opreanu, Laureniu Vochita, Iosif Marincu A65 Echovirus 30 infection with pulmonary and cardiac complications case report Vlad Murrescu, Marilena Palaghi, Alina Cristina Negu, Cornel Camburu, Adrian Streinu-Cercel A66 Herpetic encephalitis with favorable evolution in an adult immunocompetent patient Irina Duan, Patricia Poptelecan, Bogdan Trinc, Sorina Mitrescu, Livius Tirnea, Iosif Marincu A67 Clinical-evolutional aspects in present-day measles Narcisa Nicolescu, Alexandru Crian, Voichia Lzureanu, Ruxandra Laza, Virgil Musta, Adelina-Raluca Marinescu, Andreea Brlad A68 Pneumococcal superinfection in children with influenza Victor Daniel Miron, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Daniela Piigoi, Oana Sndulescu, Monica Luminia Luminos A69 Chickenpox complicated with transverse myelitis - case presentation Monica Luminos, Endis Osman, Magdalena Vasile, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Sabina chiopu, Mdlina Meriescu A70 Clinical forms of enterovirus infections during the summer season of 2016 Monica Luminos, Anca Cristina Drgnescu, Constana-Angelica Vian, Anua Bilaco, Camelia Kouris, Endis Osman, Sabina Vintil, Magda Vasile, Mdlina Meriescu A71 Face off HIV and lymphoma case series presentation Liana Ctlina Gavriliu, Otilia Elisabeta Benea, Alina Angelescu, Ramona Zamfir, Daniela Camburu, Georgeta Ducu, Alina Cozma, Roxana Dumitriu, Manuela Podani, erban Benea, Mihaela Ionic A72 Coxsackie infection complicated by pancytopenia pediatric case report Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Lucia Tudor, Sabina Vintil A73 Viral respiratory infections in children in the season 20152016 Constana-Angelica Vian, Anca Cristina Drgnescu, Anua Bilaco, Magda Vasile, Mdlina Meriescu, Camelia Kouris, Cristina Negulescu, Endis Osman, Diana-Maria Slavu, Sabina Vintil, Daniela Piigoi, Monica Luminos A75 The severity of A H1N1 Influenza,_Human infection in the 20152016 season Cleo Rocule, Catrinel Olimpia Ciuca, Dalila Toma, Ctlin Apostolescu, Andrei Rogoz, Andrei Stangaciu, Viorica Mitescu, Doina Iovnescu, Cornel Camburu, Bogdana Manu A76 Acute respiratory distress syndrome in a child with measles Ana Vaduva-Enoiu, Ramona Georgiana Stanculete, Adelina Raluca Marinescu, Voichita Elena Lazureanu A77 Management challenges of right-sided infectious endocarditis in an HIV_Seropositivity patient case presentation Elena-Violeta Ni, Snziana Dumitru, Daniela-Ioana Munteanu, Anca Ruxandra Negru, Remulus Catan, Ioan Diaconu, Bogdana Manu, Ligia Ionescu, Liliana Ion, Ctlin Tilican, Victoria Aram A78 Bacterial_Infections in critical patients with severe A H1N1 influenza virus infection epidemiology, development, therapeutic decisions Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Apostolescu, Viorica Mitescu, Tudor Vladoiu, Dalila Toma, Catrinel Ciuca A79 Epidemiological aspects of severe acute respiratory infection cases SARI in the season 20152016, in the Clinical Hospital of Communicable_Diseases Constana, Romania Iulia Gabriela erban, Marioara Neacu A80Overexpression of IL6 trans signaling pathway in viral infections Simona Roxana Georgescu, Vasile Benea, Corina Daniela Ene, Mircea Tampa, Cristina Iulia Mitran, Ilinca Nicolae A81 Acute viral hepatitis B with persistent HBsAg description and evolution George Ciprian Pribac, Mirandolina Prisca, Fulvia Ursoiu, Carmen Neamtu, Bogdan Totolici, Coralia Cotoraci, Aurel Ardelean A82 Prevalence of cervical pathogens in a population of pregnant female patients monitored in a tertiary care hospital in Bucharest, Romania Simona Elena Albu, Mara Carsote, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Cristina Vasiliu A83 Prevalence of group B Streptococcus during pregnancy in a cohort of patients monitored in a tertiary care hospital in Bucharest, Romania Cristina Vasiliu, Mara Carsote, Corina Gorgoi, Beatrice Miclu, Diana Mihai, Oana Sndulescu, Simona Elena Albu A84 Infectious hematoma in the gastrocnemius muscle case presentation Ectromelia Blescun, Gelu Breaza A85 Reflections towards the underexplored HTLV Romanian viral circulation - adult Tcell leukemialymphomas, a case series Sabina Vintila, Felicia Mihai, Meilin Omer, Cornel Dragan, Daniela Pitigoi A86 A febrile confusion syndrome with acute onset case presentation Mirela Ciucu, Marius-Dan Ionescu, Cristina Roskanovic, Valentina Barbu, Iulian Diaconescu, Florentina Dumitrescu, Irina Niculescu A87 Retrobulbar optic neuritis in a HIV-positive patient - case report Mihaela Ionic, Ramona-Alexandra Zamfir, Alina Cozma, Otilia Elisabeta Benea A88 A rare presentation of Q fever case presentation Alexandra-Snziana Dumitru, Daniela-Ioana Munteanu, Violeta Ni, Cristina Popescu, Iulia Bodosca, Angelica Tenita, Viorica Ispas, Victoria Aram A89 end_entity incognita case presentation Vasile Benea, Simona Roxana Georgescu, Mircea Tampa, Diana Oana Leahu, Cristina Maria Safta, Mihaela Anca Benea A90 Incidence and risk factors associated with TORCH infections during pregnancy Oana Sndulescu, Octavian Munteanu, Roxana Bohlea, Livia Trac, Monica Crstoiu A91 Acute respiratory failure in critical patients with sepsis Doina Viorica Iovnescu, Cleo Nicoleta Rocule, Andrei Rogoz, Ctlin Gabriel Apostolescu, Viorica Daniela Mitescu, Tudor Gheorghe Vladoiu, Dalila Toma, Catrinel Ciuca A92 Cochleo-vestibular deficit secondary to Granulicatella elegans meningitis Mdlina Georgescu A93 Influenza,_Human 20152016 clinical, epidemiological and virological characteristics of cases admitted in three infectious diseases hospitals Daniela Piigoi, Alina Elena Ivanciuc, Mihaela Lazar, Teodora Ionescu, Carmen Maria Cherciu, Cristina ecu, Maria Elena Mihai, Maria Niescu, Rodica Bacruban, Delia Azamfire, Epilepsy Dumitrescu, Elena Ianosik, Daniela Leca, Elena Duca, Andra Teodor, Codrina Bejan, Emanoil Ceauu, Simin-Aysel Florescu, Corneliu Popescu, Graiela Trdei, Codrina Juganariu, Emilia Lupulescu A94 Severe complications of varicella requiring hospitalization in previously healthy children in Braov county Ligia Rodina, Maria Elena Cocuz A95 Clinical forms of Clostridium difficile colitis in children Gheorghi Jugulete, Adina Stncescu, Cristina Elena Popescu, Luminia Marin, Diana Zaharia, Cristina Dumitrescu, Endis Osman A96 Community-acquired start_entity demographic, clinical and etiological aspects Irina Niculescu, Augustin Cupa, Iulian Diaconescu, Florentina Dumitrescu, Livia Dragonu, Andreea Stoian, Lucian Giubelan, Cristina Roskanovic A97 Acute myocarditis in an adult patient with chickenpox - Case report Ramona-Alexandra Zamfir, Mihaela Ionica, Otilia-Elisabeta Benea A98 Caustic oropharyngeal wound with acute group F streptococcal superinfection mimicking diphtheria case report and differential diagnosis Maria-Cristina Srbu, AnaMaria Dobrot, Alina Cristina Negu, Roxana Duda, Rodica Bacruban, Daniela Piigoi, Cristiana Cerasella Dragomirescu, Daniela Tlpan, Olga Dorob, Adrian Streinu-Cercel, Anca Streinu-Cercel A99 Clostridium difficile infection in HIV-positive patients admitted in the National Institute for Communicable_Diseases Prof\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"HAdV-7 caused longer duration of fever, higher morbidity of tachypneadyspnea, pleural effusion, end_entity, hepatosplenomegaly, consciousness alteration, as well as higher rates of start_entity, mechanical ventilation and higher fatality rate 28\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Numerous viruses, including respiratory syncytial virus RSV and influenza A H1N1 virus, have been implicated in the progression of start_entity to end_entity; yet the incidence of progression is unknown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The S2 subunit of the spike glycoprotein from severe acute respiratory syndrome end_entity start_entity CoV contains internal domains called fusion peptides FP that play essential roles in virus entry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Netherton Syndrome\",\n",
       "                    \"value\": \"Equid herpesviruses EHV-1, 4, 2 and 5, equine rhinitis virus-A and -B ERBV, equine adenovirus-1 and 2, equine start_entity and equine influenza virus were systematically investigated in both end_entity and TW\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a highly contagious start_entity that causes severe end_entity and death, particularly in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The end_entity start_entity is the etiologic agent for the epidemic of the end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The Severe_Acute_Respiratory_Syndrome start_entity is the etiologic agent for the epidemic of the Severe Acute Respiratory end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Background: The Kingdom of Saudi Arabia has experienced a prolonged outbreak of end_entity MERS start_entity since 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Background: The Kingdom of Saudi Arabia has experienced a prolonged outbreak of Coronavirus_Infections end_entity start_entity since 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Background: The Kingdom of Saudi Arabia has experienced a prolonged outbreak of Middle East Respiratory end_entity MERS start_entity since 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Objectives: The aim of this survey was to assess the knowledge, attitudes, infection control practices and educational needs of HCWs in the Kingdom of Saudi Arabia to end_entity start_entity and other emerging infectious diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: end_entity MERS is caused by MERS start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Coronavirus_Infections end_entity is caused by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Middle East Respiratory end_entity MERS is caused by MERS start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Risk factors for end_entity start_entity end_entity-CoV infections in humans are incompletely understood\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"We developed an efficient and rapid method with high specificity for the end_entity start_entity MERS-CoV, based on one-pot reverse transcription loop-mediated isothermal amplification one-pot RT-LAMP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"We developed an efficient and rapid method with high specificity for the Middle East Respiratory end_entity start_entity MERS-CoV, based on one-pot reverse transcription loop-mediated isothermal amplification one-pot RT-LAMP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Measles\",\n",
       "                    \"value\": \"BACKGROUND: end_entity caused by a paramyxovirus, characterized by fever, malaise, cough, coryza conjunctivitis, a maculopapular rash is known to result in start_entity, encephalitis and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"BACKGROUND: Measles caused by a paramyxovirus, characterized by fever, malaise, end_entity, coryza conjunctivitis, a maculopapular rash is known to result in start_entity, encephalitis and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity, start_entity or rhinovirus were detected in three participants; all in the placebo group\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Frontotemporal Dementia\",\n",
       "                    \"value\": \"The study group included 97 children hospitalized due to start_entity at the Karol Jonscher Teaching Hospital in Pozna, in whom multiplex real-time PCR tests end_entity respiratory pathogens 33; fast-track diagnostics were used\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: end_entity start_entity MERS-CoV is an emerging viral pathogen that causes severe morbidity and mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Middle East Respiratory end_entity start_entity MERS-CoV is an emerging viral pathogen that causes severe morbidity and mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity, which is caused by a newly discovered start_entity CoV, has recently emerged\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by the 2009 pandemic influenza A H1N1 virus caused severe lower airway inflammation and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"ute respiratory distress syndrome end_entity is caused by infectious insults, such as start_entity from various pathogens or related to other noninfectious events\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"CONCLUSION: This study has revealed that the prevalences of end_entity, tuberculosis, start_entity and other respiratory tract infections are lower among female secondary school students than males and that the prevalence of malaria is higher in males than females\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Age of secondary school students is a significant vulnerability factor for malaria, end_entity, tuberculosis and start_entity, which were the important communicable diseases most prevalent among secondary school students in Kisumu County, Kenya\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The evolutionary origins of Middle East respiratory syndrome end_entity start_entity end_entity-CoV are unknown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Because HCoV-NL63 has a low pathogenicity and is able to grow easily in cell culture, this virus can be a powerful tool to study end_entity start_entity pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"BACKGROUND: There are two biotypes of feline start_entity FCoV: the self-limiting feline enteric start_entity FECV and the feline infectious peritonitis virus end_entityV, which causes feline infectious peritonitis end_entity, a fatal disease associated with cats living in multi-cat environments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Noonan Syndrome 2\",\n",
       "                    \"value\": \"We show that the cell-lethal phenotype of ADAR deletion in human lung adenocarcinoma A549 cells is rescued by CRISPRCas9 mutagenesis of the RNASEL gene or by expression of the RNase L antagonist, murine start_entity end_entity accessory protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Parameters studied included serum levels of end_entity start_entity end_entity-CoV IgG antibody, tests of lung function, and imaging data to evaluate changes in lung fibrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Type GCNT2 transmembrane serine proteases TTSPs facilitate the spread and replication of viruses such as influenza and human start_entityes, although it remains unclear whether TTSPs play a role in the progression of animal start_entity infections, such as that by porcine epidemic end_entity virus PEDV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Currently, more than 700 start_entity sequences containing s2m can be found in GenBank, including the severe acute respiratory syndrome end_entity start_entity genome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Emerging viruses such as HIV, dengue, influenza A, end_entity start_entity, Ebola, and other viruses pose a significant threat to human health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity emerged in later February 2003, as a new epidemic form of life-threatening infection caused by a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"This paper estimates the basic reproduction number of the end_entity start_entity CoV, using data on the spread of end_entity in South Korea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Mouse models allow direct assessment of host genetic factors responsible for susceptibility to end_entity start_entity SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Mouse models allow direct assessment of host genetic factors responsible for susceptibility to Severe Acute Respiratory end_entity start_entity SARS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a new infectious disease caused by a start_entity that leads to deleterious pulmonary pathological features\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Human cell lines were infected with Cytomegalovirus, Human Herpesvirus-6, Camelpox virus, end_entity start_entity or Yellow fever virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Four human start_entityes are currently known to infect the respiratory tract: human start_entityes OC43 HCoV-OC43 and 229E HCoV-229E, end_entity associated start_entity end_entity-CoV and the recently identified human start_entity NL63 HCoV-NL63\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"hematopoietic stem cell transplantation\",\n",
       "                    \"value\": \"After successful recovery from the PJ start_entity, he underwent end_entity HSCT from the HLA-matched healthy sister using a chemotherapeutic conditioning regimen consisting of treosulfan, fludarabine, and thiotepa\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS AND FINDINGS: The success rate of the MS-based analysis for detecting end_entity start_entity end_entity-CoV sequence variations was determined to be 95 with 75 copies of viral RNA per reaction, which is sufficient to directly analyze both clinical and cultured samples\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Significant sequence variation of Middle East respiratory syndrome start_entity end_entity CoV has never been detected since it was first reported in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our results reveal that under the assumed conditions, the end_entity start_entity was most possible to have spread via the combined long-range airborne and fomite routes, and that the fomite route played a non-negligible role in the transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Two herds of dromedary camels were longitudinally sampled with nasal and rectal swabs and serum, between September 2014 and May 2015, and the samples were tested for end_entity MERS start_entity RNA and antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Two herds of dromedary camels were longitudinally sampled with nasal and rectal swabs and serum, between September 2014 and May 2015, and the samples were tested for Coronavirus_Infections end_entity start_entity RNA and antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Two herds of dromedary camels were longitudinally sampled with nasal and rectal swabs and serum, between September 2014 and May 2015, and the samples were tested for Middle East Respiratory end_entity MERS start_entity RNA and antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Besides the biological interest behind the end_entity start_entity non-structural protein 1 nsp1, 117 amino acids, this study model has two structural features that motivated its use in this work: 1- its recombinant production is dependent on the temperature, with greater solubility when expressed at low temperatures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"BACKGROUND: Feline start_entity FCoV exists as two pathotypes, and FCoV spike gene mutations are considered responsible for the pathotypic switch in feline infectious peritonitis end_entity pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by enveloped coronaviruses start_entity initiates with viral spike S proteins binding to cellular receptors, and is followed by proteolytic cleavage of receptor-bound S proteins, which prompts S protein-mediated virus-cell membrane fusion\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV, an enteropathogenic start_entity CoV of porcine, causes lethal watery end_entity and severe dehydration in piglets and leads to severe economic losses in the swine industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Newcastle Disease\",\n",
       "                    \"value\": \"The assay could detect CDV, but did not show cross-detection of canine parvovirus-2 CPV-2, canine start_entity CCoV, canine parainfluenza virus CPIV, pseudorabies virus Polycythemia_Vera or end_entity virus NDV, demonstrating high specificity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Polycythemia Vera\",\n",
       "                    \"value\": \"The assay could detect CDV, but did not show cross-detection of canine parvovirus-2 CPV-2, canine start_entity CCoV, canine parainfluenza virus CPIV, pseudorabies virus end_entity or Newcastle_Disease virus NDV, demonstrating high specificity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-start_entity SARS-CoV and SARS-like start_entity are a potential threat to global health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The most significant metabolic disruptions were the comprehensive increase of phosphatidylinositol and lysophospha tidylinositol levels in recovered end_entity patients, which coincided with the effect of methylprednisolone administration investigated further in the steroid treated non-end_entity patients with severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Thailand reported the first Middle East respiratory syndrome end_entity case on 18 June 2015 day 4 in an Omani patient with heart condition who was diagnosed with start_entity on hospital admission on 15 June 2015 day 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Subsequent examination of sputum later on day 3 confirmed end_entity start_entity end_entity-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Subsequent examination of end_entity later on day 3 confirmed MERS start_entity MERS-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome end_entity start_entity, a newly identified pathogen, causes severe start_entity in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity is caused by a start_entity known as end_entity-CoV, which attacks the respiratory system\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": \"IM: FilmArray Respiratory Panel FilmArray end_entity test is an emerging diagnostic method in fast detecting multiple respiratory pathogens; the methodology and clinical significance of FilmArray end_entity in community-acquired start_entity CAP diagnosis were evaluated in this study\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Porcine Deltastart_entity PDCoV is a newly emerged enteropathogenic start_entity that causes end_entity and mortality in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The porcine epidemic end_entity virus PEDV is a start_entity CoV belonging to the -CoV genus and it causes high mortality in infected sucking piglets, resulting in substantial losses in the farming industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a fatal disease of cats, and a sequela of systemic feline start_entity FCoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"These include severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, Hendra virus, Nipah virus, influenza viruses, end_entity MERS start_entity, and ebola\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"These include severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, Hendra virus, Nipah virus, influenza viruses, Coronavirus_Infections end_entity start_entity, and ebola\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These include severe acute respiratory syndrome end_entity, Hendra virus, Nipah virus, influenza viruses, Coronavirus_Infections MERS start_entity, and ebola\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"These include severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, Hendra virus, Nipah virus, influenza viruses, Middle East Respiratory end_entity MERS start_entity, and ebola\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"While dromedary camels are the immediate animal source of end_entity start_entity end_entity-CoV infection, the evolutionary origin of end_entity-CoV remains obscure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Coronaviruses start_entity, such as human start_entity NL63 HCoV-NL63, severe acute respiratory syndrome CoV SARS-CoV, murine hepatitis virus MHV, porcine epidemic diarrhea virus PEDV, and end_entity Coronavirus MERS-CoV, encode papain-like PL proteases that inhibit Sendai virus- SeV- induced interferon IFN- production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Coronaviruses start_entity, such as human start_entity NL63 HCoV-NL63, severe acute respiratory syndrome CoV SARS-CoV, murine hepatitis virus MHV, porcine epidemic diarrhea virus PEDV, and Middle East Respiratory end_entity Coronavirus MERS-CoV, encode papain-like PL proteases that inhibit Sendai virus- SeV- induced interferon IFN- production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Coronaviruses start_entity, such as human start_entity NL63 HCoV-NL63, severe acute respiratory syndrome CoV SARS-CoV, murine hepatitis virus MHV, porcine epidemic end_entity virus PEDV, and Coronavirus_Infections Coronavirus MERS-CoV, encode papain-like PL proteases that inhibit Sendai virus- SeV- induced interferon IFN- production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"With the emergence of start_entityes such as Severe_Acute_Respiratory_Syndrome and end_entity, the need for fast genome characterisation is ever so important\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"With the emergence of start_entityes such as end_entity and MERS, the need for fast genome characterisation is ever so important\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"start_entitye, Staphylococcus aureus, Klebsiella start_entitye, Acinetobacter baumannii, Legionella pneumophila, Escherichia coli, Middle East respiratory syndrome end_entity start_entity, influenza A virus IAV and superinfection of IAV-incuced start_entity with S\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Porcine Epidemic end_entity Virus PEDV is a start_entity that infects the intestinal tract and causes diarrhea and vomiting in older pigs or extreme dehydration and death that could reach 100 mortality in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Porcine Epidemic Diarrhea Virus PEDV is a start_entity that infects the intestinal tract and causes end_entity and vomiting in older pigs or extreme dehydration and death that could reach 100 mortality in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"BACKGROUND: Porcine Epidemic Diarrhea Virus PEDV is a start_entity that infects the intestinal tract and causes diarrhea and end_entity in older pigs or extreme dehydration and death that could reach 100 mortality in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEA15V, an enteric start_entity, is the causative agent of porcine epidemic end_entity PEA15 that damages intestinal epithelial cells and results in severe end_entity and dehydration in neonatal suckling pigs with up to 100 mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"We utilized one-step multiplex reverse transcription-PCR RT-PCR and Luminex xMAP technology to develop a respiratory multiplex liquid-chip assay rMLA for simultaneous detection of 6 common respiratory viruses, including influenza virus type A FluA and type B FluB, para-influenza virus type 3 PIV-3, respiratory syncytial virus RSV, human metapneumovirus MPV and a threatening virus to China, end_entity start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"We utilized one-step multiplex reverse transcription-PCR RT-PCR and Luminex xMAP technology to develop a respiratory multiplex liquid-chip assay rMLA for simultaneous detection of 6 common respiratory viruses, including influenza virus type A FluA and type B FluB, para-influenza virus type 3 PIV-3, respiratory syncytial virus RSV, human metapneumovirus MPV and a threatening virus to China, Middle East Respiratory end_entity start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"CONCLUSIONS: This study reported two beta start_entity closely related to end_entity that were obtained from two bats belonging to two commonly recorded species in Italy P\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \", end_entity A virus, can lead to bacterial dissemination to the lower respiratory tract, which in turn can result in severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Coronaviruses are closely monitored in the context of emerging diseases and, as illustrated with Severe_Acute_Respiratory_Syndrome start_entity SARS-CoV and end_entity-start_entity MERS-CoV, are known to cross the species barrier and eventually to move from wildlife to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Coronaviruses are closely monitored in the context of emerging diseases and, as illustrated with end_entity start_entity SARS-CoV and Coronavirus_Infections-start_entity MERS-CoV, are known to cross the species barrier and eventually to move from wildlife to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Coronaviruses are closely monitored in the context of emerging diseases and, as illustrated with Severe Acute Respiratory end_entity start_entity SARS-CoV and Middle East Respiratory end_entity-start_entity MERS-CoV, are known to cross the species barrier and eventually to move from wildlife to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"A new therapeutic toolbox being developed in response to end_entity is also teaching us more about how start_entity cause disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhage\",\n",
       "                    \"value\": \"end_entity, ventilator-associated start_entity VAP and barotrauma occurred in 45\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Middle East respiratory syndrome end_entity is caused by a start_entity end_entityCoV and is characterized by hypoxemic respiratory failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Carcinoma, Hepatocellular\",\n",
       "                    \"value\": \"The aim of this study was to investigate the incidence and risk factors of postoperative start_entity POP within 1 year after cancer surgery in patients with the five most common cancers gastric, colorectal, lung, breast cancer, and hepatocellular carcinoma end_entity in South Korea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: It had been more than 5 years since the first case of end_entity start_entity infection MERS-CoV was recorded, but no specific treatment has been investigated in randomized clinical trials\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: It had been more than 5 years since the first case of Middle East Respiratory end_entity start_entity infection MERS-CoV was recorded, but no specific treatment has been investigated in randomized clinical trials\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Symptoms are similar to those of other respiratory viral infections, ranging from mild end_entity, rhinorrhea, and fever to more severe bronchiolitis and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV is a novel human start_entity that emerged in 2012, causing severe start_entity and acute respiratory distress syndrome end_entity, with a case fatality rate of 36\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"RESULTS: The start_entity group was represented mainly by RV-C, BoV-1 and RSV-B and the end_entity group by Bacteriophage EJ-1 and TTMV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Recently, we developed a monoclonal antibody-based rapid nucleocapsid protein detection assay for diagnosis of end_entity start_entity end_entity-CoV in humans and dromedary camels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"To solve this problem, we developed and validated a 12-plex PCR coupled with matrix-assisted laser desorption ionization-time of flight mass spectrometry MALDI-TOF end_entity method bacterial pathogen-mass spectrometry, BP-end_entity that can be used to simultaneously screen for 11 key bacterial pathogens related to start_entity and meningitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In particular, respiratory infections are problematic; in early 2003, World Health Organization issued a worldwide alert for a previously unrecognized illness that was subsequently found to be caused by a start_entity severe acute respiratory syndrome end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \", as well as canine start_entity end_entity and parvovirus CPV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using a similar approach, the work presented here indicates that trimeric interactions also occur between the fusion protein TMDs of Ebola virus, influenza virus, severe acute respiratory syndrome start_entity end_entity CoV, and rabies virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with a glia- and neuronotropic start_entity demonstrates that astrocytes mount a delayed but more robust response to infection than microglia, despite their lower basal mRNA levels of IFN--inducing components\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"OBJECTIVES: The rates of asymptomatic infection with end_entity MERS start_entity vary\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"OBJECTIVES: The rates of asymptomatic infection with Coronavirus_Infections end_entity start_entity vary\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"OBJECTIVES: The rates of asymptomatic infection with Middle East Respiratory end_entity MERS start_entity vary\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"value\": \"METHODS: We selected four recent infectious disease emergencies: outbreaks of avian influenza A-H1N1 virus 2009 and H7N9 virus 2013, Middle East respiratory syndrome start_entity MERS-CoV 2013, and end_entity EVD 2014 to 2016\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The highest number of malaria 135, end_entity 266 and start_entity 371 cases occurred during the rainy season\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"01 correlation was observed between increased temperature and the incidence of malaria, enteric fever and end_entity, and a negative correlation with encephalitis, meningitis and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSIONS: Both end_entity start_entity and H7N9 viruses presented a global epidemic threat, but the social and economic impacts of H7N9 were not as serious as in the case of end_entity because the response to H7N9 was more effective\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Epidermodysplasia Verruciformis\",\n",
       "                    \"value\": \"OBJECTIVES: To determine if the pathogens adenovirus ADV, start_entity CoV, encephalomyocarditis virus EMCV, enterovirus end_entity, influenza A-D IAV, IBV, ICV, and IDV, porcine circovirus 2 PCV2, and porcine rotaviruses A and C RVA and RVC, are aerosolized at the animal-interface, and if humans working in these environments are carrying these viruses in their nasal airways\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"value\": \"The comparison with SP start_entity identified clinical, laboratory, and radiographic features that may suggest MP or end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These viruses are related to important human pathogens, including severe acute respiratory syndrome end_entity start_entity, and they share some common features; however, the mechanism that they use to produce sgRNA molecules differs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The trimeric end_entity start_entity end_entity-CoV surface spike S glycoprotein consisting of three S1-S2 heterodimers binds the cellular receptor angiotensin-converting enzyme 2 ACE2 and mediates fusion of the viral and cellular membranes through a pre- to postfusion conformation transition\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Porcine epidemic end_entity virus PEDV is emerging as a pathogenic start_entity that causes a huge economic burden to the swine industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV is a start_entity that causes severe end_entity in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"ute respiratory distress syndrome end_entity is immune-driven pathologies that are observed in severe cases of severe acute respiratory syndrome start_entity Severe_Acute_Respiratory_Syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult is immune-driven pathologies that are observed in severe cases of severe acute respiratory syndrome start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"This sample contained an adenovirus ADV, influenza virus A end_entity A, human parainfluenza virus 3 PIV3, human start_entity OC43 OC43, and human metapneumovirus HMPV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"The procedures and protocols for the pre-treatment of end_entity specimens, mainly used for the diagnosis of start_entity, are complex, labor intensive, and require skilled specialists working in a biosafety containment laboratory because of sample infectivity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Finally, we demonstrated that the PSMD1 proteins from various start_entity family members such as TGEV, IBV, CCoV, Severe_Acute_Respiratory_Syndrome and end_entity could also induce Vero-E6 cells apoptosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Finally, we demonstrated that the PSMD1 proteins from various start_entity family members such as TGEV, IBV, CCoV, end_entity and MERS could also induce Vero-E6 cells apoptosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"More than two thirds 71 of the participants were aware that end_entity is caused by the start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This risk has been recently reinforced by human epidemics in Singapore of end_entity start_entity, 2009 pandemic H1N1 influenza A virus, and enterovirus 71\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The full-length genome sequence of a novel swine acute end_entity syndrome start_entity SADS-CoV, CHFJWT2018, was determined, which was genetically most closely related to CNGDWT2017, recently discovered in Fujian, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Previous findings of end_entity start_entity MERS-CoV-related viruses in bats, and the ability of Tylonycteris-BatCoV HKU4 spike protein to utilize MERS-CoV receptor, human DPP4 hDPP4, suggest a bat ancestral origin of MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Previous findings of Middle East Respiratory end_entity start_entity MERS-CoV-related viruses in bats, and the ability of Tylonycteris-BatCoV HKU4 spike protein to utilize MERS-CoV receptor, human DPP4 hDPP4, suggest a bat ancestral origin of MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Clinical manifestations vary significantly depending on the type of virus and the type and degree of immunosuppression, ranging from asymptomatic or mild disease to rapidly progressive fatal start_entity end_entity in this population are characterized by a high rate of progression from upper to lower respiratory tract infection and prolonged viral shedding\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"However, this globalization has brought with it the rise of various pathogenic viral agents, such as Middle East respiratory syndrome start_entity MERS-CoV, severe acute respiratory syndrome start_entity SARS-CoV, Zika virus, and end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"These include start_entity that cause severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, Middle East respiratory syndrome end_entity, porcine epidemic diarrhea PEA15 and severe acute diarrhea syndrome SADS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These include start_entity that cause severe acute respiratory syndrome end_entity, Middle East respiratory syndrome MERS, porcine epidemic diarrhea PEA15 and severe acute diarrhea syndrome SADS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"These include start_entity that cause severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome, Middle East respiratory syndrome MERS, porcine epidemic end_entity PEA15 and severe acute end_entity syndrome SADS\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity start_entity end_entity-CoV is an infectious virus that was first reported in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Enteropathogenic porcine epidemic end_entity virus PEDV and porcine deltastart_entity PDCoV, members of the start_entity family, account for the majority of lethal watery end_entity in neonatal pigs in the past decade\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"PHEV produces end_entity and wasting disease VWD andor encephalomyelitis, being the only known neurotropic start_entity affecting pigs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"end_entity severity index PSI is an important scoring system that can assess the severity of community acquired start_entity and determine admission status\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"end_entity severity index score is an important factor for assessing the prognosis of patients with community-acquired start_entity, regardless of respiratory virus detection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Before the end_entity epidemic, bats were not known to be hosts for start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity start_entity end_entity-CoV, an infectious start_entity first reported in 2012, has a mortality rate greater than 35\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Epidermodysplasia Verruciformis\",\n",
       "                    \"value\": \"Specimens were examined at our collaborating institutions with a panel of molecular assays for viral pathogens including influenza A IAV, IBV, ICV, and IDV, human adenovirus AdV, human enterovirus end_entity, human start_entity CoV, respiratory syncytial virus subtype A RSV-A or RSV-B, and parainfluenza virus PIV types 14\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"BACKGROUND: Porcine deltastart_entity PDCoV is a start_entity that can cause end_entity in nursing piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome start_entity end_entity-CoV was identified in 2012 during the first Middle East respiratory syndrome end_entity outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis start_entity TGEV is an enteropathogenic start_entity that causes end_entity in pigs and is associated with high morbidity and mortality in sucking piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a newly detected porcine start_entity causing serious vomiting and end_entity in piglets, especially newborn piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a newly detected porcine start_entity causing serious end_entity and diarrhea in piglets, especially newborn piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity severe acute respiratory syndrome outbreak was caused by a start_entity CoV named the end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is an emerging respiratory disease caused by the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"For a random sample of 127 calves, serum zinc concentrations before and after treatment and a fecal antigen ELISA at end_entity start and resolution for Escherichia coli K99, rotavirus, start_entity, and Cryptosporidium parvum were performed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity can primarily cause severe start_entity, but it can also present in conjunction with or be followed by a secondary bacterial infection, most commonly by Staphylococcus aureus and Streptococcus start_entitye\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"end_entitys presenting concurrently with bacterial start_entity are now known to occur with a frequency of 3050 in both adult and pediatric populations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"In the ICU, particularly during the winter season, influenza should be suspected not only in patients with typical symptoms and epidemiology, but also in patients with severe start_entity, end_entity, sepsis with or without bacterial co-infection, as well as in patients with encephalitis, myocarditis, and rhabdomyolysis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV causes an acute and severe lower respiratory illness as well as vomiting, end_entity, and renal failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV causes an acute and severe lower respiratory illness as well as end_entity, diarrhea, and renal failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Coronaviruses start_entity have a penchant for sudden emergence, as evidenced by severe acute respiratory syndrome start_entity SARS-CoV, Middle East respiratory syndrome CoV MERS-CoV and most recently, swine acute end_entity syndrome start_entity SADS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Bovine start_entity BCoV is associated with severe end_entity in calves, winter dysentery in adult cattle, and respiratory diseases in cattle of all ages\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is an enteric start_entity causing high morbidity and mortality in porcine herds worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a start_entity that causes acute end_entity in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Acyclic fleximers have previously demonstrated antiviral activity against numerous viruses including end_entity start_entity MERS-CoV, Ebola virus EBOV, and, most recently, flaviviruses such as Dengue DENV and Yellow_Fever Virus YFV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"Acyclic fleximers have previously demonstrated antiviral activity against numerous viruses including Coronavirus_Infections start_entity MERS-CoV, Ebola virus EBOV, and, most recently, flaviviruses such as end_entity DENV and Yellow_Fever Virus YFV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Acyclic fleximers have previously demonstrated antiviral activity against numerous viruses including Coronavirus_Infections start_entity MERS-CoV, Ebola virus EBOV, and, most recently, flaviviruses such as Dengue DENV and Yellow end_entity Virus YFV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Acyclic fleximers have previously demonstrated antiviral activity against numerous viruses including Middle East Respiratory end_entity start_entity MERS-CoV, Ebola virus EBOV, and, most recently, flaviviruses such as Dengue DENV and Yellow_Fever Virus YFV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Yellow Fever\",\n",
       "                    \"value\": \"Acyclic fleximers have previously demonstrated antiviral activity against numerous viruses including Coronavirus_Infections start_entity MERS-CoV, Ebola virus EBOV, and, most recently, flaviviruses such as Dengue DENV and end_entity Virus YFV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSS\",\n",
       "                    \"value\": \"METHODS: The HIS hospital information system modified influenza surveillance system Short_Stature,_Idiopathic,_X-Linked and a newly built start_entity surveillance system end_entity were used to monitor the influenza viruses in Changsha City, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Short Stature, Idiopathic, X-Linked\",\n",
       "                    \"value\": \"METHODS: The HIS hospital information system modified influenza surveillance system end_entity and a newly built start_entity surveillance system PSS were used to monitor the influenza viruses in Changsha City, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSS\",\n",
       "                    \"value\": \"From March, 2009 to September, 2016, there were 5,491,560 inpatient cases monitored by the end_entity system, among which 362,743 were start_entity cases, with a proportion of 6\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coproporphyria, Hereditary\",\n",
       "                    \"value\": \"The critical importance of using PPE properly is highlighted by 2 potentially fatal viral infections, severe acute respiratory syndromeassociated start_entity and Ebola virus, where end_entity became infected while caring for patients due to errors in the use of PPE\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a newly emerged swine enteropathogenic start_entity affecting pigs of all ages and causing end_entity problems\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"5 C with end_entity or sore throat; or a diagnosis of start_entity during May 1June 31, 2018\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV, is an economically important enteric start_entity, with over a 90 mortality rate in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lassa Fever\",\n",
       "                    \"value\": \"While overexpression of IFI30 inhibited the entry mediated by ERVW-1s of Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome-CoV, Ebola virus EBOV and end_entity virus LASV, depletion of IFI30 enhanced the entry mediated by these viral ERVW-1s\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"While overexpression of IFI30 inhibited the entry mediated by ERVW-1s of end_entity start_entity end_entity-CoV, Ebola virus EBOV and Lassa_Fever virus LASV, depletion of IFI30 enhanced the entry mediated by these viral ERVW-1s\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Idiopathic Pulmonary Fibrosis\",\n",
       "                    \"value\": \"Idiopathic pulmonary fibrosis end_entity is a chronic, progressive, fibrosing interstitial lung disease that commonly affects older adults and is associated with the histopathological andor radiological patterns of usual interstitial start_entity UIP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a fatal disease that poses several challenges for veterinarians: clinical signs and laboratory changes are non-specific, and there are two pathotypes of the etiologic agent feline start_entity FCoV, sometimes referred to as feline enteric start_entity FECV and feline infectious peritonitis virus end_entityV that vary fundamentally in their virulence, but are indistinguishable by a number of diagnostic methods\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"In this study, we identified a newly emerged swine acute end_entity syndrome start_entity SADS-CoV in end_entityl samples of piglets from Fujian province in Southern China, and the prevalence rate of SADS-CoV was 10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"CONCLUSIONS: The findings of this study indicated that variant PEDV, PDCoV, and SADS-CoV were leading etiologic agents of porcine end_entity, and either mono-infections or co-infections of pathogenic enteric start_entity were common in pigs in Southern China during 20122018\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a fatal immune-mediated disease of cats, induced by feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"We previously developed potent fully human monoclonal antibodies and inhibitory peptides against end_entity Coronavirus MERS-CoV, a start_entity that causes severe acute respiratory illness with high mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"We previously developed potent fully human monoclonal antibodies and inhibitory peptides against Middle East Respiratory end_entity Coronavirus MERS-CoV, a start_entity that causes severe acute respiratory illness with high mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is an emerging swine start_entity that causes severe end_entity, resulting in high mortality in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"So far, dromedary camels are the only known animal reservoir for Middle East respiratory syndrome end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV has been confirmed to be the etiological agent\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV is a porcine intestinal start_entity that causes fatal severe watery end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity start_entity end_entity-CoV causes a severe respiratory disease in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity, caused by virulent feline start_entity, is the leading infectious cause of death in cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is an acute, high-mortality-rate, severe infectious disease caused by an emerging end_entity start_entity end_entity-CoV that causes severe respiratory diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The number of start_entity species with complete genomes available has increased from 9 in 2003 to 25 in 2007, of which six, including start_entity HKU1, bat end_entity start_entity, group 1 bat start_entity HKU2, groups 2c and 2d start_entityes, were sequenced by our laboratory\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using a comprehensive set of discovery and optimization tools, antibodies were produced with the ability to neutralize end_entity start_entity end_entity in Vero E6 cells and in animal models\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It is presumed that replication and transcription of the 30-kb severe acute respiratory syndrome end_entity start_entity end_entity-CoV RNA genome are catalyzed by an RdRp domain in the C-terminal part of nonstructural protein 12 nsp12, one of 16 replicase subunits\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It allows us to show that the end_entity-CoV is most closely related to a start_entity from the palm civet not from a bird as initially suspected, and the newly discovered human start_entity HCoV-HKU1 is more closely related to end_entity than to any other known member of group 2 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity encodes non-structural protein 13 nsP13, a nucleic acid helicaseNTPase belonging to superfamily 1 helicase, which efficiently unwinds both partial-duplex RNA and DNA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The new viruses cause respiratory symptoms like the common cold, end_entity, bronchitis, bronchiolitis, exacerbations of asthma and chronic obstructive pulmonary disease and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The diagnosis of viral causes of many infectious diseases is difficult due to the inherent sequence diversity of viruses as well as the ongoing emergence of novel viral pathogens, such as end_entity start_entity and 2009 pandemic H1N1 influenza virus, that are not detectable by traditional methods\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In a screen based on a yeast three-hybrid system using the 5-untranslated region 5-UTR of end_entity start_entity end_entity-CoV RNA as bait against a human cDNA library derived from HeLa cells, we found a positive candidate cellular protein, zinc finger CCHC-type and RNA-binding motif 1 ZCRB1, to be able to interact with this region of the end_entity-CoV genome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Craig Venter Institute in 2010 and has been successfully performing gene calling in start_entity, influenza, rhinovirus and rotavirus for projects at the Genome Sequencing Center for end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"KD\",\n",
       "                    \"value\": \"METHODS: RT-PCR assays were carried out to screen for the presence of respiratory syncytial virus A and B, adenovirus, rhinovirus, parainfluenza viruses 1 to 4, influenza virus A and B, metapneumovirus, bocavirus, start_entity OC43229E and NL63, and enterovirus in nasopharyngeal secretions of 55 end_entity patients and 78 control subjects\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chondrosarcoma, Extraskeletal Myxoid\",\n",
       "                    \"value\": \"newly identified betastart_entity, human start_entity end_entity HCoV-end_entity, has been isolated from several patients with respiratory and renal disease in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The recent emergence of a novel human start_entity HCoV-EMC in the Middle East raised considerable concerns, as it is associated with severe acute start_entity, renal failure, and fatal outcome and thus resembles the clinical presentation of severe acute respiratory syndrome end_entity observed in 2002 and 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our previous studies have shown that the receptor-binding domain RBD in the spike protein of severe acute respiratory syndrome end_entity-associated start_entity end_entity-CoV is a key target for the development of end_entity vaccines\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Although the epidemic was eventually controlled through the implementation of strict quarantine measures, there continues a need to investigate the end_entity start_entity end_entity-CoV and develop interventions should it re-emerge\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"novel human start_entity HCoV-EMC was recently identified in the Middle East as the causative agent of a severe acute respiratory syndrome end_entity resembling the illness caused by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"The end_entity Etiology Research for Child Health PERCH project is the largest multicountry etiology study of childhood start_entity since the Board on Science and Technology in International Development studies of the 1980s\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, we use transfection of plasmid constructs encoding full-length versions of the three transmembrane-containing nonstructural proteins nsps of the severe acute respiratory syndrome end_entity start_entity to examine the ability of each to induce double-membrane vesicles in tissue culture\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with nonvaccine pneumococcal serotypes continues to be a significant cause of start_entity in children in the UK\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome end_entity is proposed to be a zoonotic disease; however, the reservoir and mechanism for transmission of the causative agent, the end_entity start_entity, are unknown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"itic feline start_entity FCoV RNA was examined in 854 cats with suspected feline infectious peritonitis end_entity by RT-PCR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Short Stature, Idiopathic, X-Linked\",\n",
       "                    \"value\": \"Multiplex reverse-transcriptase polymerase chain reaction identified viral pathogens in nasalthroat swabs from 556 episodes of moderate-to-severe ILI, defined as ILI with start_entity, hospitalization, or maximum daily influenza symptom severity score end_entity 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Coronaviruses start_entity such as severe acute respiratory syndrome end_entity CoV and Middle East respiratory syndrome CoV are important human pathogens; however, macropinocytosis during CoV infection has not been investigated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We demonstrate that the start_entity end_entity CoV and murine hepatitis virus MHV induce macropinocytosis, which occurs late during infection, is continuous, and is not associated with virus entry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Nearly a decade following the end_entity epidemic, a new start_entity causing severe viral start_entity has emerged, i\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": \"NEXT STEPS: Since the publication of the Supplement, six new FSs yellow fever viruses-including vaccine breakthrough infections, miscellaneous arboviruses, XMRV, human parvovirusesbocaviruses other than EVA1C, and most recently the Middle East respiratory syndrome start_entity, MERS-CoV were added and 14 existing FSs updated Anaplasma, Babesia, Bartonella, Erhlichia, chronic wasting disease-CWD, human prions other than vCJD, vCJD, Coxiella burnetii-the agent of Q fever, dengue viruses, HAV, HEV, end_entity-JE complex, tick-borne encephalitis viruses-TBEV, and human parvovirus EVA1C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We identified 32 studies of end_entity start_entity infection and severe influenza\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome start_entity and Middle East respiratory syndrome end_entity start_entity cause severe infection of the lower respiratory tract, with 10 and 35 overall mortality rates, respectively; however, 50 mortality rates are seen in the aged and immunosuppressed populations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity and Middle East respiratory syndrome MERS start_entity cause severe infection of the lower respiratory tract, with 10 and 35 overall mortality rates, respectively; however, 50 mortality rates are seen in the aged and immunosuppressed populations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"The purpose of this study was to investigate the genetic features of canine start_entity end_entity strains detected in Korea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome end_entity is a new human disease caused by a start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Two different swine enteric start_entityes porcine epidemic end_entity virus and Delta start_entity have been isolated from the affected swine population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Unregulated complement activation is likely to play a crucial role in the pathogenesis of acute lung injury ALI induced by highly pathogenic virus including influenza A viruses H5N1, H7N9, and severe acute respiratory syndrome end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Robinow syndrome, autosomal recessive\",\n",
       "                    \"value\": \"32-nucleotide nt RNA motif located at the 3 end of the transmissible gastroenteritis start_entity TGEV genome was found to specifically interact with the host proteins EPRS EPRS and RARS end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In this study, the full-length nucleocapsid protein NP gene of end_entity start_entity end_entity-CoV was cloned and expressed in Escherichia coli\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity virus was the most frequently isolated virus, followed by enterovirusrhinovirus, start_entity, bocavirus, metapneumovirus, parainfluenza virus types 1, 2, 3, and 4, and respiratory syncytial virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Since the Middle East respiratory syndrome end_entity outbreak in the Republic of Korea hereafter Korea began on May 11, 2015, a total of 186 persons have been infected by the end_entity start_entity, 38 of whom have died\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Radiologic findings of Middle East respiratory syndrome end_entity, a start_entity infection, have been rarely reported\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity, an emerging infectious disease caused by end_entity start_entity end_entity-CoV, has garnered worldwide attention as a consequence of its continuous spread and pandemic potential, making the development of effective vaccines a high priority\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: During the 2015 outbreak of end_entity start_entity MERS-CoV, six different commercial MERS-CoV RNA detection kits based on real-time reverse-transcription polymerase chain reaction rRT-PCR were available in Korea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: During the 2015 outbreak of Middle East Respiratory end_entity start_entity MERS-CoV, six different commercial MERS-CoV RNA detection kits based on real-time reverse-transcription polymerase chain reaction rRT-PCR were available in Korea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"BACKGROUND: Real-time reverse transcription PCR rRT-PCR of end_entity samples is commonly used to diagnose Middle East respiratory syndrome start_entity MERS-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Genome sequencing of end_entity start_entity from 6 cases demonstrated continued circulation of the recently described recombinant virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Likewise, its potential value as a marker of severity, which is well established in patients with start_entity, remains unproven in chronic obstructive pulmonary disease end_entity exacerbations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"OBJECTIVE: To describe radiologic findings of adenovirus start_entity and to understand clinico-radiological features associated with progression to acute respiratory distress syndrome end_entity in patients with adenovirus start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"CONCLUSION: Adenovirus start_entity demonstrates high rates of end_entity and mortality, regardless of patient age and premorbid conditions, in the tertiary care setting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Nail-Patella Syndrome\",\n",
       "                    \"value\": \"For bovine start_entity BCV, agreement with TTW was moderate for Netherton_Syndrome and end_entity, and good for PARP9\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Netherton Syndrome\",\n",
       "                    \"value\": \"For bovine start_entity BCV, agreement with TTW was moderate for end_entity and Nail-Patella_Syndrome, and good for PARP9\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Since the emergence of end_entity Coronavirus SARS-CoV and Middle East Respiratory Syndrom Coronavirus MERS-CoV it has become increasingly clear that bats are important reservoirs of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Since the emergence of Severe Acute Respiratory end_entity Coronavirus SARS-CoV and Middle East Respiratory Syndrom Coronavirus MERS-CoV it has become increasingly clear that bats are important reservoirs of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"METHODS: We evaluated four patients with laboratory-confirmed end_entity start_entity CoV infections who showed neurological complications during end_entity treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Molecular detection of Middle East respiratory syndrome start_entity end_entity-CoV using real-time reverse transcription rRT-PCR assays is the method of choice for diagnosis of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: Personal protective equipment PPE and strict infection control techniques are the primary methods by which healthcare workers HCW can avoid exposure during the treatment of patients with highly pathogenic infections such as Hemorrhagic_Fever,_Ebola EVD or the end_entity start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"value\": \"BACKGROUND: Personal protective equipment PPE and strict infection control techniques are the primary methods by which healthcare workers HCW can avoid exposure during the treatment of patients with highly pathogenic infections such as end_entity EVD or the Coronavirus_Infections start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Personal protective equipment PPE and strict infection control techniques are the primary methods by which healthcare workers HCW can avoid exposure during the treatment of patients with highly pathogenic infections such as Hemorrhagic_Fever,_Ebola EVD or the Middle East Respiratory end_entity start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"BACKGROUND: Personal protective equipment PPE and strict infection control techniques are the primary methods by which healthcare workers HCW can avoid exposure during the treatment of patients with highly pathogenic infections such as Ebola end_entity EVD or the Coronavirus_Infections start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Reverse-transcription polymerase chain reaction tests for bovine viral end_entity virus, rotavirus and start_entity were all negative\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"METHODS: Enrolled children fulfilled the following criteria: 1 PICU admission; 2 age of 1 month to 16 years; 3 diagnosis of infectious start_entity and respiratory virus infection; and 4 development of severe end_entity within 72 h after PICU admission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Pathogens such as the end_entity start_entity MERS-CoV and the Zika virus represent either new viral entities or viruses emergent in new geographic locales and characterized by novel complications\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Pathogens such as the Middle East Respiratory end_entity start_entity MERS-CoV and the Zika virus represent either new viral entities or viruses emergent in new geographic locales and characterized by novel complications\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Stickler syndrome, type 1\",\n",
       "                    \"value\": \"start_entitye and all-cause start_entity, and acute otitis media end_entity between January 2013-April 2014 were retrospectively evaluated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Stickler syndrome, type 1\",\n",
       "                    \"value\": \"Data of 130 children with pneumococcal meningitis n 10, start_entity n 53, and end_entity n 67 were analyzed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Stickler syndrome, type 1\",\n",
       "                    \"value\": \"011 were significantly higher in start_entity patients aged 36 months than those aged 36 months; however, direct cost of end_entity were significantly higher in the patients aged 36 months p 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"To investigate the utility of cerebrospinal fluid CSF anti-feline start_entity FCoV antibody test for diagnosis of feline infectious peritonitis end_entity, the antibody titers were tested in CSF and sera from 271 end_entity-suspected neurological cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity start_entity MERS-CoV was first isolated from a patient with severe start_entity in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity start_entity MERS-CoV was first isolated from a patient with severe start_entity in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"They have been approved for treatment of herpes simplex virus-1, HIV, HBV, HCV, and influenza, and new drugs are being developed for the treatment of RSV, Ebola, start_entity end_entity, and other emerging viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Severe start_entity significantly impairs pulmonary function and makes long radiological sequelae in end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a contagious start_entity infecting pigs that leads to significant economic losses in the swine industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cough\",\n",
       "                    \"value\": \"end_entity, fever, radiological evidence of start_entity, and shortness of breath were identified as significant risk factors for a diagnosis of MER-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND AND OBJECTIVES: Middle Eastern respiratory syndrome caused by start_entity end_entity CoV has been a major public health challenge since it was first described in 2012 in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Four cases featured symptomatic disease, including start_entity and respiratory failure, while 2 were asymptomatic close contacts of the end_entity CoV patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"METHODS: We retrospectively analyzed data of children younger than 18 years diagnosed with start_entity at 117 end_entity Departments in Korea between 2007 and 2014\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"This study aimed to describe real-life microbiological testing of adults hospitalised with community-acquired end_entity CAP and to assess concordance with the 2007 Communicable_Diseases Society of America IDSAAmerican Thoracic Society start_entity and 2011 European Respiratory Society ERS CAP guidelines\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"This study aimed to describe real-life microbiological testing of adults hospitalised with community-acquired start_entity CAP and to assess concordance with the 2007 end_entity Society of America IDSAAmerican Thoracic Society ATS and 2011 European Respiratory Society ERS CAP guidelines\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Myotonic Disorders\",\n",
       "                    \"value\": \"BACKGROUND: We aimed to compare the therapeutic efficacy of prolonged macrolide end_entity, corticosteroids GAL3ST1, doxycycline DXC, and levofloxacin LFX against macrolide-unresponsive Mycoplasma start_entitye MP start_entity in children and to evaluate the safety of the secondary treatment agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Myotonic Disorders\",\n",
       "                    \"value\": \"CONCLUSION: The change to secondary treatment did not show better efficacy compared to end_entity in children with macrolide-unresponsive MP start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Later, the patient was readmitted with a suspected community-acquired start_entity and the end_entity smear was positive for acid-fast bacilli\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity, respiratory syncytial virus RSV, rhinovirus RV, start_entity 229E, NL63, OC43, HKU1, parainfluenzavirus PIV 14, metapneumovirus MPV, adenovirus AdV, bocavirus BoV, enterovirus, parechovirus, and M\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Middle East respiratory syndrome end_entity is caused by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: In 2015, an outbreak of end_entity start_entity MERS-CoV infection occurred in South Korea involving 186 patients, 39 of whom were healthcare workers HCWs exposed to the infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: In 2015, an outbreak of Middle East Respiratory end_entity start_entity MERS-CoV infection occurred in South Korea involving 186 patients, 39 of whom were healthcare workers HCWs exposed to the infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Mediastinal Emphysema\",\n",
       "                    \"value\": \"LEARNING POINTS: end_entity and subcutaneous emphysema are rare complications of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We evaluated the neutralizing activity in serum from three patients 1 year after recovery from Middle East respiratory syndrome end_entity associated with mild start_entity treated with antivirals during the end_entity outbreak in South Korea at 2015\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"So, significant neutralizing activity was not demonstrated in any sera of three patients with mild start_entity 1 year after being successfully treated with antiviral agents and recovering from end_entity start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia, Pneumocystis\",\n",
       "                    \"value\": \", and end_entity were identified by polymerase chain reaction testing, and Klebsiella start_entity was cultured from the bronchoalveolar lavage fluid\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"METHODS: In the PRISTINE end_entity treated with RIfampicin aTtenuates INflammation trial, a randomized, therapeutic controlled, exploratory study in patients with community-acquired pneumococcal start_entity, we looked at LTA release and inflammatory and clinical response during treatment with both rifampicin and -lactam compared with treatment with -lactam antibiotics only\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Purpura, Thrombocytopenic, Idiopathic\",\n",
       "                    \"value\": \"However, end_entity in association with start_entity infection has not previously been reported\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"PATIENTS AND METHODS: We conducted a retrospective study of outpatients with community-acquired start_entity at the end_entity Clinic of Peking University Third Hospital\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"We collected end_entity or throat swabs from patients diagnosed with community-acquired start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"end_entity children with RSV were over twice as likely to be diagnosed with bacterial start_entity as those who were afebrile 60 vs 27, P\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: end_entity MERS, caused by a start_entity, can lead to severe respiratory failure and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Coronavirus_Infections end_entity, caused by a start_entity, can lead to severe respiratory failure and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Middle East Respiratory end_entity MERS, caused by a start_entity, can lead to severe respiratory failure and death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"METHODS: The study involved a retrospective chart review of confirmed cases of end_entity start_entity end_entity-CoV infections in a tertiary care referral center in Riyadh, Saudi Arabia, from January 2015 to October 2018\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The Feline start_entity FCoV can lead to end_entity end_entity, which the precise cause is still unknown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is an emerging swine enteric start_entity that causes end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"An atypical RNA pseudoknot with an extra stem formed by complementary sequences within loop 2 of an H-type pseudoknot is characterized in the severe acute respiratory syndrome start_entity end_entity CoV genome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"siVirus will be a useful tool for designing optimal siRNAs targeting highly divergent pathogens, including human immunodeficiency virus HIV, hepatitis C virus HCV, influenza virus and end_entity start_entity, all of which pose enormous threats to global human health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In an effort to establish a screening program for high risk personal, the distribution of HLA class I and GCNT2 alleles in case and control groups was examined for the presence of an association to a genetic susceptibly or resistance to end_entity start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS: HLA-class I and GCNT2 allele typing by PCR-SSOP was performed on 37 cases of probable end_entity, 28 fever patients excluded later as probable end_entity, and 101 non-infected health care workers who were exposed or possibly exposed to end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"appeared as the most probable elements that may be favoring end_entity start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: An epidemic of a end_entity end_entity caused by a new start_entity has spread from the Guangdong province to the rest of China and to the world, with a puzzling contagion behavior\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: An epidemic of a Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome caused by a new start_entity has spread from the Guangdong province to the rest of China and to the world, with a puzzling contagion behavior\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a new human respiratory infectious disease caused by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"We describe an outbreak of end_entity, wasting, and encephalomyelitis syndrome in piglets in Argentina, caused by porcine hemagglutinating encephalomyelitis start_entity PHE-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity are also associated with otitis media, sinusitis and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here we expand this range of the spectral density to low fields through field cycling using the nucleocapsid protein of the end_entity start_entity as a model system\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"It was determined that the isolated virus was a canine start_entity end_entity, on the basis of start_entity, neutralization by canine anti-end_entity serum, and 84\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recent studies have suggested that bats are the natural reservoir of a range of coronaviruses start_entity, and that rhinolophid bats harbor viruses closely related to the severe acute respiratory syndrome end_entity CoV, which caused an outbreak of respiratory illness in humans during 20022003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The epidemic of severe acute respiratory syndrome end_entity was caused by a newly emerged start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity obliterans organizing end_entity Cryptogenic_Organizing_Pneumonia is a chronic respiratory disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cryptogenic Organizing Pneumonia\",\n",
       "                    \"value\": \"Bronchiolitis obliterans organizing start_entity end_entity is a chronic respiratory disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The disease appears to have originated in Guangdong Province, and the causative agent, end_entity start_entity, is likely to have originated from an animal host, perhaps sold in public markets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Whether severe acute respiratory syndromeassociated start_entity end_entity can be asymptomatic is unclear\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recently, we and another group independently identified several horseshoe bat species genus Rhinolophus as the reservoir host for a large number of viruses that have a close genetic relationship with the start_entity associated with severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Given the potential for laboratory-associated severe acute respiratory syndromeassociated start_entity end_entitys, we must know which cell lines are susceptible to the virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity was associated with an annual death rate from all causes, from underlying start_entity and influenza, and from underlying circulatory and respiratory conditions of 14\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To determine the prevalence of inapparent infection with severe acute respiratory syndrome end_entity among healthcare workers, we performed a serosurvey to test for immunoglobulin Ig G antibodies to the end_entity start_entity end_entity-CoV among 1,147 healthcare workers in 3 hospitals that admitted end_entity patients in mid-May 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"case-patients with laboratory-confirmed severe acute respiratory syndrome end_entity to 65 controls who tested negative for end_entity start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity A viruses were detected in 20 of patients who had influenza-like illness and in 23 of those who had clinical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"SEVERE ACUTE RESPIRATORY SYNDROMEASSOCIATED: start_entity end_entity-CoV was isolated from a pig during a survey for possible routes of viral transmission after a end_entity epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"19 were positive for end_entity start_entity immunoglobulin G antibody\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Efforts to contain severe acute respiratory syndrome end_entity have been limited by the lack of a standardized, sensitive, and specific test for end_entity-associated start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ute start_entity developed in a previously healthy man during the outbreak of severe acute respiratory syndrome end_entity in southern China in March 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Other etiologic agents should thus be sought in apparent end_entity cases when start_entity infection cannot be confirmed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"During the recent severe acute respiratory end_entity outbreak, the etiologic agent was identified as a new start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"We have isolated a SARS-associated CoV SARS-CoV strain by injecting Vero cells with a end_entity specimen from an Italian patient affected by a severe start_entity; the patient traveled from Vietnam to Italy in March 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of healthcare workers with the severe acute respiratory syndromeassociated start_entity SARS-CoV is thought to occur primarily by either contact or large respiratory droplet transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Cases of severe acute respiratory syndrome end_entity were investigated for end_entity start_entity end_entity-CoV through RNA tests, serologic response, and viral culture\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"n outbreak of severe acute respiratory syndrome end_entity in humans, associated with a new start_entity, was reported in Southeast Asia, Europe, and North America in early 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A balanced approach to screening that allows early recognition of end_entity without unnecessary isolation of patients with other respiratory illnesses will require clinicians not only to look for suggestive clinical features but also to routinely seek epidemiologic clues suggestive of end_entity start_entity exposure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Key epidemiologic risk factors include 1 exposure to settings where end_entity activity is suspected or documented, or 2 in the absence of such exposure, epidemiologic linkage to other persons with start_entity i\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"global outbreak of severe acute respiratory syndrome end_entity caused by a start_entity began in March 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, we report that recombinant human interferon IFN- 1a potently inhibits end_entity start_entity replication in vitro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Five probable cases occurred from March through April 2003; four were confirmed as end_entity start_entity by reverse transcriptionpolymerase chain reaction, serologic testing, or both\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Cerebrospinal fluid tested positive for end_entity start_entity end_entity-CoV by reverse transcriptasepolymerase chain reaction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity was first described during a 20022003 global outbreak of severe start_entity associated with human deaths and person-to-person disease transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"During the 2003 severe acute respiratory syndrome end_entity outbreak, a real-time quantitative polymerase chain reaction, which targets the nucleocapsid gene at the 3-end of the viral genome, was established to detect and identify the end_entity-associated start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We conducted an investigation of healthcare workers exposed to laboratory-confirmed end_entity patients in the United States to evaluate infection-control practices and possible end_entity-associated start_entity end_entity-CoV transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an infectious disease caused by a newly identified human start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We conducted a prospective study on the clinical, radiologic, and hematologic findings of end_entity patients with start_entity, who were admitted to National Taiwan University Hospital from March 8 to June 15, 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Environmental surveys found 9 of 119 samples of inanimate objects to be positive for end_entity start_entity RNA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These observations indicate that although transmission by direct contact with known end_entity patients was responsible for most cases, environmental contamination with the end_entity start_entity may have lead to infection among healthcare workers without documented contact with known hospitalized end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To characterize genetic variation of severe acute respiratory syndromeassociated start_entity end_entity-CoV transmitted in the Beijing area during the epidemic outbreak of 2003, we sequenced 29 full-length S genes of end_entity-CoV from 20 hospitalized end_entity patients on our unit, the Beijing 302 Hospital\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity injected intratracheally into chickens, turkeys, geese, ducks, and quail, or into the allantoic sac of their embryonating eggs, failed to cause disease or replicate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This finding suggests that domestic poultry were unlikely to have been the reservoir, or associated with dissemination, of end_entity start_entity in the animal markets of southern China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This study found infrequent transmission of severe acute respiratory syndrome end_entity start_entity to healthcare workers involved in the care of the first five case-patients in Taiwan, despite a substantial number of unprotected exposures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"This study investigated the long-term excretion of severe acute respiratory syndromeassociated start_entity in end_entity and stool specimens from 56 infected patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Clinical specimens collected from these patients were tested by provincial and national laboratories in China as well as members of the World Health Organization end_entity Reference and Verification Laboratory Network in a collaborative effort to identify and confirm end_entity-associated start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Inactivated severe acute respiratory syndromeassociated start_entity samples were used for an external quality assurance study within the World Health Organization end_entity Reference and Verification Network and other reference institutions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Serum samples from 317 patients with patients with severe acute respiratory syndrome end_entity were tested for the nucleocapsid N protein of end_entity-associated start_entity, with sensitivities of 94 and 78 for the first 5 days and 610 days after onset, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"An emergent human start_entity was identified as the causal agent of an epidemic of severe acute respiratory syndrome end_entity during 20022003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with Middle East respiratory syndrome start_entity MERS-CoV was suspected on March 21 and confirmed on March 23; the patient, who had contact with an ill camel shortly before symptom onset, died on March 26\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"We describe a case of extremely severe respiratory failure due to concurrence of PAP and end_entity A H1N1 virus start_entity which resolved with the help of this procedure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Image: see text Structure-guided design was used to generate a series of noncovalent inhibitors with nanomolar potency against the papain-like protease PLpro from the end_entity start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV develops an antagonistic mechanism by which to evade the antiviral activities of interferon IFNA1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"During the first year of enhanced end_entity start_entity surveillance in England, 77 persons traveling from the Middle East had acute respiratory illness and were tested for the virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Despite the passing of more than a year since the first outbreak of end_entity end_entity, efficient counter-measures are still few and many believe that reappearance of end_entity, or a similar disease caused by a start_entity, is not unlikely\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Despite the passing of more than a year since the first outbreak of Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome, efficient counter-measures are still few and many believe that reappearance of Severe_Acute_Respiratory_Syndrome, or a similar disease caused by a start_entity, is not unlikely\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV end_entity, has caused recurrent outbreaks worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"With the goal of accelerating the development of countermeasures against end_entity start_entity end_entity-CoV, funding agencies, nongovernmental organizations, and researchers across the world assembled in Riyadh, Saudi Arabia, on November 1415, 2015, to discuss vaccine development challenges\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"By now the putative pathogen of end_entity has been identified as a new start_entity, a single positive-strand RNA virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It is therefore important to know the mutation rate of the end_entity start_entity as it spreads through the population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Moreover, finding a date for the last common ancestor of end_entity start_entity strains would be useful for understanding the circumstances surrounding the emergence of the end_entity pandemic and the rate at which end_entity start_entity diverge\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS: We propose a mathematical model to estimate the evolution rate of the end_entity start_entity genome and the time of the last common ancestor of the sequenced end_entity strains\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"16 baseday, that is, the end_entity start_entity would on average change a base every seven days\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"govgenomevirusesvariation and includes modules for seven viral groups: influenza virus, end_entity virus, West Nile virus, Ebolavirus, MERS start_entity, Rotavirus A and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"govgenomevirusesvariation and includes modules for seven viral groups: influenza virus, Dengue virus, West Nile virus, Ebolavirus, end_entity start_entity, Rotavirus A and Zika virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"We identified from suckling piglets with end_entity in China a new bat-HKU2like porcine start_entity porcine enteric alphastart_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lassa Fever\",\n",
       "                    \"value\": \"There were 160 persons placed on PHTRs: 142 89 involved exposure to Ebola virus, 16 10 to end_entity virus, and 2 1 to Middle East respiratory syndrome start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"We evaluated procalcitonin end_entity and Creactive protein CRP in differentiating start_entity caused by mixed bacterial and 2009 H1N1 influenza infection from 2009 H1N1 influenza infection alone\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"Results Mixed bacterial and viral infection start_entity n 16 had significantly higher end_entity and CRP levels than start_entity caused by 2009 H1N1 influenza alone n 44, P 0019, 0022 respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"The sensitivity and specificity for detection of mixed bacterial infection start_entity was 56 and 84 for end_entity 15 ngml, and 69 and 63 for CRP 10 mgdl\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"Considering high specificity, combination of low CRP and end_entity result may suggest that start_entity is unlikely to be caused by mixed bacterial infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity showed radiographic evidence of alveolar start_entity significantly more frequently than single infections OR 172, 95 NDUFB6 105281\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Nail-Patella Syndrome\",\n",
       "                    \"value\": \"In children with high nasopharyngeal microbial colonisation rates, the utility of end_entity in determining the diagnosis of clinical start_entity or duration of tachypnoea or in-drawing is likely limited\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lung transplantation\",\n",
       "                    \"value\": \"ute fibrinous and organising start_entity AFOP is a histopathologic variant of acute lung injury that has been associated with infection and inflammatory disorders and has been reported as a complication of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"The receptor-interacting site is conserved in all start_entity S glycoproteins that engage 9-O-acetyl-sialogycans, with an architecture similar to the ligand-binding pockets of start_entity hemagglutinin esterases and influenza virus end_entity hemagglutinin-esterase-fusion glycoproteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Duane Retraction Syndrome\",\n",
       "                    \"value\": \"Here, we used a full-length, direct RNA sequencing end_entity approach based on nanopores to characterize viral RNAs produced in cells infected with a human start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hypotrichosis simplex\",\n",
       "                    \"value\": \"To search for effective inhibitory agents, we performed high-throughput screening end_entity of a 2,000-compound library of approved drugs and pharmacologically active compounds using the established genetically engineered human CoV OC43 HCoV-OC43 strain expressing Renilla luciferase rOC43-ns2Del-Rluc and validated the inhibitors using multiple genetically distinct start_entity in vitro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Here, we asked if the EndoU activity of porcine epidemic end_entity start_entity PEDV, which causes acute end_entity in swine, plays a role in antagonizing the innate response in porcine epithelial cells and macrophages, the sites of viral replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"end_entity occurs most often in the setting of start_entity, sepsis, aspiration of gastric contents or severe trauma, and is present in 10 of all intensive care unit patients worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Histopathologic lesions and positive immunohistochemical staining for feline start_entity in multiple tissues, including the skin, confirmed the diagnosis of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using the papain-like deISGylase from end_entity start_entity as a probe, the biochemical importance of this motif in ISG15protein engagements was illuminated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity start_entity was defined as laboratory-confirmed influenza plus radiographic start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: The ongoing Middle East respiratory syndrome start_entity end_entity-CoV infections pose threats to public health worldwide, making an understanding of end_entity pathogenesis and development of effective medical countermeasures MCMs urgent\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"METHODS: Respiratory specimens nasopharyngeal and throat swabs were collected from 300 consenting pilgrims with ARIH1 in the past one week and tested for influenza and end_entity start_entity MERS-CoV and other respiratory viruses using in-house standardized quantitative real-time reverse-transcription polymerase chain reaction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"METHODS: Respiratory specimens nasopharyngeal and throat swabs were collected from 300 consenting pilgrims with ARIH1 in the past one week and tested for influenza and Middle East Respiratory end_entity start_entity MERS-CoV and other respiratory viruses using in-house standardized quantitative real-time reverse-transcription polymerase chain reaction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity with feline foamy virus FFV, feline gammaherpesvirus 1 FcaGHV-1, and feline start_entity FCoV were also documented and analyzed for impact on cat health and FeLV disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Here, we report four crystal structures, including wild-type porcine delta start_entity PDCoV nsp9, PDCoV nsp9-N7 N-terminal 7 amino acids deleted, wild-type porcine epidemic end_entity virus PEDV nsp9, and PEDV nsp9-C59A mutant\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"INTRODUCTION: Six years have passed since Middle East respiratory syndrome end_entity start_entity end_entity-CoV, a newly emerging infectious virus, was first reported in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is a highly lethal respiratory disease caused by a novel betastart_entity end_entity start_entity, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"BACKGROUND: end_entity with influenza virus and methicillin-resistant Staphylococcus aureus MRSA causes life-threatening necrotizing start_entity in children\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"end_entity susceptibility reflects ongoing and poorly understood chronic conditions, and start_entity results in diverse and often persistent deleterious consequences for multiple physiological systems\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"IM AND OBJECTIVE: This study aims to evaluate the knowledge and attitude of practicing dental health professionals DHPs dentist and dental auxiliaries toward end_entity start_entity MERS-CoV in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"IM AND OBJECTIVE: This study aims to evaluate the knowledge and attitude of practicing dental health professionals DHPs dentist and dental auxiliaries toward Middle East Respiratory end_entity start_entity MERS-CoV in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity A H1N1-related start_entity cases appeared as more severe than start_entity cases related to other strains of influenza\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity might be a frequent etiologic agent responsible for start_entity or a predisposing status factor for pneumococcal-related start_entity in this population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hyponatremia\",\n",
       "                    \"value\": \"BACKGROUND: end_entity MT-RNR2 135 mmolL is a frequent finding in children with community-acquired start_entity CAP\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"IMPORTANCE Porcine epidemic end_entity virus PEDV is a highly contagious enteric start_entity that emerged in swine in the United States and has caused severe economic losses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"value\": \"Idiopathic start_entity syndrome end_entity is a non-infectious pulmonary complication after hematopoietic cell transplantation HCT and is difficult to diagnose\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"value\": \"002 was the best marker when comparing patients with end_entity and viral start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity end_entity-CoV is an emerging human pathogen that is the causative agent for Middle East respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"These included: Histophilus somni, Mannheimia haemolytica, Pasteurella multocida, Mycoplasma bovis, bovine respiratory syncytial virus BRSV, bovine start_entity BCoV, bovine viral end_entity virus BVDV, bovine alphaherpesvirus 1 BoHV-1, and bovine parainfluenza virus 3 BPIV-3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV is a start_entity characterized by end_entity and high morbidity rates, and the mortality rate is 100 in piglets less than 2 weeks old\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The Centers for Disease Control and Prevention CDC algorithm for detecting presence of serum antibodies against end_entity start_entity MERS-CoV in subjects with potential infections with the virus has included screening by indirect ELISA against recombinant nucleocapsid N protein and confirmation by immunofluorescent staining of infected monolayers andor micro-neutralization titration\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Centers for Disease Control and Prevention CDC algorithm for detecting presence of serum antibodies against Middle East Respiratory end_entity start_entity MERS-CoV in subjects with potential infections with the virus has included screening by indirect ELISA against recombinant nucleocapsid N protein and confirmation by immunofluorescent staining of infected monolayers andor micro-neutralization titration\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"IMPORTANCE The subfamily Coronavirinae contains several notorious human and animal pathogens, including severe acute respiratory syndrome start_entity, Middle East respiratory syndrome start_entity, and porcine epidemic end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The end_entity-coronavirus MERS-CoV causes a highly lethal start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"METHODS: As part of the Etiology of end_entity in the Community EPIC study, children aged 18 years who were hospitalized with community-acquired start_entity CAP and children asymptomatic at the time of elective outpatient surgery controls were enrolled\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"High structural similarity to the human severe acute respiratory syndrome end_entity start_entity nsp3 is present\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity are not common in those bat species, but start_entity HKU6 and adenovirus can be found commonly occurred in Myotis ricketti\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV is a highly pathogenic respiratory virus that causes morbidity and mortality in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"IMPORTANCE Porcine epidemic end_entity virus PEDV, an emerging porcine start_entity, causes an economically important enteric disease in pigs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"CONCLUSIONS: Initial NIV was associated with better survival among the subgroup of patients hospitalized with start_entity who had end_entity or heart failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The potential for infection by coronaviruses start_entity has become a serious concern with the recent emergence of Middle East respiratory syndrome and severe acute respiratory syndrome end_entity in the human population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a respiratory disease, caused by a start_entity end_entity-CoV, that is characterized by atypical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome end_entity emerged in Saudi Arabia in 2012, caused by a zoonotically transmitted start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Search terms included asthma, chronic obstructive pulmonary disease end_entity, lung cancer, fibrosis, ischemia reperfusion injury and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Distal Myopathies\",\n",
       "                    \"value\": \"It has been shown previously in the severe acute respiratory syndrome start_entity SARS-CoV that two point mutations, N15A and V25F, in the transmembrane domain end_entity of the envelope E protein abolished channel activity and led to in vivo attenuation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Between September 2012 and January 20, 2017, the World Health Organization WHO received reports from 27 countries of 1879 laboratory-confirmed cases in humans of the Middle East respiratory syndrome end_entity caused by infection with the end_entity start_entity end_entity-CoV and at least 659 related deaths\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porphyria Cutanea Tarda\",\n",
       "                    \"value\": \"BACKGROUND: Lower procalcitonin end_entity concentrations are associated with reduced risk of bacterial community-acquired start_entity CAP in adults, but data in children are limited\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The global outbreak of end_entity in 2002-2003 was caused by the infection of a new human start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"INTRODUCTION: The continual Middle East respiratory syndrome end_entity threat highlights the importance of developing effective antiviral therapeutics to prevent and treat end_entity start_entity end_entity-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV is a novel virus that emerged in 2012, causing acute respiratory distress syndrome end_entity, severe pneumonia-like symptoms, and multi-organ failure, with a case fatality rate of 36\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Limited clinical studies indicate that humans infected with MERS-CoV exhibited pathology consistent with late stages of end_entity, which is reminiscent of disease observed in patients infected with Severe_Acute_Respiratory_Syndrome start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Limited clinical studies indicate that humans infected with MERS-CoV exhibited pathology consistent with late stages of Respiratory_Distress_Syndrome,_Adult, which is reminiscent of disease observed in patients infected with end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"krusei start_entity that was initially suspected to be a Middle East respiratory syndrome end_entity case\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"In conclusion, the diagnosis of Candida start_entity should be strongly considered in the presence of growth of Candida from a end_entity culture and based on a suggestive computed tomography image\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lung transplantation\",\n",
       "                    \"value\": \"CONCLUSIONS: With respect to CARV, only viral start_entity increased the risk of both CLAD and graft loss after end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity is caused by end_entity start_entity end_entity-CoV infection, and no specific drugs or vaccines are currently available to prevent end_entity-CoV infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity start_entity PEDV is currently devastating the United States pork industry by causing an 80100 fatality rate in infected piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"IMPORTANCE end_entity with the Middle East respiratory syndrome start_entity MERS-CoV is associated with the highest mortality rate among all known human-pathogenic start_entityes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome start_entity end_entity-CoV first emerged in 2003, causing the end_entity epidemic which resulted in a 10 fatality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The outbreaks of SARS-CoV and end_entity-CoV and the continuing diagnosis of new end_entity cases highlight the need for finding therapeutics for these diseases and potential future start_entity outbreaks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"In 2012, a zoonotic start_entity was identified as the causative agent of end_entity MERS, called MERS Coronavirus MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In 2012, a zoonotic start_entity was identified as the causative agent of Coronavirus_Infections end_entity, called end_entity Coronavirus end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In 2012, a zoonotic start_entity was identified as the causative agent of Middle East Respiratory end_entity MERS, called MERS Coronavirus MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The Middle East respiratory syndrome end_entity start_entity CoV is an emerging CoV with a known zoonotic source in dromedary camels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Literature on the epidemiology and contextual factors associated with end_entity start_entity infection was collected and reviewed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"This risk assessment highlights the need for Singapore to stay vigilant and to continue enhancing core public health capacities to detect and respond to end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Human bocaviruses HBoV1 to -4 are emerging pathogens associated with start_entity andor end_entity in young children\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Of 70 TRIMs, TRIM56 is a restriction factor of several positive-strand RNA viruses, including three members of the family Flaviviridae yellow fever virus, dengue virus, and bovine viral end_entity virus and a human start_entity OC43, and this ability invariably depends upon the E3 ligase activity of TRIM56\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"First identified in 2012, Middle East respiratory syndrome end_entity start_entity end_entity-CoV is listed as a new Category C Priority Pathogen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pyridoxine-dependent epilepsy\",\n",
       "                    \"value\": \"Murine start_entity mouse hepatitis virus MHV nonstructural protein 2 ns2 is a 2,5-phosphodiesterase end_entity that cleaves 2-5A, thereby antagonizing RNase L activation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity start_entity is associated with high number of severe cases requiring hospital and intensive care unit ICU admissions with high mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is an enteropathogenic start_entity causing lethal watery end_entity in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"A diagnosis of bilateral start_entity and acute respiratory distress syndrome end_entity due to an infection by rhinovirus spp was made\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The clinical manifestations of adult community-acquired adenovirus start_entity patients with normal immune functions were mild, with such presenting symptoms as fever, end_entity, and sputum; most patients did not exhibit high levels of white blood cells or low lymphocyte counts, and the imaging features ground glass-like effusion were indicative of single-lung involvement\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"The clinical manifestations of adult community-acquired adenovirus start_entity patients with normal immune functions were mild, with such presenting symptoms as fever, cough, and end_entity; most patients did not exhibit high levels of white blood cells or low lymphocyte counts, and the imaging features ground glass-like effusion were indicative of single-lung involvement\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with the murine start_entity mouse hepatitis virus MHV activates the pattern recognition receptors IFIH1 IFIH1 and Toll-like receptor 7 TLR7 to induce transcription of type I interferon\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity emerged in November 2002 as a case of atypical start_entity in China, and the causative agent of end_entity was identified to be a start_entity, severe acute respiratory syndrome start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The evolutionary history of HCoV-229E likely shares important characteristics with that of the recently emerged highly pathogenic Middle East respiratory syndrome end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS: We estimated the association between the length of the incubation period and the severity of infection with the severe acute respiratory syndrome end_entity start_entity, using data from the epidemic in 2003 in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this work, mutants of nsp15 from Human start_entity 229E HCoV-229E were made based on structural analysis of the homologous nsp15s in end_entity start_entity SARS-CoV and Mouse hepatitis virus MHV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"First identified in 2012, Middle East respiratory syndrome end_entity is caused by an emerging human start_entity, which is distinct from the severe acute respiratory syndrome start_entity SARS-CoV, and represents a novel member of the lineage C betacoronoviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Since its identification, end_entity start_entity end_entity-CoV has been linked to more than 1372 infections manifesting with severe morbidity and, often, mortality about 495 deaths in the Arabian Peninsula, Europe, and, most recently, the United States\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Upon end_entity viral challenge, all of the monkeys in the control-vaccinated group developed characteristic disease, including start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"An immunoadhesin targeting the end_entity start_entity is in an early stage of development\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"value\": \"Common alloimmune lung complications include idiopathic start_entity syndrome end_entity, transfusion related lung injury, diffuse alveolar hemorrhage, and peri-engraftment respiratory distress syndrome, with both diffuse alveolar hemorrhage and peri-engraftment respiratory distress syndrome existing as subsets of end_entity when infection is absent\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity MERS is a highly lethal pulmonary infection caused by a previously unidentified start_entity CoV, likely transmitted to humans by infected camels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Coronavirus_Infections end_entity is a highly lethal pulmonary infection caused by a previously unidentified start_entity CoV, likely transmitted to humans by infected camels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity MERS is a highly lethal pulmonary infection caused by a previously unidentified start_entity CoV, likely transmitted to humans by infected camels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Indeed, the severe acute respiratory syndrome start_entity end_entity-CoV, causing severe acute respiratory syndrome, and the start_entity OC43 and 229E were found in the brains of end_entity patients and multiple sclerosis patients, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Polymorphisms at OAS1 have been shown to correlate with differential susceptibility to several infections of great public health significance, including hepatitis C virus, end_entity start_entity, and West Nile virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Specifically, we show the rapid generation of fully human neutralizing antibodies against the recently emerged end_entity start_entity MERS-CoV and development of a humanized mouse model for MERS-CoV infection, which was used to demonstrate the therapeutic efficacy of the isolated antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Specifically, we show the rapid generation of fully human neutralizing antibodies against the recently emerged Middle East Respiratory end_entity start_entity MERS-CoV and development of a humanized mouse model for MERS-CoV infection, which was used to demonstrate the therapeutic efficacy of the isolated antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Middle East respiratory syndrome end_entity is an illness caused by a start_entity in which infected persons develop severe acute respiratory illness\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We identified a novel VSR from start_entityes, a group of medically important mammalian viruses including end_entity start_entity SARS-CoV, and showed that the nucleocapsid protein N protein of start_entityes suppresses RNAi triggered by either short hairpin RNAs or small interfering RNAs in mammalian cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"value\": \"Newer diagnostic methods may link more idiopathic start_entity syndrome end_entity cases to an infectious agent\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"To gain entry into the target cell, Middle East respiratory syndrome end_entity start_entity end_entity-CoV uses its spike S protein S2 subunit to fuse with the plasma or endosomal membrane\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Viruses, including the end_entity human start_entity end_entity hCoV, have co-opted UbISG15-conjugation pathways for their own advantage or have evolved effector proteins to counter pro-inflammatory properties of UbISG15-conjugated host proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Viruses, including the Severe Acute Respiratory end_entity human start_entity Severe_Acute_Respiratory_Syndrome hCoV, have co-opted UbISG15-conjugation pathways for their own advantage or have evolved effector proteins to counter pro-inflammatory properties of UbISG15-conjugated host proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a start_entity that causes end_entity in nursing piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is an emerging infectious disease caused by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV, a start_entity, can cause acute end_entity and dehydration in pigs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Subsequent hunting for start_entityes start_entity led to the discovery of two additional human and over 40 animal start_entity, including the prototype lineage C betacoronaviruses, Tylonycteris bat CoV HKU4 and Pipistrellus bat CoV HKU5; these are phylogenetically closely related to the Middle East respiratory syndrome end_entity CoV, which has affected more than 1,000 patients with over 35 fatality since its emergence in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity start_entity PEDV has significantly damaged America's pork industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The end_entity start_entity MERS-CoV papain-like protease PLpro blocking loop 2 CADM1 structure differs significantly from that of SARS-CoV PLpro, where it has been proven to play a crucial role in SARS-CoV PLpro inhibitor binding\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Middle East Respiratory end_entity start_entity MERS-CoV papain-like protease PLpro blocking loop 2 CADM1 structure differs significantly from that of SARS-CoV PLpro, where it has been proven to play a crucial role in SARS-CoV PLpro inhibitor binding\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"value\": \"lthough much recent focus has been on the recognition of end_entity among travelers from West Africa, cases of Middle East respiratory syndrome start_entity MERS-CoV, including travel-associated cases, continue to be reported\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV causes a respiratory disease with a mortality rate of 10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Noonan Syndrome 4\",\n",
       "                    \"value\": \"ChRCoV HKU24 possessed genome features that resemble those of both Betastart_entity 1 and murine start_entity, being closer to Betastart_entity 1 in most predicted proteins but closer to murine start_entity by GC content, the presence of a single nonstructural protein end_entity, and an absent transcription regulatory sequence for the envelope E protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Neural Tube Defects\",\n",
       "                    \"value\": \"Its N-terminal domain end_entity demonstrated higher sequence identity to the bovine start_entity BCoV end_entity than to the mouse hepatitis virus MHV end_entity, with 3 of 4 critical sugar-binding residues in BCoV and 2 of 14 contact residues at the MHV end_entitymurine CEACAM1a interface being conserved\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by severe acute respiratory syndrome start_entity SARS-CoV causes severe respiratory distress in infected patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Quantitative RT-PCR was performed on dunked sputum and NTS samples for influenza A end_entity A, respiratory syncytial virus RSV, start_entity OC43 OC43, and human metapneumovirus HMPV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Quantitative RT-PCR was performed on dunked end_entity and NTS samples for influenza A Influenza,_Human A, respiratory syncytial virus RSV, start_entity OC43 OC43, and human metapneumovirus HMPV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV caused an acute human respiratory illness with high morbidity and mortality in 2002-2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Protease inhibitors blocking the replication of start_entity CoV, including the causative agents of severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome and Middle East respiratory syndrome end_entity, provide a promising foundation for the development of anticoronaviral therapeutics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Protease inhibitors blocking the replication of start_entity CoV, including the causative agents of severe acute respiratory syndrome end_entity and Middle East respiratory syndrome MERS, provide a promising foundation for the development of anticoronaviral therapeutics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The purpose of this study was to evaluate the changes in the serum concentrations of HP Hp, serum amyloid A SAA1 and IgG, IgA in calves with end_entity caused by rotavirus, start_entity, Escherichia coli F5 and Eimeria species\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Serum SAA1, Hp, IgA and IgG levels could be useful for the diagnosis and differential diagnosis of end_entity caused by rotavirus, start_entity, E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 2003 outbreak of severe acute respiratory syndrome end_entity first demonstrated the potentially lethal consequences of zoonotic start_entity infections in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Moreover, these compounds also inhibit the replication of end_entity start_entity and human start_entity 229E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Emerging respiratory start_entityes such as the Severe_Acute_Respiratory_Syndrome start_entity SARS-CoV and end_entity start_entity MERS-CoV pose potential biological threats to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Emerging respiratory start_entityes such as the end_entity start_entity SARS-CoV and Coronavirus_Infections start_entity MERS-CoV pose potential biological threats to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Emerging respiratory start_entityes such as the Severe Acute Respiratory end_entity start_entity SARS-CoV and Middle East Respiratory end_entity start_entity MERS-CoV pose potential biological threats to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome and end_entity are manifested as severe atypical start_entity associated with high morbidity and mortality in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity and MERS are manifested as severe atypical start_entity associated with high morbidity and mortality in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV, a porcine enteropathogenic start_entity, causes lethal watery end_entity in piglets and results in large economic losses in many Asian and European countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-related start_entity SARS-CoV is an emerging pathogen that causes severe respiratory illness\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Human start_entity NL63 mainly infects younger children and causes end_entity, fever, rhinorrhoea, bronchiolitis and croup\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Isolation of porcine epidemic end_entity start_entity PEDV from clinical material in cell culture requires supplementation of trypsin\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Pseudoparticle virus neutralization ppNT and a conventional microneutralization MN assays are specific for detecting antibodies to end_entity start_entity end_entity-CoV when used in sero-epidemiological studies in animals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"lthough many severe acute respiratory syndrome-like coronaviruses end_entity-like start_entity have been identified in bats in China, Europe, and Africa, most have a genetic organization significantly distinct from humancivet end_entity start_entity in the receptor-binding domain RBD, which mediates receptor binding and determines the host spectrum, resulting in their failure to cause human infections and making them unlikely progenitors of humancivet end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Full genomic analysis of a new end_entity-like CoV from Baoshan LYRa11 showed that it was 29,805 nucleotides nt in length with 13 open reading frames ORFs, sharing 91 nucleotide identity with humancivet end_entity start_entity and the most recently reported end_entity-like CoV Rs3367, while sharing 89 with other bat end_entity-like start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Notably, it showed the highest sequence identity with the S gene of end_entity start_entity and Rs3367, especially in the RBD region\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"IMPORTANCE Although many severe acute respiratory syndrome-like coronaviruses end_entity-like start_entity have been discovered in bats worldwide, there are significant different genic structures, particularly in the PSMD1 domain, which are responsible for host tropism determination, between bat end_entity-like start_entity and human end_entity start_entity, indicating that most reported bat end_entity-like start_entity are not the progenitors of human end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Such drugs could also be effective for many other respiratory viruses, including the recently emerged Middle East respiratory syndrome end_entity start_entity, because they are also activated by TMPRSS2 in vitro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Appropriate public health and control measures will require discovery of the zoonotic end_entity start_entity reservoirs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The newly emerging end_entity start_entity MERS-CoV causes a Severe_Acute_Respiratory_Syndrome-like disease with 43 mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The newly emerging Coronavirus_Infections start_entity MERS-CoV causes a end_entity-like disease with 43 mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The newly emerging Middle East Respiratory end_entity start_entity MERS-CoV causes a Severe Acute Respiratory end_entity-like disease with 43 mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is a newly emerging infectious disease caused by a start_entity, end_entity-start_entity end_entity-CoV, a new member in the lineage C of -start_entity -CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Within a few days the same virus was detected in a Qatari patient receiving intensive care in a London hospital, a situation reminiscent of the role air travel played in the spread of end_entity start_entity SARS-CoV in 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Within a few days the same virus was detected in a Qatari patient receiving intensive care in a London hospital, a situation reminiscent of the role air travel played in the spread of Severe Acute Respiratory end_entity start_entity SARS-CoV in 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Over a year after the emergence of this start_entity-end_entity start_entity MERS-CoV-it has caused 178 laboratory confirmed cases and 76 deaths The emergence of a second highly pathogenic start_entity within a decade highlights the importance of a coordinated global response incorporating reservoir surveillance, high-containment capacity with fundamental and applied research programs, and dependable communication pathways to ensure outbreak containment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Over a year after the emergence of this start_entity-Middle East Respiratory end_entity start_entity MERS-CoV-it has caused 178 laboratory confirmed cases and 76 deaths The emergence of a second highly pathogenic start_entity within a decade highlights the importance of a coordinated global response incorporating reservoir surveillance, high-containment capacity with fundamental and applied research programs, and dependable communication pathways to ensure outbreak containment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV and Ebola, Hendra, and Nipah viruses are members of different viral families and are known causative agents of fatal viral diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Paramyxoviridae Infections\",\n",
       "                    \"value\": \"end_entity virus type 4, human metapneumovirus, rhinovirus, start_entity, human bocavirus were investigated using multiplex PCR test\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have previously shown that severe acute respiratory syndrome end_entity start_entity M protein suppresses type I interferon IFNA1 production by impeding the formation of functional TRAF3-containing complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, we demonstrate that the IFN-antagonizing activity is specific to end_entity start_entity M protein and is mediated through its first transmembrane domain TM1 located at the N terminus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Whereas N-linked glycosylation of end_entity start_entity M protein has no influence on IFNA1 antagonism, TM1 is indispensable for the suppression of IFNA1 production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"TM1 targets end_entity start_entity M protein and heterologous proteins to the Golgi apparatus, yet Golgi localization is required but not sufficient for IFNA1 antagonism\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our work defines the molecular architecture of end_entity start_entity M protein required for suppression of innate antiviral response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Noonan Syndrome 6\",\n",
       "                    \"value\": \"Their genome size is about 32,000 nucleotides, the largest among all start_entity, as a result of multiple unique open reading frames NS5a, NS5b, NS5c, end_entity, NS7, NS8, NS9, and NS10 between their membrane M and nucleocapsid N protein genes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV is the etiological agent of a respiratory disease that has a 10 mortality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Development of vaccines for preventing a future pandemic of severe acute respiratory syndrome end_entity caused by end_entity start_entity end_entity-CoV and for biodefense preparedness is urgently needed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Two start_entityes have emerged in humans in the 21st century, Severe_Acute_Respiratory_Syndrome Coronavirus SARS-CoV and end_entity human start_entity MERS-CoV, both of which cause acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult and have high mortality rates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Two start_entityes have emerged in humans in the 21st century, Severe_Acute_Respiratory_Syndrome Coronavirus SARS-CoV and Coronavirus_Infections human start_entity MERS-CoV, both of which cause acute respiratory distress syndrome end_entity and have high mortality rates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Two start_entityes have emerged in humans in the 21st century, end_entity Coronavirus SARS-CoV and Coronavirus_Infections human start_entity MERS-CoV, both of which cause acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult and have high mortality rates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Two start_entityes have emerged in humans in the 21st century, Severe Acute Respiratory end_entity Coronavirus SARS-CoV and Middle East Respiratory end_entity human start_entity MERS-CoV, both of which cause acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult and have high mortality rates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lung transplantation\",\n",
       "                    \"value\": \"Rationale: After end_entity, insults to the allograft generally result in one of four histopathologic patterns of injury: 1 acute rejection, 2 lymphocytic bronchiolitis, 3 organizing start_entity, and 4 diffuse alveolar damage DAD\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity with high mortality rates 50 is associated with a novel group 2c betastart_entity designated Middle East respiratory syndrome start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity causes lung injury and inflammation in part through actions on the nonclassical REN angiotensin pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The lessons learned from the pandemic outbreaks of end_entity start_entity and H1N1 capture key principles of virally mediated ALI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"decade ago, severe acute respiratory syndrome end_entity start_entity end_entity-CoV caused a global pandemic with a mortality rate of 10\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Achondroplasia\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The high infectivity of the Severe_Acute_Respiratory_Syndrome end_entity with peak viral load on day 10 of illness when patients were ill, overcrowding of the old medical wards with low air changeshr start_entity, and aerosol-generating procedures while resuscitating the patients were the major factors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The high infectivity of the end_entity start_entity with peak viral load on day 10 of illness when patients were ill, overcrowding of the old medical wards with low air changeshr Achondroplasia, and aerosol-generating procedures while resuscitating the patients were the major factors\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pyridoxine-dependent epilepsy\",\n",
       "                    \"value\": \"We previously showed that murine start_entity MHV accessory protein ns2, a 2H phosphoesterase superfamily member, is a phosphodiesterase end_entity that cleaves 2-5A, thereby preventing activation of RNase L\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an infectious and highly contagious disease that is caused by end_entity start_entity end_entity-CoV and for which there are currently no approved treatments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"HIV and severe acute respiratory syndrome start_entity end_entity via interactions with their surface glycans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity SARScoronavirus CoV produces a devastating primary viral start_entity with diffuse alveolar damage and a marked increase in circulating cytokines\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We previously showed that recombinant end_entity start_entity end_entity-CoV Urbani strain based lacking envelope E protein expression rU-E provided good but not perfect protection in young mice against challenge with virulent mouse-adapted end_entity-CoV MA15\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with human start_entity 229E HCoV-229E is associated with the common cold and may result in start_entity in immunocompromised patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chondrosarcoma, Extraskeletal Myxoid\",\n",
       "                    \"value\": \"The novel human start_entity end_entity hCoV-end_entity, which recently emerged in Saudi Arabia, is highly pathogenic and could pose a significant threat to public health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chondrosarcoma, Extraskeletal Myxoid\",\n",
       "                    \"value\": \"Infection with human start_entity end_entity HCoV-end_entity are associated with severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with human start_entity Chondrosarcoma,_Extraskeletal_Myxoid HCoV-Chondrosarcoma,_Extraskeletal_Myxoid are associated with severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"end_entitys were detected in three of the well weeks and 17 of the sick weeks 10 rhinovirus, 3 start_entity, 2 influenza A, 2 influenza B, 2 respiratory syncytial virus, 1 parainfluenza\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ubunit vaccine, RBD-S, is under development to prevent severe acute respiratory syndrome end_entity caused by end_entity start_entity end_entity-CoV, which is classified by the US NIH as a category C pathogen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with severe acute respiratory syndrome start_entity SARS-CoV causes acute lung injury ALI that often leads to severe lung disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity nonstructural protein 1 nsp1 binds to the 40S ribosomal subunit and inhibits translation, and it also induces a template-dependent endonucleolytic cleavage of host mRNAs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"nsp1 inhibits the translation of cap-dependent and internal ribosome entry site IRES-driven mRNAs, including end_entity start_entity mRNAs, hepatitis C virus HCV, and cricket paralysis virus CrPV IRES-driven mRNAs that are resistant to nsp1-induced RNA cleavage\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is the etiological agent of end_entity, a fatal pulmonary disorder with no effective treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is an acute respiratory disease caused by a start_entity, which first appeared in Foshan City, China on 22 December 2002\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity SCoV is an enveloped virus containing a single-stranded, positive-sense RNA genome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cystic Fibrosis\",\n",
       "                    \"value\": \"Possible harmful effects of further viruses like adenovirus, bocavirus, start_entity, metapneumovirus, parainfluenzavirus on the lung function of end_entity patients are discussed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a highly contagious disease, caused by end_entity start_entity end_entity-CoV, for which there are no approved treatments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"KD\",\n",
       "                    \"value\": \"Here, random mutagenesis and DNA shuffling of the single-chain variable fragment of the neutralizing antibody 80R followed by bacterial display screening using anchored periplasmic expression APEx were used to generate a number of higher-affinity variants of the severe acute respiratory syndrome start_entity SARS-CoV-neutralizing antibody 80R with equilibrium dissociation constants end_entity as low as 37 pM, a 270-fold improvement relative to that of the parental 80R single-chain variable fragment scFv\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Several clinical disorders can precipitate end_entity, including start_entity, sepsis, aspiration of gastric contents, and major trauma\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, we compared the transcriptional profiles of end_entity start_entity end_entity-CoV-infected monocytic cells against that infected by start_entity 229E CoV-229E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Because of the persistent threat from the AH5N1 virus since 1997 and the outbreak of the severe acute respiratory syndrome end_entity start_entity in 2003, medical and scientific communities have been more prepared in mindset and infrastructure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our knowledge regarding immune-protective and immunopathogenic events in severe acute respiratory syndrome start_entity end_entity is limited, and little is known about the dynamics of the immune response at the primary site of disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity, an annual infection often considered relatively harmless, can increase susceptibility to both deadly bacterial start_entity and childhood ear infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We established that the outer membranes of EAV-induced DMVs are interconnected with each other and with the EREG, thus forming a reticulovesicular network RVN resembling that previously described for the distantly related severe acute respiratory syndrome end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis\",\n",
       "                    \"value\": \"end_entity induced by the sublethal start_entity JHMV was used to identify when CD4 T cells regulate CD8A T cell responses following CNS infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV causes severe acute respiratory tract disease characterized by diffuse alveolar damage and hyaline membrane formation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"This pathology often progresses to acute respiratory distress such as acute respiratory distress syndrome end_entity and atypical start_entity in humans, with characteristic age-related mortality rates approaching 50 or more in immunosenescent populations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Epidermodysplasia Verruciformis\",\n",
       "                    \"value\": \"Additionally, FilmArray Retinitis_Pigmentosa detected 138 pathogens confirmed as true positives not included in the Prodesse assays rhinovirus RVenterovirus end_entity, 118; bocavirus, 8; start_entity, 7; parainfluenza virus 4, 4; Mycoplasma pneumoniae, 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": \"Additionally, FilmArray end_entity detected 138 pathogens confirmed as true positives not included in the Prodesse assays rhinovirus RVenterovirus Epidermodysplasia_Verruciformis, 118; bocavirus, 8; start_entity, 7; parainfluenza virus 4, 4; Mycoplasma pneumoniae, 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV is an important emerging virus that is highly pathogenic in aged populations and is maintained with great diversity in zoonotic reservoirs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"Interestingly, these recently recognized viruses include not only some with oncogenic potential hepatitis B virus, rhesus papillomavirus, cottontail rabbit papillomavirus but also many without this potential influenza virus, end_entity virus, tick-borne encephalitis virus, rabies virus, severe acute respiratory syndrome start_entity, human immunodeficiency virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Public health measures successfully contained outbreaks of the severe acute respiratory syndrome start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We demonstrate here that anti-Spike immune serum, while inhibiting viral entry in a permissive cell line, potentiated infection of immune cells by end_entity-CoV Spike-pseudotyped lentiviral particles, as well as replication-competent end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sarcoma, Kaposi\",\n",
       "                    \"value\": \"Final diagnoses were bacterial start_entity 29, Pneumocystis jirovecii start_entity 27, pulmonary tuberculosis 22, and pulmonary end_entity 16; 39 77 of these cases were confirmed cases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is the aetiological agent of the highly infectious severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Neural Tube Defects\",\n",
       "                    \"value\": \"Mouse hepatitis start_entity MHV uses the N-terminal domain end_entity of its spike protein as its receptor-binding domain\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Newcastle Disease\",\n",
       "                    \"value\": \"Bovine parainfluenza virus type 3, feline start_entity, and feline calicivirus were used as models for other important avian pathogens, such as end_entity virus, infectious bronchitis virus, and avian hepatitis E virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We recently determined the crystal structures of NL63 start_entity NL63-CoV and end_entity start_entity end_entity-CoV receptor-binding domains RBDs, each complexed with their common receptor, human angiotensin-converting enzyme 2 hACE2, and proposed the existence of a virus-binding hot spot on hACE2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 288-nucleotide nt 3 untranslated region UTR in the genome of the bovine start_entity BCoV and 339-nt 3 UTR in the severe acute respiratory syndrome end_entity start_entity SCoV can each replace the 301-nt 3 UTR in the mouse hepatitis start_entity MHV for virus replication, thus demonstrating common 3 cis-replication signals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Ichthyosis prematurity syndrome\",\n",
       "                    \"value\": \"Rationale: Acute lung dysfunction of noninfectious etiology, known as idiopathic start_entity syndrome end_entity, is a severe complication following hematopoietic_stem_cell_transplantation HSCT\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"hematopoietic stem cell transplantation\",\n",
       "                    \"value\": \"Rationale: Acute lung dysfunction of noninfectious etiology, known as idiopathic start_entity syndrome Ichthyosis_prematurity_syndrome, is a severe complication following end_entity HSCT\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Methods: An start_entity committee performed PubMed and OVID searches for published, peer-reviewed articles using the keywords idiopathic end_entity syndrome or lung injury or pulmonary complications AND bone marrow transplant or hematopoietic stem cell transplant\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV emerged in early 2003 to cause a very severe acute respiratory syndrome, which eventually resulted in a 10 case-fatality rate\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"ute lung injury ALI and acute respiratory distress syndrome end_entity, caused by influenza A virus H5N1 and severe acute respiratory syndrome start_entity SARS-CoV, supposedly depend on activation of the oxidative-stress machinery that is coupled with innate immunity, resulting in a strong proinflammatory host response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The worldwide outbreak of the severe acute respiratory syndrome end_entity in 2003 was due to the transmission of end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"The condition can stem from a multitude of causes including start_entity, septicemia and trauma ultimately resulting in end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by other viruses employing similar viral entry mechanisms such as HIV-1 and severe acute respiratory syndrome start_entity can be inhibited with synthetic peptides corresponding to the native CHR sequence C-peptides\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To date, the end_entity start_entity is the only known highly pathogenic human start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is a severe respiratory illness caused by a novel virus, the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome is a severe respiratory illness caused by a novel virus, the Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Proteins in plasma and PARP9 from two neutropenic rabbit models of IPA and Pseudomonas start_entity were analyzed by SELDI-TOF end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome can cause the development of severe end-stage lung disease characterized by acute respiratory distress syndrome end_entity and pulmonary fibrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity can cause the development of severe end-stage lung disease characterized by acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult and pulmonary fibrosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"15 and as an entry blocker of severe acute respiratory syndrome end_entity start_entity and Ebola pseudotype virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The oxocarbazate and a related thiocarbazate PubChem CID 16725315 were tested in a end_entity start_entity CoV and Ebola virus-pseudotype infection assay with the oxocarbazate but not the thiocarbazate, demonstrating activity in blocking both end_entity-CoV inhibitory_concentration_50 273 49 nM and Ebola virus inhibitory_concentration_50 193 39 nM entry into human embryonic kidney 293T cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"inhibitory concentration 50\",\n",
       "                    \"value\": \"The oxocarbazate and a related thiocarbazate PubChem CID 16725315 were tested in a Severe_Acute_Respiratory_Syndrome start_entity CoV and Ebola virus-pseudotype infection assay with the oxocarbazate but not the thiocarbazate, demonstrating activity in blocking both Severe_Acute_Respiratory_Syndrome-CoV end_entity 273 49 nM and Ebola virus end_entity 193 39 nM entry into human embryonic kidney 293T cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Its tertiary structure is compared with that of severe acute respiratory syndrome end_entity start_entity PL2pro, a downstream paralog that is conserved in the nsp3's of all start_entityes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To evaluate sequential nearest-neighbor effects on quantum-chemical calculations of 13C chemical shifts, we selected the structure of the nucleic acid binding NAB protein from the end_entity start_entity determined by NMR in solution PDB id 2K87\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"RSS\",\n",
       "                    \"value\": \"Here, we have identified an end_entity from a medically important positive-sense mammalian virus, Severe_Acute_Respiratory_Syndrome start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, we have identified an RSS from a medically important positive-sense mammalian virus, end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"dysregulated innate immune response and exuberant cytokinechemokine expression are believed to be critical factors in the pathogenesis of severe acute respiratory syndrome end_entity, caused by a start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity, end_entity and asthma were the most common diagnoses in children with HMPV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The most prominent of these viruses is the end_entity start_entity SARS-CoV which causes acute respiratory and gastrointestinal infection in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The most prominent of these viruses is the Severe Acute Respiratory end_entity start_entity SARS-CoV which causes acute respiratory and gastrointestinal infection in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The 3C-like PRTN3CLpro of the severe acute respiratory syndrome end_entity start_entity plays a vital role in virus maturation and is proposed to be a key target for drug design against end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity is a lethal disease of felids caused by systemic infection with a feline start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV was identified to be the causative agent of end_entity with atypical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The discovery of a start_entity CoV as the causative agent of severe acute respiratory syndrome end_entity has highlighted the need for a better understanding of CoV replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Development of vaccines is essential for the prevention of future recurrences of severe acute respiratory syndrome end_entity, caused by the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using mice lacking functional receptors for type I IFNA1, type III IFNA1, or both, we found that IFNA1- plays an important role in the defense against several human pathogens that infect the respiratory tract, such as influenza A virus, influenza B virus, respiratory syncytial virus, human metapneumovirus, and severe acute respiratory syndrome end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interestingly, we found that end_entity start_entity was present in feces from infected mice lacking receptors for both type I and type III IFNA1 but not in those from mice lacking single receptors, supporting the view that IFNA1- contributes to the control of viral infections in epithelial cells of both respiratory and gastrointestinal tracts\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ataxia Telangiectasia\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"essment of the risks posed by severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome end_entity Severe_Acute_Respiratory_Syndrome-CoV on surfaces requires data on survival of this virus on environmental surfaces and on how survival is affected by environmental variables, such as air temperature start_entity and relative humidity RH\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"essment of the risks posed by severe acute respiratory syndrome end_entity start_entity end_entity-CoV on surfaces requires data on survival of this virus on environmental surfaces and on how survival is affected by environmental variables, such as air temperature Ataxia_Telangiectasia and relative humidity RH\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here we characterized the DUB and IFNA1 antagonism activities of the PLP domains of human start_entity NL63 and severe acute respiratory syndrome end_entity start_entity to determine if DUB activity mediates interferon antagonism\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"MeV also infects other epithelial and neuronal cells that do not express SLAMF1 and causes start_entity and end_entity and, sometimes, serious symptoms such as measles encephalitis and subacute sclerosing panencephalitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The main protease Mpro plays a vital role in proteolytic processing of the polyproteins in the replicative cycle of end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"During severe acute respiratory syndrome start_entity end_entity, the activity of the replicationtranscription complexes RTC quickly peaks at 6 hours post infection h\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a start_entity infection which broke out in Hong Kong in March 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The pathogenic agent responsible for severe acute respiratory syndrome end_entity, the end_entity start_entity end_entity-CoV, is a member of this large family of positive-strand RNA viruses that cause a spectrum of disease in humans, other mammals, and birds\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV encodes 3 major ERVW-1s: spike S, membrane M, and envelope E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A start_entity end_entity-CoV was identified as the etiological agent of end_entity, and initial assessments determined that the virus crossed to human hosts from zoonotic reservoirs, including bats, Himalayan palm civets Paguma larvata, and raccoon dogs Nyctereutes procyonoides, sold in exotic animal markets in Guangdong Province\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We characterized the cellular immune response to severe acute respiratory syndrome start_entity end_entity in 12- to 14-month-old BALBc mice, a model that mimics features of the human disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Incidentally, ACE2 is also used by group GCNT2 end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Sporadic outbreaks of epizootics including end_entity start_entity and H5N1 avian influenza remind us of the potential for communicable diseases to quickly spread into worldwide epidemics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is known to efficiently suppress the induction of antiviral type I interferons IFN- in non-lymphatic cells through inhibition of the transcription factor IRF-3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Because IL17A and IL17AF, ligands for IL17A receptor antagonist IL17ARA, have been shown to mediate neutrophil migration into the lung in response to end_entity or Gram-negative bacterial start_entity, we hypothesized that IL17ARA signaling was critical for acute lung injury in response to pulmonary influenza infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Twenty-six 41 start_entity positive patients had evidence of a lower respiratory tract infection LRTI, 17 26 presented with vomiting andor end_entity, and 5 8 presented with meningoencephalitis or seizures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Twenty-six 41 start_entity positive patients had evidence of a lower respiratory tract infection LRTI, 17 26 presented with end_entity andor diarrhea, and 5 8 presented with meningoencephalitis or seizures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We evaluated the efficacy of rhesus theta-defensin 1 RTD-1, a novel cyclic antimicrobial peptide, as a prophylactic antiviral in a mouse model of severe acute respiratory syndrome end_entity start_entity CoV lung disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Despite the identification of end_entity start_entity end_entity-CoV as the etiologic agent of end_entity, a thorough understanding of the underlying disease pathogenesis has been hampered by the lack of a suitable animal model that recapitulates the human disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity is highly pathogenic in humans and evades innate immunity at multiple levels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study we demonstrate that end_entity start_entity M protein inhibits gene transcription of type I interferons\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Taken together, our findings reveal a new mechanism by which end_entity start_entity circumvents the production of type I interferons\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV intimately engages and regulates the host innate immune responses during infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The nucleocapsid N protein of severe acute respiratory syndrome end_entity start_entity plays important roles in both viral replication and modulation of host cell processes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The aims of this study were to validate a colorimetric method to measure total sialic acid PRDX2 in feline serum and to investigate the serum concentration of PRDX2 in clinically healthy cats seronegative n 9 and seropositive n 48 for feline start_entity FCoV, and in cats affected by feline infectious peritonitis end_entity, n 28, tumors n 20, or inflammation n 16\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We previously reported that transgenic Tg mice expressing human angiotensin-converting enzyme 2 hACE2, the receptor for severe acute respiratory syndrome start_entity SARS-CoV, were highly susceptible to end_entity, which resulted in the development of disease of various severity and even death in some lineages\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recently, several potent human monoclonal antibodies hmAbs targeting the end_entity-Associated start_entity end_entity CoV S glycoproteins were developed quickly after the virus was identified in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this report, we used a yeast genetic system to functionally screen for the cap-forming enzymes encoded by severe acute respiratory syndrome end_entity start_entity and identified the nonstructural protein nsp 14 of end_entity start_entity as a guanine-N7-methyltransferase N7-MTase in vivo in yeast cells and in vitro using purified enzymes and RNA substrates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity main protease Mpro plays an essential role in the extensive proteolytic processing of the viral polyproteins pp1a and pp1ab, and it is an important target for anti-end_entity drug development\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a newly emerging infectious disease caused by a start_entity, end_entity-start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an infectious disease caused by a start_entity that cost nearly 800 lives\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"While there have been no recent outbreaks of the disease, the threat remains as end_entity start_entity end_entity-CoV like strains still exist in animal reservoirs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV, a virus that causes severe lung damage, encodes an array of proteins able to inhibit induction and signaling of type-I interferons\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"More recently, potent fully-human neutralizing mAbs have been developed against a variety of important human viral disease agents including the paramyxoviruses Hendra virus and Nipah virus, and human or humanized mAbs have been developed against severe acute respiratory syndrome start_entity end_entity CoV, and West Nile virus, among others\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV encodes several accessory proteins of unknown function\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Noonan Syndrome\",\n",
       "                    \"value\": \"The effects of the compounds were specific to end_entity, because they had no effect on the ability of the severe acute respiratory syndrome start_entity papainlike protease protein to block beta interferon promoter activation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The nuclear magnetic resonance NMR structure of a central segment of the previously annotated severe acute respiratory syndrome end_entity-unique domain SUD-M, for middle of the end_entity-unique domain in end_entity start_entity end_entity-CoV nonstructural protein 3 nsp3 has been determined\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchitis\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"However, here we show that the X-domain of Infectious start_entity Virus strain Beaudette, a Group-3 end_entity, fails to bind ADP-ribose\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lung transplantation\",\n",
       "                    \"value\": \"The objective of this study was to examine the relationship between serum ALB concentration and mortality in a large cohort of patients with idiopathic interstitial start_entity listed for end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity, which is caused by a start_entity CoV, is a highly communicable disease with the lungs as the major pathological target\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Turkey start_entity TCoV causes end_entity in young turkey poults, but little is known about its prevalence in the field\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Effective vaccines should confer long-term protection against future outbreaks of severe acute respiratory syndrome end_entity caused by a novel zoonotic start_entity end_entity-CoV with unknown animal reservoirs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity end_entity-CoV is known to take an endosomal pathway for cell entry; however, it is thought to enter directly from the cell surface when a receptor-bound virion spike S protein is affected by trypsin, which induces cleavage of the S protein and activates its fusion potential\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Sequence-specific NMR assignments of the globular core comprising the residues 10661181 within the non-structural protein nsp3e from the end_entity start_entity have been obtained using triple-resonance NMR experiments with the uniformly 13C,15N-labeled protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emergence of highly pathogenic strains like the end_entity start_entity end_entity-CoV, and the discovery of two new start_entityes, NL-63 and HKU1, corroborates the high rate of mutation and recombination that have enabled them to cross species barriers and infect novel hosts\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by HCoV-HKU1 occurs worldwide and causes syndromes such as the common cold, bronchitis, and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Blood and turbinate wash samples, and lung tissue were collected from each animal at different time points after end_entity start_entity CoV infection for determining the growth curve of virus, if any, by the standard infectivity assay in Vero E6 cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of humans with the severe acute respiratory syndrome start_entity SARS-CoV results in substantial morbidity and mortality, with death resulting primarily from respiratory failure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV is a high-risk infectious pathogen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The immunogenicity and protective efficacy of a live attenuated vaccine consisting of a recombinant severe acute respiratory syndrome end_entity start_entity lacking the E gene rend_entity-CoV-E were studied using hamsters\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome end_entity associated start_entity outbreak in late 2002, early 2003 called attention to the potential damage that start_entityes could cause in the human population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It is believed that a start_entity, severe acute respiratory syndrome start_entity end_entity-CoV, was passed from palm civets to humans and caused the epidemic of end_entity in 2002 to 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is the etiological agent of end_entity, an emerging disease characterized by atypical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"PURPOSE: The large number of deaths in a short period of time due to the spread of severe acute respiratory syndrome end_entity infection led to the unparalleled collaborative efforts world wide to determine and characterize the new start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Indeed, clusters of end_entity start_entity end_entity-CoV particles have been detected in the cytoplasm of renal tubular epithelial cells in postmortem studies, explaining the presence of infectious virus in the urine of end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity infection and growth are dependent on initiating signaling and enzyme actions upon viral entry into the host cell\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Carcinoma, Non-Small-Cell Lung\",\n",
       "                    \"value\": \"We applied a surfaceenhanced laser desorptionionization timeofflight mass spectrometry SELDITOF Multiple_Sclerosis ProteinChip system to detect 150 serum samples including 54 Carcinoma,_Small_Cell patients, 24 nonsmall cell lung cancer end_entity patients, 32 start_entity patients, and 40 healthy individuals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Carcinoma, Small Cell\",\n",
       "                    \"value\": \"We applied a surfaceenhanced laser desorptionionization timeofflight mass spectrometry SELDITOF Multiple_Sclerosis ProteinChip system to detect 150 serum samples including 54 end_entity patients, 24 nonsmall cell lung cancer Nend_entity patients, 32 start_entity patients, and 40 healthy individuals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"We applied a surfaceenhanced laser desorptionionization timeofflight mass spectrometry SELDITOF end_entity ProteinChip system to detect 150 serum samples including 54 Carcinoma,_Small_Cell patients, 24 nonsmall cell lung cancer Carcinoma,_Non-Small-Cell_Lung patients, 32 start_entity patients, and 40 healthy individuals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Carcinoma, Small Cell\",\n",
       "                    \"value\": \"Pattern 2, constructed of protein peaks with masscharge mz of 2,764 Da and 1,7368 Da, separated end_entity from start_entity with a sensitivity of 88\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Stickler syndrome, type 1\",\n",
       "                    \"value\": \"end_entity occurred in about half of children with URI1 associated with adenovirus, respiratory syncytial virus RSV, and start_entity, and about one-third of those with influenza, parainfluenza, enterovirus and rhinovirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We treated porcine respiratory start_entity PRCV-infected conventional pigs with the corticosteroid dexamethasone DEX as a model for end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV emerged in 2002, and detailed phylogenetic and epidemiological analyses have suggested that it originated from animals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, reverse transcription-PCR RT-PCR targeting of the RNAs of influenza A and influenza B viruses and end_entity start_entity was performed, and the resulting products were spliced into a fragment which was packaged into armored RNA for use as a noninfectious, quantifiable synthetic substitute\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of Severe_Combined_Immunodeficiency mice with a recombinant murine start_entity mouse hepatitis virus MHV expressing the T-cell chemoattractant CXC chemokine ligand 10 CXCL10 resulted in increased survival and reduced viral burden within the brain and liver compared to those of mice infected with an isogenic control virus MHV, supporting an important role for CXCL10 in innate immune responses following viral infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Combined Immunodeficiency\",\n",
       "                    \"value\": \"Infection of end_entity mice with a recombinant murine start_entity mouse hepatitis virus MHV expressing the T-cell chemoattractant CXC chemokine ligand 10 CXCL10 resulted in increased survival and reduced viral burden within the brain and liver compared to those of mice infected with an isogenic control virus MHV, supporting an important role for CXCL10 in innate immune responses following viral infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by the end_entity-associated start_entity end_entity-CoV, which uses angiotensin-converting enzyme 2 ACE2 as its receptor for cell entry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Virus-like particles VLPs represent a promising vaccine against severe acute respiratory syndrome start_entity end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity end_entity-CoV causes end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here we report the development of a more-sensitive immunoassay for severe acute respiratory syndrome end_entity based on an enzyme-linked immunosorbent assay using chemiluminescence CLEIA to detect the viral nucleocapsid N antigen in nasopharyngeal aspirate NPA from patients infected with end_entity start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Because the pulmonary pathology of porcine respiratory start_entity PRCV in pigs resembles end_entity, we used PRCV as a model to clarify the effects of the corticosteroid dexamethasone DEX on start_entity CoV-induced start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We analyzed this cross-reactivity by an enzyme-linked immunosorbent assay ELISA and Western blot analysis using specific antisera to animal start_entity and end_entity-CoV and end_entity patient convalescent-phase or negative sera\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The N-protein fragments comprising aa 360 to 412 and aa 1 to 213 reacted specifically with end_entity convalescent-phase sera but not with negative human sera in ELISA; the fragment comprising aa 1 to 213 cross-reacted with antisera to animal start_entity, whereas the fragment comprising aa 360 to 412 did not cross-react and could be a potential candidate for end_entity diagnosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Before the emergence of severe acute respiratory syndrome end_entity start_entity end_entity-CoV in 2003, only 12 other animal or human start_entityes were known\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"n indirect immunofluorescent assay Euroimmun AG, Luebeck, Germany was used to investigate the avidity of immunoglobulin G IgG, IgM, IgA, and total Ig IgGAM antibody responses to severe acute respiratory syndrome start_entity end_entity CoV infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is a start_entity that causes a highly contagious respiratory disease, end_entity, with significant mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by a newly emerged start_entity CoV designated end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome end_entity epidemic was caused by the spread of a previously unrecognized infectious agent, the end_entity-associated start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Murine hepatitis virus MHV and severe acute respiratory syndrome end_entity start_entity CoV are two of the best-studied representatives of the family Coronaviridae\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity encodes several accessory proteins of unknown function\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by the start_entity mouse hepatitis virus strain A59 MHV-A59 requires the release of the viral genome by fusion with the respective target membrane of the host cell\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the case of severe acute respiratory syndrome start_entity end_entity, viral entry is reported to require a low pH in intracytoplasmic vesicles; however, little is known about how SARS-CoV invades such compartments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \", Huntsville, AL detects Flu-A, Flu-B, PIV-1, PIV-2, PIV-3, PIV-4, RSV, human metapneumovirus hMPV, rhinoviruses RhVs, enteroviruses EnVs, and severe acute respiratory syndrome end_entity start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recently, a paper was published in which it was proposed that the GxxxG motif of the severe acute respiratory syndrome end_entity start_entity spike S protein transmembrane domain plays a vital role in oligomerization of the protein E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In addition, the capability of S to mediate entry of end_entity S-pseudotyped particles overall was affected moderately in the mutant proteins, also arguing for a nonvital role for the GxxxG motif in end_entity start_entity entry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using synthetic biology and reverse genetics, we describe the construction of a panel of isogenic end_entity start_entity end_entity-CoV strains bearing variant spike glycoproteins that are representative of zoonotic strains found in palm civets and raccoon dogs, as well as isolates spanning the early, middle, and late phases of the end_entity-CoV epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To analyze the immunogenicity of the severe acute respiratory syndrome end_entity start_entity CoV, end_entity-CoV, spike DNA vaccine and the immunoregulatory activity of interleukin-2 IL2, DNA vaccine plasmids pcDNA-S and pcDNA-IL2 were constructed and inoculated into BALBc mice with or without pcDNA-IL2 by using three different immunization routes the intramuscular route, electroporation, or the oral route with live attenuated Salmonella enterica serovar Typhimurium\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Since an outbreak of severe acute respiratory syndrome end_entity was averted in 2004, many start_entityes have been recognized from different species, including humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This end_entity start_entity end_entity-CoV exploited opportunities provided by 'wet markets' in southern China to adapt to the palm civet and human\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our findings suggest that the design of end_entity vaccine should consider not only preventing the reemergence of end_entity-CoV but also providing cross-protection, thus interrupting zoonotic transmission of a group of genetically divergent civet start_entity of broad geographic origin\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Dating of different start_entity lineages suggests that bat start_entityes are older than those recognized in other animals and that the human severe acute respiratory syndrome end_entity start_entity was directly derived from viruses from wild animals in wet markets of southern China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our assays demonstrated high sensitivity and specificity to the end_entity start_entity in sera collected from patients as late as 2 years postonset of symptoms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These assays will be useful not only for routine end_entity start_entity diagnostics but also for epidemiological and antibody kinetic studies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an infectious disease caused by the human start_entity, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Like other start_entityes, severe acute respiratory syndrome start_entity end_entity CoV assembles at and buds into the lumen of the endoplasmic reticulum ER-Golgi intermediate compartment ERGIC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The spectrum of illness included upper respiratory infection, croup, bronchiolitis, and start_entity with a prominence of end_entity and fever\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"nimal models for severe acute respiratory syndrome end_entity start_entity infection of humans are needed to elucidate end_entity pathogenesis and develop vaccines and antivirals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A transgenic lineage, designated AC70, was among the best characterized against end_entity start_entity infection, showing weight loss and other clinical manifestations before reaching 100 mortality within 8 days after intranasal infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severity of the disease that developed in these transgenic mice-AC70 in particular-makes these mouse models valuable not only for evaluating the efficacy of antivirals and vaccines, but also for studying end_entity start_entity pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"One or more of the unique 3-proximal open reading frames ORFs of the severe acute respiratory syndrome end_entity start_entity may encode determinants of virus virulence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity encodes a novel membrane protein 6 that can accelerate replication of a related mouse virus, a property that may explain its ability to increase in vivo virus virulence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Symptomatic residents experienced end_entity 66, fever 21 and start_entity 12\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome end_entity, caused by a start_entity end_entity-CoV, resulted in substantial morbidity, mortality, and economic losses during the 2003 epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Intranasal infection of AJ mice with the start_entity murine hepatitis virus strain 1 MHV-1 produced pulmonary pathological features of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an emerging infectious disease caused by a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To delineate the viral and cellular factor interactions, the role of four end_entity start_entity proteins, including nonstructural protein 1 nsp-1, nsp-5, envelope, and membrane, were examined in terms of cytokine induction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our results showed that the end_entity start_entity nsp-1 plays an important role in CCL5, CXCL10, and CCL3 expression in human lung epithelial cells via the activation of NF-B\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using end_entity start_entity, we now show that start_entityes uniquely encode a second RdRp residing in nsp8\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"group 2 human start_entity designated HECV-4408 was isolated from a child with acute end_entity and is antigenically and genetically more closely related to bovine start_entity BCoV than to human start_entity OC43 X\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"After challenge with bovine start_entity, no end_entity or virus shedding was detected in calves inoculated with HECV-4408, but a mock-inoculated calf developed end_entity and fecal and nasal shedding\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatolenticular Degeneration\",\n",
       "                    \"value\": \"Bovine start_entity BCoV is an etiological agent associated with winter dysentery end_entity, prevalent in adult cattle during the winter\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"44 who had immunoglobulin G antibodies to the end_entity start_entity end_entity-CoV nucleocapsid N produced in bacteria\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity end_entity-CoV uses EREG as a site for synthesis and processing of viral proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity SCoV causes a recently emerged human disease associated with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Human recombinant Fab fragments specific for the spike protein of severe acute respiratory syndrome start_entity end_entity-CoV were screened from a human Fab library, which was generated from RNAs from peripheral lymphocytes of convalescent end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emergence of a start_entity CoV as the cause of severe acute respiratory syndrome end_entity catalyzed the development of rapid diagnostic tests\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The outbreak of severe acute respiratory syndrome end_entity and the recent identification of new start_entityes have highlighted the necessity for further investigation of start_entity ecology, in particular the role of bats and other wild animals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Phylogenetic analyses of the spike, envelope, membrane, and nucleoprotein structural proteins and the two conserved replicase domains, putative RNA-dependent RNA polymerase and RNA helicase, revealed that bat start_entityes cluster in three different groups: group 1, another group that includes all end_entity and end_entity-like start_entityes putative group 4, and an independent bat start_entity group putative group 5\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SCoV 7a protein is one of the viral accessory proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To evaluate the risk of transmission of end_entity start_entity outside of the health-care setting, close household and community contacts of laboratory-confirmed end_entity cases were identified and followed up for clinical and laboratory evidence of end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Two community contacts with laboratory evidence of end_entity start_entity infection had mild or sub-clinical infection, representing 3 265 of Vietnamese end_entity cases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, using a panel of replicase-specific antisera, we have analyzed the earlier stages of severe acute respiratory syndrome start_entity end_entity in Vero E6 cells, in particular focusing on the subcellular localization of the replicase and the ultrastructure of the associated membranes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is an infectious disease which was caused by a start_entity end_entityCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These studies attempt to understand more fully the host response and pathogenesis associated with severe acute respiratory syndrome end_entity start_entity end_entity-CoV by monitoring gene expression using formalin-fixed paraffin-embedded FFPE pulmonary autopsy tissues\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV 3C-like protease 3CLpro mediates extensive proteolytic processing of replicase polyproteins, and is considered a promising target for anti-SARS drug development\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Replication of severe acute respiratory syndrome end_entity start_entity end_entity-CoV requires proteolytic processing of the replicase polyprotein by two viral cysteine proteases, a CTRL protease 3CLpro and a papain-like protease PLpro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Replication of the giant RNA genome of severe acute respiratory syndrome end_entity start_entity CoV and synthesis of as many as eight subgenomic sg mRNAs are mediated by a viral replicase-transcriptase of outstanding complexity that includes an essential endoribonuclease activity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To monitor severe acute respiratory syndrome end_entity infection, a start_entity protein microarray that harbors proteins from end_entity start_entity end_entity-CoV and five additional start_entityes was constructed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To study the cellular response in the acute phase of end_entity start_entity end_entity-CoV-host cell interaction, we investigated the induction of chemokines, adhesion molecules, and CD209 dendritic cell-specific ICAM-3-grabbing nonintegrin by end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Two months after the final outbreak, we recruited 658 employees from the hospital that suffered the first and most severe end_entity infections to help us investigate epidemiological and genetic factors associated with the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"was likely due to new interest in information about end_entity start_entity in Apr\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity was discovered during a recent global outbreak of atypical start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"OBJECTIVE: To assess the incidence of coinfection in patients confirmed to have end_entity-associated start_entity end_entity, and thus, to determine the risk of ruling out end_entity by ruling in another diagnosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": \"Numerous potent inhibitors of helicases encoded by herpes simplex virus, severe acute respiratory syndrome start_entity, hepatitis C virus, end_entity virus, West Nile virus, and human papillomavirus have been recently reported in the scientific literature\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SCoV accessory protein 3a is a virus structural protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The serum antibodies to severe acute respiratory syndrome end_entity start_entity of 18 end_entity patients were checked at 1 month and every 3 months after disease onset\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV emerged in 2002 as an important cause of severe lower respiratory tract infection in humans, and in vitro models of the lung are needed to elucidate cellular targets and the consequences of viral infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV encodes several unique group-specific open reading frames ORFs relative to other known start_entityes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The results indicate that infection of human airway epithelia by end_entity start_entity correlates with the state of cell differentiation and ACE2 expression and localization\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-CoV end_entity start_entity, a start_entity that has been etiologically associated with end_entity cases, is homologous with MHV murine hepatitis start_entity, and MHV small envelope E protein is capable of inducing apoptosis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The serological response profile of severe acute respiratory syndrome end_entity start_entity CoV infection was defined by neutralization tests and subclass-specific immunofluorescent IF tests using serial sera from 20 patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"lthough the initial isolates of the severe acute respiratory syndrome end_entity start_entity CoV are sensitive to neutralization by antibodies through their spike S glycoprotein, variants of S have since been identified that are resistant to such inhibition\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome start_entity end_entity-CoV was recently identified as the etiology of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"KD\",\n",
       "                    \"value\": \"Recently, an association between end_entity and human start_entity HCoVNew Haven Neonatal_hemochromatosis was reported, on the basis of polymerase chain reaction PCR with primers that also amplified HCoV-NL63\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Neonatal hemochromatosis\",\n",
       "                    \"value\": \"Recently, an association between KD and human start_entity HCoVNew Haven end_entity was reported, on the basis of polymerase chain reaction PCR with primers that also amplified HCoV-NL63\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interestingly, the predicted stem-loop IV homolog in the severe acute respiratory syndrome end_entity start_entity appears to be group 1-like in that it is in part duplicated with a group 1-like conserved loop sequence and is not group 2-like, as would be expected by the end_entity start_entity group 2-like 3 UTR structure\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Patent applications that incorporate the genomic sequence of the severe acute respiratory syndrome end_entity start_entity, have been filed by a number of organizations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"lthough the finding of severe acute respiratory syndrome start_entity end_entity-CoV in caged palm civets from live animal markets in China has provided evidence for interspecies transmission in the genesis of the end_entity epidemic, subsequent studies suggested that the civet may have served only as an amplification host for end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Both viral effect and immune-mediated mechanism are involved in the pathogenesis of severe acute respiratory syndrome-associated start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Neutralizing antibodies NAbs against severe acute respiratory syndrome end_entity start_entity end_entity-CoV spike S glycoprotein confer protection to animals experimentally infected with the pathogenic virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Massive numbers of palm civets were culled to remove sources for the reemergence of severe acute respiratory syndrome end_entity in Guangdong Province, China, in January 2004, following end_entity start_entity detection in market animals\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"unique start_entity severe acute respiratory syndrome-start_entity end_entity-CoV was revealed to be a causative agent of a life-threatening end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by an emergent start_entity end_entity-CoV, for which there is currently no effective treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an emerging disease characterised by fever and atypical start_entity and caused by a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"One PFU of end_entity start_entity was estimated to be 258 46 GE\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Several virus-targeted P-PMO and a random-sequence control P-PMO showed low inhibitory activity against end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity, caused by a start_entity CoV known as end_entity-CoV, is a contagious and life-threatening respiratory illness with pneumocytes as its main target\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a recently emerged human disease associated with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Inapparent infection with end_entity start_entity CoV is not well characterized\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to compare the responses of human macrophages to infections with the end_entity start_entity end_entity-CoV and other respiratory viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity SARS-CoV is a newly identified member of the family Coronaviridae and poses a serious public health threat\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However, discovery of the severe acute respiratory syndrome end_entity CoV revealed that highly pathogenic human start_entity Hstart_entity can evolve\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We describe here a rapid, sensitive, and highly efficient assay for the detection of end_entity start_entity end_entity-CoV in cultured material and a small number n 7 of clinical samples\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity-associated start_entity end_entity-CoV is the etiological agent of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"n antigen detection assay for severe acute respiratory syndrome end_entity start_entity was established in this study by an indirect immunofluorescence test, which utilized cells derived from throat wash samples of patients with end_entity and a rabbit serum that recognized the nucleocapsid protein of end_entity-associated start_entity end_entity-CoV but not that of other human start_entity tested\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"MIR7-3HG cells were found to be susceptible to both end_entity-CoV, associated with end_entity, and human start_entity 229E HCoV-229E, usually associated with the common cold\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The expression of the genomic information of severe acute respiratory syndrome start_entity end_entity CoV involves synthesis of a nested set of subgenomic RNAs sgRNAs by discontinuous transcription\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Heightened susceptibility of the elderly to severe end_entity and the ability of end_entity start_entity to replicate in mice led us to examine whether aged mice might be susceptible to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We report here that viral replication in aged mice was associated with clinical illness and start_entity, demonstrating an age-related susceptibility to end_entity disease in animals that parallels the human experience\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Different assays were used to analyze 1,621 serum specimens collected from military recruits from the People's Republic of China in 2002 for severe acute respiratory syndrome end_entity start_entity antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of the murine central nervous system CNS with a neurotropic start_entity induces encephalitis associated with increased levels of mRNA encoding MMP-3 and MMP-12\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Human angiotensin-converting enzyme 2 ACE2 is a functional receptor for end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ntibody detection with a recombinant COOH portion of the severe acute respiratory syndrome end_entity start_entity nucleocapsid N protein, N13 amino acids 221 to 422, was demonstrated to be more specific and sensitive than that with the full-length N protein, and an N13-based antigen-capturing enzyme-linked immunosorbent assay providing a convenient and specific test for serodiagnosis and epidemiological study of end_entity was developed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Of 30 cell lines and primary cells examined, productive severe acute respiratory syndrome start_entity Urbani strain end_entity after low-multiplicity inoculation was detected in only six: three African green monkey kidney epithelial cell lines Vero, Vero E6, and MA104, a human colon epithelial line CaCo-2, a porcine kidney epithelial line PK15, and mink lung epithelial cells Mv 1 Lu\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a recently emerged infectious disease caused by a novel strain of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These results suggest that the end_entity start_entity might have an antigenic profile distinct from those of other human or animal start_entityes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is caused by a novel and highly infectious virus named end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We examined severe acute respiratory syndrome-associated start_entity end_entity-CoV RNA in plasma of 32 patients probable end_entity cases by a quantitative real-time reverse transcription-PCR assay and reported that the highest detection rate, 75, was found between day 5 and day 7 of illness, followed by rates of 64, 50, and 38 found between day 8 and day 11, day 2 and day 4, and day 12 and day 16, respectively\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"A good correlation was observed between the free energy of TRS-L and cTRS-B duplex formation and the levels of subgenomic mRNA S2, demonstrating that base pairing between the leader and body beyond the end_entity is a determinant regulation factor in start_entity transcription\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity was caused by a novel virus now known as end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Human monoclonal antibodies MAbs were selected from semisynthetic antibody phage display libraries by using whole irradiated severe acute respiratory syndrome end_entity start_entity CoV virions as target\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have identified the membrane-active regions of the severe acute respiratory syndrome start_entity end_entity CoV spike glycoprotein by determining the effect on model membrane integrity of a 1618-mer end_entity CoV spike glycoprotein peptide library\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The purpose of this study was to examine whether NO inhibits the replication cycle of the severe acute respiratory syndrome start_entity end_entity CoV in vitro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"urate and timely diagnosis of severe acute respiratory syndrome start_entity end_entity is a critical step in preventing another global outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Small animal models are needed in order to evaluate the efficacy of candidate vaccines and antivirals directed against the severe acute respiratory syndrome start_entity end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the past 3 years, several novel respiratory viruses, including human metapneumovirus, severe acute respiratory syndrome end_entity start_entity end_entity-CoV, and human start_entity NL63, were discovered\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"We describe the natural history, viral dynamics, and immunobiology of feline infectious peritonitis end_entity, a highly lethal start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"IM: Nucleocapsid N protein plays an important role in reproduction and pathological reaction of severe acute respiratory syndrome end_entity start_entity SCoV, the antigenicity of the protein is better than spike S protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSION: Active recombinant severe acute respiratory syndrome end_entity start_entity nucleocapsid rSCoVN protein can be successfully expressed in recombinant methylotrophic yeast P\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Gene 1 of the start_entity associated with severe acute respiratory syndrome end_entity encodes replicase polyproteins that are predicted to be processed into 16 nonstructural proteins nsps 1 to 16 by two viral proteases, a papain-like protease PLpro and a 3C-like protease 3CLpro\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Here, we identify end_entity start_entity amino-terminal replicase products nsp1, nsp2, and nsp3 and describe trans-cleavage assays that characterize the protease activity required to generate these products\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We found that end_entity start_entity replicase products can be detected by 4 h postinfection in the cytoplasm of infected cells and that nsps 1 to 3 colocalize with newly synthesized viral RNA in punctate, perinuclear sites consistent with their predicted role in viral RNA synthesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity end_entity is caused by a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Preliminary data suggest that a high viral load of the end_entity start_entity is associated with adverse outcomes in the intensive care unit, but the relation of viral load to survival is unclear\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"82 and higher initial viral load of end_entity start_entity, according to quantitative PCR of nasopharyngeal specimens adjusted HR 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Western immunoblot assay for confirmatory serodiagnosis of severe acute respiratory syndrome end_entity was developed utilizing viral lysate antigens combined with a recombinant nucleocapsid protein, GST-N glutathione S-transferase-nucleocapsid of the end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Specific immunoglobulin G antibody for severe acute respiratory syndrome end_entity start_entity was detected in maternal blood, umbilical blood, and amniotic fluid from a pregnant end_entity patient\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"With the identification of a start_entity associated with the severe acute respiratory syndrome end_entity, computational analysis of its RNA genome sequence is expected to give useful clues to help elucidate the origin, evolution, and pathogenicity of the virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In contrast, length-six palindromes are significantly underrepresented only in the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ntigenic sites on the nucleocapsid N protein of severe acute respiratory syndrome end_entity start_entity end_entity-CoV were mapped by Pepscan analysis with overlapping peptides that span the N protein sequence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity caused by a newly identified start_entity end_entity-CoV is a serious emerging human infectious disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Intranasal inhalation of the severe acute respiratory syndrome start_entity end_entity CoV in the immunocompetent mouse strain 129SvEv resulted in infection of conducting airway epithelial cells followed by rapid clearance of virus from the lungs and the development of self-limited bronchiolitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Rhesus and cynomolgus macaques were challenged with 107 PFU of a clinical isolate of the severe acute respiratory syndrome end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV is the pathogen of end_entity, which caused a global panic in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity end_entity-CoV that causes severe acute respiratory syndrome end_entity infects cells expressing the receptor angiotensin-converting enzyme 2 ACE2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In March 2003, a start_entity was isolated from patients exhibiting atypical start_entity, and was subsequently proven to be the causative agent of the disease now referred to as end_entity severe acute respiratory syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The complete genome of the end_entity-CoV end_entity start_entity has since been sequenced\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The worldwide outbreak of severe acute respiratory syndrome end_entity was shown to be associated with a start_entity CoV now called end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Although a start_entity has been identified as the causative agent of end_entity, the pathogenic mechanisms of end_entity are not understood\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV moved into humans from a reservoir species and subsequently caused an epidemic in its new host\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Since the recognition in April 2003 of the severe acute respiratory syndrome start_entity end_entity-CoV as the causative agent of severe acute respiratory syndrome end_entity, enormous efforts have been applied to develop molecular and serological tests for end_entity which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Proof that a newly identified start_entity, severe acute respiratory syndrome start_entity end_entity-CoV is the primary cause of severe acute respiratory syndrome end_entity came from a series of studies on experimentally infected cynomolgus macaques Macaca fascicularis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The search for animal host origins of severe acute respiratory syndrome end_entity start_entity has so far remained focused on wildlife markets, restaurants and farms within China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Conclusions: This is the first case series reported with the detection of the end_entity start_entity from tears, and has important implications for the practice of ophthalmology and medicine\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The sensitivities and specificities of an immunofluorescence assay and an enzyme immunoassay for detection of antibodies specific for severe acute respiratory syndrome start_entity end_entity-CoV were compared for 148 laboratory-confirmed end_entity cases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We report the development of an enzyme-linked immunosorbent assay ELISA for the detection of severe acute respiratory syndrome end_entity start_entity CoV nucleocapsid protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Although the identity of the end_entity start_entity end_entity-CoV genome was confirmed by DNA sequencing, it is impractical to sequence the entire 29-kb end_entity-CoV genome on a routine basis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity CoV has been identified as the etiological agent of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a life-threatening disease caused by a newly identified start_entity CoV, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Exposed epitopes of the spike protein may be recognized by neutralizing antibodies against severe acute respiratory syndrome end_entity start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an infectious disease caused by a novel human start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We investigated the contributions of the structural proteins of severe acute respiratory syndrome end_entity start_entity CoV to protective immunity by expressing them individually and in combinations from a recombinant parainfluenza virus PIV type 3 vector called BHPIV3\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The nucleocapsid N protein of end_entity-associated start_entity end_entity-CoV is abundantly expressed in infected-cell culture filtrate as demonstrable by Western blotting using convalescent-phase sera from patients with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV, a newly identified group 2 start_entity, is the causative agent of severe acute respiratory syndrome, a life-threatening form of start_entity in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The immunogenicity of HLA-A2-restricted T-cell epitopes in the S protein of the end_entity start_entity SARS-CoV and of human start_entity strain 229e HCoV-229e was analyzed for the elicitation of a T-cell immune response in donors who had fully recovered from end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of a recent outbreak of an atypical start_entity, known as severe acute respiratory syndrome end_entity, has been identified as a start_entity CoV not belonging to any of the previously identified groups\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity end_entity-CoV is the primary cause of the life-threatening severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Clinical and general laboratory manifestations included fever, chills, rigor, myalgia, malaise, diarrhoea, end_entity, dyspnoea, start_entity, lymphopenia, neutrophilia, thrombocytopenia, and elevated serum lactate dehydrogenase LD, alanine_ aminotransferase ALT and creatine_kinase CK activities\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"thrombocytopenia\",\n",
       "                    \"value\": \"Clinical and general laboratory manifestations included fever, chills, rigor, myalgia, malaise, diarrhoea, cough, dyspnoea, start_entity, lymphopenia, neutrophilia, end_entity, and elevated serum lactate dehydrogenase LD, alanine_ aminotransferase ALT and creatine_kinase CK activities\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The culprit, end_entity start_entity end_entity-CoV, was detected in patient specimens by traditional cell culture using an unusual cell line for respiratory viruses, Vero E6, and by reverse transcriptase polymerase chain reaction RT-PCR targeting the polymerase 1 B region of the genome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We report the evaluation of recombinant severe acute respiratory syndrome end_entity start_entity end_entity-CoV nucleocapsid protein enzyme-linked immunosorbent assay ELISA-based antibody tests for serodiagnosis of end_entity-CoV start_entity and compare the sensitivities and specificities of this ELISA for detection of immunoglobulin G IgG, IgM, IgA, and their combinations with serum samples from 149 healthy blood donors who donated blood 3 years ago as controls and 106 end_entity-CoV start_entity patients in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The new severe acute respiratory syndrome end_entity start_entity CoV, described in February 2003, infected a total of 8,439 people\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recent outbreaks of severe acute respiratory syndrome end_entity have spurred intense research efforts around the world to deal with the serious threat to health posed by this start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In conclusion, the nucleocapsid gene represents an additional sensitive molecular marker for the diagnosis of the end_entity start_entity and can be further adapted for use in a high-throughput platform assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity end_entity-CoV has been identified as the etiological agent for end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity, severe acute respiratory syndrome start_entity end_entity-CoV, has recently been identified as the causative agent of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Results: Laboratory confirmation of end_entity start_entity infection was established in 132 95\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The entire cDNA genome sequence of the previously undescribed start_entity was determined, revealing that it is most closely related to porcine epidemic end_entity virus and HCoV 229E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a recently emerged infectious disease caused by a start_entity, but its immunopathological mechanisms have not yet been fully elucidated\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a novel infectious disease caused by the end_entity-associated start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a fatal immunity-mediated disease caused by mutants of a ubiquitous start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Following intranasal administration, the severe acute respiratory syndrome end_entity start_entity replicated to high titers in the respiratory tracts of BALBc mice\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Thus, antibodies, acting alone, can prevent replication of the end_entity start_entity in the lung, a promising observation for the development of vaccines, immunotherapy, and immunoprophylaxis regimens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity SARS-CoV is a rapidly emerging pathogen with potentially serious consequences for public health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Bovine viral end_entity virus was demonstrated in the tissues of 492 myocarditis cases compared with those of 1335 calves dying from start_entity and 044 calves dying from noninfectious causes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To identify a major antigenic determinant for use in the development of a rapid serological diagnostic test for severe acute respiratory syndrome end_entity start_entity infection and to study the immune response during end_entity start_entity infection in humans, we cloned the full length and six truncated fragments of the nucleocapsid gene, expressed them, and purified them as glutathione S-transferase-tagged recombinant proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A truncated 195-amino-acid fragment from the C terminus of the nucleocapsid protein N195 was identified that had a strong ability to detect antibodies against end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The N195 protein was used to develop a Western blot assay to detect antibodies against end_entity start_entity in 274 clinically blinded samples\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Thus, the N195 protein was identified as a suitable protein to be used as an antigen in Western blot and other possible assays for the detection of end_entity start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The disease originated in southern China and a start_entity end_entity CoV has been implicated as the causative organism\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: end_entity end_entity is a newly described form of atypical start_entity linked to a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"With the use of detailed epidemiological data from other countries, this article describes the possible reason for the end_entity epidemic not appearing in Japan, and simulates the impact of different control strategies that can break the transmission cycle of end_entity associated start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: The clinical response of patients with severe acute respiratory syndrome end_entity to a combination of lopinavirritonavir and ribavirin was examined after establishing the in vitro antiviral susceptibility of the end_entity associated start_entity to a panel of antiviral agents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods: The in vitro susceptibility of the prototype of end_entity associated start_entity to a panel of nucleoside analogues and protease inhibitors currently licensed for clinical use was studied\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Results: In vitro antiviral activity against end_entity associated start_entity was demonstrated for lopinavir and ribavirin at concentrations of 4 gml and 50 gml, respectively, only at 48 hours\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Since early March 2003, the severe acute respiratory syndrome end_entity start_entity CoV infection has claimed 346 cases and 37 deaths in Taiwan\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Effective prophylaxis and antiviral therapies are urgently needed in the event of reemergence of the highly contagious and often fatal severe acute respiratory syndrome end_entity start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Profiles of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome end_entity-associated start_entity in 445 probable end_entity patients and 3,749 healthy people or non-end_entity patients were analyzed by antigen-capturing enzyme-linked immunosorbent assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Fecal secretory immunoglobulin A IgA antibodies in dogs infected or vaccinated with canine start_entity end_entity were evaluated by an enzyme-linked immunosorbent assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"The role of TRSs was analyzed by reverse genetics using a full-length infectious start_entity cDNA and site-directed mutagenesis of the end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a deadly form of start_entity caused by a start_entity, a viral family responsible for mild respiratory tract infections in a wide variety of animals including humans, pigs, cows, mice, cats, and birds\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Analyses to date have been unable to identify the precise origin of the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This event occurred near a region that has been implicated to be the human receptor binding site and may have been directly responsible for the switch of host of the end_entity start_entity from animals to humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A previously unrecognized start_entity was identified as the causative agent, and health officials throughout the world struggled to implement measures to contain its spread, including isolation of suspect end_entity cases and quarantine of exposed persons\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of severe acute respiratory syndrome end_entity is a previously unidentified start_entity, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Positive-strand RNA viruses are the largest virus class and include many pathogens such as hepatitis C virus and the severe acute respiratory syndrome start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Recombinant severe acute respiratory syndrome end_entity start_entity nucleocapsid protein was employed to establish an antigen-capturing enzyme-linked immunosorbent assay ELISA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"newly identified severe acute respiratory syndrome start_entity end_entity-CoV, is the etiological agent responsible for the outbreak of end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"previously undescribed start_entity CoV is the etiologic agent responsible for severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The reverse transcription RT-PCR protocols of two World Health Organization WHO severe acute respiratory syndrome end_entity network laboratories WHO end_entity network laboratories at The University of Hong Kong WHO-HKU and at the Bernhard-Nocht Institute in Hamburg, Germany WHO-Hamburg were evaluated for rapid diagnosis of a start_entity CoV associated with end_entity in Hong Kong\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity end_entity is a newly discovered infectious disease caused by a start_entity, which can readily spread in the healthcare setting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome is a newly discovered infectious disease caused by a start_entity, which can readily spread in the healthcare setting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity that causes severe acute respiratory syndrome end_entity is transmitted mainly via respiratory droplets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity, also called infectious atypical start_entity, is an emerging infectious disease caused by a novel variant of start_entity end_entity-associated start_entity, end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV is a porcine start_entity that causes end_entity, leading to near 100 mortality in neonatal piglets with corresponding devastating economic consequences\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It has been proved that severe acute respiratory syndrome end_entity is caused by end_entity-associated start_entity, a start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Due to the efforts of the WHO-led network of laboratories testing for end_entity, tests for the start_entity have been developed with unprecedented speed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is an infectious atypical start_entity that has recently been recognized in the patients in 32 countries and regions\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Noonan Syndrome 2\",\n",
       "                    \"value\": \"CD8A T cells reacting to the HLA-A2-presented peptide from HPV16 E711-1920 recognized also the HLA-A2 binding peptide TMLDIQPED amino acids 52 to 60 from the human start_entity OC43 end_entity gene product\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity virus FIPV, a start_entity, is the causative agent of an invariably lethal infection in cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Canine start_entity end_entity UWSMN-1 was originally identified from an outbreak of fatal gastroenteritis in breeding colonies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Sequencing of various regions of the spike and polymerase genes confirms that UWSMN-1 is widely divergent from other end_entity and feline start_entity strains\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The viruses are bovine herpes virus types 1, 3, 4 and 5, bovine viral end_entity virus, bovine parainfluenza 3 virus, bovine respiratory syncytial virus, bovine adenovirus, bovine rhinovirus, bovine start_entity, bovine reovirus, bovine enterovirus and alcelaphine herpesvirus-1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"haemolytica, bovine start_entity and bovine viral end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Serological evidence of previous viral exposure titer at arrival and current viral exposure titer increase during a 28-day study period, was used to determine if bovine start_entity BCV or bovine viral end_entity virus BVDV was associated with the occurrence of undifferentiated bovine respiratory disease UBRD in feedlot calves\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"nested PCR nPCR assay for the detection of canine start_entity end_entity in fecal samples is described\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"A greater percentage of owners with large herds than owners of small herds reported end_entity and start_entity problems\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Among large herds, the number of herds experiencing start_entity and calf mortality associated with end_entity tended to be higher in areas of the northwest\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Harlequin type ichthyosis\",\n",
       "                    \"value\": \"From 1985 to 1988, a total of 2496 swine sera from 60 farms in the Tohoku District of the Honshu Island of Japan were examined for antibodies to swine haemagglutinating encephalomyelitis virus HEV, human start_entity HCV and bovine start_entity BCV by haemagglutination-inhibition end_entity test\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Polycythemia Vera\",\n",
       "                    \"value\": \"We have characterized the hemagglutinin-esterase CYTIP of puffinosis virus end_entity, a start_entity closely related to mouse hepatitis virus MHV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Polycythemia Vera\",\n",
       "                    \"value\": \"Furthermore, end_entity esterase was unable to remove influenza C virus receptors from human erythrocytes, indicating a substrate specificity different from HEs of influenza C virus and bovine start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"This non-infectious calf end_entity protocol has a 100 response rate, while providing a consistent and predictable hypovolemic state with end_entity that reflects most of the clinicopathologic changes observed in osmoticmaldigestive end_entity caused by infection with rotavirus, start_entity or cryptosporidia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"Recent evidence suggests that the type GCNT2 feline start_entity FCoV strains 79-1146 and 79-1683 have arisen from a homologous RNA recombination event between FCoV type I and canine start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"diagnostic test for feline infectious peritonitis virus Feline_Infectious_PeritonitisV infection based on a nested PCR nPCR assay was developed and tested with Feline_Infectious_PeritonitisV, feline enteric start_entity FECV, canine start_entity end_entity, and transmissible gastroenteritis virus TGEV and clinical fluid samples from cats with effusive feline infectious peritonitis Feline_Infectious_Peritonitis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"diagnostic test for feline infectious peritonitis virus end_entityV infection based on a nested PCR nPCR assay was developed and tested with end_entityV, feline enteric start_entity FECV, canine start_entity Cataract_congenital_Volkmann_type, and transmissible gastroenteritis virus TGEV and clinical fluid samples from cats with effusive feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"We report that cells refractory to canine start_entity end_entity and feline infectious peritonitis virus FIPV became susceptible when transfected with a chimeric aminopeptidase-N APN cDNA containing a canine domain between residues 643 and 841\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sarcoma, Ewing\",\n",
       "                    \"value\": \"These results suggest that persistent start_entity infection does not affect the differentiation of end_entity cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"128:447-449, 1991 and this report are the first description of bovine group B rotaviruses in a mixed infection with bovine start_entity or singly in fecal contents in adult cows with end_entity and this is the first report of short-genome electropherotypes among group B rotaviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Gnotobiotic and colostrum-deprived calves inoculated with each of these isolates developed end_entity and shed start_entity in their feces and from their nasal passages\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Benign Paroxysmal Positional Vertigo\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Serum antibody analyses for bovine herpesvirus type 1 BHV-1, bovine viral diarrhea virus BVDV, bovine respiratory syncytial virus BRSV, bovine end_entity BCV, and bovine rotavirus start_entity were performed on 527 randomly selected cows, before calving, and on 407 three-week-old calves\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Serum antibody analyses for bovine herpesvirus type 1 BHV-1, bovine viral end_entity virus BVDV, bovine respiratory syncytial virus BRSV, bovine start_entity BCV, and bovine rotavirus Benign_Paroxysmal_Positional_Vertigo were performed on 527 randomly selected cows, before calving, and on 407 three-week-old calves\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Benign Paroxysmal Positional Vertigo\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Bovine end_entity and start_entity were shed by 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Porcine Reproductive and Respiratory Syndrome\",\n",
       "                    \"value\": \"herd of Quebec seedstock pigs experienced in early 1992 a typical outbreak of porcine reproductive and respiratory syndrome end_entity associated with lesions of interstitial, proliferative and necrotizing start_entity in weaned piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with the murine start_entity strain JHM decreases cell surface expression of major histocompatibility complex class I antigens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": \"In order to determine if canine start_entity end_entity could be transmitted to pigs, two dogs were inoculated orally with virulent end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bulimia Nervosa\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"The humoral immune response in the central nervous system CNS of susceptible Lewis LE rats and resistant Brown Norway start_entity rats was analysed after intracerebral infection with the murine end_entity JHM MHV4\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatitis\",\n",
       "                    \"value\": \"end_entity caused by mouse hepatitis virus MHV-A59, a murine start_entity, is accompanied by direct infection and replication of virus within the liver\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of susceptible murine cells with the start_entity mouse hepatitis virus type 4 MHV4 results in extensive cell-cell fusion at pHs from 5\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Newcastle Disease\",\n",
       "                    \"value\": \"Antibody levels to three avian viruses: infectious bursal disease virus, a birnavirus; end_entity virus, a paramyxovirus; and avian infectious bronchitis virus, a start_entity were determined by enzyme-linked immunosorbent assays ELISA\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"The extent and progression of exposure to feline infectious peritonitis end_entity virus in the cheetah, Acinonyx jubatus, was monitored by a world-wide serological survey with indirect fluorescent antibody titers to start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Routine fluorescent antibody and cultural tests detected rotavirus n126, start_entity n80 and bovine viral end_entity virus n13\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Adrenocortical Carcinoma, Hereditary\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"n antibody dependent cellular cytotoxic start_entity reaction was elicited using human mixed lymphocyte cultures against end_entity 229E-infected C-16 cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sprains and Strains\",\n",
       "                    \"value\": \"end_entity of the murine start_entity mouse hepatitis virus type 4 MHV-4 which contained a mutation in the E2 peplomer glycoprotein were obtained by selection for resistance to neutralization by monoclonal antibodies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity virus also facilitates secondary virus infection in non-epithelial cells; baby hamster kidney cells BHK-21, which are normally resistant to infection by the start_entity mouse hepatitis virus MHV-A59, could be infected via the haemagglutinin-sialic acid interaction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with bovine rotavirus, bovine start_entity, Newbury agent SRV -1, and K99 Escherichia coli have been detected in the intestines from experimentally infected and conventially reared diarrhoeic or normal calves\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The agent was shown to be antigenically unrelated to the Nebraska calf end_entity start_entity and to the bovine viral end_entity virus by counterimmunoelectrophoresis and fluorescent-antibody techniques\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of cells with the avian start_entity infectious bronchitis virus results in the synthesis of five major subgenomic RNAs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Alzheimer Disease\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Paired sera from volunteers inoculated with one of the five recently isolated strains of human end_entity HCV, start_entity, GI, HO, PA, and CALR, none of which has been grown in tissue culture, or with strain OC38 were tested against end_entity antigens by enzyme-linked immunosorbent assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"When treated with formaldehyde, Tween 80, sodium oleate and Nonidet P-40, avian infectious bronchitis virus, porcine transmissible gastroenteritis virus, neonatal calf end_entity start_entity, porcine hemagglutinating encephalomyelitis virus as well as the human start_entity show similar inner structures by negative staining\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"In plaque neutralization assays, antisera prepared against multiple sclerosis isolates DKK1 and end_entity demonstrated significant cross-reactivity to each other and to murine start_entity A59, weak cross-reactivity to murine start_entity JHM, but no cross-reactivity to the human start_entity 229E\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"Antiserum to DKK1 or end_entity failed to inhibit hemagglutination of chicken erythrocytes by the human start_entity OC43\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": \"We conclude that the two multiple sclerosis virus isolates DKK1 and end_entity are closely related serologically to the murine start_entity A59 and the human start_entity OC43\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"A LITERATURE REVIEW: The importance of the calf start_entity in the etiology of neonatal end_entity of calves has been reported many times from various countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"ounterimmunoelectroosmophoresis CIE technique is described for the detection of calf end_entity start_entity antigens in intestinal contents\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The antibody reagent was prepared in rabbits against the Nebraska calf end_entity start_entity adapted to Vero cells and purified by density gradient centrifugation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"These findings are identical to those occurring in an invasive start_entity enteritis of piglets but differ markedly from those seen with enterotoxigenic end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Field trials were conducted using an experimental, modified live virus, oral vaccine for prevention of reo- and start_entity calf end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Image: see text end_entity end_entity is caused by a start_entity end_entity-CoV and has the potential to threaten global public health and socioeconomic stability\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Image: see text end_entity end_entity is caused by a newly emerged start_entity that infected more than 8000 individuals and resulted in more than 800 1015 fatalities in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of end_entity has been identified as a novel human start_entity end_entity-CoV, and its viral protease, end_entity-CoV 3CLpro, has been shown to be essential for replication and has hence been recognized as a potent drug target for end_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine acute end_entity syndrome start_entity SADS-CoV, a newly discovered enteric start_entity, is the aetiological agent that causes severe clinical end_entity and intestinal pathological damage in piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myeloid, Acute\",\n",
       "                    \"value\": \"We describe metagenomic next-generation sequencing mNGS of a human start_entity 229E from a patient with end_entity and persistent upper respiratory symptoms, who underwent hematopoietic cell transplantation HCT\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The first discovered cpsRNA UCUUUAACAAGCUUGUUAAAGA from end_entity start_entity named end_entity-CoV-cpsR-22 contained 22 nucleotides perfectly matching its reverse complementary sequence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV emerged in 2002 as a highly transmissible pathogenic human betastart_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These viruses are related to important human pathogens including severe acute respiratory syndrome end_entity start_entity and they share some common features, however the mechanism that they use to produce subgenomic RNA molecules differs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Epidermodysplasia Verruciformis\",\n",
       "                    \"value\": \"Respiratory syncytial virus RSV, human rhinovirus HRV, human metapneumovirus HMPV, human parainfluenza virus PIV, human enterovirus end_entity, influenza virus IFV, human start_entity CoV, adenovirus ADV, and human bocavirus BoV are the most common viral agents associated with ARIs, accounting for around 70 of ARIs 3, 4\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"To test this question, we incubated start_entity with end_entity and PG and evaluated infectivity finding no change following end_entity treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Measles\",\n",
       "                    \"value\": \"Particles generated by all three cores, and pseudotyped with glycoproteins from either avian leukosis virus-A, human endogenous retrovirus K HERV-K, ecotropic-MLV, HTLV-1, end_entity morbillivirus, lymphocytic choriomeningitis mammarenavirus LCMV, Marburg virus, Ebola virus, severe acute respiratory syndrome-related start_entity SARS-CoV, or VSV, were insensitive to SERINC5\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": \"The basic reproduction number R0 was calculated from the end_entity model to assess the transmissibility of the start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Detailed genomic and structure-based analysis of a new start_entity, namely start_entity, showed that the new virus is a new type of bat start_entity and is genetically fairly distant from the human end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Structure analysis of the spike S protein of this new virus showed that its S protein only binds weakly to the ACE2 receptor on human cells whereas the human end_entity start_entity exhibits strongly affinity to the ACE receptor\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"A phylogenetic tree has been built using the 15 available whole genome sequence of start_entity and 12 whole genome sequences highly similar sequences available in gene bank 5 from Severe_Acute_Respiratory_Syndrome, 2 from end_entity and 5 from Bat Severe_Acute_Respiratory_Syndrome-like Coronavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"A phylogenetic tree has been built using the 15 available whole genome sequence of start_entity and 12 whole genome sequences highly similar sequences available in gene bank 5 from end_entity, 2 from MERS and 5 from Bat end_entity-like Coronavirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"From these results, 2019nCoV could be considered a start_entity distinct from end_entity virus, probably transmitted from bats or another host where mutations conferred upon it the ability to infect humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"BackgroundThe 2019 new start_entity, start_entity, was discovered from Wuhan Viral end_entity cases in December 2019, and was named by the World Health Organization on January 12, 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia, Viral\",\n",
       "                    \"value\": \"BackgroundThe 2019 new start_entity, start_entity, was discovered from Wuhan end_entity cases in December 2019, and was named by the World Health Organization on January 12, 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"KD\",\n",
       "                    \"value\": \"Here, we report for the first time that a SARS-CoV-specific human monoclonal antibody, CR3022, could bind potently with start_entity RBD end_entity of 6\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"With the estimated intrinsic growth rate gamma, we estimated R0 by using the serial intervals SI of two other well-known start_entity diseases, end_entity and Severe_Acute_Respiratory_Syndrome, as approximations for the true unknown SI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"With the estimated intrinsic growth rate gamma, we estimated R0 by using the serial intervals SI of two other well-known start_entity diseases, MERS and end_entity, as approximations for the true unknown SI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Coronaviruses such as the newly discovered virus from Wuhan, China, start_entity, and the viruses that cause Severe_Acute_Respiratory_Syndrome and end_entity, have resulted in regional and global public health emergencies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Coronaviruses such as the newly discovered virus from Wuhan, China, start_entity, and the viruses that cause end_entity and MERS, have resulted in regional and global public health emergencies\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The outbreaks of 20022003 Severe_Acute_Respiratory_Syndrome, 20122015 end_entity and 20192020 Wuhan respiratory syndrome clearly indicate that genome evolution of an animal start_entity CoV may enable it to acquire human transmission ability, and thereby to cause serious threats to global public health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The outbreaks of 20022003 end_entity, 20122015 MERS and 20192020 Wuhan respiratory syndrome clearly indicate that genome evolution of an animal start_entity CoV may enable it to acquire human transmission ability, and thereby to cause serious threats to global public health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ACE2, the host cell receptor for severe acute respiratory syndrome start_entity end_entity, has recently been demonstrated in mediating start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interestingly, besides the respiratory system, substantial proportion of end_entity and start_entity patients showed signs of various degrees of liver damage, the mechanism and implication of which have not yet been determined\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This finding suggested the liver abnormalities of end_entity and start_entity patients may not be due to hepatocyte damage, but cholangiocyte dysfunction and other causes such as drug induced and systemic inflammatory response induced liver injury\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"In MIR7-3HG cells, 11r exhibits three-digit picomolar activity against end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In MIR7-3HG cells, 11r exhibits three-digit picomolar activity against Middle East Respiratory end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Based on phylogeny, taxonomy and established practice, the CSG formally recognizes this virus as a sister to severe acute respiratory syndrome start_entityes SARS-CoVs of the species end_entity-related start_entity and designates it as start_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The sequence identity of the 3CL proteases of start_entity and end_entity is 96, which provides a sound foundation for structural-based drug repositioning SBDR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Based on a end_entity 3CL protease X-ray crystal structure, we construct a 3D homology structure of start_entity 3CL protease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"inhibitory concentration 50\",\n",
       "                    \"value\": \"Here, we tested the efficacy of teicoplanin against start_entity virus infection and found that teicoplanin potently prevents the entrance of start_entity-Spike-pseudoviruses into the cytoplasm, with an end_entity of 1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ObjectivesWe aimed to estimate the basic and time-varying transmission dynamics of start_entity across China, and compared them with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We estimated the doubling time, basic reproduction number R0 and time-varying reproduction number Rt of start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"As a novel virus, the time-varying transmission dynamics of start_entity remain unclear, and it is also important to compare it with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"What This Study Adds to the FieldWe compared the transmission dynamics of start_entity with end_entity, and found that start_entity has a higher transmissibility than end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"As a result, we provide a comprehensive structural genomics and interactomics road-maps of start_entity and use these information to infer the possible functional differences and similarities with the related end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"he end of 2019, the start_entity induces an ongoing outbreak of start_entity in China1, even more spread than end_entity2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In sum, we propose a two-hit scenario in the emergence of the start_entity virus whereby the start_entity ancestors in bats first acquired genetic characteristics of end_entity by incorporation of a end_entity-like RBD through recombination before 2009, and subsequently, those recombinants underwent convergent evolution\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In a short period of time, angiotensin converting enzyme GCNT2 ACE2, have been proposed to serve as the receptor for the entry of start_entity, which is the same for severe acute respiratory syndrome start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our findings suggested the kidney abnormalities of end_entity and start_entity patients may be due to proximal tubule cells damage and subsequent systematic inflammatory response induced kidney injury\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ngiotensin-converting enzyme 2 ACE2 is the surface receptor for end_entity start_entity end_entity-CoV, directly interacting with the spike glycoprotein S protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity is being compared to the infamous end_entity start_entity, which resulted, between November 2002 and July 2003, in 8098 confirmed cases worldwide with a 9\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ImportanceGiven the recent emergence of start_entity, this work suggest that Muc4 expression plays a protective role in female mice not conserved in male mice following end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This new virus, called 2019 start_entity start_entity uses the same receptor called Angiotensinconverting enzyme 2 ACE2 to attack humans as the start_entity that caused the severe acute respiratory syndrome end_entity seventeen years ago\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"It was found that the S-protein from the end_entity start_entity end_entity-CoV bind stronger to ACE2 than start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome and Middle East respiratory syndrome end_entity coronaviruses start_entity are zoonotic pathogens with high fatality rates and pandemic potential\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity and Middle East respiratory syndrome MERS coronaviruses start_entity are zoonotic pathogens with high fatality rates and pandemic potential\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Using a multifaceted structural approach, we reveal a specific area of high glycan density on end_entity S that results in the formation of under-processed oligomannose-type glycan clusters, which was absent on Severe_Acute_Respiratory_Syndrome and HKU1 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using a multifaceted structural approach, we reveal a specific area of high glycan density on MERS S that results in the formation of under-processed oligomannose-type glycan clusters, which was absent on end_entity and HKU1 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"2019-Novel Coronavirus start_entity is the pathogen of Corona end_entity 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"In this study, we demonstrated that the virus inactivation treatment disrupts its genome integrity seriously when using porcine epidemic end_entity virus vaccine, a kind of start_entity, as a model\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"new porcine start_entity SADS-CoV was recently identified from suckling piglets with severe end_entity in southern China and its genome sequence is most identical 95 identity to that of bat -start_entity HKU2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Coronavirus disease 2019 start_entity is newly emerging human infectious diseases, which is caused by end_entity Coronavirus 2 start_entity, also previously known as start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Coronavirus disease 2019 start_entity is newly emerging human infectious diseases, which is caused by Severe Acute Respiratory end_entity Coronavirus 2 start_entity, also previously known as start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Coronavirus disease 2019 start_entity is a new emerging human infectious disease caused by end_entity Coronavirus 2 start_entity, also previously known as start_entity, originated in Wuhan seafood and animal market, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Coronavirus disease 2019 start_entity is a new emerging human infectious disease caused by Severe Acute Respiratory end_entity Coronavirus 2 start_entity, also previously known as start_entity, originated in Wuhan seafood and animal market, China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity CoV-2 start_entity caused the Corona Virus_Diseases 2019 start_entity cases in China has become a public health emergency of international concern PHEIC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Severe_Acute_Respiratory_Syndrome CoV-2 start_entity caused the Corona end_entity 2019 start_entity cases in China has become a public health emergency of international concern PHEIC\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity 2 start_entity has received global attention due to the recent outbreak in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We compared and contrasted the Mpro for start_entity with a highly similar end_entity protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In spite of a high level of sequence similarity, the active sites in both proteins show major differences in both shape and size indicating that repurposing end_entity drugs for start_entity may be futile\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The surface glycoprotein of start_entity was coincident with the CTD1 region of the S-protein by comparing the I-TASSER prediction model with the actual end_entity model, which suggests that start_entity may bind to the ACE2 receptor through conformational changes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"We applied high-throughput protein production and structure determination pipeline at the Center for Structural Genomics of end_entity to produce start_entity proteins and structures\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We identified multiple specific regions in start_entity that have high homology to end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Given that our results demonstrate that the protein E subcluster for the end_entity clade is quasi-identical for the key functional regions of end_entity-CoV-1 and start_entity, we conclude that use of approved drugs shown to act as end_entity E protein inhibitors can help prevent further casualties from COVID-2019 while vaccines and other preventive measures are being developed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"As a new start_entity which was responsible for a large-scale outbreak of fatal disease in piglets in China, swine acute end_entity syndrome start_entity SADS-CoV originated from the same genus of horseshoe bats Rhinolophus as SARS-CoV and possesses a broad species tropism\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The recent emergence of end_entity start_entity 2 start_entity causing start_entity is a major burden for health care systems worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"These observations suggest that the effect of ciclesonide was specific to start_entity, suggesting this is a candidate drug for treatment of patients suffering end_entity or start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"The outbreak of Corona end_entity 2019 start_entity is highly infectious and transmitted mainly through human-to-human transmission via respiratory droplets and direct or close contact to the patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"n outbreak of the Corona end_entity 2019 start_entity, caused by the severe acute respiratory syndrome CoV-2 start_entity, began in Wuhan and spread globally\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The multiple sequence alignment data correlated with already published reports on start_entity indicated that it is closely related to Bat-end_entity like start_entity Bat CoV end_entity-like and well-studied Human end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The multiple sequence alignment data correlated with already published reports on start_entity indicated that it is closely related to Bat-Severe Acute Respiratory end_entity like start_entity Bat CoV Severe_Acute_Respiratory_Syndrome-like and well-studied Human Severe_Acute_Respiratory_Syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, we have exploited the complementary approach to examine the intrinsically disordered regions in proteome of start_entity using Bat end_entity-like and Human end_entity start_entity as comparative models\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have extensively investigated the dark proteome in start_entity which will have implications for the structured and unstructured biology of end_entity or end_entity-like coronaviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BSTRACTThe outbreak of the start_entity disease 2019 start_entity, caused by the end_entity start_entity 2 start_entity, has infected more than 100,000 people worldwide with over 3,000 deaths since December 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BSTRACTThe outbreak of the start_entity disease 2019 start_entity, caused by the Severe Acute Respiratory end_entity start_entity 2 start_entity, has infected more than 100,000 people worldwide with over 3,000 deaths since December 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study, we have determined the crystal structure of the receptor-binding domain RBD of the start_entity spike S protein in complex with CR3022, a neutralizing antibody previously isolated from a convalescent end_entity patient\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ONE SENTENCE SUMMARYStructural study of a cross-reactive end_entity antibody reveals a conserved epitope on the start_entity receptor-binding domain\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"SUMMARYThe rapid and escalating spread of end_entity start_entity 2 start_entity poses an immediate public health emergency, and no approved therapeutics or vaccines are currently available\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To compare its pathogenesis with that of previously emerging coronaviruses, we inoculated cynomolgus macaques with start_entity or MERS-CoV and compared with historical end_entitys\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": \"Objectives: Latest epidemic data of Severe_Acute_Respiratory_Syndrome Coronavirus 2 start_entity infected end_entity start_entity was collected and a detailed statistical analysis was carried out to make comparison with 2003-SARS in order to provide scientific reference for the prevention and control of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Objectives: Latest epidemic data of end_entity Coronavirus 2 start_entity infected Pneumonia start_entity was collected and a detailed statistical analysis was carried out to make comparison with 2003-SARS in order to provide scientific reference for the prevention and control of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Objectives: Latest epidemic data of Severe Acute Respiratory end_entity Coronavirus 2 start_entity infected Pneumonia start_entity was collected and a detailed statistical analysis was carried out to make comparison with 2003-SARS in order to provide scientific reference for the prevention and control of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity serial interval is also shorter than the serial interval of severe acute respiratory syndrome end_entity, indicating that calculations made using the end_entity serial interval may introduce bias\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Thus, we suspect that ACE2-expressing small intestinal epithelium cells might be vulnerable to start_entity infection when people eat infected wild animals and end_entity may serve as an indicator for infection, suggesting that clinicians should pay more attention to patients with end_entity during the outbreak of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Background: A start_entity start_entity emerged in Wuhan City, China, at the end of 2019 and has caused an outbreak of human-to-human transmission with a Public Health end_entity of International Concern declared by the World Health Organization on January 30, 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Methods: Respiratory samples including nasal swabs, throat swabs, end_entity and bronchoalveolar lavage fluid BALF were collected from Guangdong CDC confirmed start_entity patients, and viral RNAs were detected using a CFDA approved detection kit\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"heart rate\",\n",
       "                    \"value\": \"Moreover, discharged start_entity patients had higher end_entity, lymphocytes levels and monocytes levels than non-discharged start_entity patients on admission to the hospital\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"WHO decides to determine a Public Health end_entity of International Concern PHEIC of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The ongoing worldwide outbreak of the start_entity is markedly similar to the severe acute respiratory syndrome end_entity outbreak 17 years ago\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ACE2 Angiotensin Converting Enzyme 2 has been shown to be one of the major receptors that mediate the entry of start_entity into human cells, which also happens in severe acute respiratory syndrome start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity of other pathogens with start_entity exists and should be acknowledged\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods: The meteorological factors during the outbreak period of the start_entity start_entity in Wuhan in 2019 were collected and analyzed, and were confirmed with those of end_entity end_entity in China in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Methods: The meteorological factors during the outbreak period of the start_entity start_entity in Wuhan in 2019 were collected and analyzed, and were confirmed with those of Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome in China in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Data of patients infected with start_entity and end_entity start_entity were collected from WHO website and other public sources\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"To control the spread of Corona end_entity start_entity, screening large numbers of suspected cases for appropriate quarantine and treatment is a priority\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Background: Corona end_entity 2019 start_entity due to start_entity start_entity emerged in Wuhan city and rapidly spread throughout China since late December 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"We reported the clinical characteristics of start_entity patients with acute respiratory distress syndrome end_entity, and further investigated the treatment and progression of end_entity in start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Interpretation: The mortality rate increased with the severity of end_entity in start_entity, and the effects of current therapies on the survival for these patients were not satisfactory, which needs more attention from clinicians\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Conclusion: end_entity and cough are the most common symptoms in patients with start_entity infection, and most of these patients have abnormal chest CT examination\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Conclusion: Fever and end_entity are the most common symptoms in patients with start_entity infection, and most of these patients have abnormal chest CT examination\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Background: China has been severely affected by start_entity Corona end_entity 2019 since December, 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anxiety Disorders\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Methods: Using a web-based cross-sectional survey, we collected data from 7,236 self-selected volunteers assessed with demographic information, end_entity related knowledge, Generalized start_entity-7 GAD-7, Center for Epidemiology Scale for Depression CES-D, and Pittsburgh Sleep Quality Index PSQI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cerebral Palsy, Ataxic, Autosomal Recessive\",\n",
       "                    \"value\": \"Conclusion: The end_entity index can predict start_entity related short-term mortality, which may be a useful and convenient tool for quickly establishing a start_entity hierarchical management system that can greatly reduce the medical burden and therefore mortality in highly endemic areas\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background:Since December 2019, end_entity start_entity 2SARS-CoV-2-infected disease Coronavirus Disease 2019,start_entity emerged in Wuhan , China,and rapidly spread throughout China,even throughout the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The main clinical symptoms of patients with start_entity were fever, end_entity and asthenia,Some patients had obvious dyspnea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: In this article, we summarized the early epidemiologic and clinical characteristics of end_entity and start_entity in different countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Methods: By searching pubmed, we analyzed and compared the typical cases of end_entity and start_entity in different countries in the early stage of the outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"end_entity, cough and MalaiseFatigue were the most common symptoms in Severe_Acute_Respiratory_Syndrome and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Fever, cough and MalaiseFatigue were the most common symptoms in end_entity and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Fever, end_entity and MalaiseFatigue were the most common symptoms in Severe_Acute_Respiratory_Syndrome and start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Compared with end_entity, start_entity was transmitted in a more diverse way, from person to person, asymptomatic infected people and possible fecal-oral transmission, created the conditions for a large-scale spread\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The mortality rates of end_entity and start_entity were 7\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"We also summarize the current reports on the pathology of start_entity, we found that the pathological features of start_entity have greatly similar with Severe_Acute_Respiratory_Syndrome, which manifested as acute respiratory distress syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We also summarize the current reports on the pathology of start_entity, we found that the pathological features of start_entity have greatly similar with end_entity, which manifested as acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interpretation: The epidemiological and clinical characteristics of end_entity and start_entity in China are very similar, but also difference\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity is very similar to the severe acute respiratory syndrome end_entity start_entity broke out 17 years ago\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The specificities of the start_entity antibodies were assessed by Western Blot analysis against NPs from start_entity, end_entity and Severe_Acute_Respiratory_Syndrome\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The specificities of the start_entity antibodies were assessed by Western Blot analysis against NPs from start_entity, MERS and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Methods: Paired specimens of throat swabs and end_entity were obtained from 54 cases, and RNA was extracted and tested for start_entity equated with start_entity by qRT-PCR assay\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Results: The positive rates of start_entity from end_entity specimens and throat swabs were 76\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Conclusions: The detection rates of start_entity from end_entity specimens are significantly higher than throat swabs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"We suggest that end_entity would benefit for the detection of start_entity in patients who produce end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Furthermore, we compared the intrinsic epidemic rules of start_entity in Hubei with that of the severe acute respiratory syndrome end_entity in Beijing, which was obtained from the Ministry of Public Health of China in 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"By comparing fitted parameters, we found that the fitted curve of the infected case is the earliest to be saturated and has the lowest semi-saturation period in both start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"While all three population groups of end_entity are later to saturate and have a longer semi-saturation period than that of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Despite the virus caused end_entity end_entity-CoV and the virus caused start_entity start_entity are homologous, their epidemiologic characteristics are quite different\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"The symptoms of start_entity varied from modest, mild to acute respiratory distress syndrome end_entity, and the latter of which is generally associated with deregulated immune cytokine production; however, we currently know little as to the interplay between the extent of clinical symptoms and the compositions of lung immune microenvironment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Importance: The recent outbreak of Novel Coronavirus start_entity Disease start_entity has put the world on alert, that is reminiscent of the end_entity outbreak seventeen years ago\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Objective: We aim to compare the severity and mortality between male and female patients with both start_entity and end_entity, to explore the most useful prognostic factors for individualized assessment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Results: Older age and high number of comorbidities were associated with higher severity and mortality in patients with both start_entity and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using 'Feidian', Chinese abbreviation for end_entity, may detect the start_entity outbreak in 2019 two weeks earlier\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"However, Impacts of start_entity epidemic on end_entity center and end_entity patients are still unknown\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"There are totally 37 cases among 230 end_entity patients and 4 cases among 33 staff being diagnosed with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"During the epidemic, 7 end_entity patients died, including 6 with start_entity and 1 without start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"Most of the leukocytes in the peripheral blood of the end_entity patients infected with start_entity decreased, and the CT images of the chest mostly showed the ground glass like changes on the right side\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"The frequency of lymphocytes in PBMCs and the serum level of inflammatory cytokines were assessed in end_entity patients contracted start_entity or not, non-end_entity start_entity patients, as well as healthy volunteers\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"end_entity patients with start_entity also displayed remarkable lower serum level of inflammatory cytokines than other start_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"Our study indicates that end_entity patients are the highly susceptible population and end_entity centers are high risk area in the outbreak of start_entity epidemic\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"end_entity Patients with start_entity are mostly clinical mild and unlikely progress to severe start_entity due to the impaired cellular immune function and incapability of mounting cytokines storm\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Huntington Disease\",\n",
       "                    \"value\": \"More attention should be paid to prevent cardiovascular events, which may be the collateral impacts of start_entity epidemic on end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Inflammation\",\n",
       "                    \"value\": \"end_entity is closely related to severity of start_entity, and IL6, TNF and CXCL8 might be promising therapeutic targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Background: Coronavirus Disease 2019 start_entity caused by end_entity start_entity 2 start_entity has become a global threat to public health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Background With the spread of start_entity from Wuhan, Hubei Province to other areas of the country, medical staff in end_entity Clinics faced the challenge of identifying suspected cases among patients with respiratory infections manifested with fever\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"We aimed to describe the prevalence and clinical features of start_entity as compared to pneumonias of other etiologies in a end_entity Clinic in Beijing\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Methods In this single-center, retrospective study, 342 cases of start_entity were diagnosed in end_entity Clinic in Peking University Third Hospital between January 21 to February 15, 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Interpretation In the period of start_entity epidemic outside Hubei Province, the prevalence of start_entity in patients with start_entity visiting to our end_entity Clinic in Beijing was 6\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ataxia Telangiectasia\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"We also studied whether air temperature start_entity could affect the above outcomes of end_entity cases by performing Spearman analysis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ataxia Telangiectasia\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Conclusions Our findings indicated that both the use of MSHs and the rise of start_entity were beneficial to the survival of end_entity cases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"The human start_entity HCoV-19 infection can cause acute respiratory distress syndrome end_entity, hypercoagulability, hypertension, extrapulmonary multiorgan dysfunction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hypokalemia\",\n",
       "                    \"value\": \"CONCLUSIONS: end_entity is prevailing in patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Compared with patients without start_entity, those with start_entity were 15 years older and had a higher rate of hypertension, higher frequencies of having a fever and end_entity, and higher levels of interleukin-6 14\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lymphopenia\",\n",
       "                    \"value\": \"Conclusions: end_entity and CRP may serve as the risk factors related to hepatic injury in patients with start_entity, which might be related to inflammatory cytokine storm in liver injury\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Since December 2019, more than 79,000 people have been diagnosed with infection of the Corona end_entity 2019 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lymphopenia\",\n",
       "                    \"value\": \"Conclusion: end_entity can be used to indicate clinical course, treatment effect and outcomes of start_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Therefore, early diagnosis and intensive care of critically severe start_entity cases, especially those combined with end_entity, will be considerably essential to reduce mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Interpretation: The observation that the data of the cumulative numbers of deaths for both the on-going start_entity outbreak and the 2003 end_entity epidemic in each geographic region were well fitted with the Boltzmann function strongly suggests that it is suitable for the simulation of deaths associated with coronaviruses-induced diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Corona end_entity 2019 start_entity is a recently emerged life-threatening disease caused by start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anoxia\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"start_entity severity was closely related with host immune cell levels, and the vicious circle between immune disorder and gut microbiota imbalance may be a high risk of fatal end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Conclusions end_entity with start_entity in critical illness is characterized by fever, lymphopenia, acute respiratory failure and multiple organ dysfunction\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Background and Objective: WHO Director-General declared that the start_entity outbreak constitutes a Public Health end_entity of International Concern,and the outbreak is still on-going\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Conclusions: end_entity and cough are the typical clinical features of start_entity patients, and chest CT mainly manifested as multiple lesions in both lungs, often accompanied by GGO, vascular enlargement and cobblestonereticular pattern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Conclusions: Fever and end_entity are the typical clinical features of start_entity patients, and chest CT mainly manifested as multiple lesions in both lungs, often accompanied by GGO, vascular enlargement and cobblestonereticular pattern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Compared with end_entity and Ebola viruses, new start_entity infections are infectious during the incubation period\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Corona end_entity 2019 start_entity has spread rapidly to more than 70 countries and regions overseas and over 80000 cases have been infected, resulting in more than three thousand deaths\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Conclusions: end_entity, cough and fatigue are common symptoms in start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Conclusions: Fever, end_entity and fatigue are common symptoms in start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"OBJECTIVES To compare chest CT findings in heart failure with those of Corona end_entity 2019 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Background: Affected by a Corona end_entity 2019 start_entity outbreak, Since December 2019, there have been more than 76,000 cases of start_entity in China, causing more than 3,000 medical staff infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"BACKGROUND Corona end_entity 2019 start_entity is spreading worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The recent outbreaks of Ebola, Zika, end_entity, and start_entity start_entity require fast, simple, and sensitive onsite nucleic acid diagnostics that can be developed rapidly to prevent the spread of diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"There was inconsistent reporting of maternal, perinatal and neonatal outcomes across case reports and series concerning start_entity, Severe_Acute_Respiratory_Syndrome, end_entity and other coronaviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"There was inconsistent reporting of maternal, perinatal and neonatal outcomes across case reports and series concerning start_entity, end_entity, MERS and other coronaviruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"CONCLUSIONS Morbidity and mortality from start_entity appears less marked than for Severe_Acute_Respiratory_Syndrome and end_entity, acknowledging the limited number of cases reported to date\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"CONCLUSIONS Morbidity and mortality from start_entity appears less marked than for end_entity and MERS, acknowledging the limited number of cases reported to date\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"The World Health Organization declared that start_entity outbreak constituted a Public Health end_entity of International Concern and the development of reliable laboratory diagnosis of start_entity became mandatory to identify, isolate and provide optimized care for patients early\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hypokalemia\",\n",
       "                    \"value\": \"end_entity and hyponatremia were common in patients with start_entity, and there was a correlation with the degree of renal injury\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"Method: This study retrospectively analyzed the clinical symptoms, laboratory results, chest CT, and treatment of children with laboratory-confirmed COVID-19ie, with samples that were positive for 2019 start_entity2019-nCoV who were admitted to Shenzhen Center of National end_entity Clinical Medical Research from January 16 to February 8, 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The aim of this study, therefore, is to perform a systematic review to compare epidemiological, clinical and laboratory features of start_entity and end_entity population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We searched PubMed, EMBASE and Cochrane Register of Controlled Trials database to identify potential studies reported start_entity or end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Thirty-two studies involving 3770 patients start_entity 1062, end_entity 2708 were included in this study\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The present study revealed that compared with start_entity population, end_entity population had a higher rate of ICU admission, discharge and fatality and longer incubation time\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"It pointed out that fever, cough and generalised weakness and myalgia were main clinical manifestations of both start_entity and end_entity, whereas Respiratory_Distress_Syndrome,_Adult was main complication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"It pointed out that fever, cough and generalised weakness and myalgia were main clinical manifestations of both start_entity and MERS, whereas end_entity was main complication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"It pointed out that fever, end_entity and generalised weakness and myalgia were main clinical manifestations of both start_entity and MERS, whereas Respiratory_Distress_Syndrome,_Adult was main complication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Death\",\n",
       "                    \"value\": \"Methods In this single center, observational study, We recruited all end_entity Cases with start_entity from Dec 30, 2019 to Feb 16, 2020 in Intensive care unit of Wuhan Jinyintan Hospital\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity due to novel Coronavirus start_entity related infection start_entity is characterized by severe ventilation perfusion mismatch leading to refractory hypoxemia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Few patients presented respiratory symptoms fever and end_entity on admission, but most had typical chest CT images of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"new cases of end_entity CoV-2 aka start_entity Coronavirus are confirmed throughout the world and millions of people are being put into quarantine, hit the developing world, such as sub-Saharan Africa, potentially leading to a global human calamity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"There is no report about the prevalence of start_entity in end_entity patients untill now\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"We aimed to describe the clinical course, outcomes of end_entity patients with start_entity and prevalence of start_entity in end_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"Methods In this multi-center survey, cross-sectional survey, observational study, the clinical data of end_entity patients with start_entity in each center were collected\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"We described and analyzed the prevalence of start_entity in end_entity patients, and focus on the clinical characteristics and outcomes of start_entity patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"The primary outcome was prevalence of start_entity in end_entity patients, as of Feb 21, 2020\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"Secondary outcomes included the history of epidemiology of end_entity patients, the clinical characteristics and outcomes of end_entity patients with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"12 respondents had fever, end_entity or shortness of breath during the epidemic, 1 case common type was confirmed with start_entity and cured after treatment\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"Of the 50 patients who failed to respond to end_entity treatment or had a poor response, 1 patient 2 had a clinical diagnosis of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"Interpretation While the 392 end_entity respondents required regular referrals to hospitals, they did not have much contact with start_entity patients during the outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": \"Patients who failed to achieved an optimal response to end_entity therapy appear more likely to have a symptomatic infection with start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"In January 30, 2020, the World Health Organization declared the outbreak of start_entity as a Public Health end_entity of International Interest PHEI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Based on the official data modeling, this paper studies the transmission process of the Corona end_entity 2019 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Thrombasthenia\",\n",
       "                    \"value\": \"Therefore, this study explored the potential use of Google Trends end_entity to monitor public restlessness toward start_entity epidemic infection in Taiwan\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Thrombasthenia\",\n",
       "                    \"value\": \"Methods We retrieved end_entity data for the specific locations of Taiwan nationwide and subregions using defined search terms related to start_entity, handwashing, and face masks\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Fatal outcomes of H7N9 infections are often attributed to the severe start_entity and acute respiratory distress syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Since the outbreak of severe acute respiratory syndrome end_entity in 2003, the three-dimensional structures of several of the replicasetranscriptase components of end_entity start_entity end_entity-CoV, the non-structural proteins Nsps, have been determined\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Susceptibility to vectors carrying end_entity start_entity S or VSV-G glycoproteins suggests that endocytic and processing pathways utilized by other viruses are intact in these cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity SARS-CoV is the cause of an atypical start_entity that affected Asia, North America and Europe in 20022003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Previously, we reported the 5 L scale expression and purification of a promising recombinant end_entity vaccine candidate, RBD219-N1, the 218amino acid residue receptor-binding domain RBD of end_entity start_entity expressed in yeastPichia pastoris X-33\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary Development of vaccines against severe acute respiratory syndrome end_entity start_entity end_entity-CoV is crucial in the prevention of end_entity reemergence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"CDC activated its end_entity Operations Center on January 21 and formalized a process for inquiries regarding persons suspected of having start_entity infection 2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Although start_entity can cause a severe respiratory illness like Severe_Acute_Respiratory_Syndrome and end_entity, evidence from clinics suggested that start_entity is generally less pathogenic than Severe_Acute_Respiratory_Syndrome-CoV, and much less than end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Although start_entity can cause a severe respiratory illness like end_entity and MERS, evidence from clinics suggested that start_entity is generally less pathogenic than end_entity-CoV, and much less than MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV, a start_entity, causes severe end_entity and high mortality in newborn piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine epidemic end_entity virus PEDV is a highly contagious start_entity that causes severe end_entity and death in neonatal piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Ebolavirus, end_entity start_entity and influenza virus are zoonotic RNA viruses, which mutate very rapidly\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In the recent West Africa Ebola outbreak, directional time-series changes in a wide range of oligonucleotides were observed in common for three geographic areas, and the directional changes were observed also for the recent end_entity start_entity epidemics starting in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity spike protein is modeled using its counterpart, the end_entity spike\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": \"The next generation matrix approach was adopted to calculate the basic reproduction number R 0 from the end_entity model to assess the transmissibility of the start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Conclusions Our model showed that the transmissibility of start_entity was higher than the Middle East respiratory syndrome in the Middle East countries, similar to severe acute respiratory syndrome, but lower than end_entity in the Republic of Korea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity start_entity MERS-CoV infections are associated with a significant mortality rate, and existing drugs show poor efficacy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity start_entity MERS-CoV infections are associated with a significant mortality rate, and existing drugs show poor efficacy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"nausea\",\n",
       "                    \"value\": \"According to a study2 including 1099 patients with laboratory-confirmed start_entity from 552 hospitals in China as of Jan 29, 2020, end_entity or vomiting, or both, and diarrhoea were reported in 55 56 and 42 38 patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"According to a study2 including 1099 patients with laboratory-confirmed start_entity from 552 hospitals in China as of Jan 29, 2020, nausea or end_entity, or both, and diarrhoea were reported in 55 56 and 42 38 patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We analyzed clinical data and specimens from fourteen end_entity patients treated in a hospital who collectively represent a wide spectrum of disease severity, ranging from mild febrile illness to fatal start_entity, and classified the patients into four groups based on severity and mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: end_entity start_entity end_entity-CoV was identified as the etiological agent of end_entity, and extensive investigations indicated that it originated from an animal source probably bats and was recently introduced into the human population via wildlife animals from wet markets in southern China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Kartagener Syndrome\",\n",
       "                    \"value\": \"Inhaled corticosteroids end_entity have limited efficacy in reducing chronic obstructive pulmonary disease Pulmonary_Disease,_Chronic_Obstructive exacerbations and increase start_entity risk, through unknown mechanisms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Inhaled corticosteroids Kartagener_Syndrome have limited efficacy in reducing chronic obstructive pulmonary disease end_entity exacerbations and increase start_entity risk, through unknown mechanisms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Kartagener Syndrome\",\n",
       "                    \"value\": \"Suppression of interferon by end_entity during virus-induced Pulmonary_Disease,_Chronic_Obstructive exacerbations likely mediates start_entity risk and raises suggestion that inhaled interferon- therapy may protect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": \"Suppression of interferon by Kartagener_Syndrome during virus-induced end_entity exacerbations likely mediates start_entity risk and raises suggestion that inhaled interferon- therapy may protect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"end_entity and start_entity disease 2019 start_entity are difficult to distinguish because they have shared clinical and laboratory features\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity virus IFV infection is a common cause of severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have tested the hypothesis that severe acute respiratory syndrome end_entity start_entity protein E SCoVE and its homologs in other start_entityes associate through their putative transmembrane domain to form homooligomeric -helical bundles in vivo\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"value\": \"Cytomegalovirus CMV start_entity is a rare opportunistic infection in the setting of HIV Human end_entity Virus-infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": \"end_entity by multiple opportunistic pathogens are common and a high degree of clinical vigilance to evaluate for multiple infections, including CMV start_entity, should be maintained\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity with Middle East respiratory syndrome start_entity MERS-CoV could be asymptomatic or cause mild influenza-like illness\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"We applied the procedure to RNAi screening data of four different positive-sense single-stranded RNA viruses, Hepatitis_C virus, Chikungunya virus, end_entity virus and Severe_Acute_Respiratory_Syndrome start_entity, and detected novel host factors, including UBC, PLCG1, and DYRK1B, which are predicted to significantly impact the replication cycles of these viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatitis\",\n",
       "                    \"value\": \"We applied the procedure to RNAi screening data of four different positive-sense single-stranded RNA viruses, end_entity C virus, Chikungunya virus, Dengue virus and Severe_Acute_Respiratory_Syndrome start_entity, and detected novel host factors, including UBC, PLCG1, and DYRK1B, which are predicted to significantly impact the replication cycles of these viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Hepatitis C\",\n",
       "                    \"value\": \"We applied the procedure to RNAi screening data of four different positive-sense single-stranded RNA viruses, end_entity virus, Chikungunya virus, Dengue virus and Severe_Acute_Respiratory_Syndrome start_entity, and detected novel host factors, including UBC, PLCG1, and DYRK1B, which are predicted to significantly impact the replication cycles of these viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We applied the procedure to RNAi screening data of four different positive-sense single-stranded RNA viruses, Hepatitis_C virus, Chikungunya virus, Dengue virus and end_entity start_entity, and detected novel host factors, including UBC, PLCG1, and DYRK1B, which are predicted to significantly impact the replication cycles of these viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by the Middle East respiratory syndrome start_entity MERS-CoV causes respiratory illness and has a high mortality rate 35\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity start_entity end_entity-CoV is a novel respiratory pathogen first reported in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"We report the safety of a fully human polyclonal IgG antibody SAB-301 produced from the hyperimmune plasma of transchromosomic cattle immunised with a end_entity start_entity vaccine\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The provincial government of Jeju, South Korea, was notified that a 42-year-old man infected with the end_entity MERS start_entity had gone sightseeing in Jeju Island\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The provincial government of Jeju, South Korea, was notified that a 42-year-old man infected with the Coronavirus_Infections end_entity start_entity had gone sightseeing in Jeju Island\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The provincial government of Jeju, South Korea, was notified that a 42-year-old man infected with the Middle East Respiratory end_entity MERS start_entity had gone sightseeing in Jeju Island\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity 2 start_entity is infecting people throughout the world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Results The approach was demonstrated for the activity of intubation of a patient with methicillin-resistant Staphylococcus aureus or end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Results The approach was demonstrated for the activity of intubation of a patient with methicillin-resistant Staphylococcus aureus or Severe Acute Respiratory end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chagas Disease\",\n",
       "                    \"value\": \"This article discusses effects of lymphocytic choriomeningitis virus, West Nile virus, severe acute respiratory syndrome start_entity, avian influenza A virus, viral hemorrhagic fevers, spirochetal illnesses, and end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by human-pathogenic coronaviruses result in diverse clinical outcomes, ranging from self-limiting flu-like symptoms to severe start_entity with extrapulmonary manifestations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sveinsson Chorioretinal Atrophy\",\n",
       "                    \"value\": \"Importantly, the inhibitory effect of LA and end_entity on virus replication was also conserved for the highly pathogenic Middle East respiratory syndrome start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"With the analysis of the papain-like protease of end_entity start_entity SARS-CoV, came the realization of the multifunctional nature of these enzymes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"With the analysis of the papain-like protease of Severe Acute Respiratory end_entity start_entity SARS-CoV, came the realization of the multifunctional nature of these enzymes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"partial characterization of the ion channels formed by the end_entity start_entity CoV envelope E protein was previously reported C\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Swine acute end_entity syndrome start_entity SADS-CoV, a newly emerging enteric start_entity, is considered to be associated with swine acute end_entity syndrome SADS which has caused significantly economic losses to the porcine industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"Methods end_entity A, B and start_entity antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls, by Severe_Combined_Immunodeficiency\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Combined Immunodeficiency\",\n",
       "                    \"value\": \"Methods Influenza,_Human A, B and start_entity antibody titers were measured in 257 subjects with recurrent unipolar and bipolar disorder and healthy controls, by end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV encodes a papain-like protease PLpro with both deubiquitinating DUB and deISGylating activities that are proposed to counteract the post-translational modification of signaling molecules that activate the innate immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV, the causative agent of the large end_entity outbreak in 2003, originated in bats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These results revealed 81 shared nucleotide identity with humancivet end_entity start_entity, which was more distant than that observed previously for bat SL-start_entity in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The response to the start_entity outbreak in China suggests that many of the lessons from the 2003 end_entity epidemic have been implemented and the response improved as a consequence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In the subsequent years, a suite of zoonotic viruses including Australian bat lyssavirus, Nipah virus, end_entity start_entity, and Ebola and Marburg viruses have been detected in bats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our results reveal important commonalities between start_entity and end_entity and identify a potential target for antiviral intervention\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"However, these bat end_entityr-CoVs show sequence differences from end_entity start_entity end_entity-CoV in different genes S, ORF8, ORF3, etc and are considered unlikely to represent the direct progenitor of end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity, a highly lethal respiratory disease caused by a start_entity end_entity-CoV, is an emerging disease with high potential for epidemic spread\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: The Middle East respiratory syndrome end_entity start_entity has caused recurrent outbreaks in the Arabian Peninsula since 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"They were inoculated intratracheally with porcine respiratory start_entity PRCV followed by lipopolysaccharide end_entity 24h later\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"In the present article we have described about risk factors, chance of infection, and prevention methods of end_entity Coronavirus MERS-CoV and severe acute respiratory syndrome SARS-CoV, human coronaviruses start_entity frequently cause a normal cold which is mild and self-restricting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In the present article we have described about risk factors, chance of infection, and prevention methods of Middle East Respiratory end_entity Coronavirus MERS-CoV and severe acute respiratory syndrome SARS-CoV, human coronaviruses start_entity frequently cause a normal cold which is mild and self-restricting\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"The prevalence of bovine herpesvirus type 1 BoHV-1, bovine adenovirus BAdV, bovine viral end_entity virus BVDV, bovine start_entity BCoV, bovine respiratory syncytial virus BRSV, bovine parainfluenza virus BPiV, Pasteurella multocida, Mannheimia haemolytica, Histophilus somni, Mycoplasma bovis, in the nasal microbiota of beef steers before and after the same long-distance journey from France to southern Italy was documented\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Summary end_entity start_entity SARS-CoV causes lethal disease in humans, which is characterized by exacerbated inflammatory response and extensive lung pathology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis virus TGEV is a porcine enteropathogenic start_entity which induces malabsorption and lethal watery end_entity in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"3 The authors argued that the use of end_entity in the virus name could confuse the public about the disease that it causes; in addition, they noted that the name start_entity is not consistent with the disease name chosen by WHO, start_entity disease 2019\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The use of end_entity in naming start_entity does not derive from the name of the end_entity disease but is a natural extension of the taxonomic practice for viruses in the end_entity species\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"The ongoing start_entity disease 2019 start_entity outbreak is a Public Health end_entity of International Concern PHEIC, and the emergence of new epicentres of spread, such as South Korea and Iran, besides Wuhan, China, should draw attention to potential superspreader events\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Korea experienced an outbreak of end_entity start_entity MERS-CoV infection in 2015, which was characterized by superspreading events in healthcare settings\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Korea experienced an outbreak of Middle East Respiratory end_entity start_entity MERS-CoV infection in 2015, which was characterized by superspreading events in healthcare settings\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Among patients with start_entity caused by start_entity start_entity start_entity or Wuhan start_entity, fever was the most common symptom, followed by end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"3 of end_entity coronavirus6 genes were utilized to define the protein products of start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"First, the protein sequences of start_entity were compared with RaTG13, human end_entity NC004718\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"With the estimated intrinsic growth rate , we estimated R0 by using the serial intervals SI of two other well-known start_entity diseases, end_entity and Severe_Acute_Respiratory_Syndrome, as approximations for the true unknown SI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"With the estimated intrinsic growth rate , we estimated R0 by using the serial intervals SI of two other well-known start_entity diseases, MERS and end_entity, as approximations for the true unknown SI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Lassa Fever\",\n",
       "                    \"value\": \"This includes 19 vaccine candidates against its priority pathogens end_entity virus, Middle East respiratory syndrome start_entity, Nipah virus, Chikungunya, Rift Valley fever and three vaccine platforms to develop vaccines against Disease X, a novel or unanticipated pathogen\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Since 2012, Middle East respiratory syndrome end_entity start_entity has infected 2,442 persons worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Clinical features of Middle East respiratory syndrome end_entity include atypical start_entity and progressive respiratory failure that is highly reminiscent of severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome caused by Severe_Acute_Respiratory_Syndrome-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Clinical features of Middle East respiratory syndrome MERS include atypical start_entity and progressive respiratory failure that is highly reminiscent of severe acute respiratory syndrome end_entity caused by end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Within months of the end_entity outbreak, collaborative work revealed the identity of the disastrous pathogen as end_entity-associated start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"These results demonstrate that IFN-I and IMM promote lethal end_entity and identify IFN-I and IMMs as potential therapeutic targets in patients infected with pathogenic start_entity and perhaps other respiratory viruses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Fever\",\n",
       "                    \"value\": \"Exotic and emerging viral pathogens associated with high morbidity and mortality in humans are being identified annually with recent examples including Lujo virus in southern Africa, Severe end_entity with Thrombocytopenia Syndrome virus in China and a SARS-like start_entity in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Exotic and emerging viral pathogens associated with high morbidity and mortality in humans are being identified annually with recent examples including Lujo virus in southern Africa, Severe Fever with Thrombocytopenia end_entity virus in China and a SARS-like start_entity in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Thrombocytopenia\",\n",
       "                    \"value\": \"Exotic and emerging viral pathogens associated with high morbidity and mortality in humans are being identified annually with recent examples including Lujo virus in southern Africa, Severe Fever with end_entity Syndrome virus in China and a SARS-like start_entity in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Although there are striking similarities between end_entity and start_entity, the differences in the virus characteristics will ultimately determine whether the same measures for end_entity will also be successful for start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"start_entity differs from end_entity in terms of infectious period, transmissibility, clinical severity, and extent of community spread\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The outbreak of severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome in 2003 and, more recently, Middle-East respiratory syndrome end_entity has demonstrated the lethality of start_entity when they cross the species barrier and infect humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The outbreak of severe acute respiratory syndrome end_entity in 2003 and, more recently, Middle-East respiratory syndrome MERS has demonstrated the lethality of start_entity when they cross the species barrier and infect humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: A end_entity start_entity MERS-CoV outbreak in South Korea in 2015 started by a single imported case and was amplified by intra- and inter-hospital transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: A Middle East Respiratory end_entity start_entity MERS-CoV outbreak in South Korea in 2015 started by a single imported case and was amplified by intra- and inter-hospital transmission\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"RESULTS: In Daejeon, a end_entity patient the index case was hospitalized at Hospital A in the first week of illness and was transferred to Hospital B because of start_entity progression in the second week of illness, where he received a bronchoscopic examination and nebulizer therapy\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Vasculopathy, Retinal, With Cerebral Leukodystrophy\",\n",
       "                    \"value\": \"To address this situation, stool samples from 325 dogs were analyzed by polymerase chain reaction for the detection of common enteric viruses such as Canine adenovirus CAdV, Canine start_entity CCoV, Canine distemper virus CDV, Canine rotavirus end_entity and Carnivorous protoparvovirus 1 canine parvovirus 2; CPV-2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Considered a relative of severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome and Middle East respiratory syndrome end_entity, start_entity is caused by a betacoronavirus named start_entity that affects the lower respiratory tract and manifests as start_entity in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Considered a relative of severe acute respiratory syndrome end_entity and Middle East respiratory syndrome MERS, start_entity is caused by a betacoronavirus named start_entity that affects the lower respiratory tract and manifests as start_entity in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The bat start_entity HKU4 belongs to the same 2c lineage as that of the deadly end_entity start_entity MERS-CoV and shows high sequence similarity, therefore potentiating a threat to the human population through a zoonotic shift or 'spill over' event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The bat start_entity HKU4 belongs to the same 2c lineage as that of the deadly Middle East Respiratory end_entity start_entity MERS-CoV and shows high sequence similarity, therefore potentiating a threat to the human population through a zoonotic shift or 'spill over' event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"From HIV to hepatotropic viruses to end_entity start_entity, humanized mice have led to the identification of factors crucial to the viral life cycle, served as an outlet for testing candidate therapies, and improved our abilities to analyze human immune responses to infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"From HIV to hepatotropic viruses to Middle East Respiratory end_entity start_entity, humanized mice have led to the identification of factors crucial to the viral life cycle, served as an outlet for testing candidate therapies, and improved our abilities to analyze human immune responses to infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Background The increasing reports of end_entity MERS caused by MERS start_entity MERS-CoV from many countries emphasize its importance for international travel\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Background The increasing reports of Coronavirus_Infections end_entity caused by end_entity start_entity end_entity-CoV from many countries emphasize its importance for international travel\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Background The increasing reports of Middle East Respiratory end_entity MERS caused by MERS start_entity MERS-CoV from many countries emphasize its importance for international travel\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Contacts who developed fever, end_entity, or shortness of breath became persons under investigation and were tested for start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Cases of start_entity are now being reported in different regions around the globe, concerning for a possible end_entity like epidemic that infected for than 8000 people in 2002-03\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity start_entity CoV envelope E protein is a transmembrane protein\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"thrombocytopenia\",\n",
       "                    \"value\": \"CONCLUSIONS: Perinatal start_entity infection may have adverse effects on newborns, causing problems such as fetal distress, premature labor, respiratory distress, end_entity accompanied by abnormal liver function, and even death\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity nsp1 protein suppresses host gene expression, including type I interferon production, by promoting host mRNA degradation and inhibiting host translation, in infected cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The emergence of Severe_Acute_Respiratory_Syndrome start_entity SARS-CoV and end_entity start_entity MERS-CoV, two strains of animal start_entityes that crossed the species barrier to infect and cause severe respiratory infections in humans within the last 12 years, have taught us that start_entityes represent a global threat that does not recognize international borders\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emergence of end_entity start_entity SARS-CoV and Coronavirus_Infections start_entity MERS-CoV, two strains of animal start_entityes that crossed the species barrier to infect and cause severe respiratory infections in humans within the last 12 years, have taught us that start_entityes represent a global threat that does not recognize international borders\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The emergence of Severe Acute Respiratory end_entity start_entity SARS-CoV and Middle East Respiratory end_entity start_entity MERS-CoV, two strains of animal start_entityes that crossed the species barrier to infect and cause severe respiratory infections in humans within the last 12 years, have taught us that start_entityes represent a global threat that does not recognize international borders\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"METHODS: Here we present a validated diagnostic workflow for start_entity, its design relying on close genetic relatedness of start_entity with end_entity start_entity, making use of synthetic nucleic acid technology\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The analysis of 22 studies reveals that human start_entityes such as Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome start_entity, end_entity MERS start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 6271 ethanol, 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The analysis of 22 studies reveals that human start_entityes such as Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome start_entity, Coronavirus_Infections end_entity start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 6271 ethanol, 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The analysis of 22 studies reveals that human start_entityes such as end_entity end_entity start_entity, Coronavirus_Infections MERS start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 6271 ethanol, 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The analysis of 22 studies reveals that human start_entityes such as Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome start_entity, Middle East Respiratory end_entity MERS start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 6271 ethanol, 0\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"METHODS: The Korea reported its first laboratory-confirmed case of end_entity MERS start_entity on May 20, 2015\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"METHODS: The Korea reported its first laboratory-confirmed case of Coronavirus_Infections end_entity start_entity on May 20, 2015\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"METHODS: The Korea reported its first laboratory-confirmed case of Middle East Respiratory end_entity MERS start_entity on May 20, 2015\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The scientific interest on start_entityes increased after the emergence of Severe_Acute_Respiratory_Syndrome start_entity SARS-CoV outbreaks in 2002-2003 followed by end_entity CoV MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The scientific interest on start_entityes increased after the emergence of end_entity start_entity SARS-CoV outbreaks in 2002-2003 followed by Coronavirus_Infections CoV MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The scientific interest on start_entityes increased after the emergence of Severe Acute Respiratory end_entity start_entity SARS-CoV outbreaks in 2002-2003 followed by Middle East Respiratory end_entity CoV MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"This decade's first CoV, named start_entity, emerged from Wuhan, China, and declared as 'Public Health end_entity of International Concern' on January 30th, 2020 by the World Health Organization WHO\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Emerging viruses such as end_entity start_entity, hantaviruses and henipaviruses have wildlife reservoirs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The recent emergence of end_entity Coronavirus MERS-CoV, nearly a decade after the Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The recent emergence of Coronavirus_Infections Coronavirus MERS-CoV, nearly a decade after the end_entity end_entity CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The recent emergence of Middle East Respiratory end_entity Coronavirus MERS-CoV, nearly a decade after the Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"BACKGROUND: end_entity MERS is a respiratory disease caused by a start_entity that was identified in 2012 in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: Coronavirus_Infections end_entity is a respiratory disease caused by a start_entity that was identified in 2012 in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: Middle East Respiratory end_entity MERS is a respiratory disease caused by a start_entity that was identified in 2012 in Saudi Arabia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The spike S protein of end_entity start_entity end_entity-CoV has been known to recognize and bind to host receptors, whose conformational changes then facilitate fusion between the viral envelope and host cell membrane, leading to viral entry into target cells\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The receptor-binding domain RBD of end_entity start_entity end_entity-CoV spike S protein contains multiple conformation-dependent epitopes that induce neutralizing antibody responses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The first outbreak of start_entity disease was the result of a cross-species barrier jump, originating in bats, and probably the musk cat as a secondary host, which began on November 16, 2002 and was named SARS-CoV end_entity - CoronaVirus in Guangdong Province, of the People's Republic of China, and extended to 17 countries, including Canada, the United States of America USA, Australia, Germany, France, Sweden, the United Kingdom and Spain\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The first outbreak of start_entity disease was the result of a cross-species barrier jump, originating in bats, and probably the musk cat as a secondary host, which began on November 16, 2002 and was named SARS-CoV Severe Acute Respiratory end_entity - CoronaVirus in Guangdong Province, of the People's Republic of China, and extended to 17 countries, including Canada, the United States of America USA, Australia, Germany, France, Sweden, the United Kingdom and Spain\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In this study we demonstrate that endogenous ferret CXCL10 exhibits similar mRNA expression patterns in the lungs of deceased end_entity patients and ferrets experimentally infected with end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity, caused by a mutated feline start_entity, is one of the most serious and fatal viral diseases in cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ground-glass opacity\",\n",
       "                    \"value\": \"According to imaging examination, 74 75 patients showed bilateral start_entity, 14 14 patients showed multiple mottling and end_entity, and one 1 patient had pneumothorax\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Currently, six human start_entity have been reported including human start_entity 229E HCoV-229E, OC43 HCoV-OC43, NL63 HCoV-NL63, HKU1 HCoV-HKU1, severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome-CoV, and MiddleEast respiratory syndrome end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Currently, six human start_entity have been reported including human start_entity 229E HCoV-229E, OC43 HCoV-OC43, NL63 HCoV-NL63, HKU1 HCoV-HKU1, severe acute respiratory syndrome end_entity start_entity end_entity-CoV, and MiddleEast respiratory syndrome MERS start_entity MERS-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"DESIGN: Data from the Saudi Ministry of Health of confirmed outbreak and non-outbreak cases of end_entity start_entity CoV infections from September 2012 through October 2015 were abstracted and analysed\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Development of effective vaccines, in particular, subunit-based vaccines, against emerging Middle East respiratory syndrome end_entity caused by the end_entity start_entity end_entity-CoV will provide the safest means of preventing the continuous spread of end_entity in humans and camels\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity infection and start_entity are known to cause much of their mortality by inducing acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult, which is the most severe form of acute lung injury ALI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Influenza,_Human infection and start_entity are known to cause much of their mortality by inducing acute respiratory distress syndrome end_entity, which is the most severe form of acute lung injury ALI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ACE2 is also the receptor for the end_entity start_entity end_entity-CoV, a group GCNT2 start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline start_entity FCoV is a complex viral agent that causes a variety of clinical manifestations in cats, commonly known as feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Finally, we discuss STING antagonism in the start_entityes end_entity start_entity and human start_entity NL63, which disrupt K63-linked polyubiquitination and dimerisation of STING both of which are required for STING-mediated activation of IRF-3 via their papain-like proteases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"N-glycans were released from the end_entity start_entity end_entity-CoV spike glycoprotein produced in Vero E6 cells and their structures were determined by a combination of matrix-assisted laser desorptionionization MALDI mass spectrometry, negative ion electrospray collision-induced dissociation time-of-flight mass spectrometry and normal-phase high-performance liquid chromatography with exoglycosidase digestion\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Middle East respiratory syndrome start_entity MERS-CoV is an emerging human pathogen related to end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Here we document the response of the end_entity Medical System EMS of the metropolitan area of Milan, Italy, to the start_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The end_entity start_entity targets the epithelial cells of the respiratory tract, resulting in diffuse alveolar damage\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline start_entity FCoV is endemic in feral cat populations and cat colonies, frequently preceding outbreaks of fatal feline infectious peritonitis end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emergence of the highly pathogenic end_entity start_entity end_entity-CoV has reignited interest in start_entity biology and pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"There are currently no approved vaccines or small molecule therapeutics available for the prophylaxis or treatment of end_entity start_entity MERS-CoV infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"There are currently no approved vaccines or small molecule therapeutics available for the prophylaxis or treatment of Middle East Respiratory end_entity start_entity MERS-CoV infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity infections had higher CXCL10 concentrations than start_entity, enterovirus or rhinovirus, and paramyxovirus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Much progress has been made in understanding the role of structural and accessory proteins in the pathogenesis of severe acute respiratory syndrome start_entity end_entitys\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity is a devastating, fatal disease of domestic cats caused by a pathogenic mutant virus derived from the ubiquitous feline enteric start_entity FECV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Bats are natural reservoir hosts of highly virulent pathogens such as Marburg virus, Nipah virus, and end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV envelope E protein is a viroporin involved in virulence\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Based on that event, the World Health Organization recommended that research be implemented to define modes of transmission of end_entity start_entity through sewage, feces, food and water\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The emergence of the start_entity start_entity has parallels with the 2003 outbreak of severe acute respiratory syndrome end_entity, which was caused by another start_entity that killed 349 of 5327 patients with confirmed infection in China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"This notification contained a reference to mental health problems and interventions that occurred during the 2003 end_entity outbreak, and mentioned that mental health care should be provided for patients with start_entity pneumonitis, close contacts, suspected cases who are isolated at home, patients in fever clinics, families and friends of affected people, health professionals caring for infected patients, and the public who are in need\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Background Corona end_entity 2019 start_entity due to the 2019 start_entity start_entity emerged in Wuhan city and rapidly spread throughout China\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine delta start_entity PDCoV is a novel emerging enterocytetropic virus causing end_entity, vomiting, dehydration, and mortality in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine delta start_entity PDCoV is a novel emerging enterocytetropic virus causing diarrhea, end_entity, dehydration, and mortality in suckling piglets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"We selected 16 bovine respiratory pathogens bovine viral end_entity virus, bovine start_entity, bovine parainfluenza virus 3, bovine respiratory syncytial virus, influenza D virus, bovine rhinitis A virus, bovine rhinitis B virus, bovine herpesvirus 1, bovine adenovirus 3, bovine adenovirus 7, Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Trueperella pyogenes, Mycoplasma bovis and Ureaplasma diversum as detection targets and designed novel specific primer-probe sets for nine of them\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a porcine enteropathogenic start_entity that causes watery end_entity, vomiting, and frequently death in piglets, causing serious economic losses to the pig industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Porcine deltastart_entity PDCoV is a porcine enteropathogenic start_entity that causes watery diarrhea, end_entity, and frequently death in piglets, causing serious economic losses to the pig industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"As proof-of-concept, we measure the NII for different epitopes on an immunogen comprised of the receptor-binding domain from end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity virus IFV infection is a common cause of severe viral start_entity associated with acute respiratory distress syndrome Respiratory_Distress_Syndrome,_Adult, which is difficult to control with general immunosuppressive therapy including corticosteroids due to the unfavorable effect on viral replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Influenza,_Human virus IFV infection is a common cause of severe viral start_entity associated with acute respiratory distress syndrome end_entity, which is difficult to control with general immunosuppressive therapy including corticosteroids due to the unfavorable effect on viral replication\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"In this study, we focused on CARD9, a signaling adaptor known to regulate innate immune activation through multiple innate sensor proteins, and investigated its role in anti-IFV defense and lung pathogenesis in a mouse model recapitulating severe influenza start_entity with end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The transcription and replication of the severe acute respiratory syndrome end_entity start_entity end_entity-CoV is regulated by specific viral genome sequences within 5- and 3-untranslated regions 5-UTR and 3-UTR\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a deadly disease that effects both domestic and wild cats and is caused by a mutation in feline start_entity FCoV that allows the virus to replicate in macrophages\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Feline start_entity infection is common among domestic and exotic felid species and usually associated with mild or asymptomatic enteritis; however, feline infectious peritonitis end_entity is a fatal disease of cats that is caused by systemic infection with a feline infectious peritonitis virus end_entityV, a variant of feline enteric start_entity FECV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"We sought to assess the diagnostic utility of polymerase chain reaction PCR for detection of respiratory viruses and bacteria in induced end_entity IS specimens from children hospitalized with severe or very severe start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Acute respiratory distress syndrome end_entity, lung failure, and fulminant start_entity are major lung diseases in H7N9 patients\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Transplantation of mesenchymal_stem_cells MSCs is a promising choice for treating virus-induced start_entity, and was used to treat H7N9-induced end_entity in 2013\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Transplantation\",\n",
       "                    \"value\": \"end_entity of mesenchymal_stem_cells MSCs is a promising choice for treating virus-induced start_entity, and was used to treat H7N9-induced Respiratory_Distress_Syndrome,_Adult in 2013\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \", end_entity and lung failure and corresponding multi-organ dysfunction, MSC-based therapy could be a possible alternative for treating start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"The Corona Virus_Diseases 2019 start_entity caused by start_entity start_entity is a Public Health end_entity of International Concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"The Corona end_entity 2019 start_entity caused by start_entity start_entity is a Public Health Emergencies of International Concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Pulmonary fibrosis can be occasionally seen as a consequence to several respiratory viral infections but is much more common after a end_entity start_entity end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Given the threat of future outbreaks of severe start_entity disease, including Middle East respiratory syndrome end_entity, it is important to understand the mechanisms responsible for pulmonary fibrosis, so as to support the development of therapeutic countermeasures and mitigate sequelae of infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"ll coronaviruses start_entity, including the causative agent of severe acute respiratory syndrome end_entity, encode a nucleocapsid N protein that harbors two independent RNA binding domains of known structure, but poorly characterized RNA binding properties\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Neural Tube Defects\",\n",
       "                    \"value\": \"We propose that the helix melting activity of the start_entity N protein end_entity plays a critical accessory role in subgenomic RNA synthesis and other processes requiring RNA remodeling\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity CoV responsible for severe acute respiratory syndrome end_entity, end_entity-CoV, encodes two large polyproteins pp1a and pp1ab that are processed by two viral proteases to yield mature non-structural proteins nsps\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"On January 30, the World Health Organization WHO Director-General declared that the start_entity outbreak constitutes a Public Health end_entity of International Concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Insectivorous bats are speculated to be ancestral hosts of Middle-East respiratory syndrome end_entity start_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chondrosarcoma, Extraskeletal Myxoid\",\n",
       "                    \"value\": \"Furthermore, two of the three mAbs S2A3 and S2D5 bound only MERS-CoV Erasmus Medical Center end_entity and not other start_entity, reflecting their high binding specificity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV and Middle East respiratory syndrome start_entity MERS-CoV encode multifunctional papain-like proteases PLPs that have the ability to process the viral polyprotein to facilitate RNA replication and antagonize the host innate immune response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"end_entity A virus IAV remains a major public health threat in the world, as indicated by the severe start_entity caused by its infection annually\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity start_entity end_entity-CoV was first identified in 2012, and it continues to threaten human health worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"These drug repurposing techniques have been successful in identifying new drug candidates for several types of cancers and were recently used to identify potential therapeutics against influenza, the newly discovered Middle Eastern Respiratory end_entity start_entity and several parasitic diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity of conventional mice with a mouse adapted MA15 severe acute respiratory syndrome Severe_Acute_Respiratory_Syndrome start_entity CoV reproduces many aspects of human Severe_Acute_Respiratory_Syndrome such as pathological changes in lung, viremia, neutrophilia, and lethality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Infection of conventional mice with a mouse adapted MA15 severe acute respiratory syndrome end_entity start_entity CoV reproduces many aspects of human end_entity such as pathological changes in lung, viremia, neutrophilia, and lethality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The recent outbreak of end_entity MERS start_entity infection in Korea resulted in large socioeconomic losses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The recent outbreak of Coronavirus_Infections end_entity start_entity infection in Korea resulted in large socioeconomic losses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The recent outbreak of Middle East Respiratory end_entity MERS start_entity infection in Korea resulted in large socioeconomic losses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": \"Her work up revealed an elevated IgM antibody and positive end_entity for Mycoplasma start_entity by polymerase chain reaction, suggesting the pathogen as the culprit for her ADEM\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"In an interim report by the start_entity National end_entity Response Center of the KCDC, epidemiological and clinical characteristics of start_entity in 28 cases in South Korea were reported\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"OBJECTIVES: This study examines perceptions of the operational and organisational management of a major outbreak of end_entity MERS caused by a start_entity MERS-CoV in the Kingdom of Saudi Arabia EPCAM\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"OBJECTIVES: This study examines perceptions of the operational and organisational management of a major outbreak of Coronavirus_Infections end_entity caused by a start_entity end_entity-CoV in the Kingdom of Saudi Arabia EPCAM\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"OBJECTIVES: This study examines perceptions of the operational and organisational management of a major outbreak of Middle East Respiratory end_entity MERS caused by a start_entity MERS-CoV in the Kingdom of Saudi Arabia EPCAM\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"The emergence of severe acute respiratory syndrome start_entity SARS-CoV in 2003 and end_entity Coronavirus MERS-CoV in late 2012 demonstrate the importance of start_entityes as emerging pathogens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The emergence of severe acute respiratory syndrome start_entity SARS-CoV in 2003 and Middle East Respiratory end_entity Coronavirus MERS-CoV in late 2012 demonstrate the importance of start_entityes as emerging pathogens\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"The ongoing outbreak of start_entity that began in Wuhan, China, has constituted a Public Health end_entity of International Concern, with cases confirmed in multiple countries\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Nonstructural protein 3 of the severe acute respiratory syndrome end_entity start_entity includes a end_entity-unique domain SUD consisting of three globular domains separated by short linker peptide segments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Overall, the present data provide evidence for molecular mechanisms involving the concerted actions of SUD-M and SUD-C, which result in specific RNA binding that might be unique to the SUD and, thus, to the end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The severe acute respiratory syndrome end_entity start_entity papain-like protease PLpro is a DUB that cleaves ISG15, a two-domain Ub-like protein, and Lys48-linked polyUb chains, releasing diUbLys48 products\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Although dromedaries are the main reservoir, other animal species might be susceptible to end_entity start_entity end_entity-CoV infection and potentially serve as reservoirs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To understand its pathogenesis, we developed an animal model using BALBc mice and the mouse-passaged Frankfurt 1 isolate of end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using next-generation sequencing, we performed a whole-transcriptome analysis of the host response to severe acute respiratory syndrome start_entity end_entity across four founder mouse strains of the Collaborative Cross\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"INTRODUCTION: Since the first case of end_entity start_entity MERS-CoV infection was reported in 2012, the virus has infected more than 1300 individuals in 26 countries, and caused more than 480 deaths\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"INTRODUCTION: Since the first case of Middle East Respiratory end_entity start_entity MERS-CoV infection was reported in 2012, the virus has infected more than 1300 individuals in 26 countries, and caused more than 480 deaths\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"In the literature, start_entity is characterised by the symptoms of viral start_entity such as fever, fatigue, dry end_entity, and lymphopenia\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The maturation of end_entity start_entity involves the autocleavage of polyproteins 1a and 1ab by the main protease Mpro and a papain-like protease; these represent attractive targets for the development of anti-end_entity drugs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"BACKGROUND: The molecular basis of severe acute respiratory syndrome end_entity start_entity CoV induced pathology is still largely unclear\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The newly emerged Middle East respiratory syndrome start_entity end_entity-CoV is currently spreading among humans, making development of effective end_entity vaccines a high priority\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Sequences of full-length end_entity start_entity end_entity-CoV from 10 patients and a partial sequence of end_entity-CoV from another patient, when compared with other end_entity-CoV sequences, demonstrated that this outbreak was part of a larger outbreak that affected multiple health care facilities in Riyadh and possibly arose from a single zoonotic transmission event that occurred in December 2013 95 highest posterior density interval November 8, 2013February 10, 2014\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity-associated start_entity SARS-CoV emerged as the causal agent of an endemic atypical start_entity, infecting thousands of people worldwide\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Little is known about CD4 T-cell immunity to the severe acute respiratory syndrome end_entity start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In two end_entity patients, we examined the memory CD4 T-cell responses to peptides derived from end_entity start_entity structural proteins\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Both start_entity disease 2019 start_entity and severe acute respiratory syndrome end_entity are characterised by an overexuberant inflammatory response and, for end_entity, viral load is not correlated with the worsening of symptoms\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In our previous Correspondence to The Lancet, we described how BenevolentAI's proprietary artificial intelligence AI-derived knowledge graph, queried by a suite of algorithms, enabled identification of a target and a potential therapeutic against end_entity start_entity 2 start_entity; the causative organism in start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"While dromedaries are the immediate animal source of end_entity MERS epidemic, viruses related to MERS start_entity MERS-CoV have also been found in bats as well as hedgehogs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"While dromedaries are the immediate animal source of Coronavirus_Infections end_entity epidemic, viruses related to end_entity start_entity end_entity-CoV have also been found in bats as well as hedgehogs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"While dromedaries are the immediate animal source of Middle East Respiratory end_entity MERS epidemic, viruses related to MERS start_entity MERS-CoV have also been found in bats as well as hedgehogs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": \"El da 11 de febrero la Otitis_Media le asigna el nombre de SARS-CoV2 e infeccin start_entity Coronavirus end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Otitis Media\",\n",
       "                    \"value\": \"El da 11 de febrero la end_entity le asigna el nombre de SARS-CoV2 e infeccin start_entity Coronavirus Communicable_Diseases\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"BACKGROUND: The pathogenesis and immune response to Middle East respiratory syndrome end_entity caused by a recently discovered start_entity, end_entity-CoV, have not been fully characterized because a suitable animal model is currently not available\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity SARS-CoV poses a considerable threat to human health\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We have previously observed that all known HIV-1 broadly neutralizing antibodies bnAbs are highly divergent from germline antibodies in contrast to bnAbs against Hendra virus, Nipah virus and end_entity start_entity end_entity CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity is an acute infectious disease of the respiratory system caused by the new betastart_entity end_entity start_entity, end_entity-CoV, which shows high mortality rates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The typical symptoms of end_entity are fever, cough, and shortness of breath, and it is often accompanied by start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The typical symptoms of MERS are fever, end_entity, and shortness of breath, and it is often accompanied by start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": \"2 The existence of hyper-cytokinemia in start_entity patients with lymphopenia could indicate a poor control of the pathogen, as showed in severe patients infected with the 2009 Pandemic end_entity virus\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"5,6 These features lymphopenia hypercytokinemia fit the characteristics of a particular immunological phenotype of community acquired start_entity CAP, lymphopenic CAP L-CAP, which, as we recently demonstrated in an article published in the Journal of end_entity, is associated with increased severity, mortality and a dysregulated immunological response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity end_entity is a highly lethal emerging disease caused by start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Immediately after start_entity was declared a Public Health end_entity of International Concern, WHO's risk communication team launched a new information platform called WHO Information Network for Epidemics EPI-WIN, with the aim of using a series of amplifiers to share tailored information with specific target groups\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"n in-depth annotation of the newly discovered start_entity start_entity genome has revealed differences between start_entity and severe acute respiratory syndrome end_entity or end_entity-like start_entityes\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The first imported case of Middle East respiratory syndrome end_entity in China recently occurred, allowing for the characterization of antibody titers in a series of the patient's sera using the following methods based on recombinant viral structural antigens: inactivated end_entity start_entity end_entity-CoV enzyme-linked immunosorbent assay ELISA, recombinant end_entity-CoV spike S, or fragments of S ELISA, nucleoprotein NP ELISA and end_entity S pseudovirus particle-based neutralization test ppNT\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome end_entity start_entity to guanidinium chloride was examined in terms of fluorescence spectroscopy, circular dichroism, analytical ultracentrifuge, and enzyme activity change\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We provide direct evidence for the functional role of C-terminal domain in stabilization of the catalytic N-terminal domain of end_entity start_entity main protease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Stress Disorders, Post-Traumatic\",\n",
       "                    \"value\": \"One month after the December 2019 start_entity outbreak in Wuhan China, we surveyed PTSS and sleep qualities among 285 residents in Wuhan and surrounding cities using the end_entity Checklist for DSM-5 PCL-5 and 4 items from the Pittsburgh Sleep Quality Index PSQI\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV emerged in 2002 as an important cause of severe lower respiratory tract infection in humans and in vitro models of the lung are needed to elucidate cellular targets and the consequences of viral infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"The severe and sudden onset of symptoms, resulting in an atypical start_entity with dry end_entity and persistent high fever in cases of severe acute respiratory virus brought to light the importance of coronaviruses as potentially lethal human pathogens and the identification of several zoonotic reservoirs has made the reemergence of new strains and future epidemics all the more possible\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"RSS\",\n",
       "                    \"value\": \"Recently, RVD has been suggested to play a role in the pathogenesis of runting and stunting syndrome end_entity, alongside other viruses such as reovirus, astrovirus, start_entity, and others, all of which cause colossal economic losses to the poultry industry\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"In recent years, however, systemic fatal start_entity infection has emerged in ferrets, which resembles feline infectious peritonitis end_entity in cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity is a highly fatal systemic disease caused by a virulent feline start_entity infection in cats\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"We have previously reported the efficacy of a protease inhibitor in cats with end_entity, demonstrating that a virally encoded 3C-like protease 3CLpro is a valid target for antiviral drug development for start_entity infections\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Middle East respiratory syndrome end_entity start_entity end_entity-CoV was originally identified in Saudi Arabia in 2012\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinitis Pigmentosa 2\",\n",
       "                    \"value\": \"Two new targets are included in the FilmArray end_entity: Middle East respiratory syndrome start_entity and Bordetella parapertussis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Diabetes Mellitus\",\n",
       "                    \"value\": \"end_entity and hypertension are recognized risk factors for severe clinical outcomes, including death, associated with Middle East respiratory syndrome start_entity infection\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"end_entity end_entity is a terminal disease of cats caused by systemic infection with a feline start_entity FCoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"To investigate this dichotomy in severe acute respiratory syndrome start_entity SARS-CoV, we developed a transcriptional network model of end_entity in mice and used the model to prioritize candidate regulatory targets for further investigation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Using beads of different sizes and molecular beacons in two fluorophore colours, synthetic nucleic acid control sequences were specifically detected for three respiratory pathogens, including the end_entity start_entity in proof-of-concept experiments\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Previous studies have described the general pathology in the lungs of end_entity patients and have identified some of the cell types infected by end_entity start_entity end_entity-CoV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"end_entity start_entity transmission probably was multifocal, occurring in multiple hospital settings\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The virus causing end_entity was identified as a start_entity end_entity-CoV and multiple genomic sequences have been revealed since mid-April, 2003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"We previously described an unusual three-stemmed pseudoknot from the severe acute respiratory syndrome end_entity start_entity CoV that stimulated -1 PRF\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"?As fomite transmission caused clusters of infection of end_entity, adequate disinfection?operations should be adopted in start_entity outbreak\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"The combination supports a multiplexed Luminex-based respiratory panel that potentially differentiates influenza viruses A and B, respiratory syncytial virus, severe acute respiratory syndrome start_entity Severe_Acute_Respiratory_Syndrome, and Middle East respiratory syndrome end_entity start_entity, detecting as few as 10 end_entity virions in a 20-l sample\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The combination supports a multiplexed Luminex-based respiratory panel that potentially differentiates influenza viruses A and B, respiratory syncytial virus, severe acute respiratory syndrome start_entity end_entity, and Middle East respiratory syndrome MERS start_entity, detecting as few as 10 MERS virions in a 20-l sample\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Epidermodysplasia Verruciformis\",\n",
       "                    \"value\": \"Fifteen respiratory viruses were included in our investigation: respiratory syncytial virus AB RSV, influenza virus A FluA and influenza virus B FluB, human metapneumovirus MPV, enterovirus end_entity, human parainfluenza virus PIV types 14, human rhinovirus RV, human start_entity OC43, NL63, and 229E, human adenovirus ADV, and human bocavirus Boca\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Gastroenteritis, Transmissible, of Swine\",\n",
       "                    \"value\": \"Transmissible gastroenteritis end_entity is a contagious and infectious disease that is characterized by severe vomiting and diarrhea of swine , especially piglet, and caused by transmissible gastroenteritis start_entity end_entityV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Transmissible gastroenteritis Gastroenteritis,_Transmissible,_of_Swine is a contagious and infectious disease that is characterized by severe vomiting and end_entity of swine , especially piglet, and caused by transmissible gastroenteritis start_entity Gastroenteritis,_Transmissible,_of_SwineV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"vomiting\",\n",
       "                    \"value\": \"Transmissible gastroenteritis Gastroenteritis,_Transmissible,_of_Swine is a contagious and infectious disease that is characterized by severe end_entity and diarrhea of swine , especially piglet, and caused by transmissible gastroenteritis start_entity Gastroenteritis,_Transmissible,_of_SwineV\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The causative agent of end_entity end_entity was identified as a start_entity CoV following the outbreak of 20022003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"The causative agent of Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome was identified as a start_entity CoV following the outbreak of 20022003\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ground-glass opacity\",\n",
       "                    \"value\": \"The most common finding on chest imaging among patients with start_entity was end_entity with bilateral involvement\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"While bats may be the primary reservoir for both viruses, Severe_Acute_Respiratory_Syndrome start_entity Severe_Acute_Respiratory_Syndrome-CoV likely crossed into humans from civets in China, and end_entity start_entity end_entity-CoV has been transmitted from camels in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"While bats may be the primary reservoir for both viruses, end_entity start_entity end_entity-CoV likely crossed into humans from civets in China, and MERS start_entity MERS-CoV has been transmitted from camels in the Middle East\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"The start_entity outbreak creates a sense of dj vu with the 2003 outbreak of severe acute respiratory syndrome end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Furthermore we compared the characteristics between severe and common confirmed cases which including mild cases, no-pneumonia cases and asymptomatic cases, and we also compared the features between start_entity and 2003 end_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Some scholars may not support the corticosteroids treatment for start_entity start_entity start_entity, because observational studies and systematic reviews have indicated inconclusive clinical evidence on the effect of corticosteroids therapy for viral start_entitys such as Severe_Acute_Respiratory_Syndrome, end_entity and H1N1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Some scholars may not support the corticosteroids treatment for start_entity start_entity start_entity, because observational studies and systematic reviews have indicated inconclusive clinical evidence on the effect of corticosteroids therapy for viral start_entitys such as end_entity, MERS and H1N1\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"end_entity by severe acute respiratory syndrome start_entity SARS-CoV is initiated by specific interactions between the SARS-CoV spike S protein and its receptor ACE2\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In closed high-contact settings, end_entity start_entity was highly infectious and pathogenicity was relatively low\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Our analysis reliably suggests that start_entity is most closely related to BatCoV RaTG13 and belongs to subgenus Sarbecovirus of Betastart_entity, together with end_entity start_entity and Bat-end_entity-like start_entity\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"With the outbreak of unknown start_entity in Wuhan, China, in December 2019, a new start_entity, end_entity Coronavirus 2 start_entity, aroused the attention of the entire world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"With the outbreak of unknown start_entity in Wuhan, China, in December 2019, a new start_entity, Severe Acute Respiratory end_entity Coronavirus 2 start_entity, aroused the attention of the entire world\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"The World Health Organization declared start_entity in China as a Public Health end_entity of International Concern\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"Two other start_entity infections-SARS in 2002-2003 and end_entity MERS in 2012-both caused severe respiratory syndrome in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Two other start_entity infections-SARS in 2002-2003 and Coronavirus_Infections end_entity in 2012-both caused severe respiratory syndrome in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Two other start_entity infections-SARS in 2002-2003 and Middle East Respiratory end_entity MERS in 2012-both caused severe respiratory syndrome in humans\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"end_entity start_entity MERS-CoV causes severe pulmonary infection, with approximately 35 mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Middle East Respiratory end_entity start_entity MERS-CoV causes severe pulmonary infection, with approximately 35 mortality\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Novel COVID-19infected start_entity NCIP is characterized by fever, fatigue, dry end_entity, and dyspnea\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Salmonella Infections\",\n",
       "                    \"value\": \"CONCLUSIONS AND CLINICAL IMPORTANCE: Equine start_entity and end_entitys share clinical features, suggesting both diseases should be differential diagnoses for horses with fever and enteric clinical signs\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"end_entity start_entity end_entity-CoV papain-like protease PLpro has been identified in TGF-1 up-regulation in human promonocytes Proteomics 2012, 12: 3193-205\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"lung transplantation\",\n",
       "                    \"value\": \"CONCLUSIONS: This study suggests that VRTI during the first year after end_entity is associated with long-term CLAD development and that start_entity infections in particular might be a risk factor\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Glucose-Galactose Malabsorption\",\n",
       "                    \"value\": \"In Hong Kong, initially, only start_entity patients without a microbiological diagnosis were tested, but surveillance has been broadened to include all inpatients with start_entity and a purposively sampled proportion of outpatients and emergency attendees totalling about 1500 per day Leung end_entity, unpublished\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": \"In a recent review on the persistence of human and veterinary start_entityes on inanimate surfaces it was shown that human start_entityes such as Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome start_entity, end_entity MERS start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"In a recent review on the persistence of human and veterinary start_entityes on inanimate surfaces it was shown that human start_entityes such as Severe_Acute_Respiratory_Syndrome Severe_Acute_Respiratory_Syndrome start_entity, Coronavirus_Infections end_entity start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"In a recent review on the persistence of human and veterinary start_entityes on inanimate surfaces it was shown that human start_entityes such as end_entity end_entity start_entity, Coronavirus_Infections MERS start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"In a recent review on the persistence of human and veterinary start_entityes on inanimate surfaces it was shown that human start_entityes such as Severe Acute Respiratory end_entity Severe_Acute_Respiratory_Syndrome start_entity, Middle East Respiratory end_entity MERS start_entity or endemic human start_entityes HCoV can persist on inanimate surfaces like metal, glass or plastic for up to 9 days\"\n",
       "                }\n",
       "            ]\n",
       "        }\n",
       "    ],\n",
       "    \"legend\": [\n",
       "        {\n",
       "            \"data\": [\n",
       "                \"Disease\",\n",
       "                \"Gene\",\n",
       "                \"Chemical\"\n",
       "            ],\n",
       "            \"selected\": {\n",
       "                \"Disease\": true,\n",
       "                \"Gene\": true,\n",
       "                \"Chemical\": true\n",
       "            },\n",
       "            \"show\": true,\n",
       "            \"left\": \"2%\",\n",
       "            \"top\": \"40%\",\n",
       "            \"orient\": \"vertical\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10,\n",
       "            \"itemWidth\": 25,\n",
       "            \"itemHeight\": 14,\n",
       "            \"icon\": \"circle\"\n",
       "        }\n",
       "    ],\n",
       "    \"tooltip\": {\n",
       "        \"show\": true,\n",
       "        \"trigger\": \"item\",\n",
       "        \"triggerOn\": \"mousemove|click\",\n",
       "        \"axisPointer\": {\n",
       "            \"type\": \"line\"\n",
       "        },\n",
       "        \"textStyle\": {\n",
       "            \"fontSize\": 14\n",
       "        },\n",
       "        \"borderWidth\": 0\n",
       "    },\n",
       "    \"title\": [\n",
       "        {\n",
       "            \"text\": \"disease-COVID-19 knowledge graph\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10\n",
       "        }\n",
       "    ]\n",
       "};\n",
       "                chart_008de673629e445d9c76a4f72eb79449.setOption(option_008de673629e445d9c76a4f72eb79449);\n",
       "        });\n",
       "    </script>\n"
      ],
      "text/plain": [
       "<pyecharts.render.display.HTML at 0x7f36494590d0>"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# gene-COVID-19 relations\n",
    "g = Build_graph(marked_sentence_df.loc[(marked_sentence_df['start_entity']=='COVID-19')&(marked_sentence_df['end_entity_type']=='Disease')|(marked_sentence_df['start_entity_type']=='Disease')&(marked_sentence_df['end_entity']=='COVID-19')],relation=False,repulsion=60,title='disease-COVID-19 knowledge graph',labelShow=True)\n",
    "g"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "# Answering researchers questions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "# merge all relation prediction and save results\n",
    "cols = ['start_entity','end_entity','start_entity_type','end_entity_type','marked_sentence','pred','pred_prob','theme']\n",
    "relation_df = pd.concat([c_d_pred_df[cols],c_g_pred_df[cols],g_d_pred_df[cols],g_g_pred_df[cols]]).append(marked_sentence_df.loc[(marked_sentence_df['start_entity_type'].isin(['Chemical','Disease'])&(marked_sentence_df['start_entity_type']==marked_sentence_df['end_entity_type']))]).reset_index(drop=True)\n",
    "relation_df.loc[(relation_df['pred'].isna())&(relation_df['start_entity_type']=='Chemical'),'pred'] = 'CC'\n",
    "relation_df.loc[(relation_df['pred'].isna())&(relation_df['start_entity_type']=='Disease'),'pred'] = 'DD'\n",
    "relation_df = relation_df[cols]\n",
    "relation_df.to_csv('relation.csv',index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "labels_df= pd.concat([c_d_label_df,c_g_label_df,g_d_label_df,g_g_label_df])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<script>\n",
       "    require.config({\n",
       "        paths: {\n",
       "            'echarts':'https://assets.pyecharts.org/assets/echarts.min'\n",
       "        }\n",
       "    });\n",
       "</script>\n",
       "\n",
       "        <div id=\"541587454d0f42beb78a1b0e0357264b\" style=\"width:900px; height:500px;\"></div>\n",
       "\n",
       "<script>\n",
       "        require(['echarts'], function(echarts) {\n",
       "                var chart_541587454d0f42beb78a1b0e0357264b = echarts.init(\n",
       "                    document.getElementById('541587454d0f42beb78a1b0e0357264b'), 'white', {renderer: 'canvas'});\n",
       "                var option_541587454d0f42beb78a1b0e0357264b = {\n",
       "    \"animation\": true,\n",
       "    \"animationThreshold\": 2000,\n",
       "    \"animationDuration\": 1000,\n",
       "    \"animationEasing\": \"cubicOut\",\n",
       "    \"animationDelay\": 0,\n",
       "    \"animationDurationUpdate\": 300,\n",
       "    \"animationEasingUpdate\": \"cubicOut\",\n",
       "    \"animationDelayUpdate\": 0,\n",
       "    \"color\": [\n",
       "        \"#c23531\",\n",
       "        \"#2f4554\",\n",
       "        \"#61a0a8\",\n",
       "        \"#d48265\",\n",
       "        \"#749f83\",\n",
       "        \"#ca8622\",\n",
       "        \"#bda29a\",\n",
       "        \"#6e7074\",\n",
       "        \"#546570\",\n",
       "        \"#c4ccd3\",\n",
       "        \"#f05b72\",\n",
       "        \"#ef5b9c\",\n",
       "        \"#f47920\",\n",
       "        \"#905a3d\",\n",
       "        \"#fab27b\",\n",
       "        \"#2a5caa\",\n",
       "        \"#444693\",\n",
       "        \"#726930\",\n",
       "        \"#b2d235\",\n",
       "        \"#6d8346\",\n",
       "        \"#ac6767\",\n",
       "        \"#1d953f\",\n",
       "        \"#6950a1\",\n",
       "        \"#918597\"\n",
       "    ],\n",
       "    \"series\": [\n",
       "        {\n",
       "            \"type\": \"graph\",\n",
       "            \"layout\": \"force\",\n",
       "            \"symbolSize\": 10,\n",
       "            \"circular\": {\n",
       "                \"rotateLabel\": false\n",
       "            },\n",
       "            \"force\": {\n",
       "                \"repulsion\": 15,\n",
       "                \"edgeLength\": 50,\n",
       "                \"gravity\": 0.2\n",
       "            },\n",
       "            \"label\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"lineStyle\": {\n",
       "                \"show\": true,\n",
       "                \"width\": 1,\n",
       "                \"opacity\": 1,\n",
       "                \"curveness\": 0,\n",
       "                \"type\": \"solid\"\n",
       "            },\n",
       "            \"roam\": true,\n",
       "            \"draggable\": false,\n",
       "            \"focusNodeAdjacency\": true,\n",
       "            \"data\": [\n",
       "                {\n",
       "                    \"name\": \"GLS2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HES5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sprains and Strains\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EXOSC10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SFTPA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GSDMB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TTN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACE2\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"diarrhea\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PORCN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LTA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TSPAN7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD177\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Newcastle Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DUSP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pranlukast\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypersensitivity, Immediate\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bronchiolitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL20\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBX3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Wounds and Injuries\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Influenza in Birds\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSF3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis, Contact\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ENPEP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL17A\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Wheat Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNL1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MERTK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Intravenous Immunoglobulin\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diarrhea\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CIA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PGF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Eosinophilia\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FHC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSME3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NFE2L1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FLOT2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nitric Oxide\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Multiple Sclerosis\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADCY10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Netherton Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"XIST\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C7orf49\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Urticaria\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UPF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYP2E1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMEM173\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FOXP3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RDX\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ABCG2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis, Allergic\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DHCR7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ataxia Telangiectasia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPL37\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SFTPC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDGFB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Inflammatory Bowel Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Peramivir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RAPGEF3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FOLH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"aspartate aminotransferase\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CX3CR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mefloquine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PCNA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL-27\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AQP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"alanine aminotransferase\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPLP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TPR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Eczema\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"P14\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FS\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYP2D6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Asthma\",\n",
       "                    \"symbolSize\": 26.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Weyers acrofacial dysostosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLAMF7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SELPLG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ORF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CASP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RASA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NDUFB6\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DKK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPS23\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Niemann-Pick Disease, Type C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EPCAM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LTF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD83\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RTKN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TAK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PTX3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"d-dimer\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSP90AA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Thrombocytopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H5\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPR50\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PEA15\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRH1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Aminophylline\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PNPLA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF2AK3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEBPA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRKAA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HLA-B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC3A2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CBLB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sarcoidosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD209\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NOS2\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL-22\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GRB2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C9orf9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GCNT2\",\n",
       "                    \"symbolSize\": 31.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DCD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GABARAPL2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL15\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSPA8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Retinitis Pigmentosa\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Tinea\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"alpha-1-Antitrypsin Deficiency, Autosomal Recessive\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DMD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GZMB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL9\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Distal Myopathies\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARP9\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Obesity\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLEKHM3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TGFB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NLRX1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gastroenteritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLIN2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Porcine Reproductive and Respiratory Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EMT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PAFAH1B1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TAC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PENK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IKBKG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AKT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Aspergillosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LGALS8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Erythematosus, Systemic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BIRC2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD163\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDIT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Coronavirus Infections\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Communicable Diseases\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"URI1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HIV Seropositivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MX1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ACTB\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL18\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HGF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Sounds\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p40\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Amantadine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PAPPA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OPA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B3GNT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pigmentary Disorder, Reticulate, with Systemic Manifestations\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"3CLpro\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDIA6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Airway Remodeling\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AGO2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL5\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BMI1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VIM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Status Asthmaticus\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UBE2I\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COVID-19\",\n",
       "                    \"symbolSize\": 46.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GCG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ISG20\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Peanut Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SOX2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CBX8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAPN5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FIS1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"REN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MYC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC4A1\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNF\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"African Swine Fever\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK8\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PYCARD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CRP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GREM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD40LG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NEAT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EFS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ITGAM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCR5\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Osteonecrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEACAM6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MOG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAVS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIT1B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Myeloproliferative Syndrome, Transient\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ciliary Motility Disorders\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p27\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MERS\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Prune Belly Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"inhibitory concentration 50\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MCD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CASP12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Aspergillosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OAS1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPI\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Glycine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Tuberculosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Colorectal Neoplasms\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dexamethasone\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NAC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSF2\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PDI\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NTS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD36\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TCF4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LFA-1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UBB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BMP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PECAM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLF4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEACAM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dysbiosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"cough\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DSCAM-AS1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sialic Acid Storage Disease\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MITF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP1LC3A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR4\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BST2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Metabolic Syndrome X\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SIGLEC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GC\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E3\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EXOSC3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRIM63\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CPSF4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SPARC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MPO\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD81\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LAMP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL13\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B2M\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p38\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HMGB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TJP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ABCC4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SKAP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hantavirus Pulmonary Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAPDH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MMRN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"THBS1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFSF11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNAR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TICAM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADRM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HSPA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL5\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD55\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV6-21\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM3\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GATA3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NOD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MRLN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"POU5F1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FCGR3A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C4A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MYD88\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Infection\",\n",
       "                    \"symbolSize\": 30.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL34\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TYK2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFITM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diclofenac\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAL3ST1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UPP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"WNT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD14\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Inflammation\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RHOD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KRT8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Emergencies\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Omalizumab\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLpro\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Kartagener Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CLEC4G\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NR3C2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX23\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL13\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diabetic Retinopathy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VDR\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Eosinophilic Esophagitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDR2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NEDD4L\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SI\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SCPEP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Alzheimer Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CNP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NAA50\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBP\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAT\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DSP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Leigh Disease\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARK2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ETV5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RETN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TP63\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ginseng\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"POMC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EFNB3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"QS-21\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Necrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCR7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV5-2\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLA2G1B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AGBL2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EGF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRAF6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Myotonic Dystrophy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UNC93B1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EFNB2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COPS8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pneumonia\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TP53\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MBP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Thrombasthenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PLD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Oseltamivir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BIRC3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRCP\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HMBS\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Encephalitis, Japanese\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neutropenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFRSF1A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypotrichosis simplex\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Aluminium\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CPD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PCN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LTB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RELN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SAA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCNB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Thyroid cancer, papillary\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATF6\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV1-16\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Recurrence\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HAMP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ANPEP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"POSTN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AADAT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ITGA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TAB3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Brucellosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL2RG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Guillain-Barre Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSNK1A1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"sputum\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LRRC16A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dengue\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nephritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMPRSS2\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Idiopathic Pulmonary Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan syndrome 3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DUOXA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Methotrexate\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KPNA3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PCBD2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP6AP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MASP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PARP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADAP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF2AK2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"remdesivir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DECR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL26\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR2\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GABARAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Burkitt Lymphoma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Arthritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NCR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MME\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CPE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Virus Diseases\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NFKB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VHLL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL10\",\n",
       "                    \"symbolSize\": 29.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KIR2DL3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FBL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV6D-21\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD274\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PAH\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RTEL1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C4B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Arthritis, Juvenile\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD8A\",\n",
       "                    \"symbolSize\": 31.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDKN2A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ventilation\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Carcinoma, Non-Small-Cell Lung\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DUSP4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSME1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RNGTT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"APLN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGHD2-15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SMN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DICER1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADSL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p28\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LEP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Egg Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EREG\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RD\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KCNE1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"symbolSize\": 39.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HDAC5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Extensively Drug-Resistant Tuberculosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZC3HAV1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Vulgaris\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NSP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polyps\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SPI1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neoplasms\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VWF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NANOG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DHDDS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBK1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EGFR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BDNF\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OAS3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Congenital Abnormalities\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FCER1G\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GTF2H5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Shock\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MSN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MCM8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KNG1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAP3K1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PD150606\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TKTL1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DCX\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FPGS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Glatiramer Acetate\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HPSE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ITGB2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MPZL2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MMP9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP12A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSG1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ENDOU\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CFD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LAG3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL6\",\n",
       "                    \"symbolSize\": 36.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pelger-Huet Anomaly\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTNNB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PON1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pruritus\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CNDP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CALR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMED10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Shock, Septic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Anaphylaxis\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PBRM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MIPOL1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"G10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"T1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYTIP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSTA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis, Atopic\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pleural Effusion\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Milk Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFRSF4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A20\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"G3BP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNFRSF11B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRPA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LAMP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Allopurinol\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"L2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Harlequin type ichthyosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL10\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cryptogenic Organizing Pneumonia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GLTSCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSRP2BP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRAK3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDK9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ATP5B\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"F2\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR3\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CFH\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEACAM5\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADIPOQ\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"H3\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Esophagitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SAS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HPRT1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E2\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRAK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Coinfection\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ARTN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VEGFA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NFKB2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPCR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"YARS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RBMS3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cataract, Coppock-Like\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypersensitivity\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UCN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sveinsson Chorioretinal Atrophy\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E1\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL8\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EVA1C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PTGDR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RAPGEF5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGKV4-1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD40\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Myotonic Disorders\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"POLD3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRGV9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"alanine \",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BMD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SRSF11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rimantadine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF3\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lymphopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lung Diseases, Interstitial\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PRB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"A2\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LMOD1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MIR7-3HG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"APC2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Influenza, Human\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RELA\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PCYT2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FUT2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cataract congenital Volkmann type\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Feline Infectious Peritonitis\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFNA1\",\n",
       "                    \"symbolSize\": 31.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NPEPPS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Arthritis, Rheumatoid\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CSF2RA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"G6PD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PTPRC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ARIH1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LRCH4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NGF\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ALPK3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 5\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DPP4\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CTSA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ISG15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PAM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"J2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GCA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bulimia Nervosa\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NCR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFI16\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"von Willebrand Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCL5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TANK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ST3GAL4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL2\",\n",
       "                    \"symbolSize\": 26.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Fever\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MLP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BSS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIT2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BCL6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BCL2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPL4\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"autoimmunity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DEFB1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRAF3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAV2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Adrenocortical Carcinoma, Hereditary\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NFIL3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Connective Tissue Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GGT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COL4A3BP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Eosinophilia\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL7\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sepsis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BSG\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL4\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LCK\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NT5C2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SGTA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FMD\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LPL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IFIH1\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Psoriasis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD86\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERVW-1\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ELANE\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"C6orf47\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TERT\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AP-1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYCSP39\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Poikiloderma with Neutropenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mucocutaneous Lymph Node Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD44\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD69\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRPV1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GRAP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TNIP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SERPINA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Strudwick syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ALB\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Osteoarthritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CEBPB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IGFBP3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"p19\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cystic Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"NR1H4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug Eruptions\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HLA-C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KPNA2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF7\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Demyelinating Diseases\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRIM56\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMEM121\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"JUN\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mannitol\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF3F\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KPNA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cough\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bleomycin\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"LPA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Airway Obstruction\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"G2\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"UIMC1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL22\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S2\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDKN2B-AS1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SRC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Retinoschisis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"YWHAZ\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PIN1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TMPRSS11E\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PES1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GPA33\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ASAH1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"THPO\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MSC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ERK\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CDK4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX58\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PA\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MEF2D\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Measles\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCR4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Diabetes Insipidus, Neurogenic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EBI3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DHX58\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SQSTM1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL1A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"EIF3D\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD68\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CXCR1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GAS2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sarcoma, Kaposi\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD38\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FASN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Zinc\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Tract Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"HK2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MRPS18B\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPS5\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Morphine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lung Injury\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"nausea\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ouabain\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"STAT1\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BTC\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MMP12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PSMD1\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Syndrome\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"FOXA1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"OSM\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KDELR2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemochromatosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"E4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CD4\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ZBTB16\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPS15\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CYGB\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Benign Paroxysmal Positional Vertigo\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Primaquine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"XIAP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TXN\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRIM27\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"creatine kinase\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL2\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"thrombocytopenia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"treatment failure\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Paramyxoviridae Infections\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Angelman Syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IQGAP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CAL\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DDX17\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TYRP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KCNQ1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SOCS3\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RPLP0\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Viremia\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"K12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bjornstad syndrome\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Precursor Cell Lymphoblastic Leukemia-Lymphoma\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL23A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SLC17A5\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ARG1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ROS1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Food Hypersensitivity\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TBATA\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TSLP\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Simvastatin\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"\\u00a0C-reactive protein\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Severe Combined Immunodeficiency\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL24\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Acute Lung Injury\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MALAT1\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CALCOCO1\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Aortic Aneurysm, Familial Abdominal 1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IRF8\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"XBP1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"S9\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TLR7\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"INS\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polycythemia Vera\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Van der Woude syndrome\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"G3BP2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hepatitis A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SEC16A\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Primary hyperoxaluria type 1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"MAPK3\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"VAPA\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Noonan Syndrome 6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"KLRK1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TRPC4\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Herpes Zoster\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CCL11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"USP18\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"DEFT1P\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"AFP\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ADAM10\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"TGOLN2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"CRY2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"B1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"IL7\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Nephritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GSR\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"GBF1\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neural Tube Defects\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ABCB11\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Corneal Dystrophy, Fleck\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PTPN6\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"RUNX2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 1\n",
       "                }\n",
       "            ],\n",
       "            \"categories\": [\n",
       "                {\n",
       "                    \"name\": \"Disease\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#FF7F50\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gene\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#48D1CC\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chemical\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#B3EE3A\"\n",
       "                        }\n",
       "                    }\n",
       "                }\n",
       "            ],\n",
       "            \"edgeLabel\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"edgeSymbol\": [\n",
       "                null,\n",
       "                null\n",
       "            ],\n",
       "            \"edgeSymbolSize\": 10,\n",
       "            \"links\": [\n",
       "                {\n",
       "                    \"source\": \"p28\",\n",
       "                    \"target\": \"SLAMF7\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C1\",\n",
       "                    \"target\": \"THPO\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"target\": \"F2\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KIR2DL3\",\n",
       "                    \"target\": \"TGOLN2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD274\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"IRF3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S4\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Multiple Sclerosis\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSG1\",\n",
       "                    \"target\": \"TGFB1\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LGALS8\",\n",
       "                    \"target\": \"LTF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMBS\",\n",
       "                    \"target\": \"CRY2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPI\",\n",
       "                    \"target\": \"CD55\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VAPA\",\n",
       "                    \"target\": \"COL4A3BP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMED10\",\n",
       "                    \"target\": \"Myeloproliferative Syndrome, Transient\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"d-dimer\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD177\",\n",
       "                    \"target\": \"PEA15\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAPPA\",\n",
       "                    \"target\": \"PGF\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNFRSF1A\",\n",
       "                    \"target\": \"FH\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRH1\",\n",
       "                    \"target\": \"PA\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERN1\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"CSF2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLpro\",\n",
       "                    \"target\": \"TP53\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPL37\",\n",
       "                    \"target\": \"RPL4\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ciliary Motility Disorders\",\n",
       "                    \"target\": \"Kartagener Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EFS\",\n",
       "                    \"target\": \"CTSA\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Brucellosis\",\n",
       "                    \"target\": \"Influenza in Birds\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Newcastle Disease\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p12\",\n",
       "                    \"target\": \"SRSF11\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL8\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E3\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LRCH4\",\n",
       "                    \"target\": \"Hemorrhagic Fever, Ebola\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"J2\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERN1\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PCBD2\",\n",
       "                    \"target\": \"TTN\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"Angelman Syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK8\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR2\",\n",
       "                    \"target\": \"CCL2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UBE2I\",\n",
       "                    \"target\": \"UIMC1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Connective Tissue Diseases\",\n",
       "                    \"target\": \"Gastroenteritis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLA2G1B\",\n",
       "                    \"target\": \"PNPLA1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CALCOCO1\",\n",
       "                    \"target\": \"Dermatitis, Atopic\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"G2\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Obesity\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p15\",\n",
       "                    \"target\": \"EXOSC3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F2\",\n",
       "                    \"target\": \"Diclofenac\",\n",
       "                    \"value\": \"Metabolism, pharmacokinetics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCD\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD36\",\n",
       "                    \"target\": \"LRRC16A\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dexamethasone\",\n",
       "                    \"target\": \"Inflammatory Bowel Diseases\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Multiple Sclerosis\",\n",
       "                    \"target\": \"PTPN6\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C6\",\n",
       "                    \"target\": \"IRF3\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H5\",\n",
       "                    \"target\": \"H1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CIA\",\n",
       "                    \"target\": \"CAT\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Lung Diseases, Interstitial\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ginseng\",\n",
       "                    \"target\": \"Gastroenteritis\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARG1\",\n",
       "                    \"target\": \"GPA33\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Congenital Abnormalities\",\n",
       "                    \"target\": \"Milk Hypersensitivity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Leigh Disease\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EXOSC10\",\n",
       "                    \"target\": \"Noonan Syndrome 2\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMGB1\",\n",
       "                    \"target\": \"Idiopathic Pulmonary Fibrosis\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Eruptions\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HPRT1\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL3\",\n",
       "                    \"target\": \"CCL4\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"Noonan Syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"PSME1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HK1\",\n",
       "                    \"target\": \"CAV2\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Emergencies\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C9orf9\",\n",
       "                    \"target\": \"Bronchiolitis\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"IFNB1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GSR\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CALCOCO1\",\n",
       "                    \"target\": \"Hypersensitivity, Immediate\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"treatment failure\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Asthma\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD209\",\n",
       "                    \"target\": \"CEACAM6\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"KDELR2\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Sepsis\",\n",
       "                    \"target\": \"Viremia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL7\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Fever\",\n",
       "                    \"target\": \"Thrombocytopenia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"CCL2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF3D\",\n",
       "                    \"target\": \"YARS\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADAP2\",\n",
       "                    \"target\": \"RASA1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Fever\",\n",
       "                    \"target\": \"Thrombocytopenia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTNNB1\",\n",
       "                    \"target\": \"LPL\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Emergencies\",\n",
       "                    \"target\": \"Pulmonary Eosinophilia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBATA\",\n",
       "                    \"target\": \"CD209\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIT3\",\n",
       "                    \"target\": \"IFIT2\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BSS\",\n",
       "                    \"target\": \"Weyers acrofacial dysostosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT3\",\n",
       "                    \"target\": \"SOCS3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"DPP4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Alzheimer Disease\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza in Birds\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"VDR\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"F2\",\n",
       "                    \"target\": \"Ginseng\",\n",
       "                    \"value\": \"Metabolism, pharmacokinetics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF7\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"T1\",\n",
       "                    \"target\": \"Distal Myopathies\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ENDOU\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LMOD1\",\n",
       "                    \"target\": \"CDKN2A\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COPS8\",\n",
       "                    \"target\": \"HMBS\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"PLP\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"GGT\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NOS2\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Communicable Diseases\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"Inflammation\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Neural Tube Defects\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR2\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cough\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"DUSP1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"RD\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"SAP\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"PRCP\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CALCOCO1\",\n",
       "                    \"target\": \"Food Hypersensitivity\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARG1\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"MX1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ST3GAL4\",\n",
       "                    \"target\": \"INS\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK3\",\n",
       "                    \"target\": \"TAK1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SPARC\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PCN\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"CNDP2\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR7\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A2\",\n",
       "                    \"target\": \"OSM\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Eczema\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Lupus Vulgaris\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"IFITM1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Omalizumab\",\n",
       "                    \"target\": \"Pruritus\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VDR\",\n",
       "                    \"target\": \"Angelman Syndrome\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"TP63\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNL1\",\n",
       "                    \"target\": \"FOXP3\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD44\",\n",
       "                    \"target\": \"DDX58\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK8\",\n",
       "                    \"target\": \"JUN\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSG1\",\n",
       "                    \"target\": \"IGKV5-2\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Retinoschisis\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pranlukast\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BCL6\",\n",
       "                    \"target\": \"WNT1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"INS\",\n",
       "                    \"target\": \"LEP\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERK\",\n",
       "                    \"target\": \"S6\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL18\",\n",
       "                    \"target\": \"CASP1\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF2AK2\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Porcine Reproductive and Respiratory Syndrome\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR3\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HR\",\n",
       "                    \"target\": \"IGKV6D-21\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX17\",\n",
       "                    \"target\": \"POLD3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KPNA2\",\n",
       "                    \"target\": \"Noonan Syndrome 5\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SFTPA1\",\n",
       "                    \"target\": \"EPCAM\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"Adrenocortical Carcinoma, Hereditary\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"TBATA\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSNK1A1\",\n",
       "                    \"target\": \"NSP2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Extensively Drug-Resistant Tuberculosis\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR5\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E3\",\n",
       "                    \"target\": \"RBMS3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLIN2\",\n",
       "                    \"target\": \"DSCAM-AS1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KPNA2\",\n",
       "                    \"target\": \"KPNA3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSME3\",\n",
       "                    \"target\": \"Dermatitis, Atopic\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MRPS18B\",\n",
       "                    \"target\": \"FIS1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GRB2\",\n",
       "                    \"target\": \"PCNA\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PECAM1\",\n",
       "                    \"target\": \"DEFB1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p19\",\n",
       "                    \"target\": \"p40\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UCN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"G3BP2\",\n",
       "                    \"target\": \"RBMS3\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"CNP\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FLOT2\",\n",
       "                    \"target\": \"BSG\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"target\": \"Tuberculosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EFNB3\",\n",
       "                    \"target\": \"EFNB2\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rimantadine\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PTX3\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B3GNT3\",\n",
       "                    \"target\": \"TRIM27\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FPGS\",\n",
       "                    \"target\": \"DECR1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Carcinoma, Non-Small-Cell Lung\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Acute Lung Injury\",\n",
       "                    \"target\": \"Fibrosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Precursor Cell Lymphoblastic Leukemia-Lymphoma\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDK9\",\n",
       "                    \"target\": \"ZC3HAV1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RTKN\",\n",
       "                    \"target\": \"IGKV5-2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Peanut Hypersensitivity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"aspartate aminotransferase\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ouabain\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Nephritis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p27\",\n",
       "                    \"target\": \"CDK4\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Colorectal Neoplasms\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS2\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Burkitt Lymphoma\",\n",
       "                    \"target\": \"Sarcoma, Kaposi\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RHOD\",\n",
       "                    \"target\": \"Neoplasms\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAP\",\n",
       "                    \"target\": \"PA\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Poikiloderma with Neutropenia\",\n",
       "                    \"target\": \"RD\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNFRSF4\",\n",
       "                    \"target\": \"IL4\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PBRM1\",\n",
       "                    \"target\": \"PA\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ginseng\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17A\",\n",
       "                    \"target\": \"TSLP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Nephritis\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Noonan Syndrome 6\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF7\",\n",
       "                    \"target\": \"C6\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATF6\",\n",
       "                    \"target\": \"EIF2AK3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSP90AA1\",\n",
       "                    \"target\": \"Food Hypersensitivity\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL23A\",\n",
       "                    \"target\": \"p40\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Mefloquine\",\n",
       "                    \"target\": \"inhibitory concentration 50\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DEFT1P\",\n",
       "                    \"target\": \"CBX8\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bleomycin\",\n",
       "                    \"target\": \"Anaphylaxis\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NR3C2\",\n",
       "                    \"target\": \"CCR7\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H2\",\n",
       "                    \"target\": \"Wheat Hypersensitivity\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LTA\",\n",
       "                    \"target\": \"SELPLG\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AADAT\",\n",
       "                    \"target\": \"CSRP2BP\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"ATP6AP1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GC\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Connective Tissue Diseases\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"POU5F1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGFBP3\",\n",
       "                    \"target\": \"MX1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"IL5\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OAS3\",\n",
       "                    \"target\": \"OAS1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SN\",\n",
       "                    \"target\": \"SI\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAL\",\n",
       "                    \"target\": \"CD40LG\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD38\",\n",
       "                    \"target\": \"FCER1G\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL7\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MCM8\",\n",
       "                    \"target\": \"Dysbiosis\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAS2\",\n",
       "                    \"target\": \"HAMP\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GLTSCR2\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": \"Mutations affect disease course\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV5-2\",\n",
       "                    \"target\": \"C4B\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"MERTK\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"POSTN\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HSPA2\",\n",
       "                    \"target\": \"HSPA8\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Tract Infections\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNL1\",\n",
       "                    \"target\": \"MX1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NOS2\",\n",
       "                    \"target\": \"BDNF\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV5-2\",\n",
       "                    \"target\": \"C4A\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPCR\",\n",
       "                    \"target\": \"TYRP1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TAP\",\n",
       "                    \"target\": \"Hepatitis A\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H3\",\n",
       "                    \"target\": \"H1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NOS2\",\n",
       "                    \"target\": \"VEGFA\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H3\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF3F\",\n",
       "                    \"target\": \"EGF\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KD\",\n",
       "                    \"target\": \"Mucocutaneous Lymph Node Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GABARAPL2\",\n",
       "                    \"target\": \"GABARAP\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBP\",\n",
       "                    \"target\": \"RPL4\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"MMP12\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GTF2H5\",\n",
       "                    \"target\": \"Myotonic Disorders\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD55\",\n",
       "                    \"target\": \"CD36\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PENK\",\n",
       "                    \"target\": \"RAPGEF5\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TAP\",\n",
       "                    \"target\": \"CYGB\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"FS\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DMD\",\n",
       "                    \"target\": \"BMD\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPL4\",\n",
       "                    \"target\": \"RPS15\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Diarrhea\",\n",
       "                    \"target\": \"Porcine Reproductive and Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRH1\",\n",
       "                    \"target\": \"Cystic Fibrosis\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PD1\",\n",
       "                    \"target\": \"CD274\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"IL1A\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"SLC3A2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AKT3\",\n",
       "                    \"target\": \"FCGR3A\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"diarrhea\",\n",
       "                    \"target\": \"PEA15\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT1\",\n",
       "                    \"target\": \"IFNAR1\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PON1\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Multiple Sclerosis\",\n",
       "                    \"target\": \"PLP\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"CEACAM5\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Egg Hypersensitivity\",\n",
       "                    \"target\": \"Esophagitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"Cystic Fibrosis\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Shock\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MMP9\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR2\",\n",
       "                    \"target\": \"CXCL1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"CCL2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CASP12\",\n",
       "                    \"target\": \"CALR\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR4\",\n",
       "                    \"target\": \"Emergencies\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"aspartate aminotransferase\",\n",
       "                    \"target\": \"alanine aminotransferase\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"Diabetes Insipidus, Neurogenic\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"MCD\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Primaquine\",\n",
       "                    \"target\": \"G6PD\",\n",
       "                    \"value\": \"Decreases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGF1\",\n",
       "                    \"target\": \"MALAT1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"target\": \"Recurrence\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERK\",\n",
       "                    \"target\": \"CD209\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GRAP2\",\n",
       "                    \"target\": \"Dermatitis\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYP2E1\",\n",
       "                    \"target\": \"CYP2D6\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HES5\",\n",
       "                    \"target\": \"ADSL\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDKN2B-AS1\",\n",
       "                    \"target\": \"OPA1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"APLN\",\n",
       "                    \"target\": \"PAH\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"IL5\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"DDX58\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"TF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR3\",\n",
       "                    \"target\": \"CALR\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"diarrhea\",\n",
       "                    \"target\": \"nausea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HLA-B\",\n",
       "                    \"target\": \"HLA-C\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Simvastatin\",\n",
       "                    \"target\": \"IRF3\",\n",
       "                    \"value\": \"Inhibits\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL20\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAM\",\n",
       "                    \"target\": \"KRT8\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ORF1\",\n",
       "                    \"target\": \"Primary hyperoxaluria type 1\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EBI3\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Myotonic Dystrophy\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"RELA\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E3\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD40\",\n",
       "                    \"target\": \"NOS2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"P14\",\n",
       "                    \"target\": \"PDIA6\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR1\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACTB\",\n",
       "                    \"target\": \"S9\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HDAC5\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Communicable Diseases\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"REN\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL18\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A20\",\n",
       "                    \"target\": \"IKBKG\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR7\",\n",
       "                    \"target\": \"MYD88\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Demyelinating Diseases\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"MME\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S3\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD69\",\n",
       "                    \"target\": \"CD38\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Pulmonary Eosinophilia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK3\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPS23\",\n",
       "                    \"target\": \"HMBS\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DICER1\",\n",
       "                    \"target\": \"SCPEP1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neutropenia\",\n",
       "                    \"target\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"IFITM3\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Harlequin type ichthyosis\",\n",
       "                    \"target\": \"SN\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RDX\",\n",
       "                    \"target\": \"ETV5\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Leukemia, Myelogenous, Chronic, BCR-ABL Positive\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FASN\",\n",
       "                    \"target\": \"HK2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATF6\",\n",
       "                    \"target\": \"CEBPA\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"Noonan Syndrome 5\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Necrosis\",\n",
       "                    \"target\": \"Neoplasms\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NP\",\n",
       "                    \"target\": \"PA\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SRC\",\n",
       "                    \"target\": \"Noonan syndrome 3\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"E1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ASAH1\",\n",
       "                    \"target\": \"DCX\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TH\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"Cryptogenic Organizing Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRPA1\",\n",
       "                    \"target\": \"TRPC4\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"Sveinsson Chorioretinal Atrophy\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A20\",\n",
       "                    \"target\": \"IGKV6D-21\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD36\",\n",
       "                    \"target\": \"CD163\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAFAH1B1\",\n",
       "                    \"target\": \"AKT3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL9\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK8\",\n",
       "                    \"target\": \"ERK\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Arthritis\",\n",
       "                    \"target\": \"Lupus Vulgaris\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"CSF3\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E3\",\n",
       "                    \"target\": \"MAVS\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"Bulimia Nervosa\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AFP\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SOX2\",\n",
       "                    \"target\": \"EMT\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD40\",\n",
       "                    \"target\": \"CD83\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"L2\",\n",
       "                    \"target\": \"IGKV1-16\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"IL-27\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Dermatitis, Contact\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Benign Paroxysmal Positional Vertigo\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ITGAM\",\n",
       "                    \"target\": \"IL13\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR8\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SIGLEC1\",\n",
       "                    \"target\": \"Neoplasms\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lymphopenia\",\n",
       "                    \"target\": \"autoimmunity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DCX\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Food Hypersensitivity\",\n",
       "                    \"target\": \"Wounds and Injuries\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARK2\",\n",
       "                    \"target\": \"DDX58\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Polycythemia Vera\",\n",
       "                    \"target\": \"CSF3\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A1\",\n",
       "                    \"target\": \"GC\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATF6\",\n",
       "                    \"target\": \"DDIT3\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H5\",\n",
       "                    \"target\": \"H3\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C6orf47\",\n",
       "                    \"target\": \"G10\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MSC\",\n",
       "                    \"target\": \"NT5C2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"DDX1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MRLN\",\n",
       "                    \"target\": \"IL4\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"IL-27\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B1\",\n",
       "                    \"target\": \"A2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLD2\",\n",
       "                    \"target\": \"PLD1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Congenital Abnormalities\",\n",
       "                    \"target\": \"ABCC4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARIH1\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRAF3\",\n",
       "                    \"target\": \"TAB3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSME3\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PDGFB\",\n",
       "                    \"target\": \"TBATA\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TKTL1\",\n",
       "                    \"target\": \"Osteoarthritis\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MX1\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"MAPK8\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MLP\",\n",
       "                    \"target\": \"TPR\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBP\",\n",
       "                    \"target\": \"ACTB\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"OAS3\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"ABCG2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CTSB\",\n",
       "                    \"target\": \"Niemann-Pick Disease, Type C\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BCL2\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSTA\",\n",
       "                    \"target\": \"HLA-B\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Eosinophilic Esophagitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MPZL2\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Shock, Septic\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VDR\",\n",
       "                    \"target\": \"NOS2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MME\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pulmonary Eosinophilia\",\n",
       "                    \"target\": \"FS\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KPNA1\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RNGTT\",\n",
       "                    \"target\": \"FHC\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p40\",\n",
       "                    \"target\": \"RELA\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SKAP2\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BIRC3\",\n",
       "                    \"target\": \"MYC\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"thrombocytopenia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DKK1\",\n",
       "                    \"target\": \"Arthritis, Rheumatoid\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NOS2\",\n",
       "                    \"target\": \"IRAK3\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"IL2\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"NEAT1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Food Hypersensitivity\",\n",
       "                    \"target\": \"Pulmonary Fibrosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Milk Hypersensitivity\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR2\",\n",
       "                    \"target\": \"CCL2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BMI1\",\n",
       "                    \"target\": \"NANOG\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RD\",\n",
       "                    \"target\": \"Oseltamivir\",\n",
       "                    \"value\": \"Metabolism, pharmacokinetics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MBP\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Lung Injury\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ROS1\",\n",
       "                    \"target\": \"Dermatitis\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL15\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TYK2\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL1A\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Emergencies\",\n",
       "                    \"target\": \"Lung Injury\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMBS\",\n",
       "                    \"target\": \"Neoplasms\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"HPSE\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17A\",\n",
       "                    \"target\": \"IL2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LAMP\",\n",
       "                    \"target\": \"EGFR\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR7\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"Sepsis\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"CYCSP39\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"inhibitory concentration 50\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"ADIPOQ\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ZBTB16\",\n",
       "                    \"target\": \"LGALS8\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"URI1\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"Noonan Syndrome 5\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OSM\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Vulgaris\",\n",
       "                    \"target\": \"Recurrence\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MIPOL1\",\n",
       "                    \"target\": \"FOXA1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT3\",\n",
       "                    \"target\": \"ATP5B\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEBPB\",\n",
       "                    \"target\": \"ZBTB16\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM1\",\n",
       "                    \"target\": \"Corneal Dystrophy, Fleck\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LPA\",\n",
       "                    \"target\": \"TMPRSS2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL13\",\n",
       "                    \"target\": \"GATA3\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"ATP12A\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MPO\",\n",
       "                    \"target\": \"ELANE\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Van der Woude syndrome\",\n",
       "                    \"target\": \"CXCR1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Aminophylline\",\n",
       "                    \"target\": \"NAA50\",\n",
       "                    \"value\": \"Inhibits\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALPK3\",\n",
       "                    \"target\": \"CALCOCO1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"CCR5\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17A\",\n",
       "                    \"target\": \"RELA\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"CCL26\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hepatitis C\",\n",
       "                    \"target\": \"Measles\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PTPRC\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GPR50\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"G3BP1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coronavirus Infections\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"QS-21\",\n",
       "                    \"target\": \"Herpes Zoster\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MRLN\",\n",
       "                    \"target\": \"Noonan Syndrome 2\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Aspergillosis\",\n",
       "                    \"target\": \"Shock\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B12\",\n",
       "                    \"target\": \"EVA1C\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRAF6\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"DSP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"USP18\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NOD2\",\n",
       "                    \"target\": \"DDX58\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"CPD\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDR2\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DUSP4\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PA\",\n",
       "                    \"target\": \"Van der Woude syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL5\",\n",
       "                    \"target\": \"IL4\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"nausea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Myeloproliferative Syndrome, Transient\",\n",
       "                    \"target\": \"EGF\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PTGDR\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"TMPRSS2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAH\",\n",
       "                    \"target\": \"PRKAA2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Inflammation\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"E1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Retinitis Pigmentosa\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NEDD4L\",\n",
       "                    \"target\": \"E3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cough\",\n",
       "                    \"target\": \"Shock\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERK\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"ADAM10\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Metabolic Syndrome X\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NFKB1\",\n",
       "                    \"target\": \"TRIM63\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H3\",\n",
       "                    \"target\": \"H1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"TNFRSF1A\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Thyroid cancer, papillary\",\n",
       "                    \"target\": \"DDX58\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Food Hypersensitivity\",\n",
       "                    \"target\": \"Respiratory Sounds\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Psoriasis\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"creatine kinase\",\n",
       "                    \"target\": \"alanine aminotransferase\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"TF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"NDUFB6\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GATA3\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PRH1\",\n",
       "                    \"target\": \"ventilation\",\n",
       "                    \"value\": \"Metabolism, pharmacokinetics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PEA15\",\n",
       "                    \"target\": \"African Swine Fever\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CPSF4\",\n",
       "                    \"target\": \"Noonan Syndrome\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BDNF\",\n",
       "                    \"target\": \"VEGFA\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"K12\",\n",
       "                    \"target\": \"IFIT1B\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Arthritis\",\n",
       "                    \"target\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"\\u00a0C-reactive protein\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDIT3\",\n",
       "                    \"target\": \"XBP1\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GREM1\",\n",
       "                    \"target\": \"CD36\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRGV9\",\n",
       "                    \"target\": \"KLRK1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"target\": \"Respiratory Tract Infections\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UPF1\",\n",
       "                    \"target\": \"Strudwick syndrome\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD55\",\n",
       "                    \"target\": \"Ataxia Telangiectasia\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"XIST\",\n",
       "                    \"target\": \"IGHD2-15\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Arthritis, Rheumatoid\",\n",
       "                    \"target\": \"Lupus Erythematosus, Systemic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H5\",\n",
       "                    \"target\": \"GPR50\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC17A5\",\n",
       "                    \"target\": \"RPLP0\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL17A\",\n",
       "                    \"target\": \"TSPAN7\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2RG\",\n",
       "                    \"target\": \"TXN\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"TJP1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DHDDS\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NDUFB6\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NLRX1\",\n",
       "                    \"target\": \"IFI16\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NOS2\",\n",
       "                    \"target\": \"TLR4\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TAC1\",\n",
       "                    \"target\": \"NGF\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL4\",\n",
       "                    \"target\": \"CCL20\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"UPP1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR2\",\n",
       "                    \"target\": \"TLR4\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VWF\",\n",
       "                    \"target\": \"von Willebrand Diseases\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR5\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FMD\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TLR2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DHX58\",\n",
       "                    \"target\": \"MAVS\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADRM1\",\n",
       "                    \"target\": \"SGTA\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Lupus Erythematosus, Systemic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NPEPPS\",\n",
       "                    \"target\": \"CNDP2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SERPINA1\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IF\",\n",
       "                    \"target\": \"PORCN\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCNB1\",\n",
       "                    \"target\": \"A2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Feline Infectious Peritonitis\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPS5\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"CLEC4G\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Emergencies\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ENPEP\",\n",
       "                    \"target\": \"PRCP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TSLP\",\n",
       "                    \"target\": \"Dermatitis, Atopic\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"nausea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRAF3\",\n",
       "                    \"target\": \"TBK1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATF6\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAH\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KCNE1\",\n",
       "                    \"target\": \"KCNQ1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NAC\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TSLP\",\n",
       "                    \"target\": \"Asthma\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SF1\",\n",
       "                    \"target\": \"HES5\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADCY10\",\n",
       "                    \"target\": \"Pelger-Huet Anomaly\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CFD\",\n",
       "                    \"target\": \"NFKB1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"Dengue\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DSCAM-AS1\",\n",
       "                    \"target\": \"PLEKHM3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PES1\",\n",
       "                    \"target\": \"PA\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Sarcoma, Kaposi\",\n",
       "                    \"target\": \"KS\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR\",\n",
       "                    \"target\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CPE\",\n",
       "                    \"target\": \"PEA15\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TCF4\",\n",
       "                    \"target\": \"EIF2AK3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"alanine aminotransferase\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Hypersensitivity\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"BST2\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"cough\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"KLF4\",\n",
       "                    \"target\": \"IL34\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"RELA\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Injury\",\n",
       "                    \"target\": \"Recurrence\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADAM10\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Sarcoidosis\",\n",
       "                    \"target\": \"alpha-1-Antitrypsin Deficiency, Autosomal Recessive\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hantavirus Pulmonary Syndrome\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT2\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"CX3CR1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT1\",\n",
       "                    \"target\": \"GAS\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pulmonary Aspergillosis\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"CEACAM1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"UNC93B1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GC\",\n",
       "                    \"target\": \"FOLH1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP12A\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"URI1\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"XIAP\",\n",
       "                    \"target\": \"BIRC2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL11\",\n",
       "                    \"target\": \"CSF2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"IGKV1-16\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MMRN1\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Promotes progression\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Omalizumab\",\n",
       "                    \"target\": \"Pigmentary Disorder, Reticulate, with Systemic Manifestations\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"Multiple Sclerosis\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL9\",\n",
       "                    \"target\": \"PYCARD\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF7\",\n",
       "                    \"target\": \"IRF3\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCR4\",\n",
       "                    \"target\": \"CXCL1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAT\",\n",
       "                    \"target\": \"CCL2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARTN\",\n",
       "                    \"target\": \"BDNF\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VHLL\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Fibrosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"IL10\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"aspartate aminotransferase\",\n",
       "                    \"target\": \"SLC17A5\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT2\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNF\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCR5\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Inflammation\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL-22\",\n",
       "                    \"target\": \"GZMB\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD9\",\n",
       "                    \"target\": \"CD81\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Dermatitis, Atopic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAA1\",\n",
       "                    \"target\": \"CRP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hamartoma Syndrome, Multiple\",\n",
       "                    \"target\": \"Osteonecrosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"cough\",\n",
       "                    \"target\": \"sputum\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"CCL5\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Aluminium\",\n",
       "                    \"target\": \"Airway Obstruction\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MIR7-3HG\",\n",
       "                    \"target\": \"Morphine\",\n",
       "                    \"value\": \"Metabolism, pharmacokinetics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Glatiramer Acetate\",\n",
       "                    \"target\": \"Airway Remodeling\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cough\",\n",
       "                    \"target\": \"Food Hypersensitivity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Cataract congenital Volkmann type\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RETN\",\n",
       "                    \"target\": \"ZBTB16\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"NFKB2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HMBS\",\n",
       "                    \"target\": \"S9\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL13\",\n",
       "                    \"target\": \"PYCARD\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ANPEP\",\n",
       "                    \"target\": \"Arthritis, Rheumatoid\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD81\",\n",
       "                    \"target\": \"Hepatitis\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DHCR7\",\n",
       "                    \"target\": \"DDX23\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GGT\",\n",
       "                    \"target\": \"SLC17A5\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEACAM5\",\n",
       "                    \"target\": \"DPP4\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"CXCR1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Eczema\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MALAT1\",\n",
       "                    \"target\": \"NFIL3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"IRF3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GBF1\",\n",
       "                    \"target\": \"GCA\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nitric Oxide\",\n",
       "                    \"target\": \"Anaphylaxis\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LCK\",\n",
       "                    \"target\": \"ATP5B\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNA1\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACE2\",\n",
       "                    \"target\": \"GCG\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Shock\",\n",
       "                    \"target\": \"VDR\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H1\",\n",
       "                    \"target\": \"H2\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AQP1\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"TP53\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Idiopathic Pulmonary Fibrosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"MAPK8\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF7\",\n",
       "                    \"target\": \"IRAK1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PCYT2\",\n",
       "                    \"target\": \"PRH1\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Food Hypersensitivity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRIM56\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ABCB11\",\n",
       "                    \"target\": \"NR1H4\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TRPV1\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"IL15\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GZMB\",\n",
       "                    \"target\": \"IL15\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERTK\",\n",
       "                    \"target\": \"CDR2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"H3\",\n",
       "                    \"target\": \"H2\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL5\",\n",
       "                    \"target\": \"CXCL10\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"CRP\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PLP2\",\n",
       "                    \"target\": \"TBK1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Glycine\",\n",
       "                    \"target\": \"Dermatitis\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"CTSL\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E1\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"YWHAZ\",\n",
       "                    \"target\": \"TBP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GC\",\n",
       "                    \"target\": \"G2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OAS1\",\n",
       "                    \"target\": \"ISG15\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pneumonia\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PEA15\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TLR3\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TERT\",\n",
       "                    \"target\": \"RTEL1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"HGF\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Van der Woude syndrome\",\n",
       "                    \"target\": \"KRT8\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFNL1\",\n",
       "                    \"target\": \"TLR2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CFH\",\n",
       "                    \"target\": \"GL\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL8\",\n",
       "                    \"target\": \"CCR7\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Netherton Syndrome\",\n",
       "                    \"target\": \"DUOXA1\",\n",
       "                    \"value\": \"Biomarkers (diagnostic)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"MAPK8\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TGFB1\",\n",
       "                    \"target\": \"GSDMB\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"XIAP\",\n",
       "                    \"target\": \"MYC\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Harlequin type ichthyosis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"Distal Myopathies\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C1\",\n",
       "                    \"target\": \"GSR\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pruritus\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"THBS1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"G2\",\n",
       "                    \"target\": \"IL13\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EIF1\",\n",
       "                    \"target\": \"GRAP2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCR2\",\n",
       "                    \"target\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RPLP0\",\n",
       "                    \"target\": \"C6orf47\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p28\",\n",
       "                    \"target\": \"SEC16A\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"STAT1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFIH1\",\n",
       "                    \"target\": \"DDX58\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Coronavirus Infections\",\n",
       "                    \"target\": \"Pneumonia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NEAT1\",\n",
       "                    \"target\": \"MALAT1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LAMP1\",\n",
       "                    \"target\": \"MAP1LC3A\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV1-16\",\n",
       "                    \"target\": \"L2\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBK1\",\n",
       "                    \"target\": \"TANK\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK8\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD81\",\n",
       "                    \"target\": \"MIR7-3HG\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF5\",\n",
       "                    \"target\": \"IRF8\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IRF3\",\n",
       "                    \"target\": \"Noonan Syndrome 5\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD4\",\n",
       "                    \"target\": \"Bjornstad syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ROS1\",\n",
       "                    \"target\": \"ERK\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"B2M\",\n",
       "                    \"target\": \"ACTB\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PAP\",\n",
       "                    \"target\": \"CSF2RA\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LTB\",\n",
       "                    \"target\": \"CTB\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BSG\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FS\",\n",
       "                    \"target\": \"Pranlukast\",\n",
       "                    \"value\": \"Metabolism, pharmacokinetics\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CEACAM5\",\n",
       "                    \"target\": \"CEACAM1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"TRPV1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAPN5\",\n",
       "                    \"target\": \"CBLB\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"OAS1\",\n",
       "                    \"target\": \"Thrombasthenia\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL5\",\n",
       "                    \"target\": \"CXCL1\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Metabolic Syndrome X\",\n",
       "                    \"target\": \"Pulmonary Disease, Chronic Obstructive\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Rhinitis, Allergic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"IL18\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERVW-1\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ITGA2\",\n",
       "                    \"target\": \"LAG3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"RPLP2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Coinfection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL11\",\n",
       "                    \"target\": \"BTC\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Prune Belly Syndrome\",\n",
       "                    \"target\": \"HR\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"CCL7\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Sprains and Strains\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NCR2\",\n",
       "                    \"target\": \"NCR1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"Colorectal Neoplasms\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SLC4A1\",\n",
       "                    \"target\": \"SPI1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SI\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A20\",\n",
       "                    \"target\": \"IL5\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GLS2\",\n",
       "                    \"target\": \"Thrombasthenia\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NFE2L1\",\n",
       "                    \"target\": \"AP-1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK3\",\n",
       "                    \"target\": \"TRAF6\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NTS\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"SFTPA1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SQSTM1\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATP6AP1\",\n",
       "                    \"target\": \"SLC4A1\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Eosinophilia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CYTIP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Amantadine\",\n",
       "                    \"target\": \"Peramivir\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CXCL10\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PSMD1\",\n",
       "                    \"target\": \"S2\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"B3GNT3\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV6-21\",\n",
       "                    \"target\": \"IL5\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"APC2\",\n",
       "                    \"target\": \"Aortic Aneurysm, Familial Abdominal 1\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ERK\",\n",
       "                    \"target\": \"E2\",\n",
       "                    \"value\": \"Enhances response\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HL\",\n",
       "                    \"target\": \"Hemochromatosis\",\n",
       "                    \"value\": \"Polymorphisms alter risk\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MSN\",\n",
       "                    \"target\": \"CD68\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AGO2\",\n",
       "                    \"target\": \"MEF2D\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RAPGEF3\",\n",
       "                    \"target\": \"Hypotrichosis simplex\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ROS1\",\n",
       "                    \"target\": \"PARP1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR4\",\n",
       "                    \"target\": \"FUT2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"CD274\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SFTPC\",\n",
       "                    \"target\": \"EREG\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FP\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"inhibitory concentration 50\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CAT\",\n",
       "                    \"target\": \"POMC\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C9orf9\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IFITM3\",\n",
       "                    \"target\": \"CD4\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"LFA-1\",\n",
       "                    \"target\": \"ITGB2\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SAS\",\n",
       "                    \"target\": \"TLR4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Myeloproliferative Syndrome, Transient\",\n",
       "                    \"target\": \"CLEC4G\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HIV Seropositivity\",\n",
       "                    \"target\": \"Tinea\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TMPRSS11E\",\n",
       "                    \"target\": \"TMPRSS2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CA1\",\n",
       "                    \"target\": \"CD274\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAL3ST1\",\n",
       "                    \"target\": \"Myotonic Disorders\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CSF2\",\n",
       "                    \"target\": \"IL17A\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PD150606\",\n",
       "                    \"target\": \"PIN1\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TMEM173\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CR2\",\n",
       "                    \"target\": \"CD14\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IKBKG\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ATR\",\n",
       "                    \"target\": \"ATM\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"C7orf49\",\n",
       "                    \"target\": \"NDUFB6\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TICAM1\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"JUN\",\n",
       "                    \"target\": \"GCNT2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"PLpro\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DDX58\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"target\": \"Sialic Acid Storage Disease\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL4\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Food Hypersensitivity\",\n",
       "                    \"target\": \"Shock, Septic\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Status Asthmaticus\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"STAT1\",\n",
       "                    \"target\": \"NFKB2\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MASP2\",\n",
       "                    \"target\": \"AGBL2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Obesity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BMP2\",\n",
       "                    \"target\": \"RUNX2\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Respiratory Sounds\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"SERPINA1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"G2\",\n",
       "                    \"target\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"Paramyxoviridae Infections\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GC\",\n",
       "                    \"target\": \"G2\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GCNT2\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pleural Effusion\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MERS\",\n",
       "                    \"target\": \"Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RELA\",\n",
       "                    \"target\": \"RELN\",\n",
       "                    \"value\": \"Signaling pathway\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Communicable Diseases\",\n",
       "                    \"target\": \"Guillain-Barre Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p28\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"VWF\",\n",
       "                    \"target\": \"VIM\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Eruptions\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"p38\",\n",
       "                    \"target\": \"MAPK1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"APLN\",\n",
       "                    \"target\": \"KNG1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Virus Diseases\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ISG20\",\n",
       "                    \"target\": \"diarrhea\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD86\",\n",
       "                    \"target\": \"CD40\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dengue\",\n",
       "                    \"target\": \"Noonan syndrome 3\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Communicable Diseases\",\n",
       "                    \"target\": \"Influenza, Human\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"FBL\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"3CLpro\",\n",
       "                    \"target\": \"TMEM121\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"A2\",\n",
       "                    \"target\": \"Diabetic Retinopathy\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"AP-1\",\n",
       "                    \"target\": \"DUSP1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ataxia Telangiectasia\",\n",
       "                    \"target\": \"ACE2\",\n",
       "                    \"value\": \"Overexpression in disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EREG\",\n",
       "                    \"target\": \"RPN1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GAPDH\",\n",
       "                    \"target\": \"ATP5B\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TLR3\",\n",
       "                    \"target\": \"IFIH1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"PRCP\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Rhinitis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SMN1\",\n",
       "                    \"target\": \"PRB1\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"JUN\",\n",
       "                    \"target\": \"p38\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ADM\",\n",
       "                    \"target\": \"PTX3\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Allopurinol\",\n",
       "                    \"target\": \"MITF\",\n",
       "                    \"value\": \"Affects expression/production (neutral)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Arthritis, Juvenile\",\n",
       "                    \"target\": \"Psoriasis\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL2\",\n",
       "                    \"target\": \"CXCL8\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Neutropenia\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL10\",\n",
       "                    \"target\": \"Cataract, Coppock-Like\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"Encephalitis, Japanese\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD8A\",\n",
       "                    \"target\": \"MOG\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL22\",\n",
       "                    \"target\": \"IL6\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"DPP4\",\n",
       "                    \"target\": \"CD69\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Prevents, suppresses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"target\": \"E4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNIP1\",\n",
       "                    \"target\": \"Hypersensitivity\",\n",
       "                    \"value\": \"Causal mutations\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD14\",\n",
       "                    \"target\": \"Polyps\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL2\",\n",
       "                    \"target\": \"CXCL9\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"HPRT1\",\n",
       "                    \"target\": \"B2M\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IGKV4-1\",\n",
       "                    \"target\": \"IGKV5-2\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Acquired Immunodeficiency Syndrome\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"BST2\",\n",
       "                    \"target\": \"IFNA1\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis\",\n",
       "                    \"target\": \"Obesity\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TNFRSF11B\",\n",
       "                    \"target\": \"TNFSF11\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ARG1\",\n",
       "                    \"target\": \"TSLP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALPK3\",\n",
       "                    \"target\": \"TLR4\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PEA15\",\n",
       "                    \"target\": \"Prune Belly Syndrome\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CD81\",\n",
       "                    \"target\": \"CBLB\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"S2\",\n",
       "                    \"target\": \"PSMD1\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"IL6\",\n",
       "                    \"target\": \"TLR7\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ACTB\",\n",
       "                    \"target\": \"UBB\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"NOS2\",\n",
       "                    \"target\": \"TNF\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"\\u00a0C-reactive protein\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"DPP4\",\n",
       "                    \"value\": \"Improper regulation linked to disease\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PARP9\",\n",
       "                    \"target\": \"CD8A\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"alanine \",\n",
       "                    \"target\": \"ERVW-1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MAPK1\",\n",
       "                    \"target\": \"MAP3K1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"GH1\",\n",
       "                    \"target\": \"PDI\",\n",
       "                    \"value\": \"Same protein or complex\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CCL24\",\n",
       "                    \"target\": \"IL13\",\n",
       "                    \"value\": \"Increases expression/production\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Urticaria\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"E2\",\n",
       "                    \"target\": \"E3\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"Severe Combined Immunodeficiency\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"EGFR\",\n",
       "                    \"target\": \"LAMP\",\n",
       "                    \"value\": \"Activates, stimulates\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"RD\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Distress Syndrome, Adult\",\n",
       "                    \"target\": \"Severe Acute Respiratory Syndrome\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"MERS\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CDR2\",\n",
       "                    \"target\": \"Peanut Hypersensitivity\",\n",
       "                    \"value\": \"Possible therapeutic effect\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PORCN\",\n",
       "                    \"target\": \"NAC\",\n",
       "                    \"value\": \"Production by cell population\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"CRP\",\n",
       "                    \"target\": \"KD\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Infection\",\n",
       "                    \"value\": null\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"TBX3\",\n",
       "                    \"target\": \"POU5F1\",\n",
       "                    \"value\": \"Binding, ligand (esp. receptors)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ALB\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Drug targets\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"MSN\",\n",
       "                    \"target\": \"IQGAP1\",\n",
       "                    \"value\": \"Regulation\"\n",
       "                }\n",
       "            ]\n",
       "        }\n",
       "    ],\n",
       "    \"legend\": [\n",
       "        {\n",
       "            \"data\": [\n",
       "                \"Disease\",\n",
       "                \"Gene\",\n",
       "                \"Chemical\"\n",
       "            ],\n",
       "            \"selected\": {\n",
       "                \"Disease\": true,\n",
       "                \"Gene\": true,\n",
       "                \"Chemical\": true\n",
       "            },\n",
       "            \"show\": true,\n",
       "            \"left\": \"2%\",\n",
       "            \"top\": \"40%\",\n",
       "            \"orient\": \"vertical\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10,\n",
       "            \"itemWidth\": 25,\n",
       "            \"itemHeight\": 14,\n",
       "            \"icon\": \"circle\"\n",
       "        }\n",
       "    ],\n",
       "    \"tooltip\": {\n",
       "        \"show\": true,\n",
       "        \"trigger\": \"item\",\n",
       "        \"triggerOn\": \"mousemove|click\",\n",
       "        \"axisPointer\": {\n",
       "            \"type\": \"line\"\n",
       "        },\n",
       "        \"textStyle\": {\n",
       "            \"fontSize\": 14\n",
       "        },\n",
       "        \"borderWidth\": 0\n",
       "    },\n",
       "    \"title\": [\n",
       "        {\n",
       "            \"text\": \"subsample of COVID-19 knowledge graph\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10\n",
       "        }\n",
       "    ]\n",
       "};\n",
       "                chart_541587454d0f42beb78a1b0e0357264b.setOption(option_541587454d0f42beb78a1b0e0357264b);\n",
       "        });\n",
       "    </script>\n"
      ],
      "text/plain": [
       "<pyecharts.render.display.HTML at 0x7f361fa64c90>"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# subsample of Combined knowledge graph\n",
    "g = Build_graph(relation_df.sample(1000),relation=True,repulsion=15,title='subsample of COVID-19 knowledge graph',labelShow=False)\n",
    "g"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "# Knowledge graph between pair of entities(Covid specific and Non specific also)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "ch1='Chemical'\n",
    "ch2='Disease'\n",
    "ch3=2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<script>\n",
       "    require.config({\n",
       "        paths: {\n",
       "            'echarts':'https://assets.pyecharts.org/assets/echarts.min'\n",
       "        }\n",
       "    });\n",
       "</script>\n",
       "\n",
       "        <div id=\"545bf5893037472980c0fc657b4762a9\" style=\"width:900px; height:500px;\"></div>\n",
       "\n",
       "<script>\n",
       "        require(['echarts'], function(echarts) {\n",
       "                var chart_545bf5893037472980c0fc657b4762a9 = echarts.init(\n",
       "                    document.getElementById('545bf5893037472980c0fc657b4762a9'), 'white', {renderer: 'canvas'});\n",
       "                var option_545bf5893037472980c0fc657b4762a9 = {\n",
       "    \"animation\": true,\n",
       "    \"animationThreshold\": 2000,\n",
       "    \"animationDuration\": 1000,\n",
       "    \"animationEasing\": \"cubicOut\",\n",
       "    \"animationDelay\": 0,\n",
       "    \"animationDurationUpdate\": 300,\n",
       "    \"animationEasingUpdate\": \"cubicOut\",\n",
       "    \"animationDelayUpdate\": 0,\n",
       "    \"color\": [\n",
       "        \"#c23531\",\n",
       "        \"#2f4554\",\n",
       "        \"#61a0a8\",\n",
       "        \"#d48265\",\n",
       "        \"#749f83\",\n",
       "        \"#ca8622\",\n",
       "        \"#bda29a\",\n",
       "        \"#6e7074\",\n",
       "        \"#546570\",\n",
       "        \"#c4ccd3\",\n",
       "        \"#f05b72\",\n",
       "        \"#ef5b9c\",\n",
       "        \"#f47920\",\n",
       "        \"#905a3d\",\n",
       "        \"#fab27b\",\n",
       "        \"#2a5caa\",\n",
       "        \"#444693\",\n",
       "        \"#726930\",\n",
       "        \"#b2d235\",\n",
       "        \"#6d8346\",\n",
       "        \"#ac6767\",\n",
       "        \"#1d953f\",\n",
       "        \"#6950a1\",\n",
       "        \"#918597\"\n",
       "    ],\n",
       "    \"series\": [\n",
       "        {\n",
       "            \"type\": \"graph\",\n",
       "            \"layout\": \"force\",\n",
       "            \"symbolSize\": 10,\n",
       "            \"circular\": {\n",
       "                \"rotateLabel\": false\n",
       "            },\n",
       "            \"force\": {\n",
       "                \"repulsion\": 15,\n",
       "                \"edgeLength\": 50,\n",
       "                \"gravity\": 0.2\n",
       "            },\n",
       "            \"label\": {\n",
       "                \"show\": true,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"lineStyle\": {\n",
       "                \"show\": true,\n",
       "                \"width\": 1,\n",
       "                \"opacity\": 1,\n",
       "                \"curveness\": 0,\n",
       "                \"type\": \"solid\"\n",
       "            },\n",
       "            \"roam\": true,\n",
       "            \"draggable\": false,\n",
       "            \"focusNodeAdjacency\": true,\n",
       "            \"data\": [\n",
       "                {\n",
       "                    \"name\": \"Chloroquine\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \" oxygen therapy \",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COVID-19\",\n",
       "                    \"symbolSize\": 43.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"PX-12\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Zinc\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"ventilation\",\n",
       "                    \"symbolSize\": 34.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Doxycycline\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Toluene\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"SSYA10-001\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"glucocorticoids\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Vitamin C\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"remdesivir\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Daptomycin\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lopinavir/Ritonavir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Amantadine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Oseltamivir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lopinavir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nitazoxanide\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"oseltamivir\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"membrane oxygenation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"mesenchymal stem cells\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Ganciclovir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hydroxychloroquine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hexamethylene amiloride\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                }\n",
       "            ],\n",
       "            \"categories\": [\n",
       "                {\n",
       "                    \"name\": \"Disease\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#FF7F50\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gene\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#48D1CC\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chemical\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#B3EE3A\"\n",
       "                        }\n",
       "                    }\n",
       "                }\n",
       "            ],\n",
       "            \"edgeLabel\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"edgeSymbol\": [\n",
       "                null,\n",
       "                null\n",
       "            ],\n",
       "            \"edgeSymbolSize\": 10,\n",
       "            \"links\": [\n",
       "                {\n",
       "                    \"source\": \"Hydroxychloroquine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"PX-12\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Amantadine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Alleviates, reduces\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Daptomycin\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Ganciclovir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Chloroquine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"glucocorticoids\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Chloroquine\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"membrane oxygenation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lopinavir/Ritonavir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"glucocorticoids\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \" oxygen therapy \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSYA10-001\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"remdesivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"mesenchymal stem cells\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \" oxygen therapy \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"glucocorticoids\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Treatment/therapy (incl. investigatory)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Side effect/adverse event\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Prevents, suppresses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Prevents, suppresses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Vitamin C\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Prevents, suppresses\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nitazoxanide\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nitazoxanide\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"SSYA10-001\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Oseltamivir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Inhibits cell growth (esp. cancers)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lopinavir\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \" oxygen therapy \",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hexamethylene amiloride\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Zinc\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"ventilation\",\n",
       "                    \"target\": \"COVID-19\",\n",
       "                    \"value\": \"Role in pathogenesis\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"remdesivir\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chloroquine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                }\n",
       "            ]\n",
       "        }\n",
       "    ],\n",
       "    \"legend\": [\n",
       "        {\n",
       "            \"data\": [\n",
       "                \"Disease\",\n",
       "                \"Gene\",\n",
       "                \"Chemical\"\n",
       "            ],\n",
       "            \"selected\": {\n",
       "                \"Disease\": true,\n",
       "                \"Gene\": true,\n",
       "                \"Chemical\": true\n",
       "            },\n",
       "            \"show\": true,\n",
       "            \"left\": \"2%\",\n",
       "            \"top\": \"40%\",\n",
       "            \"orient\": \"vertical\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10,\n",
       "            \"itemWidth\": 25,\n",
       "            \"itemHeight\": 14,\n",
       "            \"icon\": \"circle\"\n",
       "        }\n",
       "    ],\n",
       "    \"tooltip\": {\n",
       "        \"show\": true,\n",
       "        \"trigger\": \"item\",\n",
       "        \"triggerOn\": \"mousemove|click\",\n",
       "        \"axisPointer\": {\n",
       "            \"type\": \"line\"\n",
       "        },\n",
       "        \"textStyle\": {\n",
       "            \"fontSize\": 14\n",
       "        },\n",
       "        \"borderWidth\": 0\n",
       "    },\n",
       "    \"title\": [\n",
       "        {\n",
       "            \"text\": \"Covid19 Specific_Chemical_Disease_knowledge graph\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10\n",
       "        }\n",
       "    ]\n",
       "};\n",
       "                chart_545bf5893037472980c0fc657b4762a9.setOption(option_545bf5893037472980c0fc657b4762a9);\n",
       "        });\n",
       "    </script>\n"
      ],
      "text/plain": [
       "<pyecharts.render.display.HTML at 0x7f3624fa8c90>"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# ch1=input('enter choice 1 : Chemical,Gene,Disease = You selected ')\n",
    "# ch2=input('enter choice 2 : Chemical,Gene,Disease = You selected ')\n",
    "# ch3=int(input('enter 2-Covid19 related OR  1- Not specific to Covid  = You selected '))\n",
    "if ch3==1:\n",
    "    temp=relation_df.loc[((relation_df['start_entity_type']==ch1)&(relation_df['end_entity_type']==ch2))|((relation_df['start_entity_type']==ch2)&(relation_df['end_entity_type']==ch1))]#\n",
    "    temp = temp[cols]\n",
    "    g = Build_graph(temp,relation=True,repulsion=15,title= ch1+'_'+ch2+'_knowledge graph',labelShow=True)\n",
    "    temp.to_csv(ch1+'_'+ch2+'_knowledge graph.csv')\n",
    "else:\n",
    "    temp=relation_df.loc[((relation_df['start_entity_type']==ch1)&(relation_df['end_entity_type']==ch2))|((relation_df['start_entity_type']==ch2)&(relation_df['end_entity_type']==ch1))]#\n",
    "    temp=temp.loc[(relation_df['start_entity']=='COVID-19')|(relation_df['end_entity']=='COVID-19')]\n",
    "    temp = temp[cols]\n",
    "    g = Build_graph(temp,relation=True,repulsion=15,title= 'Covid19 Specific_'+ch1+'_'+ch2+'_knowledge graph',labelShow=True)\n",
    "    temp.to_csv('Covid19 Specific_'+ch1+'_'+ch2+'_knowledge graph.csv')\n",
    "g"
   ]
  },
  {
   "cell_type": "markdown",
   "execution_count": null,
   "metadata": {},
   "source": [
    "# Search based on desired relationships"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pred</th>\n",
       "      <th>label</th>\n",
       "      <th>theme</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>C</td>\n",
       "      <td>0</td>\n",
       "      <td>Inhibits cell growth (esp. cancers)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>J</td>\n",
       "      <td>1</td>\n",
       "      <td>Role in pathogenesis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Mp</td>\n",
       "      <td>2</td>\n",
       "      <td>Biomarkers (progression)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Pa</td>\n",
       "      <td>3</td>\n",
       "      <td>Alleviates, reduces</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Pr</td>\n",
       "      <td>4</td>\n",
       "      <td>Prevents, suppresses</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Sa</td>\n",
       "      <td>5</td>\n",
       "      <td>Side effect/adverse event</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>T</td>\n",
       "      <td>6</td>\n",
       "      <td>Treatment/therapy (incl. investigatory)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>A+</td>\n",
       "      <td>0</td>\n",
       "      <td>Agonism, activation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>A-</td>\n",
       "      <td>1</td>\n",
       "      <td>Antagonism, blocking</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>B</td>\n",
       "      <td>2</td>\n",
       "      <td>Binding, ligand (esp. receptors)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>E</td>\n",
       "      <td>3</td>\n",
       "      <td>Affects expression/production (neutral)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>E-</td>\n",
       "      <td>4</td>\n",
       "      <td>Decreases expression/production</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>K</td>\n",
       "      <td>5</td>\n",
       "      <td>Metabolism, pharmacokinetics</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>N</td>\n",
       "      <td>6</td>\n",
       "      <td>Inhibits</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>O</td>\n",
       "      <td>7</td>\n",
       "      <td>Transport, channels</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Z</td>\n",
       "      <td>8</td>\n",
       "      <td>Enzyme activity</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>D</td>\n",
       "      <td>0</td>\n",
       "      <td>Drug targets</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>G</td>\n",
       "      <td>1</td>\n",
       "      <td>Promotes progression</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>J</td>\n",
       "      <td>2</td>\n",
       "      <td>Role in pathogenesis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>L</td>\n",
       "      <td>3</td>\n",
       "      <td>Improper regulation linked to disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Md</td>\n",
       "      <td>4</td>\n",
       "      <td>Biomarkers (diagnostic)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Te</td>\n",
       "      <td>5</td>\n",
       "      <td>Possible therapeutic effect</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>U</td>\n",
       "      <td>6</td>\n",
       "      <td>Causal mutations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Ud</td>\n",
       "      <td>7</td>\n",
       "      <td>Mutations affect disease course</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>X</td>\n",
       "      <td>8</td>\n",
       "      <td>Overexpression in disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Y</td>\n",
       "      <td>9</td>\n",
       "      <td>Polymorphisms alter risk</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>B</td>\n",
       "      <td>0</td>\n",
       "      <td>Binding, ligand (esp. receptors)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>E</td>\n",
       "      <td>1</td>\n",
       "      <td>Affects expression/production (neutral)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>E+</td>\n",
       "      <td>2</td>\n",
       "      <td>Increases expression/production</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>H</td>\n",
       "      <td>3</td>\n",
       "      <td>Same protein or complex</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>I</td>\n",
       "      <td>4</td>\n",
       "      <td>Signaling pathway</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Q</td>\n",
       "      <td>5</td>\n",
       "      <td>Production by cell population</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Rg</td>\n",
       "      <td>6</td>\n",
       "      <td>Regulation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>V+</td>\n",
       "      <td>7</td>\n",
       "      <td>Activates, stimulates</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>W</td>\n",
       "      <td>8</td>\n",
       "      <td>Enhances response</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  pred  label                                    theme\n",
       "0    C      0      Inhibits cell growth (esp. cancers)\n",
       "1    J      1                     Role in pathogenesis\n",
       "2   Mp      2                 Biomarkers (progression)\n",
       "3   Pa      3                      Alleviates, reduces\n",
       "4   Pr      4                     Prevents, suppresses\n",
       "5   Sa      5                Side effect/adverse event\n",
       "6    T      6  Treatment/therapy (incl. investigatory)\n",
       "0   A+      0                      Agonism, activation\n",
       "1   A-      1                     Antagonism, blocking\n",
       "2    B      2         Binding, ligand (esp. receptors)\n",
       "3    E      3  Affects expression/production (neutral)\n",
       "4   E-      4          Decreases expression/production\n",
       "5    K      5             Metabolism, pharmacokinetics\n",
       "6    N      6                                 Inhibits\n",
       "7    O      7                      Transport, channels\n",
       "8    Z      8                          Enzyme activity\n",
       "0    D      0                             Drug targets\n",
       "1    G      1                     Promotes progression\n",
       "2    J      2                     Role in pathogenesis\n",
       "3    L      3    Improper regulation linked to disease\n",
       "4   Md      4                  Biomarkers (diagnostic)\n",
       "5   Te      5              Possible therapeutic effect\n",
       "6    U      6                         Causal mutations\n",
       "7   Ud      7          Mutations affect disease course\n",
       "8    X      8                Overexpression in disease\n",
       "9    Y      9                 Polymorphisms alter risk\n",
       "0    B      0         Binding, ligand (esp. receptors)\n",
       "1    E      1  Affects expression/production (neutral)\n",
       "2   E+      2          Increases expression/production\n",
       "3    H      3                  Same protein or complex\n",
       "4    I      4                        Signaling pathway\n",
       "5    Q      5            Production by cell population\n",
       "6   Rg      6                               Regulation\n",
       "7   V+      7                    Activates, stimulates\n",
       "8    W      8                        Enhances response"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "labels_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<script>\n",
       "    require.config({\n",
       "        paths: {\n",
       "            'echarts':'https://assets.pyecharts.org/assets/echarts.min'\n",
       "        }\n",
       "    });\n",
       "</script>\n",
       "\n",
       "        <div id=\"f652bec4e6ee46ff81cb333dd9af52dd\" style=\"width:900px; height:500px;\"></div>\n",
       "\n",
       "<script>\n",
       "        require(['echarts'], function(echarts) {\n",
       "                var chart_f652bec4e6ee46ff81cb333dd9af52dd = echarts.init(\n",
       "                    document.getElementById('f652bec4e6ee46ff81cb333dd9af52dd'), 'white', {renderer: 'canvas'});\n",
       "                var option_f652bec4e6ee46ff81cb333dd9af52dd = {\n",
       "    \"animation\": true,\n",
       "    \"animationThreshold\": 2000,\n",
       "    \"animationDuration\": 1000,\n",
       "    \"animationEasing\": \"cubicOut\",\n",
       "    \"animationDelay\": 0,\n",
       "    \"animationDurationUpdate\": 300,\n",
       "    \"animationEasingUpdate\": \"cubicOut\",\n",
       "    \"animationDelayUpdate\": 0,\n",
       "    \"color\": [\n",
       "        \"#c23531\",\n",
       "        \"#2f4554\",\n",
       "        \"#61a0a8\",\n",
       "        \"#d48265\",\n",
       "        \"#749f83\",\n",
       "        \"#ca8622\",\n",
       "        \"#bda29a\",\n",
       "        \"#6e7074\",\n",
       "        \"#546570\",\n",
       "        \"#c4ccd3\",\n",
       "        \"#f05b72\",\n",
       "        \"#ef5b9c\",\n",
       "        \"#f47920\",\n",
       "        \"#905a3d\",\n",
       "        \"#fab27b\",\n",
       "        \"#2a5caa\",\n",
       "        \"#444693\",\n",
       "        \"#726930\",\n",
       "        \"#b2d235\",\n",
       "        \"#6d8346\",\n",
       "        \"#ac6767\",\n",
       "        \"#1d953f\",\n",
       "        \"#6950a1\",\n",
       "        \"#918597\"\n",
       "    ],\n",
       "    \"series\": [\n",
       "        {\n",
       "            \"type\": \"graph\",\n",
       "            \"layout\": \"force\",\n",
       "            \"symbolSize\": 10,\n",
       "            \"circular\": {\n",
       "                \"rotateLabel\": false\n",
       "            },\n",
       "            \"force\": {\n",
       "                \"repulsion\": 15,\n",
       "                \"edgeLength\": 50,\n",
       "                \"gravity\": 0.2\n",
       "            },\n",
       "            \"label\": {\n",
       "                \"show\": true,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"lineStyle\": {\n",
       "                \"show\": true,\n",
       "                \"width\": 1,\n",
       "                \"opacity\": 1,\n",
       "                \"curveness\": 0,\n",
       "                \"type\": \"solid\"\n",
       "            },\n",
       "            \"roam\": true,\n",
       "            \"draggable\": false,\n",
       "            \"focusNodeAdjacency\": true,\n",
       "            \"data\": [\n",
       "                {\n",
       "                    \"name\": \"Infection\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chloroquine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pulmonary Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nephritis\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Budesonide\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Shock, Septic\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Anaphylaxis\",\n",
       "                    \"symbolSize\": 23.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Doxycycline\",\n",
       "                    \"symbolSize\": 26.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Toluene\",\n",
       "                    \"symbolSize\": 26.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Tract Infections\",\n",
       "                    \"symbolSize\": 17.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Inflammation\",\n",
       "                    \"symbolSize\": 20.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Methotrexate\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Aminophylline\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Emergencies\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Omalizumab\",\n",
       "                    \"symbolSize\": 35.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypersensitivity, Immediate\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis, Atopic\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"remdesivir\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Bronchiolitis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Syndrome\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nasal Polyps\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Fibrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis, Contact\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Eosinophilia\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cyclosporine\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Intravenous Immunoglobulin\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Sleep Wake Disorders\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Acitretin\",\n",
       "                    \"symbolSize\": 32.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypohidrosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Psoriasis\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Obesity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gastroenteritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nitric Oxide\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Aspergillosis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Urticaria\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Food Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Hypersensitivity\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Montelukast\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Thymoma\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Vulgaris\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Calcium\",\n",
       "                    \"symbolSize\": 35.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Polyps\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pneumonia\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neoplasms\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Respiratory Sounds\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis, Allergic\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Exanthema\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Mannitol\",\n",
       "                    \"symbolSize\": 28.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Airway Obstruction\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Cough\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Amantadine\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Shock\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Skin Diseases\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lung Diseases, Interstitial\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Neutropenia\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Nephritis, Interstitial\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Molluscum Contagiosum\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Influenza, Human\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Status Asthmaticus\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"COVID-19\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Overdose\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Peanut Hypersensitivity\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Eczema\",\n",
       "                    \"symbolSize\": 21.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Recurrence\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lupus Nephritis\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Asthma\",\n",
       "                    \"symbolSize\": 25.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Enteritis\",\n",
       "                    \"symbolSize\": 16.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"BV2\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Methacholine\",\n",
       "                    \"symbolSize\": 19.0,\n",
       "                    \"category\": 2\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"sputum\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Dermatitis\",\n",
       "                    \"symbolSize\": 27.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Lung Neoplasms\",\n",
       "                    \"symbolSize\": 13.0,\n",
       "                    \"category\": 0\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Pruritus\",\n",
       "                    \"symbolSize\": 10,\n",
       "                    \"category\": 0\n",
       "                }\n",
       "            ],\n",
       "            \"categories\": [\n",
       "                {\n",
       "                    \"name\": \"Disease\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#FF7F50\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Gene\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#48D1CC\"\n",
       "                        }\n",
       "                    }\n",
       "                },\n",
       "                {\n",
       "                    \"name\": \"Chemical\",\n",
       "                    \"itemStyle\": {\n",
       "                        \"normal\": {\n",
       "                            \"color\": \"#B3EE3A\"\n",
       "                        }\n",
       "                    }\n",
       "                }\n",
       "            ],\n",
       "            \"edgeLabel\": {\n",
       "                \"show\": false,\n",
       "                \"position\": \"top\",\n",
       "                \"margin\": 8\n",
       "            },\n",
       "            \"edgeSymbol\": [\n",
       "                null,\n",
       "                null\n",
       "            ],\n",
       "            \"edgeSymbolSize\": 10,\n",
       "            \"links\": [\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Amantadine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"remdesivir\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nasal Polyps\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Peanut Hypersensitivity\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pneumonia\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Polyps\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Sleep Wake Disorders\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"sputum\",\n",
       "                    \"target\": \"Doxycycline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nasal Polyps\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Peanut Hypersensitivity\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pneumonia\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Polyps\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic, Seasonal\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Sleep Wake Disorders\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"sputum\",\n",
       "                    \"target\": \"Toluene\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Budesonide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Budesonide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Budesonide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Budesonide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Budesonide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pruritus\",\n",
       "                    \"target\": \"Budesonide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Neoplasms\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neoplasms\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Tract Infections\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Cyclosporine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Neoplasms\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neoplasms\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Tract Infections\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Nitric Oxide\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Neoplasms\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neoplasms\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Tract Infections\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Montelukast\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Exanthema\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Methacholine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Methacholine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Methacholine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Exanthema\",\n",
       "                    \"target\": \"Methacholine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Methacholine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Methacholine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Fibrosis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Gastroenteritis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Overdose\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pulmonary Fibrosis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Recurrence\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Mannitol\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Contact\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Enteritis\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Diseases, Interstitial\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis, Interstitial\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neutropenia\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pneumonia\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Psoriasis\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Skin Diseases\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Syndrome\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Thymoma\",\n",
       "                    \"target\": \"Intravenous Immunoglobulin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Contact\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Enteritis\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Diseases, Interstitial\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis, Interstitial\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neutropenia\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pneumonia\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Psoriasis\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Skin Diseases\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Syndrome\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Thymoma\",\n",
       "                    \"target\": \"Acitretin\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Contact\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Enteritis\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Diseases, Interstitial\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis, Interstitial\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neutropenia\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pneumonia\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Psoriasis\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Skin Diseases\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Syndrome\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Thymoma\",\n",
       "                    \"target\": \"Methotrexate\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Contact\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug Hypersensitivity Syndrome\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Drug-Related Side Effects and Adverse Reactions\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eczema\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Enteritis\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Eosinophilia\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Immunologic Deficiency Syndromes\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lung Diseases, Interstitial\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis, Interstitial\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Neutropenia\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Pneumonia\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Psoriasis\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Skin Diseases\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Stevens-Johnson Syndrome\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Syndrome\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Thymoma\",\n",
       "                    \"target\": \"Aminophylline\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Airway Obstruction\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Aspergillosis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cough\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Emergencies\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Food Hypersensitivity\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity, Immediate\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypohidrosis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Nephritis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Vulgaris\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Molluscum Contagiosum\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nasal Polyps\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Obesity\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Polyps\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Recurrence\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Tract Infections\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Shock\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Shock, Septic\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Status Asthmaticus\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Syndrome\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Urticaria\",\n",
       "                    \"target\": \"Omalizumab\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Airway Obstruction\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Anaphylaxis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Aspergillosis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Asthma\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Bronchiolitis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cough\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Dermatitis, Atopic\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Emergencies\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Food Hypersensitivity\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypersensitivity, Immediate\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Hypohidrosis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Infection\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Inflammation\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Influenza, Human\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Nephritis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Lupus Vulgaris\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Molluscum Contagiosum\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nasal Polyps\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Nephritis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Obesity\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Polyps\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Recurrence\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Sounds\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Respiratory Tract Infections\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Rhinitis, Allergic\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Shock\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Shock, Septic\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Status Asthmaticus\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Syndrome\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Urticaria\",\n",
       "                    \"target\": \"Calcium\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"Cleft Palate, Isolated, And Mental Retardation\",\n",
       "                    \"target\": \"BV2\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                },\n",
       "                {\n",
       "                    \"source\": \"COVID-19\",\n",
       "                    \"target\": \"Chloroquine\",\n",
       "                    \"value\": \"Biomarkers (progression)\"\n",
       "                }\n",
       "            ]\n",
       "        }\n",
       "    ],\n",
       "    \"legend\": [\n",
       "        {\n",
       "            \"data\": [\n",
       "                \"Disease\",\n",
       "                \"Gene\",\n",
       "                \"Chemical\"\n",
       "            ],\n",
       "            \"selected\": {\n",
       "                \"Disease\": true,\n",
       "                \"Gene\": true,\n",
       "                \"Chemical\": true\n",
       "            },\n",
       "            \"show\": true,\n",
       "            \"left\": \"2%\",\n",
       "            \"top\": \"40%\",\n",
       "            \"orient\": \"vertical\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10,\n",
       "            \"itemWidth\": 25,\n",
       "            \"itemHeight\": 14,\n",
       "            \"icon\": \"circle\"\n",
       "        }\n",
       "    ],\n",
       "    \"tooltip\": {\n",
       "        \"show\": true,\n",
       "        \"trigger\": \"item\",\n",
       "        \"triggerOn\": \"mousemove|click\",\n",
       "        \"axisPointer\": {\n",
       "            \"type\": \"line\"\n",
       "        },\n",
       "        \"textStyle\": {\n",
       "            \"fontSize\": 14\n",
       "        },\n",
       "        \"borderWidth\": 0\n",
       "    },\n",
       "    \"title\": [\n",
       "        {\n",
       "            \"text\": \"Biomarkers (progression)_knowledge graph\",\n",
       "            \"padding\": 5,\n",
       "            \"itemGap\": 10\n",
       "        }\n",
       "    ]\n",
       "};\n",
       "                chart_f652bec4e6ee46ff81cb333dd9af52dd.setOption(option_f652bec4e6ee46ff81cb333dd9af52dd);\n",
       "        });\n",
       "    </script>\n"
      ],
      "text/plain": [
       "<pyecharts.render.display.HTML at 0x7f3624f4c950>"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "ch5='Biomarkers (progression)'\n",
    "# ch5=input('enter desired relationship')\n",
    "temp=relation_df.loc[(relation_df['theme']==ch5)]#\n",
    "if temp is None:\n",
    "    print('yes')\n",
    "temp = temp[cols]\n",
    "ch5=re.sub(r'/', '_', ch5)\n",
    "g = Build_graph(temp,relation=True,repulsion=15,title=ch5+'_knowledge graph',labelShow=True)\n",
    "temp.to_csv(ch5+'_knowledge graph.csv')\n",
    "g"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
